world health organization used first time term novel coronavirus reference coronavirus affected lower respiratory tract patients pneumonia wuhan china december <NUMBER> <NUMBER> stated official name novel coronavirus covid<NUMBER> coronavirus disease <NUMBER> reference name virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> considers essential fight spread sarscov<NUMBER> increase scientific knowledge disease develop test new diagnostic methods virus order carry screenings population fact countries made extensive use diagnostic tests entire population regardless presence symptoms achieved drastic drop infection spread infection date tool officially recognized italian ministry health diagnosis sarscov<NUMBER> virus infection real time rtpcr method samples obtained bronchoscopy blood feces diagnostic method limitations related cost reagents time required complete analysis along unacceptably large number false negatives <NUMBER> therefore urgent need develop accurate rapid inexpensive methods combined epidemiological radiological <NUMBER> <NUMBER> clinical data <NUMBER> order enhance rtpcr potential identify infected well asymptomatic carriers prevent virus transmission assure timely treatment <NUMBER> total <NUMBER> volunteers participated study <NUMBER> <NUMBER> healthcare workers <NUMBER> <NUMBER> administrative workers <NUMBER> <NUMBER> patients subjects asymptomatic tested gender <NUMBER> males <NUMBER> <NUMBER> females <NUMBER> mean age <NUMBER> years old median age <NUMBER> years old study conducted performing prima lab sa covid<NUMBER> iggigm rapid test qualitative membranebased immunoassay detection igg igm antibodies covid<NUMBER> whole blood serum plasma samples tests carried nurse taking approximately <NUMBER>μl capillary blood sterile lancet pipetting cassette port adding two drops diluent drive capillary action along strip entire rapid test took <NUMBER> minutes total <NUMBER> covid<NUMBER> iggigm rapid tests performed <NUMBER> subjects repeated covid<NUMBER> iggigm rapid test twice day second test performed nurse puncturing different finger new sterile lancet given limitations imposed local authorities availability rtpcr swabs rely self reported information provided volunteers total <NUMBER> <NUMBER> subjects reported previously undergone rtpcr nasopharyngeal swabs table <NUMBER> data obtained show covid<NUMBER> iggigm rapid test technical reproducibility <NUMBER> result suggests accuracy lower assumed prima lab sa claims accuracy covid<NUMBER> iggigm rapid test <NUMBER> igm <NUMBER> igg specificity <NUMBER> igm <NUMBER> igg sensitivity <NUMBER> igm <NUMBER> igg respectively according data sensitivity specificity estimated manufacturer reduced <NUMBER> factor corresponding reproducibility error highlighted analysis technical reproducibility discrepancy reliable unreliable covid<NUMBER> iggigm rapid tests results suggests reliable results considered true moreover every test performed least twice double check results considered correct order get accurate result recent studies provided producers instructions shown qualitative membranebased immunoassay tests affected sensibility specificity variation igg igm antibodies caused time symptoms onset test performance technical reproducibility results obtained study investigated correlation symptoms onset order evaluate technical reproducibility percentage gets better <NUMBER> days symptoms confirming considered best moment using covid<NUMBER> iggigm rapid test invalid results observed <NUMBER> <NUMBER> measurements prima lab sa states insufficient sample volume incorrect procedural techniques hematocrit level falling <NUMBER> <NUMBER> likely reasons missing control line covid<NUMBER> iggigm rapid test results compared rtpcr <NUMBER> subjects observed agreement <NUMBER> two techniques literature known sarscov<NUMBER> detectable rtpcr <NUMBER> days prior <NUMBER> days symptom onset peak seven days symptoms appearance <NUMBER> anticovid<NUMBER> antibodies production expected start <NUMBER> days symptom onset igm <NUMBER> days igg respectively <NUMBER> means igm immunoglobulins detectable first stage disease subject positive pcr swab igg immunoglobulins detectable last stage disease subject become negative pcr swab since rapid test likely produce negative results early stages infection possible <NUMBER> <NUMBER> negative subjects positive rtpcr sarscov<NUMBER> detectable antibodies seroconversion started yet two three <NUMBER> negative values igm one three negatives igmigg <NUMBER> negative rtpcr could explained false igm positive give low igm sensitivity <NUMBER> overall found rapid test appears valid method detecting negative sarscov<NUMBER> positive igg patients contrary rapid test appear effective detection positive negative igm subjects therefore performed unless followed rtpcr beginning covid<NUMBER> pandemic virtually information protocols available clinic management suspected sarscov<NUMBER> patients quickly number serological tests became available market promise identify people disease given difficulty securing adequate supply rtpcr kits centro medico santagostino decided test qualitative serological test prima lab sa covid<NUMBER> iggigm rapid test assess efficacy weaknesses rapid tests period ten weeks performed <NUMBER> covid<NUMBER> iggigm rapid tests <NUMBER> volunteers convenient sample pretense representative underlying italian population data collected suggests test technical reproducibility <NUMBER> technical failure <NUMBER> <NUMBER> agreement rtpcr <NUMBER> <NUMBER> covid<NUMBER> iggigm rapid test represents lowcost easily applicable tool detecting sarscov<NUMBER> diffusion general population capability identify quite reliably subjects exposed virus recent distant past suggested presence absence specific igg data suggest test unlikely provide adequate information regarding recent current exposure virus given evident unreliability igm antibodies detection must conformed rtpcr test rtpcr immunochromatographybased covid<NUMBER> immunoglobulin g iggimmunoglobulin igm rapid test sera study population applied measure sensitivity specificity positive predictive value ppv negative predictive value npv receiver operating characteristic roc curve compared rtpcr <NUMBER> confidence interval ci igm igg antibodies detected <NUMBER> subjects sarscov<NUMBER> <NUMBER> disease also referred coronavirus disease <NUMBER> <NUMBER> global mortality rate covid<NUMBER> reported range <NUMBER> <NUMBER> <NUMBER> currently diagnosis covid<NUMBER> confirmed using nextgeneration sequencing realtime reverse baseline characteristics study population described headache positive covid<NUMBER> group higher negative group p <NUMBER> p <NUMBER> p <NUMBER> p <NUMBER> respectively analysis immmunochromatography covid <NUMBER> subjects rtpcr positive group two subjects <NUMBER> rtpcr negative group produced igm antibody table <NUMBER> addition <NUMBER> patients figure <NUMBER>a gradual decrease npv either igm igg positivity <NUMBER> <NUMBER> observed increasing <NUMBER> <NUMBER> disease prevalence figure <NUMBER>b announced chinese authorities identified novel type coronavirus <NUMBER> january <NUMBER> <NUMBER> presently rtpcr nucleic acid amplification test naat routinely used detect covid<NUMBER> infection many countries around world <NUMBER> <NUMBER> <NUMBER> <NUMBER> study assessed diagnostic value new immunochromatography assay detect igm igg antibodies however limitations weaknesses areas confirmation covid<NUMBER> diagnosis rtpcr testing alone inability distinguish virus viability production indeterminate falsenegative results due low numbers target cells specimens although rtpcr remains powerful technique microbial diagnostics <NUMBER> laboratory assays elisa immunochromatography use serum blood sampled suspected established patients covid<NUMBER> infection proposed overcome supplement limitations one study using inhouse antisarsrcov igg igm elisa target n gene showed igm antibody level increased rapidly early stages covid<NUMBER> infection decreased later stages <NUMBER> furthermore igg antibody insignificantly expressed early stages infection increased rapidly later stages interestingly titers igm igg antibodies covid<NUMBER> patients significantly higher assessed healthy subjects infections reported reactivated patients confirmed rtpcr testing <NUMBER> therefore serial quantitative results using elisa may help confirm diagnosis also predict clinical course patient immunochromatography another diagnostic alternative proposed detect covid<NUMBER> infection technique developed late <NUMBER>s detect antigens blood recently used rapid diagnostic method various viral infections norovirus influenza <NUMBER> <NUMBER> benefits advantages immunochromatography include ability performed bedside without special laboratory equipment ease performance simple interpretation rapid time produce results may compare favorably diagnostic tools rtpcr elisa methods limitations study first possible observe changes antibodies time patient diagnosis time participation study study conducted crosssectional manner second quantitative titer antibody expressed test kit could confirmed therefore methodological limitation immunochromatography third may difficult fully represent diagnostic values especially sensitivity specificity diagnostic kit due small size study population conclusion immunochromatography demonstrated higher epidemic quickly spread china <NUMBER> countries <NUMBER> listed public health emergency international concern <NUMBER> outbreak disease caused chinese government take drastic measures contain outbreak including quarantine millions residents wuhan affected cities countrywide interventions include delaying resumption workplaces encouraging citizens stay work home however efforts limited one hard problem differentiate covid<NUMBER> cases healthy confirmed covid<NUMBER> cases reported common clinical symptoms include fever cough myalgia fatigue <NUMBER> yet symptoms unique features covid<NUMBER> symptoms similar virusinfected diseases influenza <NUMBER> currently virus nucleic acid realtime polymerase chain reaction rtpcr ct imaging hematology parameters primary tools clinical diagnosis infection <NUMBER> therefore urgent need rapid simple use sensitive accurate test quickly identify infected patients sarscov<NUMBER> prevent virus transmission assure timely treatment patients testing specific antibodies sarscov<NUMBER> patient blood good choice rapid simple highly sensitive diagnosis covid<NUMBER> widely accepted immunoglobulin igm provides first line defense viral infections generation adaptive highaffinity igg responses important long term immunity immunological memory <NUMBER> reported sars infection igm antibody could detected patient blood <NUMBER> <NUMBER> days igg could detected <NUMBER> days <NUMBER> <NUMBER> since covid<NUMBER> belongs large family viruses cause mers sars outbreak assume antibody generation process similar detection igg igm antibody sarscov<NUMBER> indication infection several different designs antigen tested optimized eventually mk<NUMBER> picked testing product bovine serum albumin bsa goat antihuman igg igm antibodies rabbit igg goat antirabbit igg antibodies obtained sigmaaldrich fortynanometer gold nanoparticle aunp colloids nc membrane plastic pad obtained shanghai kinbio inc glass fiber conjugate pad obtained whatman phosphatebuffered saline pbs purchased sigmaaldrich prepare aunp conjugate sarscov<NUMBER> recombinant protein dissolved pbs <NUMBER> mgml added mixture <NUMBER> ml aunp colloid <NUMBER> nm diameter od <NUMBER> <NUMBER> ml borate buffer <NUMBER> ph <NUMBER> incubation <NUMBER> minutes room temperature <NUMBER> ml <NUMBER> mgml bsa pbs added solution block aunp surface incubation <NUMBER> minutes room temperature mixture centrifuged <NUMBER> <NUMBER> rpm <NUMBER>°c <NUMBER> minutes supernatant discarded <NUMBER> ml <NUMBER> mgml bsa pbs added aunp conjugate resuspended centrifugation suspension processes repeated twice final suspension solution pbs aunprabbit igg conjugates prepared purified procedure main body test strip consists five parts including plastic backing sample pad conjugate pad absorbent pad nc membrane every component strip given pretreatment described follows nc membrane attached plastic backing layer cutting handling antihumanigm antihumanigg antirabbitigg immobilized test g control line c linerespectively conjugate pad sprayed mixture aunpcovid<NUMBER> recombinant antigen conjugate aunprabbitigg sample pad pretreated bsa <NUMBER> wv tween<NUMBER> <NUMBER> wv use patients recruited conform diagnostic criteria suspected case covid<NUMBER> according guidelines diagnosis treatment covid<NUMBER> <NUMBER> including typical epidemiological history clinical characteristics samples collected various hospitals cdc testing laboratories total eight six different provinces china tests conducted sites clinical staff followed test procedure described product inserts respiratory tract specimen including pharyngeal swab sputum used confirm covid<NUMBER> cases blood including serum plasma used test igm igg antibody testing pouched device opened immediately use refrigerated blood samples used test warmed room temperature <NUMBER>°c<NUMBER>°c testing <NUMBER> μl whole blood sample <NUMBER> μl serumplasma samples pipetted sample port followed adding two three drops <NUMBER> μl dilution buffer <NUMBER> mm pbs buffer drive capillary action along strip entire test took <NUMBER> minutes finish rapid sarscov<NUMBER> iggigm combined antibody test kits tested eight hospitals chinese cdc laboratories different provinces total <NUMBER> clinical positive <NUMBER> clinical negative patient blood samples test data collected analyzed specificity sensitivity rapid test kits calculated according following formulas specificity <NUMBER> true negative true negative false positive sensitivity <NUMBER> true positive true positive false negative conjugated colloidal gold nanoparticles sprayed conjugation pads aunprabbit igg conjugates also sprayed conjugation pads binding antirabbit igg antibody immobilized control line figure <NUMBER>a testing <NUMBER> <NUMBER> μl specimen added sample port followed addition sample dilution buffer mechanism assay based hydration transport reagents interact specimen across strip via chromatographic lateral flow figure <NUMBER>a specimen flows li et al <NUMBER> sarscov<NUMBER> iggigm combined antibody test different types blood samples results verified sensitivity specificity kit detection uninactivated vein blood however convenient collect fingerstick blood outside hospitals clinics achieve simpler operating process tested performance sarscov<NUMBER> iggigm combined antibody kit peripheral blood patient fingerstick blood vein blood plasma patient tested shown table <NUMBER> make kit suitable different stages disease developed iggigm combined antibody test covid<NUMBER> infection figure <NUMBER> also confirmed detection sensibility higher iggigm combined antibody test individual igg igm antibody test table <NUMBER> therefore recommend publication believe good test products used clinical sites information emerge carry comparison studies later certainly test cannot confirm virus presence provide evidence recent infection provides important immunological evidence physicians make correct diagnosis along tests start treatment patients addition possible crossreactivity coronaviruses flu viruses studied change level antibody compared different stages sarscov<NUMBER> infection believe combination nucleic acid rtpcr igmigg antibody test provide accurate sarscov<NUMBER> infection diagnosis developed rapid sarscov<NUMBER> iggigm combined antibody test using lateral flow immune assay techniques takes less <NUMBER> minutes generate results determine whether recent sarscov<NUMBER> infection easy use additional equipment required results study demonstrated test sensitive specific rapid test great potential benefits fast screening sarscov<NUMBER> infections already generated tremendous interest increased clinical uses short time testing chinese hospitals acute respiratory disease ard accounts large proportion acute morbidities well mortalities worldwide among acute viral respiratory tract infection leading cause appropriate <NUMBER> <NUMBER> major viral pathogens include influenza virus respiratory syncytial virus rsv coronavirus adenovirus rhinovirus children age five combined global mortality influenza rsv reaches <NUMBER> <NUMBER> deaths year <NUMBER> respiratory viruses adenovirus rhinovirus associated lower mortality significant morbidity causing huge economic burden <NUMBER> highly pathogenic emerging reemerging coronaviruses may cause epidemics pandemics released january <NUMBER> <NUMBER> httpvirologicalorgtinitialgenomereleaseofnovelcoronavirus<NUMBER>fromgroupmessageisap pinstalled<NUMBER> <NUMBER> identical sarscov bat sarslike coronavirus slcov <NUMBER> accurate fast diagnosis causative viral pathogens important select appropriate treatment save peoples lives stop epidemics reduce unnecessary use antibiotics viruses mentioned cause upper lower respiratory tract infections well overlapping clinical presentations making difficult physicians distinguish causative agents without solid laboratory analysis conventional diagnostic methods viral culture directindirect immunofluorescence assay ifa timeconsuming labor intensive limited sensitivity rapid accurate diagnosis respiratory viruses help epidemiologic monitoring along taking effective prevention steps implementing appropriate antiviral therapies past decades evolution viral diagnostic testing seen way conventional approaches rapid antigen detection recently highly sensitive nucleic acid amplification tests naat pointofcare tests poct developed <NUMBER> review describe various approaches currently available development diagnosis common respiratory virus infections humans anticipated data assist clinical laboratories rapidly accurately diagnose respiratory viruses thus providing physicians essential information timely appropriate treatment patients commonly used diagnostic approaches influenza virus rsv coronavirus adenovirus rhinovirus summarized table <NUMBER> described detail following review <NUMBER> immunofluorescence assay rapidly detect rsv antigens using fluorescencetagged primary secondary antibody also assay sensitive rtpct probing f g proteins qds confocal microscopy could detect progression rsv infection hep<NUMBER> cell line method found sensitive compared rtpcr <NUMBER> lateral flow immunoassay lfia another rapid rsv detection method based immunochromatographic technique using samples nasal washes aspirates many lfia kits available market bd directigen ez rsv binax rsv rsv respistrip remel xpect quicklab rsv test <NUMBER> <NUMBER> <NUMBER> sensitivity specificity abovementioned kits normally higher <NUMBER> <NUMBER> differ manufacturer pcr method based nested rtpcr technique involving outer inner primers designed f gene rsva b method developed circle time operability adult infections <NUMBER> therefore used detect samples low viral titers sensitively perform identification using antigenbased detection approaches suggesting greater accuracy sensitivity taqman pcr assay <NUMBER> addition locked nucleic acid lnabased onetube nested realtime otnrtpcr assay high sensitivity low incidence crosscontamination detection rsv <NUMBER> <NUMBER> therefore overall sensitivity specificity six rrtpcr kits sufficient diagnosing merscov infection rtlamp assay two primer sets constructed one set targeting n gene one set targeting orf<NUMBER>a gene sets shown high efficiency amplifying target sequences derived different merscov strains crossreactivity observed respiratory viruses <NUMBER> isolation adenovirus growth cell culture immunological detection generally thought gold serotypes amplification sequencing amplification elements l<NUMBER> l<NUMBER> <NUMBER> shimada studied conservative hexon gene hvr type <NUMBER> serotypes limited hadv serotypes lead corneal conjunctivitis <NUMBER> realtime pcr sensitive quantitative technique diagnose hadv infections realtime pcr consensus primer probe conserved region hexon gene designed detect <NUMBER> prototypes sensitivity assay ≤<NUMBER> copies per run linear range quantitation <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> copiesrun <NUMBER> realstar adenovirus pcr kit <NUMBER> realtime pcrbased diagnostic test vitro detection quantification hadvspecific dna sensitivity <NUMBER> copiesμl <NUMBER> <NUMBER> copiesμl crossreactivity <NUMBER> human viral pathogens compared realstar adenovirus pcr kit inhouse qpcr assay sensitive reliable detection quantification hadvspecific dna performance characteristics inhouse qpcr evaluated realstar adenovirus pcr kit using <NUMBER> clinical specimens <NUMBER> proficiency samples <NUMBER> study inhouse hadv qpcr assay detected six hadv species f except species g using realstar adenovirus pcr kit reference sensitivity specificity <NUMBER> <NUMBER> respectively inhouse qpcr assay correlation two assays quite good r <NUMBER> <NUMBER> furthermore inhouse qpcr assay linear range <NUMBER> log<NUMBER> copiesm cv values suggested quite low intrainterassay variations picornaviridae genus enterovirus classified <NUMBER> species c <NUMBER> serotypes <NUMBER> <NUMBER> <NUMBER> <NUMBER> rvs small singlestranded rna viruses icosahedral symmetrical capsid <NUMBER> rvs frequent cause respiratory tract infections children adults rva rvc common rv species causing lower airway illness wheezing acute asthma lead severe symptoms rvb children <NUMBER> <NUMBER> culture isolation virus combined acid stabilization test classic method rv diagnosis however assay timeconsuming laborious limiting value clinical treatment human rv antibodies detected immunological methods complement fixation test cft hi test elisa however owing lack suitable crossreactive antigens cover large number rv serotypes application methods greatly limited contrast onestep realtime pcr assay detects rvs using sequence detection system assay improves workflow reduces preparation time eliminates crosscontamination might introduced cdna transfer reverse transcription reaction pcr reaction step <NUMBER> seminested rtpcr assay based extremely sensitive pcr detect airborne rvs limit detection lod approximately <NUMBER> median tissue culture infectious dose tcid <NUMBER> <NUMBER> onestep panenterhinoge<NUMBER> realtime rtrcr assay developed validated using internal extraction control serial dilutions vitrotranscribed rhinovirus rna reference standard <NUMBER> lod limit quantification loq assay <NUMBER> log copiesml <NUMBER> log copiesml respectively linearity conserved <NUMBER> <NUMBER> log copiesml intraassay reproducibility r <NUMBER> <NUMBER> <NUMBER> rapid development zhang et al wgs technology laboratories may perform wgs human rv isolates clinically discovery hrvc data volume wholegenome hrv sequencing increased improved significantly help researchers clinicians understand evolutionary recombination rv <NUMBER> may improve diagnosis although single respiratory viruses detected patients symptoms respiratory viruses may also exist simultaneously children especially <NUMBER> years age present higher frequency coinfections <NUMBER> <NUMBER> <NUMBER> multiplex assays contain one viral gene target single tube advantage rapid detection several potential viral pathogens simultaneously specificity test <NUMBER> <NUMBER> sensitivity piv<NUMBER> hmpv piv<NUMBER> bov reported <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively sensitivity flua env oc<NUMBER> rsv h<NUMBER>n<NUMBER> relatively low <NUMBER> filmarray multiplex pcr system multiplex pcr panel used detect <NUMBER> viruses including rsva rsvb <NUMBER> bacteria platform requires <NUMBER> minutes handson time sample preparation <NUMBER> hour device running time testing platform integrates cell lysis reagents dnarna extraction reagents purification reagents amplification reagents also detection reagents one pouch <NUMBER> finishing run software analyses performed test results presented integrated table includes tested pathogens <NUMBER> studies revealed sensitivity <NUMBER> rsva <NUMBER> rsvb specificity <NUMBER> rsva rsvb compared combination reference esensor xtag laboratorydeveloped test <NUMBER> sensitivity specificity <NUMBER> <NUMBER> compared prodesse assay <NUMBER> infectious diseases still major threat world today <NUMBER> diagnosis realtime tracking emerging <NUMBER> reemerging infectious diseases must reliable fast affordable healthcare systems use different approaches make infectious diseases diagnoses clinical assessment signs symptoms microscopy microbiological cultures radiology molecular techniques classical realtime polymerase chain reaction pcr genome sequencing detection presence nucleic acid serology detection pathogens host antibodies artificial intelligence machine learning <NUMBER> modern medical diagnostics whole targeted genome sequencing detection technologies indispensable event novel pathogens coronavirus technologies offer shortest turnaround time tat results reported coupling comprehensive clinical evaluation triaging genomicbased diagnostics epidemiology innovative digital disease detection raises possibility open global pathogen surveillance system current case coronavirus global pandemic <NUMBER> healthcare systems challenge massive testing isolating quarantine suspected exposed virus retesting end viral incubation period treating managing turn positive well realtime tracing contacts diagnosis novel infectious disease covid<NUMBER> furthermore presents challenge studying understanding pathogenesis developing rapid test assays used subsequently diagnose cases disease continues infect people development test aspects sensitivity specificity false positive false negative rates diagnostic test meticulously considered great undertaking requiring high scientific expertise laboratory financial resources nations especially lowincome settings rely support developed nations make modifications country level reach healthcare needs <NUMBER> current covid<NUMBER> outbreak confronted scientists unprecedented infectious disease challenge demands highest level sharing infectious diseaserelated information infectious disease outbreaks becoming less confined geographical climatic boundaries <NUMBER> data sharing ensures nations use available facts minimize wastage time resources another lesson learnt pandemic nations also end secrecy public health decisionmaking especially amidst suspected disease outbreaks promote global cooperation <NUMBER> globally governments ready share outbreak information acquisition transmission treatment well make efforts fight spreading fake news related outbreaks nations networks highcontainment biological laboratories must guarantee safety agents custody prevent potential deployment bioweapons review briefly describes currently available testing approaches well selected two easy use pointofcare test assays including xpert ® xpress sarscov<NUMBER> abbott id covid<NUMBER> tests diagnosis novel covid<NUMBER> infection date publication us food drug administration fda granted emergency use authorizations clearance <NUMBER> tests seen table <NUMBER> routinely updated list fda approved tests accessed manifestation covid<NUMBER> infection highly nonspecific presents respiratory symptoms fever cough dyspnoea viral pneumonia <NUMBER> thus diagnostic tests specific infection urgently required confirm suspected cases screen patients conduct virus surveillance scenario rapid robust costefficient device used anywhere necessarily require trained technician operate <NUMBER> ie pointofcare crucial urgently needed detection covid<NUMBER> <NUMBER> several assays detect sarscov<NUMBER> developed far including rapid igmigg combined antibody test coronavirus raybiotech life <NUMBER>ncov iggigm antibody detection kit mybiosource inc qsarscov<NUMBER> iggigm rapid test cellex inc aries sarscov<NUMBER> assay luminex corporation sgtiflex covid<NUMBER> igmigg sugentech inc still development ultrasensitive rapid portable coronavirus sarscov<NUMBER> nucleic acid sequence detection system uses nanobiosensorbased aptamer technology <NUMBER> currently development inhouse commercially available assays detect novel form virus may also detect viral strains eg sarscov genetically similar sarscov<NUMBER> <NUMBER> status evaluation sarscov<NUMBER> molecular diagnostics tests found includes viral molecular target utilised test country manufacturer regulatory status emerging reemerging pathogens global challenges public health <NUMBER> laboratory biosafety requirements related covid<NUMBER> virus include availability biosafety requirements viral cultures manipulations world health organisation recommends procedures must performed based risk assessment highly trained personnel demonstrated capability strict observance relevant protocols times <NUMBER> nonpropagative diagnostic laboratory work viral genome sequencing nucleic acid amplification tests must conducted containment facilities procedures equivalent biosafety level <NUMBER> bsl<NUMBER> propagative work involves coronavirus culture isolation animal inoculation neutralization assays must done highbiocontainment laboratory inward directional airflow minimum bsl<NUMBER> <NUMBER> viral cultures recommended routine diagnosis must carried minimum bsl<NUMBER> facility bsl<NUMBER> <NUMBER> however sarscov<NUMBER> virus isolation cell cultures critical obtain isolates characterization support development vaccines therapeutic agents <NUMBER> new better diagnostic tests addition virological culture serological tests currently development could enable diagnosis covid<NUMBER> especially patients acute convalescent paired samples available drawn approximately <NUMBER> weeks apart monitor significant changes antibody titers patients however development types tests currently challenging due lack knowledge antibody response elicited sarscov<NUMBER> infection humans including question concerning antigenic differences sarscov<NUMBER> sarscov <NUMBER> addition serological tests may face challenge crossreactivity coronaviruses <NUMBER> however fda offered emergency use authorization first antibodybased test covid<NUMBER> detects antibodies ones blood rather virus nose throat samples test done certified laboratories even though takes <NUMBER> <NUMBER> minutes get result sample collection bedside test <NUMBER> pointofcare testing means results delivered patients patient care setting hospitals urgent care centers medical emergency rooms instead samples sent testing laboratory realtime pcr also known quantitative pcr commonly used molecular pointofcare testing amplify one genomic target case covid<NUMBER> orf<NUMBER>ab coronaviruses occupy two thirds genomes encodes replicase polyprotein translated orf<NUMBER>a orf<NUMBER>b egene envelope protein ngene nucleocapsid protein <NUMBER> rnadependent rna polymerase rdrp essential viral enzyme replicates positivestrand rna viral genome specificity molecular diagnostic assays amplify one molecular target virus minimize chances three targets mutating hence missed diagnostic test <NUMBER> development disease testing assays us manufacturers apply emergency clinical use authorization fda european union manufacturers obtain conformité européene literally means european conformity marking vitro diagnostic use <NUMBER> addition two covid<NUMBER> molecular diagnostic tests designed near patient testing variety healthcare environments using range sample types throat nasal nasopharyngeal oropharyngeal swabs facilitates effective patient management number confirmed cases covid<NUMBER> rises rapidly throughout world nations continue require reliable testing rapid inexpensive easytouse pointofcare diagnostic device integrated smartphone could reduce transportation needs lower risk spreading infection alleviate strain healthcare system mitigate cost testing individuals governments <NUMBER> unfortunately scaling production available covid<NUMBER> diagnostics well personal protective equipment remain ongoing challenge fight disease list diagnostics development testing listed <NUMBER> prequalification team activated emergency use listing eul candidates vitro diagnostics detect sarscov<NUMBER> currently total <NUMBER> different diagnostic tests time publication <NUMBER> since sarscov<NUMBER> diagnostics development approval rapidly changing information updated weekly portal governments around world encouraged rapidly test large percentage populations fight coronavirus <NUMBER> tests critical meeting demand following emergence sarscov<NUMBER> genomic analyses continue play key role public health response informing design appropriate molecular diagnostics corroborating epidemiological efforts trace contacts <NUMBER> order better understand spread pandemic design better interventions whole genome sequencing virus range clinical presentations disease different parts world must occur figure <NUMBER> suggested rapid data sharing using publicly available sequence data platforms pandemic pointsource outbreak <NUMBER> <NUMBER> therefore researchers need data whole genomes sarscov<NUMBER> including viral transcriptome <NUMBER> potential reveal insights biology emergent pathogen <NUMBER> nanopore minion sequencing technology used sequence sarscov<NUMBER> genomes <NUMBER> <NUMBER> many genomes successfully uploaded global initiative sharing influenza data gisaid reference laboratories globally nextstrain public repositories number sequences genbank sequence read archive us national center biotechnology currently <NUMBER> million infected individuals <NUMBER> sovereign states <NUMBER> deaths globally <NUMBER> time writing covid<NUMBER> pandemic may see deployment covid<NUMBER> rapid noninvasive pointofcare tests civil airports national borders screen individuals avoid imported cases infection would similar mitigation aircraft hijackings inflight sabotage using mandatory civil aviation security procedures including strict security screening passengers baggage commercial airports <NUMBER> currently screening covid<NUMBER> performed checking high fever individuals coming airports border controls using thermal screening guns nanosensor diagnostic platform development test virus replace thermal screening guns specific technology form handheld device promises give results specific virus within one minute detecting nucleocapsid protein specific virus using nanosensor aptamer technology <NUMBER> minimise current covid<NUMBER> pandemic related pressure health systems globally especially arising ramping testing capacity quickly readily accessible cheap easy use interpret pointofcare diagnostic tests high sensitivity must developed produced distributed widely data associated article identification us public health officials presumptive covid<NUMBER> cases believed due community transmission infection brings sharp focus importance laboratory diagnosis infection caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current recommendations laboratory diagnosis covid<NUMBER> cdc clinicians coordinate testing local public health authorities andor cdc preferred testing method realtime reverse transcriptionpcr rtpcr test <NUMBER> <NUMBER> <NUMBER> similar developed diagnosis sarscov <NUMBER> <NUMBER> viral cultures recommended commentary addresses current issues laboratory diagnosis covid<NUMBER> must understood clinicians clinical microbiology laboratories public health authorities preanalytical issues initial respiratory tract specimen collection diagnosis screening patients covid<NUMBER> pneumonia within <NUMBER> <NUMBER> days onset symptoms patients covid<NUMBER> demonstrated high viral loads upper lower respiratory tracts <NUMBER> <NUMBER> <NUMBER> <NUMBER> nasopharyngeal np swab andor oropharyngeal op swab often recommended screening diagnosis early infection <NUMBER> <NUMBER> <NUMBER> single np swab become preferred swab tolerated better patient safer operator np swabs inherent quality control usually reach correct area tested nasal cavity wang et al reported op swabs n ϭ <NUMBER> used much frequently nasal swabs n ϭ <NUMBER> china covid<NUMBER> outbreak however sarscov<NUMBER> rna detected <NUMBER> op swabs significantly lower level nasal swabs <NUMBER> <NUMBER> collectiontesting nasal op swabs either independent specimens together within single aliquot viral transport medium might attractive option normal circumstances institutions must also consider potential stress pandemic places nationalinternational supply chains light another excellent reason limit testing np swabs prolong supplies flocked swabs andor transport media however understand respiratory oral contact routes transmission may learn patients pharyngitis dominant initial presenting symptom adequately sampled via op route order properly obtain np swab specimen swab must inserted deeply nasal cavity patients likely flinch means swab hit target swabs kept place <NUMBER> twirled three times swabs flocked nontoxic synthetic fibers polyester well synthetic nylon handles <NUMBER> collecting npop swab specimen may carry theoretical risk transmitting sarscov<NUMBER> particularly airborne transmission demonstrated investigation covid<NUMBER> outbreak continues <NUMBER> personal protective equipment ppe cannot utilized due scarcity ppe means collecting upper respiratory tract specimens needed <NUMBER> one alternative option collecting upper respiratory tract specimen evaluate patients suspected covid<NUMBER> pneumonia selfcollected saliva specimen <NUMBER> <NUMBER> <NUMBER> <NUMBER> supply swabs become scarce nonflocked swabs transport media cleared equivalently food drug administration fda emergency use authorization eua headtohead comparisons lacking currently collection swabs placed viral universal transport medium rapid transportation clinical microbiology laboratory ideally refrigerated conditions <NUMBER> noted however cases salivanpsops may miss early infection later infection main site replication may shifted low respiratory tract repeated testing obtaining lower respiratory tract specimens may required moreover respiratory viral pathogens influenza respiratory syncytial viruses must ruled many ways covid<NUMBER> highlights key difference analytic clinical sensitivities ability assay detect pathogen present clinical specimen versus ability test identify patients overall infected status latter course reflects various factors include specimen site method collection conjunction burden organism function anatomic location disease severity time symptomatic variability factors individual individual repeated testing may particularly important patient clinical picture viral pneumonia potential exposure history andor radiographic findings chest computed tomography ct magnetic resonance imaging mri scan consistent covid<NUMBER> pneumonia equally challenging results single undetected result impact decisions regarding patient quarantine social distancing particular patients health care providers including clinical laboratory staff serology discussed postanalytical section may assist situations ii late detection monitoring patients severe covid<NUMBER> pneumonia ideally sputum sampling bronchoalveolar lavage used collecting lower respiratory tract specimens yielded highest viral loads diagnosis covid<NUMBER> <NUMBER> <NUMBER> recent study revealed samples bronchoalveolar lavage bal fluid yielded highest sarscov<NUMBER> rna rate although study compareevaluate results np swabs <NUMBER> patients present severe pneumonia acute respiratory distress syndrome may require emergent intubation well respiratory isolation negativepressure room possible lower respiratory tract sputum specimen collected intubation procedure alternatively sputum andor bronchoalveolar lavage fluid specimens collected intubation <NUMBER> <NUMBER> however patients covid<NUMBER> pneumonia demonstrated high viral rna loads sarscov<NUMBER> fecal material <NUMBER> <NUMBER> well delayed shedding respiratory tract <NUMBER> <NUMBER> late clinical course enteric involvement previously seen patients severe novel coronavirus infections <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> four studies sars coronavirus isolated stool cultures <NUMBER> <NUMBER> <NUMBER> another study sars coronavirus demonstrated inside enterocytes electron microscopy <NUMBER> thus aside direct respiratory sampling preferred method detecting sarscov<NUMBER> advanced covid<NUMBER> cases may rectal swab realtime rtpcr <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> iii safety measures specimen processing pcr processing testing processing respiratory specimens done class ii biological safety cabinet <NUMBER> <NUMBER> <NUMBER> although laboratories would argue biosafety level three bsl<NUMBER> work procedures used safety cabinet negativepressure room within laboratory used mycobacterial cultures nucleic acid extraction realtime rtpcr performed specimen transferred lysis buffer bsl<NUMBER> cabinet lysis buffer contain guanidiniumbased inactivating agent well nondenaturing detergent indeed buffers included common commercial extraction platforms biomérieux easymag qiagen ez<NUMBER> contain guanidiumdetergents able inactivate viable coronavirus <NUMBER> <NUMBER> <NUMBER> similarly universal transport medium includes guanidinium salt available merlin biomedical xiamen china http wwwchinamerlincomenindexphppϭproductsshowidϭ<NUMBER>sidϭcidϭ<NUMBER> lanmuϭ<NUMBER> test reverse transcription method salivaswabs used collect clinical specimens quickly added lysis buffer disinfect specimen well stop degradation coronavirus rna <NUMBER> <NUMBER> <NUMBER> clinical specimensswabs heated <NUMBER>°c <NUMBER> min evidence suggests process may also degrade coronavirus rna even inactivates viable coronavirus <NUMBER> <NUMBER> moreover selfenclosed systems integrating nucleic acid extraction amplification detection id abbott san diego ca <NUMBER> <NUMBER> cobas liat roche molecular systems pleasanton ca genexpert cepheid sunnyvale ca <NUMBER> available meeting local regulatory requirements sarscov<NUMBER> testing useful clinical specimen viral transport medium transferred cartridge class ii biosafety cabinet cartridge sealed many randomaccess sealed devices suitable pointofcare testing local hospitals clinics without biosafety cabinets situation specimen collector appropriate protective gear splash guardgoggles mask gloves disposable laboratory coat could directly transfer specimen detection cartridges bedside location without class ii biosafety cabinet closed cartridge could safely placed instrument testing however spills transport solution transfer cartridgebased tests avoided occur decontamination performed appropriate analytical issues assay selection immunoassays developed rapid detection sarscov<NUMBER> antigens antibodies rapid pointofcare immunoassays generally lateral flow assays highthroughput immunoanalyzer versions also development populationlevel screening lateral flow assays developed detecting antigens sarscov<NUMBER> virus detecting antibodies igm igg covid<NUMBER> rapid antigen lateral flow assays would theoretically provide advantage fast time result lowcost detection sarscov<NUMBER> likely suffer poor sensitivity early infection based experience method influenza flu viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> monoclonal antibodies specifically sarscov<NUMBER> development several rapid antigen assays developed <NUMBER> concern given variability viral loads covid<NUMBER> patients antigen detection may miss cases due low infectious burden sampling variability serology measures host response infection indirect measure infection best utilized retrospectively serological methods rapidly developed proven useful confirming past covid<NUMBER> <NUMBER> serology previously important role epidemiology sars <NUMBER> coronavirus outbreaks <NUMBER> rapid lateral flow assays igm igg antibodies undoubtably play important role covid<NUMBER> outbreak allow burden infection role asymptomatic infections basic reproduction number overall mortality determined however igm responses notoriously nonspecific given weeks required develop specific igg responses serology detection likely play role active case management except diagnoseconfirm late covid<NUMBER> cases determine immunity health care workers outbreak progresses cell culture recommended diagnostic purposes ii assay selection molecular detection sarscov<NUMBER> randomamplification deepsequencing methods played major role initial identification sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> deep sequencing molecular methods nextgeneration sequencing metagenomic nextgeneration sequencing continue needed determine future mutations sarscov<NUMBER> currently impractical diagnosing covid<NUMBER> molecular diagnostics developed diagnosis covid<NUMBER> involve realtime rtpcr assays including us centers disease control prevention <NUMBER> charité institute virology berlin germany <NUMBER> <NUMBER> hong kong university <NUMBER> <NUMBER> molecular methods developed evaluated worldwide include loopmediated isothermal amplification multiplex isothermal amplification followed microarray detection crispr clustered regularly interspaced short palindromic repeatsbased assays <NUMBER> iii target selection realtime rtpcr assays realtime rtpcr method recommended molecular testing <NUMBER> <NUMBER> <NUMBER> <NUMBER> major advantage realtime rtpcr assays amplification analysis done simultaneously closed system minimize falsepositive results associated amplification product contamination number coronaviruses cause respiratory intestinal infections humans <NUMBER> <NUMBER> among coronaviruses group sarslike bat coronaviruses including sarscov sarscov<NUMBER> comprise unique clade subgenus sarbecovirus <NUMBER> <NUMBER> coronaviruses number molecular targets within positivesense singlestranded rna genome used pcr assays <NUMBER> <NUMBER> <NUMBER> <NUMBER> include genes encoding structural proteins including envelope glycoproteins spike envelope e transmembrane helicase hel nucleocapsid n <NUMBER> <NUMBER> <NUMBER> addition genes encode structural proteins speciesspecific accessory genes required viral replication include rnadependent rna polymerase rdrp hemagglutininesterase open reading frame <NUMBER>a orf<NUMBER>a orf<NUMBER>b <NUMBER> <NUMBER> <NUMBER> <NUMBER> united states cdc recommends two nucleocapsid protein targets n<NUMBER> n<NUMBER> <NUMBER> recommends firstline screening e gene assay followed confirmatory assay using rdrp gene <NUMBER> chan et al developed compared performance three novel realtime rtpcr assays targeting rdrphel n genes sarscov<NUMBER> among covid<NUMBER>rdrphel assay lowest limit detection vitro higher sensitivity specificity <NUMBER> however likely welloptimized targets arise number viral genomic locations since assay performance usually dictated reagent design target since viral genes present equal copy numbers avoid potential crossreaction endemic coronaviruses well potential genetic drift sarscov<NUMBER> least two molecular targets included assay various investigators different countries used number molecular targets realtime rtpcr assays united states cdc selected two loci nucleocapsid gene twotarget assay appears performing well <NUMBER> one study utilized two sequence regions open reading frame <NUMBER>b nucleocapsid protein highly conserved among sarbecoviruses initial realtime rtpcr testing <NUMBER> another study hong kong china used two targets rtpcr assay first used nucleocapsid screening followed confirmation open reading frame <NUMBER>b <NUMBER> germany two molecular targets envelope rnadependent rna polymerase selected <NUMBER> china time manuscript preparation several molecular devices received urgent approval <NUMBER> date indication one sequence regions used offers unique advantage clinical diagnostic testing however ideal design would include least one conserved region one specific region mitigate effects genetic drift especially virus evolves within new populations united states regulatory issues complicated development implementation laboratorydeveloped molecular tests diagnosis covid<NUMBER> <NUMBER> february <NUMBER> fda issued new guidance laboratories able develop implement covid<NUMBER> molecular diagnostic tests prior obtaining eua laboratories required submit eau fda within <NUMBER> business days validation moreover validation must include specimen types eg nasopharyngeal oropharyngeal saliva used clinically although new regulatory burdens prohibit development molecular laboratory testing diagnosis covid<NUMBER> create lot extra work time writing us fda granted quite euas httpswwwfdagovmedicaldevicesemergency situationsmedicaldevicesemergencyuseauthorizationscoronavirus<NUMBER> accessed <NUMBER> march <NUMBER> postanalytical issues interpretation molecular results united states initially two targets cdc assay nucleocapsid proteins n<NUMBER> n<NUMBER> test positive case considered laboratory confirmed <NUMBER> cycle threshold c value less <NUMBER> defined positive test c value <NUMBER> defined negative test c value ͻ<NUMBER> one two nucleocapsid protein n<NUMBER> n<NUMBER> defined indeterminant requires confirmation retesting <NUMBER> currently china assays three targets positives two targets considered positive <NUMBER> although correlations revealed viral loads determined realtime rtpcr assays used yet indicate covid<NUMBER> severity monitor therapeutic response <NUMBER> <NUMBER> <NUMBER> however low c values indicating high viral loads may used indication transmissibility <NUMBER> <NUMBER> ii test cure test infectivity monitoring patients resolution covid<NUMBER> pneumonia may also important terms released isolation discharged discharged patients still shedding viable coronavirus likely infect people <NUMBER> therefore selfquarantine <NUMBER> month recommended cases np op swabs may sufficient either test cure test infectivity <NUMBER> needs investigation one approach test cure demonstrate two consecutive negative realtime rtpcr tests rectal swabs suggestion based fact sarscov<NUMBER> cultured stool <NUMBER> sars outbreak <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> cultured stool covid<NUMBER> outbreak <NUMBER> thus rectal swab positive realtime pcr testing suggests patient may shedding viable sarscov<NUMBER> stools thereby remaining infectious <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however recent study <NUMBER> serial covid<NUMBER> patients indicated infectious virus isolated stool samples spite high virus rna concentrations <NUMBER> correlation rtpcr positivity stool recovery live virus samples remains fully investigated iii serology covid<NUMBER> members coronavirus family four structural proteins spike membrane envelope e nucleocapsid n proteins two proteins appear important antigenic sites development serological assays detect covid<NUMBER> serological methods focused detecting serum antibodies proteins coronavirus spike <NUMBER> coronavirus envelope spike responsible receptor binding fusion determines host tropism transmission capability <NUMBER> <NUMBER> proteins determined gene functionally divided two subunits s<NUMBER> s<NUMBER> s<NUMBER> domain responsible receptor binding s<NUMBER> domain responsible fusion sarscov sarscov<NUMBER> bind human angiotensinconverting enzyme <NUMBER> found human respiratory cells renal cells gastrointestinal cells <NUMBER> <NUMBER> <NUMBER> protein appears important antigenic site development serological assays detect covid<NUMBER> n protein structural component helical nucleocapsid n protein plays important role viral pathogenesis replication rna packaging antibodies n protein frequently detected covid<NUMBER> patients <NUMBER> <NUMBER> suggesting n protein may one immunodominant antigens early diagnosis covid<NUMBER> <NUMBER> mentioned rapid lateral flow assays antibodies igm igg produced covid<NUMBER> developed <NUMBER> seroconversion occurred <NUMBER> days symptomatic infection <NUMBER> patients <NUMBER> days followed rapid decline viral load <NUMBER> serological methods available play important role epidemiology covid<NUMBER> determining immune status asymptomatic patients unlikely play role screening diagnosis early infections <NUMBER> <NUMBER> <NUMBER> however serology may useful confirming diagnosis covid<NUMBER> <NUMBER> concluding remarks ongoing unprecedented outbreak covid<NUMBER> globally emphasized importance laboratory diagnosis human coronavirus infections order limit spread well appropriately treat patients serious infection commentary addressed current issues regarding testing sarscov<NUMBER> example np rather op swab recommended early diagnosis screening provides higher diagnostic yields better tolerated patient safer operator np swab combined op swab increase sensitivity requires twice number swabs np swabs become scarce selfcollected saliva nasal washes could used alternative specimen type epidemiological screening worried well asymptomatic persons exposure history wish tested sure infected np swabs would reserved hospitalized patients test negative may need deep sputum bal fluid samples collected importance repeated testing use bronchoscopy patients severe illness first screening test negative must understood role rectal swabs testing patients late infection test infectivitycure currently well studied needs urgent attention equally unappreciated need broad screeningtesting molecular testing andor serological testing order determine true mortality rate well epidemiological markers finally importance rapid development integrated randomaccess pointofcare molecular devices accurate diagnosis sarscov<NUMBER> infections cannot overemphasized shortturnaroundtime stat tests important realtime patient management infection control decisions especially less infectious forms pneumonia present respiratory isolate resources scarce assays safe simple fast used local clinics hospitals already needed instruments responsible identifying treating patients since first appearance <NUMBER> middle east respiratory syndrome mers affected <NUMBER> countries four continents <NUMBER> cases high fatality rate <NUMBER> <NUMBER> novel lineage c betacoronavirus mers coronavirus merscov confirmed etiological agent <NUMBER> human dipeptidyl peptidase <NUMBER> hdpp<NUMBER> found cellular receptor merscov <NUMBER> subsequent detection merscov antibodies dromedaries various countries middle east north africa implied animals probably reservoir merscov <NUMBER> <NUMBER> <NUMBER> lineage c betacoronaviruses bats eg tylonycteris bat cov hku<NUMBER> tybatcovhku<NUMBER> pipistrellus bat cov hku<NUMBER> pibatcovhku<NUMBER> hedgehogs found closely related merscov <NUMBER> far detection merscov discoveries closely related covs efficiently achieved rtpcr although rtpcr highly sensitive turnaroundtime <NUMBER> h test requires expensive equipment stringent laboratory setup personal attention prevent laboratory pcr product cross contamination may lead falsepositive results recently developed monoclonal antibodybased rapid nucleocapsid protein detection assay onsite diagnosis merscov finished <NUMBER> min <NUMBER> rapid test highly specific merscov human dromedary samples samples containing human covs hcovoc<NUMBER> hcov<NUMBER>e hcovnl<NUMBER> hcovhku<NUMBER> dromedary cov uaehku<NUMBER> showed negative results however human dromedary covs nonlineage c betacoronaviruses known nucleocapsid protein lineage c betacoronaviruses merscov may crossreact merscov hypothesize crossreactivity may occur rapid test pick lineage c betacoronaviruses closely related merscov hence would useful discovery merscov ancestors test hypothesis examined usefulness rapid test detect four alphacoronaviruses four lineage b c betacoronaviruses previously discovered alimentary samples bats <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> differential positive rate detecting lineage c betacoronaviruses showed different relatedness merscov also discussed cloning purification <NUMBER> tagged recombinant nucleocapsid protein tybatcovhku<NUMBER> cloning purification <NUMBER> tagged recombinant nucleocapsid protein tybatcovhku<NUMBER> performed using protocol described previously <NUMBER> <NUMBER> produce plasmid protein purification primers <NUMBER>′act cgc tag cat ggc aac tcc tgc tgca cct<NUMBER>′ <NUMBER>′tca tgc tag ctc aag cct ctg aat cga agg taa<NUMBER>′ used amplify gene encoding nucleocapsid protein tybatcovhku<NUMBER> strain sm<NUMBER>a rtpcr sequence coding amino acid residues <NUMBER> <NUMBER> nucleocapsid protein amplified cloned nhei site expression vector pet<NUMBER>b novagen merck millipore billerica usa frame upstream series six histidine residues recombinant nucleocapsid protein expressed purified using ninta affinity chromatograph column qiagen hilden germany according manufacturers instructions rapid merscov nucleocapsid protein detection assay format lateral flow immunoassay performed described previously <NUMBER> using lfia test strip millipore bedford usa two highly specific mybatcovhku<NUMBER> <NUMBER> <NUMBER> miniopterus pusillus mibatcovhku<NUMBER> <NUMBER> <NUMBER> rousettus leschenaultii robatcovhku<NUMBER> <NUMBER> <NUMBER> hipposideros pomona hibatcovhku<NUMBER> <NUMBER> <NUMBER> monoclonal antibodies merscov recombinant nucleocapsid protein md<NUMBER>e<NUMBER> coating md<NUMBER>b<NUMBER> conjugating testing carried mixing <NUMBER> µl sample originally collected mixing fecal swab <NUMBER> ml virus transport medium <NUMBER> µl lysis buffer <NUMBER> room temperature <NUMBER> µl pretreated sample transferred pipette sample well test card slowly room temperature results read visually <NUMBER> min result considered negative control line positive test line negative considered positive control test lines positive control line negative test considered invalid viral loads tybatcovhku<NUMBER> pibatcovhku<NUMBER> performed quantitative realtime rtpcr described previously <NUMBER> <NUMBER> rna amplified lightcycler instrument superscript iii platinum one step quantitative rtpcr system invitrogen san diego ca usa using forward primer <NUMBER>′cgg aaa atc aac acc ggt aat ggt<NUMBER>′ reverse primer <NUMBER>′tag cct ctg gtc cag tcc ca<NUMBER>′ probe <NUMBER>′famtta aac aat tgg cyc cca gat ggt tct tct act acabhq<NUMBER>′ tybatcovhku<NUMBER> forward primer <NUMBER>′ccc aga cct gcc cct aat ac<NUMBER>′ reverse primer <NUMBER>′aag agg ctg ctt acc gtg ct<NUMBER>′ probe <NUMBER>′famcac tgt ctc atg gtt cac ggg cct tacibfq<NUMBER>′ pibatcovhku<NUMBER> quantitative analysis reference standard prepared using pcriitopo vector invitrogen san diego ca usa containing target sequence calibration curve generated serial <NUMBER>fold dilutions equivalent <NUMBER> <NUMBER> <NUMBER> <NUMBER> copies per reaction mixture parallel test samples phylogenetic tree constructed using n gene maximum likelihood method based substitution model whelan goldman model gamma distribution wagg mega <NUMBER> bestfit substitution model selected using mega <NUMBER> rapid merscov nucleocapsid protein detection assay tested positive <NUMBER> <NUMBER> <NUMBER> table <NUMBER> significantly tybatcovhku<NUMBER> rnapositive alimentary samples pibatcovhku<NUMBER> rnapositive alimentary samples tested positive rapid merscov nucleocapsid protein detection assay p <NUMBER> chisquare test rapid merscov nucleocapsid protein detection assay tested negative <NUMBER> alimentary samples rnapositive alphacoronaviruses <NUMBER> alimentary samples rnapositive lineage b lineage betacoronaviruses table <NUMBER> purified recombinant nucleocapsid protein tybatcovhku<NUMBER> strain sm<NUMBER>a sample showed positive result tested positive fig <NUMBER>b three tybatcovhku<NUMBER> rnanegative alimentary samples tylonycteris pachypus three pibatcovhku<NUMBER> rnanegative alimentary samples pipistrellus abramus tested negative fig <NUMBER>a rapid test confirming positive results due nucleocapsid protein cov ingredients chemicals alimentary samples bats recombinant nucleocapsid protein tybatcovhku<NUMBER> strain sm<NUMBER>a detection limit <NUMBER> µg protein median range viral loads <NUMBER> tybatcovhku<NUMBER> <NUMBER> pibatcovhku<NUMBER> positive alimentary samples <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> copiesg <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> copiesg respectively table <NUMBER> significant difference observed viral loads tybatcovhku<NUMBER>pibatcovhku<NUMBER> rnapositive alimentary samples tested positive negative rapid merscov nucleocapsid protein detection assay mannwitney u test phylogenetic tree constructed using amino acid sequences nucleocapsid protein merscov tybatcovhku<NUMBER> pibatcovhku<NUMBER> observed nucleocapsid protein merscov closely related tybatcovhku<NUMBER> pibatcovhku<NUMBER> fig <NUMBER> rapid merscov nucleocapsid protein detection assay able rapidly detect lineage c betacoronaviruses bats potential animal reservoir two years ago developed monoclonal antibodiesbased merscov nucleocapsid protein capture enzymelinked immunosorbent assay using two merscov nucleocapsid protein specific monoclonal antibodies <NUMBER> two monoclonal antibodies reacted nucleocapsid <NUMBER> subsequently using format lateral flow immunoassay developed rapid merscov nucleocapsid protein detection assay <NUMBER> enzymelinked immunosorbent assay rapid assay showed high specificity merscov human dromedary samples respiratory alimentary samples contained alphacoronaviruses lineage b betacoronaviruses human dromedary origins comparable viral load ranges samples contained tybatcovhku<NUMBER> pibatcovhku<NUMBER> data shown tested negative assays <NUMBER> <NUMBER> study demonstrated exploited relative nonspecificity rapid assay detect tybatcovhku<NUMBER> pibatcovhku<NUMBER> lineage c bat betacoronaviruses closely related merscov rapid merscov nucleocapsid protein detection assay detected significantly tybatcovhku<NUMBER> pibatcovhku<NUMBER> previous studies shown receptor binding domain spike protein tybatcovhku<NUMBER> pibatcovhku<NUMBER> able bind hdpp<NUMBER> <NUMBER> <NUMBER> moreover pseudotyped virus embedding spike protein tybatcovhku<NUMBER> pibatcovhku<NUMBER> use hdpp<NUMBER> receptor infecting cells <NUMBER> <NUMBER> furthermore phylogenetic analysis showed protein merscov closely related tybatcovhku<NUMBER> pibatcovhku<NUMBER> fig <NUMBER> receptor binding domain pibatcovhku<NUMBER> deletions compared merscov tybatcovhku<NUMBER> <NUMBER> target nucleocapsid protein monoclonal antibodies rapid assay present study captured phylogenetic analysis based amino acid sequence comparison also showed nucleocapsid protein merscov closely related tybatcovhku<NUMBER> pibatcovhku<NUMBER> fig <NUMBER> may explain rapid test able pick almost <NUMBER> tybatcovhku<NUMBER> <NUMBER> pibatcovhku<NUMBER> indicating antigenically epitopes nucleocapsid protein tybatcovhku<NUMBER> readily crossreact corresponding ones nucleocapsid protein merscov pibatcovhku<NUMBER> also line results multiple alignments amino acid sequences merscov tybatcovhku<NUMBER> pibatcovhku<NUMBER> nucleocapsid proteins comparing variable sites three viruses found <NUMBER> residues identical merscov tybatcovhku<NUMBER> pibatcovhku<NUMBER> <NUMBER> residues identical merscov pibatcovhku<NUMBER> tybatcovhku<NUMBER> fig <NUMBER> based results speculate whether specific tybatcovhku<NUMBER> pibatcovhku<NUMBER> strain picked rapid test depends sequence epitopes recognized monoclonal antibodies viral load sample high viral load samples eg sm<NUMBER>a could tested negative low viral load samples eg wlp<NUMBER>a could tested positive table <NUMBER> rapid merscov nucleocapsid protein detection assay facilitate rapid onsite mass screening bat samples ancestors merscov closely related merscov far detection merscov ancestors performed collection animal samples mostly middle east north africa transporting laboratories developed countries viral rna detection quantitative realtime rtpcr metagenomics technologies <NUMBER> <NUMBER> viral studies seldom performed field laboratories middle east resources expertize could limited moreover expensive laborintensive perform nucleic detection assays screening thousands bat samples diverse species may needed pick dozen positive samples surveillance studies compared quantitative realtime rtpcr metagenomics cost present rapid assay much lower also require expertize molecular technology expensive setup molecular studies may present clinical laboratories middle east specimen transport hot climate often problem middle east north africa userfriendly rapid test suitable testing large number bat samples study field particular sample positive investigator easily collect samples particular bat species studies hand certain sample negative bat released back wild strategies would extremely useful tracking transmission patterns merscov close ancestors different bat species across different countries notable although rapid test able pick <NUMBER> tybatcovhku<NUMBER> lineage c betacoronavirus bind utilize hdpp<NUMBER> detect <NUMBER> pibatcovhku<NUMBER> lineage c betacoronavirus cannot bind utilize hdpp<NUMBER> limitation renders rapid test mainly suitable onsite mass screening ancestors merscov closely related merscov application rapid antigen assay large number samples field coupled confirmation rtpcr equipped laboratories may speed allow costeffective surveillance studies animal ancestors merscov red color shows amino acid residues identical nucleocapsid proteins merscov tybatcovhku<NUMBER> pibatcovhku<NUMBER> blue color shows amino acid residues identical nucleocapsid proteins merscov pibatcovhku<NUMBER> tybatcovhku<NUMBER> since coronavirus disease <NUMBER> covid<NUMBER> emerged end <NUMBER> wuhan china rapidly progressed pandemic status caused tremendous repercussions human health life <NUMBER> <NUMBER> newly emerged virus normally assigned species based phylogeny taxonomy <NUMBER> <NUMBER> causative pathogen covid<NUMBER> officially named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> sarscov<NUMBER> found closely related severe acute respiratory syndrome coronavirus sarscov identified <NUMBER> sarscov sarscov<NUMBER> may originated bats evolved capable humantohuman transmission accumulation genetic mutations <NUMBER> facing emerging infectious disease rapid identification causative microorganism analysis genome composition helps development diagnostic tests therapeutic drugs vaccines required contain spread disease mitigate impact disease especially true viral disease high transmissibility pathogenicity virulence observed current covid<NUMBER> pandemic viral culture gold standard diagnosis viral infections timeconsuming method performed high biosafety level laboratory specifically designed handling biohazardous pathogens realtime reverse transcriptase polymerase chain reaction rrtpcr assay used amplification detection specific viral nucleic acid sequences within hours important irreplaceable diagnostic tool recent years however rrtpcr assay remains laborintensive expertisedependent available hospitals qualified microbiology laboratory <NUMBER> <NUMBER> surge capacity rrtpcr assay limited mass influx patients covid<NUMBER> due largescale community outbreak disease addition site specimen collection technique timing disease course significantly affect sensitivity specificity rrtpcr assay diagnosis covid<NUMBER> thus simple easytouse accurate diagnostic tool needed supplement diagnosis covid<NUMBER> improve patient outcome resource allocation infection control interventions serological tests based pointofcare poc lateral flow immunoassays lfias developed detect antisarscov<NUMBER> antibodies simultaneously separately diagnosis covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> compared rrtpcr serological tests advantage decreased technical requirement short turnaround time affordability lower sampling specimen preparation risk higher detection sensitivity specificity serological testing therefore important diagnostic tool <NUMBER> used adjuvant rrtpcr mass screening clinical diagnosis epidemiological study covid<NUMBER> many rapid serological tests targeting antisarscov<NUMBER> immunoglobulin iga immunoglobulin igm immunoglobulin g igg antibodies applied clinical use many countries <NUMBER> <NUMBER> however usefulness poc rapid serological tests based lateral flow immunoassays lfias elaborately studied therefore primary goal study evaluate compare usefulness four poc antibody rapid tests diagnosis covid<NUMBER> infection based different time courses disease hypothesized might exist difference dynamic antibody response patients covid<NUMBER> different levels severity therefore second goal study test hypothesis comparing difference time symptom onset seroconversion patients covid<NUMBER> without pneumonia taiwan samples patients meet reporting criteria covid<NUMBER> submitted virology laboratories validated contracted centers diseases control prevention taiwan taiwan cdc sarscov<NUMBER> rrtpcr testing <NUMBER> samples include oropharyngeal nasopharyngeal swabs oral gargling sputum three sets primers probes targeting sarscov<NUMBER> envelope e nucleocapsid n rnadependent rna polymerase rdrp genes used addition sarscov<NUMBER> rtpcr testing respiratory samples simultaneously evaluated presence influenza ab viruses using rtpcr results negative sarscov<NUMBER> influenza ab viruses additional sarscov<NUMBER> rrtpcr test another respiratory sample suspected covid patient performed <NUMBER> <NUMBER> <NUMBER> rrtpcr confirmed patients covid<NUMBER> reported national health command center nhcc mandatorily hospitalized negativepressure isolation room prevent spread sarscov<NUMBER> community may <NUMBER> <NUMBER> taiwan maintained record limited community transmission covid<NUMBER> <NUMBER> confirmed cases <NUMBER> hospital national taiwan university ntuh <NUMBER>bed teaching hospital northern taiwan admitted total <NUMBER> rrtpcrpositive nhccconfirmed patients covid<NUMBER> january <NUMBER> <NUMBER> april <NUMBER> <NUMBER> retrospective observational study undertaken ntuh <NUMBER> rrtpcr confirmed patients covid<NUMBER> enrolled study approved institutional review board hospital ntuh<NUMBER>rind requirement informed consent patient waived used residual blood samples collected attending physicians providing regular medical care blood samples collected date venipuncture multiple blood samples collected patient covid<NUMBER> day one sample used antibody rapid testing serum samples collected study patients stored <NUMBER>ºc use frozen samples stored analysis single freezethaw cycle addition <NUMBER> control serum samples collected <NUMBER> hospitalized patients median duration symptom onset <NUMBER> days range <NUMBER> days respiratory tract infection fever two negative results sarscov<NUMBER> rrtpcr test evaluated validate performance assay none cases confirmed positive covid<NUMBER> rrtpcr hospitalization patient data including sex age date symptom onset date hospitalization requirement intensive care unit admission icu date icu admission retrieved electronic medical records also recorded results sarscov<NUMBER> rrtpcr test performed using respiratory tract specimens collected day blood samples <NUMBER> confirmed covid<NUMBER> patients least <NUMBER> chest roentgenographic survey hospitalization chest roentgenograms reviewed presence pneumonia chest roentgenogram confirmed patients covid<NUMBER> judged two investigators independently wu jl tseng wp discrepancy interpretation initial chest roentgenogram third investigators chen sy opinion sought reach final consensus <NUMBER> covid<NUMBER>negative cases opd followup records laboratory study results infection etiology collected validate accuracy four poc rapid tests detecting antisarscov<NUMBER> antibodies serial plasma samples one covid<NUMBER>positive patient prolonged airway viral shedding simultaneously tested antinucleocapsid antibody using western blot wb method previously described <NUMBER> <NUMBER> definitions seroconversion defined earliest date positive antisarscov<NUMBER> antibody response detected serum sample using specific poc rapid test time seroconversion detection defined duration date symptom onset date seroconversion diagnostic sensitivity poc rapid test defined percentage serum samples confirmed patients covid<NUMBER> found positive antibodies sarscov<NUMBER> diagnostic specificity poc rapid test defined percentage serum samples control patients found negative antibodies sarscov<NUMBER> calculated means standard deviations sds age variables percentages categorical variables cumulative probabilities detection seroconversion specific rapid test obtained using kaplanmeier method difference cumulative probability detection seroconversion four antibody rapid tests evaluated using log rank test difference cumulative probability detection seroconversion patients covid<NUMBER> without pneumonia investigated using log rank test <NUMBER> confirmed patients covid<NUMBER> least two range <NUMBER> median <NUMBER> positive rrtpcr results performed using either throat lower respiratory specimens mean age <NUMBER> years standard deviation sd <NUMBER> years higher male patients female patients mean ± sd <NUMBER> ± <NUMBER> vs <NUMBER> ± <NUMBER> p <NUMBER> nine <NUMBER> <NUMBER> patients covid<NUMBER> men one three patients required intensive care one received extracorporeal membrane oxygenation support serial plasma samples one patient covid<NUMBER> simultaneously tested antinucleocapsid antibody using wb method days <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> symptom onset <NUMBER> antinucleocapsid antibody persistently detected day <NUMBER> onwards wb method serum samples obtained <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> days symptom onset patient evaluated using four poc rapid tests antibody response found negative sample obtained day <NUMBER> positive samples obtained day <NUMBER> beyond using four rapid tests consistent results obtained wb method <NUMBER> antibody responses different time points disease course symptom onset evaluated using found rapid tests fig <NUMBER> antisarscov<NUMBER> antibody detected <NUMBER> serum samples collected <NUMBER> weeks symptom onset n <NUMBER> using four rapid tests fig <NUMBER>a <NUMBER> results rrtpcr performed detection sarscov<NUMBER> respiratory tract specimens positive <NUMBER> <NUMBER> <NUMBER> blood samples collecting date respiratory tract specimens obtained <NUMBER> patients covid<NUMBER> remained sarscov<NUMBER> rrtpcr positive irrespective positive antisarscov<NUMBER> antibody response detected blood samples <NUMBER> patients <NUMBER> sequential negative rrtpcr results discharged hospital isolation average duration persistent positive rrtpcr results seroconversion <NUMBER> ± <NUMBER> days range <NUMBER> days median <NUMBER> days date two studies investigated usefulness poc antibody rapid tests diagnosis covid<NUMBER> studies reported variable results diagnostic sensitivity <NUMBER> <NUMBER> specificity <NUMBER> <NUMBER> <NUMBER> study overall diagnostic sensitivity ranged <NUMBER> <NUMBER> specificity consistently <NUMBER> four poc antibody rapid tests performance lower observed previous two studies however time point serum sample collection crucial evaluation diagnostic performance poc rapid tests targeting host immune responsive antibodies studies shown increase serum antibody levels nucleocapsid protein np surface spike protein receptor binding domain rbd samples patients covid<NUMBER> obtained <NUMBER> days symptom onset analyzed using enzyme linked immunosorbent assay elisa magnetic chemiluminescence enzyme immunoassay mclia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current study diagnostic sensitivity high increased <NUMBER> <NUMBER> days symptom onset reached <NUMBER> <NUMBER> weeks symptom onset four poc antibody rapid tests study provided supportive evidence detail chronological analysis validated observation poc antibody rapid tests based lfia combining results previous studies diagnosis covid<NUMBER> infection serological responsive antibodies valuable <NUMBER> weeks symptom onset furthermore poc rapid test detecting igm separately igg antibodies sarscov<NUMBER> add early overall diagnostic value compared poc rapid test detecting total mixed igg igm antibodies similar result also observed studies et al long et al showed earlier onset higher overall seroconversion rate antinp igg antinp igm antibody among patients covid<NUMBER> <NUMBER> <NUMBER> observed antisarscov<NUMBER>np antisarscov<NUMBER>rbd igg levels correlated virus neutralization titer viral load also seemed related inversely serum antibody response <NUMBER> <NUMBER> therefore presence virusspecific antibodies expected associated rapid virus eradication clinical improvement however prolonged viral shedding median duration <NUMBER> days seroconversion observed current study also found <NUMBER> study several limitations first singlecenter study thus generalization findings requires confirmation second inadequate case number might failed demonstrate statistical difference diagnostic performance different poc antibody rapid tests third nine serum samples collected march <NUMBER> seven first two second enrolled patient covid<NUMBER> stored <NUMBER>ºc <NUMBER> days testing antibody response <NUMBER> two nine samples negative antibody response four poc rapid tests two samples obtained days <NUMBER> <NUMBER> symptom onset could exclude possibility false negative results two serum samples due prolonged storage fourth laboratory tests concomitant respiratory tract viral pathogens especially coronaviruses inadequate retrospective study therefore could exclude possibility coinfection patients covid<NUMBER> cross reactivity nonsarscov<NUMBER> coronaviruses four poc rapid antibody tests well investigated table <NUMBER> fifth pneumonia diagnosis covid<NUMBER> patients primarily based chest roentgenogram study plain chest roentgenogram less sensitive computed tomography scan detecting parenchymal change viral pneumonia could exclude possibility misclassification covid<NUMBER> pneumonia patient subclinical pulmonary infiltration nonpneumonia patient finally nonprotocolized retrospective study serum samples tested different postsymptom stages consistent therefore study subject information bias clinical laboratory data limitations findings current study need confirmed prospectively recruited adequately powered diagnostic accuracy study conclusion serological testing may useful diagnostic tool addition rrtpcr diagnosis patients covid<NUMBER> study detection sensitivity poc rapid tests corresponded antibody dynamics reached <NUMBER> <NUMBER> weeks symptom onset covid<NUMBER> patients complicated pneumonia exhibited earlier seroconversion without pneumonia however presence antisarscov<NUMBER> antibodies neither indicated rapid eradication virus provided immune protection disease deterioration study findings provide supportive evidence appropriate application interpretation poc antibody tests diagnosis management patients covid<NUMBER> diagnostic sensitivity specificity four pointofcare antibody rapid tests symptom onset respiratory tract infections leading cause hospital admission morbidity mortality <NUMBER> <NUMBER> <NUMBER> <NUMBER> presentation etiological agents respiratory tract infection cannot identified solely based clinical signs symptoms therefore awaiting microbiological confirmation empirical antibiotic antiviral treatment initiated based severity score influenza season <NUMBER> since minority infections caused bacteria empiric antibiotic treatment approach redundant lead increase antibiotic resistance moreover empiric isolation precautions installed protect patients healthcare workers possible viral infection altogether need rapid identification exclusion viral respiratory tract infection reduce inappropriate unnecessary hospital hygienic interventions focus shorten antibacterialantiviral treatment currently diagnosis respiratory infections usually based combination molecular amplification methods bacterial culture laboratory laboratorydeveloped realtime polymerase chain reaction pcr multiplex assays ldt used show excellent sensitivity specificity however approach limited number targets per multiplex reaction need batchwise testing assays performed daily time result approximately <NUMBER> h recently respiratory pathogen rp panel genmark diagnostics carlsbad ca usa become available detection extensive panel respiratory pathogens <NUMBER> respiratory viruses three bacterial species see methods section using esensor technology <NUMBER> test cartridgebased molecular assay used eplex® platform time result approximately <NUMBER> min showed concordance <NUMBER> compared ldt <NUMBER> hypothetically eplex® rp panel testing represents considerable reduction time diagnosis compared ldt could significant clinical benefits paper pilot study reported analyzed implications using eplex® rp panel detection respiratory infections compared ldt regarding time result isolation precautions antibacterialantiviral therapy prospective singlecenter study leiden university medical center lumc included patients january march <NUMBER> patients symptoms acute respiratory infection included upon request physician acute ward intensive care unit pediatric department specimens included obtained weekdays tested rp panel ldt consulting microbiologist information regarding baseline characteristics infection parameters admittance isolation treatment obtained electronic patient records additional information cultures retrieved laboratory information system glims mips belgium medical ethics review committee lumc approved study primary endpoint study time result eplex® rp panel compared ldt eplex® rp panel offered pilot elevate pressure droplet isolation rooms thus isolation discontinued based eplex® rp panel results due pilot nature study antibacterial antiviral treatment adjusted based eplex® rp panel results therefore theoretical time reduction treatment calculated using time results eplex® rp panel ldt secondary outcome measures reduction isolation days based eplex® rp panel ahead ldt results theoretical reduction hours oseltamivir atypical pneumonias treatment calculated time results ldt eplex® rp panel possible additional diagnosis found eplex® rp panel ldt viral testing testing mycoplasma pneumoniae chlamydia pneumoniae chlamydia psittaci performed day samples arrived laboratory <NUMBER> samples arriving laboratory <NUMBER> pm tested legionella pneumophila bordetella parapertussis following day assays performed daily monday till friday request weekend days viral respiratory panel ldt consists adenovirus bocavirus coronavirus <NUMBER>e coronavirus hku<NUMBER> coronavirus nl<NUMBER> coronavirus oc<NUMBER> influenza influenza b human metapneumovirus parainfluenza <NUMBER> differentiation differently labeled probes respiratory syncytial virus rhinovirus addition testing bacterial pathogens could requested legionella species legionella pneumophila mycoplasma pneumoniae chlamydia pneumoniae chlamydia psittaci bordetella pertussis bordetella parapertussis sputa samples <NUMBER> diluted phosphatebuffered saline pbs homogenized beadbeating prior extraction <NUMBER> μl respiratory sample used extract <NUMBER> μl total nucleic acids using total nucleic acid extraction kit magna pure lc system roche diagnostics nucleic acid amplification detection realtime pcr performed biorad cfx<NUMBER> thermocycler using primers probes conditions described previously <NUMBER> <NUMBER> <NUMBER> detection mycoplasma pneumoniae chlamydia pneumoniae chlamydia psittaci bcap assay biolegio nijmegen netherlands developed bdmax system used testing <NUMBER> μl respiratory sample according manufacturers instructions <NUMBER> ldt results reported electronic patient record time result ldt calculated time receipt sample laboratory time results available electronic patient record specimens diagnosis using ceivd cleared rp panel accepted weekdays <NUMBER> <NUMBER> pm tested day soon possible eplex® rp panel offered weekend treatment adjusted based results rp panel used study able detect adenovirus bocavirus coronavirus <NUMBER>e coronavirus hku<NUMBER> coronavirus nl<NUMBER> coronavirus oc<NUMBER> influenza h<NUMBER> influenza <NUMBER> h<NUMBER>n<NUMBER> influenza h<NUMBER> influenza b metapneumovirus middle east respiratory syndrome coronavirus parainfluenza <NUMBER> respiratory syncytial virus b rhinovirusenterovirus bordetella pertussis legionella pneumophila mycoplasma pneumoniae ldt sputa samples diluted <NUMBER> dilution using pbs according manufacturers instructions <NUMBER> μl respiratory sample pipetted buffer tube vortexing transferred eplex cartridge subsequently eplex tower test gave invalid result run repeated results reported telephone requesting physician since results reported electronic patient record time result calculated time receipt sample time results reported telephone time result compared wilcoxon signedrank test using ibm spss statistics version <NUMBER> software windows pvalue <NUMBER> considered statistically significant january march <NUMBER> <NUMBER> patients included symptoms acute respiratory infection whose characteristics summarized table <NUMBER> total <NUMBER> samples tested comprising <NUMBER> throat swabs <NUMBER> sputum samples <NUMBER> nasal lavages four nasopharyngeal swabs thirtyfour tested positive respiratory pathogen one assays six samples failed eplex® rp panel two gave valid result upon retesting four retested two insufficient remaining sample volume failed samples retested excluded analysis leaving <NUMBER> samples <NUMBER> patients analysis none samples failed ldt <NUMBER> samples <NUMBER> tested positive total <NUMBER> pathogens ldt eplex® rp panel table <NUMBER> using ldt <NUMBER> tested positive <NUMBER> negative whereas <NUMBER> <NUMBER> using eplex® rp panel shown table <NUMBER> discordant result found five samples three patients different sample types tested table <NUMBER> first sputum throat swab collected first tested ldt positive influenza second tested rhinovirus positive nasal lavage ldt negative sputum third patient sputum throat swab tested sputum tested coronavirus <NUMBER>e positive two remaining samples delay requesting authorization test subsequently eplex® rp panel four samples time result <NUMBER> h two samples already laboratory several hours eplex® rp panel testing requested testing two samples requested <NUMBER> pm therefore performed next day one due failure initial sample <NUMBER> patients included analysis <NUMBER> admitted hospital time respiratory testing requested fiftyone hospitalized patients isolated awaiting test results whereas nine patients admitted isolation cases isolation installed mainly low clinical suspicion pathogen requiring isolation one nine patients needed isolation since eplex® rp panel tested positive influenza <NUMBER> days ahead ldt tests showed <NUMBER> <NUMBER> patients admitted isolation respiratory pathogen requiring isolation remaining <NUMBER> patients one died test results became available one patient duration isolation unknown leaving <NUMBER> patients analysis <NUMBER> isolation discontinued based eplex® rp panel results ahead ldt results resulted total reduction <NUMBER> isolation days median reduction <NUMBER> days range <NUMBER> days per patient eight remaining patients isolation discontinued ldt results became available eight patients three children isolation withdrawn moment ldt results reported total <NUMBER> <NUMBER> patients received antiviral antibacterial treatment hospitalization oseltamivir treatment initiated <NUMBER> patients awaiting test results five tested positive influenza <NUMBER> influenza eplex® rp panel negative patients oseltamivir could stopped approximately one day earlier median <NUMBER> h range <NUMBER> based eplex® rp results compared ldt table <NUMBER> total <NUMBER> patients tested influenza positive remaining six receive oseltamivir time diagnosis one patient oseltamivir treatment started soon eplex® rp panel showed influenza one day prior ldt results one patient started ldt positive four patients receive antiviral treatment two already dismissed time definite ldt diagnosis awaiting test results <NUMBER> patients received antibiotic treatment bacteria causing atypical pneumonias none patients either eplex® rp panel ldt eight tested positive bordetella pertussis legionella pneumophila mycoplasma pneumoniae theory <NUMBER> patients median duration <NUMBER> h range <NUMBER> antibiotic treatment atypical pneumonia could saved treatment stopped eplex® rp panel tested negative <NUMBER> patients two tested positive eplex® rp panel bacterial agent one bordetella pertussis one mycoplasma pneumoniae patients testing pathogens requested clinician consequence included routine diagnostic ldt workflow positive eplex® rp panel results confirmed ldt quantification cycle cq values <NUMBER> <NUMBER> b pertussis pneumoniae respectively ldt atypical bacterial pathogens mycoplasma pneumoniae chlamydia pneumoniae chlamydia psittaci requested <NUMBER> patients legionella ldt requested ten patients hypothesized diagnosis eplex® rp assay significantly reduced time result median <NUMBER> h compared batchwise ldt consequently total <NUMBER> isolation days saved three days influenza exposure prevented unnecessary oseltamivir treatment could shortened least <NUMBER> h <NUMBER> patients antibiotic treatment atypical pneumonias median <NUMBER> h <NUMBER> patients proper therapeutic isolation measurements could installed two patients bacterial pathogens based eplex® rp panel detection considered treating physicians therefore analyzed routine ldt knowledge study first report use eplex® rp panel clinical setting demonstrated significant time reduction reflecting previous clinical studies implementing rapid molecular testing <NUMBER> <NUMBER> <NUMBER> <NUMBER> significantly reduced number isolation days furthermore confirmation single viral cause infection cohort patients enabled cohort nursing increased number isolation rooms available patients awaiting identification respiratory pathogen efficient use isolation rooms essential influenza season demand rooms high rapid eplex® rp panel results could resulted reduction oseltamivir usage line previous studies <NUMBER> results regarding reduction antibiotic treatment atypical pneumonias interpreted care according dutch guidelines indicated legionella pneumophila highrisk populations also stopped based negative urine antigen testing lack routine testing atypical respiratory bacterial pathogens mostly legionella pneumophila finding additional respiratory pathogens initially considered clinicians underline importance syndromic respiratory testing study number limitations first clinical impact pilot study hampered design since eplex® rp assay readily offered reduce quest isolation rooms coinciding influenza respiratory syncytial virus epidemics early <NUMBER> test results yet shown hospital information system reported phone creating bias moreover eplex® rp panel result reported provisional result awaiting routine ldt confirmation delay showing test results electronic patient record might withheld clinicians discontinue isolation therefore created underestimation true clinical potential furthermore findings study cannot extrapolated readily since singlecenter study part one winter season benefits rapid diagnostics might pronounced assessing complete respiratory seasons far eplex® rp panel ceivd cleared nasopharyngeal swabs however especially samples lower respiratory tract sputum bronchoalveolar lavage important include ceivd clearance since study shows samples might higher diagnostic yield however previous current study several different sample types tested good results <NUMBER> nevertheless eplex® rp panel failure rate nearly <NUMBER> two cases due internal control failure none ldt failed overall eplex® rp panel results showed excellent concordance ldt three ldt positives cq values <NUMBER> could detected using eplex® rp panel line previous findings reported nijhuis et al <NUMBER> eplex® rp panel based syndromic testing standard panel containing common respiratory pathogens requested physician however eplex® rp panel complete especially caring immunocompromised patients case additional ldt testing legionella species cytomegalovirus herpesvirus toxoplasmosis fungal pathogens would still necessary compared ldt eplex® rp panel testing expensive regarding reagents consumables cheaper respect handson time addition rapid diagnostics result cost reduction clinical departments demonstrated previously <NUMBER> conclusion diagnosis respiratory infections eplex® rp assay resulted significant reduction time result compared ldt causes reduction isolation days theoretically improved treatment regimens advantages assume rapid diagnostic molecular assay added value ongoing improvement patient care december <NUMBER> outbreak unexplained pneumonia originated city wuhan hubei province china huang et al <NUMBER> guan et al <NUMBER> initial outbreak novel coronavirus sarscov<NUMBER> quickly identified etiological agent associated disease defined covid<NUMBER> named acronym corona virus disease <NUMBER> stands year virus firstly detected exponential growth affected individuals led world health organization declaring global pandemic march <NUMBER> <NUMBER> huang et al <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths worldwide april <NUMBER> <NUMBER> many anticipated utilization direct molecular diagnostic testing based sequencing sarscov<NUMBER> critical identifying infected individuals however lock measures begun bite race develop approve tests different purpose assess current viral infection rather immunity severe sarscov<NUMBER> facilitate return work however antibody testing may also relevant critical evaluation disease including understanding kinetics immune response infection ii understanding immune response relative disease severity timeline iii understanding whether crossreactivity coronaviruses leads crossprotection iv clarifying whether infection protects future infection long immunity last v correlates protection guide public health measures addition critical questions immediate clinical applications would include diagnosis triage patients seek medical attention later phases disease ii contact tracing iii stratifying workforces patients immunity shown lasting iv seroepidemiological studies understand extent covid<NUMBER> spread understanding application diagnostic performance different testing approaches sarscov<NUMBER> essential fight pandemic field tests believed many one milestones recommencement clinical activity recent eshre wwweshreeuhomecovid<NUMBER>wg position statement highlighted current lack understanding field invitro diagnostic assays particular serological testing asrm wwwasrmorgnewsandpublicationscovid<NUMBER> called healthcare providers aware limitations tests purpose review provide overview current diagnostic approaches sarscov<NUMBER> particular highlight issues serological testing objective providing clear guide clinicians assays currently available literature search carried studies focused diagnostic serological testing sarscov<NUMBER> using keywords coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> covid<NUMBER> pubmed google scholar embase databases searched without language restrictions inception april <NUMBER> <NUMBER> updated may <NUMBER> <NUMBER> given rapidly developing field rapid dissemination scientific findings respect covid<NUMBER> preprint servers health sciences medrxiv biology biorxiv databases also performed additional journal articles identified bibliographies included studies main objective review original studies reporting sensitivity andor specificity antibodies sarscov<NUMBER> included analysis <NUMBER> articles published sarscov<NUMBER> <NUMBER> articles related coronavirus antibodies serology screening title abstract <NUMBER> full text studies retrieved <NUMBER> studies meeting inclusion criteria reporting data test sensitivity specificity summarized table <NUMBER> coronaviruses cov belong subfamily coronavirinae family coronaviridae order nidovirales subfamily four genera included alphacoronavirus betacoronavirus gammacoronavirus deltacoronavirus genome virus singlestranded positivesense rna ssrna <NUMBER> kb <NUMBER>′cap structure <NUMBER>′polya tail genome subgenomes typical coronavirus may present six open reading frames orfs even first orfs orf<NUMBER>ab encompass approximately <NUMBER> whole genome encode <NUMBER> nonstructural proteins nsp<NUMBER> mainly involved replication covs orfs encompassing onethird genome near <NUMBER>′terminus encode main structural proteins spike membrane envelope e nucleocapsid n proteins chen et al <NUMBER>a different coronaviruses exhibit <NUMBER> identity whole rna <NUMBER> identity nonstructural proteinscoding region <NUMBER> identity structural proteincoding region sequence analysis shows new coronavirus incorporates typical genome structure cov belongs cluster betaccov includes batsarslike slzc<NUMBER> batsl zxc<NUMBER> sarscov merscov based phylogenetic tree covs <NUMBER>ncov closely related batslcov zc<NUMBER> batslcov zxc<NUMBER> distantly related sarscov chen et al <NUMBER>a four principal structural proteins essential virion assembly associated infective capacity homotrimers proteins make spikes viral surface responsible attachment receptors host cells protein three transmembrane domains shapes virions promotes membrane curvature covers nucleocapsid e protein participates virus assembly release involved viral pathogenesis n protein presents two domains bind virus rna genome via different mechanisms n protein binds nsp<NUMBER> protein help tether genome replicationtranscription complex package encapsidated genome virions n protein also antagonist interferon viral encoded repressor rna interference may beneficial viral replication database held foundation innovative new diagnostics collaborating centre laboratory strengthening diagnostic technology evaluation <NUMBER> may <NUMBER> contained <NUMBER> sarscov<NUMBER> laboratory tests diagnosis covid<NUMBER> comprises <NUMBER> molecular assays <NUMBER> immunoassays excluding intended research use <NUMBER> molecular assays <NUMBER> immunoassays ceivd marked principally two types tests available covid<NUMBER> viral tests antibody tests viral tests direct tests designed detect virus therefore reflect current infection contrast antibody tests indirect tests detect virus rather ascertain established seroconversion previous infection early seroconversion ongoing infection recommended test sarscov<NUMBER> infection diagnosis detecting viral rna nucleic acid amplification tests naat rtpcr wwwecdceuropaeu areas widespread community transmission sarscov<NUMBER> laboratory resources limited detection rtpcr single discriminatory target considered sufficient however still specific technical considerations laboratory testing including specimen collection variable collection methods samples collect upper lower respiratory tract biospecimens samples time collection relation course disease availability different laboratory test methods kits may standardized approved authorities food drug administration infrastructure considerations approved laboratory facilities trained manpower available methodology rapidly scaled test results interpreted false negatives excluded issues faced whole scientific community collective response develop guidance currently used protocol developed optimized detection novel coronavirus charité university hospital collaboration several laboratories germany netherlands china france uk belgium corman et al <NUMBER> additionally existing protocol optimized center disease control cdc united states comprehensive comparison validation alternative available kits nucleic acid extraction use alternative probe primer sets efficient sarscov<NUMBER> detection clinical samples wwwcdcgovcoronavirus similar approaches undertaken national authorities continue scale provision laboratories using ce marked assays wwwenglandnhsukcoronavirus importance variability specimen collection initially highlighted comparison positive rates pharyngeal nasal blood sputum feces urine brochoalveolar lavage fluid fibrobronchoscope brush biopsy patients confirmed covid<NUMBER> zou et al <NUMBER> present cdc recommend collecting testing upper respiratory specimen nasopharyngeal specimen preferred choice swabbased sarscov<NUMBER> testing collection nasopharyngeal swab possible following acceptable alternatives oropharyngeal specimen nasal midturbinate using flocked tapered swab anterior nares nasal swab specimen using flocked spun polyester swab nasopharyngeal washaspirate nasal aspirate specimen invasive procedures lower respiratory tract specimens also recommended available although detected specimens like blood stools generally less reliable respiratory specimens present recommended specimens collected soon possible decision made pursue sarscov<NUMBER> testing regardless time symptom onset viral load throat swabs greatest time viral onset decrease monotonically thereafter zou et al <NUMBER> analysis temporal dynamics suggests viral shedding may begin <NUMBER> <NUMBER> days appearance first symptoms facilitating presymptomatic asymptomatic transmission covs number molecular targets within positivesense singlestranded rna genome used rtpcr assays provided primers genes encode structural proteins viral envelope e nucleocapsid n rnadependent rna polymerase rdrp key part viruss replication machinery makes copies rna genome corman et al <NUMBER> however demonstration one three e n rdrp sequences may offer advantage clinical diagnostic testing different targets preferred different authorities example public health england assay employs two probes rdrp one pan sarbecoprobe detect <NUMBER>ncov sarscov batsarsrelated covs second probe specific <NUMBER>ncov continued refinement naat assays ongoing facilitate upscaling maintaining laboratory safety lowcost highsensitivity et al <NUMBER> great efforts carried order develop tests rapid detection sarscov<NUMBER> antigens antigen detection tests designed directly detect viral particles biological samples like nasopharyngeal secretions several rapid antigen tests proposed diao et al <NUMBER> however principal concern false negative rate due either low variable viral load variability sampling latter potential compound cases low viral titres thereby increasing false negative rate tang et al <NUMBER> diao colleagues <NUMBER> reported preliminary results utilization fluorescence immunochromatographic assay detecting nucleocapsid protein sarscov<NUMBER> nasopharyngeal swab sample urine <NUMBER> participants comparison natt testing intersection amplification curve diagnostic threshold line ct value set either ≤<NUMBER> ≤<NUMBER> diao et al <NUMBER> higher viral load sample prespecified ct value may lower fewer replication cycles required achieve detectable signal however low viral load greater number replication cycles higher ct value required detectable signal attained assay prevalence <NUMBER> although positive predictive value <NUMBER> negative predictive value <NUMBER> ct ≤<NUMBER> increasing <NUMBER> patients higher viral load demonstrated ct≤<NUMBER> would suggest present assay would useful excluding high viral loads whether alternative approaches previously suggested influenza viruses children including utilization colloidal goldlabeled iggs detection reagent increase sensitivity rapid antigen tests respiratory viruses feasible still consideration monoclonal antibodies specifically sarscov<NUMBER> development validation technique similar approaches larger populations including asymptomatic cases warranted consideration approaches try concentrate antigen amplify detection phase however likely needed methods clinical utility loeffelholz et al <NUMBER> present april <NUMBER> <NUMBER> nongovernmental organization find httpswwwfinddxorg listed four cemarked rapid sarscov<NUMBER> antigen detection tests primarily lateral flow immunochromatographic assays based presence colloid gold conjugate pad membrane strip precoated antibodies specific sarscov<NUMBER> antigens test line sarscov<NUMBER> antigens present specimen withdrawn nasopharyngeal swab visible band appears test line antibodyantigenantibody gold conjugate complex forms evaluation diagnostic tests however limited cemark means manufacturers state conform relevant eu legislation may still available purchase according ivd directive <NUMBER>ec affix cemark covid<NUMBER> diagnostic devices used health professionals manufacturer specify device performance characteristics selfdeclare conformity safety performance requirements listed directive contrast selftests intended used patients must also assessed third party body notified body tests yet happen although direct antigen tests registered several health authorities sensitivity tests lower rtpcr previous antigen detecting elsias developed sarscov limits detection <NUMBER>pgml che et al <NUMBER> di et al <NUMBER> furthermore clarification specificity sarscov<NUMBER> awaited given potential crossreaction human coronaviruses despite limitations chief advantages antigen tests including rapidity <NUMBER> mins compared hours naat testing ease interpretation limited technical skill infrastructure required compared naat based testing continue make worth pursuing however experience influenza antigen testing invites caution tests may low sensitivity specificity moreover noted false negatives rate critical tang et al <NUMBER> greatest utility come fruition may symptomatic patients viral load greatest enable accurate triage contrast natt based testing soon sequence known diagnostic test built diagnostic technology methodology underlying serological test development quite different substantially longer timeline obtain robust product suitable routine deployment principal difference antibody tests require identification distinct proteins form viral coat elucidation proteins divergent previous coronavirus proteins identification specific antibodies proteins part acquired immune response viral exposure finally testing ensure limited crossreactivity antibodies developed historical coronaviruses previous two coronaviruses variety assays encompassing different methodologies developed including elisa chemiluminescence western blot protein microarray immunofluorescence platforms elisa chemiluminescence deemed suitable clinical application costs timetoresults relative simplicity ability scale large throughput platforms examined detection antibodies sarscov<NUMBER> appropriate thresholds sensitivity specificity antibody test depend purpose must considered prior implementation diagnosis symptomatic patients high sensitivity required generally ≥ <NUMBER> context slight reduction specificity may acceptable false positives may tolerated provided potential diagnoses considered acceptance overdiagnosis may result unnecessary interventions sarscov<NUMBER> may include quarantining however antibody tests deployed individuallevel approach inform release social isolation return normal activities high specificity essential falsepositive results return nonimmune individuals risk exposure purposes mind uk medicines healthcare products regulatory agency set minimum <NUMBER> specificity threshold lateral flow immunoassays lfias particularly challenging particularly given scale validation study required suitable candidate lfia demonstrate high specificity true underlying value <NUMBER> <NUMBER> negative controls would required estimate specificity assay <NUMBER> approximately <NUMBER> power part evaluation test performance influence population prevalence also needs considered acknowledging present rapidly changing brenner gefeller <NUMBER> considered proportion positive tests wrong well number incorrect positive tests per <NUMBER> people tested example point care test <NUMBER> sensitivity <NUMBER> specificity proportion positive tests wrong <NUMBER> <NUMBER> population seroprevalence <NUMBER> falsepositives<NUMBER> tested <NUMBER> <NUMBER> seroprevalence <NUMBER> falsepositives<NUMBER> <NUMBER> <NUMBER> seroprevalence <NUMBER> falsepositives<NUMBER> according available data seropositivity prevalence still low prevalence antibodies sarscov<NUMBER> among high risk category healthcare personnel <NUMBER> utah grzelak et al <NUMBER> <NUMBER> denmark erikstrup et al <NUMBER> <NUMBER> kobe japan doi et al <NUMBER> <NUMBER> whuan china <NUMBER> guilan iran shakiba et al <NUMBER> large scale seroprevalence studies ongoing understanding background rates essential accurate interpretation diagnostic tests potential risk test providing false reassurance release sheltered nonimmune individuals therefore widely based underlying seroprevalence still assumes antibodypositivity correlate protective immunity may incorrect understanding viral host interactions acute convalescent phases critical able understand timing initial seroconversion exposure sarscov<NUMBER> subsequent duration antibodies however present studies regarding seroconversion developed parallel assays limiting conclusions data suggest seroconversion exposure sarscov<NUMBER> similar acute viral infections igg concentration beginning rise igm levels reach plateau figure <NUMBER> however observations igm iga growth relatively slow related respiratory viruses suggested contribute heterogeneous pathogenicity sarscov<NUMBER> covid<NUMBER> patients zhao et al <NUMBER> comprehensive study date seroconversion assessed <NUMBER> patients affected covid<NUMBER> utilizing assay developed detect antibodies receptor binding domain rbd spike protein sarscov<NUMBER> zhao et al <NUMBER> median seroconversion time total ab igm igg antibodies <NUMBER> <NUMBER> <NUMBER> days respectively zhao et al <NUMBER> respective seroconversion rates total ab igm igg <NUMBER> <NUMBER> <NUMBER> zhao et al <NUMBER> cumulative seroconversion curve suggesting rate total ab igm reached <NUMBER> <NUMBER> days onset studies also highlighted temporal nature testing despite patients subsequently confirmed covid<NUMBER> positive early phase illness within <NUMBER>day since onset natt test exhibited <NUMBER> sensitivity antibody assays even lower positive rate <NUMBER> zhao et al <NUMBER> however sensitivity ab overtook rna test since day <NUMBER> symptom onset reached <NUMBER> across day <NUMBER> onset among samples patients later phase day <NUMBER> since onset sensitivities total ab igm igg <NUMBER> <NUMBER> <NUMBER> respectively contrast rna detectable <NUMBER> samples day <NUMBER> separate small series nine cases seroconversion occurred <NUMBER> days <NUMBER> patients <NUMBER> days followed rapid decline viral load wolfel et al <NUMBER> analysis <NUMBER> patients would support igg seroconversion within <NUMBER> days symptom onset long et al <NUMBER> collectively data suggests role tests depending patient infection journey combined use natt ab tests markedly improving sensitivity pathogenicdiagnosis covid<NUMBER> patients different phases respect antibody titres disease severity critically ill hospitalized patients reported exhibit significantly higher ab title values noncritical cases studies zhao et al <NUMBER> long et al <NUMBER> studies previous epidemics sarscov merscov antibody titres positively associated disease severity okba et al <NUMBER> choe et al <NUMBER> limited case series n<NUMBER> confirmed sarscov<NUMBER> cases six patients detectable viral rna blood increased risk severe disease progression compared low titres unfortunately authors measure antibody titres chen et al <NUMBER>b clarification whether even previously healthy individuals high viral titre high antibody titer predict disease severity likely progression awaited extensive search identified <NUMBER> peerreviewed articles <NUMBER> preprint studies reporting sensitivity specificity immunoassays covid<NUMBER> sample size ranging <NUMBER> <NUMBER> subjects table <NUMBER> studies conducted china coming western countries overall sensitivity ranged <NUMBER> <NUMBER> specificity <NUMBER> <NUMBER> performance highly time sensitive reflecting dynamics seroconversion general assays performed better shortly initial symptom resolution accepting limited time frames evaluated studies date evaluation nine commercially available sarscov<NUMBER> immunoassays sensitivities varied duration disease early phase <NUMBER> <NUMBER> days onset disease symptoms sensitivities ranged <NUMBER> <NUMBER> middle phase <NUMBER> <NUMBER> days onset disease symptoms sensitivities ranged <NUMBER> <NUMBER> late phase ≥<NUMBER> days onset disease symptoms sensitivities ranged <NUMBER> <NUMBER> lassauniere et al <NUMBER> range assays released extensive apparently limited validation gonzalez colleagues reviewed four web databases sarscov<NUMBER> immunoassay april <NUMBER> <NUMBER> already <NUMBER> immunoassays <NUMBER> different countries technical data sheet available online <NUMBER> tests despite <NUMBER> claiming regulatory certification four pubmed listed papers gonzalez et al <NUMBER> despite wide claims sensitivity specificity practically present almost impossible conclude antibody test would one use pragmatic choice would use automated immunoassay scaleable wellknown established manufacturer complete clear technical data sheet received regulatory certification issued health authority validated independently accordance recent novel assays utilize fully automated chemiluminescence immunoassays clias implemented high throughput laboratory instrumentation systems <NUMBER> igg assays also exhibited different concordance early phases symptom onset concordance improved <NUMBER> days symptom onset studies longer timelines known cases range symptoms help confirm alignment assays inevitably anticipate enormous number studies comparing available assays advantages disadvantages respective assays discussed length point care poc immunoassays also developed rapid detection sarscov<NUMBER> antibodies igg igm primary advantage tests like home pregnancy test obtain diagnosis without sending samples centralized laboratories thereby enabling communities without necessary laboratory infrastructure detect sarscov<NUMBER> exposed subjects use finger prick testing rather formal blood draws thereby reducing training requirements enable clinicians validated test bedside devices cheap manufacture store distribute provided positive antibody test confirmed accurate surrogate immunity infection would also able inform decision making would particularly case secure confirmation antibody status would reduce anxiety provide confidence allow individuals relax social distancing measures guide policymakers staged release population lockdown potentially tandem digital approaches contact tracing rapid pointofcare immunoassays generally lateral flow immunoassays lfia lateral flow assays membrane strip coated two lines gold nanoparticleantibody conjugates one line bind antibodies blood sample patient put membrane proteins draw membrane strip capillarity passes first line antigen binds gold nanoparticleantibody conjugate complex flows together across membrane generally rapid assays low diagnostic performance compared elisa assays explained wellknown technical differences two methodologies also possible low antibody concentrations may contribute false negatives observed rapid tests present <NUMBER> peerreviewed articles <NUMBER> preprint studies reported diagnostic performance rapid assays summarised table <NUMBER> published studies sensitivity specificity ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively table <NUMBER> preprint articles sensitivity specificity ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively note sensitivity tests performed nonchinese countries substantially lower reported studies conducted china extensive evaluation manufacturers claims performance tests optimal timing required studies date sample size limited testing across large diverse population range geographical locations ethnic groups required inclusion children individuals autoimmune disease immunosuppression extensive evaluation likely technical performance may deteriorate present evaluation current lfia devices suggest although may provide information populationlevel surveys performance inadequate individual patient applications interpretation test sarscov<NUMBER> depend combination accuracy test estimated risk covid<NUMBER> prior performing test watson et al bmj <NUMBER> positive direct antigen test specifically nucleic acid amplification tests strongly suggestive current infection due high specificity moderate sensitivity patient reassured confident covid<NUMBER> managed accordance local policies regarding positive cases contrast negative tests need interpreted caution single negative sarscov<NUMBER> test patient strongly suggestive symptoms relied upon exclude covid<NUMBER> situation would still safer patient treated positive local policies regarding retesting isolation followed serological tests clinical implication seroconversion respect future immunity continue elucidated similar principles evaluating test result clinical context history previous infection exposure critical particularly false positive could lead false reassurance inappropriate behaviour may enhance community disease transmission present natt based methodologies remain cornerstone invitro diagnostic assays sarscov<NUMBER> urgent need development serological assays high sensitivity screening adequate specificity avoid unnecessary interventions confirmation seropositivity equates immunity present none point care diagnostics sarscov<NUMBER> appear suitable widescale deployment large prospective studies urgently needed clarify utility evaluation performance potentially scaleable highthroughput immunoassays ongoing however extensive validation across different populations required routinely used inform critical decision making clinicians public health community policymakers molecular serological assays sarscov<NUMBER> developed implemented exponential rate suite complementary tests inform crucial decisions healthcare providers policy makers understanding strengths limitations critical judicious application treatment public health strategies legend figure figure <NUMBER> time correlation viral load symptoms positivity diagnostic tests onset symptoms day <NUMBER> usually begins <NUMBER> days infection <NUMBER> early stage corresponding window asymptomatic period viral load could rtpcr threshold test may give false negative results well end disease patient recovering seroconversion usually may detectable <NUMBER> <NUMBER> days onset symptoms hence first <NUMBER> days infection serological tests likely give false negative results recently novel coronavirus sarscov<NUMBER> coronavirus disease <NUMBER> covid<NUMBER> emerged rapidly spreading severely straining capacity global health community many nations employing combinations containment mitigation strategies early diagnosis covid<NUMBER> vital controlling illness progression limiting viral spread within population thus rapid accurate methods early detection vital contain covid<NUMBER> prevent spread predicted subsequent infectious waves viral recurrence future immediately initial characterization chinese american centers disease control prevention cdcs rapidly employed molecular assays detection covid<NUMBER> mostly employing realtime polymerase chain reaction rtpcr methods however methods require specific expensive items equipment highly trained analysts requiring upwards <NUMBER> hours process requirements coupled associated financial pressures may prevent effective deployment diagnostic tests loop mediated isothermal amplification lamp method nucleic acid amplification exhibits increased sensitivity specificity significantly rapid require expensive reagents instruments aids cost reduction coronavirus detection studies shown successful application lamp assays various forms detect coronavirus rna patient samples demonstrating <NUMBER> copies viral rna template per reaction sufficient successful detection <NUMBER>fold sensitive conventional rtpcr methods importantly studies also demonstrated effectiveness lamp methodology detection sarscov<NUMBER> rna significantly low levels particularly following numerous improvements lamp assay protocols hypothesise recent advancements enhanced lamp protocols assay perhaps represent best chance rapid robust assay field diagnosis covid<NUMBER> without requirement specialized equipment highly trained professionals interpret results herein present <NUMBER> however early diagnosis covid<NUMBER> vital controlling illness progression limiting viral spread within population employed part mitigation strategies stop onward transmission decrease load healthcare systems <NUMBER> <NUMBER> thus rapid accurate methods early detection vital contain covid<NUMBER> prevent spread predicted subsequent infectious waves viral recurrence future figure <NUMBER> although covid<NUMBER> generally thought milder compared sars merscov full extent impact covid<NUMBER> remains pending however outbreak represents opportunity multiple governmental health sector stakeholders partner develop rapid diagnostic tests infectious agents global health concern <NUMBER> enable effective identification isolation strategies rapid robust diagnostic test essential conductible field local pointofcare poc centres without requirement specialized equipment highly trained professionals interpret results herein propose collection recently published articles potential protocol based loop mediated isothermal amplification lamp prevention cdcs rapidly employed molecular assays detection covid<NUMBER> clinical samples <NUMBER> <NUMBER> <NUMBER> methods groups mostly employed development quantitative rtpcr characterized rapid detection high sensitivity specificity often described gold standard virus detection <NUMBER> however novel pcrbased methods also present enhanced specificity assay sensitivity pcr produces numerous copies amplification gene series genetic sequences using primer sequence dna polymerase enzymes exponentially increase amount dna required pcr widely used amplify minute quantities dna enable adequate requisite amounts laboratory analysis diagnosis owing simplicity high sensitivity high sequence specificity pcrbased method routine reliable method detecting coronavirus infection patients <NUMBER> <NUMBER> <NUMBER> principle assays employed following conversion coronavirus rna complementary dna reverse transcription following pcr performed resultant amplification dna subject specific detection analytical methods electrophoresis sequencing <NUMBER> <NUMBER> <NUMBER> rtpcr significantly sensitive conventional methods <NUMBER> <NUMBER> routinely employed predominant method detection coronaviruses <NUMBER> <NUMBER> including covid<NUMBER> <NUMBER> concern however particularly current demanding times analysis requires various specialist expensive items equipment alongside highly trained analysts furthermore current pcrbased methods analysis require realistically speaking particularly dealing increasing volumes potential infected upwards <NUMBER> hours process requirements addition financial pressures dictating samples tested sent potentially hundreds miles away requisite facilities resources present perform diagnostic analysis may result inflation required time finances perform diagnostic tests loop mediated isothermal amplification lamp novel isothermal nucleic acid amplification method lamp exhibits increased sensitivity specificity due exponential amplification feature utilises <NUMBER> different target sequences simultaneously identified separate distinct primers reaction <NUMBER> lamp assays significantly rapid require expensive reagents instruments aids cost reduction coronavirus detection <NUMBER> first fip anneals template extension occurs using polymerase displacement activity bst polymerase displace product obtained fip extension reaction associated f<NUMBER> primer subsequently extension reaction occurs using bip product fip template dna due displacement dna synthesis associated b<NUMBER> primer reactions result product dumbbelllike structure essential lamp establish isothermal amplification loop structures always single stranded annealed fip bip loop structure formation eliminates denaturing step otherwise essential pcr obtaining singlestranded dna also establishes cyclic reaction dumbbelllike structure complementary product leading elongated products various copies target sequence produced reviews detailed schematics refer <NUMBER> <NUMBER> numerous studies shown successful application lamp assays various forms detect coronavirus rna patients samples <NUMBER> <NUMBER> <NUMBER> <NUMBER> demonstrating <NUMBER> copies viral rna template per reaction sufficient successful detection <NUMBER>fold sensitive conventional rtpcr methods <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> course however emerging technology disadvantages associated lamp assays methodology prevents inclusion internal pcr inhibition control necessitating duplication reactions testing another disadvantage perceived complexity methodology requiring complex primer design system constrain target site selection resolution specificity furthermore final product large fragment downstream applications cloning limited however despite drawbacks lamp ultrasensitive nucleic acid amplification method detect minute quantities dna rna templates within roughly hour far outstripping normally utilised rtpcr methods particularly current demands rapid sensitive testing growing number suspected covid<NUMBER> cases exceeds capacity many hospitals many patients remain untested impeding efforts control disease rapid pointofcare diagnostic covid<NUMBER> urgently needed propose lamp method detection table <NUMBER> eltholoth et al <NUMBER> recently described design two stage lamp covid<NUMBER> pennramp strategy could carried closed tubes either fluorescence colorimetric detection performance assays comparable conventional rtpcr assays also exhibited <NUMBER>fold higher sensitivity testing tested patient samples less tested patient samples importantly however zhang et al <NUMBER> described successful application lamp methodology identify covid<NUMBER> viral rna purified rna patient cell lysis using visual colorimetric detection results verified using rna samples purified respiratory swabs collected covid<NUMBER> patients wuhan china performance comparable commercial rtpcr tests requiring heating visual inspection intriguingly results obtained also comparable spiked rna samples patient samples suggesting improved methodology eltholoth et al <NUMBER> yield satisfactory results patient samples figure <NUMBER> considering success obtained zhang et al <NUMBER> using relatively lesssensitive lamp enhanced sensitivity pennramp strategy employed eltholoth et al <NUMBER> attributable modified twostep lamp protocol could prove significantly successful diagnostic pennramp involves preliminary reaction outer lamp primers amplify targets recombinase polymerase amplification rpa targets amplified concurrently second highly specific lamp reaction initiated specifically first stage uses outer lamp primers f<NUMBER> b<NUMBER> second stage combines <NUMBER> ramp primers nested principle significantly enhanced lamp sensitivity <NUMBER>fold compared normal lamp particularly operating purified crude samples <NUMBER> indeed pennramp methodology applied mock trials eltholoth et al <NUMBER> provided success rate <NUMBER> <NUMBER> copies viral rna per reaction compared <NUMBER> success rate <NUMBER> viral rna copies required pcr methods <NUMBER> <NUMBER> degree hypothesise modified lamp assay proposed eltholoth et al <NUMBER> perhaps represent best chance rapid robust assay field diagnosis covid<NUMBER> figure <NUMBER> using primer sequence strategies utilised hypothesise assay rapid costeffective simple method could applied within field shortnotice utilised users even limited training equipment would required would hotblock heater capable differential heating reagentwise costs would similar real time rtpcr real advantage would rapidity assay yielding results within hour testing compared <NUMBER> hours taken rtpcr methods aim necessarily quantitative measure infection rather simple positivenegative assay rapid detectionconfirmation consider strategy applied rapidly confirmed viability clinical samples rolled massdiagnostic testing current times pdf file article undergone enhancements acceptance addition cover page metadata formatting readability yet definitive version record version undergo additional copyediting typesetting review published final form providing version give early visibility article please note production process errors may discovered could affect content legal disclaimers apply journal pertain week alerting cluster pneumonia unknown etiology wuhan chinese authorities announced <NUMBER> january <NUMBER> novel coronavirus identified cause pneumonia according phylogenetic analysis novel severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> previously named <NUMBER>ncov belongs b lineage betacoronavirus genus sarbecovirus subgenus <NUMBER> j u r n l p r e p r f nucleotide sequence identity bat sarslike cov genome published previously <NUMBER> initially described china coronavirus disease covid<NUMBER> caused sarscov<NUMBER> rapidly gained ground evidence humantohuman transmission rose january <NUMBER> declared covid<NUMBER> outbreak public health emergency international concern disease spread worldwide highly sensitive specific tests crucial identify manage covid<NUMBER> patients implement control measures limit outbreak real aim study assess performances covid<NUMBER> ag respistrip frontline testing comparison molecular technique j u r n l p r e p r f nasopharyngeal swab specimens collected samples received microbiology department cliniques universitaires saintluc hospital tertiary hospital <NUMBER> beds brussels april <NUMBER> april <NUMBER> <NUMBER> samples selected random rapid antigen test performed immediately samples stored <NUMBER>°c test second time samples ultracentrifuged <NUMBER>g <NUMBER> hours <NUMBER>°c discarding supernatant <NUMBER> µl residual sample vortexed analyzed rapid test criteria used performance assessment covid<NUMBER> ag respistrip sensitivity specificity rtqpcr considered gold standard evaluation therefore positive negative samples molecular techniques considered true positive true negative samples respectively overall percentage agreement cohens kappa coefficient κ used evaluate assay agreement analyses performed using graphpad prism <NUMBER> graphpad prism software inc san diego california medcalc <NUMBER> medcalc software ltd ostend belgium collected <NUMBER> nasopharyngeal samples <NUMBER> patients median age study population <NUMBER> range <NUMBER> sex ratio <NUMBER> <NUMBER> men <NUMBER> women according ongoing pandemic context covid<NUMBER> diagnostic testing sarscov<NUMBER> crucial order limit spread virus well appropriately manage infected patients different diagnostic test manufacturers developed rapid tests based sarscov<NUMBER> proteins detection respiratory samples however analytical performances rapid antigenic tests depend different factors including viral load quality specimen processed performances also depend setting patients tested although covid<NUMBER> ag respistrip several advantages ease fast achievement test rapid answer lower cost nonrequirement special equipment skills compared molecular techniques data presented suggested rapid test suffering poor sensitivity rapid antigen detection test able detect sarscov<NUMBER> high sensitivity nasopharyngeal samples high viral load equivalent least <NUMBER> x <NUMBER> <NUMBER> copiesml ct <NUMBER> sensitivity declines substantially viral load decreases ct values <NUMBER> equivalent <NUMBER> x <NUMBER> <NUMBER> copiesml often case patients suffering covid<NUMBER> actually study specificity <NUMBER> overall sensitivity covid<NUMBER> ag respistrip <NUMBER> lack sensitivity rapid diagnostic tests virus detection already observed influenza h<NUMBER>n<NUMBER> pandemic <NUMBER> ensuring accurate diagnosis essential limit spread virus poor sensitivity covid<NUMBER> ag respistrip leads false negative results times pandemic great consequence rapid test thought used first line covid<NUMBER> diagnostic test belgium order possibility reduce number rtqpcr testing case positive results requiring confirmation negative results however negative results cannot rule sarscov<NUMBER> infection test little use j u r n l p r e p r f log copiesml internet connectivity opened door new techniques disease detection worldwide<NUMBER> ideas applied influenza given annual occurrence potential pandemics emerging infections<NUMBER> accurate rapid surveillance influenza acute respiratory infections could reduce costs associated unnecessary investigations facilitate timely hence effective use antiviral drugs influenza help prevent secondary spread infection reduce unnecessary use antibiotics shorten hospital stays<NUMBER> last decade internetbased influenza surveillance systems developed deployed nationally australia united states canada <NUMBER> countries europe<NUMBER> <NUMBER> <NUMBER> systems pioneered ability involve individual volunteers public health participatory process influenza acute respiratory illnessrelated symptoms collected community members voluntarily report health status weekly basis via web mobile apps data systems demonstrated potential better understand acute respiratory illness population detecting trends early point contact piecing together realtime patterns disease spread identifying important subpopulations monitoring course epidemic pandemic helping target prevention control efforts however none internetbased systems employ molecular diagnostics rapidly confirm viral cause illness important clinical presentation influenza similar illness caused respiratory pathogens<NUMBER> new detection technologies rapidly emerging homebased point care diagnosis harness realtime polymerase chain reaction well newer techniques high sensitivity specificity molecular detection<NUMBER> <NUMBER> technologies common threads needing investigation respect types specimens regards feasibility viral detection well willingness capability individuals generate sample specimens molecular detection acute respiratory infections generally consist nasopharyngeal wash aspirate gold standard however safety concerns lay volunteers collect type specimen home<NUMBER> nasal swabs successfully used volunteers collect viable samples influenza culture home first individuals classified nurses colds flu <NUMBER> <NUMBER> nasal self sampling used part populationbased surveillance respiratory virus infections compared contemporaneous clinical surveillance specimens general practitioner sampling european cohorts <NUMBER> <NUMBER> date none systems considered specimen types reported individuals symptoms linked detected infection nasal swabs easy use noninvasive nature oral specimen collection makes easier convenient thus preferable alternative nasal swabs<NUMBER> <NUMBER> oral specimens widely used obtain genetic material directtoconsumer medical tests<NUMBER> well although literature sparse oral specimens shown reliable detection certain respiratory pathogens saliva found accurate reliable detection h<NUMBER>n<NUMBER> comparable nasopharyngeal swab<NUMBER> oral specimens also found effective detection sars measles betahemolytic streptococcus pediatric patients<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> others found oral specimens inferior nasal swabs detection respiratory viruses still suitable settings obtaining nasal swab would impractical<NUMBER> beyond specimen type community participation analysis specimen collection flu surveillance also unexplored academic commercial entities demonstrated<NUMBER> <NUMBER> <NUMBER> home sample collection feasible community scale genomic microbiome std testing<NUMBER> <NUMBER> however utility format information communicated back individuals order useful impact public health behaviors related open question sum efforts use nasal swabs selfcollection specimens surveillance acute respiratory infection scale work reported adds existing efforts considering important questions utility different specimen types linking individual participatory symptom reports specimen types resulting surveillance information used individual level address needs developed goviral platform platform designed acquire community generated diagnostic samples couple contemporaneous information participatory syndromic reports thus goviral enables us test <NUMBER> types samples individuals able willing generate homes timely fashion acute respiratory infection along appropriate processing methods <NUMBER> usergenerated diagnostic information corresponds selfreported symptoms <NUMBER> reception use information public herein report results initial deployment <NUMBER> influenza season participant recruitment sign cohort lay volunteers recruited massachusetts recruitment open throughout study period november <NUMBER> <NUMBER> april <NUMBER> <NUMBER> used convenience sample order rapidly recruit participants evaluate platform first season thus anticipating participants skewed towards access internet permitting investigation via representative sampling subsequent years enrollment driven largely announcements local radio stations word mouth paid online advertisements social media also used means recruiting volunteers study study size limited ability recruit engage participants order register volunteers signed electronic consent form reported email address name mailing address gender age volunteers immediately sent kit see section keep home users instructed became sick symptoms cold flu perform specimen collection rapid test within <NUMBER> hours experiencing symptoms participants returned kit sent replacement allowing report second illness second illness included specimen provided least <NUMBER> weeks initial specimen goviral participants also registered flu near reported symptoms weekly surveys previously described<NUMBER> participant reported symptoms weekly survey immediately sent email reminder follow instructions kit submit specimens instructions submission kit made available report page report page individual confirms symptoms view video instructions supplementary information sample types rapid test record date illness began numbering sample tubes test results rapid test participants signed massachusetts mailing address sent kit symptom reports included study ethics protocol approved boston children’s hospital institutional review board kit contents kit figure <NUMBER> included oragene om<NUMBER> saliva collection tube dna genotek inc flocked nasal swab viral collection media part number <NUMBER>c diagnostic hybrids lateral flow immunoassay rapid test certest biotec certest rapid test tested influenza influenza b rsv adenovirus nasal specimen selected nasal swab rather nasopharyngeal swab easier collect individual previous study demonstrated comparable sensitivity using molecular diagnostic tests<NUMBER> selfcollected flocked swabs also found equivalent cell yield compared staff collected flocked swabs<NUMBER> respiratory cell yields higher using flocked nasal swabs compared rayon swabs<NUMBER> saliva sample used oragene saliva collection tube designed collection stabilization microbial dna rna saliva samples reported remain stable room temperature <NUMBER> weeks stability solution included tube<NUMBER> kits along prepaid postage mailed participants beginning influenza season prepaid return overnight postage used usps participants simply return kits dropping mailbox post office kits paired customized written instructions instructional videos see specimen collection section  specimen collection participants instructed collect nasal sample inserting flocked nasal swab approximately <NUMBER> cm one nostril rotating swab placed transport media testing <NUMBER> ml saliva transport media collected second nasal swab mixed reagent collected reagent used per instructions rapid test <NUMBER> written goviral kit instructions participants directed goviral website submit symptom information kit number photo rapid test results customized youtube instructional videos httpswwwyoutubecomwatchvgwrmbvfjrsg httpswwwyoutubecomwatchvjaqof<NUMBER>cya httpswwwyoutubecomwatchvs<NUMBER>oe<NUMBER>dldiw<NUMBER> showed participants collect oral nasal specimens package mailing samples sent overnight mail laboratory detection specimen preparation analysis specimens received excluded pair nasal saliva specimens received leaked due poor packaging appeared saliva added tested samples genmark respiratory viral panel biofire filmarray respiratory panel offer multiplex panel respiratory pathogens however differ dnarna extraction methods used measured sensitivity specificity nasopharyngeal specimens workflow parameters handson time time result relative ease use previous studies compared molecular multiplex platforms including laboratory developed molecular methods pcr<NUMBER> studies using nasopharyngeal np swab specimens different nucleic extraction methods platform potential differences viral load location saliva versus nasal specimens performance sample types still indeterminate detection genmark prior detection genmark assay dnarna extracted samples using magna pure extraction protocol details procedure reported supplementary information section genmark panel includes influenza subtype influenza h<NUMBER> influenza h<NUMBER> influenza <NUMBER> h<NUMBER>n influenza b respiratory syncytial virus rsv respiratory syncytial virus rsv b parainfluenza virus piv <NUMBER> parainfluenza virus piv <NUMBER> parainfluenza virus piv <NUMBER> human metapneumovirus hmpv human rhinovirus hrv adenovirus adenovirus c viral targets filmarray influenza influenza h<NUMBER> influenza h<NUMBER> influenza <NUMBER> h<NUMBER>n<NUMBER> influenza b respiratory syncytial virus rsv coronavirus hku<NUMBER> coronavirus nl<NUMBER> coronavirus <NUMBER>e coronavirus oc<NUMBER> parainfluenza virus piv <NUMBER> parainfluenza virus piv <NUMBER> parainfluenza virus piv <NUMBER> parainfluenza virus piv <NUMBER> human metapneumovirus hmpv human rhinovirusenterovirus adenovirus result binary threshold cycle c­­t <NUMBER> determined experience genmark system used classify pathogen detected analysis detection biofire filmarray specimens processed following procedure found filmarray respiratory panel instruction booklet filmarray rp contains extraction procedure internal controls within pouch filmarray dnarna extracted sample physical agitation chemical disruption cells beads possible results include detected detected equivocal influenza invalid survey order gauge diagnostic test results flu risk actually influence individuals change behaviors participants sent survey completion study period one two versions survey sent depending whether participant sent diagnostic samples participants asked preventative behaviors difficulty specimen collection protocols questions responses table s<NUMBER> outcomes statistical methods analyses performed using r version <NUMBER> r development core team vienna austria key outcomes interest selfreported symptoms participants could report fever cough sore throat shortness breath chills fatigue nausea diarrhea body aches headache diagnostic results nasal saliva specimens via genmark biofire systems set specimens sent timing specimen collection compared symptom onset noted order understand potential selfcollection univariate comparisons symptoms diagnostic results performed sample size low warrant analyses participant demographics participation november <NUMBER> <NUMBER> april <NUMBER> <NUMBER> <NUMBER> participants enrolled study received kit study period also sent second kit participants already completed one kit allowing second illnesses captured among cohort enrolled study participants <NUMBER> individuals reported symptoms study time frame individuals <NUMBER> pairs diagnostic samples returned <NUMBER> returned nasal sample accompanying saliva sample sent nucleic acid analysis participants submitted kits average <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> days symptom onset figure <NUMBER> people ages <NUMBER> <NUMBER> signed received kits figure <NUMBER> <NUMBER> signups women kits returned individuals ranging age <NUMBER> <NUMBER>   pathogens detected biofire filmarray genmark rapid tests <NUMBER> pairs samples tested <NUMBER> sets samples tested positive least one specimen systems <NUMBER> negative <NUMBER> cases saliva nasal specimens tested one system detect virus detected least one specimen using system influenza detected one nasal specimen genmark filmarray coronavirus detected one saliva sample detected genmark filmarray coronavirus detected one nasal sample filmarray genmark coronavirus detected one saliva sample filmarray genmark rsv detected nasal saliva samples one person filmarray genmark distribution samples viruses detected least one specimen saliva nasal systems illustrated figures <NUMBER>a b <NUMBER> cases difference results nasal saliva specimen pairs least one systems pathogen also detected system table s<NUMBER>  rapid immunoassays performed users useful identifying specimens positive influenza rsv adenovirus none rapid tests returned alongside <NUMBER> returned pairs specimens demonstrated positive results pathogens even ones determined positive pcrbased methods relationship symptoms diagnostic results people reported cdc centers disease control prevention’s “influenzalike illness” ili symptom profile fever cough sore throat two twelve tested positive influenza five twelve test positive anything panel five twelve tested positive viruses coronavirus hmpv rsv full summary symptom profiles pathogen provided table s<NUMBER> participant survey results results survey reported table s<NUMBER> overall found participants sent kit seek interventions healthcare professionals illness <NUMBER> ii harder people produce nasal sample saliva sample iii beyond finding diagnosis individuals reported would find also useful know others area near <NUMBER> sent kits <NUMBER> study seeks specifically study user preferences specimen types towards building scalable method connecting selfreported symptoms infection type understanding community prevalence respiratory infections multiple initial findings offered diagnostic samples generated public demonstrated high user participation rate half people reported symptoms completed kit sent specimens initial validation oral specimens compared nasal specimens used identification upper respiratory pathogens along reports greater comfort preference oral specimens anticipate participation rate biased upwards based types people may agreed participate study indicates sick home people willing able complete specimen collection influenza rsv coronavirus <NUMBER> subtypes hmpv hrv detected saliva nasal samples high concordance nasal saliva samples measured two different detection methods pairing symptom profiles detected viruses showed people selfreport common ili profile influenza survey found individuals became ill returned sample seek healthcare going clinic hospital overall saliva collection reported easier nasal swab specimen collection rapid immunoassays show value community use compared pcr detection communityacquired specimens beyond expected lower sensitivity specificity rapid tests specifications tests determined using nasopharyngeal swabs children thus performance specimens adults using nasal swabs attributed difference different assays genmark biofire filmarray demonstrated similar performance false negatives saliva nasal specimens system compared also found individuals would find useful know pathogens detected people community regarding finding diagnosis common reasons cited desiring information included concern exposure others especially also mentioned work healthcare results presented suggest methods achieving preferences studies involving diverse groups power conclusions increase many aspects study improved future research address one limitation study small nonrepresentative sample volunteers based internet mobile requirement participation well selfselective nature interest participants study similar demographically participatory systems<NUMBER> geographically recruitment purposefully limited expanded future target underrepresented groups although number samples received consistent expected number individuals would sick type respiratory infection indicates order increase number samples greater number participants required finally rapid tests included kits obtaining rapid results incentive individuals participate performance specific sensitive enough warrant use different rapid diagnostic tests may experimented forthcoming kits majority individuals report would like receive results tests within two days feasible model realtime test optimal decision making study represents advance respect field participatory public health surveillance systems todate reports literature online participatory studies limited selfreported syndromic information studies combined selfreported influenza symptoms serology understand attack rates population however linkage symptoms limited selfsampling studies although studies demonstrated individuals obtain nasal swab specimen report individuals prefer saliva initial results indicate potentially provide feasible medium acute upper respiratory infection detection finally via results survey indicated participatory information crowdsourced used generate contextspecific rapid information disease surveillance potential impact public health behaviors going forward study data goviral surveillance method offers potential benefits understanding household transmission characteristics enabling evaluation relationship reported symptom profiles viral etiology well spatiotemporal distribution upper respiratory infection duration symptoms relation viral etiology impact efforts individual’s public health healthcare seeking behavior beyond cohort approach community specimen collection used seasonal outbreak pandemic investigations future work increase number representatively study participant demographics well employ nextgeneration detection technologies improve sensitivity speed generating diagnostic results authors confirmed financial personal professional competing interests report <NUMBER> take preventative measures flu season multiple choices allowed sent kits n <NUMBER> responses  send kits <NUMBER> responses  <NUMBER> illness season sent sample prevent household member who’s specimen participating normal activities work school yes many days sent kits <NUMBER> responses  <NUMBER> go see doctor go hospital seek kind care illness sent kits <NUMBER> responses  <NUMBER> part process submitting sample easiest sent kits <NUMBER> responses  <NUMBER> part process submitting sample hardest sent kits <NUMBER> responses  <NUMBER> would find useful know result start feeling sick sent kits <NUMBER> responses  send kit <NUMBER> responses  <NUMBER> would find useful know others area near map sent kits <NUMBER> responses  send kit <NUMBER> responses  <NUMBER> would information sent kits <NUMBER> responses  didn’t send kit <NUMBER> responses    end december <NUMBER> patients symptoms flu like illness admitted wuhan china infecting organism remained unknown preliminary etiological agents suspected like influenza respiratory viruses chlamydia pneumoniae mycoplasma pneumoniae found laboratory investigations identify pathogen responsible metagenomic rna sequencing patients sample done complete viral genome data suggested new rna virus related family coronaviridae later designated <NUMBER>ncov novel cov<NUMBER> analysis revealed virus <NUMBER> genomic similarity sarslike bat coronaviruses belongs sarbecovirus subgenus betacoronavirusgenus <NUMBER> february <NUMBER> international virus classification commission renamed novel cov<NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> basis genetic composition similarity coronaviruses disease caused virus renamed covid<NUMBER> <NUMBER> coronaviruses group large sized <NUMBER> nm spherical positively sense nonsegmented singlestranded rna genome sized <NUMBER> kb largest among known rna viruses known infect animals humans <NUMBER> <NUMBER> <NUMBER> <NUMBER> coronavirus classified four genera aalpha bbeta cgamma ddelta two generaalpha contains covnl<NUMBER> cov<NUMBER>e beta contains covoc<NUMBER> covhku<NUMBER> middle east respiratory syndrome coronavirus merscov sarscov found infectious human <NUMBER> <NUMBER> genome covid<NUMBER> virus constitutes <NUMBER> nucleotides upon fresh reannotation mapping rnasequences obtained presented <NUMBER> reads assembly similar slcovzc<NUMBER>an already known bat strain sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> group viruses easily undergo mutation recombination adapt environment thus survive altering wide host range <NUMBER> causing constant longterm health threats therefore necessary understand virology prevent rapid spreading safety mankind coronavirus among top ten deadliest viruses known human beings high fatality rate <NUMBER> merscov <NUMBER> <NUMBER> sarscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> current sarscov<NUMBER> already infected around <NUMBER> million persons killing <NUMBER> persons <NUMBER> countries happened within <NUMBER> days emergence new virus <NUMBER> april <NUMBER> international air travel facility asymptomatic carriers state patients mainly responsible rapid exponential increase incidences covid<NUMBER> infections globe slow curtain covid<NUMBER> spread first step many countries including india followed complete lockdown countries second step slow spread disease identify infected persons early possible early prevention cure patient infected virus shows symptoms mild symptoms infection matching confusing common coldflu potential pathogen estimated reproduction number r <NUMBER> average secondary cases infected individual r <NUMBER> sarscov<NUMBER> told much higher ie <NUMBER> earlier human coronaviruses sars <NUMBER> mers <NUMBER> hence potential covid<NUMBER> potential causing pandemic turned true within short time span <NUMBER> <NUMBER> <NUMBER> even reported studies r <NUMBER> sarscov<NUMBER> estimated around <NUMBER> thus indicating even bigger pandemic situation present status <NUMBER> <NUMBER> asymptomatic carriers increase disease transmission uncontrollable manner identified quarantine early stage situation mass screening disease becomes necessary hence fast testing devices strongly advised prevent spread virus therefore rapid onthespot accurate screening potential virus carriers along critical observation patients without indicative symptoms much essential controlling spread covid<NUMBER> thus present review paper summarized various detection methods available detection covid<NUMBER> advantages disadvantages urgent need rapid poc detection method spot biosensor feasibly importance presence ever increasing countdown covid<NUMBER> infected patients coronavirus detection approaches generally based travel history person affected areas well analysis clinical symptoms along auxiliary examinations clinical symptoms like pneumonia due covid<NUMBER> highly atypical quite similar diseases due respiratory viral pneumonia rapid sensitive diagnosis covid<NUMBER> still unavailable although diagnosis methods available presently fig <NUMBER> virus detection different degree specificity based single multiple target molecule sarscov<NUMBER> methods use pathological changes patients organ imaging like ct viral nucleic acid like rt pcr using one gene next generation sequencing whole genome immunological molecules produced patient virus patients bodyantigenantibody reaction based tests like elisa utilizing diagnosis approach advantages shortcoming present scenario table <NUMBER> methods already established considered gold standard methods could replicated novel virus also others developed evaluated diagnosis virus hands methods technologiesdevices also developed pending regulatory approval intended use covid<NUMBER> methods described nucleic acid based technologies utilizes genetic material dnarna based principle highly specific base paring homologous strands genetic materialsbased detection diagnostics comparatively faster traditional culturebased methods useful highthroughput testing also provide clinical useful information like drug resistance virulence factors strain subtypes within hours relatively expensive technologies polymerase chain reaction pcr dna microarrays high throughput automated sequencing methods tremendous role routine clinical diagnosis discovering novel strains bacteria viruses pathogens current state art nucleic acidbased technologies diagnostics covid<NUMBER> future advancements along pro cons using technologies described nextgeneration sequencing ngs also called highthroughput sequencing hts method determine genomic sequence even <NUMBER> million base pairs single experiment technique diagnose inheritable diseases cancer infectious diseases earlier also technology used uk tracking outbreak due methicillin resistant staphylococcus aureus mrsa <NUMBER> <NUMBER> high precision traceability even single patient routine surveillance techniques could much precision ngs helps discovery novel viral strains large scale also provides rapid detection viruses link human diseases ngs technology along bioinformatics tools largely influenced modern viral parthenogenesis studies viral diagnostics technology also played great application present covid<NUMBER> outbreak initiation current outbreak sarscov<NUMBER> samples patients admitted acute respiratory distress syndrome negative suspected already known pathogens etiological pathogen identified ngs metagenomic rna sequencing phylogenetic analysis complete genome generated could conclude new strain rna virus belonged coronaviridae family designated sarscov<NUMBER> nucleotide similarity genome matching existing pathogens genome <NUMBER> therefore technology great importance identifying unknown pathogens mutation recombination genome pathogen short span time huge cost presently quantitative reverse transcriptionpolymerase chain reaction rrtpcr used diagnosis covid<NUMBER> gold standard molecular diagnostic technique many viruses well single step quantitative rtpcr taqman chemistry sensitive specific technology well established used easily needs specific primerprobe designed synthesized remaining components reaction remain used viruses without little change first sequence results sarscov<NUMBER> virus china candidate diagnostic rrtpcr assays designed made available public domain researchers various agencies manufacturers opted different set genes many genes sarscov<NUMBER> orf<NUMBER>a gene orf<NUMBER>b gene rdrp gene n gene e gene etc every assay varied degree sensitivity per standard protocol one patient confirmed infection selected target genes come positive httpivdcchinacdccnkyjz<NUMBER>t<NUMBER> <NUMBER>html <NUMBER> reported studies two individual singlestep rtpcr assays based upon taqmanchemistry performed identification amplification two segment two genes mostly n orf<NUMBER>b viral genome separately others used multiplex assays using one genes amplification single reaction https wwwcdcgovcoronavirus<NUMBER>ncovlabrtpcrpanelprimer probeshtml <NUMBER> although methods sensitive almost <NUMBER> take longer time confirmation test done well sophisticated laboratory testing done two steps first step screening assay using sarscov<NUMBER>specific e gene second step confirmatory assays targeted rdrp gene n gene orf<NUMBER>b positive control material used assays vitro transcribed rna known copy numbers rnase p gene detection used respiratory viruses used internal control give information quality sample collection rna extraction process standard testing protocol per httpsappswhointirisbitstream handle<NUMBER>whocovid<NUMBER>labtesting<NUMBER>engpdf involves <NUMBER> steps <NUMBER> sample collection patient <NUMBER> proper transportation collected samples laboratory <NUMBER> providing demographic clinical information laboratory <NUMBER> sample testing laboratory <NUMBER> preparing reporting correct appropriate test results testing carried specific centers delays diagnosis make condition patient severe pcr assays provide good results hand laborious expensive well studies using rtpcr syber green dye based assay found less specificity taqman probe based assays similar results reported recently china patients selfcollected saliva showed <NUMBER> <NUMBER> <NUMBER> positive sarscov<NUMBER> diagnosing sybr based rtqpcr <NUMBER> rtqpcr assays reported highly sensitive specific sarscov merscov detection also covid<NUMBER> technology prone false negative rates could result severe consequences due missed diagnosis covid<NUMBER> <NUMBER> real example present current outbreak sarscov<NUMBER> five patients reported negative rtqpcr found positive ct scan examination chest done recollected samples repeated rtqpcr patients confirmed positive sarscov<NUMBER> <NUMBER> sensitivity rtqpcr detection sarscov reported <NUMBER> <NUMBER> depends adopted protocol quality sample time collection amount maintenance cold chain total number samples <NUMBER> <NUMBER> needs improvement using synergistic approaches besides sensitivity problem rtqpcr drawbacks possible biological safety hazards occurred transport sample processing nucleic acid extraction requirement sophisticated laboratory equipment like biosafety cabinets often available main central laboratory <NUMBER> <NUMBER> technical expertise along sample transportation inevitable makes overall process time consuming drawbacks could make process less useful case health emergency present global outbreak situation moreover pcr able detect target virus also perform codetection several respiratory viruses leads increase false positive negative results <NUMBER> <NUMBER> lamp comparatively novel technique process approval covid<NUMBER> diagnosis molecular amplification technique amplify genomic material high efficiency shorter time technique based synthesis target dna constant temperature <NUMBER>°c using specially designed primer sand enzyme dna polymerase strand displacement activity instead heat denaturation pcr techniques <NUMBER> hour lesser time amplify target sequence <NUMBER> <NUMBER> copies forming cauliflower shaped structure final product consisting stem loop form dna many inverted repeats lamp userfriendly technique provides reliable sensitive specific results lesser time compared conventional techniques therefore become quite popular development focusing applications microbial detection <NUMBER> <NUMBER> technique advantage requiring single constant temperature thus eliminating need thermocycler power consumption ct scan also one diagnosis techniques high sensitivity due many researchers recommend use one necessary auxiliary diagnostic method covid<NUMBER> moreover results come even clinical symptoms appear typical features ct covid<NUMBER> patient include bilateral multilobar groundglass opacificities differently distributions posteriors also peripheral <NUMBER> along subpleura ascendance thickened lobular septa variable alveolar filling amalgation <NUMBER> according recent report wuhan ct significantly sensitive pcr isarscov<NUMBER> suspected persons results concluded patients negative rtqpcr reports sensitive accurate conclusion achieved using combination ctscan standard techniques like rtqpcr sensitive diagnostic tests moreover highresolution ct chest also proved essential tool detection sarscov<NUMBER> early stage take rapid necessary intervention <NUMBER> therefore various studies recently utilizing chest ct images diagnose covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> earlier also typical ct images patients infected sarscov merscov showed similar symptoms covid<NUMBER> <NUMBER> <NUMBER> per findings ct scans found great diagnostic tool screening covid<NUMBER> patients especially high prevalence pandemic areas ct scans indicative confirmatory tool pathogen detection covid<NUMBER> diagnosis associated shortcomings also inability separate cases pneumonia viral nonviral hysteresis abnormal ct imaging serological based testing methods normally use blood samples detection virus instead nasopharyngeal swab samples used pcr test blood samples contain either significant measurable concentration antibodies virus specific antigens two main type antibodies covid<NUMBER> diagnostic approaches different roads destination blood test looks immunoglobin g igg immunoglobulin igm bodys way remembering prior infection responded infection previous encounter crucial body able attack pathogen antibodies igm appears within days act first line active defense followed production igg start clearing infection kind infections fought igm igg bodys immune response mechanism utilized detect particular pathogen blood test covid<NUMBER> detect protein signature antigenbiomarkers antibodies particular virus sarscov<NUMBER> confirmed sarscov<NUMBER> specific antibodies case antigen detection confirmed sarscov<NUMBER> antigen case antibodies detection produced seasonal flu virus currently two types covid<NUMBER> tests reported one direct utilizing antigen based detection viral component present time infection second indirect using antibodies appears patients serum later due development immune response virus httpswwwecdceuropaeuenpublicationsdataoverviewrapidtestsituationcovid<NUMBER>diagnosiseueea antigen detection tests find nongovernmental organization httpswwwfinddxorgcovid<NUMBER>pipeline lists ten rapid antigen detection tests covid<NUMBER> eu approval ivds directives <NUMBER>ec yet come market due nonavailability distributors devices however reports competent authorities indicates availability three cemarked devices soon antibody detection tests nearly <NUMBER> antibody tests marked rapid sarscov<NUMBER> expected come soon market along various inhouse validated tests sarscov<NUMBER> many researchers help early diagnostic commercial scale <NUMBER> also number point care poct kits based igm igg elisa covid<NUMBER> showing higher detection rates compared nucleic acid based detection methods developed pretested many companies still commercial stage <NUMBER> elisa based detection kits developed developed using antibodies spike nucleocapsid membrane envelope proteins considered one sensitive method covid<NUMBER> diagnosis earlier also method using nbased igg elisa sbased igg elisa showed good sensitivity sarscov ie <NUMBER> <NUMBER> respectively <NUMBER> sensitivity elisa kit sarscov<NUMBER> still study also antibodiesbased diagnostic assays useful early active diagnosis covid<NUMBER> due longer time requirement <NUMBER> days developed host provides positive results detectable antibodies produced late appearance symptoms <NUMBER> <NUMBER> developed persist long infection cleared great urgency develop auxiliary method accurate diagnosis covid<NUMBER> enough sensitive specific cost effective rapid tests one involve nonautomated mostly qualitative cases quantitative also used vitro diagnostics ivds many diseases already also tried covid<NUMBER> diagnosis tests provide results within <NUMBER> min results considered instant compared molecular tests generally takes <NUMBER> h moreover tests user friendly thus wont require extensive training expertise operate used either hospital environment laboratories patient bedside without difficulty point care testing poct name indicates used patients bedside ease without experts trained person operate devices useful detecting various diseases including infectious viral like hiv influenza hepatitis etc bacterial disease cost effective userfriendly way help finding source health outbreaks quickly providing enough time authorities taking necessary preventive therapeutic measures many types poc devices handheld pocts great importance medical diagnostics includes various type biosensors biosensor selfcontained integrated analytical device consisting bioreceptor transducer signal detector interaction bioreceptor target analyte produces electronic signal transduces amplified detector circuit processed displayed biosensors helps development point care portable devices sensitive specific rapid diagnosis disease cost effective way use various diagnostics principles pcr involving rna dna sequences gel electrophoresis enzymelinked immunosorbent assay elisa also called sandwich assay involving interaction antigen antibodies detection procedures coupled fluorescent radioactive labeling <NUMBER> nowadays several advanced biosensorsbased diagnosis approaches utilized fabrication innovated novel handheld devices overcome drawbacks lengthy gold standard detection protocol biosensors use nanomaterials tunneling quantum properties leading enhancement signal amplification <NUMBER> nanomaterials high surfacetovolume ratio enhanced high sensitivity many fold <NUMBER> moreover viruses target analytes also nanoscale features make nanosensors potential diagnostics tool <NUMBER> nanobiosensors using aptamers one potent analytical tools rapid diagnosis diseases high sensitivity specificity cost effective userfriendly manner compared conventional methods <NUMBER> nanosensor great potential detection sarscov<NUMBER> even person without symptoms high sensitivity specificity selectivity covid<NUMBER> aptamers originated word aptus latin word means fit <NUMBER> <NUMBER> <NUMBER> consist oligonucleotides nucleic acids even small peptide molecules high specific binding affinity certain target molecules leading increase sensitive accurate detection molecules membrane protein amino acids toxins immunoglobulins cytokines growth factors coupling agents ionic metals intact cells small molecules aptasensors easily converted specific design surface activation modification chemical treatment induce linkers coupling sites due high reproducibility purity stability reversibility harsh environmental conditions vast availability target specific linkers aptamers used novel diagnostics tools <NUMBER> <NUMBER> <NUMBER> aptamers specially designed synthesized sarscov<NUMBER> using nucleocapsid protein obtain fast test results within seconds wont require sample preparation step pinpoints aptamer based poc detection sarscov<NUMBER> developmental stage developers claiming provide sarscov<NUMBER> test result within <NUMBER> min precise <NUMBER> httpswwwrapidmicrobiologycomnewspin point<NUMBER>slowcosthandheldcovid<NUMBER>aptamerbaseddiag nosticdeviceindevelopment alternative paperbased technology using waste water samples suggested kang mao et al <NUMBER> paper based device based integration different functional area like extraction elution purification amplification detection small inexpensive disposable paper printed wax surface form zones much possible complete whole testing process without power source energy simply folding paper various modes thus beneficial expensive complicated multistep techniques analytical devices provide highquality fast still precise method pathogens detection additionally low manufacturing cost userfriendly nature <NUMBER> <NUMBER> technology act alternative detection tool rapid tracing source presence causative agents like covid<NUMBER> pandemic area faeces urine disease carriers community entering sewer system could contain many biomarkers virus confirmed recent study showed infectious agents remain active several days even disseminated patients found suitable environment <NUMBER> <NUMBER> strong potential paperbased device trace covid<NUMBER> transmission community wastewater analyzing sarscov<NUMBER> faeces urine excreted output human presently various referral laboratories along european commission member states especially working validation various commercial testing assays developed covid<NUMBER> also trying find rapid diagnostic tests covid<NUMBER> researches regularly clinical trials rapid diagnostic tests finally getting approval regulatory bodies use public health safety regulatory authorities like european commission member state authorities find working close association updating every significant research outcome form product protocol earlier validated approved earliest upscaled device production distribution meet pace present demand testing screening rapid spread covid<NUMBER> across world become intense concern health officials globally urgent need developing better methods mass screening prevent spread virus emerged today scanning foreheads fever using thermal scanner widely used test cannot detect asymptomatic pre symptomatic infections distinguish novel coronavirus respiratory illnesses either rtpcr sarscov<NUMBER> specific diagnostic tests like rapid antibodiesbased kits used development seems worthy mass screening essential diagnose suspected cases clinic hospital results take time anywhere hours days slow frontline screening thus requirement rapid diagnostic tool like nanobiosensor based technology provide diagnosis result within seconds quite high mass screening need developed commercial scale soon possible many methodology devices aiming rapid diagnosis covid<NUMBER> pipeline development different stages poct biosensors alternative devices potential become technology future high sensitivity specificity reproducibility december <NUMBER> major outbreak wuhan reported world health organization country office china covid<NUMBER> highly infectious diseases reporting first case china rapidly covered entire world affected life millions people <NUMBER>th april total <NUMBER> confirmed cases <NUMBER> deaths covid<NUMBER> reported globally <NUMBER> due occurrence many cases worldwide january <NUMBER>th <NUMBER> world health organization declared public health emergency international concern <NUMBER> india present total number active cases deaths reported <NUMBER> <NUMBER> respectively government agencies <NUMBER> covid<NUMBER> infection also affected badly united states america spain italy countries occurrence epidemic respiratory infections wuhan china cdc country office china documented etiology attributed novel virus belongs coronavirus cov family includes alpha gamma coronoaviruses virus wide range host humans mammals birds infected one may exhibit symptoms may remain asymptomatic may severe symp toms respiratory digestive organs <NUMBER> <NUMBER> coronavirus rna virus contains approximately <NUMBER> kb positivesense singlestranded rna <NUMBER> <NUMBER> like corona viruses ncov least six open reading frames orfs many accessory genes <NUMBER> terminal twothirds genome consists two open reading frames orfs orf<NUMBER> orf<NUMBER> orf encodes two polyproteins namely pp<NUMBER>a pp<NUMBER>ab cleaved <NUMBER> <NUMBER> proteins respectively <NUMBER> terminal various structural proteins located nucleocapsid n membrane protein envelope protein e spike viruses also contain accessory protein help virus replication gene help ncov host specificity receptor binding may also contain hemagglutininesterase protein virion <NUMBER> covid<NUMBER> infected patients clinical manifestation includes fever cough primary clinical presentations others shortness breath myalgia etc patients may serious complications acute respiratory distress syndrome ards cytokine storm may leads death <NUMBER> collection appropriate specimen crucial detection infected cases covid<NUMBER> nasopharyngeal swab usually collected instances may miss detection therefore lower respiratory tract specimens sputum bronchoalveolar lavage bal may alternate choice <NUMBER> pandemic sarscov<NUMBER> reliable early accurate diagnosis crucial provide timely medical help infected individual well helps government agencies prevent spread individuals saves peoples lives false negative test result may lead spread epidemic community similarly false positive result may lead unnecessary treatment mental trauma patients therefore urgent need accurate rapid readily available reliable diagnostic test sarscov<NUMBER> infection till date various immunological nucleic acid amplification diagnostic tests developed easily available various integrated pointofcare molecular devices currently development available provide accurate fast diagnostic services sarscov<NUMBER> infections present crisis covid<NUMBER> accessible reliable testing need hour review try explore selection appropriate specimen availability utility various diagnostic tools purpose diagnosis covid<NUMBER> infected cases help authorities utilize suitable diagnostic tool tracking virus take timely action suppress transmission <NUMBER> per centre disease control prevention cdc recommendations upper respiratory specimens collected rtpcr based testing covid<NUMBER> especially nasopharyngeal specimen preferred choice <NUMBER> cdc also recommended nasopharyngeal swab possible specimen oropharyngeal op specimen nasal midturbinate nmt swab anterior nares nasal swab ns specimen nasopharyngeal washaspirate nasal aspirate na specimen collected alternatively specimens placed tube containing viral transport medium transported laboratory time similarly serological assay blood sample collected healthcare professional adhere infection prevention control guidelines use personal protective equipment gown gloves eye protection n<NUMBER> mask collecting specimen <NUMBER> shipping specimen reference diagnostic laboratories required sample must transported triple packaging system sample vial must properly labeled sealed kept outer covering absorbent material primary container placed secondary container secondary container placed frozen gel packs thermocol box outer container processes including packaging labeling shipping must done per guideline <NUMBER> various studies conducted given evidence sarscov<NUMBER> invade digestives system haematological system along respiratory system <NUMBER> peng et al <NUMBER> china study collected different types specimen detection sarscov<NUMBER> rna found highest positivity rate pharyngeal swab <NUMBER> equally blood anal swab <NUMBER> <NUMBER> urine another study published united states found stool oropharyngeal swab nasopaharyngeal swab positive sarscov<NUMBER> serum urine found negative however study published case report included one patient <NUMBER> study china enrolled <NUMBER> patients laboratory confirmed sarscov<NUMBER> infected among six blood specimens found positive <NUMBER> respiratory specimens found positive <NUMBER> another study china found interesting results virus detected feces blood along respiratory specimens however percentage promising <NUMBER> recently published case report japan investigators documented clinical suspicion high negative pcr test throat swabs sufficient rule covid<NUMBER> infection bronchoalveolar lavage bal lower respiratory tract specimen preferred diagnosis <NUMBER> thus important conclude final result highly suspected sarscov<NUMBER> infected individuals consider collecting various types specimen improve detection rate reduce false negative results similarly peng et al advocated usefulness testing different specimen types sarscov<NUMBER> infection monitor disease changes progression well establishing prognosis <NUMBER> virus culture done standard methodology described kim et al briefly vero cells cultured <NUMBER> × dulbeccos modified eagles medium dmem supplemented <NUMBER> fetal bovine serum <NUMBER> • c <NUMBER> co <NUMBER> used inoculation nasopharyngeal oropharyngeal samples <NUMBER> <NUMBER> days inoculation specific cytopathic effects observed later also confirmed using real time rt pcr researcher wuhan china done virus isolation human airway epithelial cells vero e<NUMBER> huh<NUMBER> cell lines inoculation bronchoalveolarlavage samples isolated virus named <NUMBER>ncov <NUMBER> using human airway epithelial cell cultures virus isolation skilled labor intensive task however found promising analysis respiratory pathogens humans <NUMBER> recently indian study reported first isolation sarscov<NUMBER> using vero ccl<NUMBER> cells <NUMBER> inoculated cells nasopharyngeal oropharyngeal samples visualized specific cytopathic effects covid<NUMBER> cells fixed dehydrated cut sections transmission electron microscopy standard methodology described kim et al <NUMBER> kim et al reported observed coronavirusspecific morphology found virus particle size ranged <NUMBER> <NUMBER> nm also found virus observed wide range intracellular organelles especially vesicles <NUMBER> viral culture sarscov<NUMBER> needs conducted biosafety level<NUMBER> facility cell culture useful isolation characterization viruses basically cell culture virus isolation recommended diagnostic purposes immunological test measures antibodies generated host bodys immune response virus infection measures proteins covid<NUMBER> virus present respiratory specimens virus enters human body elicit immune response produce antibody virus detection antibody infected person useful whether person symptoms symptom thus type tests provides valuable information person exposed covid<NUMBER> thing antibody detection test identification active cases sarscov<NUMBER> infections time severe acute respiratory syndrome sars epidemic various reports documented detection viral specific igm igg valid serological diagnosis <NUMBER> xiang et al <NUMBER> conducted study china found serodiagnosis covid<NUMBER> based igm igg elisa great specificity diagnosis covid<NUMBER> study found sensitivity specificity detection igm <NUMBER> <NUMBER> igg detection <NUMBER> <NUMBER> respectively confirmed patients covid<NUMBER> similarly suspected covid<NUMBER> cases sensitivity specificity found igm <NUMBER> <NUMBER> igg <NUMBER> <NUMBER> respectively thus detection igg igm higher specificity makes reliable could help us establish diagnosis covi<NUMBER> patients general lateral flow assay used rapid point care immunoassay assay could help us rapid onsite detection covid<NUMBER> especially case emergency assays developed detect antigen sars cov<NUMBER> virus detecting igg igm antibodies sars cov<NUMBER> virus infection <NUMBER> tang et al <NUMBER> emphasized detection igm igg antibodies rapid lateral flow assay play important role covid<NUMBER> infections help us assess burden infections find asymptomatic patients etc <NUMBER> covid<NUMBER> igmigg rapid test biomedomics point care device <NUMBER> sensitivity available market nguyen et al <NUMBER> despite rapidity low cost immunoassays based antigen detection sarscov<NUMBER> previous experience influenza flu viruses utilizing type assay limitation uses utilizing type antigen detection test one keep mind due sampling variability low viral load infected person may miss case serological assays rapidly developed measure host immune response invading pathogens serological assay used earlier sars corona virus outbreaks played important role <NUMBER> <NUMBER> study china documented immunehistochemical analysis detect antigen lung tissue patients detection igm igg antiviral antibodies serum provide additional evidences confirm covid<NUMBER> cases <NUMBER> recent study china analyzing family cluster sarscov<NUMBER> infections revealed serology testing assist timely diagnosis screening close contacts <NUMBER> although recommended serology testing used molecular testing available <NUMBER> however study china emphasized need serology testing pandemic covid<NUMBER> due high number cases <NUMBER> immunological tests limitation use early phase infection time immune response still building case covid<NUMBER> infection early phase developing immunological diagnosis diagnostic test approved food drug administration america still recommended use solely diagnosis covid<NUMBER> <NUMBER> similarly also recommended points care immunodiagnostic test used research setting purpose clinical decision making unless evidences also supported <NUMBER> even though certain limitations future immunological tests may critical role identification individuals recovered covid infection past test result may also help us choosing convalescent plasma used treatment option covid<NUMBER> infected individuals <NUMBER> acute respiratory infection rtpcr routinely used detect causative viruses respiratory secretions nucleic acid testing assay real time reverse transcriptionpolymerase chain reaction real time rtpcr one best accurate laboratory methods detecting tracking studying coronavirus real time rtpcr method detect presence specific target genetic material nowadays various fluorescent dyes used marker detect specific genetic target earlier radioactive isotopes used marker important aspect using realtime rtpcr assays amplification analysis carried closed system therefore chances false positive results minimized <NUMBER> real time rtpcr facilitates analyzing result real time even though process still ongoing makes useful conventional rtpcr provides result end recent emergence coronavirus covid<NUMBER> demonstrated need reliable rapid detection thus present scenario real time rtpcr widely used methods detection coronavirus molecular testing still gold standard relevant case diagnosis <NUMBER> molecular diagnostics developed based realtime rtpcr assays covid<NUMBER> infection loopmediated isothermal amplification clustered regularly interspaced short palindromic repeats multiplex isothermal amplification followed microarray detection methods developed evaluated worldwide <NUMBER> conducting pcr assay number molecular target identified within rna corona viruses helicase hel nucleocapsid n transmembrane envelope e envelope glycoproteins spike <NUMBER> hemagglutininesterase open reading frames orf<NUMBER>a orf<NUMBER>b rnadependent rna polymerase rdrp genes encode structural proteins utilized covid<NUMBER> diagnosis <NUMBER> real time pcr assay viral rna measured cycle threshold ct defined number cycles required fluorescent signal cross threshold becomes detectable interpretation result real timepcr based ct values specimen value less <NUMBER> clinically reported pcr positive rtpcr time results <NUMBER> specific false negative result may also occur may due sampling error inappropriate timing sampling <NUMBER> recommended e gene assay followed confirmatory assay using rdrp gene utilized first line screening covid<NUMBER> cases <NUMBER> united states cdc asked use two nucleocapsid protein targets n<NUMBER> n<NUMBER> molecular assay <NUMBER> study published hong kong china found rdrphel assay lowest limit detection vitro higher sensitivity specificity among three developed novel realtime rtpcr assays targeting rdrphel n genes sarscov<NUMBER> <NUMBER> advisable use least two molecular targets avoid situation potential genetic drift sarscov<NUMBER> crossreaction endemic coronaviruses well however ideal design would include least one conserved region one specific region mitigate effects genetic drift especially virus evolves within new populations <NUMBER> various studies conducted worldwide using molecular assay rtpcr assay diagnosis covid<NUMBER> infections table <NUMBER> studies used least two target assay combination diagnosis covid<NUMBER> infections study germany chosen envelope rnadependent rna polymerase <NUMBER> another study hong kong china researcher first used nucleocapsid screening followed confirmation open reading frame <NUMBER>b <NUMBER> similarly cdc conducted study united states selecting two loci nucleocapsid gene found good performance detection coivd<NUMBER> <NUMBER> view critical situations covid<NUMBER> infections worldwide various companies attempted develop commercial kits detection sarscov<NUMBER> rna real time pcr various institutes indian council medical research new delhi icmr till date <NUMBER> evaluated performance <NUMBER> commercial kits among <NUMBER> kits found satisfactory <NUMBER> even though rtpcr tool definitive diagnosis covid<NUMBER> sensitivity reported lower chest ct examinations however chest ct alone differentiate covid<NUMBER> pneumonia viral pneumonia <NUMBER> another molecular method loopmediated isothermal amplification lamp reaction could serve alternative method rtqpcr detect covid<NUMBER> lamp nucleic acid amplification technique amplifies dna isothermal condition rapidity high specificity method utilised diagnosis covid<NUMBER> without need specialized equipments trained analysts near future pointofcare device based lamp potential diagnostic tool diagnosis covid<NUMBER> infected individuals <NUMBER> recently prof feng zhang et al given crisprcas<NUMBER> clustered regularly interspaced short palindromic repeatsand associated cas proteins<NUMBER> based sherlock specific highsensitivity enzymatic reporter unlocking protocols accurate rapid method novel coronavirus covid<NUMBER> <NUMBER> kim et al study reported constructed next generation sequencing ngs library amplifying fulllength genes isolates using synthesized cdna primers specific sarscov<NUMBER> <NUMBER> development inclusion new technologies diagnosis covid<NUMBER> provide better accurate rapid tool developments may also reduce need sophisticated equipments specific training help us reach wide community screening well diagnosing present scenario early diagnosis crucial identify infectious cases prevent community transmission present scenario various technologies available provide better diagnostic services community outbreak need collect right specimen right time proper diagnosis due high risk infection challenges keep healthcare professional safe appropriate ppe kits real time rtpcr assay remain molecular test choice etiologic diagnosis covid<NUMBER> cases antibody based immunological test used supplementary tools screening whole community confirming molecular assay real time rtpcr immunological assay help us tackle major outbreak covid<NUMBER> impacted life people global economy rapid test kits demand providing rapid diagnostic services emergency situation well bedside patients summary proper utilization available test alone combination detect covid<NUMBER> cases soon possible saves lives human funding sources none declared required uncited references q<NUMBER> <NUMBER> since middecember <NUMBER> early february <NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov originating wuhan hubei province china infected <NUMBER> laboratoryconfirmed cases across <NUMBER> countries <NUMBER> deaths casefatality rate <NUMBER> <NUMBER> cases deaths china <NUMBER> based initial reported surge cases wuhan majority males median age <NUMBER> years linked huanan seafood wholesale market <NUMBER> reported cases similar symptoms onset illness fever cough myalgia fatigue cases developed pneumonia severe even fatal respiratory diseases acute respiratory distress syndrome <NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov betacoronavirus forms clade within subgenus sarbecovirus orthocoronavirinae subfamily <NUMBER> severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov also betacoronaviruses zoonotic origin linked potential fatal illness outbreaks <NUMBER> <NUMBER> respectively <NUMBER> <NUMBER> based current evidence pathogenicity <NUMBER>ncov <NUMBER> significantly lower sarscov <NUMBER> merscov <NUMBER> <NUMBER> however <NUMBER>ncov potentially higher transmissibility r <NUMBER> <NUMBER> sarscov r <NUMBER> <NUMBER> merscov r <NUMBER> <NUMBER> <NUMBER> possible expansion <NUMBER>ncov globally <NUMBER> declaration <NUMBER>ncov outbreak public health emergency international concern world health organization urgent need rapid diagnostics vaccines therapeutics detect prevent contain <NUMBER>ncov promptly however currently lack understanding available early phase <NUMBER>ncov outbreak systematic review describes assesses potential rapid diagnostics vaccines therapeutics <NUMBER>ncov based part developments merscov sarscov systematic search carried three major electronic databases pubmed embase cochrane library identify published studies examining diagnosis therapeutic drugs vaccines severe acute respiratory syndrome sars middle east respiratory syndrome mers <NUMBER> novel coronavirus <NUMBER>ncov accordance preferred reporting items systematic reviews metaanalyses prisma guidelines two independent reviewers focusing sars mers <NUMBER>ncov respectively third independent reviewer engaged resolve conflicting article interest used key words sars coronavirus mers <NUMBER> novel coronavirus wuhan virus identify diseases search strategy systematic searches diagnosis therapeutic drugs vaccines carried independently key words drug therapy vaccine diagnosis point care testing rapid diagnostic test used conjunction disease key words respective searches examples search strings found table s<NUMBER> searched randomized controlled trials rcts validation trials diagnostics test published english measured sensitivity andor specificity rapid diagnostic test pointofcare testing kit b impact drug therapy c vaccine efficacy either diseases date restriction applied <NUMBER>ncov searched vitro animal human studies published english <NUMBER> december <NUMBER> <NUMBER> february <NUMBER> outcomes interest addition reviewed references retrieved articles order identify additional studies reports retrieved initial searches studies examined mechanisms diagnostic tests drug therapy vaccine efficacy sars mers <NUMBER>ncov excluded google search <NUMBER>ncov diagnostics <NUMBER> february <NUMBER> table s<NUMBER> yielded five webpage links government international bodies official information guidelines europe cdc us cdc us fda three webpage links diagnostic protocols scientific commentaries five webpage links market news press releases six protocols diagnostics using reverse transcriptase polymerase chain reaction rtpcr six countries published whos website <NUMBER> google search <NUMBER>ncov vaccines yielded <NUMBER> relevant articles emergence <NUMBER>ncov real time rtpcr remains primary means diagnosing new virus strain among many diagnostic platforms available <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table s<NUMBER> among <NUMBER> diagnostics studies selected one study discussed use rtpcr diagnosing patients <NUMBER>ncov <NUMBER> table <NUMBER> period type specimen collected rtpcr play important role diagnosis <NUMBER>ncov found respiratory specimens positive virus serum negative early period also suggested early days illness patients high levels virus despite mild symptoms apart commonly used rtpcr diagnosing merscov four studies identified various diagnostic methods reverse transcription loopmediated isothermal amplification rtlamp rtinsulated isothermal pcr rtiipcr onestep rrtpcr assay based specific taqman probes rtlamp similar sensitivity real time rtpcr also highly specific used detect merscov comparable usual diagnostic tests rapid simple convenient likewise rtiipcr onestep rrtpcr assay also shown similar sensitivity high specificity mercov lastly one study focused validation six commercial real rtpcr kits high accuracy although real time rtpcr primary method diagnosing merscov high levels pcr inhibition may hinder pcr sensitivity table <NUMBER> eleven studies focus sarscov diagnostic testing table <NUMBER> papers described diagnostic methods detect virus majority using molecular testing diagnosis comparison molecular test ie rtpcr serological test ie elisa showed molecular test better sensitivity specificity hence enhancements current molecular test conducted improve diagnosis studies looked using nested pcr include preamplification step incorporating n gene additional sensitive molecular marker improve sensitivity table <NUMBER> addition seven potential rapid diagnostic kits <NUMBER> january <NUMBER> table <NUMBER> available market <NUMBER>ncov six research purposes one kit beijing genome institute bgi approved use clinical setting rapid diagnosis kits rtpcr two kits bgi china veredus singapore capability detect multiple pathogens using sequencing microarray technologies respectively limit detection enhanced realtime pcr method <NUMBER> <NUMBER> fold higher standard realtime pcr assay <NUMBER> <NUMBER> fold higher conventional pcr methods clinical aspect enhanced realtime pcr method able detect <NUMBER> cases sarscov positive samples confirmed assay <NUMBER> sarscov detected <NUMBER> <NUMBER> <NUMBER> samples sars patients day <NUMBER> day <NUMBER> illness none <NUMBER> samples healthy controls <NUMBER> • real time pcr threshold sensitivity <NUMBER> genome equivalents per reaction good reproducibility interassay coefficients variation <NUMBER> <NUMBER> • <NUMBER> specimens <NUMBER> patients positive viral load range <NUMBER> <NUMBER> genome equivalentsml realtime rtpcr reaction sensitive nested pcr reaction detection limit nested pcr reaction <NUMBER> <NUMBER> genome equivalents standard cdna control <NUMBER> realtime reversetranscription pcr rrtpcr rnadependent rna polymerase rdrp open reading frame <NUMBER>a orf<NUMBER>a loopmediated isothermal amplification lamp enzymelinked immunosorbent assay elisa immunofluorescent assay ifa immunochromatographic test ict nasopharyngeal aspirate npa emergence <NUMBER>ncov <NUMBER> potential vaccine candidates pipeline globally table <NUMBER> wide range technology messenger rna dnabased nanoparticle synthetic modified viruslike particle applied likely take year candidates start phase <NUMBER> clinical trials except funded coalition epidemic preparedness innovations cepi however kit developed bgi passed emergency approval procedure national medical products administration currently used clinical surveillance centers china <NUMBER> total <NUMBER> unique studies <NUMBER>ncov sars cov merscov vaccines screened four eventually included review studies sars mers vaccines excluded performed cell animal models figure <NUMBER> four studies included review phase clinical trials sars mers vaccines table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies population type cell animal human <NUMBER>ncov point screening published clinical trials mostly done united states except one sars vaccine done china <NUMBER> vaccine candidates sars mers reported safe welltolerated able trigger relevant appropriate immune responses participants addition highlight six ongoing phase clinical trials identified clinicaltrialsgov register <NUMBER> <NUMBER> table s<NUMBER> <NUMBER> <NUMBER> <NUMBER> trials testing safety immunogenicity respective merscov vaccine candidates excluded results published yet trials projected complete december <NUMBER> two studies russia <NUMBER> <NUMBER> december <NUMBER> germany <NUMBER> existing literature search return results completed <NUMBER>ncov trials time writing among <NUMBER> trials found systematic review table <NUMBER> nine clinical trials registered clinical trials registry clinicaltrialsgov <NUMBER>ncov therapeutics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> five studies hydroxychloroquine lopinavir plus ritonavir arbidol mesenchymal stem cells traditional chinese medicine glucocorticoid therapy usage commenced recruitment remaining four studies encompass investigation antivirals interferon atomization darunavir cobicistat arbidol remdesivir usage <NUMBER>ncov patients table <NUMBER> seroconversion measured s<NUMBER>elisa occurred <NUMBER> <NUMBER> participants <NUMBER> <NUMBER> doses respectively maintained <NUMBER> participants study end week <NUMBER> neutralising antibodies detected <NUMBER> participants one time points study <NUMBER> maintained neutralisation activity end study tcell responses detected <NUMBER> <NUMBER> participants <NUMBER> <NUMBER> doses respectively differences immune responses dose groups <NUMBER> weeks vaccineinduced humoral cellular responses respectively detected <NUMBER> <NUMBER> participants week <NUMBER> <NUMBER> molecules developed university scientists inhibit two coronavirus enzymes prevent replication discovered drug targets said <NUMBER> similar enzyme targets found sars virus researchers note identified drugs may available address ongoing outbreak hope make accessible future outbreaks <NUMBER> <NUMBER> first affiliated hospital guangzhou medical university xue bi jing tcm chictr<NUMBER> approved recruitment subjects started <NUMBER> besides six completed randomized controlled trials rct selected systematic review table <NUMBER> one ongoing randomized controlled trial targeted sars therapeutics <NUMBER> studies found clinicaltrialsgov updated since <NUMBER> many prospective retrospective cohort studies conducted epidemic centered usage ribavirin lopinavirritonavir ribavirin yet welldesigned clinical trials investigating usage three completed randomized controlled trials conducted sars epidemic<NUMBER> china <NUMBER> taiwan <NUMBER> hong kong <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies respectively investigated antibiotic usage involving <NUMBER> participants combination western chinese treatment vs chinese treatment <NUMBER> participants integrative chinese western treatment <NUMBER> patients usage specific chinese medicine four participants early use corticosteroid <NUMBER> participants another notable study open nonrandomized study investigating ribavirinlopinavirritonavir usage <NUMBER> participants <NUMBER> one randomized controlled trial investigating integrative western chinese treatment sars epidemic excluded chinese article <NUMBER> one ongoing randomized controlled trial targeted mers therapeutics <NUMBER> investigates usage lopinavirritonavir interferon beta <NUMBER>b likewise many prospective retrospective cohort studies conducted epidemic centered usage ribavirin lopinavirritonavirribavirin interferon convalescent plasma usage date one trial completed one phase <NUMBER> clinical trial investigating safety tolerability fully human polyclonal igg immunoglobulin sab<NUMBER> found available literature <NUMBER> trial conducted united states <NUMBER> demonstrated sab<NUMBER> safe welltolerated single doses another trial mers therapeutics found clinicaltrialsgova phase <NUMBER> trial united states evaluating safety tolerability pharmacokinetics pk immunogenicity coadministered merscov antibodies regn<NUMBER> regn<NUMBER> <NUMBER> however particularly respect improving clinical symptoms elevating quality life promoting immune function recovery promoting absorption pulmonary inflammation reducing dosage cortisteroid shortening therapeutic course treatment integrative chinese western medicine treatment obvious superiority compared using control treatment alone <NUMBER> microneutralization titres also correlated sab<NUMBER> levels serum single infusions sab<NUMBER> <NUMBER> mgkg appear safe welltolerated healthy participants <NUMBER> <NUMBER> discussion rapid diagnostics plays important role disease outbreak management fast accurate diagnosis specific viral infection enables prompt accurate public health surveillance prevention control measures local transmission clusters prevented delayed isolation laboratoryconfirmed cases close contacts quarantined monitored home rapid diagnostic also facilitates specific public health interventions closure highrisk facilities areas associated confirmed cases prompt infection control environmental decontamination <NUMBER> <NUMBER> laboratory diagnosis performed detecting genetic material virus b detecting antibodies neutralize viral particles interest c detecting viral epitopes interest antibodies serological testing culture isolation viable virus particles key limitations genetic material detection lack knowledge presence viable virus potential crossreactivity nonspecific genetic regions short timeframe accurate detection acute infection phase key limitations serological testing need collect paired serum samples acute convalescent phases cases investigation confirmation eliminate potential crossreactivity nonspecific antibodies past exposure andor infection coronaviruses limitation virus culture isolation long duration highly specialized skills required technicians process samples biological samples taken also play role sensitivity tests sarscov merscov specimens collected lower respiratory tract sputum tracheal aspirates higher prolonged levels viral rna tropism virus merscov viral loads also higher severe cases longer viral shedding compared mild cases although upper respiratory tract specimens nasopharyngeal oropharyngeal swabs used potentially lower viral loads may higher risk falsenegatives among mild mers sars cases <NUMBER> <NUMBER> likely among <NUMBER>ncov cases existing practices detecting genetic material coronaviruses sarscov merscov include reverse transcriptionpolymerase chain reaction rtpcr b realtime rtpcr rrtpcr c reverse transcription loopmediated isothermal amplification rtlamp realtime rtlamp <NUMBER> nucleic amplification tests naat usually preferred case merscov diagnosis highest sensitivity earliest time point acute phase infection <NUMBER> chinese health authorities recently posted full genome <NUMBER>ncov genbank gisaid portal facilitate detection virus <NUMBER> several laboratory assays developed detect novel coronavirus wuhan highlighted whos interim guidance ncov laboratory testing suspected cases include protocols countries thailand japan china <NUMBER> first validated diagnostic test designed germany corman et al initially designed candidate diagnostic rtpcr assay based sars sarsrelated coronavirus suggested circulating virus sarslike upon release sequence assays selected based match <NUMBER>ncov upon inspection sequence alignment two assays used rna dependent rna polymerase rdrp gene e gene e gene assay acts firstline screening tool rdrp gene assay confirmatory testing assays highly sensitive specific crossreact coronavirus also human clinical samples contained respiratory viruses <NUMBER> hong kong university used two monoplex assays reactive coronaviruses subgenus sarbecovirus consisting <NUMBER>ncov sarscov sarslike coronavirus viral rna extracted sarscov used positive control suggested protocol assuming sars eradicated proposed n gene rtpcr used screening assay orf<NUMBER>b assay acts confirmatory test however protocol evaluated panel controls positive control sarscov rna synthetic oligonucleotide positive control <NUMBER>ncov yet tested <NUMBER> us cdc shared protocol real time rtpcr assay detection <NUMBER>ncov primers probes designed universal detection sarslike coronavirus specific detection <NUMBER>ncov however protocol validated platforms chemistries apart protocol described limitations assay analysts engaged trained familiar testing procedure result interpretation false negative results may occur due insufficient organisms specimen resulting improper collection transportation handling also rna viruses may show substantial genetic variability could result mismatch primer probes target sequence diminish assay performance result false negative results <NUMBER> pointofcare test kit potentially minimize limitations highly prioritized research development next months serological testing elisa iift neutralization tests effective determining extent infection including estimating asymptomatic attack rate compared detection viral genome molecular methods serological testing detects antibodies antigens would lag period antibodies specifically targeting virus would normally appear <NUMBER> <NUMBER> days illness onset <NUMBER> furthermore studies suggest low antibody titers second week delayed antibody production could associated mortality high viral load hence serological diagnoses likely used nucleic amplification tests naat available accessible <NUMBER> vaccines prevent protect infection disease occurrence exposed specific pathogen interest especially vulnerable populations prone severe outcomes context current <NUMBER>ncov outbreak vaccines help control reduce disease transmission creating herd immunity addition protecting healthy individuals infection decreases effective r<NUMBER> value disease nonetheless social clinical economic hurdles vaccine vaccination programmes including willingness public undergo vaccination novel vaccine b side effects severe adverse reactions vaccination c potential difference andor low efficacy vaccine populations different clinical trials populations accessibility vaccines given population including cost availability vaccine vaccines <NUMBER>ncov currently development none testing time writing <NUMBER> january <NUMBER> coalition epidemic preparedness innovations cepi announced fund vaccine development programmes inovio university queensland moderna inc respectively aim test experimental vaccines clinically <NUMBER> weeks june <NUMBER> vaccine candidates developed dna recombinant mrna vaccine platforms organizations <NUMBER> based recent merscov outbreak already number vaccine candidates developed still preclinical testing stage vaccines development include viral vectorbased vaccine dna vaccine subunit vaccine viruslike particles vlpsbased vaccine inactivated wholevirus iwv vaccine live attenuated vaccine latest findings vaccines arebased review yong et al <NUMBER> august <NUMBER> <NUMBER> date reporting one published clinical study merscov vaccine geneone life science inovio pharmaceuticals <NUMBER> one sars vaccine trial conducted us national institute allergy infectious diseases phase clinical trials reported positive results one announced plans proceed phase <NUMBER> trial <NUMBER> due close genetic relatedness sarscov <NUMBER> <NUMBER>ncov <NUMBER> may potential crossprotective effect using safe sarscov vaccine awaiting <NUMBER>ncov vaccine however would require small scale phasebyphase implementation close monitoring vaccinees large scale implementation apart timely diagnosis cases achievement favorable clinical outcomes depends timely treatment administered ace<NUMBER> reported cell entry receptor used <NUMBER>ncov infect humans sarscov <NUMBER> hence clinical similarity two viruses expected particularly severe cases addition died merscov sarscov <NUMBER>ncov advance age underlying health conditions hypertension diabetes cardiovascular disease compromised immune systems <NUMBER> coronaviruses errorprone rnadependent rna polymerases rdrp result frequent mutations recombination events results quasispecies diversity closely associated adaptive evolution capacity enhance viralcell entry cause disease time specific population atrisk <NUMBER> since ace<NUMBER> abundantly present humans epithelia lung small intestine coronaviruses likely infect upper respiratory gastrointestinal tract may influence type therapeutics <NUMBER>ncov similarly sarcov however years following two major coronavirus outbreaks sarscov <NUMBER> merscov <NUMBER> remains consensus optimal therapy either disease <NUMBER> <NUMBER> welldesigned clinical trials provide gold standard assessing therapeutic measures scarce coronavirus protease inhibitors successfully completed preclinical development program despite large efforts exploring sarscov inhibitors bulk potential therapeutic strategies remain experimental phase handful crossing vitro hurdle stronger efforts required research treatment options major coronaviruses given pandemic potential effective treatment options essential maximize restoration affected populations good health following infections clinical trials commenced china identify effective treatments <NUMBER>ncov based treatment evidence sars mers currently effective specific antiviral highlevel evidence specific antiviral therapy provided context clinical studytrial treatments shown real curative action sars mers literature generally describes isolated cases small case series many interferons three classes tested antiviral activities sarscov vitro animal models interferon β consistently shown active followed interferon α use corticosteroids interferon alfacon<NUMBER> synthetic interferon α appeared improved oxygenation faster resolution chest radiograph abnormalities observational studies untreated controls interferon used multiple observational studies treat sarscov merscov patients <NUMBER> <NUMBER> interferons without ribavirin lopinavirritonavir likely beneficial trialed china <NUMBER>ncov drug treatment appears advanced timing treatment likely important factor effectiveness combination ribavirin lopinavirritonavir used postexposure prophylaxis health care workers may reduced risk infection ribavirin alone unlikely substantial antiviral activities clinically used dosages hence ribavirin without corticosteroids lopinavir ritonavir among combinations employed common agent reported available literature efficacy assessed observational studies retrospective case series retrospective cohort study prospective observational study prospective cohort study randomized controlled trial ranging seven <NUMBER> participants <NUMBER> lopinavirritonavir kaletra earliest protease inhibitor combination introduced treatment sarscov efficacy documented several studies causing notably lower incidence adverse outcomes ribavirin alone combined usage ribavirin also associated lower incidence acute respiratory distress syndrome nosocomial infection death amongst favorable outcomes recent vitro studies shown another hiv protease inhibitor nelfinavir antiviral capacity sarscov although yet show favorable outcomes animal studies <NUMBER> remdesivir gilead sciences gs<NUMBER> nucleoside analogue vitro vivo data support gs<NUMBER> development potential pancoronavirus antiviral based results several coronaviruses covs including highly pathogenic covs potentially emergent batcovs use remdesivir may good candidate investigational treatment improved mortality following receipt convalescent plasma various doses consistently reported several observational studies involving cases severe acute respiratory infections saris viral etiology significant reduction pooled odds mortality following treatment <NUMBER> compared placebo therapy observed <NUMBER> studies however moderate high risk bias given small sample sizes allocation treatment based physicians discretion availability plasma factors like concomitant treatment may also confounded results associations convalescent plasma hospital length stay viral antibody levels viral load respectively similarly inconsistent across available literature convalescent plasma promising likely yet feasible given limited pool potential donors issues scalability monoclonal antibody treatment progressing sarscov enters host cells binding spike protein angiotensin converting enzyme <NUMBER> ace<NUMBER> cd<NUMBER>l <NUMBER> human monoclonal antibodies protein shown significantly reduce severity lung pathology nonhuman primates following merscov infection <NUMBER> neutralizing antibodies elicited active passive immunization using vaccines convalescent plasma respectively neutralizing antibodies theoretically harvested individuals immunized vaccines uncertainty achievement therapeutic levels antibodies therapeutic agents also reported known antimalarial agent chloroquine elicits antiviral effects multiple viruses including hiv type <NUMBER> hepatitis b hcov<NUMBER>e chloroquine also immunomodulatory capable suppressing production release factors mediate inflammatory complications viral diseases tumor necrosis factor interleukin <NUMBER> <NUMBER> postulated chloroquine works altering ace<NUMBER> glycosylation endosomal ph antiinflammatory properties may beneficial treatment sars niclosamide known drug used antihelminthic treatment efficacy niclosamide inhibitor virus replication proven several assays immunoblot analysis immunofluorescence assays niclosamide treatment observed completely inhibit viral antigen synthesis reduction virus yield infected cells dose dependent niclosamide likely interfere early stages virus attachment entry cells function protease inhibitor mechanisms niclosamide activity warrant investigation <NUMBER> glycyrrhizin also reportedly inhibits virus adsorption penetration early steps virus replication glycyrrhizin significantly potent inhibitor low selectivity index tested several pathogenic flaviviruses preliminary results suggest production nitrous oxide inhibits virus replication induction nitrous oxide synthase mechanism glycyrrhizin sarscov remains unclear compound also relatively lower toxicity compared protease inhibitors like ribavirin <NUMBER> inhibitory activity also detected baicalin <NUMBER> extracted another herb used treatment sars china hong kong findings compounds limited vitro studies <NUMBER> <NUMBER> <NUMBER> <NUMBER> due rapidly evolving situation <NUMBER>ncov potential limitations systematic review systematic review likely publication bias developments yet reported developments intention report publicly scientific platforms due confidentiality concerns however may limited developments review publicity help branding extent company andor funder furthermore due rapid need share status developments may reporting bias details provided authors scientific articles commentary articles traditional media lastly viable form quality assessment metaanalysis selected articles due limited data provided heterogeneous style reporting different articles paper provided comprehensive overview potential developments pharmaceutical interventions early phase outbreak systematic review would useful crosscheck quality assessment metaanalysis developments performed followup study rapid diagnostics vaccines therapeutics key pharmaceutical interventions limit transmission respiratory infectious diseases many potential developments pharmaceutical interventions <NUMBER>ncov ongoing containment phase outbreak potentially due better pandemic preparedness however lessons merscov sarscov shown journeys developments still challenging moving ahead supplementary materials following available online httpwwwmdpicom<NUMBER>s<NUMBER> table s<NUMBER> example full search strategy pubmed table s<NUMBER> google search <NUMBER>ncov diagnostics table s<NUMBER> summary diagnostic assays developed <NUMBER>ncov table s<NUMBER> children admitted emergency departments ed fever respiratory symptoms represent major burden health care system well significant anxiety expense parents caregivers physicians often order diagnostic tests may prescribe antibiotics unsure cause illness concerned possibility serious bacterial infection however cases fever respiratory symptoms caused viruses addition children virus found cause illness risk serious bacterial infection low review conducted assess whether rapid viral test done ed changes physicians treating children found previously healthy children coming ed fever respiratory symptoms rapid viral test reduces use chest xrays trend toward less antibiotic usage blood urine investigations true impact intervention latter three outcomes requires trials larger enrollment numbers acute respiratory infections aris serious public health issue rank among top five causes illness hospitalization children influenza seasons fever respiratory infection symptoms make <NUMBER> reasons visit emergency department ed silka <NUMBER> although aris caused bacteria commonly caused viral infections rapid diagnosis viral infection may lead decrease use antibiotics additional testing possibly admissions commonly implicated causal viruses influenza b respiratory syncytial virus rsv human parainfluenza <NUMBER> <NUMBER> <NUMBER> rhinovirus adenovirus viruses account <NUMBER> <NUMBER> children ari variability range positive viral diagnosis may affected choice viral tests used scope viral detection jennings <NUMBER> weigl <NUMBER> risk concurrent bacterial infection children confirmed viral ari study children aged <NUMBER> <NUMBER> months recognizable viral infections showed concurrent rate bacteremia <NUMBER> <NUMBER> greens <NUMBER> prospective multicenter study infants less <NUMBER> days old ari showed significant difference rate urinary tract infection rsv positive <NUMBER> negative infants <NUMBER> nonsignificant difference rate bacteremia <NUMBER> <NUMBER> cases bacterial meningitis among <NUMBER> rsv positive infants <NUMBER> cases <NUMBER> rsv negative infants statistically significant levine <NUMBER> however symptoms viral ari overlap bacterial infections pneumonia bacteremia meningitis cases difficult distinguish without confirmed viral diagnosis medical assessment diagnostic tests often used decision patient management parental advice hospital admission made precautionary tests lead intense use human health resources nursing laboratory radiology staff hospital facilities furthermore tests often invasive sometimes unnecessarily prolonging childs visit ed resulting suboptimal ed service provision contributing lengthy ed wait times overcrowding aris impose large costs health system high number physician visits ed visits hospitalization antibiotic prescriptions studies comparing health care utilization aris children <NUMBER> <NUMBER> years old influenza season rest year showed significant excess physician visits <NUMBER> <NUMBER> age specific population annually ed visits <NUMBER> age specific population annually hospital admission <NUMBER> <NUMBER> age specific population annually antibiotic prescription <NUMBER> age specific population annually burden came children three years age menec <NUMBER> neuzil <NUMBER> study comparing costs associated visit ed versus primary care provider showed average cost assessing patient ari ed excluding antibiotics cost <NUMBER> <NUMBER> comparison <NUMBER> <NUMBER> primary care providers office <NUMBER> patients common cold treated antimicrobials costs <NUMBER> million annually rosenstein <NUMBER> despite aris caused viruses physician nursing costs contributed <NUMBER> ari management costs martin <NUMBER> suggests extra investigations antibiotic prescribing ed may responsible much unnecessary costs sars outbreak <NUMBER> access rapid respiratory viral diagnosis acute care settings provision sameday identification influenza virus b parainfluenza virus <NUMBER> <NUMBER> <NUMBER> rsv adenovirus enabled rapid informed patient management decisions helped triaging suggests role rapid viral diagnosis alleviating burden eds improving health service delivery health resource allocation situation increased use eds ari symptoms prompt viral diagnosis might improve decisionmaking reduces unnecessary hospital admittance prescription antibiotics diagnostic investigations supported observational data retrospective chart reviews children admitted hospital subsequent confirmed diagnosis adenovirus infection revealed change management <NUMBER> including revision antibiotic treatment use antiviral therapy rocholl <NUMBER> similarly chart reviews children testing positive via rapid influenza diagnostic test less likely prescribed antibiotics ed <NUMBER> versus <NUMBER> p <NUMBER> admitted antibiotics fewer days <NUMBER> versus <NUMBER> days p <NUMBER> noyola <NUMBER> children early diagnosis influenza also fewer blood tests <NUMBER> versus <NUMBER> p <NUMBER> urine tests performed <NUMBER> versus <NUMBER> p <NUMBER> compared children late diagnosis sharma <NUMBER> advances virology testing allow viral detection within <NUMBER> <NUMBER> minutes direct immunofluorescent antibody detection reported high sensitivity <NUMBER> specificity <NUMBER> vega <NUMBER> confirmation specific diagnosis viral respiratory infection accessible reliable better investigating possible diagnosis children presenting ed fever respiratory symptoms may improve management rational decisions investigations treatment literature yet systematically reviewed may evidence substantial reductions unnecessary investigation costs antibiotic prescribing children ari ed positively identifying viral illness rather attempting exclude serious bacterial cause determine use rapid viral detection test children ari eds changes patient management resource use ed compared using rapid viral detection test hypothesized rapid viral testing reduces antibiotic use ed well reduces rate ancillary testing length ed visits • randomized controlled trials rcts evaluating use rapid viral diagnosis children admitted ed ari included • studies otherwise healthy children aged <NUMBER> <NUMBER> years old • studies reported separately subgroups children <NUMBER> years age admitted ed clinical presentation consistent ari fever respiratory symptoms cough runny nose sore throat congested nose evidbased child health <NUMBER> <NUMBER> <NUMBER> consider • studies including participants immunocompromized • studies including participants underlying chronic severe respiratory conditions cystic fibrosis bronchopulmonary dysplasia • studies including participants chronic heart conditions uncorrected cyanotic heart lesions prosthetic valves rapid viral diagnosis nasal pharyngeal aspirates swabs direct indirect immunofluorescent antibody test idf ifa enzyme immunoassays eia optical immunoassay oia molecular testing multiplex pcr rapid viral diagnosis implies results made available participants stay ed intervention group include participants rapid viral diagnostic testing participants control group rapid viral diagnostic test performed treating physician knowledge test results • antimicrobial prescription rate ed reduction antibiotic use <NUMBER> rr <NUMBER> considered clinically important • length hospital ed stay reduction <NUMBER> minutes considered clinically important • rate ancillary tests blood tests chest imaging urine investigations requested reduction ancillary testing <NUMBER> rr <NUMBER> considered clinically important • rate physician visit ed office within two weeks discharge ed relative increase physician visit within two weeks discharge ed <NUMBER> rr <NUMBER> considered clinically important • hospital admission rate reduction admission rate <NUMBER> rr <NUMBER> considered clinically important • acceptability nasal specimen collection sampling rapid viral testing discomfort level invasiveness procedure searched cochrane central register controlled trials central cochrane library <NUMBER> issue <NUMBER> contains ari groups specialized register medline <NUMBER> april week <NUMBER> <NUMBER> embase <NUMBER> week <NUMBER> <NUMBER> medline inprocess nonindexed citations april <NUMBER> <NUMBER> healthstar <NUMBER> <NUMBER> biosis previews <NUMBER> <NUMBER> cab abstracts <NUMBER> <NUMBER> cbca reference <NUMBER> reference <NUMBER> proquest dissertations theses full text <NUMBER> <NUMBER> search terms adapted accommodate controlled vocabulary search language electronic resource medline search terms combined highly sensitive search strategy identifying rcts lefebvre <NUMBER> filter modified use medline inprocess nonindexed citations embase healthstar search strategies included pediatric terms restrict pediatric studies language date restrictions applied search strategies detailed search strategies available appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> appendix <NUMBER> included articles derived original search provided principal researcher tracked forward using cited reference search feature web science scopus citation tracker clinical trialsgov searched additional unpublished trials pediatric academic society society pediatric research joint conference abstracts databases <NUMBER> <NUMBER> searched identification meeting abstracts two reviewers qd pe searched pediatric academic society society pediatric research joint meetings abstract archives <NUMBER> <NUMBER> potential studies rapid viral testing relevant abstracts also found electronic databases two reviewers qd pe independently extracted verified data entry accuracy used review manager revman <NUMBER> statistical package conduct analyses pooled differences rate investigations antibiotic use analyzed using mantelhanzel test expressed risk ratio rr <NUMBER> confidence interval ci pooled difference ed length visits analyzed using inverse variance method expressed mean difference <NUMBER> ci randomeffects model applied statistical analyses two reviewers qd pe screened titles abstracts identified citations exclude trials clearly relevant meet inclusion criteria review abstracts titles deemed relevant potentially meeting criteria either review author full article retrieved examination two review authors assessed articles confirm meet inclusion criteria review two review authors independently extracted data published studies using standardized data extraction forms trial authors contacted obtain unpublished information including outcome data explicitly stated published papers disagreements data extraction resolved discussion consensus review authors evaluated methodological quality trial review authors used risk bias tables higgins <NUMBER> allocation concealment described schulz assessed clearly adequate clearly inadequate unclear schulz <NUMBER> dichotomous data antibiotic prescription ed primary objective ancillary tests performed ed admission hospital physician visits revisits ed within two weeks discharge original ed visit expressed rr continuous data mean length stay ed expressed mean difference md heterogeneity tested using chi <NUMBER> statistic provided revman <NUMBER> statistical package intended use visual inspection funnel plots assess publication bias small study effects small number studies included review would make interpretation plots difficult questionable meaning perform subgroup analyses data consistently available age groups performed sensitivity analysis comparing studies risk bias deemed adequate inclusion given invasive nature specimen acquisition rapid respiratory virus testing intervention cannot blinded therefore study deemed free bias electronic database searches resulted <NUMBER> references duplicates eliminated six prospective randomized trials rapid viral testing children search pas conference proceedings yielded references already recovered electronic search found one additional potential study clinical trialsgov registry many attempts contacting author enquire status study unsuccessful snowballing using scopus web sciences hand searching references included studies yielded one additional study rapid viral testing children cohen <NUMBER> total seven studies carefully reviewed four meeting inclusion criteria bonner <NUMBER> single center rct assessing participants presenting large american tertiary center pediatric ed fever symptoms acute respiratory illness less <NUMBER> hours goal study assess whether prior knowledge positive influenza test changed physician decisionmaking management participants results study found statistically significant lower rate antibiotic prescription risk ratio rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> shorter mean ed length visit <NUMBER> min <NUMBER> ci <NUMBER> <NUMBER> lower rate chest radiography rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> participants whos rapid influenza test results made available treating physician trend lower rate blood urine investigations also found statistically significant details pertaining participants outcome measures limitations found charateristics included studies tables poehling <NUMBER> rct assessing participants presenting pediatric ed acute care clinic signs symptoms respiratory tract infections data analyzed reported separately two populations considered study population enrolled ed goal study assess whether rapid diagnosis influenza affects evaluation treatment children acute respiratory illnesses approximately <NUMBER> study population deemed highrisk medical participants defined publication red book cid <NUMBER> patient influenza vaccination recommended <NUMBER> children chronic disorders pulmonary cardiovascular systems including asthma <NUMBER> children required regular medical followup hospitalization preceding year chronic metabolic diseases including diabetes mellitus renal dysfunction hemoglobinopathies immunosuppression including immunosuppression caused medications human immunodeficiency hiv virus <NUMBER> children adolescents receiving longterm aspirin therapy therefore might risk developing reyes syndrome influenza infection primary trial author contacted clarification <NUMBER> five participants condition may met exclusion criteria congenital heart disease bronchopulmonary dysplasia unknown severity possible immune defect reported parents unrelated chemotherapy rest asthma exclusion criteria review raw data excluding five participants obtained primary author used metaanalysis reanalyzed data showed trend lower rate blood urine investigations chest radiography higher rate antibiotic prescription participants rapid influenza results available treating physician none findings statistically significant details pertaining participants outcome measures limitations found charateristics included studies tables iyer <NUMBER> prospective quazirandomized controlled trial assessing participants presenting large urban tertiarycare pediatric emergency department goal study assess effect rapid influenza diagnosis physician management previously healthy febrile participants aged two <NUMBER> months risk serious bacterial infection despite fact study mentioned fever inclusion criteria close <NUMBER> children enrolled study also symptoms acute respiratory illness study reported significant differences mean length ed visit laboratory testing chest radiography antibiotic use return ed visit rates two study groups per original randomization details pertaining participants outcome measures limitations found charateristics included studies tables doan <NUMBER> single center openlabel randomized controlled trial assessing participants presenting large canadian tertiary center pediatric ed goal study measure effect multiviral rapid diagnostic test clinical management resource utilization pertaining healthy children presented ed signs symptoms febrile acute respiratory infection respect primary endpoint statistically significant reduction length ed visits well statistically significant difference found ordering chest radiographs blood tests urine analysis antibiotic prescription interestingly though significant reduction rate antibiotic prescription primary care providers one week discharge ed rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> details pertaining participants outcome measures limitations found charateristics included studies tables esposito <NUMBER> single center rct assessing children presenting pediatric ed fever signssymptoms respiratory illness goal study assess effect rapid diagnosis influenza management children influenzalike illnesses children meeting inclusion criteria randomized undergo tonsillarpharyngeal swabs rapid influenza testing standard care results influenza testing made available treating physician within approximately <NUMBER> minutes decided testing management endpoints analyzed study included rates routine blood examinations chest xrays antibiotic prescription days antibiotics admission hospital antiviral drug use study participants positive influenza diagnosis significantly less likely receive routine blood examinations prescribed antibiotics compared receiving rapid viral testing significant differences found two groups respect rates chest xrays admission hospital children prescribed antibiotics difference length antibiotic use children prescribed antivirals study excluded due fact children underlying illnesses included study included children congenital heart disease asthma malignancy neurological deficits cystic fibrosis abanses <NUMBER> large single center rct assessing healthy participants aged three <NUMBER> months presenting large urban pediatric ed <NUMBER> patient visits per year fever goal study assess rapid influenza testing febrile infants children affected physician decisionmaking respect diagnostic testing well ed charges patient time ed although inclusion criteria based fever paper analyzed large proportion children <NUMBER> found respiratory symptoms form tachypnea children meeting inclusion criteria randomized two groups one group rapid influenza test results available treating physician prior assessment group influenza testing done discretion treating physician initial assessment study endpoints stated rates diagnostic testing ed charges length ed visit although block randomization mentioned described actually cluster randomization <NUMBER> hour periods despite initial intent conduct rct nonadherence protocol led significant number participants receiving treatment randomly allocated receive decision made analyze data per actual treatment received hence convenience sample although mention itt analysis yielding significant difference outcome measures two study groups results reported due failed randomization study meet reviews inclusion criteria cohen <NUMBER> multicenter cluster rct <NUMBER> community pediatric offices france <NUMBER> offices randomized use quickvue rapid influenza test <NUMBER> total <NUMBER> participants aged one <NUMBER> years old influenzalike illnesses chills upper respiratory symptoms headaches myalgia without focal infections enrolled primary objective compare oseltamivir use secondary objectives included comparisons clinical presentation ancillary testing antibiotic use two study groups study found participants enrolled pediatric offices rapid influenza testing used oseltamivir used frequently <NUMBER> versus <NUMBER> p <NUMBER> antibiotics <NUMBER> versus <NUMBER> p <NUMBER> chest radiography <NUMBER> versus <NUMBER> p <NUMBER> also frequently used rapid influenza testing group statistically clinically significant differences clinical features two study groups included younger mean age <NUMBER> versus <NUMBER> years old p <NUMBER> larger proportion asthmatic participants <NUMBER> versus <NUMBER> p <NUMBER> first rct rapid influenza testing community pediatric practices study included review setting ed one particular concern study large number analytical comparisons well <NUMBER> without corrections surrounding statistical significance level bonner <NUMBER> doan <NUMBER> used computer randomization programs block randomize participants study groups poehling <NUMBER> used random number generator randomize study days blocks four six iyer <NUMBER> allocated participants study groups using alternating days intervention lend blinding incomplete outcome data successfully retrieved contacting individual study authors selective reporting found included trials two trials participants individually randomized bonner <NUMBER> doan <NUMBER> opposed randomizing days like poehling <NUMBER> trial potential contamination many children rapidly diagnosed influenza given day intervention group possible children without rapid viral testing control group would assumed treating physician influenza due commonality presentation children intervention group would introduce conservative bias reducing difference effect two study groups increasing type ii error four studies reported proportion participants receiving prescribed antibiotics ed study groups three find statistically significant effect despite trend favoring rapid viral testing bonner <NUMBER> trial report statistically significant effect rapid influenza testing antibiotic prescription rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> pooled results showed nonstatistically significant trend reduced antibiotic prescription ed favoring treatment group rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> sensitivity analysis using three trials deemed adequate higher quality method higgins <NUMBER> bonner <NUMBER> doan <NUMBER> poehling <NUMBER> find statistically significant effect either rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> three studies reported outcome bonner <NUMBER> showed statistically significant effect doan <NUMBER> iyer <NUMBER> showed trend favoring rapid viral testing pooled results showed statistically significant reduction mean ed length visit mean difference <NUMBER> min <NUMBER> ci <NUMBER> <NUMBER> sensitivity analysis using two trials deemed adequate method higgins <NUMBER> doan <NUMBER> bonner <NUMBER> find statistically significant effect either mean difference <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> four studies reported proportions participants undergoing blood investigations bonner <NUMBER> iyer <NUMBER> reported complete blood count cbc blood cultures separately anticipated substantial overlap participants receiving cbc blood cultures analyzed one outcome authors contacted data outcome provided analyze one outcome four showed trend reduced blood investigations treatment group statistically significant pooled results showed lower rate blood investigations treatment group statistically significant rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> sensitivity analysis three trials deemed adequate method higgins <NUMBER> however found significant effect rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> four studies reported proportion participants undergoing urine investigations bonner <NUMBER> iyer <NUMBER> reported urine analyses urine cultures separately anticipated overlap participants undergoing urine analysis urine cultures analyzed one outcome authors contacted data outcome provided analyze one outcome none studies found statistically significant difference rate urine investigations study groups pooled results showed meaningful statistically significant effect rapid viral testing urine investigations ed rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> sensitivity analysis using three trials deemed adequate method higgins <NUMBER> found similar results rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> four studies reported outcome three find statistically significant effect despite trend favoring rapid viral testing bonner <NUMBER> one report statistically significant effect rapid influenza testing chest radiography rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> pooled results showed statistically significant effect rapid viral testing chest radiography ed favoring treatment group rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> sensitivity analysis three trials deemed adequate method higgins <NUMBER> found similar stronger effect rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> two studies reported outcome doan <NUMBER> iyer <NUMBER> neither found statistically significant effect pooled results find significant effect either rr <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> doan <NUMBER> deemed adequate method higgins <NUMBER> hence sensitivity analysis performed outcome one study reported outcome iyer <NUMBER> none included studies provided data outcome tests heterogeneity performed outcome measures suggestion significant heterogeneity small number trials included review may contributed lack significance statistical tests metaanalysis demonstrated use rapid viral diagnostic test dramatically affect physician decisionmaking exception fact rapid diagnosis viral infection decreased rate chest radiography use ed sensitivity analysis rate blood investigations weak trend toward reduction antibiotics ed length visit seen statistically significant results metaanalysis suggest benefit using rapid respiratory viral testing mainly reducing rate chest radiography blood investigations evidence surrounding antibiotics still incomplete although weak trend reduction antibiotic prescription rate shown statistically significant results individual trials outcome conflicting making current evidence yet applicable studies rapid viral testing aimed detecting influenza virus except one used multirespiratory viral panel multiviral panel capture larger number viruses test used doan <NUMBER> laboratory bound freely accessible clinicians rapid influenza test performed bedside therefore offers much rapid result treating physician although point care testing rsv available shown high sensitivity <NUMBER> specificity <NUMBER> mackie <NUMBER> found trials using rapid rsv testing meeting criteria review considering rsv influenza formed <NUMBER> <NUMBER> positive viral tests study doan <NUMBER> perhaps using point care testing influenza rsv ed future studies would provide evidence support practice rapid viral testing ed evidence gathered review still lacking information key issues surrounding implementation rapid viral testing ed found information safety side effects intervention cost comparisons rapid viral test averted ancillary testing using intervention difficult evaluate value caregivers assign averting blood sampling radiography exposure unnecessary antibiotics well shortening ed visit may require different approach rcts three four included studies high quality rcts one quazirctiyer <NUMBER> clearly stated methodology well described therefore presented results individual outcomes possible without contribution quazirct bias contamination may introduced two trials individual subject randomization bonner <NUMBER> doan <NUMBER> would conservative one strengthens validity significant findings metaanalysis best knowledge bias introduced review process reasons lack effect antibiotic prescription rates urine investigations unclear although levine <NUMBER> byington <NUMBER> reported lower rates bacterial infections febrile infants less three months old tested positive viral infection rate bacterial urinary tract infection group negligible <NUMBER> possible physicians may still apprehensive dismissing potential concurrent urinary tract infection despite presence virus persist ordering urine tests prescribing precautionary antibiotics urinary testing dependant obtaining urine sample young children may take long time hence prolong ed length visits however purcell <NUMBER> reports rate bacterial infection urinary tract infections febrile rsv positive children two years old <NUMBER> less three months old much lower less <NUMBER> puts question precautionary practice least children three months old number rapid viral testing studies report subgroup analyses participants positive rapid viral results versus negative results demonstrated positive rapid viral diagnosis decreased number ancillary tests antibiotics prescribed ed length visits interesting see positive result decrease amount additional tests question whether rapid viral test worth one knows result rapid viral diagnosis requires invasive uncomfortable test children either nasopharyngeal swabs washings important determine may affect outcome tested population whole four studies mentioned rate positive viral diagnosis ranged low <NUMBER> <NUMBER> <NUMBER> <NUMBER> influenza testing alone <NUMBER> multiviral testing therefore least onethird children received invasive test may altered course workup management one cannot definitively predict whether child positive test prior represents large number nonhelpful tests actually add burden presented children febrile respiratory illnesses current evidence insufficient although promising supporting widespread implementation rapid viral diagnostic testing ed reduce antibiotic prescription ancillary investigations combined number participants available studies large enough statistically detect significant effect rapid viral testing primary outcome secondary outcomes pediatric ed physicians become comfortable managing febrile children confirmed viral diagnosis without ancillary testing precautionary antibiotics trials rapid viral testing may demonstrate sizable impact would detected upon itt analyses rather subgroup analyses large rct still needed findings metaanalysis found opposing effects antibiotic use ed studies also suggest positive effect rapid viral testing blood investigations ed length visit lacked power reach statistical significance future studies also needed assess impact intervention secondary outcomes include adverse effects intervention effects hospital admissions rate severe concurrent bacterial infections addition important evaluate cost effectiveness intervention implemented widely rocholl c gerber k daly j pavia byington cl adenoviral infections children impact rapid diagnosis randomized controlled trial participants previously healthy participants age <NUMBER> months <NUMBER> years old presenting alabama childrens hospital emergency department fever respiratory symptoms malaise headaches <NUMBER> hrs duration less n <NUMBER> treatment group results nasopharyngeal swab rapid influenza testing using fluoia test turnaround time <NUMBER> minutes revealed treating physicians initial patient assessment control group results rapid test available treating physician proportion participants undergoing laboratory testing radiographs antibiotics antiviral use length ed stay proportion participants visits physician new prescriptions illness post discharge ed length school daycare work time loss related illness original published data analyzed using participants revealed negative rapid influenza test results control group obtained unpublished raw data analyse participants <NUMBER> study groups rapid test results revealed treating physician irrespective test results intervention group whose rapid inluenza test results revealed treating physician control adequate sequence generation yes computerized randomization program blocks <NUMBER> participants <NUMBER> intervention <NUMBER> control allocation concealment unclear randomization list produced prior study mentioned whether individual allocation concealed prior enrolment blinding outcomes impact knowing results viral testing intervention tested could blinded incomplete outcome data addressed outcomes yes <NUMBER> enrolled participants left seen treating physician received treatment hence could contribute outcomes free selective reporting yes outcomes reported although published data reported per subgroup rapid viral testing result contacted author supplied complete data review free bias yes significant bias found randomized controlled trial using days unit randomization treatment allocation children age <NUMBER> years old fever acute respiratory symptoms <NUMBER> <NUMBER> influenza season coming vanderbilt pediatric emergency department n <NUMBER> universitybased pediatric ed nashville tennessee caring approximately <NUMBER> children annually three days per week participants enrolled study study days prospectively randomized blocks <NUMBER> <NUMBER> using random number generator pointofcare rapid influenza testing results made available treating physician prior patient assessment versus standard testing results made unavailable subject discharged form ed equal numbers study days group proportion participants undergoing laboratory testing urine blood chest radiographs antibiotics antiviral use although study enrolled <NUMBER> participants chronic cardiorespiratory bronchopulmonary dysplasia congenital heart defect immune disorders unknown severity reported parents related chemotherapy may meet review exclusion criteria primary author contacted raw data excluding <NUMBER> participants obtained n <NUMBER> used data purpose metaanalysis adequate sequence generation yes block days randomization random number generator allocation concealment unclear although participants could known treatment going effect coming ed specified publication whether participants unaware treatment allocation consent study participoehling <NUMBER> continued pation obtained blinding outcomes impact knowing results viral testing intervention tested could blinded incomplete outcome data addressed outcomes unclear study period <NUMBER> eligible children enrolled study mention made children enrolled free selective reporting yes outcomes reported significant bias found methods quazirandomized controlled trial using alternating days treatment allocation participants children <NUMBER> <NUMBER> months age coming cincinnati childrens hospital medical center ed fever n <NUMBER> treatment group nasal swab rapid influenza testing using quickvue providing result within <NUMBER> minutes control group nasal swab rapid influenza testing using quickvue performed twice daily simulate routine laboratory testing turnaround results available treating physician patient discharged ed proportion participants blood culture complete blood count urine analyses chest radiography antibiotics use hospital admission return visits ed within <NUMBER> days discharge ed length visits visitassociated costs adequate sequence generation alternate days used treatment allocation allocation concealment unclear although participants could known treatment going effect coming ed specified publication whether participants unaware treatment allocation consent study participation obtained iyer <NUMBER> continued blinding outcomes impact knowing results viral testing intervention tested could blinded incomplete outcome data addressed outcomes study period <NUMBER> eligible participants enrolled study thirtysix children missed initial screening process discovered retrospective review daily patient logs informed consent obtained <NUMBER> participants five participants left evaluation physician <NUMBER> enrolled twice within one month information documented <NUMBER> participants therefore unclear remaining <NUMBER> participants might affected outcome free selective reporting yes outcomes reported significant bias noted methods randomized controlled trial participants previously healthy children age <NUMBER> months old coming ed british columbia childrens hospital fever respiratory symptoms n <NUMBER> treatment group nasopharyngeal aspirate rapid respiratory virus panel influenza ab parainfluenza <NUMBER> rsv adenovirus using direct immunofluorescence assay light diagnostics simul fluor respiratory screening agent control group routine admission ed test done requested assessment treating physician outcomes ed length visit proportion participants undergoing laboratory testing blood urine radiographs antibiotics use outcome measures also assessed post ed discharge two authors cochrane review also investigators trial adequate sequence generation yes patients randomized either study groups using computer randomization program variable block size <NUMBER> <NUMBER> <NUMBER> <NUMBER> allocation concealment yes computer program accessed time consent study participation obtained blinding outcomes impact knowing results viral testing intervention tested could blinded abanses <NUMBER> although set rct treatment provided per randomized allocation participants reassigned control group vice versa analyzed convenience sample study longer analyzed rct hence meet inclusion criteria trial set community pediatric clinics ed esposito <NUMBER> trial included children congenital heart diseases without specification correction status significant chronic respiratory diseases cystic fibrosis onsite testing emerging infectious diseases crispr pcr serological tests lateral flow assays biosensors announced pandemic <NUMBER> march severe acute respiratoryrelated coronavirus <NUMBER> sarscov<NUMBER> leading unexpected public health crisis worldwide fauci et al <NUMBER> also becoming unprecedented socioeconomic burden schochspana <NUMBER> context world health organization urging international community perform massive diagnostic testing fight transmission virus decrease number undetected cases since testing also valuable tool aiding researchers learn epidemiology disease moreover diagnostics play decisive role making timely decisions treatment isolation infected people thereby slowing stopping spread infectious diseases testing along risk management healthcare system pivotal response outbreaks extraordinary examples response occurring countries instance south korea able test around <NUMBER> citizens per day using aggressive testing campaigns enabled drivethrough phone booths tests south korean hospitals phone booth coronavirus tests <NUMBER> south koreas drivethrough coronavirus testing stations <NUMBER> testing times <NUMBER> german laboratories currently carrying <NUMBER> coronavirus tests every week welle <NUMBER> may contributing lowest mortality rates due covid<NUMBER> world however countries paucity massive testing given supply problems example specialized swabs face masks reagents thomas <NUMBER> disparity terms politics public health measurements apuzzo gebrekidan <NUMBER> cnn <NUMBER> wittenbergcox <NUMBER> technology behind testing biosensing aims detect biological biochemical agents employing biologically derived biomimetic recognition element either undergoing biochemical reaction example enzymebased biosensors binding target molecule ie analyte highly specific way binding event transduced measurable signal either directly example means impedance measurements surface plasmon resonance employing signaling molecules ie labels including enzymes fluorophores electrochemicallyoptically active compounds china published coronavirus genetic code early january polymerase chain reaction pcrbased tests developed around world covid<NUMBER> conventionally diagnosed means gold standard method chu et al <NUMBER> read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> pcr tests also crucial order take decisions related contact tracing isolation specific citizens worth mentioning thoracic imaging via computer tomography scans portable chest xrays flexible bronchoscopy also valuable diagnosis therapy monitoring discharge assessment related covid<NUMBER> infection since far known mainly respiratory illness covid<NUMBER> coagulopathy hematologyorg <NUMBER> read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> udugama et al <NUMBER> pcr involves amplification minute traces genetic material ie ribonucleic acid rna virus leading highly specific sensitive detection however pcr tests generally performed centralized diagnostic services highly skilled personnel results may take <NUMBER> hours <NUMBER> days apart pcr tests prone following limiting factors sampling error nasopharyngeal swab suitably performed take mucus ventilatory system however may give rise false negatives optimal sampling moment still ambiguous ii besides sample preparation including cell lysis nucleic acid purification pcr analysis required number tests also number extraction kits limiting factor ramping covid<NUMBER> testing shortage rna extraction kits hampers efforts ramp covid<NUMBER> coronavirus testing <NUMBER> iii generally pcr samples require specialized handling transportation genetic material may denatured inadequate transportation bringing also false negatives iv quality reagents utilized different pcr kit manufacturers may also affect consistency among results v standard pcr methods may lack sensitivity potentially giving rise false negative results covid<NUMBER> patients unapparent clinical symptoms patients recovery resulted heatedly debated issue reinfection accurately redetectable positive patients confirming tests moresensitive methods delivered positive results vi nucleic acid amplification employed special primers probes target necessary limits pcrs flexibility scaling nucleic acids easy rapid manner vii previous point could even problem target since sarscov<NUMBER> rna likely undergo mutations kupferschmidt et al <NUMBER> therefore sequencing genetic material virus continuously monitored confirmed ensure accuracy method regard biosensing technologies offer complementary approach standard pcrbased tests terms sensitivity also terms diagnostics therapeutic decisions moreover biosensing community actively working improve portability time cost pcrbased sarscov<NUMBER> detection nunezbajo et al <NUMBER> well create easytouse pcrbased microfluidic devices integrated sample preparation state funds development rapid tests coronavirus <NUMBER> interestingly international company envisions alternative approach detecting covid<NUMBER> within exhaled breath condensate using combination pcr lfa technology since airborne droplet infection detection covid<NUMBER> breath followed pcr <NUMBER> contrast pcr isothermal amplification genetic material constant temperature enables develop pointofcare devices rapid detection nucleic acids remarkable example approved technology covid<NUMBER> determination shown company abbott delivers results around <NUMBER> minutes abbott launches molecular pointofcare test detect novel coronavirus little five minutes mar <NUMBER> <NUMBER> possible ways target sarscov<NUMBER> via different biomolecules summarized figure <NUMBER> covid<NUMBER> testing apart aforementioned viral rna novel coronavirus exhibits spike proteins immunogenic grifoni et al <NUMBER> hence immune system able produce immunoglobulins trigger immune response pathogen importantly immunoglobulins valuable detect covid<NUMBER> also potential therapy immunoglobulin igm antibodies produced onset infectious disease <NUMBER> <NUMBER> days whereas immunoglobulin g igg response produced later around <NUMBER> weeks immunoglobulin antibody overview sciencedirect topics <NUMBER> read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> figure <NUMBER> schematic illustrating structure sarscov<NUMBER> related targeting sites biomolecules used covid<NUMBER> detection scale order overcome aforementioned issues pcrbased systems researchers around world pushing hard develop different methods devices allowing easy rapid affordable highly sensitive selective quantification nucleic acids lowresource settings doctors practices directly home purpose promising powerful tool clustered regularly interspaced short palindromic repeats crispr technology mainly employed gene editing li et al <NUMBER> zuo et al <NUMBER> thanks different crisprassociated cas enzymes programmed singleguide rnas sgrnas crispr rnas crrnas crispr technology enables target types nucleic acids wide range various targets including bacteria viruses micrornas cancer mutations simple easily scalable way changing targetspecific sgrnacrrna bruch et al <NUMBER>b li et al <NUMBER> current crisprtailored approaches based two different detection modes bindingor cleavagebased shown figure <NUMBER> bruch et al <NUMBER>c cleavagebased approach recognition event target gene sarscov<NUMBER> cascrrna complex gets activated cleaves surrounding labelled reporter rnas rerna resulting concentrationdependent signal change bindingbased crispr detection catalytically deactivated cascrrna complex specific target sequence covid<NUMBER> immobilized sensor surface example graphenebased field effect transistor previously applied detecting genetic mutations hajian et al <NUMBER> upon recognition target resulting signal read via handheld device mammoth biosciences sherlock biosciences leading companies field crispr diagnostics already presented crisprpowered assays enable rapid lowcost tests sarscov<NUMBER> employing conventional lateral flow assays lfas sheridan <NUMBER> using cas<NUMBER> effector capable targeting singlestranded dnas rnas orf<NUMBER>ab gene covid<NUMBER> detection limits <NUMBER> <NUMBER> copies per µl respectively less <NUMBER> hour employing recombinase polymerase amplification rpa along cas<NUMBER>a enzyme targeting singlestranded rnas approach validated yet patient samples however systems still employ target amplification lamp rpa broughton et al <NUMBER> shen et al <NUMBER> covers crisprs great versatility different primers probes target required regard two amplificationfree biosensing systems using crispr technology recently introduced crisprchip electrical detection genetic mutations using cas<NUMBER> hajian et al <NUMBER> electrochemical crisprbiosensor microrna analysis employing cas<NUMBER>a bruch et al <NUMBER>a groups announced interest extend systems amplificationfree onsite covid<NUMBER> testing cardean transistors tm made available companies government agencies willing build handheld coronavirus detection devices <NUMBER> diagnostics molecular scissors also possible onsite covid<NUMBER> tests <NUMBER> besides crisprbiosensors group would like target two characteristic genome sequences e gene rdrp gene sarscov<NUMBER> simultaneously using multiplexed microfluidic chip principle crisprpowered approaches allow easy adaptation nucleic acids thus address potential mutations sarscov<NUMBER> timely manner another nucleic acid amplificationfree approach optical biosensor combining plasmonic photothermal effect localized surface plasmon resonance recently demonstrated discriminate similar gene sequences high analytical sensitivity qiu et al <NUMBER> another convenient way sensing use substrates ie sensor material functionalized recombinant viral antigens exploited bind aforementioned immunoglobulins possible detect presence novel coronavirus via igm provide history past infections via igg antibodies much longer present blood vogel et al <NUMBER> regard lfas wellknown athome pregnancy ovulation tests offer equipment free userfriendly rapid platform optical onsite testing masterpiece biosensing nanotechnology far marquez moralesnarváez <NUMBER> moreover lfa utilizes cellulosebased materials paper amenable mass production low costs moralesnarváez et al <NUMBER> hence commercial lfas targeting aforementioned immunoglobulins even simultaneously already developed approved around world including australia china germany singapore south korea usa sheridan <NUMBER> devices valuable tool monitor course sarscov<NUMBER> infection using drop human serum plasma even whole blood offering qualitative results within <NUMBER> minutes point care example home primary care sheridan <NUMBER> interestingly collective positive tests facilitated lfas could lead spot herd immunity regions thereby possibly abandoning lockdowns moreover germany planning issue immunity certificates allowing citizens positive antibody tests stop lockdown early bienkov <NUMBER> however highly sensitive approaches enabling quantitative testing also demanded since measurement virusrelated immunoglobulin levels employed diagnostic criteria suspected cases negative pcr results read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> addition determination breadth kinetics immune responses meaningful study nonsevere cases novel coronavirus thereby forecasting infection outcome thevarajan et al <NUMBER> although employment serological tests determine covid<NUMBER> immunity still debate feuer <NUMBER> mallapaty <NUMBER> likewise protection capability face masks cautiously discussed devlin campbell <NUMBER> believe serological test crucial tool execute serosurveys stadlbauer et al <NUMBER> thereby offering relevant information take measures aimed ceasing lockdowns getting back common life gradually biosensing strategies using antibodies selectively capture whole virus exist recent example convat project supported european union aims optical detection whole virus <NUMBER> minutes determine viral load viral content per ml saliva samples whose result would followed via pcr platform laura lechuga investigadora del csic llevamos tiempo reclamando que hay que invertir más dinero en prevención análisis <NUMBER> similarly graphenebased fieldeffect transistors enabling portable devices engineered determine covid<NUMBER> viral load clinical nasopharyngeal samples using specific antibody spike protein seo et al <NUMBER> viral load conventionally determined using quantitative realtime pcr important determine severity infectious disease also monitor viral dynamics infected patients therapy response hence viral load determination may help facilitate decisions driven personalized medicine thereby effective clinical procedures applied nevertheless antibodybased approaches mainly suffer relatively slow typically weeks development compared nucleic acid tests new infection well timeconsuming expensive production depending specificity employed antibodies may also suffer false positives caused potential crossreactivity coronaviruses importantly existing literature summarizes current commercialized technologies focused covid<NUMBER> diagnosis compare strengths weaknesses mallapaty <NUMBER> sheridan <NUMBER> detection additional biomarkers different immunoglobulins another approach perform effective assessment clinical progress provide alertness severity critical trends covid<NUMBER> infection also valuable blueprint formulate therapeutic procedures first affiliated hospital zhejiang university school medicine top hospital china zero fatalities recommends surveillance following inflammatory response biomarkers sarscov<NUMBER> infection creactive protein procalcitonin ferritin ddimer il<NUMBER> il<NUMBER> il<NUMBER> tnfα infγ worth mentioning low total number lymphocytes onset disease also indicator poor prognosis whereas severe infections display gradually decreased number peripheral blood lymphocytes read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> hence lymphocyte analysis also effective resource emerging infectious disease clinical relevance biomarkers discussed table <NUMBER> context biosensing community urged create affordable rapid sensitive multiplexed systems amenable mass production order detect biomarkers simultaneously besides biosensing devices incorporating artificial antibodies molecularly imprinted polymers innovative antibodies ex shark antibodies matz dooley <NUMBER> would great value emerging infectious disease diagnostics since amenable withstand harsh conditions handling delivery il<NUMBER> il<NUMBER> dramatically increased levels severe condition covid<NUMBER> infection covid<NUMBER> coagulopathy hematologyorg <NUMBER> read onlinehandbook covid<NUMBER> prevention treatmentpdf <NUMBER> early career scientists members biosensing community facing dramatic situation ever experienced xxi century believe undergo disease outbreaks caused viral also bacterial pathogens world rethink way cope situations thus offer following seven recommendations <NUMBER> investment pandemic preparedness terms diagnostic tools pivotal prevent spread emerging infectious diseases joint even international task different entities including governments funding agencies academia industries believe timely largescale testing based reliable biosensing technology might lead avoid soften stringent measures lockdowns border closing travel bans shown example south korea iceland collaborative networks formed involve experts biosensing also biosecurity corresponding facilities well robust biotechnology companies ready mass production actually getting central innovation opportunities testing dominated already established methods like pcr biosensing community play critical role control slow hinder prevent pandemic outbreaks case stringent measures border closings country prepared ie sustainable independent terms manufacture biosensing technology protection equipment instance germany develops various kind machines production protection equipment even germany limited activity fabricate protection materials masks protective clothing leading shortages items aforementioned collaborative networks ready develop new diagnostic tools adapt existing ones rapidly governments offer fasttrack approval programs food drug administration fda examine tools rapidly biosensing devices testing infectious diseases rigorously satisfy following requirements must disposable offering reliable mass production ii accessible affordable allowing largescale population screening iii easytouse minimally trained users even patients iv equipmentfree operated inexpensive portable readout unit v rapid enabling short sampletoresult times less hour vi able work low sample volumes easily accessible samples example blood finger prick noninvasive swab samples vii highly selective sensitive possible without target amplification delivering accurate results accordance central laboratory findings viii integrated sample preparation including lysis isolation nucleic acid testing plasma separation proteomics ix easily scalable flexible detect different targets using platform crisprpowered systems x capable multiplexing simultaneous detection different analytes including controls dincer et al <NUMBER> ideally systems also able perform multiomics simultaneously instance detection nucleic acids along immunoglobulins <NUMBER> internetofthings connecting sensors via databases healthcare workers realize decentralized healthcare also important tool provide valuable insights terms emerging infectious disease scenarios dynamics determination herd immunity regions well epidemiology big data order secure information blockchain technology known cryptocurrencies like bitcoin could applied internetofthings general population trained advance perform effective selfsampling example collect nasal swabs well selftesting especially lfabased immunity testing order estimate population coverage regard would helpful classes high secondary school seminars companies general public gets familiar issues like sample collection performing selftests similar fire drills <NUMBER> january <NUMBER> world health organization declared global public health emergency <NUMBER> outbreak new coronavirus called <NUMBER> novel coronavirus <NUMBER>ncov originated wuhan city hubei province china <NUMBER> february officially named disease coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> humantohuman transmission figure <NUMBER> confirmed centers disease control prevention cdc united states <NUMBER> evidence persontoperson transmission three different cases outside china namely us <NUMBER> germany <NUMBER> vietnam <NUMBER> covid<NUMBER> continuously spread <NUMBER> countries number confirmed infections reached <NUMBER> <NUMBER> march <NUMBER> <NUMBER> death toll china overtaken sars epidemic <NUMBER>–<NUMBER> risen <NUMBER> <NUMBER> slow spread covid<NUMBER> least <NUMBER> million people china placed lockdown <NUMBER> <NUMBER> march <NUMBER> italy also undertook measures northern part country placed lockdown affecting <NUMBER> million people <NUMBER> definition coronaviruses listed table <NUMBER> reproduction number r<NUMBER> ie average number secondary cases generated typical infectious individual estimated <NUMBER> doubling time estimated <NUMBER> days <NUMBER> manifestation covid<NUMBER> infection highly nonspecific including respiratory symptoms fever cough dyspnea viral pneumonia <NUMBER> thus diagnostic tests specific infection urgently required confirm suspected cases screen patients conduct virus surveillance scenario pointofcare poc device ie rapid robust costefficient device used onsite field necessarily require trained technician operate <NUMBER> crucial urgently needed detection covid<NUMBER> figure <NUMBER> shows dramatic impact early detection infectious diseases controlling outbreak <NUMBER> poc device used limited emergency situation diamond princess cruise ship case recently reported diamond princess cruise ship quarantined yokohama japan due serious spreading covid<NUMBER> cruise least <NUMBER> infected cases <NUMBER> passengers crew reported <NUMBER> <NUMBER> february <NUMBER> detection covid<NUMBER> may prompt enough enough test kits diagnose passengers ship order timely respond rapid spreading disease <NUMBER> current standard molecular technique used detect covid<NUMBER> realtime reverse transcriptionpolymerase chain reaction rrtpcr protocol documented available online website since <NUMBER> january <NUMBER> <NUMBER> testing procedure includes specimen collection ii packing storage shipment clinical specimens iii good communication laboratory providing needed information iv laboratory testing v reporting results rrtpcr technique requires sophisticated laboratory equipment often located central laboratory biosafety level <NUMBER> <NUMBER> sample transportation inevitable consequence time required obtain results <NUMBER> <NUMBER> days case public health emergency covid<NUMBER> outbreak timeconsuming process sample testing extremely disadvantageous also dangerous since virus needs contained addition commercial pcrbased methods expensive depend upon technical expertise presence viral rna dna always reflect acute disease <NUMBER> furthermore using pcr codetection respiratory viruses frequently encountered coronaviruses covs contribution positive cov pcr results disease severity always explicitly exhibited <NUMBER> furthermore <NUMBER> february <NUMBER> united states mentioned interim guidelines collecting handling testing clinical specimens persons investigation puis <NUMBER> novel coronavirus diagnostic testing covid<NUMBER> conducted cdc <NUMBER> february <NUMBER> onwards covid<NUMBER> tests also done laboratories designated cdc likewise china outbreak ongoing samples sent beijing testing reported <NUMBER> january <NUMBER> <NUMBER> <NUMBER> february <NUMBER> china’s cdc deployed mobile biosafety laboratory wuhan hubei province assist response <NUMBER> <NUMBER> february <NUMBER> emergency test laboratory biosafety level <NUMBER> run bgi genomics global heartquare shenzhen china set wuhan hubei province assist covid<NUMBER> epidemic <NUMBER> order overcome current timeconsuming laborious detection technique using rtqpcr alternative molecular amplification technique deployed loopmediated isothermal amplification lamp reaction novel nucleic acid amplification technique amplifies dna high specificity efficiency rapidity isothermal conditions method uses set four specially designed primers dna polymerase strand displacement activity <NUMBER> synthesize target dna <NUMBER> copies less hour constant temperature <NUMBER> °c final products stemloop dnas multiple inverted repeats target bearing structures cauliflowerlike appearance lamp high specificity sensitivity simple perform hence soon initial development became enormously popular isothermal amplification method molecular biology application pathogen detection lamp uses stranddisplacement polymerases instead heat denaturation generate singlestranded template hence advantage running constant temperature simultaneously reducing cumbersomeness thermocycler well energy required lamp technology proven stable <NUMBER> sensitive <NUMBER> detection compared pcr advantages lamp compared pcr shown table <NUMBER> believe lamp assay could potential candidate pointofcare device application detection covid<NUMBER> example using lamp pointofcare device detection zoonotic virus causing respiratory symptoms avian influenza virus aiv vivaldi veterinary validation pointofcare diagnostic instrument project <NUMBER> poc devices vetpod <NUMBER> veterinary portable onsite detection vivaldi project detection time less <NUMBER> h besides poc devices using disposable polymer chips lamp assays vetpod vivaldi project lateral flow strip lfs would also suitable candidate rapid onsite detection covid<NUMBER> device covid<NUMBER> igmigg rapid test biomedomics good example <NUMBER> sensitivity covid<NUMBER> igmigg rapid test <NUMBER> expected lower sensitivity tests based lampreaction assays <NUMBER> therefore combination lfs lamp one device could excellent candidate poc testing covid<NUMBER> furthermore alongside detecting containing virus sake public health response regarding dynamics outbreak socioeconomic impact covid<NUMBER> equally urgent need announced fight spread covid<NUMBER> international community launched us<NUMBER> million preparedness response plan february april <NUMBER> <NUMBER> <NUMBER> sarscov virus pulled world’s output <NUMBER> billion early estimation cost global economy result outbreak covid<NUMBER> <NUMBER> billion <NUMBER> china’s gdp shares approximately <NUMBER> globally <NUMBER> four times higher <NUMBER> confirmed infected cases time economic estimation ie beginning february <NUMBER> <NUMBER> times larger total sars given number infected cases <NUMBER> confirmed cases currently approximately <NUMBER> times larger sars cases <NUMBER> death toll due covid<NUMBER> surpassed sars epidemic economic impact covid<NUMBER> might much larger <NUMBER> billion furthermore order win battle outbreak information epidemiological characteristics identification animal reservoirs <NUMBER> figure <NUMBER> risk factor disease also essential intermediate host carrying disease important identify current epidemic also eliminate future outbreak together aforementioned factors race vaccination covid<NUMBER> equally essential although stage registered treatment vaccine covid<NUMBER> zhang recently mentioned potential interventions <NUMBER> nutritional interventions vitamin b c e trace minerals zinc iron due high percentage identicality sequence <NUMBER> genome structure sarscov<NUMBER> sarscov virus immunoenhancers specific treatment applied sars could also considered <NUMBER> use treatment sarscov<NUMBER> first wuhan china sarscov<NUMBER> arose new viral infection currently named coronavirus disease <NUMBER> new coronavirus merscov sarscov different strains coronaviruses belonging βcoronavirus cluster p sarscov<NUMBER> chief pathogen human respiratory system third zoonotic coronavirus disease third major medical crisis different genome sarscov sarscov<NUMBER> mostly transmitted respiratory system droplets gastric tract close human interaction located nasal mucosa mouth lungs exposed individuals note middleaged elderly individuals well patients chronic autoimmune underlying diseases susceptible infection sarscov<NUMBER> incredibly coronavirus become critical challenge global public health due rapid development extreme spread active carriers humantohuman transmission riou althaus <NUMBER> clinically covid<NUMBER> brings severe respiratory infections lethal sickness sars mers besides respiratory system injury covid<NUMBER> hurts various organs including kidney liver gastrointestinal neurologic systems yin wunderink <NUMBER> structurally coronavirus characterized enveloped nonsegmented singlestranded safa tahmasebi elnaz khosh contributed equally study rna virus structure composed envelope e nucleocapsid n membrane spike proteins e proteins central role virus assembly release virus schoeman fielding <NUMBER> sheikh altaher alnazawi almubarak kandeel <NUMBER> protein immense multipurpose viral transmembrane protein induces immune responses mediating virus attachment host receptors f li <NUMBER> n protein multifunctional protein identified viral rna silencing suppressor n protein substantial role viral transcription replication involved packaging encapsidated genome virions regarding overexpression high immunogenicity n protein considered potential diagnostic target sarscov<NUMBER> detection hurst koetzner masters <NUMBER> exposure virus enters target cells acts binding receptor socalled angiotensinconverting enzyme <NUMBER> ace<NUMBER> ace<NUMBER> present type ii alveolar epithelial cells healthy lung tissue also reported organ failure occur body organ cells express ace<NUMBER> interaction sarscov<NUMBER> ace<NUMBER> leads overexpression ace<NUMBER> resulting alveolar cell detriment interstitial alveolar edema respiratory system failure ards among various laboratory abnormalities lymphopenia without leukocyte irregularities commonly observed major paraclinical criterion covid<NUMBER> infected patients l according sarscov<NUMBER> immunopathogenesis lymphopenia characterized decrease lymphocytes particularly cd<NUMBER> cells slight increase neutrophils wan et al <NUMBER> moreover found sarscov<NUMBER> indirectly infect immune cells mostly cells macrophages elicits destruction increased frequency infected immune cells lymphopenia high levels inflammatory cytokines considered related elements covid<NUMBER> immunopathogenesis regard elevated levels proand inflammatory cytokines including tumor necrosis factorα tnfα granulocyte colonystimulating factor gcsf macrophage inflammatory protein mip<NUMBER>a monocyte chemoattractant protein<NUMBER> mcp<NUMBER> interferon gammainduced protein<NUMBER> ip<NUMBER> interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> documented covid<NUMBER> patients severe conditions generate cytokine storm seems cytokine storm primary phenomenon virus pathogenesis leading inflammation lung injury ards organ failures wan et al <NUMBER> hence critical need detection infected suspected cases soon possible apply appropriate treatments covid<NUMBER> prevent spread virus reason review focus im importance different diagnostic methods covid<NUMBER> emphasized many studies several studies designed underway investigate efficacy covid<NUMBER> diagnostic methods listed table <NUMBER> igg antibodies viral antigens recently use serological tests rule confirm infection specifically negative naats suggested due ease use quick presentation results well acceptable specificity sensitivity contrarily viral culture need used detection due research aspect culture however applied determine contagiousness infection presence virus different surfaces study efficacy various treatments cultured cells following described detail different types diagnostic methods two general clinical paraclinical categories sample collection important procedure done correctly achieve accurate diagnostic results regard transmission sarscov<NUMBER> respiratory tract fecaloral body fluids anal swabs oral swabs blood samples different methods sample collection diagnosis novel coronavirus w zhang et al <NUMBER> recent study analyzed repeated sample collection positive cases showed <NUMBER> infected patients still virus days receiving treatments reported might positive oral swabs first day sampling positive anal swabs late period sampling notably prolonged positive stool samples correlated severity disease positive zhang et al <NUMBER> also evaluated levels igm igg antibodies samples day <NUMBER> day <NUMBER> positive rate igm shifted <NUMBER> <NUMBER> positive rate igg shifted <NUMBER> <NUMBER> basis high detection rate antibody titers beneficial assess serological molecular tests suspected patients one latest studies analyzed <NUMBER> samples collected different sites <NUMBER> infected patients specimens collected pharynx urine feces sputum blood nasal centers disease control cdc reported newly prevalent virus mild severe clinical manifestations many cases sometimes leads death cdc suspected patients symptoms almost appear fever cough fatigue pneumonia respiratory distress whereass symptoms rhinorrhea diarrhea hemoptysis headache phlegmproducing cough rare patients adhikari et al <NUMBER> lung medullary cardiorespiratory center synapseconnected routes seems infection nervous system could reason respiratory failure coronavirus according research average time interval onset initial symptom dyspnea <NUMBER> days admission hospital <NUMBER> days receive intensive care <NUMBER> days latency time interval enough virus penetrate nervous system selected orf<NUMBER>b n genes highly conserved targets sars coronavirus nucleic acids wereconsidered positive controls result respiratory specimens two infected patients <NUMBER> tahmasebi et al showed positive results detectionby two rtpcr assays n gene assay revealed significant sensitivity <NUMBER> times orf<NUMBER>b gene positive specimens overall findings study suggest using nrtpcr screening assay orf<NUMBER>brtpcr confirmatory assay decades ago pooling diagnostic tests developed optimize detection time save reagents quickly detect large numbers suspicious contaminated cases infectious disease beneficially intricate equipment additional training required use tests nguyen bish aprahamian <NUMBER> pooling evidenced rtqpcr would allow rtpcr detect lowconcentration rna optimization arnold et al <NUMBER> noted possibility positive rtpcr result covid<NUMBER> recovered patients point view study evaluated four treated covid<NUMBER> patients wuhan china rrtpcr confirm whether could return work patients recovery confirmed rehabilitation criteria including normal temperature <NUMBER> days relieved respiratory difficulties confirmed ct imaging based recovered acute exudative lesions finally confirmation two separated negative rtpcr results led hospital discharge discontinuation quarantine accordingly rtpcr assays carried throat swabs patients using biogerm kits <NUMBER> days hospital discharge discontinuation quarantine positive lan et al <NUMBER> surprisingly results revealed proportion rehabilitated patients virus carriers continue quarantine protocol <NUMBER> days also rtpcr assay reevaluated confirm complete remission treated patients several advantages rtpcr assays make potent effective diagnostic techniques covid<NUMBER> infection rtpcr assay identified practical diagnostic approach used confirm covid<NUMBER> positive cases roberts et al <NUMBER> capability precise reproducible determination infected cases also employed quantify presence absence viral rna viral load patients specimens plasma therapy selection confirmation covid<NUMBER> recovered patients appro according report one sarscov<NUMBER> infected patient rtqpcr ngs positive results confirmedby tahmasebi et al <NUMBER> rtqpcr testing within <NUMBER> weeks obtaining balf data suggests high fnr inconsistency r laboratory screening tests laboratory findings based assessing biological chemical factors blood would helpful better determination covid<NUMBER> infected patients although higher specificity sensitivity table <NUMBER> moreover higher level ddimer also detected patients severe conditions bangash patel parekh <NUMBER> f zhou et al <NUMBER> procalcitonin level mostly normal covid<NUMBER> patients higherlevel reported bacterial coinfection increased levels proand inflammatory cytokines serum infected covid<NUMBER> patients also reported several studies considered main reason cytokine storm c huang et al <NUMBER> addition laboratory findings mentioned detecting lymphocyte subsets levels blood samples patients would provide valuable information better diagnosis infection study wan et al <NUMBER> systematic review metaanalysis study pormohammad et al <NUMBER> investigating available laboratory data among <NUMBER> sarscov<NUMBER> patients results demonstrated <NUMBER> leukocytosis <NUMBER> leukopenia <NUMBER> lymphopenia furthermore among <NUMBER> patients increased levels platelets thrombocytosis crp reported <NUMBER> <NUMBER> patients respectively also case report study w han et al <NUMBER> neutrophils consequently despite nonspecific findings blood count parameters diagnosing covid<NUMBER> infected patients laboratory findings would helpful early detection infected cases combination highly specific sensitive approaches ct imaging rtpcr assay following exposure sarscov<NUMBER> host immune system releases igm igg antibodies virus first igm appears initial exposure response sarscov<NUMBER> antigens involved primary immune responses however igg also engaged secondary immune responses igm first produced antibody low concentration low affinity limited maintenance time disappeared end infection contrarily igg later secreted high concentration affinity maintenance time also persists infection recovery accordingly igm detection indicates acute infection igg diagnostic index previous middle late infection thereby developing elisa tests detecting antisarscov<NUMBER> antibodies would help early detection positive cases least weeks infection onset interestingly large number suspected cases identified short time simple facilities acceptable sensitivityspecificity rates well low rate falsenegative results one study w zhang et al <NUMBER> another study liu liu wang zheng <NUMBER> performed analyze diagnostic values igm igg antibodies n protein sarscov<NUMBER> <NUMBER> hospital admitted patients confirmed suspected sarscovid<NUMBER> infection surprisingly elisa findings indicated suspected cases positively contaminated sarscov<NUMBER> also detected igm igg <NUMBER> cases <NUMBER> positive rate considerably rtpcr assay <NUMBER> additionally found elisa detected suspected patients negative rtpcr results <NUMBER> positive rate igm igg w measured produced igm igg antibodies nucleocapsid protein rn spike protein rs sarscov<NUMBER> <NUMBER> covid<NUMBER> confirmed patients using elisa successfully rnbased igm igg detected <NUMBER> <NUMBER> patients respectively besides rsbased igm igg discovered <NUMBER> <NUMBER> patients respectively findings also reported positive rates igmigg <NUMBER> <NUMBER> rnand rsbased detections respectively furthermore found rsbased detection igm higher sensitivity rnbased detection investigation amanat et al <NUMBER> elisa developed using recombinant antigens originating spike protein sp sarscov<NUMBER> showed screening identification covid<NUMBER> seroconverters possible early <NUMBER> days following symptom onset high sensitivity specificity expected reactivity observed individuals exposed sarscov<NUMBER> completely naive sp reliance details exposedimmune naive people easily distinguished related study stadlbauer et al <NUMBER> detailed protocol provided expression antigens derived spike protein used substrate setting elisa immunological assays claimed presented protocol adapted local needs including research diagnostic clinical laboratories respect applications elisa detecting antisarscov<NUMBER> igmigg antibodies based findings mentioned considered applicable serological assay detection covid<NUMBER> high sensitivity specificity one study long et al <NUMBER> whereas <NUMBER> days igm around <NUMBER> positive rate also found igm igg titers gradually increased within <NUMBER> weeks onset symptoms however igm indicated slight decrease <NUMBER> weeks moreover understood patients severe condition igg igm titers remarkable nonsevere condi another investigation lfa qualitative immunoassay another potent serological technology used detect covid<NUMBER> infected cases rapid simple lowcost procedure lfa acts based paperbased platform quantifying multiple analytes sample within according study conducted antigen rapid test findings demonstrated high sensitivity detecting n antigen derived sarscov early stages infection useful early diagnostic approach sarscov che et al <NUMBER> di et al <NUMBER> prepeer reviewed study diao et al <NUMBER> cohort <NUMBER> participants suspected sarscov<NUMBER> infection included detect viral antigen accordingly nucleocapsid protein np sarscov<NUMBER> evaluated nasopharyngeal swab urine sample within <NUMBER> minutes using fluor infections confirms advantage early detection serological tests compared rtpcr also importance specimen quality serological assays less stringent compared rtpcr assays importantly falsenegative results derived sampling quality fewer using antibodies serological diagnosis xiao wu liu <NUMBER> basis suggested using serological assays provides facility early diagnosis positive cases even improper sample collection unsatisfied molecular examinations another benefit broad scale infection diagnosis achieved using elisa technique detects antibodies automatic devices moreover elisa provides feasibility identifying large number infected cases quick turnaround time limitations rnabased assays led critical necessity use elisa include requiring upscale expensive lab facilities restrictive biosafety levels low middle detection sensitivity specificity different sampling locations technical experts another essential issue ease using serological tests clinical laboratory hospital opposed molecular approach requires specific wellequipped laboratory notably reporting mild asymptomatically infected cases large population without viral rnabased testing another critical aspect considered hence detection specific igg antibody largescale seroepidemiological study would help understand true scale humantohuman transmission report accurate rate covid<NUMBER> infected cases xiao et al <NUMBER> promisingly types applicable diagnostic tests would contribute early detection infected suspected cases prevent spread virus recently new abbott id covid<NUMBER> test received emergency use authorization eua fda detect novel coronavirus sarscov<NUMBER> fastest available molecular tahmasebi et al <NUMBER> pointofcare test abbott id test identified rapid isothermal instrumentbased system used qualitative identification infections interestingly approach unique isothermal nucleic acid amplification technology provides molecular results short time lets clinicians make evidencebased clinical decisions patient visit accordingly reported abbott id assay presents positive results <NUMBER> min negative results within <NUMBER> min based rrtpcr assay moreover detection influenza ab strep respiratory syncytial virus rsv id pioneer molecular pointofcare platform abbott <NUMBER> regardto current outbreak novel coronavirus <NUMBER>ncov worldwide arisen wuhan china critically required identifypractical strategies precise diagnostic methods appropriate treatment choices rapid humantohuman transmission sarscov<NUMBER> even asymptomatic carriers led intensive health disaster common clinical manifestations disease fever cough dyspnea complications ards acute kidney injury liver damage may also occur process disease cause death subsequently additionally elevated levels proand inflammatory cytokines elicit cytokine storm phenomenon proved prominent reason respiratory system destruction typical laboratory abnormalities covid<NUMBER> patients include lymphopenia hypoalbuminemia increased levels crp esr ldh ast alt ddimer although characteristics clinical features abnormal laboratory finding results guide healthcare workers toward primary diagnosis final detection covid<NUMBER> patients confirmed spiral lung ct scans molecular assays serological tests mostly bilateral peripheral ggos andor occasional consolidations observed radiological findings lung involvements indisputably initial chest ct could performed potential diagnostic modality symptomatic cases especially early stages disease note considered suspected patients may ct findings therefore repeated ct imaging diagnostic techniques would assist ruling confirming suspected individuals applicable confirmation methods rnabased molecular assays among rrtpcr test goldstandard approach despite rapid definite diagnosis infected cases highfnr lengthy procedure necessity intricate equipment restricts utilization rtpcr assays compared ct imaging recently serological techniques developed another quick diagnostic test based detecting sarscov<NUMBER>specific igmigg antibodies high sensitivity specificity besides worth noting accurate process sample collection sampling clinical specimens multiple sites different detection rates positive specimens considered achieve accurate test results covid<NUMBER> diagnosis conclusion profound comprehension various application aspects diagnostic approaches advantages disadvantages well appropriate administration could lead taking efficacious steps forward prevent virus outbreak manage current pandemic state contribute infected patients recovery subsequently promote public health authors would like dedicate study healthcare workers struggling novel coronavirus authors declare research conducted absence commercial financial relationships could considered potential conflict interest e k h contributed data gathering writing primary draft manuscript designing figures tables e contributed hypothesis correspondence scientific structural editing verifying manuscript submission na orcid abdolreza esmaeilzadeh httporcidorg<NUMBER> novel sarscoronavirus <NUMBER> ncov<NUMBER> causes disease covid<NUMBER> name given <NUMBER>th january declared public health emergency condition adapted pandemic situation globally <NUMBER> confirmed cases covid<NUMBER> includes <NUMBER> total deaths<NUMBER> report ministry national health services regulations coordination field epidemiology disease surveillance division fedsd national institute health nih islamabad reported current scenario disease burden total <NUMBER> confirmed cases death cases <NUMBER> till may <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases still status active cases disease spread <NUMBER> countries territories around world <NUMBER> centers disease control prevention cdc reported sarscov<NUMBER> respiratory virus hence transmission adhered respiratory droplets infected asymptomatic carrier coughs sneezes prevention possible maintaining least sixfoot distance individuals virus also spreads close contact touching surface object already contaminated touching nose mouth<NUMBER> common symptoms covid<NUMBER> fever dry cough tiredness followed less common symptoms aches sore throat diarrhea conjunctivitis headache loss taste smell patients serious symptoms observe difficulty breathing shortness breath chest pain pressure loss speech movement clinical settings<NUMBER> developing countries needed surveillance outbreak order combat pandemic situation prompt public health intervention prevention robust accurate pointofcare diagnostic device designed achieving public health objectives disease diagnosis epidemiologic surveillance pointofcare poc testing devices used rapid timely diagnosis various infectious diseases require trained expert professional poc testing portable molecular test advantage availability physician offices urgent healthcaretype settings era public health emergency poc testing significantly contribute towards low cost robust economical diagnosis early detection covid<NUMBER> well decreasing cases infectious disease controlling outbreak present reverse transcriptase polymerase chain reaction rtpcr dominant diagnosis ncov<NUMBER> methods used different poc testing devices frequent accurate loop mediated isothermal amplification lamp assay closed tube colorimetric detection serologic detection covid<NUMBER> igmigg rapid test device review focuses poc device integrated mobile phone contributing public health response control well highlighting use lamp assay method covid<NUMBER> diagnosis articles providing essential literature poc diagnostics covid<NUMBER> lamp assay molecular technique diagnosis infectious agents search terms data base appropriate syntax sars corona virus covid<NUMBER> point care diagnostics included preprint peer reviewed retrieved full text articles examined citation chain article included current diagnostic technique indicating current infection use referenced method globally reverse realtime pcr assay rrtpcr require sophisticated lab setup expensive instrument well trained qualified staff transportation efforts deals broad variety clinical specimens nasal swab pharyngeal swab broncho alveolar lavage fluid sputum feces fibro bronchoscope brush biopsies blood <NUMBER> antibody testing serum indicates previous infection covid<NUMBER> involves lateral flow method indicating vitro qualitative detection igm igg antibodies <NUMBER> prof jinzhao song<NUMBER> conducted study midfebruary reported single twostage novel closedtube covid<NUMBER> assay home clinic points entry based nucleic acid detection amplification method includes loop mediated isothermal amplification performed closed tube calorimetric detection using bioinformatics tools designed primers conserved region viral genome open reading frame <NUMBER>ab orf<NUMBER>ab gene higher sensitivity address two stage isothermal method known dubbed pennramp <NUMBER>they reported <NUMBER> times higher sensitivity respect lamp pcr purified processed nucleic acid however study performed synthetic samples requires actual patient samples yang et al<NUMBER> reported invention poc diagnostic device covid<NUMBER> research paper published <NUMBER> march <NUMBER> integrate mobile phone paperbased poc testing device also method pcr loop mediated isothermal amplification concept behind method nucleic acid detection adopted previous research <NUMBER> combine paperbased poc device lamp technology integrated mobile phone app accessible covid<NUMBER> diagnostic tool selfquarantined patent easily collects nasal swab sample performs userfriendly test device result shared mobile app clinicians public health concerned trieu nguyen reported <NUMBER> opinion report <NUMBER> march <NUMBER> poc testing paving road rapid detection virus proposed poc diagnostic potential candidate detecting covid<NUMBER> well response outbreaks integrate mobile phone app loop mediated isothermal amplification technology lamp paperbased poc device lamp advantage highly sensitive easy time efficient characterized reaction catalyzed isothermal condition technology uses strand displacement rather conventional heat denaturation principle therefore reaction advantage run constant thermal environment lamp uses four different primers ie forward innerouter primer backward innerouter primer complementary template sequence using strand displacement polymerases enzyme catalyze chain elongation displaced strand forming cauliflowerlike loop dumbbell structure loop structures contain multiple sites initiation synthesis copies providing binding sites another set primers swab sample containing covid<NUMBER> transferred tube specific reagent added lamp reaction reaction colorimetric reaction detected mobile phone app specially designed detect colorimetric changes paper result shared patient well public health department epidemiologic surveillance high sensitivity specificity lamp technology popular method detection pathogens molecular biology pointofcare poc testing devices used rapid timely diagnosis various infectious diseases require trained expert professional poc testing portable molecular test advantage availability physician offices urgent healthcaretype settings era public health emergency poc testing significantly contribute towards low cost robust economical diagnosis early detection covid<NUMBER> well decreasing cases infectious disease controlling outbreak rapid accurate costeffective detection device little requirement benefit individual government reducing transportation needs lowering spread infection well mitigating cost testing rapid accurate testing significantly contributes towards epidemiologic surveillance future outbreaks infectious diseases inhouse testing reverse transcriptionpolymerase chain reaction rtpcr endorsed cdc adopted many reference laboratories <NUMBER> <NUMBER> however challenging time health care resources insufficient combat situation due increasing numbers patients infected seeking care poc testing shall regarded essential testing viral genome nucleic acid thereby reducing chances spreading infection distant areas eluding consequences delayed reporting infectious disease covid<NUMBER> various studies reported dramatic effect late reporting infectious disease stated elisabeth reijn et al <NUMBER> timely accurate diagnosis radically contribute towards effective public health response well averting secondary cases outbreaks infectious diseases timeliness infectious diseases important factor delay mostly occurs situation referring cases general practitioner diagnosing cases local municipal health service netherlands health care providers strictly gratified reporting surveillance department infectious diseases order control secondary cases develop prevention guidelines precautionary measures poc device integrated mobile phone app infectious disease creates road map towards operative epidemiologic surveillance public health intervention form active passive immunization post exposure rehabilitation case covid<NUMBER> highly reliable accurate diagnostic poc testing device high sensitivity specificity positive predictive negative predictive values required order combat different infectious diseases future current situation covid<NUMBER> pandemic developed underdeveloped countries around globe mobile phone integration testing device eliminates transportation requisite economic burden mitigates spread infection stakeholders take initiative installing project large scale validity reliability poc testing device disposable kits diagnosis various infectious diseases capacity deal extensive spectrum clinical samples authors declare conflicts interest work received specific grant funding agency following first reports coronavirus disease<NUMBER> covid<NUMBER> china world health organization <NUMBER>st december <NUMBER> <NUMBER> novel severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> cases reported authorities <NUMBER> countries territories <NUMBER>th may <NUMBER> outbreak spread covid<NUMBER> worldwide highlights critical need developing rapid accurate diagnostic testing methods emerging human coronavirus cov infections testing crucial track spread disease pandemic swiftly permit public health interventions including isolation quarantine appropriate clinical management afflicted individuals key components viral diagnostic tests <NUMBER> collection appropriate sample blood nasal swab throat swab <NUMBER> availability genetic proteomic sequences novel virus analysis <NUMBER> rapid accurate laboratory testing methods current gold standard molecular diagnosis sarscov<NUMBER> infection realtime reverse transcriptasepolymerase chain reaction rtpcr qualitative quantitative detection viral nucleic acids relevant laboratory methods include enzymelinked immunoassays eia viral antibody antigen detection serum viral neutralization svn assays antibody neutralization determination challenges faced developing diagnostic test novel pathogen ability measure low viral loads early detection provide low crossreactivity viral strains deliver results rapidly several pointofcare molecular devices currently integrated fast accurate diagnosis sarscov<NUMBER> infections review discusses current laboratory methods available test coronaviruses focusing present covid<NUMBER> outbreak laboratory testing methods novel severe acute respiratory syndromecoronavirus<NUMBER> sarscov<NUMBER> coronavirus disease<NUMBER> covid<NUMBER> caused novel coronavirus cov originally reported wuhan hubei province china december <NUMBER> world health organization <NUMBER>a international committee taxonomy viruses named virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infection sarscov<NUMBER> causes respiratory illness varies severity mild upper respiratory symptoms akin seasonal flu severe progressive respiratory failure requires intensive care lead death asymptomatic carriers virus also reported pose significant public health threat due ability unknowingly spread virus chan et al <NUMBER>a sarscov<NUMBER> represents third cov millennium cross species animals humans cause severe respiratory disease middleeast respiratory syndrome coronavirus merscov <NUMBER> zaki et al <NUMBER> sarscov <NUMBER> drosten et al <NUMBER> ksiazek et al <NUMBER> novel cov identified seventh cov transmissible humans including hcov<NUMBER>e hcovoc<NUMBER> hcovnl<NUMBER> hcovhku<NUMBER> salata et al <NUMBER> <NUMBER>th january <NUMBER> world health organization declared sarscov<NUMBER> epidemic public health emergency international concern upgraded pandemic <NUMBER>th march <NUMBER> least <NUMBER> confirmed cases <NUMBER> deaths worldwide reported <NUMBER>th may <NUMBER> worldometersinfocoronavirus diagnostic testing critical pandemic ability track spread sarscov<NUMBER> essential effective disease management control sarscov<NUMBER> positivesense singlestranded rna ssrna group iv virus genome sequenced bronchoalveolar lavage fluid patient genbank mn<NUMBER> shared global initiative sharing influenza data gisaid platform <NUMBER>th january <NUMBER> ∼<NUMBER> k base pair genome highly similar human sarscov bat covsarslike genomes <NUMBER> open reading frames orfs encode structural replication nonstructural accessory proteins depicted figure <NUMBER> molecular modeling studies demonstrate like sarscov sarscov<NUMBER> surrounded lipid bilayer membrane containing structural membrane envelope e proteins interact form viral envelope durrant et al <NUMBER> layer also contains spike glycoproteins give characteristic corona appearance family viruses spike proteins bind specific host cell receptors facilitate host cell attachment entry graham baric <NUMBER> nucleic acidassociated protein binds rna genome forms nucleocapsid n proteins include replication nonstructural accessory proteins listed figure <NUMBER> schematic representation sarscov<NUMBER> genome sarscov<NUMBER> contains positivesense positivestranded mrna genome <NUMBER> ′ capped mrna sequence c <NUMBER> ′ polya tail coding genes orf<NUMBER>a orf<NUMBER>b spike orf<NUMBER>a orf<NUMBER>b envelope e membrane orf<NUMBER> orf<NUMBER>a orf<NUMBER>b orf<NUMBER> orf<NUMBER>b orf<NUMBER> nucleocapsid n orf<NUMBER> table <NUMBER> reports different strains sarscov<NUMBER> suggest early split sarscov<NUMBER> lineage andor virus mutating ongoing research provides insight unique conserved features genome proteome sarscov<NUMBER> track mutations generates evidence evolution virus phan <NUMBER> wang et al <NUMBER> important changes may affect key structural nonstructural components sarscov<NUMBER> render diagnostic tests ineffective less sensitive also impact selection epitopes development new tests spread sarscov<NUMBER> primarily respiratory droplets arise individuals harbor virus symptomatic individuals disease one source virus major public health concern transmission mildly ill asymptomatic individuals incubation period rapid viral diagnostic testing sarscov<NUMBER> critical identify individuals facilitate implementation protective measures social distancing quarantine isolation help mitigate spread virus community development rapid accurate tests detect antibodies postinfection provide information individuals exposure virus used monitor possibility immunity relapse reinfection supports interventions protect higher risk populations developing severe illness used investigate efficacy passive antibody therapies covid<NUMBER> infection review describes available testing methods sarscov<NUMBER> brings light importance laboratory testing control disease prepare possible future disease threats detection sarscov<NUMBER> real time reversetranscriptase polymerase chain reaction rtpcr upper lower respiratory samples collected detection hcov nasopharyngeal swabs high priority specimens sarscov<NUMBER> low priority specimens include oropharyngeal swabs bronchoalveolar lavage tracheal aspirates sputum cdc <NUMBER>a rna extracted clinical specimens using approved viral isolation kits rna reverse transcribed cdna subsequently amplified using realtime quantitative pcr instrument announced various primer probe sets sarscov<NUMBER> previously developed china germany hong kong japan thailand usa world health organization <NUMBER>b table <NUMBER> primers targeting different sections virus genetic sequence including envelope e gene rnadependent rna polymerase rdrp gene n gene corman et al <NUMBER> world health organization <NUMBER>b targeting e gene reported highest sensitivity followed rdrp gene confirmation laboratories multiplexed pcr tests consisting multiple primer probe sets located different regions sarscov<NUMBER> genome assays designed contain primer sets targeting multiple genes simultaneously rdrphel n chan et al <NUMBER>b detect different regions single target n gene ufad administration <NUMBER> table <NUMBER> use multiplex assays potentially beneficial improve sensitivity cases loss degradation viral rna specimen collection nucleic acid extraction event mutation virus genome assays use vitro synthesized rna derived transcripts eg betacovwuhanwiv<NUMBER> gisaid access number epiisl<NUMBER> positive controls generate standard curves internal control using rnase p rp verifies presence quality nucleic acid samples molecular grade nucleasefree water used negative amplification control negative patient sample serves negative extraction control monitor cross contamination across samples validate test reagents rtpcr frontline diagnostic test covid<NUMBER> capable analyzing thousands specimens single day shows testing sensitivity <NUMBER> anticipated limit detection sarscov<NUMBER> rtpcr test <NUMBER> copiesreaction allows early detection low viral titers gene amplification indicates positive result presence sarscov<NUMBER> rna correlate clinical observations patient history epidemiological information false positive results could generated crossreactivity primers nucleic acids arising coinfection viruses bacteria cases agent detected may definite cause disease matching sarscov<NUMBER> rtpcr primers probes using reliable libraries eg blast necessary ensure homology covs like sarscov <NUMBER> organisms staphylococcus aureus candida albicans false positives also occur reagents laboratory become contaminated major concern particularly high volume testing encountered pandemic negative patient sample useful identify error testing falsenegative results could potentially arise mutations occurring primer probe target regions sarscov<NUMBER> genome negative results preclude sarscov<NUMBER> infection results validated different primer sets gene target combined patient history clinical data accurately determine patient infection status provisions testing laboratories use approved tests validation results governing authorities develop master protocols use multiple investigators must place achieve rapid testing capacity output number tests per day number individuals tested per day relies laboratory capacity trained staff reagents supplies equipment large quantities specific highgrade reagents needed perform tests supplies quickly depleted pandemic impacts turnaround time rtpcr diagnostic testing ranges <NUMBER> <NUMBER> days strategies rapidly scale testing novel hcovs must considered future diagnostic testing eia assays diagnostic methods used identify antibodies patient blood sample nasopharyngeal swabs enzymelinked immunosorbent assays elisas antibody detection sarscov<NUMBER> measure host humoral response including igm igg iga define previous exposure virus guo et al <NUMBER> okba et al <NUMBER> igm first immunoglobulin produced response antigen primarily detected early onset disease <NUMBER> days igg abundant immunoglobulin produced response antigen <NUMBER> days maintained body initial exposure may protective role acquired immunity iga immunoglobulin plays crucial role immune function mucous membranes sarscov<NUMBER> glycoprotein mediates attachment entry cells surface exposed key target production host neutralizing antibodies walls et al <NUMBER> feature made protein focal target antibody vaccine development n protein hcovs functions antagonist interferon kopeckybromberg et al <NUMBER> mcbride et al <NUMBER> viral encoded repressor vsr rna interference rnai facilitates viral replication also key target antibody design leung et al <NUMBER> recombinant antigens derived receptor binding domain protein rs well recombinant n protein rn developed suitable diagnostic targets detect igm igg iga antibodies dual detection igmigg iggiga immunoglobulins development use conjunction nucleic acid detection detecting active infection define previous exposure sarscov<NUMBER> systemic blood samples collected individuals extraction serum purified rs rn immobilized surface multiwellplate capture antigens controls inactivated sarscov<NUMBER> serum samples incubated antigen sarscov<NUMBER> antibodyantigen binding labeled secondary antibodyconjugate eg horseradish peroxidase bound sarscov antibodies signal detection substrate addition quantification antibody tests provide advantage simple method detection sarscov<NUMBER> antibodies convenient compare multiple samples single patient positive rates detection sarscov<NUMBER> igg patients elisa measurements <NUMBER> <NUMBER> igm guo et al <NUMBER> jin et al <NUMBER> reported sensitivities serum igm igg antibodies detection <NUMBER> <NUMBER> specificities <NUMBER> <NUMBER> highest sensitivity antibody tests recorded <NUMBER> weeks first symptoms disease lower igm sensitivity may igm response occurs early decreases offer strong detectable signal igg signals may readily detected present beyond <NUMBER> days incorporation unique immunoglobulin labels may increase sensitivity rapid antibody tests respiratory viruses li r et al <NUMBER> results antibody testing could inform infection status define previous exposure sarscov<NUMBER> antibody detection also used identify recovered patients human donors generation convalescent patient serum plasma investigational treatment critically ill patients shen et al <NUMBER> results sarscov<NUMBER> antibody tests may vary apparent disease periods time symptom onset well reliability diagnostic assays yet known igm igg antibodies specific sarscov<NUMBER> virus become detectable infection long antibodies persist following infection extent protection neutralizing antibodies subsequent infection virus overall sensitivity specificity indicate possibility false negatives false positives testing method since risk recurrent infection sarscov<NUMBER> known covid<NUMBER> detection one two antibodies igm andor igg necessarily guarantee immunity reinfection negative results rule sarscov<NUMBER> infection particularly contact virus positive results may due past present infection sarscov guo et al <NUMBER> possibly nonsarscov strains gaunt et al <NUMBER> critical conduct stringent evaluation antibody diagnostic assays determine accuracy reliability results recombinant systems routinely used express recombinant proteins develop antibody assays however proteinexpression systems result significant discrepancies recombinant native viral proteins example use e coli competent cells produces proteins lack critical posttranslational modifications human cells eg glycosylation alter epitopes protein conformation gupta shukla <NUMBER> consequently compromise sensitivity specificity antigens diagnostic assays use mammalian expression systems express recombinant proteins produce antigens posttranslation modifications closely resemble human native proteins bandaranayake almo <NUMBER> leading higher sensitivity specificity assays serological assays currently accelerated development diagnosis hcov infections commercial reagents need validated clinical trials using samples patients confirmed infections sarscov<NUMBER> approved regulatory review process nonetheless rapid sensitive platform identification antibody titers also support screening identify minimize risk viral spread others well epidemiological studies vaccine evaluation studies us fda allows use rapid antibody tests sarscov<NUMBER> emergency use authorization eua expedites assessment optimization diagnostic tests expectation test sufficiently experimentally validated made available patients tests provide accurate results impair prevention efforts delay appropriate treatment global pandemic response several research laboratories used eia platform develop lateral flow immunoassays lfia rapid qualitative detection sarscov designed simple portable diagnostic strip measure either sarscov<NUMBER> antibodies antigens viral titers often low nasal swabs serum plasma detection antigens may challenging comparison detection antibodies serological antigen assays target s<NUMBER> s<NUMBER> domains protein binds angiotensinconverting enzyme<NUMBER> ace<NUMBER> integral transmembrane protein lung alveolar epithelium serves initial attachment site sarscov<NUMBER> n proteins design lateral flow test stripdipstick containing immobilized test reagents enclosed cassette drops patients blood deposited strip contains coating purified monoclonal antibody mab recombinant antigen localized specific regions nitrocellulose membrane mab targets viral antigen recombinant antigen recognized antibodies present infected patients strip also contains labeled detector antibodies bind antigen positive antibody result indicates binding coating antigen patient antibodies binding detector antibody generates colored signal positive antigen result indicates binding coating antibody patient antigen two drops blood sufficient detection sarscov<NUMBER> antibodies method technique delivers results ∼<NUMBER> min uses visual detection naked eye comparison rtpcr <NUMBER> days detection antibodies shows previous viral exposure detection antigens indicates active carriers sarscov<NUMBER> virus specificity sensitivity lifas comparable antibody antigen assays tests detect sarscov<NUMBER> patients identifying viral antigens challenging develop tests detect neutralizing antibodies sarscov<NUMBER> see purified monoclonal antibodies must generated target antigens assays need assessed optimized using blood infected patients rapid development antigens assays led use prototype pathogens silico models antibodyantigen interactions used generate artificial antibody libraries shao et al <NUMBER> antibody phage display technology applied discover antibodies antigens ledsgaard et al <NUMBER> rapidly generated produce prototypes diagnostic tests validation studies expedite assessment optimization final commercial diagnostic kits available integrating fast portable tests epidemiological surveillance also provide quick reliable information public health authorities monitoring spread sarscov<NUMBER> svn assay serological test measures ability patients antibodies neutralize infectivity sarscov<NUMBER> attenuate infection assay considered reliable assessment protective antibody inform use convalescent plasma passive antibody therapy covid<NUMBER> infection particularly severely ill patients although limited clinical data early studies suggest transfusion convalescent plasma suppress sarscov<NUMBER> viral replication protect individual infection guo et al <NUMBER> shen et al <NUMBER> svn assay used routine diagnosis frontline special indication plasma prepared systemic blood samples collected covid<NUMBER> convalescent donors written informed consent required donor recipient several cell lines suitable sarscov<NUMBER> transduction including vero monkey kidney cell line huh<NUMBER> human hepatoma cell line <NUMBER>t human kidney cell line nie et al <NUMBER> serial dilutions patient convalescent serum added known strains virus betacovshenzhenszth<NUMBER> strain virus gisaid access number epiisl<NUMBER> shen et al <NUMBER> mixture inoculated susceptible cell monolayer incubated virus adsorption cytopathic effect measured microscopic examination shen et al <NUMBER> <NUMBER>day incubation fluorescence nie et al <NUMBER> plaque formation following <NUMBER> h incubation neutralizing antibody titer highest dilution serum reduces activity sarscov<NUMBER> svn assay highly robust reproducible test may applied detect sarscov<NUMBER> neutralizing antibodies convalescent plasma samples identify best candidates treatment neutralizing activities along viral load antibody titers simultaneously monitored paired plasma samples patients receiving convalescence plasma establish algorithms determining patient donor factors predict clinical efficacy accessibility live sarscov<NUMBER> strain regulated limits development laboratory testing svn inexpensive manual assay requires careful inhouse standardization quality control preliminary case report positive responses <NUMBER> severely ill patients covid<NUMBER> treated shenzhen third peoples hospital china using plasma recovered individuals recently published shen et al <NUMBER> convalescent plasma contained functional igg igm antisarscov<NUMBER> neutralizing antibodies inhibited viral growth cell cultures notably snv assay reliably measured increases patients neutralizing antibody titers <NUMBER> <NUMBER> days plasma transfusion study evaluated randomized clinical trial limitations data interpretation nonetheless findings demonstrate utility svn assay evaluating antisarscov<NUMBER> neutralizing antibodies future convalescent plasma assessment rigorous clinical investigations involving larger cohort patients severe covid<NUMBER> illness methods rapid detection nucleic acids used develop applications clinical diagnostics sarcov<NUMBER> method amplifies dna rna target sequence streamlined exponential manner detection contrast pcr require thermal cycling wide variety nucleic acid detection assays developed including loopmediated isothermal amplification lamp singletube technique amplification dna reverse transcriptionlamp combines reverse transcriptase lamp detect rna rtlamp notomi et al <NUMBER> recombinase polymerase amplification rpa helicasedependent amplification hda vincent et al <NUMBER> strand displacement amplification sda walker et al <NUMBER> nucleic acid sequencebased amplification nasba compton <NUMBER> assays incorporate isothermal methods enable primer binding followed amplification using polymerase stranddisplacement activity separates strand annealed target sequence detection amplified gene products detected photometry isothermal nucleic acid amplification utilized several commercial molecular diagnostic platforms considered fastest available molecular laboratory pointofcare test detection novel sarscov<NUMBER> rtlamp method shown effectively detect sarscov<NUMBER> clinical samples individuals covid<NUMBER> yan et al <NUMBER> multiple loop primers targeting orf<NUMBER>ab gene gene used dna strand displacement activity target amplification achieved detection <NUMBER> copiesreaction <NUMBER> copiesreaction respectively results comparable rtpcr amplification reported <NUMBER> sensitivity <NUMBER> specificity mean time detection <NUMBER> min demonstrates definitive testing method method detected total viral rna derived cell culture supernatant <NUMBER> nasopharyngeal swab samples <NUMBER> positive <NUMBER> negative sarscov<NUMBER> behrmann et al <NUMBER> approach integrates isothermal methods reverse transcription followed recombinase activity mediates primer targeting n gene binding homologous sequence dsdna subsequent amplification polymerase mediated primer extension achieved <NUMBER> diagnostic sensitivity specificity method offers potential advantages rtpcr speed scale portability allowing evidencebased clinical decisions made patient visit crispr assay functionality applied detection dna rna using nucleic acid preamplification combined crisprcas enzymology specific recognition sequences crisprcas<NUMBER>a system recently discovered crisprrna crrna guided detection method specific rna applied sarscov<NUMBER> detection key feature approach cas<NUMBER>a formerly named c<NUMBER>c<NUMBER> enzyme recognizes binds targeted rnas sequencespecific manner followed nonspecific transendonuclease cleavage nontargeted rna collateral cleavage signal amplification nucleic acid detection cas<NUMBER>a assay paired target nucleic acid amplification sensitive results using isothermal exponential amplification technique commonly rpa coupled technique termed sherlock specific highsensitivity enzymatic reporter unlocking allows fluorescence colorimetric lateral flow readout approaches enable rapid detection variety targets kellner et al <NUMBER> unlike vivo crispr tools cas<NUMBER>a protein must recombinantly expressed purified endonuclease activity purified cas<NUMBER>a uses crrna targeting sequences gene orf<NUMBER>ab sarscov<NUMBER> rna target siterecognition activates transcleavage reporter probes resulting increases fluorescence output signals confirming presence viral rna using synthetic sarscov<NUMBER> reported performance method detection target sequences <NUMBER> kellner et al <NUMBER> cas<NUMBER>acrrna platform adapted lateralflow assays could wide applications sarscov<NUMBER> detector research clinic assays designed paper dipstick test delivers signals <NUMBER> min using promising technology positive advances science offer immense hope future disease control nextgeneration sequencing ngs enables complete sequencing ∼<NUMBER> nucleotides sarscov<NUMBER> genome ngs provides method identification sarscov<NUMBER> environmental monitoring surveillance testing also providing insight strain origin viral evolution sequence deposited gisaid epicovtm database date <NUMBER> sarscov<NUMBER> sequences global ngs efforts rna extracted clinical specimens rtpcr purified remove human cytoplasmic ribosomal rrna rna fragmented followed cdna synthesis use set highly specific universal cov primers genomic segments amplified dna amplicons sequenced deliver highly accurate sarscov<NUMBER> typing <NUMBER> h virus titer efficiency human rrna depletion number reads per sample impact number virusspecific reads obtained accurate coverage viral genome collectively global ngs data suggest sarscov<NUMBER> genome relatively stable although mutations identified symptomatic individuals present original strain wuhan china two recent ngs studies report large base pair deletion consisting <NUMBER> nucleotides sarscov<NUMBER> orf<NUMBER>a virus sample us patient holland et al <NUMBER> point mutations may suggest infectious strain virus original strain korber et al <NUMBER> orf<NUMBER>a gene encodes accessory protein involved viral infection host cell death schaecher et al <NUMBER> findings require investigation patient samples determine whether mutations selected asymptomatic symptomatic individuals although ngs one comprehensive approaches figure <NUMBER> molecular structure sarscov<NUMBER> summary available laboratory tests target molecules sarscov<NUMBER> lipid bilayer membrane contains envelope e membrane proteins make envelope spike glycoproteins project surface virion nucleocapsid protein n composed protein associated viral genetic material rtpcr reverse transcriptase polymerase chain reaction eia enzyme immunoassay lfia lateral flow immunoassay svna serum virus neutralization assay inaa isothermal nucleic acid amplification crispr clustered regularly interspaced short palindromic repeats ngs next generation sequencing rtlamp reverse transcriptase loopmediated isothermal amplification rpa recombinase polymerase amplification identifying sarscov<NUMBER> method relatively expensive multiple sample preparation steps used largescale testing regulating authorities provide interim guidance handling specimens associated sarscov<NUMBER> cdc <NUMBER>b samples testing performed bsl<NUMBER> laboratory unidirectional airflow bsl<NUMBER> precautions respiratory protection designated area personal protective equipment changes recommended isolation sarscov<NUMBER> cell culture initial characterization viral agents recovered cultures patient samples conducted biosafety level <NUMBER> bsl<NUMBER> regulatory approval guidance figure <NUMBER> table <NUMBER> summarize main laboratory tests detection components sarscov<NUMBER> humoral response virus depict key features approaches given public health emergency expanding covid<NUMBER> outbreak presents widespread testing needed investigate disease eg prevalence population severity age groups identify individuals infected symptoms detailed epidemiological data sets better establish rates severe infection death among infected populations ongoing research critical optimize existing antibody tests determine whether immunity prevents recurrent infection investigate efficacy passive antibody therapies covid<NUMBER> infection identification novel disease biomarkers may valuable understanding makes people susceptible covid<NUMBER> infection predicting severity progression disease researchers could request approval analyze stored samples human blood animals might natural reservoir virus specifically guidance would needed direct blood plasma collection centers allow access samples covid<NUMBER> patients covid<NUMBER> pandemic showcases quickly information needs shared responders address rapidly evolving situations establishing communication across laboratories worldwide helps develop master protocols establish reference panels use multiple investigators aid coordinating collection use data regulatory infrastructure range tests also puts less pressure one manufacturer supply chain different suppliers may use different materials could help alleviate difficult decisions limit testing vulnerable patients great public health consequences rdc vs contributed concept writing manuscript ac contributed writing prepared tables figure manuscript work provided part nemoursthe fund severe acute respiratory syndrome sars epidemic spreads specific rapid practical diagnostic tests become increasingly critical control epidemic management patients present outside east southeast asia diagnosis depends clinical case definition includes travel exposure sick contacts traveled specific parts world <NUMBER> epidemic matures however epidemiologic connections increasingly difficult demonstrate clinical case definition depends information become increasingly irrelevant east southeast asia rapidly expanding epidemic makes specific viral diagnosis even essential evolving situation report poon et al hong kong <NUMBER> combination published diagnostic technologies group others europe united states <NUMBER> <NUMBER> <NUMBER> takes extraordinary importance moreover development publication rapid test sars coronavirus clinical samples weeks first reports emergence disease <NUMBER> extraordinary historical footnote technologic tour de force extreme contrast diagnostic tests led first descriptions coronaviruses <NUMBER> years ago time rapid diagnosis production cytopathic effect subpassage tissue culture <NUMBER> coronaviruses recognized use human embryo tracheal organ cultures viral presence detected cessation ciliary motion electron microscopy nutrient media cumbersome inoculation production colds human volunteers <NUMBER> <NUMBER> fact difficulty diagnosis dogged field human coronaviruses hampered progress throughout history test described poon et al <NUMBER> looks good appears become positive antibodies first appear would expect sensitive test virus limited studies described performed quite well although well could hoped sensitivity <NUMBER> specificity <NUMBER> relation acutetoconvalescent seroconversion melting curves judged viral sequence vary patient patient bodes well pcrbased technique clearly test requires validation larger series cases noncases refine estimates performance particularly critical regard specificity rapid viral diagnosis likely play extremely important role areas sars actively epidemic settings false positives potential fuel panic test used much often sars coronavirus infection almost equal importance demonstration test exported laboratories without loss sensitivity specificity judge real value test therefore use optimally need much information best specimens obtain patients germans found sputum contained far stronger pcr signal upper respiratory tract samples <NUMBER> poon colleagues <NUMBER> tested nasopharyngeal aspirates could sputum used instead sensitivity test would closer <NUMBER> course illness infection samples become positive become negative distribution virus body blood urine appears present stool almost information either quantity timing duration shedding pcrbased diagnostic test infectious disease advantages disadvantages expected sensitive allows readout matter hours also potential quantitative hand expensive requires technology trained technologists often available locality disease addition says nothing infectiousness virus found like tests virus however anticipated become positive early course illness allowing guidance therapeutic management decisions well early institution precautions control contagion turns sensitive course disease value negative test may even greater positive test capacity relieve patient family community anxiety moreover test virus give valuable information trying contain epidemic locally globally test well tests infectious virus need applied large number cases prospective manner make educated guesses course illness infected individuals likely contagious case reports sars described presence fever beginning respiratory symptoms <NUMBER> <NUMBER> virus respiratory secretions stage even fever begins studies old coronaviruses human volunteers virus could isolated nasal secretions onset respiratory symptoms <NUMBER> true questions asked fecal shedding already know antibody sars coronavirus appears relatively late course infection information available yet however time appearance igm antibody may prove important adjunctive test early identification infections ideal test virus rapid sensitive specific also inexpensive technologically simple available point care even editorial clinical chemistry <NUMBER> <NUMBER> <NUMBER> small hospitals communities developing world tests designed detect virus clinical samples satisfied criteria antigen detection tests probably come closest academic biotechnical epidemiologic forces around world frantically working create specific sensitive monoand polyclonal antibodies virus assembling antigen detection tests move us quickly next era diagnosis specific diagnosis help lessen fear test follow make major contribution public health care patients respiratory infections sars coronavirus spreads world world currently impacted novel coronavirus disease world health organisation coordinates global efforts manage impacts declared covid<NUMBER> global pandemic march <NUMBER> <NUMBER> <NUMBER> scale impacts unprecedented studies suggested might take decade world recover societally economically <NUMBER> might significantly compromise progress sustainable development agenda sdgs <NUMBER> march <NUMBER>th g<NUMBER> countries pledged <NUMBER> trillion defend global economy covid<NUMBER> <NUMBER> united nations un launched global humanitarian response plan covid<NUMBER> <NUMBER> pandemic started city wuhan hubei province china brought many new challenges public health various countries world experienced global public health crises last <NUMBER> years caused novel virus infections hiv influenza virus subtype h<NUMBER>n<NUMBER> influenza virus subtype h<NUMBER>n<NUMBER> sarscov<NUMBER> merscov ebola progress disaster science <NUMBER> <NUMBER> <NUMBER> ☆ final version available progress disaster science <NUMBER> april <NUMBER> preproof available online <NUMBER> april <NUMBER> <NUMBER> httpswwwsciencedirectcomsciencearticlepii s<NUMBER> ⁎ corresponding author united nations universityinstitute advanced study however epidemiological novelty covid<NUMBER> caused strain coronavirus sarscov<NUMBER> revealed lack preparedness given sudden rapid spread caught many governments around world unprepared march <NUMBER>th issued six prioritised strategies undertaken governments cope pandemic strategies follow expand train deploy healthcare workers implement systems find suspected cases ramp production tests increase availability identify facilities transformed coronavirus health centres develop plans quarantine cases refocus government measures suppressing virus <NUMBER> lowering delaying epidemic peak important uncontrolled measures lead rapid increase number cases reach peak earlier require capacity healthcare systems respond stringent control measures implemented early help lower number cases delay reaching peak need considerably lower capacity healthcare systems <NUMBER> indonesia fourth populous country world thus predicted suffer greatly longer time period compared lesspopulous countries <NUMBER> novel coronavirus sarscov<NUMBER> hit china severely months december <NUMBER>february <NUMBER> indonesia reported case infection march <NUMBER> <NUMBER> president joko widodo reported first confirmed two cases covid<NUMBER> infection indonesia april <NUMBER> country reached <NUMBER> confirmed cases <NUMBER> new cases <NUMBER> number deaths <NUMBER> number recoveries <NUMBER> <NUMBER> paper one first policyresponsefocused academic publications aimed providing brief reporting analysis evaluation current rapid responses covid<NUMBER> indonesia allow rapid publication dissemination information paper intend provide exhaustive list responses aims capture current governmentled responses middle crisis paper viewed realtime evaluation provides insights lessons stakeholders improve adjust existing policy options mainly national level april <NUMBER> till end crisis three objectives paper first highlight key response strategies actions responding covid<NUMBER> emergencies indonesia second analyse gaps opportunities responses third put forward recommendations toward rapid comprehensive systematic approaches shortand longerterm methodology includes rapid analysis based media content analysis including governments speeches reports well observation various social media platforms available january march <NUMBER> especially targeted online media contents website www covid<NUMBER>goid mass media well participant observations social media platforms eg facebook postings governments relevant stakeholders paper interdisciplinary nature authors coming various disciplines collaborative work following calls coauthorships first author march <NUMBER>th <NUMBER> authors indonesian scholars experienced practitioners broad expertise healthpublic health basic biology disaster governance law engineering public policy environmental science culture community advocacy risk communication aim balanced analysis natural social scientists focussing analysis policyrelevant responses authors involved response activities providing government advice nationally locally structure paper follows section <NUMBER> provides context rationale aim paper briefly presents covid<NUMBER> impacts date <NUMBER> march <NUMBER> present report key health strategies taken national government section <NUMBER> analyse role different organisations section <NUMBER> review roles key ministries national level responses provincial local government level along roles major organisations community level section <NUMBER> complemented analysis responses focussing gaps limitations finally section <NUMBER> outline recommendations improving current responses grouped healthrelated wider recommendations section reports key responses indonesia first discuss existing institutional framework responding health emergencies focus early rapid detection diagnosis infections initial zero case reported indonesia prior global pandemic declaration questionable many eg <NUMBER> period despite reports increasing numbers infection countries surrounding indonesia time indonesia issue form travel restrictions specific quarantines travellers coming incoming back indonesia even severely hit countries china january <NUMBER> <NUMBER> indonesia issued travel restriction hubei province time epicentre global covid<NUMBER> time evacuated <NUMBER> indonesians wuhan initial subsequent reports infections indonesia started realize direness situation since issued various policies actions tackle covid<NUMBER> including appointing <NUMBER> domestic general hospitals referral hospitals rumah sakit rujukan march <NUMBER> <NUMBER> cope everincreasing number covid<NUMBER> patients number referral hospitals increased <NUMBER> march <NUMBER> <NUMBER> however despite efforts number victims keeps increasing rapidly ministry health indonesia provides live data covid<NUMBER> impacts indonesia <NUMBER> coordinated information covid<NUMBER> coordination presented newly established website httpswwwcovid<NUMBER>goid fig <NUMBER> shows front page date <NUMBER> dedicated websites provincial governments data transparency early response criticised several mainstream media least since <NUMBER> march <NUMBER> public started critically demand data transparency toward government plea emerged digital news media <NUMBER> <NUMBER> time already <NUMBER> cases reported lack data transparency might caused underreporting actual number cases dissemination probably actual number cases detected number actual infections could undetected example lack proper diagnoses misinformation could severely impede governments future responses indicated possibility efforts enough presently rtpcr reverse transcription polymerase chain reaction acknowledged method rapidly accurately detect covid<NUMBER> infection humans <NUMBER> <NUMBER> first enzyme reverse transcriptase used change rna genetic material sarscov<NUMBER> nasopharyngeal swab samples dna reverse transcription step next using specific primers section synthesized dna originated virus amplified using polymerase chain reaction pcr method swab samples containing human virus rna show positive results earlier mass media reports indonesia onset peak epidemics wuhan china suggested zero infection country happened months even various reports shown indonesias neighbouring countries reported least one infection lack rapid scientific surveys deployed government make swift decisions actions caused many pseudoscientific explanations cause spreading indonesia seen mass social media ranging racial superiority religious paranormal reasons eg <NUMBER> however later reports strongly indicated zero case scientifically improbable example suggested harvard university <NUMBER> later severely criticised indonesian minister health <NUMBER> various international mass media foreign bodies outside indonesia even became stringent went far questioning abilities indonesian scientists medical practitioners well presence enough technical facilities skills detect diagnose disease investigations reported many suspected covid<NUMBER> persons diagnosed clinically tested using pcr method including indonesians evacuated wuhan could one reasons likely incorrect report zero infections initial period global pandemic present extensive coordination among different institutions indonesia started pcr analyses suspected citizens however compared countries japan korea china number enough reflect likely actual present condition infection indonesia march <NUMBER> <NUMBER> president joko widodo announced indonesia conduct massive testing conducting rapid detection tests citizens <NUMBER> test use recently developed testing kits based serology <NUMBER> results <NUMBER> min much faster pcr test <NUMBER> h depending method news mass media suggested indonesian government ordered <NUMBER> testing kits china mass media reported results first batch tests conducted jakarta <NUMBER> positive <NUMBER> negatives <NUMBER> <NUMBER> problem although testing kits developed even sold various companies none kits passed clinical testing without clinical assessment actual specificity sensitivity reports indicated coronaviruses even dengue might give false positive results moreover unlike pcr test targeted presence actual genetic materials sarscov<NUMBER> samples immunoreactionbased testing targets presence antibodies bodies patients antibodies sarscov<NUMBER> known present <NUMBER> <NUMBER> days symptoms appear means antibodyantigenbased test cannot detect infection prior symptoms appearance thus might give false negative results meanwhile test might also detect antibodies presence recovering cured patients thus giving another false positive result indonesians shouldnt used guinea pigs giving pharmaceutical companies free nationwide clinical trials therefore data must handled carefully since recent report business insider suggested rapid tests using serologybased rdt <NUMBER> accurate <NUMBER> indonesia needs quickly ambitiously collect information order obtain big picture present nationwide covid<NUMBER> distributions information important deciding actual policies therefore immunoreactionbased rapid detection kits rdt actually useful carefully used example test could conducted first line rapid public diagnoses select must take expensive elaborate accurate pcr test tested positive rdt must required pcr test meanwhile tested negative must take test multiple times least three times interval <NUMBER> <NUMBER> days considering incubation period virus also result test useful global covid<NUMBER> countermeasures private sectors producing test kits indonesia must negotiate position also benefit using rdt kits late march <NUMBER> indonesian task force covid<NUMBER> gugus tugas percepatan penanganan covid<NUMBER> issued guidelines medical rapid response public health aspects covid<NUMBER> indonesia guide targets medical force general public terms informing means mitigate impacts death rates information includes protocols rapid tests using rdt lab testing patient handling outreachcommunications means protocols rapid testing lab testing recognize three levels risks without symptoms asymptomatic person surveillance odporang dalam pemantauan patient surveillance pdppasien dalam pengawasan test involves isolation suspected person rapid testing ultimately required pcr indonesian public health association iakmi also regularly issued key recommendations task force general supported government measures advocated evidencebased policy one instance circular <NUMBER> march <NUMBER> iakmi encouraged government strengthen role primary health care system facilitate communitybased responses covid<NUMBER> including education surveillance recommendations also made indonesias association specialist doctors clinical pathology medical lab pds patklim instance issued cautions possible caveats interpreting results serologybased rdt tests covid<NUMBER> suggested negative results must repeatedly tested method time positive results retested pcr <NUMBER> emphasize rapid tests viewed mainly implement broader surveillance epidemiological studies source <NUMBER> order understand breadth covid<NUMBER> infection indonesia pds patklim circular <NUMBER> march <NUMBER> section presents key responses different governmental organisations start analysing regulatory institutional frameworks health emergency responses indonesia discuss formation indonesian special task force covid<NUMBER> important step response countries caught unprepared speed scale impacts covid<NUMBER> several national regulations produced government different levels president ministerial levels januarymarch <NUMBER> table <NUMBER> ordered chronologically summarises rules regulations produced guide national local response indonesia table shows regulations issued <NUMBER> march president established task force head national disaster management agency bnpb appointed commander prior decree national level response minimal indicated two sectoral regulations issued first health ministry declaration novel <NUMBER>ncov disease outlines potential transform covid<NUMBER> outbreak done <NUMBER> february <NUMBER> second national declaration specific emergency situation covid<NUMBER> head bnpb <NUMBER> february <NUMBER> one important one presidents directives <NUMBER> instruksi presiden nomor <NUMBER> specifically instructing refocusing development activities reallocation government budget procurement goods services rapid accelerated response covid<NUMBER> refocussing kegiatan realokasi anggaran serta pengadaan barang dan jasa dalam rangka percepatan penanganan corona virus disease <NUMBER> see president directive inpres <NUMBER> table <NUMBER> president directive major points calling rapid active strategies related budget reallocation ensuring food security strengthening health sector basic health services national insurance scheme bpjs covid<NUMBER> patients changes teaching delivery cancellation national exam schools strengthening local governments local economy reduction taxes selected commodities implementation various economic fiscal strategies ensuring affected receive certain compensations <NUMBER> policy directions followed ministerial levels seen rest section central local governments working together related stakeholders execute presidents directives mentioned however unclear whether say recommendations implemented since issued <NUMBER> weeks ago however directive inpres <NUMBER> strong enough create national scale imperatives rapidly end spread covid<NUMBER> therefore pressures made many stakeholders finally long overdue president indonesia issued one decree two fundamental regulations last day march <NUMBER> article goes print regulations include first regulation national budgeting policy stability budgeting system covid<NUMBER> pandemic disaster andor managing threats national economy andor stabilisation budgeting system second declaration community health emergency situation covid<NUMBER> third big scale social restriction accelerating covid<NUMBER> eradication table <NUMBER> coordinated response extremely important first significant regulation formation task force rapid response covid<NUMBER> gugus tugas percepatan penanganan covid<NUMBER> <NUMBER> march <NUMBER> suggests despite gaps top leadership took <NUMBER> days first confirmed cases early march <NUMBER> establishment task force provides better interagency coordination response mechanisms task force led head bnpb general doni monardo mr achmad yurianto task force spokesman also medical doctor current health ministrys disease control prevention directorgeneral managing epidemic natural mandate bnpb however given presidential preference decision head bpbp tasked chief task force see section <NUMBER> overall able provide evaluation bnpb given lack time observation however worth noting addition key roles task force national disaster management agency bnpb tasked collaborate ministry health disseminate information covid<NUMBER> different media platforms including sms blasts established rapid response team provide logistics materials health facilities conduct surveillance new potential cases covid<NUMBER> collaborate indonesia national armed forces indonesia national police ministry health bnpb equipped approximately <NUMBER> officials join existing team pusat pengendalian operasi penanganan bencanathe center disaster management operation complacency plagued ministry proactive able lead pandemic national levels despite heavily criticised reluctant informed public academics within outside country ministry health one first ministerial level agencies formally respond covid<NUMBER> since <NUMBER> february <NUMBER> elsewhere indonesia health system capacity capacity cope pandemic moment legacy national committee avian influenza control pandemic influenza preparedness <NUMBER> could seen present crisis lack preparedness seen throughout six building blocks health system ranging health service delivery workforce information system access essential medicines health system financing leadership governance therefore starting <NUMBER> february clear indication acceleration response covid<NUMBER> first confirmed cases moment despite criticisms agile enough moh playing critical roles national spokesperson covid<NUMBER> starting february till <NUMBER> march <NUMBER> least <NUMBER> tests conducted covid<NUMBER> suspects <NUMBER> confirmed positive first half march <NUMBER> <NUMBER> tests carried <NUMBER> confirmed positive starting <NUMBER> march <NUMBER> least <NUMBER> tests done <NUMBER> confirmed positive overall testing slow government quite passive conducting diagnostic testing health infrastructure especially health laboratories indonesia identified one weakest problems indonesia health system <NUMBER> spread covid<NUMBER> revealed health infrastructure gaps example present indonesian moh designated <NUMBER> laboratories across indonesia covid<NUMBER> diagnostics wwwlitbangkemkesgoid ministry finance headed former world banks managing director sri mulyani indrawati made four major decisions namely taxincentives policy labour protection rescheduling loan repayment small medium enterprises smes reallocation fiscal policy local government levels <NUMBER> new policies issued last week march <NUMBER> point time limited information implementation financial monetary responses ministry finance however provide overview policies promises future reference first decision expand labour insurance bpjs tenaga kerja cover covid<NUMBER> related job losses policy form protection workers via <NUMBER>months cash transfers program affected worker entitled rp <NUMBER> million per month second provision minimum business protection measures including big push banking relax payments certain business groups risky removed supply chains <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> spread covid<NUMBER> virus greatest impact financial investment business sector including affected one aviation tourism hotel restaurant shipping transportation third socalled countercycle policy government decided relax fiscal policy namely widening <NUMBER> state budget deficit around <NUMBER> gdp originally planned <NUMBER> gdp widening deficit means added spending president indonesia recently highlighted agenda fight two wars namely war covid<NUMBER> prevention economic crisis bank indonesia bi vital role play ensuring policy measures anticipate impact coronavirus financial market mitigate macroeconomic impacts key policies stabilize financial market due coronavirus introduced bi continue monitor developments financial markets economy including impact corona virus continue strengthen policy mix coordination government relevant authorities maintain economic stability encourage economic growth momentum accelerate structural reforms <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> democratic country using military police forces popular option however indonesian national armed forces tni tentara nasional indonesia participation war covid<NUMBER> necessary able assess effectiveness exhaustively fairly briefly highlight involvements example use military assets personals essential response military aircrafts used help logistical response times civilian system provide support tni involved preparation emergency hospitals locations wisma atlet jakarta natuna pulau sebaru pulau galang pangdam therefore roles nontraditional war essential interestingly also observed emerging paradigm nontraditional view security forces social media mainstream media last weeks view frontline medical workers including doctors nurses viewed armies combatting war covid<NUMBER> since enforcement ensure social distance mitigation measures place also observed role police critical enforcing mitigation measures head police kapolri issued mandate letter mak<NUMBER>iii<NUMBER> <NUMBER> march <NUMBER> prohibit mass gatherings group activities public private environments one vulnerable groups people remote disadvantaged regions indonesia health system access health service remains limited good news last five years central government created nationwide incentive village development village development fund add moment instructed president responded directly ministry village regional disadvantage transmigration allow village governments ca <NUMBER> shift existing funds cash work therefore subject future studies investigations village governments truly help covid<NUMBER> affected communities using funding add section review roles responses focussing religious socioeconomic organisations well communities acknowledge many groups contributed responses international nongovernment organisations civilsociety groups discussed paper religions provide comfort sense security throughout history human civilisation roles pandemics productive counterproductive time religious country indonesia experienced good inconvenient experiences regard religious views covid<NUMBER> human fellowship characterised routinised human contacts gatherings around house prayers key features religious tradition abrahamic religions islam christian well hindu buddhism well countless faithbased traditions indonesia fellowship source dense social capitals shape worldview source inspiration wisdom todays pandemic also past covid<NUMBER> brings new imperatives socialcultural change default therefore covid<NUMBER> hit world agenda social distancing isolation seen attack culture tradition lasted millennium despite unique adherents degree counterproductive response times epidemic religions seen solution problem provide brief overview potential religions countering covid<NUMBER> pandemics observed religious public gatherings march <NUMBER> amid covid<NUMBER> later led spread covid<NUMBER> perspective disaster governance managing risk beyond government centric paradigm <NUMBER> religious organisations must seen governing power equally powerful governments given capacity institutions resources members country highest number muslims world government indonesia cannot ignore religious factors roles handling spread covid<NUMBER> <NUMBER> three largest islamic organisations mui nahdlatul ulama muhammadiyah developed governing structure statelike structure consisting multilevel institutions national village levels governments resources masscampaign covid<NUMBER> mitigation alone fact government must rely organisations use resources schools health facilities volunteers clerics structures conduct rapid promotion education covid<NUMBER> indonesian ulema council mui real potential power shape narratives help islamic communities indonesia follow certain safety dakwah imperatives times perils socialdistancing promoted sounded like act traditions mui trying introduce new imperatives aimed mitigate covid<NUMBER> spreading mui fatwa commission issued fatwa <NUMBER> <NUMBER> fatwa explained implementation worship covid<NUMBER> pandemic situation aim safety preventing spread disease among muslims <NUMBER> mui forbids actions cause panic cause public harm buying hoarding basic necessities including protection masks mui fatwa also states people exposed sarscov<NUMBER> must isolate wont infect others exposed virus replace friday prayers zuhr prayer respective residences management corpses exposed covid<NUMBER> mui stipulates bathing caving must accordance medical protocols carried competent authorities due regards provisions sharia meanwhile burials need follow standard procedures <NUMBER> muhammadiyah formed covid<NUMBER> command center allocated hospitals <NUMBER> muhammadiyah transformed one agile promoters healthbased hospitalbased emergency response mdmc instrumental disaster response system indonesia institutions provide clinical services covid<NUMBER> patients hospitals indonesian council churches pgi proactively called congregants come churches sunday worships services internet <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pgi also calls churches form posts deal corona virus outbreak case synod assembly council western indonesian churches gpib <NUMBER> february <NUMBER> <NUMBER> four participants tested positive coronavirus pgi prepared volunteers clean house worship spraying disinfectant liquid <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> majelis buddhayana indonesia indonesian buddhist tzu chi foundation instrumental postdisaster response indonesia including covid<NUMBER> response foundation collaboration indonesian chamber commerce kadin able fundraise us <NUMBER> million idr <NUMBER> billion distributed items insulation clothing masks goggles gloves well ventilators ministry health along several hospitals nationwide drops tourist arrivals late february march <NUMBER> made tourism industry one first hardest hit businesses sectors <NUMBER> indonesian hotel restaurant association phri reported loss us <NUMBER> billion due corona virus outbreak since january <NUMBER> indonesian travel agent association astindo reported since february <NUMBER> relatively income travel agent industry loss experienced travel industry form <NUMBER> potential passenger cancellations likely continue grow future nationwide indonesian business sectors including tourism limited business continuity plans management bcpm lack business preparedness long overdue issue barely addressed sector government moment clarity help sector survive recovery covid<NUMBER> due competing priorities government tax incentives government could help longterm recovery sector needs serious thinking digital platforms gojek tokopedia bukalapak halodoc ruangguru provided facilities support working home learning home praying worshiping home according respective fields service <NUMBER> gojek halodoc provided facilities monitoring checking health home bukalapak tokopedia gojek grab open opportunities work home ruangguru facilitates learning process home mainstream media front correct governments slow response since january till today <NUMBER> recently march <NUMBER> <NUMBER> first content published hashtag amandirumah well launch hashtag medialawancovid<NUMBER> <NUMBER> content created multiplatform broadcast simultaneously tuesday morning various television channels radio newspapers cyber media social media awareness expected rate spread corona virus inhibited pattern hoped available educational publication material multiply utilized national local media initiatives share information educate public covid<NUMBER> carried journalists media industry objective media movement spread variety educational content massive scale effort combat spread corona virus indonesia initiative attended <NUMBER> national regional media various platforms namely television radio print media cyber media social media indonesia <NUMBER> initiative arose spontaneously media independent without affiliation funded party way journalistic work still run continuing uphold principle independence networked work hoped various important messages fight spread corona virus spread widely reach levels society quickly three frequent changes public behaviour staying home washing hands applied social distancing <NUMBER> communities mindful risks others communities responses seen key end pandemic seen part solutions problem earlier phase outbreak seemed obvious governments scepticism hesitance even denial potential pandemic occurring indonesia direct impacts drifted communities away favourable risk perceptions toward pandemic coupled relatively low awareness drills pandemics although number socializations already facilitated example ministry health past peoples perception covid<NUMBER> risk might low despite complex rapid flow information last since january <NUMBER> took time general public process information covid<NUMBER> take serious action protect earlier phase pandemic scientific nonindigenous terminologies eg corona covid<NUMBER> confusion differences outbreak epidemic pandemic etc used introducing risk hence created distance pandemic affect ones life later simplified technical terms related covid<NUMBER> introduced local language initiated academics experts english terminologies social distancing literally adopted governments general public slow progression information disclosures suspects patients positive diagnosis also created lack senses emergency perceived risk indicated government response fact contributed shaping communitys risk perception low perceptions risk least early phase also shaped unfavourable responses later created immense problems government deciding whether extreme measures taken contain virus spread school closed nationwide families decide go mass family holiday go back hometown sense context evolved vicious cyclical way hinder appropriate responses government communities although later also due extremely high exposure narratives types media covid<NUMBER> pandemic corona also terms wfh work home relatively contemporary terminologies slowly entered public acceptance new norm shown attitude communities follow selfisolation stay home advice government still adopting position holding nationwide lockdown nevertheless selfisolation process also new norm almost never reflection indonesian general subcultures different japan example multiplied numbers informal workers types professions simply allow person work home earn living seen social media postings communities indonesia provided food infected neighbour house isolation community selfscreening outsiders health checks also conducted example communities lombok island many migrant workers returned back malaysia countries however limitation technical knowledge tools impedes effectiveness initiatives public misinformation lack communication among government levels triggered misleading interpretation instant social media tools eg wa facebook etc herbal medication beat viruses quickly brings skyrocketing prices particular commodities garlic onions ginger even quick guidelines make instant hand sanitizer disinfectant publicly spread community activities prevent proliferation viruses sunbathing implemented routinely communities government entities resilience key enable rapid successful sustained coordinated approach responses toward covid<NUMBER> future crises emergencies see eg <NUMBER> resilience nations communities though physical mental health also economy physical social infrastructure well nature environments <NUMBER> outlined six priority strategies countries implement expand train deploy healthcare workers implement systems find suspected cases ramp production tests increase availability identify facilities transformed coronavirus health centres develop plans quarantine cases refocus government suppressing virus specifically indonesia underline following recommendations <NUMBER> active tracing close contacted patients massive rapid tests socializing staying home physical distancing well identifying mapping every single infected person close contacts helpful contact tracing mass rapid test <NUMBER> coordinating collaborating utilizing pcr laboratories research institutes universities hospitals clinics local government support pcrbased diagnoses attention must also put health infrastructure development including health laboratory development provinces <NUMBER> rapid detection tests rdt using kits based antibody detections known far less accurate pcrbased tests therefore tests must conducted thoughtfully results must handled care example multiple tests least three times must conducted tested negatives pcr tests must done tested positive however rapidity obtained data used ballpark order get broad view range scope covid<NUMBER> spread preferably whenever possible rapid pcr methods using current techniques eg microfluidic rtpcr much faster ca <NUMBER> min result conventional methods <NUMBER> h adopted rather serologybased rdt <NUMBER> increase number referral hospitals adequately equip hospitals treatment properly includes properly set treatment facilities eg respirators isolation chambers diagnostics facilities eg pcr machines diagnostics kits medicine pharmaceuticals management medical doctors specialists nurses health volunteers safety protection equipment frontline practitioners eg safety goggles protection masks hazardous materials suits <NUMBER> incentive disincentive incentive given voluntarily report symptoms hotlinereferral hospitals disincentive must implemented still available without relevant reason <NUMBER> mass spraying disinfectant road house park schools reconsidered since may little effect may harm inhalation people <NUMBER> develop proper health infrastructure including proper government health laboratory system might include limited resources private diagnostic labs research institutes universities provinces allow local covid<NUMBER> testing without delays suggest moh dohs local levels aggressive expand coverage whole six building blocks health system <NUMBER> furthermore long term covid<NUMBER> reveals need mainstream onehealth approach animal human health development integrated order achieve sdgs current approach separates health systems proven effective revealed covid<NUMBER> covid<NUMBER> case yet tied indonesias elephant room namely rampant wildlife trade multiple scales example domestic wildlife markets especially java eg <NUMBER> ongoing animals source drugs including traditional chinese medicines business sumatra bushmeat consumption including endangered bats north sulawesi delicate issues matter traditional food part culture allowing continue without reserve goes contrary safety principles wildlife human infections zoonoses <NUMBER> systems need built ensure safety eg testing known pathogens prevent novel zoonotic pandemics <NUMBER> proactive noregret approach save life strengthen disasters humanitarian coordination decisionmaking capacity subnational governments crisis emergency situation pandemic proves difficult time rapid largescale decision making governments worldwide presidential nationwide decisions changing minutebyminute leaders faced criticisms deciding whether impose nationwide lockdowns example study shows lockdowns already saved thousands lives <NUMBER> adaptive risk governance coping complexity uncertainty ambiguity <NUMBER> <NUMBER> country strengthen disastershumanitarian coordination manage pandemic broader emergencies across levels also regionally within asean <NUMBER> indonesia great experiences managing disasters coordinated approach government unocha indonesia asean aha center coordinated effectively <NUMBER> <NUMBER> moreover indonesia still needs ready earthquake floods occur including potential occurrence amid covid<NUMBER> djalante et al <NUMBER> showed focuses mainly made national government response limited varied focus cross sectors cross government levels important mandate local governments urgently form special task force gugus tugas percepatan penanganan covid<NUMBER> tingkat provinsi dan kabupatenkota accelerate responses achieve coordinated coherent responses involving key government offices agencies especially health communications information subnational governments also need start proactive tracing mass rapid tests suspected persons even decided close entrance areas resilience ability absorb impacts reorganise learn adapt transform <NUMBER> capacity sustain development expected surprising change diverse development pathways development <NUMBER> country business leaders moving urgently protect nations organisations immediate action critical also need embrace broader sustainability society march <NUMBER> un launched new plan deal potential socioeconomic impacts covid<NUMBER> pandemic calling everyone act together lessen blow people <NUMBER> three global measures outlined <NUMBER> global stimulus package amount doubledigit percentage points worlds gdp focussing developing countries <NUMBER> regional mobilisation consider impacts monetary coordination fiscal social measures involvement private financial sector <NUMBER> national solidarity needs prioritize social cohesion provide fiscal stimulus vulnerable along support smalland mediumsized enterprises decent work education extremely relevant indonesia economy needs capacity absorb impact focus vulnerable people millions jobs lost global assessment international labour organization ilo five <NUMBER> million jobs eradicated world lose <NUMBER> billion <NUMBER> trillion labour income <NUMBER> health unemployment insurance social protection necessary also support business large medium small scales prevent job losses <NUMBER> utilise sciencebased multidisciplinary decision makingadvisory supported big dataopen sciencecitizen data ensure transparency strategic crisis risk communication involve social influencers especially encourage general public undertake selfisolation health precautions note covid<NUMBER> task force included scientists recognised sciencebased datadriven advisory decision making role science advisory notable helping governments respond important progress needs continuity multidisciplinary advice healthpublic health researchers practitioners social scientists economists legal experts modellers lead better understanding contexts potential impacts big data artificial intelligence openscience citizendata accelerate current responses countries singapore south korea china attributed aggressive monitoring use technologies governments different levels prepare manage crisis risk communication strategy anticipating information overload social media create system pro antigovernment hoaxes minimised transparency key managing pandemic provides condition infected persons quickly identified treated accordingly timely fashion central local government must develop integrated strategy crisis risk communication strategy <NUMBER> allow people informed minimise irrational behaviours panic buying local markets also important build capacity highlevel officials local level governments provincial districts decision making crisis communication crises situations good start made provinces developing databases websites sharing monitoring data provincial jurisdiction commendable social media played good part eg advocating economic solidarity increasing neighbourhood spending informal workers interesting short videos raising awareness selfisolation made members public including najwa shihab renowned news anchor nadiem makarim minister education recently awareness videos made local languages javanese sundanese sasaknese however many times also social media invaded dangerous hoaxes eg promoting chloroquine reliable drug fight covid<NUMBER> alcoholbased hand sanitizer soap effective prevention government developed hoax buster httpwwwcovid<NUMBER>goidhoaks albeit limited amounts information civil society anti hoax society group masyarakat anti fitnah also developing hoax buster httpsturnbackhoaxid communitybased responses may help reduce pressure local governments provide relief responses government also needs ensure inclusive approach considering vulnerable groups include people disability un secretarygeneral launched global humanitarian response plan explicitly includes persons disabilities remarks launch secretarygeneral highlighted situation persons disabilities relation response well planning future <NUMBER> organisation arbeitersamariterbund asb long advocated inclusive approach conclusion paper presented recent responses covid<NUMBER> indonesia importantly outlined key healthrelated strategies roles different agencies responses complemented analysis gaps limitations current strategies put forward recommendations improve efficiency responses coupled wider considerations current covid<NUMBER> responses used window opportunities strengthen state health place indonesia path healthy people planet influenza viruses cause similar symptoms diagnosing influenza basis clinical presentation alone difficult reported sensitivity ranging <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapid influenza antigen tests pointofcare tests might prove useful fast turnaround time <NUMBER> min require minimal training perform however data diagnostic accuracy rapid influenza antigen tests pandemic influenza ah<NUMBER>n<NUMBER> virus <NUMBER> soon onset pandemic influenza ah<NUMBER>n<NUMBER> outbreak received reports poor performance rapid influenza antigen tests report findings clinical accuracy <NUMBER> commonly used rapid influenza tests diagnosis pandemic ah<NUMBER>n<NUMBER> influenza methods period <NUMBER> may <NUMBER> <NUMBER> june <NUMBER> convenience sample <NUMBER> positive nonduplicate nasopharyngeal specimens tested using <NUMBER> different rapid antigen test kits bd directigen ez flu ab test becton dickinson binaxnow influenza ab inverness medical quickvue influenza ab test quidel testing performed accordance manufacturers instructions test result interpreted least <NUMBER> study authors nasopharyngeal specimens collected patients presenting influenzalike illness using sterile polyester nasopharyngeal swab transported microbiology laboratory m<NUMBER>rt viral transport medium remel specimens positive respiratory viruses using luminex xtag rvp luminex included luminex xtag rvp multiplex rtpcr assay allows simultaneous detection <NUMBER> respiratory virus typessubtypes including metapneumovirus coronaviruses influenza virus subtypes h<NUMBER> h<NUMBER> influenza b virus parainfluenza virus types <NUMBER> respiratory syncytial virus adenovirus rhinovirus specimens refrigerated rapid antigen tests performed р<NUMBER> h specimen receipt specimens included <NUMBER> nasopharyngeal samples positive pandemic influenza ah<NUMBER>n<NUMBER> virus results confirmed using cdcs rtpcr assay pandemic influenza ah<NUMBER>n<NUMBER> virus control specimens included <NUMBER> nasopharyngeal specimens positive respiratory viruses follows adenovirus coron p <NUMBER> navirus concurrent coronavirus rhinovirus n p <NUMBER> n p metapneumovirus rhinovirus concurrent <NUMBER> n p <NUMBER> n p <NUMBER> rhinovirus parainfluenza virus parainfluenza virus n p <NUMBER> respiratory syncytial virus n p <NUMBER> n p <NUMBER> calculated sensitivity specificity rapid antigen test determined prevalence pandemic h<NUMBER>n<NUMBER> influenza study period used calculate positive predictive value ppv negative predictive value npv patient charts reviewed available potential factors may associated rapid antigen test result included patient age duration symptoms presentation inpatient emergency department versus outpatient status median number rtpcr fluorescence intensity mfi units data analysis performed using spss version <NUMBER> spss mannwhitney u test used comparison continuous variables x <NUMBER> mcnemar tests used categorical independent paired variables respectively p values <NUMBER> considered statistically significant study approved institutional review board rush university medical center chicago il results majority patients pandemic ah<NUMBER>n<NUMBER> influenza children young adults median age <NUMBER> years range <NUMBER> months <NUMBER> years total <NUMBER> patients <NUMBER> assessed emergency department <NUMBER> patients <NUMBER> seen physicians offices twentytwo <NUMBER> <NUMBER> patients evaluated emergency department subsequently hospitalized information duration illness presentation available <NUMBER> <NUMBER> patients majority patients <NUMBER> presented р<NUMBER> days developing symptoms influenzalike illness mean interval <NUMBER> days range <NUMBER> days control patients median age <NUMBER> years range <NUMBER> months <NUMBER> years <NUMBER> control patients <NUMBER> presented emergency department <NUMBER> <NUMBER> outpatients analytic performance <NUMBER> rapid antigen tests compared luminex xtag rvp presented table <NUMBER> overall respective sensitivity specificity bd directigen ez flu ab test <NUMBER> <NUMBER> <NUMBER> specimens <NUMBER> binaxnow influenza ab test <NUMBER> <NUMBER> <NUMBER> specimens <NUMBER> quickvue influenza ab test <NUMBER> <NUMBER> <NUMBER> specimens <NUMBER> quickvue influenza ab test significantly sensitive binaxnow influenza ab test sigp <NUMBER> nificant difference rapid antigen tests study period overall prevalence pandemic ah<NUMBER>n<NUMBER> virus <NUMBER> <NUMBER> confidence interval <NUMBER> among specimens submitted respiratory virus rtpcr testing basis prevalence calculated ppvs <NUMBER> <NUMBER> tests calculated npvs <NUMBER> <NUMBER> <NUMBER> bd directigen ez flu ab test binaxnow influenza ab quickvue influenza ab test respectively patient age duration symptoms prior collection respiratory specimen correlate significantly results rapid antigen tests higher mfi unit rtpcr p <NUMBER> <NUMBER> correlates higher viral load significantly associated positive results rapid antigen tests table <NUMBER> p <NUMBER> discussion rapid antigen tests commonly used many hospital laboratories emergency departments doctors offices influenza rapid antigen tests lateral flow chromatographic immunoassays patient samples applied chromatographic strip contains monoclonal antibodies influenza b viruses onsite diagnosis influenza pointofcare tests shown limit antibiotic prescriptions use blood cultures chest radiography ultimately reduce patient costs <NUMBER> however rapid antigen tests demonstrated wide range sensitivities detection seasonal influenza viruses ranging <NUMBER> bd directigen ez flu ab test <NUMBER> <NUMBER> <NUMBER> binaxnow influenza ab test <NUMBER> <NUMBER> <NUMBER> quickvue influenza ab test <NUMBER> <NUMBER> found <NUMBER> rapid antigen tests low modest sensitivities diagnosis pandemic influenza ah<NUMBER>n<NUMBER> although tests demonstrated excellent specificity crossreactivity cocirculating respiratory viruses possible reasons low sensitivities study include fact sample collection technique standardized specimens refrigerated tested completion rtpcr may led antigen degradation however think unlikely findings consistent similar study ginocchio et al <NUMBER> rapid antigen tests sensitivity <NUMBER> pandemic influenza ah<NUMBER>n<NUMBER> virus compared luminex xtag rvp alternative explanation may related differences test sensitivity detection pandemic influenza ah<NUMBER>n<NUMBER> virus compared seasonal influenza viruses study used titered pandemic influenza ah<NUMBER>n<NUMBER> virus grown cell cultures rapid antigen tests required <NUMBER>log higher viral loads human seasonal virus positive result <NUMBER> limitations study include fact employed known convenience sample positive specimens widespread interest regarding clinical performance rapid antigen tests detection pandemic influenza ah<NUMBER>n<NUMBER> virus used convenience sample positive specimens allow quick yet relatively accurate assessment tests addition specimens decoded investigators performing tests blinded rtpcr results finally design study permit accurate determination npv ppv calculated values basis prevalence novel influenza h<NUMBER>n<NUMBER> study period values would clearly vary according prevalence disease ppv would highest peak outbreak increased numbers falsepositive results disease prevalence low table <NUMBER> despite modest sensitivities rapid influenza antigen testing could prove useful tests speed portability ease performance clinicians aware patients presenting influenzalike illness negative rapid antigen test result undergo laboratory testing however positive rapid antigen test result would allow presumptive diagnosis novel influenza h<NUMBER>n<NUMBER> virus infection lead timely institution infection control measures treatment prophylaxis finally approach <NUMBER> winter season desirable manufacturers develop sensitive rapid antigen kits also differentiate seasonal influenza viruses pandemic influenza ah<NUMBER>n<NUMBER> virus view different antiviral susceptibilities late december <NUMBER> coronavirus infectious disease covid‐<NUMBER> epidemics spread wuhan china world including italy <NUMBER> <NUMBER> <NUMBER> date real‐time reverse transcription‐polymerase chain reaction rt‐pcr respiratory samples current gold standard method diagnosis covid‐<NUMBER> <NUMBER> <NUMBER> however molecular testings time consuming require specialized operators factors limit use real life rapid diagnosis required fast intervention decisions recently easy perform serological assay assessed <NUMBER> differentiate covid‐<NUMBER> positive patients negative subjects herein report results real‐life study performed emergency room department tertiary hospital northern italy validate vivadiag covid‐<NUMBER> igmigg rapid test lateral flow immunoassay lfia rapid diagnosis covid‐<NUMBER> overall <NUMBER> subjects tested covid‐<NUMBER>‐specific serological assay fondazione irccs policlinico san matteo detail enrolled <NUMBER> healthy volunteers documented negative results covid‐<NUMBER> rt‐pcr respiratory samples <NUMBER>f <NUMBER> median age <NUMBER> range <NUMBER>‐<NUMBER> years ten <NUMBER> infected past one common oc<NUMBER> <NUMBER>e hku<NUMBER> nl<NUMBER> coronavirus thirty covid‐<NUMBER>‐positive patients <NUMBER> m<NUMBER> f median age <NUMBER> range <NUMBER>‐<NUMBER> years admitted infectious diseases department intensive care unit tested positive controls finally performance vivadiag covid‐<NUMBER> igmigg rapid test lfia tested <NUMBER> patients first access emergency room department fever respiratory syndrome <NUMBER> m<NUMBER> f median age <NUMBER> range <NUMBER>‐<NUMBER> years comparison results nasal swab molecular screening <NUMBER> vivadiag covid‐<NUMBER> igmigg vivachek performed according manufacturers instruction adding <NUMBER> µl serum whole blood sample sample port followed adding <NUMBER> <NUMBER> drops <NUMBER>‐<NUMBER> µl dilution buffer <NUMBER> <NUMBER> minutes results read respiratory samples floqswabs copan italia brescia italy collected patients total nucleic acids dnarna extracted <NUMBER> µl utm using qiasymphony instrument qiasymphony dsp viruspathogen midi kit complex <NUMBER> protocols according manufacturers instructions qiagen qiagen hilden germany specific real‐time rt‐pcr targeting rna‐dependent rna polymerase e genes used detect presence sars‐cov‐<NUMBER> according guidelines <NUMBER> corman et al <NUMBER> protocols cohort patients admitted emergency room department data serological tests compared molecular results define specificity sensitivity positive predictive value ppv negative predictive value npv rapid serological test expected <NUMBER> covid‐<NUMBER> negative volunteers negative immunoglobulin g igg immunoglobulin igm using vivadiag covid‐<NUMBER> igmigg rapid test cross‐reactivity detected <NUMBER> subjects previous coronaviruses infection supporting high specificity vivadiag covid‐<NUMBER> igmigg rapid test lfia serum samples obtained median <NUMBER> days interquartile range <NUMBER>‐<NUMBER> first covid‐<NUMBER> positive result <NUMBER> hospitalized patients total <NUMBER> <NUMBER> <NUMBER> positive igm igg <NUMBER> <NUMBER> <NUMBER> negative igg igm <NUMBER> <NUMBER> <NUMBER> weakly positive igm igg <NUMBER> <NUMBER> <NUMBER> positive igm negative igg thus sensitivity rapid assay suboptimal data shown possible explanation low antibody titers delayed humoral response <NUMBER> focusing acute patients enrolled emergency room department <NUMBER> <NUMBER> <NUMBER> negative covid‐<NUMBER> real‐time rt‐pcr <NUMBER> <NUMBER> showed positive results vivadiag covid‐<NUMBER> igmigg rapid test <NUMBER> <NUMBER> <NUMBER> tested negative side <NUMBER> patients positive covid‐<NUMBER> real‐time rt‐pcr <NUMBER> <NUMBER> showed positive weak positive serology igm andor igg <NUMBER> <NUMBER> <NUMBER> tested negative rapid serology assay table <NUMBER> thus sensitivity vivadiag covid‐<NUMBER> igmigg rapid test <NUMBER> specificity <NUMBER> npv <NUMBER> ppv <NUMBER> patients enrolled emergency room department contrast high levels sensitivity reported previous study <NUMBER> vivadiag covid‐<NUMBER> igmigg rapid test revealed poor sensitivity less <NUMBER> indeed majority patients tested positive covid‐<NUMBER> real‐time rt‐pcr would identified negative using rapid serological assay leading misdiagnosis covid‐<NUMBER> disease vast majority patients basis results vivadiag covid‐<NUMBER> igmigg rapid test lfia recommended triage patients suspected covid‐<NUMBER> r bruno mondelli e brunetti di matteo e seminari l maiocchi v zuccaro l pagnucco b mariani ludovisi r lissandrin parisi p sacchi f patruno g michelone r gulminetti zanaboni novati r maserati p orsolini vecchia id staff sciarra e asperges colaneri di filippo sambo biscarini lupi roda c pieri gallazzi sachs p valsecchi id resident perlini c alfano bonzano f briganti g crescenzi g falchi r guarnone b guglielmana e maggi martino p pettenazza pioli di marco f quaglia sabena f salinaro f speciale zunino ecu staff emergency care unit de lorenzo g secco l dimitry g cappa maisak b chiodi sciarrini b barcella f resta l moroni g vezzoni l scattaglia e boscolo c zattera f tassi v capozza vignaroli bazzini ecu resident emergency care unit g iotti f mojoli belliato l perotti mongodi g tavazzi intensive care unit g marseglia licari brambilla pediatric unit barbarini bruno p cambieri g campanini g comolli corbella r daturi furione b mariani r maserati e monzillo paolucci parea e percivalle piralla f rovida sarasini zavattoni virology staff g adzasehoun l bellotti e cabano g casali l dossena g frisco g garbagnoli girello v landini c lucchelli v maliardi pezzaia premoli virology technical staff bonetti g caneva cassaniti corcione r di martino di napoli ferrari g ferrari l fiorina f giardina mercato f novazzi g ratano b rossi sciabica tallarita e vecchio nepita virology resident calvi tizzoni pharmacy unit c nicora triarico v petronella c marena muzzi p lago hospital management authors declare conflict interests ic fn fg fs ms sp rb fm fb members san matteo pavia covid‐<NUMBER> task force listed reviewed approved manuscript ic fn discussed results data analysis wrote paper fg fs ms collected samples sp rb fm discussed results fb conceived study coronavirus disease <NUMBER> covid <NUMBER> due novel virus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> global pandemic <NUMBER> million confirmed cases across almost every country world time writing early april <NUMBER> close <NUMBER> <NUMBER> recorded deaths <NUMBER> diagnosis covid<NUMBER> challenging disease entity number factors including disease stage disease prevalence patient profile sample type quality influence diagnostic test performance review outline performance outcomes key tests used diagnose covid<NUMBER> considerations modulate performance safety healthcare workers collecting samples laboratory safety aspects experimental approaches detection volatile organic compounds exhaled breath mass spectrometry studies different sample types methods signal amplification utility novel approaches discussed countryspecific indications criteria testing evolved rapidly updated information emerges epidemic progresses recommendations guided phase epidemic available resources generally speaking testing covid<NUMBER> currently considered anyone symptoms acute respiratory tract infection upper lower without systemic symptoms fever fatigue myalgia <NUMBER> <NUMBER> <NUMBER> <NUMBER> mild disease testing directs need selfisolation identification new cases contact tracing testing contacts epidemic progresses forecasted limited testing capacity testing may directed specific subgroups enhanced risk poor outcome clinical setting covid<NUMBER> form part differential diagnosis acute respiratory presentation including infectious causes pneumonia eg bacterial influenza viral pneumonia pneumocystis pneumonia tuberculosis tb etc acute exacerbations asthma chronic obstructive pulmonary disease copd acute pulmonary embolism cardiac failure conditions relevant investigations depend clinical context likely include pulmonary imaging relevant laboratory investigations blood cultures interrogation urine andor lower respiratory tract specimens rule viral mycobacterial fungal andor bacterial cause clinical laboratory parameters may suggest viral infection include pyrexia acute malaise myalgia lymphopenia creactive protein unhelpful distinguishing covid<NUMBER> infections procalcitonin elevated severe covid<NUMBER> secondary bacterial infection <NUMBER> <NUMBER> early disease low procalcitonin may distinguish covid<NUMBER> bacterial infections viral diseases data awaited confirm supposition underlying asthma copd presence pulmonary infiltrates may favour respiratory infectionrelated cause though cardiac cause must also considered differential diagnosis common sample types sent testing usually means reverse transcription polymerase chain reaction rtpcr nasopharyngeal oropharyngeal samples obtained using swab placed viral transport medium already considerable shortage reagents swabs meaning dry swabs sent laboratories centres dry swabs less costly conducive communitybased testing data urgently required determine comparative sensitivity dry swabs compared using viral transport medium taking account time sample acquisition sample processing samples lower respiratory tract including sputum tracheal aspirate bronchial washings bronchoalveolar lavage may also sent patients covid<NUMBER> disease samples lower respiratory tract likely test positive discussed viral rna also detected stool <NUMBER> cases blood <NUMBER> cases <NUMBER> rarely urine recent data infections special contexts cruise liners <NUMBER> close contacts covid<NUMBER> patients <NUMBER> demonstrated sarscov<NUMBER>specific rtpcr may positive early phase disease viral shedding asymptomatic phase early prodromal phase considerable <NUMBER> <NUMBER> present screening asymptomatic individuals rtpcr constrained limited testing capacity need focus public health efforts resources symptomatic persons symptomatic individuals <NUMBER> <NUMBER> patients mild symptoms requiring hospitalisation depending age presence risk factors <NUMBER> <NUMBER> symptomatic persons may require admission hospital respiratory complications individuals enhanced risk category may one factors including age <NUMBER> years comorbidities history significant tobacco smoking underlying immunocompromising illnesses <NUMBER> <NUMBER> mild disease especially early stages rtpcr false negative rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> metaanalysis reported single test <NUMBER> days post symptom development <NUMBER> false negative rate using nasopharyngeal swab <NUMBER> throat swab <NUMBER> ai et al <NUMBER> reported false negative rate <NUMBER> cohort <NUMBER> <NUMBER> hospitalised patients estimated median standard deviation interval initial negative test subsequent positive rtpcr result <NUMBER> <NUMBER> days selection studies reported false negative rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> notably patients required five repeat tests positive result ascertained <NUMBER> false negativity phenomenon may result several factors including low viral load detection limit assay low sample volume cellular mass acquisition sampling location upper v lower respiratory tract sample degradation transport storage sample processing methodology timing sampling relation stage disease rtpcr positivity may progressively increase course disease <NUMBER> test accuracy depend quality specimen collec ted <NUMBER> since shown specimens lower respiratory tract higher viral load hence likely test positive specimens upper respiratory tract <NUMBER> <NUMBER> nasopharyngeal specimens better yield oropharyngeal samples <NUMBER> <NUMBER> hospitalised patients severe disease wang et al <NUMBER> found sensitivity <NUMBER> bronchoalveolar lavage fluid high aerosolgenerating procedure <NUMBER> sputum <NUMBER> nasal swabs sensitivity ranged <NUMBER> <NUMBER> pharyngeal swabs faeces blood urine given considerations negative test upper respiratory tract specimen repeated <NUMBER> <NUMBER> days optimal timing unclear lower respiratory tract specimen obtained exclude false negative result clinical suspicion high <NUMBER> viral shedding asymptomatic early prodromal minimally symptomatic individuals resolution symptoms helps explain rapid extensive spread covid<NUMBER> patients severe disease including lower respiratory tract infection also individuals mild disease high viral loads often detected several days resolution symptoms <NUMBER> significance remains unclear although recent data limited number patients suggest rtpcr positivity necessarily mean shedding infectious virus symptom resolution <NUMBER> zhifeng et al <NUMBER> demonstrated rtpcr using nasopharyngeal samples negative even computed tomography scan evidence covid<NUMBER> pneumonia <NUMBER> ali et al <NUMBER> showed improvement disease extent <NUMBER> ct scans prior rtpcr tests becoming negative unclear whether patients whose symptoms resolved continue detectable viral rna respiratory samples transmit infection furthermore symptoms resolved especially given limited testing capacity remains unclear patients may discharged intensive care unit general ward setting hospital community especially individuals highrisk profiles living household therefore clearly defined guidelines safe social mixing occur symptoms resolved healthcare worker safety must taken account collecting sputum ideally performed infectioncontrolled environment open air ambulant patients currently rtpcr imperfect gold standard diagnosis covid<NUMBER> development molecular detection assays facilitated sequencing sarscov<NUMBER> <NUMBER> assay consists two principal steps viral rna extraction patient specimens performed manually using automated platforms ii reverse transcription pcr amplification using specific primers specific probes realtime detection see fig <NUMBER> overview use robotic systems allows increased throughput rna extraction pcr setup current resource constraints trained personnel reagents necessity rapidly deliver test outcomes diagnostic laboratories skipping postextraction rna quality quantification check costly labour intensive several sarscov<NUMBER> targets used include envelope nucleocapsid rnadependent rna polymerase rdrp genes two large open reading frames orf<NUMBER>aorf<NUMBER>b ribonuclease p <NUMBER> generally least two target genes need identified sarscov<NUMBER> confirmation however interpretation algorithms differ respect number genes need detected test considered positive protocols results interpreted indeterminate negative one genes detected whereas others identification one gene used screening test subsequent genes serves confirmatory test <NUMBER> laboratory perspective multiplexing targets allows better efficiency shorter turnaround times optimal management laboratory consumables <NUMBER> vogels et al <NUMBER> evaluated nine primerprobe sets confirmed pair detection efficiency <NUMBER> differences ability differentiate true negatives positives patients low viral load sets led inconclusive results due nonspecific background amplification including initial sets issued us centers disease control prevention subsequent rectification viral evolution nucleotide substitutions may emerge could affect primerprobe binding regions could alter sensitivity pcr indeed potentially problematic mismatch rdrpsarsr reverse primer already confirmed threshold cycle value target gene remains quantitative endpoint ascertain viral load depending kit used value generally lies <NUMBER> <NUMBER> range <NUMBER> <NUMBER> control nonspecific pcr inhibition internal positive amplification control eg sarscov<NUMBER> egene rna sarscov frankfurt <NUMBER> rna included assay negative control interrogates contamination sample preparation digital pcr dpcr used perform quality assurance verification rtpcr <NUMBER> dpcr involves partitioning sample many individual parallel pcr reactions allowing even single molecule amplified millionfold using technique sensitivity significantly improved <NUMBER> rtpcr <NUMBER> rtdpcr <NUMBER> moreover <NUMBER> close contacts south korea guidelines laboratory diagnosis coronavirus disease <NUMBER> covid<NUMBER>inconclusive conventional rtpcr likely targets interest detected dpcrpositive overall sensitivity specificity diagnostic accuracy rtdpcr <NUMBER> <NUMBER> <NUMBER> respectively moreover higher sensitivity rtdpcr translated detection viral rna longer periods conventional rtpcr convalescing patients rtdpcr sensitive suitable detecting low viral loads accessibility limited complexity system cost implications inability multiplex target genes interest <NUMBER> several automated rapid nucleic acid amplification tests recently received food drug administration fda approval emergency use cepheids xpert xpress sarscov<NUMBER> run gene xpert platform detects multiple gene targets provide result within <NUMBER> minutes httpswwwcepheidcomcoronavirus abbotts rapid covid<NUMBER> test run abbott id device provide results within <NUMBER> minutes httpswwwalerecomenhomeproductdetailsidnowcovid<NUMBER>html former may convenient countries south africa sa extensive gene xpert infrastructure technology lends onsite pointofcare testing using portable xpert platforms xpert edge rtpcr currently remains imperfect gold standard rapid confirmation sarscov<NUMBER> infection ongoing genetic evolution virus highlights need closely monitor review methodology based emerging data possible better stagespecific reference standard may emerge incorporating immunoassay results limited testing capacity remains challenge widespread surveillance testing sa expanding testing services researchbased laboratories fraught challenges including need accreditation laboratories south african national accreditation system sa personnel health professions council sa capacity shortfalls compounded international countrywide shortage kits reagents severe reduction international freight shipping capacity however implementation rapid automated molecular testing xpert xpress sarscov<NUMBER> helpful enough cartridges procured several antigenbased immunoassays developed detect antibodies serum plasma <NUMBER> one assay recently fda approved foundation innovative new diagnostics website lists <NUMBER> companies either making made assays <NUMBER> rapid lateral flow assay lfabased others enzymelinked immunosorbent assay elisalike tests formats antigen impregnated test line plasticplate surface detect human igg igm sometimes also iga antibodies meantime rapid capture assays detect viral antigens nasopharyngeal aspirates also developed evaluated tandem despite proliferation different testing devices kits emerging independent validation data specific assays work optimally therefore sensitivity specificity predictive values individual tests different contexts remain unknown webbased resource developed lists assays approved use specific countries <NUMBER> tests purchased specific countries already found meet expectations <NUMBER> spain one worsthit european nations health authorities purchased thousands rapid serological tests biotech company china later found sensitivity <NUMBER> <NUMBER> sa companies already produced iterations lfa platforms currently evaluated one concern test specificity four common human coronaviruses cause third common cold episodes poorly designed antibody tests may crossreact preexisting anticoronavirus antibodies high falsepositivity rates may erroneously indicate disease without covid<NUMBER> resulting wasted public health contacttracing efforts unnecessary anxiety even worse unintended exposure individuals covid<NUMBER> testing centres wards hospitalised suboptimal sensitivity lfa formats without signal amplification step potential concern lfa depending context may suboptimal sensitivity compared elisabased assays however extent applies covid<NUMBER> remains seen several recent articles describe longitudinal antibody responses patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> broadly speaking igm responses tend become detectable <NUMBER> <NUMBER> days onset symptoms <NUMBER> <NUMBER> robust responses generally develop second week illness <NUMBER> <NUMBER> given considerations antibodybased tests recommended firstline diagnosis within first days symptoms evidence combining antibody rtpcr data early phase disease may useful may incremental benefit though studies required however sa health products regulatory agency agencies recently indicated based guidance sa national institute communicable diseases world health organization serological testing suitable diagnosis acute sars cov<NUMBER> infection limited epidemiological surveys least data become available indeed undisputed role immunoassays surveillance studies may guide public health planning help define trajectory epidemic potential role targeting vaccination certain subgroups investigated suggested immunoassays could identify previously infected recovered healthcare workers essential workers could potentially return work assumption immune reinfection whether case long immunity lasts case covid<NUMBER> remains unclear therefore validity concept immunity passports remains unclear <NUMBER> currently data diagnostic management prognostic considerations may different hivinfected v uninfected persons hivinfected patients presenting respiratory tract infection general possibilities outlined considered including considering pneumocystis carinii pneumonia tb differential diagnosis although well documented widely appreciated <NUMBER> <NUMBER> communityacquired pneumonia acute lower respiratory tract infection subsaharan africa parts asia due mycobacterium tuberculosis <NUMBER> <NUMBER> <NUMBER> proportion even higher hivinfected persons <NUMBER> <NUMBER> also possible covid<NUMBER> infection may unmask subclinical tb hivinfected uninfected persons hand particularly hivinfected persons covid<NUMBER> pneumonia case influenza <NUMBER> may associated poorer prognosis hospitalised patients tb whether sarscov<NUMBER> viral load higher hivinfected persons therefore rtpcr sensitivity better remains unclear hivuninfected persons coinfection one pathogen already documented eg coinfection covid<NUMBER> influenza andor bacterial organisms <NUMBER> possible coinfection one pathogen may frequent hivinfected persons advanced immunosuppression unanswered questions resolved data become available rapidly spreading covid<NUMBER> pandemic exposed capacity weaknesses healthcare laboratory testing systems although mainstay testing remains rtpcr several drawbacks including significant false negative rate early course disease assay cost lack assay simplicity requirement complex laboratory infrastructure emerging shortage reagents including rna extraction kits likely worsen already many centres using dry nasopharyngeal swabs shortage viral transport medium antibodybased immunoassays developed although limited role early diagnosis symptomatic patients incremental benefit rtpcr assays role applications including surveillance targeting individuals vaccination redeployment workforce investigation declaration none children bear heaviest burden viral respiratory illness studies used viral culture estimate developed countries infants preschool children experience mean <NUMBER> viral infections annually schoolage children adolescents experience <NUMBER> illnesses annually <NUMBER> limited sensitivity culture methods certainly underestimate although many viral infections limited upper respiratory tract viral infections lower respiratory tract cause enormous disease burden children <NUMBER> recently role respiratory viruses serious lower respiratory tract infections lrtis older adults begun appreciated although article focuses infections children many issues apply older adults syndromes lrti children include bronchiolitis exacerbations asthma wheezing croup pneumonia although working definitions exist overlap among syndromes although respiratory viruses strongly associated specific syndromes many viruses shown cause syndrome table <NUMBER> often difficult differentiate viral bacterial pneumonia children seven viruses considered usual suspects lrti sought many studies respiratory syncytial virus rsv influenza b parainfluenza <NUMBER> <NUMBER> <NUMBER> adenovirus past decade least <NUMBER> new viruses associated respiratory infection identified including human metapneumovirus hmpv severe acute respiratory syndrome coronavirus human coronavirus nl<NUMBER> hku<NUMBER> parainfluenza <NUMBER> bocavirus <NUMBER> <NUMBER> viruses responsible large proportion lrtis children antibiotics often prescribed viral illnesses addition viral infections cause majority febrile episodes infants <NUMBER> months age <NUMBER> however inability accurately identify minority infants serious bacterial infections majority febrile infants hospitalized receive antibiotics existing viral diagnostics enzyme immunoassaybased rapid tests limited sensitivity detect influenza rsv case direct fluorescent antibody detection shell vial culture require sophisticated virology laboratory furthermore several newer pathogens grow well culture better diagnostic tests establish cause lrtis children potential reduce overall antibiotic use improve targeted use antibiotics addition rapid identification viral infections help control nosocomial transmission studies using currently approved rapid tests direct fluorescent antibody testing despite limitations methods already demonstrated improvements clinical practice <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> bronchiolitis disease children <NUMBER> years age characterized acute inflammation edema necrosis epithelial cells lining small airways increased mucus production leading bronchospasm wheezing hyperexpansion lungs hypoxia bronchiolitis causes <NUMBER> hospitalizations infants <NUMBER> year age annually <NUMBER> infants hospitalized bronchiolitis annually <NUMBER> rsv common cause bronchiolitis detected <NUMBER> cases however viruses cause bronchiolitis clinically indistinguishable rsvinduced disease including parainfluenza virus adenovirus rhinovirus hmpv coronavirus bocavirus <NUMBER> <NUMBER> polymerase chain reaction pcrbased testing coinfection <NUMBER> viruses detected <NUMBER> children thus potential nosocomial transmission variety viruses among children hospitalized bronchiolitis high diagnostic testing potential influence cohorting clinical management prevention health careassociated infections <NUMBER> <NUMBER> communityacquired pneumonia cap important cause morbidity hospitalization children developed countries one leading causes death children less developed countries <NUMBER> large number established emerging pathogens cause pneumonia difficulty determining microbial cause complicate management pneumonia children addition difficult obtain adequate specimens lower respiratory tract nasopharyngeal carriage potential pathogens common healthy children moreover coinfection <NUMBER> pathogens common etiologies pneumonia children differ according age child season clinical presentation relatively contemporary studies etiology pediatric pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies vary population studied case definition clinical specimens test methodology number pathogens sought prospective studies potential pathogen identified <NUMBER> children pneumonia table <NUMBER> summarizes several recent studies children hospitalized cap despite differences methods used age groups studied overall results generally similar studies least <NUMBER> potential pathogen identified <NUMBER> children studied least <NUMBER> virus identified <NUMBER> children mixed viral bacterial infections identified <NUMBER> studies viral infections common children <NUMBER> years age viral causes pneumonia important age groups use pcr increases proportion children cap found viral infection tsolia et al <NUMBER> studied <NUMBER> schoolage children hospitalized cap use conventional cultures pcr assays influenza rsv parainfluenza adenovirus mycoplasma pneumoniae chlamydophila pneumoniae pathogen demonstrated <NUMBER> <NUMBER> <NUMBER> <NUMBER> virus <NUMBER> bacterial infection <NUMBER> coinfection <NUMBER> adenovirus present <NUMBER> <NUMBER> procalcitonin creactive protein levels significantly higher children bacterial infection sensitivity tests modest <NUMBER> <NUMBER> respectively specificity low <NUMBER> <NUMBER> respectively association radiologic description etiology remains unclear studies whether children coinfection viruses bacteria severe illness although clear influenza parainfluenza rsv human metapneumovirus adenovirus important causes cap absence bacterial coinfection role rhinoviruses newly described viruses including human coronaviruses bocavirus harder determine rhinoviruses common cause mild upper respiratory illness detection rhinovirus asymptomatic persons relatively common <NUMBER> <NUMBER> jartti et al <NUMBER> reviewed studies reported detection viruses asymptomatic adults children although participants household contacts ill patients use conventional culture rhinovirus detection uncommon mean <NUMBER> range <NUMBER> use pcr rhinovirus detected frequently mean <NUMBER> range <NUMBER> studies performed sequential sampling shown pcr positivity relatively brief <NUMBER> <NUMBER> replication many strains rhinovirus limited higher temperatures thought prevent replication lower respiratory tract however recent studies demonstrated rhinovirus replicate higher temperatures infect lower respiratory tract <NUMBER> although seasonand agematched control subjects would helpful detection rhinovirus young children hospitalized cap substantially higher studies would expected children uncomplicated urti <NUMBER> <NUMBER> pcrbased detection sequencing rhinoviruses revealed greater degree genetic divergence appreciated culturebased detection <NUMBER> <NUMBER> possible better understanding viruses identify genotypes greater capacity lower respiratory tract disease severe disease <NUMBER> <NUMBER> three new coronaviruses capable infecting humans described recently severe acute respiratory syndrome coronavirus rapidly identified outbreaks severe respiratory disease detected china vietnam singapore early <NUMBER> <NUMBER> fortunately sporadic laboratoryassociated cases detected since containment worldwide outbreaks end <NUMBER> human coronavirus nl<NUMBER> hcovnl<NUMBER> identified netherlands <NUMBER> <NUMBER> clearly associated croup bronchiolitis occasionally pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> human coronavirus hku<NUMBER> hcovhku<NUMBER> detected adult hong kong <NUMBER> <NUMBER> one initial studies hong kong hcovhku<NUMBER> detected <NUMBER> patients cap <NUMBER> studies shown slightly lower frequency hku<NUMBER> detected respiratory pathogen <NUMBER> <NUMBER> <NUMBER> specimens hospitalized children seattle <NUMBER> prospective active surveillance study involving children <NUMBER> years age nashville coronaviruses including hku<NUMBER> nl<NUMBER> oc<NUMBER> <NUMBER>e isolated <NUMBER> children hospitalized respiratory disease thus coronaviruses appear significant relatively uncommon cause hospitalization among children bocavirus first isolated <NUMBER> nasopharyngeal aspirate specimens children respiratory tract infection <NUMBER> unlike many respiratory viruses singlestranded dna virus family parvoviridae bocavirus also isolated stool serum samples bocavirus frequently detected conjunction pathogens may detected prolonged periods thus challenging demonstrate clinical importance bocavirus detection <NUMBER> <NUMBER> <NUMBER> however least <NUMBER> studies showed isolation bocavirus alone common ill children control subjects <NUMBER> <NUMBER> bocavirus loads significantly higher patients bocavirus coinfection <NUMBER> <NUMBER> thus accumulating data support role bocavirus true pathogen determining relevance isolation individual patient remains difficult respiratory viral infections important cause severe disease children adults receive solid organ hematopoietic stem cell transplants <NUMBER> <NUMBER> <NUMBER> children appear increased risk infection respiratory viruses compared adult transplant recipients respiratory viruses cause severe fatal pneumonia may trigger chronic progressive airway obstruction role rsv influenza virus adenovirus parainfluenza viruses appreciated several years reasonably well understood seasonal distribution parallels epidemiology community infections may attributable shedding visitors staff patients upper respiratory tracts many outbreaks described transplant units horizontal transmission recipients stem cell transplants mortality associated lower respiratory tract infection due older respiratory viruses <NUMBER> <NUMBER> improved molecular detection led increased recognition hmpv coronavirus bocavirus rhinovirus infections transplant recipients <NUMBER> <NUMBER> reports severe disease associated pathogens however many unanswered questions remain risk factors natural history optimal management pathogens accurate timely diagnosis cause lrti children potential benefits including improved treatment individual child decreasing overall costs care reducing selection antimicrobial organisms due excessive antibiotic use specific viral diagnosis may provide reassurance parents providers randomized trials case series examined potential viral testing improve management <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> bonner et al <NUMBER> conducted randomized trial providing emergency department physicians results influenza rapid tests febrile children children influenza access test results reduced number antibiotic prescriptions ordering urinalysis urine culture complete blood counts blood cultures chest radiographs differences seen among influenza quasirandomized trial influenza rapid testing showed similar results <NUMBER> analysis included children use rapid test influence clinician behavior however among children tested positive influenza either method rapid influenza test less likely urinalysis urine culture complete blood count ordered doan et al <NUMBER> studied <NUMBER> children <NUMBER> years age seen emergency department fever least <NUMBER> respiratory symptom randomized direct fluorescent antibody test <NUMBER> respiratory viruses routine care statistically significant difference duration emergency department stay performance chest radiographs blood tests urine analyses use antibiotic prescriptions groups however children tested <NUMBER> reduction likelihood receiving antibiotics another provider within <NUMBER> week visit among tested positive virus testing associated median <NUMBER>min reduction duration emergency department stay transplant recipients respiratory infection ability detect full range viral pathogens critical known respiratory viral pathogens sought addition cytomegalovirus epstein barr virus human herpesvirus type <NUMBER> herpes simplex virus highly sensitive multiplex platforms offer obvious advantages combination direct fluorescent antibody testing dfa culture individual pcr assays nosocomial viral infections impose substantial burden childrens hospitals pose particular risk immunocompromised children <NUMBER> early identification allows effective cohorting isolation inability distinguish among multiple viral causes bronchiolitis means practice cohorting children syndrome without viral diagnosis exposes substantial risk acquiring new virus hospitalization virusspecific cohorting reduce risk largest potential societal benefit may come reduction unnecessary use antibiotics lrti children <NUMBER> although many factors contribute rapid emergence antimicrobial resistance respiratory tract infections remain common reason prescribing antibiotics course antibiotics adds selective pressure <NUMBER> clinical interpretation detection virus nasopharyngeal secretions child lrti challenging possible virus resolving upper respiratory infection cause lower respiratory tract disease detection influenza adenovirus rsv probably human metapneumovirus generally assumed correlate infection lower respiratory tract coinfection superinfection bacteria rare biphasic illness focal consolidation chest radiograph elevated inflammatory markers increase likelihood bacterial coinfection research needed help determine isolation rhinovirus bocavirus coronavirus cause pneumonia viral quantification may prove helpful determine isolate associated severe disease preliminary results encouraging <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> data using consistent samples methods needed validate usefulness establish cutoff values evaluating new diagnostic platforms enough demonstrate new test correctly identifies presence large number respiratory pathogens clinician must able interpret positive test result context clinical illness determine appropriate management unreasonable expect advanced molecular diagnostic tests able isolation instead tests result need interpreted knowledge epidemiology pathogen pretest probability infection patients symptoms clinical information additional epidemiologic studies needed establish importance presentation several recently diagnosed pathogens need better understand role multiple infections lrti also enough demonstrate improved diagnostic accuracy tests must ultimately change behavior clinicians improve patient outcomes although preliminary results aforementioned trials promising tests studied limited breadth accuracy none incorporate detection bacterial causes lrti studies needed use newer multiplex platforms address hospitalized children pneumonia ideally diagnostic tests able rapidly identify viral bacterial pathogens simultaneously detect antibiotic resistance financial support work supported national institutes health nih <NUMBER>u<NUMBER>ai<NUMBER> p centers disease control prevention <NUMBER>u<NUMBER>p<NUMBER> p p received travel support food drug administration attend meeting also coinvestigator nihfunded research scientists idaho technologies coinvestigators supplement sponsorship article published part supplement entitled workshop molecular diagnostics respiratory tract infections food drug administration infectious diseases society america sponsored workshop astrazeneca pharmaceuticals bio merieux inc cepheid gilead sciences intelligent mdx inc inverness medical innovations roche molecular systems provided financial support solely purpose publishing supplement potential conflicts interest author certifies potential conflicts interest coronavirus first time identified <NUMBER> cause common cold enveloped rna virus singlestranded pleomorphic spherical shape projections glycoprotein various subtypes alpha beta gamma delta coronavirus along serotypes subtype human coronavirus oc<NUMBER>like <NUMBER>elike also found bats pigs birds cats dogs mice whales coronavirus transmitted airborne droplets replication virus occurs ciliated epithelium causes cell damage inflammatory reactions site infection <NUMBER> consequently covid<NUMBER> fatality rate <NUMBER> observed higher older generation making vulnerable group milder cases covid<NUMBER> include nasal congestion sore throat difficulty breathing chest pains chills kidney failure pneumonia virus infect several organs human body respiratory hepatic central nervous gastrointestinal systems rate outbreak emerging coronavirus increasing alarmingly current methods diagnosis polymerase chain reaction ideal far costeffectiveness accuracy speed concerned therefore faster simpler method detection viral infections biofluids become frontline tool order tackle spread deadly disease <NUMBER> <NUMBER> realtime polymerase chain reaction rtpcr used detection covid<NUMBER> timeconsuming sample preparation required prior analysis rtpcr also known quantitative pcr qpcr therein amplification dna detected real time pcr progress use fluorescent reporter detects nucleic acids either presence absence amount pcr testing highly sensitive technique <NUMBER> copies per reaction sensitivity researcher relying upon falsenegative tests result failure detection covid<NUMBER>infected patients <NUMBER> therefore correct procedure pcr crucial according guidelines regarding covid<NUMBER> laboratory testing available research toward improved detection desperately needed dynamics virus subsequent immunological responses significant molecular testing thus certain factors severity disease several populations relationship severity viral concentration duration shedding development serological assays validation monitoring mutations affect molecular testing encouragement sharing data significant order better manage covid<NUMBER> outbreak initiation development several molecular techniques detect quick easy prevention diagnosis covid<NUMBER> outbreak crucial develop countermeasures date diagnostic kits developed different countries detection covid<NUMBER> based nucleic acid assay widely distributed china <NUMBER> hence timely detection along clinical validation sensitivity specificity technique important overcome diagnostic challenges implementation test personnel training quick detection timing availability primers probes definite need better techniques portable technology benefit researchers clinicians spectroscopy offer promising detection approach potential disease molecularchemical biomarkers <NUMBER> spectroscopy advances technology central novel applications bioengineering natural sciences medical field raman rs infrared ir spectroscopies help diagnosis infections point care <NUMBER> <NUMBER> spectroscopic techniques attracted growing interest biomedical tools early diagnosis monitoring human disease need study bacteria viruses seen renewed interest recent technologies capable providing snapshot information overall composition biological species <NUMBER> <NUMBER> result complex biological samples urine cvf blood saliva breast milk etc assessed unparalleled efficiency resolution using techniques proton nuclear magnetic resonance <NUMBER> hnmr rs ir <NUMBER> <NUMBER> <NUMBER> analytical techniques vibrational spectroscopic techniques look molecular vibrations chemical structure molecules viral proteins antibody proteins immune system response detected vibrational spectrum <NUMBER> wood et al emphasized need better methods diagnosis reported detection viruses infrared spectroscopy claiming offers significant economic social benefits community <NUMBER> recently successfully separated different types bacteria ftir raman spectroscopy data published provides compelling evidence encouraging strongly believe techniques used detecting viruses glycoprotein nucleic acids species analyzed ultimately paving way rapid accurate diagnosis continuous monitoring spectroscopy coupled multivariate analysis approach could powerful tool explore biomolecules artificial intelligence potential customize deep neural networks ability learn spectra could training make instant predictions regarding spectra additional studies investigate diagnostic capability spectroscopy machine learning <NUMBER> effectiveness sensitivity specificity methods although significant could still improved pandemic situation around globe calls sharing data among countries anonymized samples researchers able explore diagnostic opportunities rapid development point care testing methodology developed strengthening global fightback spread covid<NUMBER> spectroscopic device based either ir orand rs detection viruses bacteria developed analyzing proteins nucleic acid structure multiplexed fashion spectroscopic techniques immense potential diagnosing human diseases including bacterial viral infections inflammatory conditions various cancers demonstrated schematic diagram figure <NUMBER> currently although pcr aid diagnosis viral diseases process timeconsuming sample preparation intensive proposed spectroscopic techniques immense value rapid accurate relatively costeffective methods detecting infections also monitoring monitoring aspect even crucial viruses known change rna relation surrounding environment making difficult find cure use rs ir combined artificial intelligence machine learning allow monitoring chemical pathway progression disease identify changes chemical structure viruses bacteria may occur addition due ability precisely determine chemical structural changes spectroscopy possible detect concentration various infections saliva urine blood serum aim develop spectroscopic test methodology employing infrared raman spectroscopies diagnostic techniques analyze covid<NUMBER> samples compare spectral results current pcr method routinely used vibrational spectroscopy help understanding process viral infection rapid accurate detection also monitoring could lead understanding mutation drug development covid<NUMBER> well complete spectroscopic detection system next diagnostic tool going different stages spectral data acquisition defining test methodology statistical process control spectral data mining hence developing rapid diagnostic system many factors response sarscov<NUMBER> united states us <NUMBER> different previous pandemic responses goal document challenges sars<NUMBER> cov<NUMBER> response provide initial recommendations better prepare next pandemic <NUMBER> <NUMBER> influenza h<NUMBER>n<NUMBER> pandemic first pandemic age molecular diagnostics large <NUMBER> network academic community hospital laboratories throughout united states able <NUMBER> develop validate molecular tests first week outbreak rule h<NUMBER>n<NUMBER> cause <NUMBER> patients illness played critical role containing h<NUMBER>n<NUMBER> pandemic example chicago <NUMBER> first month pandemic <NUMBER> patients screened h<NUMBER>n<NUMBER> influenza tested <NUMBER> community molecular diagnostics laboratories typical turnaround time <NUMBER> hours <NUMBER> clinical <NUMBER> laboratory community rapidly provided widely available h<NUMBER>n<NUMBER> influenza molecular testing facilitating <NUMBER> swift pandemic response <NUMBER> <NUMBER> <NUMBER> ten years later laboratories responding sarscov<NUMBER> pandemic <NUMBER> go press <NUMBER> us surpassed countries number diagnosed infections deaths <NUMBER> httpscoronavirusjhuedumaphtml last accessed <NUMBER> us federal government continues <NUMBER> recommend social distancing measures many states taken significant public health <NUMBER> measures slow sarscov<NUMBER> spread communities <NUMBER> httpswwwkfforghealthcostsissue<NUMBER> briefstatedataandpolicyactionstoaddresscoronavirus last accessed <NUMBER> highest rates <NUMBER> infection currently observed urban areas consistent patterns observed seasonal flu <NUMBER> outbreaks however community spread identified <NUMBER> states reported incidence <NUMBER> increased areas smaller population density testing expands <NUMBER> experts believe due <NUMBER> number factors seeing tip iceberg regard numbers patients infected <NUMBER> using current diagnostic test strategies inability identify asymptomatic yet sarscov<NUMBER> challenges cdc released guidance safely reopen us may <NUMBER> <NUMBER> httpswwwcdcgovcoronavirus<NUMBER>ncovdownloadsphpcdcactivitiesinitiativesforcovid<NUMBER> responsepdf last accessed <NUMBER> key guidance building testing capacity <NUMBER> symptomatic asymptomatic individuals <NUMBER> new coronavirus unique biological characteristics would challenge health care systems <NUMBER> response including high levels infectivity <NUMBER> httpswwwncbinlmnihgovbooksnbk<NUMBER> last <NUMBER> accessed <NUMBER> novel pathogen existing clinical tests could identify covid<NUMBER> patients <NUMBER> confirmation diagnosis required molecular testing sarscov<NUMBER> viral rna <NUMBER> genetic <NUMBER> sequence virus became available early january <NUMBER> httpvirologicalorgtgenome<NUMBER> sequencesbydateandlocation<NUMBER> last accessed <NUMBER> clinical tests could developed <NUMBER> performed reliance single assay production test modality ie centers disease control <NUMBER> prevention cdc test kit performed cdc laboratories httpswwwcdcgovcoronavirus<NUMBER> ncovlabrtpcrpanelprimerprobeshtml last accessed <NUMBER> provided inadequate testing <NUMBER> sarscov<NUMBER> detection capacity ultimately hindering public health system response eg <NUMBER> httpswwwnytimescom<NUMBER>ustestingcoronaviruspandemichtml subscription required <NUMBER> last accessed <NUMBER> <NUMBER> lack access local levels high complexity clinical diagnostic laboratories began <NUMBER> appropriately developing tests faced additional regulatory hurdles due invocation <NUMBER> emergency use authorization eua requirements us food drug administration fda <NUMBER> eg httpswwwgqcomstoryinsideamericascoronavirustestingcrisis last accessed <NUMBER> us public health laboratories however kit subsequently found manufacturing <NUMBER> problem httpswwwcnncom<NUMBER>politicscdccoronavirustesting<NUMBER> contaminationindexhtml last accessed <NUMBER> february <NUMBER> association public health <NUMBER> laboratories wrote letter fda requesting enforcement discretion allow state local public <NUMBER> health laboratories ability create laboratorydeveloped test detection sarscov<NUMBER> <NUMBER> denied httpswww<NUMBER>dxcomclinicallabmanagementaphlasksfdamakeowntests<NUMBER> cdcstrugglesprovidesarscov<NUMBER>testkitsxp<NUMBER>d<NUMBER>chkiul httpswww<NUMBER>dxcomregulatorynews<NUMBER> fdaapprovalsfdadeclinesaphlrequestmakeownsarscov<NUMBER>testkitsxqliuwhkiuk last accessed <NUMBER> <NUMBER> registration required remanufactured cdc test available public health labs <NUMBER> february <NUMBER> <NUMBER> use test initially restricted specific reagent lots extraction <NUMBER> platforms realtime pcr instruments placed significant additional barriers widespread <NUMBER> implementation httpswwwreuterscominvestigatesspecialreporthealthcoronavirushospital<NUMBER> test last accessed <NUMBER> need sarscov<NUMBER> testing community resulted fda <NUMBER> changing eua policy procedure end february allowing academic laboratories <NUMBER> rapidly make test available march <NUMBER> <NUMBER> fda granted first eua <NUMBER> commercial test kits multiple molecular platforms became available use clinical diagnostic <NUMBER> laboratories httpswwwwsjcomarticleshowwashingtonfailedtobuildarobustcoronavirus<NUMBER> testingsystem<NUMBER>modarticleinline subscription required last accessed <NUMBER> <NUMBER> <NUMBER> clinical laboratories rapidly responded make sarscov<NUMBER> diagnostic testing available <NUMBER> patients supply chain issues limited testing capacity led bottlenecks hindered <NUMBER> widespread availability necessary tests eg httpsabcnewsgocomhealthwirestoryus<NUMBER> virustestingfacesheadwindlabsupplyshortages<NUMBER> last accessed <NUMBER> situation httpsoighhsgovoeireportsoei<NUMBER>pdf last accessed <NUMBER> <NUMBER> critical shortages cdc recommendations providing specific clinical presentation epidemiological <NUMBER> criteria identify eligible diagnostic testing httpswwwcdcgovcoronavirus<NUMBER> ncovhcpclinicalcriteriahtml last accessed <NUMBER> initial data set performance <NUMBER> sarscov<NUMBER> diagnostics reflected symptomatic patients biased towards ill diagnostic data <NUMBER> critical determinations mortality rate infection rates critical metrics upon <NUMBER> existing modeling predictions based therefore potentially contains testing bias <NUMBER> yet fully comprehend <NUMBER> httpswwwstatnewscom<NUMBER>covid<NUMBER>overcomingtesting<NUMBER> challenges last accessed <NUMBER> full diagnostic testing capacity include serological screening <NUMBER> identify persons community exposed recovered sarscov<NUMBER> <NUMBER> becoming available many months first confirmed us case sarscov<NUMBER> <NUMBER> recent autopsy <NUMBER> data indicates earliest identified death weeks earlier <NUMBER> httpswwwnprorgsectionscoronavirusliveupdates<NUMBER>stknownuscovid<NUMBER> <NUMBER>deathwasonfeb<NUMBER>apostmortemtestreveals last accessed <NUMBER> additional <NUMBER> testing research disease pathogenesis fully understand scope pathogenicity <NUMBER> covid<NUMBER> disease <NUMBER> association molecular pathology amps infectious diseases subdivision leadership aware <NUMBER> involved multiple efforts address sarscov<NUMBER> testing development test quality <NUMBER> interpretation operation limited resource management pandemic guidance amp <NUMBER> subject matter experts continue provided multiple formats authors anticipate providing <NUMBER> additional communications needed document address emerging challenges throughout related scientific regulatory reimbursement resources httpswwwamporgclinical<NUMBER> practicetestingresourcesforcovid<NUMBER> last accessed <NUMBER> february <NUMBER> may <NUMBER> amp <NUMBER> provided freely accessible online education regarding covid<NUMBER> pandemic <NUMBER> httpseducateamporglocalcatalogviewproductphpproductid<NUMBER> last accessed <NUMBER> <NUMBER> httpseducateamporglocalcatalogviewproductphpproductid<NUMBER> last accessed <NUMBER> <NUMBER> additional webinars provide periodic updates amp conducted robust covid<NUMBER> testing survey <NUMBER> designed identify understand laboratory communitys challenges initial data <NUMBER> <NUMBER> usbased laboratories available httpswwwamporgadvocacysarscov<NUMBER>survey last accessed <NUMBER> <NUMBER> amp member peertopeer listserv communications robust colleagues rapidly <NUMBER> shared concerns challenges knowledge experience solutions support clinical laboratory <NUMBER> communitys covid<NUMBER> testing response multiple amp subject matter experts featured <NUMBER> media interviews interacting social media outlets effectively communicating laboratory <NUMBER> community concerns highlighting numerous success stories spite challenging conditions eg <NUMBER> httpswwwcnncom<NUMBER>politicscoronavirustestingcdcfdaredtapeinvsindexhtml last <NUMBER> accessed <NUMBER> applaud efforts amp members world <NUMBER> professional societies laboratory professionals around world leadership dedication <NUMBER> patient care time rapid change instability clinical laboratory physicians professionals vanguard response sarscov<NUMBER> <NUMBER> pandemic providing accurate highquality laboratory results aid diagnosis treatment <NUMBER> epidemiology role encountered numerous regulatory reimbursement supplychain <NUMBER> logistical systems problems struggled overcome order fulfill calling <NUMBER> provide patient care despite challenges setbacks cadre highlytrained dedicated <NUMBER> molecular diagnostic professionals amp risen challenge providing vital <NUMBER> diagnostic intelligence needed effective management pandemic current successes <NUMBER> achieved determination ingenuity experiences suggest hurdles <NUMBER> obstacles encountered inevitable certainly impaired national <NUMBER> recognition response pandemic order prepare next unexpected challenges <NUMBER> thoughtful retrospection intervention key areas improve ability care patients <NUMBER> society next crisis arises <NUMBER> <NUMBER> behalf amp recognize thank members members multidisciplinary <NUMBER> medical teams expertise dedication service organizationally amp continue <NUMBER> proactively provide critical information resources support laboratory professionals involved <NUMBER> covid<NUMBER> response activities also continue engage encourage support disclaimer association molecular pathology amp perspectives developed <NUMBER> assistance laboratory health care professionals providing guidance <NUMBER> recommendations particular areas practice perspectives considered inclusive <NUMBER> proper approaches methods exclusive others perspectives cannot guarantee <NUMBER> specific outcome establish standard care perspectives intended dictate <NUMBER> treatment particular patient treatment decisions must made basis <NUMBER> independent judgment health care providers patients individual circumstances amp <NUMBER> makes warranty express implied regarding perspectives specifically excludes <NUMBER> warranties merchantability fitness particular use purpose amp shall liable <NUMBER> direct indirect special incidental consequential damages related use information <NUMBER> contained herein <NUMBER> respiratory tract infections rti cause considerable morbidity mortality among elderly population general decline respiratory immune systems age increasing recognition many rtis viral origin viruses contributing <NUMBER> acute rti falsey et al <NUMBER> flamaing et al <NUMBER> infectious outbreaks commonly occur among older adult communities graat et al <NUMBER> hicks et al <NUMBER> loeb et al <NUMBER> strausbaugh joseph <NUMBER> clinical clues often unreliable indicators infection traditional laboratory methods cumbersome slow variably insensitive making diagnoses retrospective falsey et al <NUMBER> walsh et al <NUMBER> emerging molecular diagnostic techniques offer potential test greater breadth viruses detect increased sensitivity rapidity kuypers et al <NUMBER> oosterheert et al <NUMBER> templeton et al <NUMBER> previous studies often limited design knowledge etiologic agents available diagnostic tests angeles marcos et al <NUMBER> flamaing et al <NUMBER> jennings et al <NUMBER> templeton et al <NUMBER> multiplex reverse transcriptase polymerase chain reaction rtpcr rapid diagnosis viral rti powerful diagnostic tool providing clinical financial benefits upon health care system barenfanger et al <NUMBER> gruteke et al <NUMBER> marshall et al <NUMBER> woo et al <NUMBER> excellent sensitivity specificity multiplex rtpcr help make diagnosis viral respiratory infections timely clinically relevant manner allowing effective clinical care appropriate use antimicrobial mahony et al <NUMBER> although testing characteristics traditional newer diagnostic methods defined diverse adult children populations arden et al <NUMBER> jennings et al <NUMBER> little data exist optimal diagnostic test older adults viral rti aside influenza respiratory syncytial virus rsv testing population comprehensive comparison current modalities detection respiratory viruses ie direct fluorescent antibody testing dfa culture multiplex nucleic acid amplification rapid antigen assays test performance likely differ adults known shed fewer virus particles children rti hall et al <NUMBER> seek define performance characteristics <NUMBER> viral diagnostic tests older adult population hypothesize highly sensitive assays rtpcr favored considering speed accuracy diagnosis older adult patients age ≥<NUMBER> years rti prospectively enrolled february <NUMBER> august <NUMBER> <NUMBER>room <NUMBER>bed longterm care facility durham va medical center durham nc rti defined presence least <NUMBER> respiratory symptoms new onset increase chronic cough new onset increase sputum dyspnea chills headache myalgias malaise sore throat nasal congestion <NUMBER> respiratory symptoms temperature ≥<NUMBER>°c children rti presenting employee health clinic arup laboratories salt lake city ut december <NUMBER> march <NUMBER> also enrolled comparison group multiplex rtpcr respiratory viral panel rvp testing nasopharyngeal np specimens obtained using flocked swabs diagnostic hybrids dhi athens oh kept refrigerated <NUMBER>ml universal transport media analysis within <NUMBER> h collection dfa testing culture performed specimens detection influenza b rsv parainfluenza <NUMBER> <NUMBER> adenovirus <NUMBER> ultra dfa respiratory kit dhi human metapneumovirus dhi dfa culture performed using standard laboratory protocol includes inoculation <NUMBER>ml patient specimen <NUMBER> ml rmix refeed media dunn et al <NUMBER> rmix cell lines dhi cultured stained <NUMBER> <NUMBER> h inoculation subset specimens rapid antigen testing rsv influenza ab performed lateral flow binax inverness medical waltham according manufacturers recommended protocol idtag™ rvp luminex austin tx multiplex rtpcr platform detection influenza h<NUMBER>h<NUMBER> influenza b rsv b parainfluenza <NUMBER> <NUMBER> coronaviruses <NUMBER>e oc<NUMBER> nl<NUMBER> hku<NUMBER> human metapneumovirus enterovirusrhinovirus adenovirus performed according manufacturers instructions total nucleic acid extracted <NUMBER>ml transport media <NUMBER>h culture supernatant qiaamp virus biorobot <NUMBER> kit qiagen valencia ca <NUMBER>μl multiplex <NUMBER>step rtpcr reaction consisted <NUMBER>μl molecular grade water <NUMBER>μl qiagen onestep rtpcr enzyme mix <NUMBER>μl <NUMBER>× qiagen onestep rtpcr buffer <NUMBER>μl qiagen <NUMBER> mmoll deoxyribonucleotide triphosphate dntp mix <NUMBER>μl rvp rtpcr primer mix luminex <NUMBER>μl template nucleic acid reverse transcription performed <NUMBER>°c <NUMBER> min inactivation <NUMBER>°c <NUMBER> min pcr targetspecific primer extension bead hybridization signal detection performed previously described mahony et al <NUMBER> data analyzed luminex® xmap® system using tagit data analysis software rvpi mean fluorescence intensities mfi positive samples recorded statistical comparison adult pediatric patients made using <NUMBER>sample wilcoxon ranksum mannwhitney test proportions compared using <NUMBER>sample test equality proportions continuity correction seventyfour np swab specimens obtained <NUMBER> patients <NUMBER> <NUMBER> years age positive result test methods <NUMBER> specimens <NUMBER> <NUMBER> patients distribution positive results patient shown table <NUMBER> specimens tested rvp direct specimen dfa culture <NUMBER> specimens tested rvp <NUMBER>h culture supernatant thirtyone specimens also underwent rapid antigen testing rsv influenza b distribution positive results type respiratory virus summarized table <NUMBER> pediatric comparison group patient ages <NUMBER> month <NUMBER> years <NUMBER> <NUMBER> <NUMBER> samples positive direct specimen rvp <NUMBER> np swabs <NUMBER> <NUMBER> inadequate cellularity dfa interpretation <NUMBER> specimens found positive method <NUMBER> <NUMBER> inadequate cellularity significant difference <NUMBER> proportions p <NUMBER> four specimens positive direct specimen dfa <NUMBER> rsvs <NUMBER> influenza b <NUMBER> parainfluenza <NUMBER> culture positive <NUMBER> cases <NUMBER> influenza b <NUMBER> parainfluenza <NUMBER> also detected rvp direct specimen post<NUMBER>h culture dfa rvp direct specimen yielded <NUMBER> positive results rvp <NUMBER>h culture detected <NUMBER> <NUMBER> positive results <NUMBER> <NUMBER> specimens tested rvp <NUMBER>h culture supernatant negative direct specimen rvp dfa culture <NUMBER> pediatric specimens positive rvp included <NUMBER> rsvs <NUMBER> influenza <NUMBER> influenza b <NUMBER> human metapneumovirus <NUMBER> enterovirusrhinovirus <NUMBER> coronavirus <NUMBER> dual enterovirusrhinovirus influenza mfi positive samples adult patients rti significantly lower pediatric patients rti median <NUMBER> versus <NUMBER> u p <NUMBER> <NUMBER> specimens none positive rsv influenza influenza b rapid antigen testing including <NUMBER> specimens rsv positive least <NUMBER> test method <NUMBER> specimens positive influenza b rvp tested rapid antigen specimens study positive influenza rapid antigen test method although many studies examined utility various methods used diagnosis respiratory virus infections knowledge none systematically concurrently examined performance characteristics dfa culture rapid antigen testing pcr older adult population barenfanger et al <NUMBER> falsey et al <NUMBER> falsey et al <NUMBER> lam et al <NUMBER> templeton et al <NUMBER> found approximately onefifth older adult patients acute rti detectable viral etiology somewhat lower frequency seen studies found viral etiology approximately onethird elderly patients rti using various combinations culture serology antigen detection falsey et al <NUMBER> flamaing et al <NUMBER> study surveillance group asymptomatic older adults establish causal relationship respiratory viruses found generally low percentage b<NUMBER> adult surveillance specimens pcr used jartti et al <NUMBER> data study indicate multiplexed rtpcr highly sensitive detecting respiratory viruses older adults compared dfa culture rapid antigen testing mfi data rvp assay suggest older adults shed less virus children rti virus detection older adult population therefore enhanced highly sensitive methods rtpcr additional advantage rvp assay viruses routinely cultured stained detected rhinovirus coronavirus especially useful elderly patients rhinovirus coronavirus cause severe fatal respiratory disease greenberg <NUMBER> hicks et al <NUMBER> although may seem intuitive rvp testing <NUMBER> h culture would equally sensitive rvp direct specimen found opposite true may due dilution specimen culture media particularly low numbers infective virus particles original sample furthermore rmix cells optimized rapid viral antigen detection <NUMBER> <NUMBER> h propagation virus wilkey et al <NUMBER> observation rvp supernatant <NUMBER>h rmix culture associated reduced sensitivity important finding especially developing diagnostic algorithms detection respiratory viruses dfa respiratory specimens remains useful test young children shed large amounts virus dfa quicker simpler perform compared rtpcr older adult population studied dfa failed detect viral pathogen <NUMBER> <NUMBER> possible cases whereas rvp miss cases found dfa culture even less sensitive dfa contributing additional information patients tested studies also found viral culture insensitive especially older adults falsey et al <NUMBER> although convenient rapid antigen testing rsv recommended testing older adults insensitivity patient population finding corroborated investigators casianocolon et al <NUMBER> falsey et al <NUMBER> influenza b cases available testing rapid antigen thus conclusions rapid antigen testing influenza older adults cannot made dual infections found older adults study whereas young children found <NUMBER> patients tested investigations gruteke et al <NUMBER> kuypers et al <NUMBER> incidence mixed viral rti older adults studied using highly sensitive modalities rtpcr reported low frequency use test methods serology culture falsey et al <NUMBER> flamaing et al <NUMBER> study include serologic testing another sensitive testing modality serology largely retrospective contrast test methods used study acknowledge results study may affected high number inadequate specimens however specimens collected experienced nursing medical staff moreover underscores importance highly sensitive diagnostic assays older adults highlights need modified protocols specimen collection especially elderly population dry winter conditions proportion inadequate specimens overall among specimens positive results differ statistically finding suggests pcr sufficiently sensitive detect virus even specimens poor cellularity low number positive results dfa culture may due specimen inadequacy noted pcr culture rapid antigen testing specimen cellularity routinely assessed would noted microscopy eg dfa performed study demonstrates older adults highly sensitive platform necessary minimize falsenegative test results rapid antigen testing rsv recommended older adults negative dfa culture results interpreted caution methods insensitive particularly older adult population nucleic acid amplificationbased testing superior sensitivity serves robust method detect respiratory viruses older adults study warranted determine clinical epidemiologic financial benefits traditional methods may <NUMBER>th <NUMBER> maharashtra delhi gujarat states reported hotspots covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> confirmed cases respectively date <NUMBER> patients recovered <NUMBER> deaths reported india <NUMBER> impose social distancing janata curfew <NUMBER> h lockdown ordered march <NUMBER>nd <NUMBER> lockdown initiated <NUMBER> days starting march <NUMBER>th <NUMBER> extended may <NUMBER>rd <NUMBER> owing increasing number positive cases lockdown extended third time may <NUMBER>th <NUMBER> <NUMBER> currently <NUMBER> states eight union territories india <NUMBER> states six union territories reported covid<NUMBER> cases additionally health ministry identified <NUMBER> districts hotspot zones red zones <NUMBER> orange zones sarscov<NUMBER> infections <NUMBER> green zones sarscov<NUMBER> infection may <NUMBER>th <NUMBER> hotspot districts identified report <NUMBER> cases across nation nineteen districts uttar pradesh identified hotspot districts followed <NUMBER> <NUMBER> districts maharashtra tamil nadu respectively <NUMBER> complete lockdown implemented containment zones stoplimit community transmission <NUMBER> may <NUMBER>th <NUMBER> <NUMBER> government laboratories <NUMBER> private laboratories across country involved sarscov<NUMBER> testing per icmr report <NUMBER> samples tested till date <NUMBER> per thousand people <NUMBER> recent outbreak covid<NUMBER> several countries similar previous outbreaks sars middle east respiratory syndrome mers emerged <NUMBER> <NUMBER> china saudi arabia respectively <NUMBER> <NUMBER> <NUMBER> coronavirus responsible sars covid<NUMBER> diseases affect respiratory tract cause major disease outbreaks worldwide sars caused sarscov whereas sarscov<NUMBER> causes covid<NUMBER> far particular treatment available treat sars covid<NUMBER> current search covid<NUMBER> cure evidence point sarscov<NUMBER> similar human coronavirus hku<NUMBER> <NUMBER>e strains <NUMBER> <NUMBER> even though new coronavirus family members reports suggest humans immunity virus allowing easy rapid spread among human populations contact infected person sarscov<NUMBER> transmissible sarscov two possible reasons could viral load quantity virus tends relatively higher covid<NUMBER>positive patients especially nose throat immediately develop symptoms ii binding affinity sarscov<NUMBER> host cell receptors higher sarscov <NUMBER> <NUMBER> comparisons sars covid<NUMBER> tabulated table <NUMBER> references provided <NUMBER> <NUMBER> <NUMBER> per official government guidelines india making preparations covid<NUMBER> outbreak avoiding specific crisis actions understating importance extremely severe implications neighboring countries india reported positive covid<NUMBER> cases protect deadly virus indian government taken <NUMBER> <NUMBER> <NUMBER> <NUMBER> outbreak sars china catastrophic led changes health care medical systems <NUMBER> <NUMBER> compared china ability india counter pandemic seems much lower recent study reported affected family members visit wuhan market china suggesting sarscov<NUMBER> may spread without manifesting symptoms <NUMBER> researchers believe phenomenon normal many viruses india population <NUMBER> billionthe second largest population worldwill difficulty treating severe covid<NUMBER> cases country <NUMBER> ventilators minimal amount number covid<NUMBER> cases increases nation would catastrophe india <NUMBER> <NUMBER> economists assume impact covid<NUMBER> economy high negative compared sars impact <NUMBER> instance estimated number tourists arriving china much higher tourists traveled season sars emerged <NUMBER> shows covid<NUMBER> effect tourism industry estimated sars <NUMBER> <NUMBER> decline yearly rail passenger road passenger traffic respectively <NUMBER> moreover compared world economy <NUMBER> years ago world economies currently much interrelated estimated covid<NUMBER> hurt emerging market currencies also impact oil prices <NUMBER> <NUMBER> <NUMBER> retail industrys perspective consumer savings seem high might adverse effect consumption rates supply chains likely affected turn would impact supply compared demand various necessary product items <NUMBER> clearly proves based estimated losses due effect sars tourism retail sales lost around usd <NUMBER> billion usd <NUMBER> billion lost global macroeconomic level cannot estimate impact covid<NUMBER> point possible spread covid<NUMBER> fully controlled time estimates rather ambiguous imprecise <NUMBER> oecd interim economic assessment provided briefing reports highlighting role china global supply chain commodity markets japan south korea australia countries susceptible adverse effects close ties china estimated <NUMBER> decline car sales <NUMBER> monthly decline china january <NUMBER> shows even industrial production affected covid<NUMBER> far several factors thus identified major economic impact labor mobility lack working hours interruptions global supply chain less consumption tourism less demand commodity market global level <NUMBER> turn need adequately analyzed industry type corporate leaders need prioritize supply chain product line economy trends via demand consumer end amidst several debates sustainable economy covid<NUMBER> impact estimated indias gdp international monetary fund cut <NUMBER> <NUMBER> fy<NUMBER> financial crisis emerged owing worldwide lockdown reflects adverse effect several industries global supply chain resulted gdp dropping <NUMBER> fy<NUMBER> previously estimated <NUMBER> nevertheless roughly estimated india china experiencing considerable positive growth among major economies <NUMBER> easy way decrease sarscov<NUMBER> infection rates avoid virus exposure people india avoid traveling countries highly affected virus practice proper hygiene avoid consuming food home cooked necessary preventive measures wearing mask regular hand washing avoiding direct contact infected persons also practiced ministry health family welfare mohfw india raised awareness recent outbreak taken necessary action control covid<NUMBER> besides mohfw created <NUMBER> h<NUMBER> daysaweek disease alert helpline <NUMBER> <NUMBER> policy guidelines surveillance clinical management infection prevention control sample collection transportation discharging suspected confirmed cases <NUMBER> <NUMBER> traveled china countries exhibited symptoms including fever difficulty breathing sore throat cough breathlessness asked visit nearest hospital health checkup officials seven different airports including chennai cochin new delhi kolkata hyderabad bengaluru ordered screen monitor indian travelers china affected countries addition travel advisory released request cessation travel affected countries anyone travel history included china since january <NUMBER>th <NUMBER> would quarantined centralized control room set delhi government directorate general health services <NUMBER> districts done india implemented covid<NUMBER> travel advisory intraand interpassenger aircraft restrictions information additional travel advisory accessed provided link httpswwwmohfwgovin pdftraveladvisorypdf india known traditional medicines form ayush ayurvedic yoga naturopathy unani siddha homeopathy polyherbal powder nilavembukudineer showed promising effects dengue chikungunya fevers past <NUMBER> outbreak covid<NUMBER> ministry ayush released press note advisory coronavirus mentioning useful medications improve immunity individuals <NUMBER> currently according icmr guidelines doctors prescribe combination lopinavir ritonavir severe covid<NUMBER> cases hydroxychloroquine prophylaxis sarscov<NUMBER> infection <NUMBER> <NUMBER> collaboration icmr conduct therapeutic trial covid<NUMBER> india <NUMBER> icmr recommends using usfdaapproved closed realtime rtpcr systems genexpert roche cobas<NUMBER> used diagnose chronic myeloid leukemia melanoma respectively <NUMBER> addition truenattm beta cov test truelabtm workstation validated icmr recommended screening test positive results obtained platform need confirmed confirmatory assays sarscov<NUMBER> negative results require testing antibodybased rapid tests validated niv pune found satisfactory rapid test kits follows infections caused viruses enormous global health threat major cause death adverse socioeconomic effects continually exacerbated therefore potential treatment initiatives approaches need developed first india taking necessary preventive measures reduce viral transmission second icmr ministry ayush provided guidelines use conventional preventive treatment strategies increase immunity covid<NUMBER> <NUMBER> <NUMBER> guidelines could help reduce severity viral infection elderly patients increase life expectancy <NUMBER> recent report director icmr mentioned india would undergo randomized controlled trials using convalescent plasma completely recovered covid<NUMBER> patients convalescent plasma therapy highly recommended provided moderate success sars mers <NUMBER> rolled <NUMBER> health centers increased month may <NUMBER> <NUMBER> india expertise specialized medicalpharmaceutical industries production facilities government established fasttracking research develop rapid diagnostic test kits vaccines low cost <NUMBER> addition serum institute india started developing vaccine sarscov<NUMBER> infection <NUMBER> obtain appropriate vaccine highly recommended screen red zoned areas stop transmission virus medical college doctors kerala india implemented lowcost wisk walkin sample kiosk collect samples without direct exposure contact <NUMBER> <NUMBER> kerala defense research development organization drdo developed walkin kiosks collect covid<NUMBER> samples named covid<NUMBER> sample collection kiosk covsack <NUMBER> swab collection testing sarscov<NUMBER> achieved existing diagnostic facility india facility used massive screening least red zoned areas without need personal protective equipment kits <NUMBER> <NUMBER> india attempted broaden research facilities shift toward testing mass population recommended medical experts india worldwide <NUMBER> publicly available datasets analyzed study data found httpswwwmohfwgovin httpswww icmrgovin sk dk cd involved design study acquisition analysis interpretation data drafting manuscript bc involved interpretation data cd supervised entire study manuscript reviewed approved authors <NUMBER> february <NUMBER> world health organizations communicable disease surveillance response csr unit published report chinese ministry health outbreak acute respiratory syndrome guangdong province <NUMBER> cases <NUMBER> deaths time mass media reported pneumonia epidemic guangdong causing considerable fear disruption among local population provided details etiology apparently infectious disease one week later csr reported detection avian influenza h<NUMBER>n<NUMBER> virus child hong kong following visit mainland china several members family presented similar illness two childs relatives succumbed although many observers tempted see possible causal link two reports relating adjacent geographic areas chinese ministry health stated <NUMBER> february atypical pneumonia outbreak guangdong probably caused chlamydia pneumoniae days later doctor treated patients disease guangdong booked hong kong hotel family reunion days succumbed disease hong kong hospital unwittingly infected <NUMBER> family members <NUMBER> hotel guests <NUMBER> health care staff thus became epicenter international spread illness traveling hotel guests infected brought disease within days vietnam singapore canada ireland usa indirectly germany <NUMBER> march <NUMBER> issued global alert cases atypical pneumonia spreading hospital staff alert raised doctor working vietnam dr carlo urbani recognized novel infectious disease enormous potential nosocomial transmission tragically became infected later succumbed emergency travel advisory followed <NUMBER> march <NUMBER> reporting worldwide spread first time termed severe acute respiratory syndrome sars unprecedented move initiated collaborative multicenter research project identify causative agent sars avian influenza quickly ruled several laboratories diagnosed active infections chlamydia paramyxoviruses far patients suffering sars however good evidence neither plausible etiological agents novel infectious disease network comprised laboratories access sars patient samples particular expertise emerging respiratory viruses several weeks spirit cooperation rather competition prevailed samples exchanged results findings shared continuously via daily telephone conferences passwordprotected website within weeks groups hong kong germany canada united states america found hitherto unknown member coronavirus family sars patients achieved independent studies certainly benefited greatly realtime sharing interim results although different approaches employed including cell culture electron microscopy molecular techniques sequencing data showed laboratories identified coronavirus previously unknown human veterinary virology figure <NUMBER> shown sars patients seroconverted virus course illness healthy unexposed control individuals lacked antibody reactivity however remained proven novel coronavirus indeed etiological agent sars rather innocent bystander newly discovered thorough studies experimental infection macaques newly isolated agent shown cause sarslike illness subsequent reisolation agent kochs postulates fulfilled <NUMBER> april <NUMBER> officially announced provisionally termed sarsassociated coronavirus sarscov causative agent sars based breakthrough tests detection viral sequences specific antibodies quickly developed made available affected countries addition numerous scientists embarked programmes develop vaccines drugs antibodies prophylactic therapeutic use within months sars outbreak brought control <NUMBER> july <NUMBER> declared last chain persontoperson transmission interrupted measures including source isolation patients became infectious onset clinical symptoms strict infection control health care facilities timely identification quarantining exposed contacts perhaps also measures increase social distance travel warnings screening travelers led remarkable remarkably rapid success thorough consistent implementation measures eventually brought end sars outbreak even worst affected areas meantime however several areas different chinese provinces guangdong prominently capital beijing also toronto canada taiwan paid high price implementing adequate countermeasures timely fashion typically socalled superspreader highly contagious sars patient would seek treatment poorly prepared facility time danger realized scores staff patients become infected become sources spread interestingly despite rapid identification agent laboratory tests becoming available almost immediately formidable achievements contribute much containment outbreak instead prudent thorough use oldfashioned measures isolation quarantine proved key success identification suspected cases based clinical epidemiological criteria high fever <NUMBER>c plus symptoms respiratory tract infection plus exposure history details depended locations sars status time additional positive sarscov test result radiological pathological evidence pneumonia respiratory distress syndrome would make probable case final case count <NUMBER> november <NUMBER> <NUMBER> july <NUMBER> <NUMBER> <NUMBER> deaths since mid<NUMBER> sars reappeared four occasions three involved laboratoryacquired infections demonstrates dangers breaching biosafety procedures risks subsequent spread community secondary transmission outside laboratory fourth sars outbreak due reintroduction reservoir minimize risk reemergence issued guidelines surveillance possible sars cases risk categories guide adequate national surveillance strategies guard possible reemergence sars emergence wildlife animal reservoirs emergence introduction laboratories via international travel low risk sarscov emergence introduction also urges countries conduct inventory laboratories working storing sarscov ensure strict enforcement biosafety procedures sars two coronaviruses hcov<NUMBER> e hcovoc<NUMBER> known infect humans cause relatively minor disease difficult propagate laboratory received relatively little attention diagnostic research laboratories contrast several coronaviruses recognized animal pathogens infecting pigs dogs rabbits cats mice rats turkeys chicken time played important roles veterinary medicine obvious majority human sars cases acquired transmission sars sufferers proved key eventual control however seemed highly unlikely previously existing disease entity recognized propensity cause nosocomial outbreaks often hospital settings would overlooked long first sars cases identified retrospectively various localities guangdong province first early cases occurred foshan november <NUMBER> several following weeks nearby places interest soon focused early index cases characteristic patients common could point source sarscov infection indeed many early index patients either worked kitchens markets lived nearby constantly exposed multitude species domestic wild animals traded kept captivity finally slaughtered prepared consumption provided impetus studying animals sold guangdong markets infection coronaviruses closely related sarscov identified different species commonly masked palm civet paguma larvata also chinese ferret badger melogale moschata raccoon dog nyctereutes procyonoides small sars outbreak occurred guangdong late <NUMBER>early <NUMBER> molecular analysis virus isolates human cases animals sampled place time confirmed zoonotically acquired paguma larvata however investigations revealed widely consumed species likely animal reservoir populations studied uninfected later research identified multitude coronaviruses different species bats asia elsewhere among probably progenitor sarscov studies different groups demonstrate sars result spillover wildlife reservoir likely bats intermediate host hosts importantly paguma larvata human population rapid viral evolution demonstrated likely pivotal factor allowed sarscov rapidly adapt nonreservoir species table <NUMBER> shows distribution several different coronaviruses humans animals classification different groups disease caused sarscov may present rather nonspecific clinical signs symptoms differential diagnosis therefore wide may include various common respiratory pathogens including influenza parainfluenza respiratory syncytial viruses rsv laboratory diagnosis sars remains challenge fact despite rapid identification sarscov etiological agent testing contributed little successful control <NUMBER> outbreak insufficient test specificity occasions caused falsepositive results leading considerable confusion many viral diseases virus shedding greatest early symptomatic phase around immediately following onset symptoms unfortunately virus excretion comparatively low initial phase sars peaks respiratory specimens stools around day <NUMBER> onset clinical illness addition currently laboratory tests available reliably diagnose sars first days illness highest test sensitivity achieved bronchoalveolar lavage fluid lung biopsy tissue onset illness invasiveness procedures associated risk transmission nasopharyngeal aspirates throat washings taken respiratory precautions preserved viral transport medium remain important diagnostic specimens commonly viral genome detection usually reverse transcriptasepolymerase chain reaction rtpcr used diagnostically nucleic acid amplification tests designed targeting orf<NUMBER>b nucleoprotein genes clearly proven clinical studies superior realtime rtpcr nasopharyngeal aspirates sensitive rapid method furthermore determination viral load nasopharyngeal specimens serum shown clinical value important prognostic factor avoid falsepositive results stipulates following tested least two different clinical specimen types eg nasopharyngeal aspirate stool type clinical specimen collected least two occasions course illness eg sequential nasopharyngeal aspirates original clinical sample two different assays repeating assay using new rna extract test sarscov cultivable vero caco<NUMBER> cells respiratory materials also fecal samples figure <NUMBER> isolated virus must identified sarscov using tests cell culture demanding test currently exception animal trials means show existence live virus antigen detection respiratory fecal specimens using enzyme immunoassay eia generally less sensitive rtpcr however antigen detection serum specimens monoclonal antibodies monospecific polyclonal antibody viral n protein found sensitive specific test diagnosis sars serum antibody levels start rise day <NUMBER> onset illness sensitivity serum antigen assay progressively decreased <NUMBER> day <NUMBER> antibody testing allows indirect diagnosis sarscov infection unsuitable acute illness positive antibody test results indicate previous infection sarscov seroconversion negative positive fourfold rise antibody titer acute convalescent serum indicates recent infection negative antibody test result later <NUMBER> days onset illness likely indicate infection sarscov taken place virusspecific serum igg igm iga antibodies sarscov appear around time days <NUMBER> <NUMBER> onset symptoms antibody testing therefore generally useful first week illness antibody testing indirect immunofluorescent antibody test commonly performed neutralizing antibody test cell cultures requires biosafety level <NUMBER> laboratory figure <NUMBER> recombinant nucleocapsid eia may used rapid screening test possesses higher sensitivity detection early day <NUMBER> onset illness single lowtiter positive antibody results due crossreactivity human coronaviruses require confirmation specific western blotting neutralization assays regards seroconversion least fourfold rise antibody titer acute convalescent serum proof infection updated guidelines global surveillance sars october <NUMBER> replace previous guidance sars surveillance response one key recommendation independent test used strongly recommends interepidemic period countries seek verification laboratoryconfirmed cases sars preliminary positive cases preferably external laboratory part sars international reference verification laboratory network figure <NUMBER> human sarscov longer circulating human population nevertheless virus still present animal reservoir virological laboratories reemerge anytime single test used diagnose sars reasonable degree accuracy diagnosis therefore continues rely clinical examination supported case definitions include risk assessment according <NUMBER> updated guidelines tables <NUMBER> <NUMBER> initial symptoms sars nonspecific complicating differential diagnosis mean incubation period <NUMBER> days range <NUMBER> days although isolated reports longer incubation periods unlike influenza virus patients infectious first <NUMBER> days illness transmission symptomatic sars patients usually occurred fifth day onset disease line rising viral load nasopharyngeal secretions peaked around day <NUMBER> reports transmission occurring onset symptoms typical clinical presentation sars viral pneumonia rapid respiratory deterioration patients initially develop influenzalike prodromal symptoms fever malaise myalgia headache rigors nonproductive cough major presenting symptoms whereas rhinorrhea sore throat less frequently seen clinical deterioration often accompanied watery diarrhea commonly occurs <NUMBER> week onset illness although history fever frequently reported symptom may absent initial measurement severe cases develop rapidly progressing respiratory distress oxygen desaturation approximately <NUMBER> requiring intensive care chest radiographs typically show groundglass opacities focal consolidations especially periphery subpleural regions lower zones progressive involvement lungs uncommon features later stages sometimes included spontaneous pneumothorax pneumomediastinum subpleural fibrosis cystic changes nosocomial transmission sarscov striking feature sars outbreak majority cases occurred adults children less commonly affected adults usually milder illness overall mortality rate approximately <NUMBER> age presence comorbidities poor prognostic indicators although sars outbreak still ongoing first half <NUMBER> significant funding made available sarsrelated research immunomodulators ie corticosteroids intravenous immunoglobulins thymosin antitnf empirically used treatment sars initial epidemic correlation viral load clinical outcome suggests suppression viral replication effective antiviral drugs key preventing morbidity mortality numerous potential antiviral agents identified using different approaches vitro susceptibility test results demonstrate ifnalpha ifnbeta potential activity ribavirin good activity tested human caco<NUMBER> cells despite lack activity vero cells viral proteases important targets development antiviral drugs protease inhibitors like nelfinavir glycyrrhizin chloroquine many others well many herbal formulations found possess antiviral activity sarscov vitro addition use nitric oxide snitronacetylpenicillamine inhalation experimental form rescue therapy sars appeared inhibitory activity sarscov screening chemical libraries identified several inhibitors viral protease helicase identification angiotensinconverting enzyme <NUMBER> ace<NUMBER> obligatory cellular receptor sarscov contributed understanding sarscov entry process helped characterize two targets antiviral therapeutics sarscov spike protein ace<NUMBER> however chemicals approaches evaluated human animal models various approaches toward producing vaccine sars pursued including use inactivated sarscov plasmid dna adenovirus vectors one obvious problem vaccine would face given absence sarscov transmission however waiting renewed outbreak occurs commencing vaccination means precious weeks would lost individuals risk become immune administration preformed antibodies obtained human animal donors recently produced vitro effective preventing number different infections hepatitis b varicella rsv similarly could shown neutralizing antibodies sarscov protect experimental animals infection using screening large naive antibody library antibody phage display technology neutralizing antibodies identified produced protective vitro evidence enhancement sarscov infection subneutralizing concentrations antibodies immune escape mutants generated theory could ideal tool sufficient stocks human monoclonal antibodies could procured would ready use wherever sars reemerges one could passively immunize anyone contact source patients affording immediate protection summary sars novel severe infectious disease presumably originated guangdong southern china largescale wildlife trade consumption favored emergence zoonosis hitherto unrecognized animal reservoir zoonotic origins new agent quickly spread within human population transmitted mostly via respiratory route close humantohuman contact sars rapidly disseminated via metropolis hong kong international air travel important potential nosocomial transmission community hospitals soon recognized allowed appropriate measures instituted places unprecedented rapid gain knowledge global networking international collaboration led unfortunately took major outbreaks affecting industrialized countries modern health care systems first sars epidemic controlled thus end rapid success achieved traditional sanitary measures mainly rapid identification suspect cases isolation diseased fortunately sarscov least far established permanently human population relatively low transmissibility exception superspreaders led low basic reproduction number r <NUMBER> together fact infected individuals become infectious developed clinical disease made traditional public health measures effective fact first pandemic twentyfirst century quickly contained reason take comfort knowledge history humankind reached phase biomedical sciences information technology able deal threats probably first rapid success remarkable unfortunately though reflect preparedness <NUMBER> donald burke proposed following criteria identifying virus families high pandemic risk <NUMBER> caused pandemics human populations recent past <NUMBER> proven ability cause larger epizootics <NUMBER> intrinsic propensity rapidly undergo evolution basis high mutation rate genome organization favoring recombination intrinsic evolvability interestingly even sars outbreak obviously fulfills first criterion coronavirus family clearly regarded high risk starting late <NUMBER>s porcine epidemic diarrhea coronavirus pedv caused severe swine epizootic europe asia second criterion high evolvability coronavirus family also demonstrated porcine respiratory coronavirus prcv evolved deletion mutation gene transmissible gastroenteritis virus tgev mutant different tissue tropism less virulent second infectious disease emergence zoonotic sources wellrecognized threat long sars nevertheless took another fortunately minor sars outbreak decisive steps taken control least trade directly implicated paguma larvata southern china starting shortly sars controlled another agent pandemic potential caused ongoing epizootic unprecedented proportions highly pathogenic influenza h<NUMBER>n<NUMBER> virus transmission humans occurs almost exclusively close contact infected sick poultry despite possibility avian influenza virus become fully humanized trigger next influenza pandemic even activities recognized high risk wet markets mostly curtailed finally lessons sars particularly experiences beijing toronto taiwan suffered devastating sars outbreaks later phase outbreak emphasize enormous importance open timely communication times may mean admitting problems least initially reflect negatively country territory concerned medium long term however openness way prevent consequences would much worse although widely accepted wake sars experience strong influence new international health regulations entered force june <NUMBER> information policies countries h<NUMBER>n<NUMBER> epizootic unfortunately attest notwithstanding grave consequences humanitarian political economic terms sars serve example achieved international cooperation modern science rigorous use traditional approaches even prudent precautions suddenly adopted sars certainly last highly pathogenic novel infectious agent crosses species barrier human population although bats must high list culprits emerging viral diseases identified reservoir hosts number emerging viruses reason groups animals figure prominently future mechanisms behind emergence studied may linked agent new host species ie human beings certain cases also intermediate hosts connection many factors determinants disease emergence related human activities although accompanied humankind throughout history fact may helped shape human history speed extent humaninduced changes accelerated markedly recent times although case sars people lucky end may quite different next time round important improve understanding emergence minimize risks natural phenomenon much aggravated human behavior unprecedented move initiated collaborative multicenter research project identify causative agent sars avian influenza quickly ruled several laboratories diagnosed active infections chlamydia paramyxoviruses somebut far allpatients suffering sars however good evidence neither plausible etiological agents novel infectious disease network comprised laboratories access sars patient samples particular expertise emerging respiratory viruses several weeks spirit cooperation rather competition prevailed samples exchanged results findings shared continuously via daily telephone conferences passwordprotected website within weeks groups hong kong germany canada united states america found hitherto unknown member coronavirus family sars patients achieved independent studies certainly benefited greatly realtime sharing interim results although different approaches employed including cell culture electron microscopy molecular techniques sequencing data showed laboratories identified coronavirus previously unknown human veterinary virology figure <NUMBER> shown sars patients seroconverted virus course illness healthy unexposed control individuals lacked antibody reactivity however remained proven novel coronavirus indeed etiological agent sars rather innocent bystander newly discovered thorough studies experimental infection macaques newly isolated agent shown cause sarslike illness subsequent reisolation agent kochs postulates fulfilled <NUMBER> april <NUMBER> officially announced provisionally termed sarsassociated coronavirus sarscov causative agent sars based breakthrough tests detection viral sequences specific antibodies quickly developed made available affected countries addition numerous scientists embarked programmes develop vaccines drugs antibodies prophylactic therapeutic use within months sars outbreak brought control <NUMBER> july <NUMBER> declared last chain persontoperson transmission interrupted measures including source isolation patientswho became infectious onset clinical symptomsstrict infection control health care facilities timely identification quarantining exposed contacts perhaps also measures increase social distance travel warnings screening travelers led remarkable remarkably rapid success thorough consistent implementation measures eventually brought end sars outbreak even worst affected areas meantime however several areasdifferent chinese provinces guangdong prominently capital beijing also toronto canada taiwanpaid high price implementing adequate countermeasures timely fashion typically socalled superspreader highly contagious sars patient would seek treatment poorly prepared facility time danger realized scores staff patients become infected become sources spread interestingly despite rapid identification agent laboratory tests becoming available almost immediately formidable achievements contribute much containment outbreak instead prudent thorough use oldfashioned measures isolation quarantine proved key success identification suspected cases based clinical epidemiological criteria high fever <NUMBER> c plus symptoms respiratory tract infection plus exposure history details depended locations sars status time additional positive sarscov test result radiological pathological evidence pneumonia respiratory distress syndrome would make probable case final case count <NUMBER> november <NUMBER> <NUMBER> july <NUMBER> <NUMBER> <NUMBER> deaths since mid<NUMBER> sars reappeared four occasions three involved laboratoryacquired infections demonstrates dangers breaching biosafety procedures risks subsequent spread community secondary transmission outside laboratory fourth sars outbreak due reintroduction reservoir minimize risk reemergence issued guidelines surveillance possible sars cases risk categories guide adequate national surveillance strategies guard possible reemergence sars emergence wildlife animal reservoirs emergence introduction laboratories via international travel low risk sarscov emergence introduction also urges countries conduct inventory laboratories working storing sarscov ensure strict enforcement biosafety procedures sars two coronaviruses hcov<NUMBER> e hcovoc<NUMBER> known infect humans cause relatively minor disease difficult propagate laboratory received relatively little attention diagnostic research laboratories contrast several coronaviruses recognized animal pathogens infecting pigs dogs rabbits cats mice rats turkeys chicken time played important roles veterinary medicine obvious majority human sars cases acquired transmission sars sufferers proved key eventual control however seemed highly unlikely previously existing disease entity recognized propensity cause nosocomial outbreaks often hospital settings would overlooked long first sars cases identified retrospectively various localities guangdong province first early cases occurred foshan november <NUMBER> several following weeks nearby places interest soon focused early index cases characteristic patients common could point source sarscov infection indeed many early index patients either worked kitchens markets lived nearby constantly exposed multitude species domestic wild animals traded kept captivity finally slaughtered prepared consumption provided impetus studying animals sold guangdong markets infection coronaviruses closely related sarscov identified different species commonly masked palm civet paguma larvata also chinese ferret badger melogale moschata raccoon dog nyctereutes procyonoides small sars outbreak occurred guangdong late <NUMBER>early <NUMBER> molecular analysis virus isolates human cases animals sampled place time confirmed zoonotically acquired paguma larvata however investigations revealed widely consumed species likely animal reservoir populations studied uninfected later research identified multitude coronaviruses different species bats asia elsewhere among probably progenitor sarscov studies different groups demonstrate sars result spillover wildlife reservoirmost likely batsinto intermediate host hosts importantly paguma larvata human population rapid viral evolution demonstrated likely pivotal factor allowed sarscov rapidly adapt nonreservoir species table <NUMBER> shows distribution several different coronaviruses humans animals classification different groups disease caused sarscov may present rather nonspecific clinical signs symptoms differential diagnosis therefore wide may include various common respiratory pathogens including influenza parainfluenza respiratory syncytial viruses rsv laboratory diagnosis sars remains challenge fact despite rapid identification sarscov etiological agent testing contributed little successful control <NUMBER> outbreak insufficient test specificity occasions caused falsepositive results leading considerable confusion many viral diseases virus shedding greatest early symptomatic phase around immediately following onset symptoms unfortunately virus excretion comparatively low initial phase sars peaks respiratory specimens stools around day <NUMBER> onset clinical illness addition currently laboratory tests available reliably diagnose sars first days illness highest test sensitivity achieved bronchoalveolar lavage fluid lung biopsy tissue onset illness invasiveness procedures associated risk transmission nasopharyngeal aspirates throat washings taken respiratory precautions preserved viral transport medium remain important diagnostic specimens commonly viral genome detection usually reverse transcriptasepolymerase chain reaction rtpcr used diagnostically nucleic acid amplification tests designed targeting orf<NUMBER>b nucleoprotein genes clearly proven clinical studies superior realtime rtpcr nasopharyngeal aspirates sensitive rapid method furthermore determination viral load nasopharyngeal specimens serum shown clinical value important prognostic factor avoid falsepositive results stipulates following tested least two different clinical specimen types eg nasopharyngeal aspirate stool type clinical specimen collected least two occasions course illness eg sequential nasopharyngeal aspirates original clinical sample two different assays repeating assay using new rna extract test sarscov cultivable vero caco<NUMBER> cells respiratory materials also fecal samples figure <NUMBER> isolated virus must identified sarscov using tests cell culture demanding test currently exception animal trials means show existence live virus antigen detection respiratory fecal specimens using enzyme immunoassay eia generally less sensitive rtpcr however antigen detection serum specimens monoclonal antibodies monospecific polyclonal antibody viral n protein found sensitive specific test diagnosis sars serum antibody levels start rise day <NUMBER> onset illness sensitivity serum antigen assay progressively decreased <NUMBER> day <NUMBER> antibody testing allows indirect diagnosis sarscov infection unsuitable acute illness positive antibody test results indicate previous infection sarscov seroconversion negative positive fourfold rise antibody titer acute convalescent serum indicates recent infection negative antibody test result later <NUMBER> days onset illness likely indicate infection sarscov taken place virusspecific serum igg igm iga antibodies sarscov appear around time days <NUMBER> <NUMBER> onset symptoms antibody testing therefore generally useful first week illness antibody testing indirect immunofluorescent antibody test commonly performed neutralizing antibody test cell cultures requires biosafety level <NUMBER> laboratory figure <NUMBER> recombinant nucleocapsid eia may used rapid screening test possesses higher sensitivity detection early day <NUMBER> onset illness single lowtiter positive antibody results due crossreactivity human coronaviruses require confirmation specific western blotting neutralization assays regards seroconversion least fourfold rise antibody titer acute convalescent serum proof infection updated guidelines global surveillance sars october <NUMBER> replace previous guidance sars surveillance response one key recommendation independent test used strongly recommends interepidemic period countries seek verification laboratoryconfirmed cases sars preliminary positive cases preferably external laboratory part sars international reference verification laboratory network figure <NUMBER> human sarscov longer circulating human population nevertheless virus still present animal reservoir virological laboratories reemerge anytime single test used diagnose sars reasonable degree accuracy diagnosis therefore continues rely clinical examination supported case definitions include risk assessment according <NUMBER> updated guidelines tables <NUMBER> <NUMBER> initial symptoms sars nonspecific complicating differential diagnosis mean incubation period <NUMBER> days range <NUMBER> days although isolated reports longer incubation periods unlike influenza virus patients infectious first <NUMBER> days illness transmission symptomatic sars patients usually occurred fifth day onset disease line rising viral load nasopharyngeal secretions peaked around day <NUMBER> reports transmission occurring onset symptoms typical clinical presentation sars viral pneumonia rapid respiratory deterioration patients initially develop influenzalike prodromal symptoms fever malaise myalgia headache rigors nonproductive cough major presenting symptoms whereas rhinorrhea sore throat less frequently seen clinical deterioration often accompanied watery diarrhea commonly occurs <NUMBER> week onset illness although history fever frequently reported symptom may absent initial measurement severe cases develop rapidly progressing respiratory distress oxygen desaturation approximately <NUMBER> requiring intensive care chest radiographs typically show groundglass opacities focal consolidations especially periphery subpleural regions lower zones progressive involvement lungs uncommon features later stages sometimes included spontaneous pneumothorax pneumomediastinum subpleural fibrosis cystic changes nosocomial transmission sarscov striking feature sars outbreak majority cases occurred adults children less commonly affected adults usually milder illness overall mortality rate approximately <NUMBER> age presence comorbidities poor prognostic indicators although sars outbreak still ongoing first half <NUMBER> significant funding made available sarsrelated research immunomodulators ie corticosteroids intravenous immunoglobulins thymosin antitnf empirically used treatment sars initial epidemic correlation viral load clinical outcome suggests suppression viral replication effective antiviral drugs key preventing morbidity mortality numerous potential antiviral agents identified using different approaches vitro susceptibility test results demonstrate ifnalpha ifnbeta potential activity ribavirin good activity tested human caco<NUMBER> cells despite lack activity vero cells viral proteases important targets development antiviral drugs protease inhibitors like nelfinavir glycyrrhizin chloroquine many others well many herbal formulations found possess antiviral activity sarscov vitro addition use nitric oxide snitronacetylpenicillamine inhalation experimental form rescue therapy sars appeared inhibitory activity sarscov screening chemical libraries identified several inhibitors viral protease helicase identification angiotensinconverting enzyme <NUMBER> ace<NUMBER> obligatory cellular receptor table <NUMBER> risk categories emergence sars emergence sarscovlike viruses wildlife animal reservoirs countriesareas identified sources epidemic <NUMBER> southern china areas increased likelihood animaltohuman transmission sarscovlike viruses wildlife animal reservoirs emergence introduction sarscov laboratories international travel countriesareas potentially higher risk sarscov emergence introduction due presence laboratories sarscov sarscovlike viruses studied clinical specimens infected sarscov processed stored countriesareas entry large numbers persons areas wildlife animal reservoirs sarscovlike viruses found low risk sarscov emergence introduction countriesareas never reported cases reported imported cases <NUMBER> epidemic conduct research using live sarscovlike viruses store clinical samples sars cases sarscov contributed understanding sarscov entry process helped characterize two targets antiviral therapeutics sarscov spike protein ace<NUMBER> however chemicals approaches evaluated human animal models various approaches toward producing vaccine sars pursued including use inactivated sarscov plasmid dna adenovirus vectors one obvious problem vaccine would face given absence sarscov transmission however waiting renewed outbreak occurs commencing vaccination means precious weeks would lost individuals risk become immune administration preformed antibodies obtained human animal donors recently produced vitro effective preventing number different infections hepatitis b varicella rsv similarly could shown neutralizing antibodies sarscov protect experimental animals infection using screening large naive antibody library antibody phage display technology neutralizing antibodies identified produced protective vitro evidence enhancement sarscov infection subneutralizing concentrations antibodies immune escape mutants generated theory could ideal tool sufficient stocks human monoclonal antibodies could procured would ready use wherever sars reemerges one could passively immunize anyone contact source patients affording immediate protection summary sars novel severe infectious disease presumably originated guangdong southern china largescale wildlife trade consumption favored emergence zoonosis hitherto unrecognized animal reservoir zoonotic origins new agent quickly spread within human population transmitted mostly via respiratory route close humantohuman contact sars rapidly disseminated via metropolis hong kong international air travel important potential nosocomial transmission community hospitals soon recognized allowed appropriate measures instituted places unprecedented rapid gain knowledge global networking international collaboration led unfortunately took major outbreaks affecting industrialized countries modern health care systems first sars epidemic controlled thus end rapid success achieved traditional sanitary measures mainly rapid identification suspect cases isolation diseased fortunately sarscov hasat least farnot established permanently human population relatively low transmissibility exception superspreaders led low basic reproduction number r <NUMBER> together fact infected individuals become infectious developed clinical disease made traditional public health measures effective fact first pandemic twentyfirst century quickly contained reason take comfort knowledge history humankind reached phase biomedical sciences information technology able deal threats probably first rapid success remarkable unfortunately though reflect preparedness <NUMBER> donald burke proposed following criteria identifying virus families high pandemic risk <NUMBER> caused pandemics human populations recent past <NUMBER> proven ability cause larger epizootics <NUMBER> intrinsic propensity rapidly undergo evolution basis high mutation rate genome organization favoring recombination intrinsic evolvability interestingly even sars outbreak obviously fulfills first criterion coronavirus family clearly regarded high risk starting late <NUMBER>s porcine epidemic diarrhea coronavirus pedv caused severe swine epizootic europe asia second criterion high evolvability coronavirus family also demonstrated porcine respiratory coronavirus prcv evolved deletion mutation gene transmissible gastroenteritis virus tgev mutant different tissue tropism less virulent second infectious disease emergence zoonotic sources wellrecognized threat long sars nevertheless took anotherfortunately minor sars outbreak decisive steps taken control least trade directly implicated paguma larvata southern china starting shortly sars controlled another agent pandemic potential caused ongoing epizootic unprecedented proportions highly pathogenic influenza h<NUMBER>n<NUMBER> virus transmission humans occurs almost exclusively close contact infectedand sickpoultry despite possibility avian influenza virus become fully humanized trigger next influenza pandemic even activities recognized high risk wet markets mostly curtailed finally lessons sarsparticularly experiences beijing toronto taiwan suffered devastating sars outbreaks later phase outbreakemphasize enormous importance open timely communication times may mean admitting problems least initially reflect negatively country territory concerned medium long term however openness way prevent consequences would much worse although widely accepted wake sars experience strong influence new international health regulations entered force june <NUMBER> information policies countries h<NUMBER>n<NUMBER> epizootic unfortunately attest notwithstanding grave consequences humanitarian political economic terms sars serve example achieved international cooperation modern science rigorous use traditional approaches even prudent precautions suddenly adopted sars certainly last highly pathogenic novel infectious agent crosses species barrier human population although bats must high list culprits emerging viral diseases identified reservoir hosts number emerging viruses reason groups animals figure prominently future mechanisms behind emergence studied may linked agent new host species ie human beings certain cases also intermediate hosts connection many factors determinants disease emergence related human activities although accompanied humankind throughout history fact may helped shape human history speed extent humaninduced changes accelerated markedly recent times although case sars people lucky end may quite different next time round important improve understanding emergence minimize risks natural phenomenon much aggravated human behavior management febrile infants younger <NUMBER> months emergency room er challenging higher risk serious bacterial infection sbi older children clinical evaluation low sensitivity specificity identifying infants sbi <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> therefore additional examinations usually performed diagnose sbi identify infants higher lower risk sbi accordingly large proportion infants considered higher risk sbi admitted hospital treated empirically intravenous antibiotics awaiting microbiological confirmation whereas lower risk sbi managed outpatients provided adequate surveillance ascertained <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> traditional viral bacterial diagnostic techniques allow find etiology febrile episodes half cases <NUMBER> <NUMBER> development molecular techniques ability diagnose viral infections improved substantially recent years multiple realtime polymerase chain reactions pcrs developed increasing detection rate cultivable viruses allowing detection nonor difficulttocultivate viruses <NUMBER> recently techniques multiplex pcrs microarrays allow codetection large panels viruses single assay <NUMBER> furthermore new tools generate accurate results within hours <NUMBER> several clinical situations rapid report microbial pathogens identification clinical specimens shown significantly improve management outcome infected patients enabling rapid adjustment antibiotic treatments shortened hospital stay lower hospitalization costs <NUMBER> <NUMBER> regarding management febrile infants younger <NUMBER> months several authors shown infants presenting proven viral infection significantly lower risk sbi <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> early diagnosis viral infection could help consider larger proportion febrile infants lower risk sbi lead conservative approach regarding additional invasive procedures antibiotic treatments hospital admission molecular techniques allowing early diagnosis expensive conventional methods real clinical benefits remain poorly studied aims prospective study evaluate analytical performances multiplex diagnostic tool detecting frequent respiratory viruses compared set homemade realtime pcrs potential contribution molecular methods etiologic diagnosis febrile episodes infants younger <NUMBER> months life study conducted saintpierre hospital universityaffiliated hospital located downtown brussels <NUMBER> <NUMBER> patients per year attend pediatric er infants ≤<NUMBER> days age admitted pediatric er november <NUMBER> <NUMBER> may <NUMBER> <NUMBER> reporting presenting rectal temperature ≥<NUMBER>°c eligible study according published guidelines <NUMBER> standard procedure patients includes thorough clinical interview complete physical examination following laboratory tests complete blood count blood bacterial culture viral rapid antigen testing viral culture nasopharyngeal aspirates npa urinalysis bacterial culture cerebrospinal fluid obtained cytology bacterial culture enterovirus ev detection pcr infants <NUMBER> days <NUMBER> <NUMBER> days toxic aspect following laboratory findings white blood cell ≥<NUMBER> <NUMBER>mm <NUMBER> ≤<NUMBER>mm <NUMBER> creactive protein ≥<NUMBER> mgl white cell count <NUMBER> µl urine sediment collected catheterization additional tests chest xray stool culture stool viral antigen tests performed whenever clinically indicated patients admission proposed intravenous empirical antibiotic started nearly infants <NUMBER> days older <NUMBER> days clinical laboratory alterations samples received laboratory business hours processed receipt sample arriving outside business hours stored <NUMBER>°c processed next working day standard viral diagnostic procedures consisted viral culture confluent vero mrc<NUMBER> llcmk <NUMBER> cell lines vircell santafé spain combination <NUMBER> following rapid detection tests according season lateral flow chromatography influenza b binaxnow influenza ab alere inc waltham respiratory syncytial virus rsv binaxnow rsv alere inc adenovirus adv adeno respistrip coris bioconcept gembloux belgium direct fluorescent immunoassays human metapneumovirus hmpv parainfluenza virus piv argene biomérieux marcy letoile france rapid tests negative <NUMBER> sets molecular assays performed <NUMBER> clart pneumovir dna array genomica coslada spain detecting influenza b c piv <NUMBER> <NUMBER> <NUMBER> <NUMBER> rsv b hmpv b adv ev solely echoviruses rhinoviruses coronavirus <NUMBER>e bocaviruses <NUMBER> homemade realtime pcrs detecting influenza b piv <NUMBER> <NUMBER> <NUMBER> <NUMBER> rsv b hmpv b adv ev rhinoviruses coronavirus <NUMBER>e nl<NUMBER> oc<NUMBER> bocaviruses extraction nucleic acids arried magna pure lc extraction system roche diagnostics using total nucleic acid large volume isolation kit input volume <NUMBER> µl output volume <NUMBER> µl pneumovir assay performed according manufacturers instructions detection interpretation results conducted carreader genomica molecular techniques performed week except pcr targeting ev performed twice week npa negative rapid tests molecular tests used presumably sensitive reference standard viral culture constructed recommended <NUMBER> composite reference standard order avoid bias establishing specificity evaluated tests composite reference standard constructed follows <NUMBER> samples considered positive viral pathogen tested positive least <NUMBER> <NUMBER> assays used viral culture pneumovir homemade pcrs <NUMBER> considered negative tested negative least <NUMBER> <NUMBER> assays samples fitting one categories classified undetermined consequence analytical performances pcr detecting coronavirus nl<NUMBER> oc<NUMBER> could evaluated method used able detect viruses patient following demographic clinical biological microbiological data recorded age gender duration gestation immunization status duration maximal documented temperature home er symptoms laboratory results treatment administered duration destination discharge er complications length stay hospitalized patients files reviewed infectious diseases senior pediatrician infants classified <NUMBER> groups according clinical symptoms presentation <NUMBER> respiratory infection <NUMBER> suspected infection viral bacterial suspected infection defined clinical signs nonspecific laboratory tests matching either viral bacterial infections microbiological documentation etiology etiology defined febrile episodes matching definitions described febrile episode matched <NUMBER> diagnostic definitions severe one considered responsible fever data recorded excel files microsoft office windows analyzed using descriptive statistics verbal informed consent obtained parents legal guardians inclusion study approved local ethics committee study period <NUMBER> infants enrolled admittance er total <NUMBER> febrile episodes <NUMBER> infants presented <NUMBER> episodes median <NUMBER> days episodes <NUMBER> days median age <NUMBER> days <NUMBER> days <NUMBER> males <NUMBER> prematurely born babies median measured fever er <NUMBER>°c <NUMBER>°c home median duration <NUMBER> hours <NUMBER> hours arrival <NUMBER> infants older <NUMBER> days immunization program yet started belgian immunization program free starts <NUMBER> weeks age blood culture urine culture npa performed <NUMBER> <NUMBER> <NUMBER> patients respectively lumbar puncture performed <NUMBER> infants <NUMBER> infants <NUMBER> days <NUMBER> older infants toxic aspect laboratory alterations stool viral antigenic tests <NUMBER> stool culture <NUMBER> skin pus culture <NUMBER> <NUMBER> patient <NUMBER> <NUMBER> episodes npa available complete viral evaluation <NUMBER> patients sampled <NUMBER> samples analyzed rapid test viral culture <NUMBER> others analyzed molecular techniques due technical issues seventyfive <NUMBER> npa <NUMBER> positive rapid antigen detection test figure <NUMBER> <NUMBER> positive results <NUMBER> confirmed culture among <NUMBER> culturenegative rapid testpositive samples <NUMBER> hmpv whose culture growth known difficult remaining <NUMBER> cases explored molecular methods previously said <NUMBER> analyzed pneumovir assay <NUMBER> samples evaluable analytical performances composite reference standard negative <NUMBER> samples positive <NUMBER> samples undetermined <NUMBER> samples culture negative molecular tests discordant note among <NUMBER> negative samples <NUMBER> coronaviruses oc<NUMBER> <NUMBER> coronaviruses nl<NUMBER> detected pcr shown table <NUMBER> culture expected technique lowest sensitivity <NUMBER> missing mainly hmpvs rhinoviruses mixed infections specificity <NUMBER> inhouse realtime pcrs showed good specificity <NUMBER> positive predictive value <NUMBER> sensitivity reach <NUMBER> pneumovir assay hand achieved best sensitivity <NUMBER> negative predictive value <NUMBER> lacked specificity <NUMBER> mainly due <NUMBER> results considered false positives rhinoviruses according composite standard eightyfour percent episodes n <NUMBER> led hospitalization <NUMBER> episodes <NUMBER> intravenous empirical antibiotic treatment using standard protocol rate documented microbiological etiology <NUMBER> er discharge <NUMBER> end hospitalization <NUMBER> viral cultures results became available molecular methods increased documented etiology rate <NUMBER> total <NUMBER> episodes figure <NUMBER> highest rate documented episodes achieved infants respiratory symptoms presentation <NUMBER> followed gastrointestinal symptoms <NUMBER> contribution molecular methods establish etiology febrile episode highest infants fever without clinical focus increasing rate microbiological documentation <NUMBER> total <NUMBER> figure <NUMBER> among <NUMBER> episodes documented etiology sbi diagnosed <NUMBER> patients <NUMBER> <NUMBER> urinary tract infections utis <NUMBER> bacterial enteritis <NUMBER> finger cellulitis table <NUMBER> viruses detected npa <NUMBER> <NUMBER> infants <NUMBER> <NUMBER> rsv <NUMBER> rhinovirus <NUMBER> piv <NUMBER> coronavirus nl<NUMBER> <NUMBER> cytomegalovirus remaining <NUMBER> documented viral infections twentyone <NUMBER> episodes <NUMBER> proven viral etiology suspected bacterial coinfection clinical basis laboratory signs inflammation <NUMBER> episodes occurred infants respiratory symptoms presentation <NUMBER> episodes <NUMBER> infants considered low risk bacterial infection workup er figure <NUMBER> <NUMBER> <NUMBER> infants hospitalized <NUMBER> <NUMBER> clinical observation <NUMBER> required supportive treatment one single episode classified low risk er discharge ended bacterial proven infection namely campylobacter jejuni enteritis among <NUMBER> infants febrile episodes considered low risk sbi hospitalized observation <NUMBER> <NUMBER> ended documented viral infection first prospective study reporting contribution large panel techniques including molecular methods multiple respiratory viruses establish etiology febrile episodes infants younger <NUMBER> months evaluated possible contribution clinical decisions parallel chronology availability laboratory results led episode documentation study presents limitation conducted mainly autumnwinter season single center explain important rate infants presenting respiratory symptoms nevertheless rate sbi similar reported literature <NUMBER> predominance uti among sbi demonstrating cohort considered representative etiologic case mix usually observed among febrile episodes infants younger <NUMBER> months identifying infants risk sbi among presenting febrile episode remains important challenge several scales based clinical biological microbiological data recommended <NUMBER> past years important advances made terms laboratory techniques either help better identify highrisk infants confirm sbi rapidly procalcitonin level <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapid bacterial identification blood culture malditof matrixassisted laser desorptionionizationtimeofflight mass spectrometry <NUMBER> authors focused detecting infants low risk sbi using clinical scores <NUMBER> documenting viral infection also shown contribute identify febrile infants low risk sbi <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however proven viral infection fully rule risk sbi especially uti <NUMBER> viral tests cannot replace blood urine analysis must seen additional tools management patients current routine viral tests rapid relatively sensitive pediatric population available limited number viruses consequence viral infection always documented time affect clinical care study infants considered low risk sbi discharged er finally turned proven viral infection represented <NUMBER> total cohort n <NUMBER> numbers similar published huppler et al identified large metaanalysis <NUMBER> studies similar rate infants <NUMBER> observed without receiving empiric antibiotic therapy sent back home identified lowrisk <NUMBER> population namely low risk infants presumed viral infection probably population could benefit adding molecular tools management sparing bundle downsides associated hospitalization empiric antibiotic therapy including costs adverse effects development resistant organisms nosocomial infections psychosocial stress family dynamics present evaluation demonstrates molecular techniques greatly improve detection rate viral infections especially challenging group febrile infants without clinical source among increase microbiological documentation nearly <NUMBER> clart pneumovir powerful tool tested multiplexing <NUMBER> viral targets sensitivity rate <NUMBER> negative predictive value <NUMBER> however also presented <NUMBER> potential drawbacks lack specificity falsepositive results rhinoviruses fact target circulating coronaviruses unfortunately molecular methods used expensive need trained staff yet routinely used management febrile infants younger <NUMBER> months <NUMBER> furthermore useful clinical practice results techniques available timespan patients management treatment followup decided new samplein answerout pointofcare platforms enable fully automated detection comprehensive panels respiratory pathogens <NUMBER> hour available soon enable expected improvement patients management <NUMBER> conclusion study demonstrates use molecular techniques increases <NUMBER> proportion documented etiology febrile episodes infants younger <NUMBER> months also identified population techniques highest contribution making tests available <NUMBER> hours<NUMBER> <NUMBER> days<NUMBER> could help lightening management patients study provides adequate information design prospective study could fully assess contribution new rapid pointofcare multiplex molecular tools management febrile infants younger <NUMBER> months authors gratefully thank fondation vésale supporting molecular analyses used study authors also thank jerôme de marchin contribution design data collection instruments beatriz epalza help analyzing data ce conceptualized designed study coordinated patients recruitment designed data collection instruments coordinated supervised data collection drafted initial manuscript approved final manuscript submitted mh supervised molecular techniques carried laboratory data analysis critically reviewed revised manuscript approved final manuscript submitted lb supervised laboratory techniques reviewed manuscript approved final manuscript submitted sd helped patients recruitment reviewed manuscript approved final manuscript submitted pdb helped patients recruitment reviewed manuscript approved final manuscript submitted ov reviewed manuscript approved final manuscript submitted jl conceptualized designed study critically reviewed revised manuscript approved final manuscript submitted authors approved final manuscript submitted agree accountable aspects work authors declared potential conflicts interest respect research authorship andor publication article authors disclosed receipt following financial support research authorship andor publication article fondation vésale supported molecular analyses used study cristina epalza httpsorcidorg<NUMBER> supplemental material article available online coronavirus disease <NUMBER> caused novel coronavirus severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> formerly known <NUMBER>ncov appeared china first time subsequently spread worldwide <NUMBER> <NUMBER> <NUMBER> january <NUMBER> world health organization officially announced covid<NUMBER> epidemics threat public health internationally subsequently march <NUMBER> global situation escalated covid<NUMBER> pandemic johns hopkins university reported <NUMBER> cases infection <NUMBER> deaths <NUMBER> june <NUMBER> <NUMBER> result rapidly progressing covid<NUMBER> pandemic limited laboratorybased molecular testing capacities new pointofcare poc scalable rapid diagnostic tests invented recently easytouse tools allow covid<NUMBER> diagnostics outside laboratory settings urgent need multiply testing covid<NUMBER> clearly identified essential element anticoronavirus strategy world diagnostic sensitivity specificity accuracy concerning suspected covid<NUMBER> infection based controlled testing performance data clinical settings substantial importance context limiting scope coronavirus epidemics unreliable unproved tests may detect patients active infection may incorrectly indicate covid<NUMBER>negative patients positive hampering healthcare efforts diagnostic laboratory pointofcare tests pocts present work going worldwide develop new methods simplify speed detection novel coronavirus currently nearly <NUMBER> commercially available genetic tests companies awaiting completion procedure food drug administration fda vitro diagnostics ivd certificate issued worth noting large portion available tests provided merely research use ruo certificate fact imply anything concerning test quality validation rigorous tests apply products certified ivd complying iso<NUMBER> norm addition ivd reagents subject local regulations ce marking europe hence comply directive <NUMBER>ec european parliament council <NUMBER> october <NUMBER> vitro diagnostic medical devices extensive evaluation including validation clinical samples real time rtqpcr genetic tests meant identification differentiation sarscov<NUMBER> materialspecimens collected patients covid<NUMBER> symptoms detecting rna sequences unique sarscov<NUMBER> genetic material virus extracted specimens sputum tracheal aspirate bronchoalveolar lavage swabs nasopharynx pharynx blood urine stool amplified means pcr technique real time use reverse transcription rt detected means fluorescent reporter probes specific sarscov<NUMBER> <NUMBER> <NUMBER> present rtqpcr tests available world market meant detect orf<NUMBER>ab e n gene sequences various combinations tests differ sensitivity stability examination time test protocol complex costly mainly suitable large centralized diagnostic laboratories tests usually take <NUMBER> h yet logistic requirements concerning sending clinical specimens imply execution time <NUMBER> h <NUMBER> accordance recommendations rtqpcr tests must enable detection three genes single reaction e gene n gene rdrp gene allows us detect viruses betacoronavirus group e gene well identify sarscov<NUMBER> virus n gene rdrp orf<NUMBER>ab design guarantees double confirmation cases infection also limits risk obtaining false negative results case detecting one target sarscov<NUMBER> reduces possibility obtaining doubtful results case necessity verification occurs <NUMBER> comparison review rtqpcr dedicated sarscov<NUMBER> genes target points presented table <NUMBER> present work going worldwide develop new methods simplify speed detection novel coronavirus currently nearly <NUMBER> commercially available genetic tests companies awaiting completion procedure food drug administration fda vitro diagnostics ivd certificate issued worth noting large portion available tests provided merely research use ruo certificate fact imply anything concerning test quality validation rigorous tests apply products certified ivd complying iso<NUMBER> norm addition ivd reagents subject local regulations ce marking europe hence comply directive <NUMBER>ec european parliament council <NUMBER> october <NUMBER> vitro diagnostic medical devices extensive evaluation including validation clinical samples real time rtqpcr genetic tests meant identification differentiation sarscov<NUMBER> materialspecimens collected patients covid<NUMBER> symptoms detecting rna sequences unique sarscov<NUMBER> genetic material virus extracted specimens sputum tracheal aspirate bronchoalveolar lavage swabs nasopharynx pharynx blood urine stool amplified means pcr technique real time use reverse transcription rt detected means fluorescent reporter probes specific sarscov<NUMBER> <NUMBER> <NUMBER> present rtqpcr tests available world market meant detect orf<NUMBER>ab e n gene sequences various combinations tests differ sensitivity stability examination time test protocol complex costly mainly suitable large centralized diagnostic laboratories tests usually take <NUMBER> h yet logistic requirements concerning sending clinical specimens imply execution time <NUMBER> h <NUMBER> accordance recommendations rtqpcr tests must enable detection three genes single reaction e gene n gene rdrp gene allows us detect viruses betacoronavirus group e gene well identify sarscov<NUMBER> virus n gene rdrp orf<NUMBER>ab design guarantees double confirmation cases infection also limits risk obtaining false negative results case detecting one target sarscov<NUMBER> reduces possibility obtaining doubtful results case necessity verification occurs <NUMBER> comparison review rtqpcr dedicated sarscov<NUMBER> genes target points presented table <NUMBER> standard protocol application rtqpcr method demanding timeconsuming reason scientists constantly strive invent date modifications rtqpcr tests would cut time required analyses <NUMBER> bosch healthcare solutions announced developed quick test may provide results <NUMBER> h fast testing kit vivalytic platform fully automated pcr test performed simply inserting swab cartridge subsequently analyzed machine universal platform molecular laboratory diagnostics option various samples testing different analytical methods carried entirely automated mode within short time unfortunately equipment available many healthcare institutions yet diagnostic cartridges dedicated solely specific analyzing device <NUMBER> biomaxima invented test whose main advantages include short waiting time results obtained mere <NUMBER> h moreover analytical sensitivity test level ≥<NUMBER> rna copies per reaction higher comparable systems seems important molecular test kit contains reagents substantially enhanced stability allows us transport safely store room temperature whereas many tests available market need stored freezer transported dry ice storing reagents even short time conditions deviate indicated risky may result generating false negative test results <NUMBER> latest technology molecular tests developed scientists oxford university sensitive previous ones implies possibility examining patients earlier stages reacting quickly effectively preventing spread coronavirus new test diagnosing sarscov<NUMBER> provides rapid results within <NUMBER> min whereas fastest current methods concentrate viral rna give results <NUMBER> <NUMBER> h ie three times faster presently quickest testing methods requires application relatively simple technical devices apart advantages scientists responsible tests development claim may even help detect patients infected coronavirus earlier stages comparison current methods results read naked eye makes available wider spectrum healthcare units specialists fastmolecular test recently registered fda utilizes diagnostic system recent years proved function perfectly diagnosing multiple infections including hepatitis c virushcv influenza <NUMBER> rna detection may performed means rtqpcr reverse transcriptionloop amplification rtlamp standard rtqpcr test takes <NUMBER> <NUMBER> min average test set samples whereas lamp may completed <NUMBER> min indirect isothermal amplification lamp fast technology dna amplification applied detection pathogens viruses bacteria lamp reaction usually takes place constant temperature target dna may amplified <NUMBER> min lamp method utilizes four six starters binding six regions target dna specificity exceptionally high sarscov<NUMBER> rnatype virus length <NUMBER> kb single reverse transcriptase rt reaction lamp may jointly significantly shorten reaction time omitting stage purifying cdna reverse transcriptase thanks sarscov<NUMBER> may quickly detected noted similarly onestep rtqpcr method require cdna purification single stage reaction team oxford university developed four sets lamp starters comprising six starters setkit focused viral rna sarscov<NUMBER> regions orf<NUMBER>ab gene n gene interpretation results colorimetric method applied enables reading results viral rna amplification naked eye without necessity using expensive equipment moreover sensitivity method may <NUMBER> copies viral rna per <NUMBER> ml sample single stage process without separate rna extraction enables amplification rna directly sample <NUMBER> <NUMBER> performing examinations use fast molecular tests may particularly useful emergency departments admission rooms pocts needed speed process taking clinical decisions decrease workload centralized testing laboratories <NUMBER> poct means test results instantly delivered patient care settings hospitals urgent care centers emergency rooms instead use expensive timeconsuming laboratory processes additionally american company cepheid developed quick test declare takes <NUMBER> min dutch pharmacists owning qiagen developed <NUMBER>h test us food drug administration issued emergency authorization use cepheids pointofcare covid<NUMBER> diagnostics xpert xpress sarscov<NUMBER> according statement agency test designed provide detection novel coronavirus within short period <NUMBER> min using specimens nasopharyngeal swab nasal washaspirate another poct xpert xpress sarscov<NUMBER> test cartridge dedicated detecting sarscov<NUMBER> nucleic acid utilizing rtqpcr require use reagents contrary genexpert system needs test run cliaapproved laboratory clinical laboratory improvement amendments selection patient care settings <NUMBER> equally important understand rtqpcr tests also certain limitations useful case positive results although appear less diagnostic value situations covid<NUMBER> must ruled negative rtqpcr test results necessarily indicate person contracted infectious disease individual factors also need considered exposure risk potential laboratory errors false negative results may occur sample properly collected transported handledtreated result improper extraction nucleic acid clinical materials <NUMBER> moreover false positive results related situation sample contains inhibitors amplification insufficient amount virus molecules contrary false positive result may due crosscontamination sample handling preparation patient samples influence vaccines antiviral drugs antibiotics chemotherapeutic agents immunosuppressive drugs taken consideration moreover setkit exclude diseases caused bacterial viral pathogens negative results exclude infection sole basis patients treatment test results using kit serve clinical purposes clinical diagnosis treatment patients considered conjunction manifestations symptoms medical history response treatment laboratory tests <NUMBER> general sensitivity molecular method may vary depending specimen collection bronchoalveolar lavage sputum nasal swabs throat swabs accuracy depends upon stage infection rate sarscov<NUMBER> multiplication also degree clearance interestingly provided values rtqpcr accuracies seem higher vitro validation utilizing sarscov<NUMBER>dedicated primers cultures highly controlled laboratory settings <NUMBER> assumed optimal outcome clearcut diagnostic gold standard might depend upon development hybrid assays order minimize fraction false negative results enhanced rtqpcr test combined serological immunoassays either antibodydetecting antigendetecting would bring additional diagnostic value accurate quick covid<NUMBER> diagnosis vitro diagnostics human body reacts infectious biostimulant <NUMBER> progress made recent years diagnostics infections enables application often simultaneously numerous methods order detect respiratory viruses effectively choice suitable tests depends upon type virus detected presumed number antigens patient population tested well technical abilities experience testing unit validation rtqpcr tests seems important step combating new coronavirus one significant parameters regarding efficiency diagnostic procedure probably one related minimum amount analyte may detected quantitatively determine means particular test parameters describing properties known limit detection lod limit quantification loq many laboratories lod used interchangeably sensitivity analytical sensitivity orand detection limit may misleading though sensitivity also understood used ways sensitivity clinical diagnostic specificity two different parameters diagnostic sensitivity proportion true positive results sum true positive true negative results sensitivity ratio <NUMBER> implies sick people identified specificity test proportion true negative results sum true negative false positive ones specificity <NUMBER> implies healthy people given test correctly identified healthynot condition indicated table <NUMBER> sensitivity specificity tests already <NUMBER> exceptions still one notice differences analytical sensitivity test lod vast majority molecular tests kits contain socalled internal positive control ipc utilized either extraction control internal control ipc essential evaluation whether genetical material extraction procedure amplification stage carried correctly failure ipc detection using patients specimen may indicate improper extraction nucleic acid clinical material consequence nucleic acid loss transposition pcr inhibitors lack sufficient biological material collected sample needs noted many molecular tests may provide sets extraction stages need acquired separately however tests reviewed detect rna sarscov<NUMBER> contain ipc another important factor describes diagnostic test analytical specificity ability test detect specific target eg virus great importance check whether starters used pcr test specific given virus two components analytical sensitivity crossreactivity interference crossreactivity may occur sample collected patient organisms genetically related imitate virus analysed causes test starters cross react shown table <NUMBER> producers analysed tests perspective crossreactivity unfortunately analysis selective concern microorganisms tuberculosis nd nd nd nd nd streptococcus pneumoniae nd nd nd streptococcus pyogenes nd nd nd nd bordetella parapertussis nd nd nd nd nd nd nd nd nd nd nd nd bordetella bronchiseptica nd nd nd nd nd nd nd nd nd nd nd nd bordetella pertussis nd nd nd data available nd crossreact analyzed pathogen immunological methods often chemiluminescent assaying immunoglobulin igg igm sarscov<NUMBER> blood analyzer immunochromatographic assessment form rapid pocts requiring additional equipment methods detecting antisarscov<NUMBER> antibodies despite ongoing research develop may even applied coronavirus epidemics <NUMBER> <NUMBER> week first clinical manifestations sensitivity molecular diagnostics pcr diminishes gradually sarscov<NUMBER> infections due decreasing amount virus particles respiratory tract epithelium cases patients may false negative results despite ongoing infection among many contemporary technologies available special attention paid rapid lateral flow immunoassay lfia also referred immunochromatographic tests perhaps much appreciated scientific community pcr methods enzymelinked immunosorbent assay elisa tests despite fact find application diagnostics often differ depending type test basic principle action invariably samethey make use unique property antibodies possess selective binding specific particle group similar particles antigen lfias provide uncomplicated relatively inexpensive tool meant detecting presence absence given component examined specimen presence virus analyzed blood sample examination use tests possible various types test materialwhole human blood blood plasma serum stool urine sweat cerebrospinal fluid even tears <NUMBER> test principle based immunological method using specific antibodies often complex colloidal gold drop examined substance first moves along nitrocellulose membrane using capillary phenomena sample absorbed membrane antigen test prove positive binds colloidal gold complex respective antibodies consequently effect reaction formation complex detected test interpretation results consists confirmation ruling presence antigens examined sample based color test strips appear test <NUMBER> <NUMBER> brief comparison advantages disadvantages immunochromatographic tests presented table <NUMBER> table <NUMBER> brief comparison advantages disadvantages immunochromatographic tests <NUMBER> <NUMBER> <NUMBER> <NUMBER> short reaction time tests amounting <NUMBER> min suboptimal sensitivity results often false negative particularly enhanced activity virus simple comfortable use perform tests may performed outpatient clinics patients bed despite substantial specificity sometimes results false negative particularly virus much active reading often possible naked eye necessary verify positive doubtful results small amount material collected variety material increased risk operator becoming infected best date distant usually <NUMBER> months manufacturing date present immunoenzymatic tests available based immunochromatic technique difference tests depends upon molecule assayed pc antigens structure performance time diagnostic material may supposed future rapid tests enable easier quicker diagnostics many diseases without necessity performing tedious complicated procedures would reduce waiting time obtaining results accelerate decision making regarding suitable treatment <NUMBER> <NUMBER> <NUMBER> detection specific sarscov<NUMBER> serum antibodies allows rapid costeffective reasonably sensitive clinical diagnosis covid<NUMBER> immunoglobulins igm provide initial humoral response first stage viral infection prior onset adaptive highaffinity igg response essential longterm immunological memory research indicates sars infection antibodies igm class may detected patients blood <NUMBER> days infection igg may already detected <NUMBER> days sarscov<NUMBER> belongs large family viruses includes causing middle east respiratory syndrome mers severe acute respiratory syndrome sars assumed process producing antibodies similar case viruses belonging family detection igg antibodies igm antibodies acting sarscov<NUMBER> may indication infection moreover detection igm antibodies usually indicates recent exposure sarscov<NUMBER> whereas detection igg antibodies case covid<NUMBER> indicates exposure virus time ago <NUMBER> serological tests detecting solely igm class antibodies find applications diagnostic purposes using tests detect igm igg antibodies one remember positive result may evidence past infection active infection table <NUMBER> negative results serological tests exclude sarscov<NUMBER> infection window period delay production antibodies may exceed <NUMBER> days serological tests may also give false positive results may case past ongoing infection virus strains sarscov<NUMBER> coronavirus hku<NUMBER> nl<NUMBER> oc<NUMBER> <NUMBER>e moreover first tests assessing titer iga class antibodies launched perspective immunology extreme importance provides possibility testing antibodies material blood samples collected patients eg respiratory tract secretions type test window period test designed detect specific disease p serological tests thus applied adjunctive method monitoring epidemiological situation yet may performed faster less costly genetic tests diagnostic method limited sensitivity yet efforts improve ongoing useful monitoring infection due insufficient data concerning among others dynamics immunological response infection diagnostic value available tests detecting igm igg class antibodies comprising sensitivity specificity positive negative predictive value many countries currently recommended use serological tests diagnostic purposes table <NUMBER> displays evaluation serological tests validated fda table <NUMBER> provides comparison selected immunochromatographic tests sarscov<NUMBER> based sensitivity specificity sample type test performance time selected immunochromatographic tests sarscov<NUMBER> based sensitivity specificity sample type test performance time serological ivd socalled window period much importancethat time specific antibodies yet detectable patients blood initial phase infection production antibodies initiated level still low thus test results may prove negative antisarscov<NUMBER> antibodies appear quite late ie days clinical manifestations serological tests cannot used basic tool diagnosing sarscov<NUMBER> infections <NUMBER> serological ivd socalled window period much importancethat time specific antibodies yet detectable patients blood initial phase infection production antibodies initiated level still low thus test results may prove negative antisarscov<NUMBER> antibodies appear quite late ie days clinical manifestations serological tests cannot used basic tool diagnosing sarscov<NUMBER> infections <NUMBER> detection specific antisarscov<NUMBER> antibodies possible <NUMBER> days first clinical manifestations infection thus serves purpose confirming contact coronavirus enormous importance epidemiological perspective allows us detect subjects infection asymptomatic oligosymptomatic could source infection people silent carriersvectors also allows us determine spread covid<NUMBER> infection population comparative review currently available serological immunodiagnostic covid<NUMBER> tests presented table <NUMBER> protein microarray method pmm proteomic screening technique serving purpose simultaneousparallel quantitative qualitative analysis mixtures containing many proteins chip used composed supporting surface eg modified glass plate nitrocellulose membrane microtitration plate matrix capturing proteins immobilized accordance determined formula performing function probe material captured may antibodies enzymes ligands protein analyte added matrix may modified means various types markers among others radioisotopes fluorescence luminescence markers interaction micromatrix proteins analyte induces analytical signal registered means suitable equipment advantages protein micromatrices include short time required analysis modest consumption samples reagents high sensitivity automation testing allow us investigate functions effects proteins large scale <NUMBER> <NUMBER> newly developed pepperchip ® sarscov<NUMBER> proteome microarray pepperprint based sarscov<NUMBER> genome derived virus isolate wuhanhu<NUMBER> genbank id mn<NUMBER> enables us serologically screen <NUMBER> individual peptides spanning whole viral proteome sequences orf<NUMBER>ab protein surface glycoprotein orf<NUMBER>a protein coat protein membrane glycoprotein orf<NUMBER> protein orf<NUMBER>a protein orf<NUMBER> protein nucleocapsid phosphoprotein orf<NUMBER> protein elongated connected means neutral gsgsgsg connectors elongated protein sequences transcribed <NUMBER> different peptides composed <NUMBER> amino acids printed two repetitions <NUMBER> peptide sites order obtain highresolution epitope data case sarscov emerged <NUMBER> demonstrated application pmm characterized enhanced sensitivity chinese subjects diagnosed sarspositive applying pmm comparison elisa tests pmm seems reliable allows us determine protein antigens virus <NUMBER> additional advantage tests possibility automating entire analytical process unfortunately method several imperfections including repeatability test cost testing equipment used micromatrix diagnostics significant makes pmm method less accessible standard laboratory settings <NUMBER> undoubtedly scalable reliable pocts used community outside laboratories would opportunity reduce time obtain covid<NUMBER> diagnostic results might support early implementation isolation resources infection control measures medical workforce point view antibodyand antigendetecting tests appear significant role identifying healthcare workers recovered sarscov<NUMBER> infection assess suitability provide frontline health services hand false negative serology tests could cause spread covid<NUMBER> unjustified reassurance change public behavior undoubtedly negative results serology tests swabs treated definitive ruling positive test results beneficial rule coronavirus infection sufficient accuracy serology tests used widely allow us make appropriate decision regarding lifting restrictions national level nevertheless wider implementation pocd ultimately support public health strategies potential lifting social distancing restrictions future <NUMBER> moreover limited data available present antibodydetecting antigendetecting rapid pocd intense research potential diagnostic utility highly encouraged tests demonstrate adequate accuracy likely could potentially used triage tests quick identification patients suspected contracting covid<NUMBER> reducing need expensive reference molecular pcr testing <NUMBER> <NUMBER> finally worth noting psychological behavioral consequences correctly established known immunity status within community recently test developed based clustered regularly interspaced short palindromic repeats crisprcas<NUMBER>a visual readouts test detect <NUMBER> copies virus gene merely <NUMBER> min providing simple reliable diagnostic method additionally demonstrates high sensitivity specificity order enable fast diagnosis hospital admission test provided ssdna reporter labeled blank green fluorescent particle split cas<NUMBER>a protein nucleic acid sarscov<NUMBER> found detection system way green signal fluorescence obtained visible naked eye inthe light wavelength <NUMBER> nm high specificity test obtained designing <NUMBER> crrnas may distinguish polymorphisms single nucleotide viruses related sars four domains orf<NUMBER>a orf<NUMBER>b n e genes <NUMBER> search new diagnostic methods continued sarscov<NUMBER> spread droplets diagnostic sensitivity specificity index rtqpcr tests highest bronchoalveolar lavage bal higher sputum nosethroat swabs scientists recently proposed use exhaled breath condensate ebc diagnostic purposes ebc similar biochemical composition origin bal examinations use ebc relatively novel diagnostic method used mainly assess inflammation within respiratory tract components reflect composition fluid lining bronchi alveoli ebc condensed form small droplets fluid lining lungs usually exhaled contains various components small ions proteins organelles may even contain viruses fungi bacteria taking samples condensate safe totally noninvasive easy perform may repeated many times may also performed patients severe complications covid<NUMBER> enormous advantage may performed small children use special facial masks course examination patient requested exhale breathing uneventfully <NUMBER> min apparatus provided cooling system allows us accumulate condensate sarscov<NUMBER> may detected application method seems justified public health perspective false positive results presently obtained contribute continued spread virus worldwide <NUMBER> <NUMBER> optimization laboratory diagnostics dynamically developing field time covid<NUMBER> pandemic supporting contemporary medicine government decisions healthcare strategies efforts scientistclinician teams focus first upon implementing reliable diagnostic tools however covid<NUMBER> new nosological entity enough data yet would enable determination standards interpretation serological pocts infectious diseases diagnostic value test method collecting material quality sample equipment applied equally essential preanalytical considerations also time point sample collected well suitable procedure storage handling prior analysis moment collecting biological material assaying stage funding study received external funding authors declare conflict interest acute respiratory tract infections significant cause morbidity mortality especially winter months elderly immunocompromised patients respiratory problems emphysema asthma particularly vulnerable developing severe disease viruses commonly cause respiratory illness include influenza virus parainfluenza virus respiratory syncytial virus rsv adenovirus human metapneumovirus viruses produce range symptoms including fever rhinitis pharyngitis myalgia serious complications bronchitis bronchiolitis pneumonia death boivin et al <NUMBER> influenza virus rsv among common viral agents rapid identification aetiology infection allows better patient management terms treatment infection control woo et al <NUMBER> rapid detection viral respiratory pathogens also important monitoring emerging influenza strains may cause epidemics pandemics conventional detection methods influenza virus include cell culture antigen detection serological tests immunofluorescent antibodybased ifa methods however tests either slow allow timely diagnosis lack sensitivity speci corresponding author ficity recently immunochromatographic point care tests poct developed fast turn around times aslanzadeh et al <NUMBER> selvarangan et al <NUMBER> however assays often limitations sensitivity specificity compared molecular tests boivin et al <NUMBER> development molecular diagnostic assays superior sensitivity significantly reduced turn around times compared conventional methodologies led considered gold standard respiratory virus detection leven <NUMBER> numerous realtime rtpcr assays detection influenza virus rsv described either monoplex gueudin et al <NUMBER> kuypers et al <NUMBER> smith et al <NUMBER> stone et al <NUMBER> van elden et al <NUMBER> multiplex format brittainlong et al <NUMBER> gunson et al <NUMBER> hymas hillyard <NUMBER> regional health protection agency newcastle laboratory tests respiratory samples panel inhouse multiplex realtime pcr assays target influenza b parainfluenza <NUMBER> rsv b rhinovirus adenovirus human metapnuemovirus coronaviruses nl<NUMBER> oc<NUMBER> <NUMBER>e however feasible provide urgent hours testing based multiplex format therefore alternative virus specific testing preferable urgent individual samples rapid realtime pcrbased diagnostic test rsv influenza b performed relatively short turn around time would extremely useful patient management goodrich miller <NUMBER> addition resulting improved treatment patients presenting respiratory illness would help infection control reduce nosocomial spread reduce length patient hospital stay woo et al <NUMBER> smartcyler rapid random access modular realtime pcr instrument perform <NUMBER> pcr cycles less <NUMBER> h habibbein et al <NUMBER> aim study evaluate two multiplex realtime rtpcr assays rapid smartcycler realtime pcr system detection influenza b rsv assays used respiratory syncytial virus analyte specific reagent asr bead influenza ab asr bead cepheid sunnyvale usa contain pcr primers probes lyophilized bead format rsv asr bead contains primers famlabelled probes targeting n nucleocapsid protein gene rsv types b influenza ab asr bead contains primers famlabelled probe alexa fluor <NUMBER>labelled probe detection differentiation influenza b respectively reconstituted asr bead provides sufficient primers probes two <NUMBER> l pcr reactions influenza b asr reagents evaluated previously determine utility detection influenza clinical samples patients respiratory disease study asr reagents evaluated realtime rtpcr assays using smartcycler realtime pcr instrument new assays applied detection influenza virus rsv collection samples previously tested using inhouse multiplex realtime rtpcr assay collection <NUMBER> respiratory samples patients acute respiratory tract infections tested study samples collected previously <NUMBER> winter respiratory seasons sample types included nasopharangeal aspirates nasal swabs throat swabs sputum tracheal secretions bronchoalveolar lavages <NUMBER> samples <NUMBER> shown previously positive rsv <NUMBER> type <NUMBER> type b one dual infection b <NUMBER> samples positive influenza virus <NUMBER> influenza <NUMBER> influenza b two multiplex realtime rtpcr assays targeting nucleocapsid protein gene n gene rsv described previously gunson et al <NUMBER> influenza matrix gene influenza b n gene described previously anon <NUMBER> curran et al <NUMBER> inhouse assays performed using taqman fast <NUMBER> realtime pcr instrument majority samples also tested ifa ifa negative samples tested cell culture prior nucleic acid extraction samples stored −<NUMBER> • c total nucleic acid extracted using roche magna pure instrument roche magna pure total na large volume kit roche diagnostics lewes uk according manufacturers protocol two hundred microlitres sample extracted nucleic acid extract eluted <NUMBER> l elution buffer roche diagnostics lewes uk prior pcr testing nucleic acid extracts stored −<NUMBER> • c smartcycler rsv assay applied <NUMBER> samples tested previously multiplex inhouse assay fortythree samples negative rsv methods <NUMBER> samples positive assays one sputum sample negative smartcycler rsv assay although positive rsv inhouse realtime pcr test sample retested smartcycler assay however remained negative rsv using new test <NUMBER> samples positive rsv <NUMBER> also contained coinfecting viruses including rhinovirus n <NUMBER> bocavirus n <NUMBER> human metapneumovirus n <NUMBER> adenovirus n <NUMBER> coronavirus <NUMBER>e n <NUMBER> <NUMBER> samples negative rsv smartcycler assay <NUMBER> shown positive viruses including rhinovirus n <NUMBER> human metapnuemovirus n <NUMBER> bocavirus n <NUMBER> parainfluenza virus <NUMBER> n <NUMBER> parainfluenza virus <NUMBER> n <NUMBER> parainfluenza virus <NUMBER> n <NUMBER> amplification nucleic acids <NUMBER> samples produced crossreactions smartcycler rsv assay overall compared inhouse multiplex assay smartcycler rsv assay demonstrated specificity <NUMBER> sensitivity <NUMBER> <NUMBER> samples investigated <NUMBER> negative <NUMBER> positive influenza virus smartcycler inhouse multiplex pcr methods <NUMBER> positive samples included <NUMBER> positive influenza <NUMBER> positive influenza b one sample positive influenza b using inhouse multiplex assay however influenza detected using smartcycler assay two nasalthroat swab samples positive influenza inhouse pcr negative smartcycler influenza assay retesting samples remained negative <NUMBER> samples negative smartcycler influenza assay <NUMBER> shown positive viruses including rhinovirus n <NUMBER> human metapnuemovirus n <NUMBER> bocavirus n <NUMBER> parainfluenza virus <NUMBER> n <NUMBER> rsv n <NUMBER> adenovirus n <NUMBER> coronavirus oc<NUMBER> n <NUMBER> coronavirus <NUMBER>e n <NUMBER> amplification nucleic acids <NUMBER> samples produced crossreactions smartcycler rsv assay overall compared inhouse multiplex assay smartcycler influenza assay demonstrated specificity <NUMBER> sensitivity <NUMBER> development multiplex realtime pcrbased methods detection respiratory viruses significantly improved diagnosis respiratory disease leven <NUMBER> multiplex assays targeting wide range individual viruses considered gold standard diagnosis viral respiratory disease test results achieved within hours samples received laboratory stone et al <NUMBER> however majority laboratories batch samples together perform one test runs per day therefore turn around times slower rapid tests used poct addition feasible many laboratories provide multiplex pcr testing outside normal laboratory opening hours therefore alternative pcrbased methods performed using random access realtime pcr instrument would shorten turn around times obvious benefits patient care study two rapid realtime pcr assays evaluated detection influenza rsv respiratory samples using smartcycler realtime pcr instrument rsv influenza assays applied total <NUMBER> samples tested previously inhouse multiplex realtime pcr test comparison results demonstrated concordance two tests <NUMBER> smartcycler rsv test failed detect rsv single sample detected inhouse multiplex assay false negative result may due degradation sample extracted nucleic acids stored −<NUMBER> • c greater <NUMBER> month following testing inhouse multiplex assay prior retesting smartcycler assay sample also produced high ct value <NUMBER> original inhouse assay indicating contained relatively low numbers target virus smartcycler influenza assay failed detect influenza two samples positive influenza inhouse multiplex assay extracted nucleic acid samples stored −<NUMBER> • c greater <NUMBER> month therefore sample degradation may occurred one samples also relatively high ct value <NUMBER> inhouse assay indicating contained low levels target virus three samples retested inhouse assays original results confirmed smartcycler assay also failed detect influenza b sample demonstrated contain influenza b may due sample degradation storage alternatively may reflect differences sensitivity smartcycler assay different influenza types finally false negative results smartcycler rsv influenza assays may due sequence variation target gene assays may adversely affect binding primers probes interestingly ct values generated smartcycler assays positive samples lower inhouse test eg influenza b mean reduction ct value <NUMBER> sd <NUMBER> indicating smartcycler assay may sensitive inhouse test alternatively differences may due way two realtime pcr instruments calculated ct values relative automatically calculated threshold cut offs positive predictive value smartcycler tests <NUMBER> rsv influenza negative predictive value <NUMBER> <NUMBER> respectively rsv influenza smartcycler asr beadbased primers probes simplified assay preparation steps reducing time taken assay set considerably compared inhouse assay assay plus random access realtime pcr system used conjunction rapid nucleic acid extraction instrument qiagen ez<NUMBER> instrument barkham <NUMBER> dundas et al <NUMBER> sample turn around times could significantly reduced pcr assay set simplified may facilitate urgent testing respiratory samples realtime pcr methods outside normal working day outside batched runs normal working day overall asr beadbased assay smartcycler instrument provide sensitive specific rapid detection rsv influenza virus clinical samples patients respiratory disease introduction rapid realtime pcr methods diagnosis illness caused rsv influenza particularly outside normal laboratory working day would improve patient management treatment new emerging infectious diseases continue plague world significant concern recombinant infectious agents used bioterrorism threats microbiologists increasingly asked apply scientific knowledge respond threats recent pandemic caused severe acute respiratory syndrome sars coronavirus illustrated newly evolved pathogen rapidly spread throughout world also global community unite identify causative agent control spread rapid response research mechanisms used sars accelerated vaccine initiative savi shown application emergency management techniques together rapid response research highly effective applied appropriately new infectious diseases throughout human history infectious diseases important role shaping evolving world pandemics epidemics commonplace density worlds population international travel trade increased support global spread pathogens microbial pathogens constantly evolving new pathogens continually emerging nature recent emergence many new pathogens including hiv enterohaemorrhagic escherichia coli west nile virus legionella pneumophila cryptococcus neoformans subspecies gattii various influenza strains actually biology taking normal course microorganisms evolve exploit new altered ecological niches <NUMBER> <NUMBER> therefore surprise first pandemic twentyfirst century appeared quickly late <NUMBER> severe acute respiratory syndrome coronavirus sarscov causing significant morbidity approximately <NUMBER> cases mortality <NUMBER> deaths estimated economic impact us <NUMBER> billion worldwide <NUMBER> sars outbreak provided excellent opportunity attempt harness power modern science provide rapid solutions public health emergency placed pressure many microbiologists worldwide identify sequence virus characterize disease apply modern epidemiological techniques track trace virus origins develop strategies treat control pathogen worldwide scientists responded challenges extreme vigour many achievements made fig <NUMBER> including identifying causative agent sequencing genome developing animal models infection determining pathogen originated nature globally spread human communities however despite acquisition large body scientific information sars spreading around world method controlling virus required case escaped containment measures meant alternative therapeutic preventative methods urgently needed development vaccines therapeutic agents usually takes least decade costs hundreds millions dollars yet practical solution sars needed beginning next respiratory virus season addition new microbial threats likely emerge scientists asked provide rapid solutions fast successful response sars could provide example science effectively applied response new emerging diseases unfortunately usual scientific process designed focused quickly solving practical problem grant applications peer review funding mechanisms traditionally rapid processes responding emerging infectious diseases pressing public health importance requires scientific process significantly different traditional procedures response must focus science directly practical solution problem solve several scientific problems parallel instead sequence sars pandemic provided perfect opportunity attempt develop system clinical trials regulatory affairs international collaborations developed parallel instead sequentially soon genome became available bioinformatics web site created used savi scientists well many sars researchers around world see sars bioinformatics suite online links box addition large demand worldwide fulllength sequenced clones various sars coronavirus genes several programmes put place clone express viral proteins could used reagents vaccine studies methods developed growing virus tissue culture using vero cells neutralization assay developed necessary vaccine development important factor producing vaccine quickly early availability information basis immunological protection disease although immune correlates protection sarscov yet completely defined individuals convalescing sars known develop high titres neutralizing antibodies <NUMBER> appearance neutralizing antibodies coincided onset resolution sars pneumonia <NUMBER> coronaviruses <NUMBER> inverse relationship disease severity levels preexisting serum antibodies neutralizing antibodies likely important protection sars tcell immunity also likely necessary protection sars many viruses instance low concentrations cd<NUMBER> cd<NUMBER> cells sars infection correlated increased disease severity mortality <NUMBER> specific human leukocyte antigen hla class alleles correlated sars susceptibility <NUMBER> taken together data indicated vaccine sars would need induce neutralizing antibodies possibly cd<NUMBER> cd<NUMBER> tcell responses knowledge proved helpful selecting vaccine candidates immunization approaches many potential vaccine strategies considered sarscov including whole killed viral vaccine attenuated virus adenovirus vaccinia virus expressing sars proteins recombinant sars proteins dna vaccines successful vaccines developed animal coronaviruses indicating one strategies might work information sars proteins could used candidate vaccine antigens also obtained development animal coronavirus vaccines <NUMBER> emergence sars many scientific groups worldwide began study disease canada particularly affected sarsthere <NUMBER> cases <NUMBER> deaths world health organization travel health advisory issued therefore strong interest pandemic <NUMBER> <NUMBER> michael smith genome sciences centre vancouver emergency management plan place allowed entire facility dedicated rapid sequencing infectious agent collaboration british columbia centre disease control health supplied sars clinical virus strain known toronto <NUMBER> tor<NUMBER> centre generated first genome sequence sarscov within six days receiving viral nucleic acid <NUMBER> several groups followed genome sequences shortly thereafter <NUMBER> <NUMBER> key sequencing genome quickly rapid response emergency management plan already place entailed topdown management approach taken team members parallel projects able dedicate time expertise assigned tasks success coupled concern canada quarantine would contain sarscov led provincial british columbia government providing cdn <NUMBER> million april <NUMBER> establish sars accelerated vaccine initiative savi dedicated developing human sars vaccine rapidly possible vaccine approach chosen several reasons including previous success animal coronavirus vaccines ease product development use vaccines prevent infection cases defined risk exposure healthcare workers hospitals savi established apply rapid response research public health issue designed one goal develop safe effective human sars vaccine rapidly possible savifunded vaccinedevelopment initiatives evaluated goal mind senior management committee established significant expertise animal coronavirus vaccines epidemiology clinical trials grantfunding mechanisms emergency management strategy adopted weekly teleconferences members well regular management committee discussions parallel research strategies designed vaccine development ultimate goal addition identifying vaccine candidates immunological assays intellectual property successfully commercialize vaccine strong intellectual property position needed <NUMBER> savi fortunate partnered group sequenced sarscov protected genome sequence <NUMBER> however additional intellectual property issues arise project progresses also preexisting intellectual property place must incorporated use live attenuated vectors protein expression systems savi decided make legal entity leave ownership intellectual property inventors home universities saved significant time intellectual property mechanisms already established various partner universities issues royalty rates already settled appropriate way deal intellectual property remains significant challenge worldwide development commercialization sars vaccines regulatory issues regulatory issues another consideration rapidly developing vaccine vaccines often take many years develop yet need sars vaccine urgent beginning initiative discussions held appropriate regulatory bodies health canada us fda gain support obtain documents describing regulatory guidelines biological agents addition savi worked regulatory authorities consultants define steps needed vaccine development including use clinically approved cell lines vaccine generation avoidance animal products vaccine production identification plasmids another important consideration vaccine testing availability relevant animal infection challenge model vaccine studies initiated animal models available assumed would developed quickly rapid vaccine development ultimate goal decided assuming became available initially test vaccine candidates relevant animal infection model possible nonhuman primates smallanimal vaccine models misleading time consuming soon macaque infection model published <NUMBER> <NUMBER> significant efforts made secure primates studies however recently significant concerns primate models best infection models tests many laboratories indicate exhibit mild respiratory infections <NUMBER> present ferrets seem relevant disease model <NUMBER> relevant murine models developed allow viral replication <NUMBER> owing high costs primate experiments biosafety level iii containment facilities concerns relevance primate challenge model present savi vaccines first tested ferrets mice nonhuman primates small animals safety immunogenicity similarly groups testing adenoviruses <NUMBER> modified vaccinia viruses <NUMBER> dna vaccine <NUMBER> murine macaque models although additional step adds time project necessary imperative show protection animal infection model closely mimics human disease anticipated testing multiple animal models would also help eliminate concerns regarding vaccineinduced immune enhancement immunopathology <NUMBER> addition fundamental scientific questions associated vaccine development several related issues impacted directly success project fig <NUMBER> include spike surface glycoprotein found viral surface giving viral particle crown therefore name nucleocapsid n protein found inside viral particle packages rna viral genome fig <NUMBER> deciding antigens vaccine approach use posed significant challenges advantages disadvantages research groups chose particular vaccine method familiar contrast savi chose develop three vaccine approaches parallel making final decision candidate progress human clinical trials direct comparison three vaccines relevant animal infection models strategy also provided opportunity use one vaccine primeboost strategy necessary although approach initially required work thought would significantly increase likelihood successful vaccine developed work began three strategies developing whole killed inactivated virus developing recombinant protein modifying adenovirus vaccinia virus express sarscov n proteins whole killed virus recombinant protein targeted inducing neutralizing antibodies whereas adenovirus vaccinia virus vectors targeted inducing cellular immunity neutralizing antibodies proved important bringing together disparate research communities common effort researchers obtained funding still held accountable standard grant regulations research guidelines including adequate accounting reporting completion project project director periodically reviews progress funded collaborators ensure adequate progress relevance well coordinating diverse research groups international collaboration vaccine development sars pandemic international coordination collaboration essential important role coordinating responses following epidemic addition october <NUMBER> hosted meeting geneva attended nearly main research groups working sarscov sars vaccines meeting useful many respects including allowing various groups discuss strategies progress resolving intellectual property regulatory issues selecting developing animal models several additional collaborations formed meeting well better understanding world stood regard vaccines recently february <NUMBER> held meeting rotterdam reach consensus regarding animal models represent best infection models test sars vaccine candidates although macaque model described sars <NUMBER> still questions regarding suitability vaccine testing least three north american laboratories little success observing lung pathology severe clinical signs macaques live sarscov challenge <NUMBER> factors dose strain sarscov route administration day autopsy might account variability laboratories consensus meeting rotterdam standardization conditions sarscov challenge needed different laboratories nonhuman primates could used vaccine testing strains mice balbc c<NUMBER> shown support sarscov replication demonstrate significant pathology clinical disease <NUMBER> smallanimal models sars ferrets <NUMBER> hamsters unpublished observations meeting rotterdam <NUMBER> ref <NUMBER> also support viral replication demonstrate level pathology similar humans animals offer canada united states extremely supportive willing work according riskbenefit platform sars developed next major pandemic would done everything possible expedite approval process counter risk disease sars currently major threat agree normal regulatory approval mechanisms apply expediting vaccine approval might unnecessary handling media major disease outbreak receives significant media attention continual demand updates research progress potential therapeutics preventatives vaccines therefore mechanisms need place deal responsibly media requests projects progress consequently system established enabled effective communication media needed provided consistent message handled expand expectations provided important messages progress project media briefings also provided every six months scientific symposia held every six months keep entire savi group collaborators abreast progress made different areas project funding mechanisms important hurdle rapid response research distributing funds researchers timely manner timeframe starting write peerreviewed grant application funds received laboratory usually one year unsuitable rapid response research rapid funding mechanisms must established ensure appropriate research carried timely manner savi established michael smith foundation health research provincial health research funding agency british columbia used control dispense research funds using fivemember senior management committee consisting senior scientists rapid review mechanism established short <NUMBER>page focused research proposals together proposed research budget dealt directly aspects vaccine development solicited accepted research community committee reviewed evaluated projects basis scientific merit direct need project funds dispersed successful applicants immediately usually <NUMBER> hours application submitted ensuring applications peerreviewed rapid review process significantly enhanced speed project nature reviews microbiology volume <NUMBER> july <NUMBER> <NUMBER> <NUMBER> <NUMBER> infectious diseases exemplified sars patient consent clinical samples taken especially early outbreak potential research uses samples known difficult specify exactly used however large collection clinical samples crucial understanding infectious disease mechanisms collecting sharing samples must place outbreak occurs vaccine therapeutic product used human clinical trials made stringent gmp <NUMBER> ideally rapid response research would done conditions start nearly impossible especially infectious agents instead candidate vaccine therapeutic identified work reproduced conditions significantly lengthens production time outset standardized cell lines vero cells attenuated viral vectors adenovirus adjuvant alum chosen already approved human use significant time saved product development <NUMBER> <NUMBER> sars particularly challenging requires biosafety level iii containment animal studies must done stringent containment facilities world similarly whole killed viral vaccine manufactured highly specialized biosafety level iii gmp facilities needed exist worldwide <NUMBER> owing perceived threat biological agents several biosafety level iii containment facilities recently approved construction however performing rapid response research highly infectious agents new world places major burden specialized facilities especially biosafety level iii large animal primate gmp facilities efficient use space requires global cooperation judicial prioritization commercialization commercialization sars vaccine raises several complex issues seems sars worldwide threat present significant commercial market vaccine companies unwilling spend hundreds millions dollars needed commercialize vaccine unlikely recover expenses <NUMBER> several reasons industry unwilling commit developing specific vaccines first huge cost vaccine development us <NUMBER> million small uncertain revenue traditional vaccines made vaccine manufacturers ability rapid research response emerging infectious disease significant appeal sars seen major public health threat canada several countries asia countries particular felt compelled act canada indicated concept working together rapid response research towards sars vaccine rapidly accepted researchers approached fact scholars nonlifescience areas academia also freely offered time skills deal related problems scientists willing contribute relevant expertise portion laboratorys resources work towards common goal particular individual gain immediately obvious although willingness probably accentuated one perceives significant threat ones country also powerful motivating factor seeking obtain particular expertise rapid response research similarly international cooperation coordination needed avoid significant duplication redundancy efforts well share progress ideal situation expertise around world would coordinated poses major logistical political challenges pivotal role throughout sars pandemic tracking disease also convening meetings researchers working potential vaccine therapeutics diagnostics face future pandemics coordinated international rapid response research approach essential develop new ways controlling scourges main difficulty sars research limited availability clinical samples researchers standardization samples countries national centres disease control collected coordinated clinical samples whereas others left individual hospitals important problem studying emerging alternative inexpensive disease model compared nonhuman primates although reports use small animals sarscov vaccine testing scarce however despite different animal models single animal species shown reproduce clinical signs lethality observed humans infected sarscov anticipating reemergence sars would likely occur close original site origin savi initiated collaboration chinese scientists guangdong province southern china resulted bilateral agreement work together sars vaccine trials collaboration greatly facilitated strong political support china canada two countries significantly affected sars obvious question sars vaccines evaluated human efficacy given lack human sars cases globally year ordinarily phase phase iii human clinical trials designed provide understanding safety immunogenicity vaccine humans well identification correlates immunity without outbreak sars could used test efficacy vaccines humans licensure vaccine emergency conditions might take place fdas animal efficacy rule states vaccines biological agents licensed meet two criteria human safety demonstration adequate protection deliberate infection challenge two species animals see vaccine policy online links sars vaccines go directly animals humans conditions vaccine efficacy safety must evaluated animals followed phase safety evaluation immunogenicity testing healthy human volunteers phase study currently ongoing china inactivated sars virus <NUMBER> present enough sars cases test vaccine phase ii iii trials despite lack ongoing sars threat rapid response initiatives savi continue necessary important vaccine available sars return furthermore initiatives strongly supported internationally recognized scientists strong expertise particular area research development contrast pharmaceutical companies product focus diffuse expertise suitable gmp vaccine manufacturing organizing clinical trials humans concept working together rapid response research towards sars vaccine rapidly accepted researchers approached scientists willing … work towards common goal recent novel corona virussevere acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER>ncov pandemic subsequent disease caused virus coronavirus disease <NUMBER> covid<NUMBER> generated global concern given rapid spread multiple countries possible fatal progression infection initially many patients reported exposure large seafood animal market wuhan china suggesting animaltoperson transmission virus however since many patients reported exposure animal markets indicating persontoperson transmission occurring currently vaccine targeted therapeutic sarscov<NUMBER> sarscov<NUMBER> infection difficult diagnose early infection patients remain asymptomatic present nonspecific clinical symptoms including fever cough shortness breath symptoms may appear <NUMBER> days <NUMBER> weeks exposure <NUMBER> quantitative reverse transcription pcr qrtpcr covid<NUMBER> respiratory samples currently standard diagnostic molecular testing however requires expensive equipment trained personnel reverse transcription loopmediated isothermal amplification rtlamp onestep nucleic acid amplification method based pcr technology used diagnose infectious diseases <NUMBER> rtlamp several advantages making attractive clinical utility includes high specificity sensitivity ability completed less hour furthermore work various ph temperature ranges advantageous clinical samples <NUMBER> lastly reagents relatively inexpensive stable room temperature previously used rtlamp detect zika virus clinical serum urine samples well crude lysates single mosquitos <NUMBER> <NUMBER> study describes rtlamp methodology detect sarscov<NUMBER> simulated patient samples well clinical samples <NUMBER> minutes test could used pointofcare field local personnel rapid diagnosis individuals optimal treatment isolation rapid contact tracing methodology could rapidly developed investigation outbreaks unknown respiratory diseases genetic sequence pathogen known consensus sequences <NUMBER> different sarscov<NUMBER> strains epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> epiisl<NUMBER> established aligned lasergene megalign dnastar identify areas sequence conservation improve specificity areas divergence sarscov<NUMBER> genbank mn<NUMBER> sequencerelated coronavirus bat severe acute respiratory syndrome sarslike coronavirus genbank ky<NUMBER> identified using blast <NUMBER> basic local alignment search tool ncbi area genbank mn<NUMBER> sequence high homology sarscov<NUMBER> strains divergent bat sarslike coronavirus targeted rtlamp primer design genome equivalent sarscov coding region orf<NUMBER> purposely avoided coding region demonstrated mutations among sarscov isolated strains suggesting region may prone positive selective pressure major deletions observed orf<NUMBER> region sarscov genome variants <NUMBER> rtlamp primers designed using lamp designer <NUMBER> premier biosoft blasted using primerblast ncbi genomes interest primer selection prioritized described guide lamp primer designing httpsprimerexplorerjpev<NUMBER>manual addition primers selected four guanines row prevent formation tetraplex structures could disrupt rtlamp reaction rtlamp primers listed table <NUMBER> correspond nonstructural protein <NUMBER> nsp<NUMBER> coding region open reading frame orf <NUMBER>ab primer sets include outer forward primer f<NUMBER> outer backward primer b<NUMBER> forward inner primer fip backward inner primer bip loop forward primer lf loop backward primer lb primers ordered integrated dna technologies fips bips hplc purified sarscov<NUMBER> pcrstandard designed nucleotide <NUMBER> sarscov<NUMBER> wuhanhu<NUMBER> complete genome mn<NUMBER> sarscov<NUMBER> ssdna control fragment synthesized invitrogen geneart oligo genbank mn<NUMBER> used commercial sources sarscov<NUMBER> control plasmid time paper prepared fragment reconstituted <NUMBER>ngμl used lamp qpcr experiments approximate copy numbers calculated using copy number calculator <NUMBER> rtlamp pcr controls middle east respiratory syndrome mers betacoronavirus england<NUMBER> btcov murine hepatitis virus mhv similarity made unable make rtlamp pcr control sars sequences controlled european union export regulations studies compliance ethical practices approved beaumont healths institutional review board irb approval <NUMBER> <NUMBER> studies using samples healthy participants study participants provided information sheet gave informed verbal consent participate approved irb since samples deidentified study presented minimal risk harm subjects written consent obtained principal risk would potential harm resulting breach confidentiality irb determined waiver consent documentation appropriate given study involves minimal risk human participants per code federal regulations submission sample interpreted participants informed consent participate studies using samples covid<NUMBER> symptoms full written consent obtained documented patients medical record experiments performed accordance ethical standards noted <NUMBER> declaration helsinki later amendments samples multiple consenting adult volunteers tested either fresh frozen state assay fresh samples kept ice analysis whole mouth saliva oropharyngeal swabs participants refrained eating drinking anything water <NUMBER> minutes prior collection rinsed mouths water prior collection oropharyngeal swab nasopharyngeal swabs samples collected using flocked sterile plastic swab applicator placed <NUMBER>ml universal media viruses chlamydiae percent mismatch rtlamp primers determined aligning sarscov<NUMBER> genome wuhan city hubei <NUMBER> genbank id mn<NUMBER> <NUMBER> sequenced sarscov<NUMBER> strains various locations around world using global initiative sharing influenza data gisaid epiflu database blast global alignment tool <NUMBER> <NUMBER> rtlamp primers also compared coronaviruses using blast global alignment tool determine specificity percent mismatch using method percent mismatch calculated using following equation setup execution rtlamp reactions done enclosed room using designated pipettes filter tips analysis imaging took place separate rooms prevent contamination rtlamp reactions executed total volume <NUMBER>μl <NUMBER>x isothermic amplification buffer <NUMBER> testing serial dilution sarscov<NUMBER> ssdna control fragment made <NUMBER> ng <NUMBER> fg nucleasefree ddh <NUMBER> used template control template control sarscov<NUMBER> added sybrselect master mix thermofisher <NUMBER> μm forward reverse primers total reaction volume <NUMBER> μl primers used f <NUMBER>atttggtgc cacttctgctgc <NUMBER> r <NUMBER>tcactgccgtcttgttgacca <NUMBER> cycling conditions <NUMBER>˚c <NUMBER> minutes <NUMBER>˚c <NUMBER> minutes followed <NUMBER> cycles <NUMBER>˚c <NUMBER> seconds <NUMBER>˚c <NUMBER> minute performed quantstudio <NUMBER> pcr system applied biosystems <NUMBER> sybr green life technologies dilution made tae buffer <NUMBER> μl sybr dilution added rtlamp reactions visual change color orange yellow used identify positive amplifications addition sybr green pcr tubes imaged uv light biorad chemidoc xrs imaging system reaction creates fluorescent output one half rtlamp reaction electrophoresed along invitrogen low dna mass ladder <NUMBER> agarose gel <NUMBER>x tae buffer <NUMBER> mm tris <NUMBER> mm acetic acid <NUMBER> mm edta <NUMBER> v <NUMBER> minutes gels imaged uv light using biorad chemidoc xrs imaging system lanes containing laddered banding pattern qualified positive amplification clinical samples considered positive rtlamp products fluorescent signal excitation uv light laddering pattern run gel establish optimal conditions rtlamp using sarscov<NUMBER> pcrstandard designed nucleotide <NUMBER> sarscov<NUMBER> wuhanhu<NUMBER> complete genome mn<NUMBER> several primer sets ranges incubation temperatures <NUMBER>˚c incubation times <NUMBER> mins tested best amplification results obtained <NUMBER>˚c <NUMBER> minutes indicated banding pattern electrophoresis gel fig <NUMBER> positive reactions containing sybr green could observed naked eye color change orange yellow fig <NUMBER>top panel fluorescent light response uv excitation fig <NUMBER>middle panel laddering pattern bands electrophoresis gel fig <NUMBER>bottom panel rtlamp reaction required <NUMBER> primers work optimized conditions removing forward backward inner primers loop primers result positive result fig <NUMBER> order determine lower detection limit rtlamp reaction sarscov<NUMBER> dilution series ranging <NUMBER> ng <NUMBER> fg sarscov<NUMBER> dna olgio amplified fig <NUMBER> corresponds approximately <NUMBER>×<NUMBER> <NUMBER> <NUMBER> copies virus viral load patients reported range <NUMBER> copiesml <NUMBER>×<NUMBER> <NUMBER> copiesml median <NUMBER>×<NUMBER> <NUMBER> throat samples <NUMBER>×<NUMBER> <NUMBER> sputum samples <NUMBER> limit detection estimated <NUMBER> fg approximately equal <NUMBER> viral copies dilution series run parallel qrtpcr using primers targeted region sarscov<NUMBER> genome qrtpcr ct values dilution series reported s<NUMBER> table demonstrate clinical utility system sarscov<NUMBER> detection spiked various human specimens sarscov<NUMBER> middle east respiratory syndrome mers betacoronavirus england<NUMBER> btcov murine hepatitis virus mhv control oligos mers btcov mhv spiked samples used test specificity rtlamp assay spiked specimens included serum urine saliva oropharyngeal swabs nasopharyngeal swabs wanted verify substances present samples would interfere rtlamp samples directly used rtlamp without performing nucleic acid isolation samples containing sarscov<NUMBER> mers btcov mhv positive rtlamp reactions indicating specificity reaction sarscov<NUMBER> fig <NUMBER> furthermore rtlamp could successfully completed using human serum urine saliva oropharyngeal swabs nasopharyngeal swabs sequences rtlamp primers also compared aligned sequences various strains severe acute respiratory syndrome coronaviruses sars coronaviruses commonly associated common cold human coronavirus strains <NUMBER>e nl<NUMBER> hku<NUMBER> oc<NUMBER> coronaviruses <NUMBER> nucleotide mismatch rtlamp sarscov<NUMBER> rtlamp detection primers making highly unlikely would give positive rtlamp result supporting specificity assay sarscov<NUMBER> table <NUMBER> given viruses prone genetic mutation likewise examined rtlamp primers mismatch <NUMBER> different isolated strains sarscov<NUMBER> various locations <NUMBER> strains different regions china hubei zhejiang guangdong providences france thailand finland united states australia strains collected sequenced <NUMBER> <NUMBER> <NUMBER> thus <NUMBER> strains reflect one region time point <NUMBER> mismatch strains examined suggesting rtlamp primers would identify <NUMBER> strains sarscov<NUMBER> examined s<NUMBER> table next sought determine rtlamp could detect sarscov<NUMBER> samples collected patients covid<NUMBER> patients covid<NUMBER> symptoms confirmed positive negative sarscov<NUMBER> using standard clinical qrtpcr testing using rna patients used qrtpcr testing rtlamp agreement qrtpcr results <NUMBER> n <NUMBER> sarscov<NUMBER> positive qrtpcr patients fig <NUMBER>a <NUMBER> n <NUMBER> sarscov<NUMBER> negative qrtpcr patients fig <NUMBER>b given spiking nasopharyngeal swabs samples viral transport media sarscov<NUMBER> control oligos able work rtlamp fig <NUMBER> next tested determine rtlamp could detect sarscov<NUMBER> directly without rna isolation nasopharyngeal swab samples rtlamp detected <NUMBER> n <NUMBER> sarscov<NUMBER> positive qrtpcr patients <NUMBER> n <NUMBER> sarscov<NUMBER> negative qrtpcr patients fig <NUMBER> samples positive rtlamp high level viremia indicated ct values less <NUMBER> ct qrtpcr contrast samples negative rtlamp ct value greater <NUMBER> ct qrtpcr given rapid emergence sarscov<NUMBER> severe complications result including acute respiratory distress syndrome ards pneumonia even death improved sarscov<NUMBER> rtlamp detection diagnostic options fast reliable easy affordable required critical since sarscov<NUMBER> infection rapidly progress hospital admission ards <NUMBER> days sarscov<NUMBER> infection fatal <NUMBER> qrtpcr specific sensitive however qrtpcr requires trained clinical laboratory personnel use specialized equipment qualified laboratory setting since virus spreading rapidly highly contagious centralized labs trouble keeping testing demands part due significant shortage available qrtpcr tests despite significant investments local governments private industry feasibility study demonstrated rtlamp allows rapid detection sarscov<NUMBER> variety common human specimens collected clinical testing including serum urine saliva oropharyngeal swabs nasopharyngeal swabs httpsdoiorg<NUMBER>journalpone<NUMBER>g<NUMBER> currently clinical testing sarscov<NUMBER> done central testing laboratories may take one days study sought improve upon developing potential pointofcare test pointofcare testing several advantages sarscov<NUMBER> pointofcare testing fast easy use range users low cost require little laboratory infrastructure furthermore test needs reliable sensitive specific rtlamp meets requirements therefore large value screening testing sarscov<NUMBER> potentially exposed populations groups working adopt rtlamp sarcov<NUMBER> alternative readouts example primers designed group along two primer sets adopted fluorogenic oligonucleotide strand exchange osd probes <NUMBER> method could allow multiplexing thus one genomic target sarscov<NUMBER> included assay furthermore group also demonstrated rtlamp primers described modified osd compatible rtlamp bst dna polymerase large fragment bstlf possesses reverse transcriptase ability well dna polymerase activity detected <NUMBER> sarscov<NUMBER> genomes <NUMBER> bstlf made bacteria without purification step useful situations interrupted supply chain settings resource poor rtlamp including primers described also currently adopted lampseq <NUMBER> could allow large scale processing using barcoding nextgeneration sequencing pool samples subsequently identify positive individuals rtlamp sensitive detection sarscov<NUMBER> able detect equivalent approximately <NUMBER> viral copies bharda et al also reported use six rtlamp primers detect <NUMBER> copies sarscov<NUMBER> genomic rna <NUMBER> viral load patients reported range <NUMBER> copiesml <NUMBER>×<NUMBER> <NUMBER> copies ml median <NUMBER>×<NUMBER> <NUMBER> throat samples <NUMBER>×<NUMBER> <NUMBER> sputum samples <NUMBER> rtlamp sensitive enough detection sarscov<NUMBER> clinical samples sought determine rtlamp assay worked range different samples might collected clinical setting possible noninvasive screening tool important determine since may feasible always collect certain specimens example swabs used nasopharyngeal sampling well viral transport media experienced shortages recently although sarscov<NUMBER> reported detectable serum patients <NUMBER> serum may also difficult collect patients critically sick dehydrated elderly children neonates furthermore biological samples may compatible rtlamp sample types may contain chemicals inhibit nucleic acid assays sample tested directly without first isolating rna rtlamp worked human sample types tested sarscov<NUMBER> control olgios spiked samples tested samples collected several individuals control variation sample composition across different people also demonstrated rtlamp similar performance qrtlamp detecting sarscov<NUMBER> rna isolated clinical nasopharyngeal samples overall rtlamp positive <NUMBER> n <NUMBER> <NUMBER> samples positive qrtpcr rtlamp also negative <NUMBER> n <NUMBER> samples negative qrtpcr two samples positive rtlamp negative qrtpcr could represent false positives contamination increased sensitivity rtlamp compared qrtpcr rtlamp prone false positives taken several precautions control assay setup false positives usually positive samples tested retesting samples still positive suggests false positives use good laboratory practice reduce contamination cannot exclude possibility lastly possible rtlamp sensitive qrtpcr previously described although one samples positive qrtpcr negative rtlamp <NUMBER> previously demonstrated rtlamp zikv require prior rna isolation urine serum samples <NUMBER> <NUMBER> use unprocessed samples could save considerable time reduce costs therefore tested rtlamp nasopharyngeal swabs placed viral transport media directly without rna isolation step order detect low levels viremia increased sample volume added rtlamp reaction <NUMBER> μl also increased rtlamp incubation time <NUMBER> <NUMBER> minutes rna also isolated samples verify samples contained sarscov<NUMBER> qrtpcr rtlamp detected <NUMBER> n <NUMBER> sarscov<NUMBER> positive qrtpcr patients negative <NUMBER> n <NUMBER> sarscov<NUMBER> samples also negative qrtpcr samples positive rtlamp high level viremia indicated ct values less <NUMBER> ct qrtpcr data suggests viral transport media may contain inhibitors possibly glucose make rtlamp less effective hence rtlamp able detect sarscov<NUMBER> samples high levels virus clinical utility rtlamp better performance rna purified samples compared direct testing nasopharyngeal swabs placed viral transport media may direct testing nasopharyngeal swabs possible clinical utility rtlamp nasal swabs placed alternative matrix saline water ideally preservative stabilize rna render virus inactive potential direct rtlamp testing sample types saliva also possible primers designed conserved span sarscov<NUMBER> sequence found <NUMBER> isolated sarscov<NUMBER> strains sequence also divergent related coronavirus sars given isolated strains sarscov<NUMBER> thus far shown little genetic differences anticipate rtlamp detect sarscov<NUMBER> level confidence qrtpcr molecular test including pcr possible viral evolution may impact primer binding monitored new strains sequenced mutations thus far reported april <NUMBER> <NUMBER> <NUMBER> none reported mutations corresponded sequence targeted rtlamp primers sarscov<NUMBER> rtlamp assay highly specific give positive result mers btcov mhv rtlamp primers also significant mismatch numerous strains sars <NUMBER> mismatch common cold associated human coronavirus strains <NUMBER>e nl<NUMBER> hku<NUMBER> oc<NUMBER> <NUMBER> mismatch making highly unlikely crossreactivity respiratory viruses tested range temperatures <NUMBER>˚c <NUMBER>˚c temperatures gave comparable results indicating rtlamp sarscov<NUMBER> large working temperature range optimal temperate <NUMBER>˚c also tested range incubation times <NUMBER> minutes optimal time detection rtlamp products <NUMBER> minutes however sarscov<NUMBER> rtlamp products detectable uv light excitation banding patterns gels little <NUMBER> minutes study several limitations first sarscov<NUMBER> biosafety level <NUMBER> laboratory unable work directly purified virus experiments presented used nucleotide oligo sarscov<NUMBER> corresponding genbank mn<NUMBER> sequence similarly unable directly test related coronaviruses instead used nucleotide oligos region viruses primers evaluated specificity blasting related coronavirus sequences however demonstrated rtlamp detect sarscov<NUMBER> rna isolated nasopharyngeal swab samples similar detection rate qrtpcr furthermore rtlamp could detect sarscov<NUMBER> nasopharyngeal swab samples directly without rna isolation step represent proofoffeasibility assay rtlamp primers detect sarscov<NUMBER> clinical samples highly specific sarscov<NUMBER> detect related viruses although rtlamp reactions highly specific quantitative test groups working improving read outs rtlamp assays including use smartphoneintegrated sensors make interpretation assay even userfriendly <NUMBER> rtlamp reactions higher rate false positives compared qrtpcr took several precautions including lateral work flow experiments using filter pipet tips including thermolabile uracildna glycosylase udg reactions prevent possible carryover contamination rtlamp products previous reactions study powered determine sensitivity clinical population lastly rapidly developing area study information presented time publication represent authors best knowledge time understanding sarscov<NUMBER> continues develop information may change describe fast robust assay detection sarscov<NUMBER> <NUMBER> minutes simple assay could used outside central laboratory various types biological samples assay completed individuals without specialty training equipment may provide new diagnostic strategy combatting spread sarscov<NUMBER> pointofrisk chancellor respiratory virus infections represent major public health problem worldwide occurrence ease spread community considerable morbidity mortality mortality respiratory virus infections healthy individuals developed countries rare however less developed countries childhood mortality quite high estimated <NUMBER> million children globally <NUMBER> years dying annually respiratory virus infections worldwide occurrence results people ages susceptible respiratory virus infections however average children infected two three times frequently adults acute respiratory virus infections common infections experienced healthy children often resulting loss school time significant socioeconomic cost medical visits medications parents loss work time viruses transmitted direct contact droplets although transmitted aerosols viruses primarily infect respiratory tract include influenza adenoviruses parainfluenza viruses respiratory syncytial virus rsv coronaviruses human metapneumovirus rhinoviruses enteroviruses recently new virus bocavirus identified influenza parainfluenza human metapneumovirus hmpv rsv occur epidemics adenovirus coronavirus rhinoviruses occur endemically viruses cause respiratory diseases commonly immunosuppressed people include measles varicella zoster virus vzv herpes simplex virus hsv cytomegalovirus cmv aetiological diagnosis viral respiratory tract illness requires laboratory confirmation symptoms signs clinical illness lack specificity permit aetiological recognition clinical grounds alone development safe chemotherapeutic agents highly immunogenetic protective vaccines individual respiratory viruses continuing priority except influenza virus goal remains elusive respiratory virus infections often seasonal distribution especially temperate climates peak incidence varies year year often predominant seasonal occurrence rsv influenza peak incidence winter peaks usually coincide overlap parainfluenza virus piv <NUMBER> usually peaks winter piv <NUMBER> piv <NUMBER> peaking autumn early winter picornaviridae cause infections year round enteroviruses common summer autumn rhinoviruses common winter spring adenoviruses tend cause infections year round herpesviridae except varicella prevalent late winter early spring viral culture original method used diagnosing respiratory virus infections culture viruses using primary immortalized cells expanded wider diagnostic use <NUMBER>s main advantage traditional cell culture methods ability isolate identify wide range viruses <NUMBER> enabled identification many viruses including commonly causing respiratory infections influenza rsv piv <NUMBER> adenoviruses measles enteroviruses rhinoviruses vzv cmv hsv recently recognized viruses severe acute respiratory syndrome coronavirus sarscov hmpv also grown cell culture virus isolation successful careful attention needs paid number issues include selection appropriate patients collection adequate specimens transport specimen virology laboratory optimal conditions processing methods clinical samples respiratory samples virus isolation include nasopharyngeal aspirates nasopharyngeal andor oropharyngeal swabs nasopharyngeal washes bronchioalveolar lavages sputum lung biopsies open lung biopsies specimens contaminated commensal respiratory flora dacron polyester swabs collected respiratory tract placed viral transport medium containing antibiotics specimens kept cool <NUMBER> <NUMBER>c wet ice inoculation cell cultures maintain virus infectivity especially labile viruses rsv <NUMBER> detection viruses cell culture requires considerable expertise performed microscopic examination looking degenerative morphological changes cell monolayer called cytopathic effect cpe viruses grow cell types clinical specimens usually inoculated several types cells provide environment isolation suitable range viruses use broad range cell types potentially allows isolation agents expected rather limiting detection virus types approach also allow detection one virus given specimen occur <NUMBER> immunocompetent individuals frequently immunocompromised patients especially viruses latency cmv hsv recently commercially produced cocultivated cryopreserved cells become available rapid identification viruses rmix rapid cell culture diagnostic hybrids patented cell monolayer containing mixture a<NUMBER> mink lung mv<NUMBER>lu cells <NUMBER> <NUMBER> h culture using pooled single fluorescein isothiocyanate fitclabelled monoclonal antibodies directed influenza b rsv parainfluenza <NUMBER> adenoviruses rapid identification respiratory virus infection established growth virus cell culture indicates presence viable replication competent virus finding cannot determined using antigen nucleic acid detection addition propagation isolate provides virus antiviral susceptibility testing serotyping epidemiological studies recently newer viral culture formats developed allow rapid detection viruses useful detection viruses grow slowly conventional cell culture decreasing time cpe detectable achieved many viruses centrifugation culture sample added viruses unable centrifuged conventional centrifuges enhanced detection may result better contact cells specimen cell culture thus allowing earlier extensive infection cell culture sheet furthermore detection viral protein production antigen detection evidence cpe conventional culture also decreased time identify virus thus enhanced clinical utility viral culture testing detection viral protein production usually performed using fluorescentlabelled eg fitc monoclonal antibody directed viral protein processing reading cultures labour intensive however common viruses detected <NUMBER> h alternatively enzymelinked immunosorbent assay elisa detection viral proteins cell culture supernatants also performed activate promoter <NUMBER> technology exploited allow detection hsv<NUMBER> <NUMBER> using baby hampster kidney bhk cell line stably transformed promoter ul<NUMBER> hsv linked escherichia coli lacz gene hsv detected within <NUMBER> h infection using chromogenic substrate turns infected cells colourless blue hsv infected cells easily identified technique could expanded determine viral titre specimens required system marketed diagnostic hybrids name elvis enzymelinked virusinducible system <NUMBER> ability detect viruses significantly enhanced development monoclonal antibodies mab directed specific viral proteins viruses hsv<NUMBER> hsv<NUMBER> vzv cmv influenza influenza b parainfluenza <NUMBER> adenovirus linked fluorescent molecule fitc staining procedures rapid samples batch run results usually available within <NUMBER> h depending number specimens tested rapid immunofluorescent staining methods direct detection viral antigens respiratory specimens excellent specificity good sensitivity respiratory viruses produce cpe conventional cell cultures often slow minimal extent rapid detection respiratory viruses influenza influenza b parainfluenza <NUMBER> adenovirus available many laboratories extremely useful detection viruses especially paediatric patients shed relatively large amounts virus longer period adults performance characteristics test depend type specimen age patient duration illness mab reagent level expertise laboratory staff generally methods respiratory viruses little less sensitive culture exception rsv however greater sensitivity rsv compared rsv culture due lability rsv rapidly inactivated samples kept refrigerated transported laboratory quickly inoculation cell cultures within short period collection specimen reported sensitivities detection respiratory viruses varies broadly <NUMBER> rsv <NUMBER> influenza b <NUMBER> parainfluenza <NUMBER> <NUMBER> adenoviruses <NUMBER> mabs directed hmpv developed currently investigation establish clinical utility membranebased cassettebased enzyme immunoassays eias optical immunoassays immunochromographic lateralflow systems introduced less technically demanding detection respiratory viruses <NUMBER> differentiate viruses eg influenza influenza b rsv influenza include positive control monitor performance assay user significant aim manufacturers tests allow testing occur consulting physicians office techniques advantage decreasing turnaround time test results considerably simplified technical component tests sensitive specific viral culture direct dif detection respiratory viruses positive predictive value assays usually higher greater prevalence disease respiratory virus season virus question shown circulating community viral culture periods relatively high prevalence positive results usually accepted correct however negative results confirmed second method eg dif culture <NUMBER> viruses detected clinical samples using highly specific nucleic acid probes complementary sequence viral rnas viral dnas using nucleic acid amplification technique polymerase chain reaction pcr branch chain dna detection bdna nucleic acid sequence based amplification nasba techniques becoming increasingly available diagnostic laboratories testing multiple viruses using molecular methods considerably expensive conventional techniques methodology needs developed house evidence would suggest testing using molecular methods little sensitive conventional approaches information available date variable <NUMBER> influenza virus isolated <NUMBER> influenza b <NUMBER> influenza c virus <NUMBER> influenza b viruses belonged family orthomyxoviridae genus influenzavirus influenza c virus belongs separate genus influenza virions enveloped particles ie surrounded lipid bilayer membrane cellular origin containing singlestranded negativesense segmented rna genome surrounded helical capsid influenza b containing eight segments rna influenza c containing seven segments influenza b clinically important influenza c infection occurs uncommonly usually associated mild upper respiratory tract illness rarely cause bronchitis pneumonia enveloped virion peplomers spikes consisting two glycoproteins haemagglutinin h involved attachment virus cells initiation infection neuraminidase n facilitates release newly formed virions cells two glycoproteins h n exhibit substantial antigenic variation among influenza viruses <NUMBER> h subtypes <NUMBER> n subtypes recognized influenza b one type h n glycoproteins occurrence annual influenza epidemics throughout world due high rate antigenic variation stepwise mutation h n genes reflected variations antigenic characteristics proteins thus escape immune memory h n glycoproteins influenza b viruses stepwise mutation h n results antigenic drift recurrent annual influenza epidemics seen winter virus infect produce disease among populations would otherwise possess immunity previous infection antibodies fail recognize new antigenic variations reason necessity annual influenza vaccination differing serotypes influenza b viruses additionally segmented nature influenza genome allows antigenic shift reassortment genome segments two different influenza viruses major changes h n proteins major variation genetic makeup gives influenza virus potential development global pandemics past years new influenza viruses isolated hong kong h<NUMBER>n<NUMBER> appear spread poultry small number persons shown high mortality rate caused high degree global concern spread avian influenza strains humans usually uncommon several hundred human cases h<NUMBER>ni infection identified countries across world <NUMBER> major limitation virus causing pandemic huge impact health economy failure h<NUMBER>n<NUMBER> influenza establish sustained humantohuman transmission occur pandemic would inevitable commonly available routine diagnostic tests laboratories differentiate influenza influenza b however unable identify subtype identification strain influenza performed variety methods reference laboratories required <NUMBER> laboratory diagnosis influenza virus infection isolation virus cell culture gold standard technique technique however slow allow diagnosis within time frame specific treatment however virus isolation remains critically important epidemiological studies recognition specific types influenza circulating community identification new types thus pandemics information influenza types used design vaccines upcoming influenza season influenza culture performed nasopharyngeal aspirates nasopharyngeal swabs throat swabs sputum lung biopsy tissue bronchoalveolar lavages specimens kept <NUMBER> <NUMBER>c processed recently rapid cultures involving growth influenza <NUMBER> days labelling cells antibodies directed influenza using immunoperoxidase fluorescence technique developed techniques rapid relatively inexpensive require high degree technical competency accurately differentiate influenza b viruses suitable identifying h type influenza thus tests would diagnostic early stages pandemic new h type influenza would cocirculating old h type direct detection viral antigen respiratory specimens also performed technique choice rapid sensitive assay reverse transcriptionpolymerase chain reaction rtpcr available many laboratories differentiate influenza b viruses also used identify differing h n types influenza detection immunological response fourfold greater rise serum antibody titres using haemagglutination inhibition complement fixation techniques acute convalescent samples compared also provides evidence acute infection influenza b virus serological tests rarely diagnostic individual cases within timeframe allows judicious use antiinfluenza drugs useful tracking epidemics community elisa tests igm single sample also available igm iga specific antibodies influenza peak <NUMBER> days infection igg specific antibody peaks <NUMBER> weeks serological diagnosis typing influenza virus complicated fact anamnestic response infection highest strain causing primary infection even subsequent infection strains termed doctrine original antigenic sin lead lack strain specificity serological tests parainfluenza virus types <NUMBER> <NUMBER> <NUMBER> occur worldwide among persons age groups parainfluenza viruses <NUMBER>a <NUMBER>b much less frequent parainfluenza <NUMBER> occurs epidemics usually autumn alternate years parainfluenza <NUMBER> occurs sporadically parainfluenza <NUMBER> tends cause annual winter epidemics temperate climates parainfluenza <NUMBER> main causes croup infants young children <NUMBER> years age parainfluenza <NUMBER> also cause viral pneumonia bronchiolitis infants small children parainfluenza <NUMBER> occurs infrequently usually associated mild symptoms upper respiratory tract illness rhinorrhea pharyngitis cough primary infection parainfluenza provides measure immunity immunity complete long lasting reinfections occur commonly rarely severe illnesses seen primary infection laboratory diagnosis parainfluenza infection based viral isolation tissue culture remains gold standard respiratory secretion specimens must kept <NUMBER> <NUMBER>c processed parainfluenza grows relatively slowly taking <NUMBER> days viruses cause direct cpe detected using haemadsorption adsorption guinea pig red blood cells infected cells rapid diagnostic tests detection viral antigen respiratory specimens using dif specific parainfluenza virus types show high sensitivity specificity rtpcr procedures either detect single viruses parainfluenza group high sensitivity specificity serological response detection fourfold greater rise serum antibody levels acute convalescent samples collected <NUMBER> weeks onset acute illness may also provides evidence infection antibody measured using complement fixation haemagglutination inhibition neutralization interpretation serological test relative parainfluenza type producing infection may complicated heterotopic antibody responses seen infected individuals rsv first isolated <NUMBER> laboratory chimpanzee illness resembling common cold shortly demonstrated human pathogen epidemiological studies shown rsv represents single important cause serious lower respiratory tract disease especially bronchiolitis pneumonia infants children rsv cause severe pneumonia death persons underlying immune deficiency rsv belongs family paramyxoviridae genus pneumovirus enveloped virus singlestranded negativesense nonsegmented rna genome least <NUMBER> viral proteins antigenic analysis rsv identified two subgroups b based reactivity panel monoclonal antibodies b strain differentiated two variants b<NUMBER> b<NUMBER> annual epidemics rsv occur winter temperate climates two subgroups usually cocirculate geographical area often predominance subgroup diagnosis rsv commonly made direct examination respiratory secretions using eia technique number commercial rapid pointofcare diagnostic eia kits identify rsv antigen respiratory secretions available kits provide high degree sensitivity specificity although sensitive dif rsv also grown cell cultures virus extremely labile great care must taken transport ensure remains <NUMBER> <NUMBER>c rsv also diagnosed serologically using complement fixation detection fourfold rise antibody titre however like respiratory virus serology testing clinically useful delay diagnosis furthermore infants may possess maternal antibodies thus complicating interpretation serological data adenoviruses isolated primary cell cultures adenoids children early <NUMBER>s adenoviruses nonenveloped particles contain linear doublestranded dna surrounded icosahedral capsid fibrelike projections extending <NUMBER> capsid vertices adenovirus infections occur worldwide transmission varies sporadic epidemic since adenoviruses stable easily transmitted environment fomites adenoviruses important cause upper lower respiratory tract disease types <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> accounting <NUMBER> infections rarely adenoviruses isolated lungs livers kidneys brains patients fatal infection adenoviruses isolated cell cultures presumptively recognized characteristic cytopathic effect currently <NUMBER> human adenovirus serotypes identified grouped six subgenera designated f based differing classification schemes concerned guanine g cytosine c content dna determined using dna restriction analysis procedures pcr <NUMBER> individual isolates serotyped using haemagglutination inhibition neutralization however time consuming routinely available adenoviruses detected directly respiratory secretions using pcr elisa immunochromatography adenovirus infection diagnosed serologically using complement fixation detection fourfold greater rise antibody titre convalescence typespecific antibody responses assayed haemagglutination inhibition elisa neutralization assay however except epidemiological investigations antibody determination much less efficient means determining infection using direct methods pcr antigen detection rhinoviruses group <NUMBER> serotypes cause common cold minor upper respiratory tract illness virus infects respiratory tract account one half common colds occurring children consequently cause substantial absenteeism schools persons underlying lung disease immune disorders rhinoviruses cause pneumonia rhinoviruses belong family picornaviridae small nonenveloped viruses singlestranded positivesense rna genome unlike enteroviruses also picornaviridae rhinoviruses inactivated exposed mild acid ph <NUMBER> accounting failure infect gastrointestinal tract rhinoviruses also caused otitis media infants children recovered middle ear fluid <NUMBER> subacute chronic cases negative bacteria recent studies associate rhinovirus infection exacerbations asthma acute lower respiratory tract disease especially persons chronic obstructive airway disease cystic fibrosis immunocompromised rhinoviruses prefer grow lower temperatures many respiratory viruses <NUMBER> <NUMBER>c grow less well higher temperature lungs nose however establish infection lung typespecific immunity develops following infection characterized igg neutralizing antibodies serum secretions long lasting immunity best correlates level secretion iga antibody nasal mucous membranes diagnosis rhinovirus infection rarely requires laboratory testing virus isolation detection viral rna rtpcr antigen detection dif cells respiratory secretions detection fourfold rise antibody titres neutralization test eia performed required viral isolation cell culture sensitive especially collected early illness viral isolation labour intensive requires several days confirmation individual rhinovirus serotype requiring antigenic characterization typespecific antibody therefore used routine diagnostic test rtpcr unlikely available except research procedure human coronaviruses <NUMBER>e oc<NUMBER> important cause common cold belong family coronaviridae genus coronavirus enveloped helical nucleocapsid possessing singlestranded positivesense rna genome coronavirus infections occur sporadically throughout winter spring distributed worldwide spread large droplets via respiratory route children commonly experience one coronavirus infection per year three times frequently adults coronaviruses associated <NUMBER> upper respiratory tract illness mainly causing common colds otitis media pneumonia rarely occurs nonsars coronavirus infection typespecific antibodies single coronavirus types develop response infection persist <NUMBER> months circulating mucosal antibody confers protection illness possession coronavirus antibodies increases age circulating antibody found children older <NUMBER> years nevertheless reinfections common laboratory diagnosis coronavirus infections achieved using virus isolation detection viral antigen detection viral rna rtpcr andor demonstration fourfold greater rise antibody titre convalescence virus isolation complicated generally recommended routine diagnostic test since illnesses minor common colds procedures antibody measurement include elisa neutralization hemagglutination inhibition sars first recognized china november <NUMBER> rapidly spread around world significant morbidity mortality clusters affected patients eg healthcare workers family contacts <NUMBER> coronavirus identified cause interestingly children adolescents significantly less severe disease adults <NUMBER> sars coronavirus detected using rtpcr viral culture due high transmissibility agent severe outcomes patient considered sars isolated laboratory specimens collected high level precautions laboratory notified culture sars coronavirus attempted high biocontainment facilities specimens may need referral external public health laboratories dutch researchers reported isolation agent induced cytopathic effects cultured cells <NUMBER> respiratory specimens collected <NUMBER> year period <NUMBER> electron microscopy revealed filamentous virallike particles suggesting agent virus using random arbitrarily primedpcr virus discovered found member paramyxoviridae family first human pathogen genus metapneumovirus named human metapneumovirus hmpv since initial discovery hmpv identified worldwide general hmpv infection accounts approximately <NUMBER> paediatric lower respiratory illness <NUMBER> rtpcr detection reliable method detection present standard methods isolating hmpv culture although possible monoclonal antibodies detect virus dif tested clinical utility human bocavirus newly discovered parvovirus first identified sweden occurs globally <NUMBER> <NUMBER> bocavirus detected young children respiratory distress many pneumonia interstitial infiltrates noted chest xray however whether bocavirus cause respiratory disease yet fully determined common colds common usually selfdiagnosed term cold constitute single viral entity rather syndrome nasal congestion sneezing rhinorrhoea pharyngitis severe clinical disease associated high fever children colds generally selflimiting median duration <NUMBER> days many viruses variety viral families may associated syndrome pattern symptoms associated colds appear vary significantly agents approximately <NUMBER> colds found associated rhinovirus infection frequently occurring agents including coronaviruses enteroviruses nonprimary infections parainfluenza virus rsv transmission viruses responsible common cold direct contact inoculation virus upper respiratory tract infection rhinovirus results development long lasting antibody protective reinfection serotype also produces degree resistance challenge heterologous rhinovirus serotypes protection incomplete short lived recognized complications colds include secondary bacterial infection paranasal sinuses andor middle ear exacerbations asthma bronchitis viral otitis media commonly complicates colds children probably due eustachian tube dysfunction rhinoviruses <NUMBER> rsv influenza virus adenovirus <NUMBER> detected middle ear fluids <NUMBER> cases otitis media effusion children specific viral diagnosis generally attempted required isolation aetiological agent cell culture performed rtpcr may sensitive detection agents especially rhinoviruses enteroviruses coronaviruses pharyngitis common reason seeking outpatient medical care divided syndrome nasal symptoms predominately viral cause cases without nasal symptoms caused diverse spectrum aetiological agents including group nongroup streptococci chlamydia pneumoniae mycoplasma pneumoniae epsteinbarr virus croup viral laryngotracheobronchitis clinically distinct illness predominately affects children <NUMBER> years age characteristic physical finding croup inspiratory stridor pivs account <NUMBER> cases croup <NUMBER> piv <NUMBER> piv <NUMBER> commonly associated causes croup include rsv influenza b rhinoviruses adenoviruses well pneumoniae pneumoniae influenza tend cause croup older children piv <NUMBER> influenza associated severe disease <NUMBER> generally clinical presentation croup syndrome due individual agents similar measles rare cause croup cause especially severe disease <NUMBER> specific viral cause croup established viral culture routinely performed clinical syndrome sufficient diagnosis management bronchiolitis due inflammation bronchioles leading clinical syndrome characterised obstruction expiratory airflow usually proceeded nasal congestion rhinorrhea may often history exposure adult sibling cold minor respiratory illness exposure another infant bronchiolitis within day care setting mild conjunctivitis may occur one third cases otitis media recognized <NUMBER> hospital course variable infants improve within <NUMBER> days <NUMBER> bronchiolitis disease predominately infancy epidemiology disease closely parallels incidence major infectious cause rsv peak incident age infants <NUMBER> <NUMBER> months <NUMBER> cases occurring first year life <NUMBER> rsv causes majority cases bronchiolitis however respiratory viruses include pivs influenza rhinoviruses piv <NUMBER> adenovirus types <NUMBER> <NUMBER> <NUMBER> relatively uncommon may associated severe disease including bronchiolitis obliterans <NUMBER> rhinoviruses cause bronchiolitis infants bronchopulmonary dysplasia <NUMBER> <NUMBER> <NUMBER> pertussis occasionally confused bronchiolitis anatomic defects vascular rings foreign bodies gastrooesophageal reflux additional differential diagnoses bronchiolitis pneumonia part spectrum lower respiratory tract involvement frequently coexist cannot clearly distinguished pneumonia defined development abnormalities alveolar gas exchange accompanied inflammation lung parenchyma often associated visible changes chest xray ct scanning gallium scanning considerable variety presentation viral pneumonia depending age immunological competence host well specific viral pathogen viral pneumonia important cause morbidity mortality individuals compromised immune system clinical presentation varies considerably specific causative agent typically includes fever lower respiratory tract symptoms signs tachypnoea nonproductive cough wheeze increased breath sound young infants may present apnoeic episodes minimal fever bacterial superinfection potential serious complication viral lower respiratory tract infection particularly influenza underlying cardiopulmonary disease valvular heart disease chronic obstructive pulmonary disease well recognized risk factors increased severity disease viral pneumonia diagnosis specific cause acute pneumonia due particular viral agent complicated difficulty obtaining appropriate lower respiratory tract samples culture isolating detecting certain pathogens additionally frequent asymptomatic shedding viruses eg herpes simplex virus adenoviruses viruses clearly important frequent causes pneumonia young children less apparent older children rsv associated largest proportion viral pneumonia young children particularly accompanied bronchiolitis <NUMBER> piv <NUMBER> influenza b significant causes pneumonia children especially periods epidemic prevalence <NUMBER> adenoviruses frequently isolated children respiratory disease implicated <NUMBER> childhood pneumonias however true impact difficult access long intermittent asymptomatic respiratory shedding adenoviruses children adenoviruses described cause significant outbreaks viral pneumonia institutionalized children pneumonia frequent serious complication measles rhinoviruses associated communityacquired pneumonia children despite apparent temperature sensitivity occasional causes enteroviruses hsv vsv serological diagnosis essentially establishes temporal causal relationship viral infection clinical syndrome positive serological result may misleading times high prevalence particular viral agent covid<NUMBER> pandemic probably challenging health crisis modern era april <NUMBER> <NUMBER> countries around world registered least one confirmed case novel coronavirus infection <NUMBER> million positive patients around world <NUMBER> world health organizations general director pointed testing crucial <NUMBER> detection sarscov<NUMBER> virus causes covid<NUMBER> achieved via detection viral rna realtime polymerase chain reaction rtpcr <NUMBER> properly collected specimens collected analysis contains virus rtpcr high specificity sensitivity however technique limitations narrow number patients tested given time increased risk exposure highdose virus healthcare workers collecting sample throatswabbing generate aerosol considerable amount time test response <NUMBER> addition sample properly collected may case mass emergency screening single operator performs hundreds swabs single shift may lead high number falsenegative results overall sensitivity <NUMBER> <NUMBER> <NUMBER> furthermore rtpcr requires certified laboratories expensive equipment trained technicians operate finally major constraint remains cutoff value ascertain whether test positive generally given value reached specimen tested considered positive however degradation probebased fluorophore crosscontamination nonspecific amplification background nucleic acids forces adoption arbitrary cut medical report given negative operating procedure outside clinical context lead evaluation errors raising number falsenegative results moreover realtime amplification efficiency varies within laboratories set cutoff might constant across runs therefore recommended normalize cutoff relative absolute quantification approaches <NUMBER> world health organization fostered development new strategies standardize diagnosis covid<NUMBER> <NUMBER> yet countries completely unprepared onslaught virus possible alternative rtpcr assessment immune response host virus however cannot research covid<NUMBER> merely translating technologies knowhow already place comes study comparable diseases three months since beginning outbreak protocols real experimental studies carried still know immune response human body sarscov<NUMBER> still unclear evaluate antibody production diagnosis covid<NUMBER> use igm igg detection single patients population epidemiological purposes recently idea producing easytouse decentralized pointofcare poc tests emerged deploying widely <NUMBER> poc tests simple easy administer interpret accelerate clinical decisionmaking take workload centralized test laboratories example sheridan <NUMBER> recently reported current main commercial rapid test sarscov<NUMBER> nature biotechnology tenmin lateral flow immunoassays detect igm igg antibodies directed sarscov<NUMBER> xiamen amonmed biotechnology fujian china technical specifications available httpwwwbiotimecnenprindexgci<NUMBER>html sugentech daejeon korea technical specifications available httpssugentechcomproductsproductsviewphpct<NUMBER>target<NUMBER> cellex biotech guangzhou china technical specifications available httpsenwondfocom cnproductscatid<NUMBER>level<NUMBER> developed similar test called wondfo sarscov<NUMBER> antibody test similar tests promoted jiangsu medomics medical technologies nanjing china <NUMBER> innovita biological technology shipping abbott produced poc pcr isothermal test delivers positive result five minutes negative result thirteen minutes <NUMBER> approved food drug administration fda emergency use eu fda approved multiplex pcr test well runs automated aries system delivers result two hours snibe diagnostic shenzhen china technical specifications available httpwwwsnibecomzhenen productsaspxid<NUMBER> created automated central laboratory rapid test runs maglumi chemiluminescence immunoassay system pharmact berlin germany deployed poc <NUMBER>min test detecting sarscov<NUMBER> exposure identification igg igm antibodies biotech xiamen amonmed biotechnology sugentech snibe diagnostic pharmact obtained ce mark serological test cellex developed similar one also approved eu fda available poc tests need studied current emergency setting proposed protocol template better assess effectiveness serology testing <NUMBER> also consistent suggested updated version laboratory testing coronavirus disease covid<NUMBER> suspected human cases <NUMBER> however currently impossible assess compare different poc tests lack reliable data aim evaluate efficacy covid<NUMBER> rapid tests serological assays reallife settings particular focus territorial emergencies ongoing pandemic designed research protocol aimed establish use diagnostics correctly taking account different possible clinical epidemiological scenarios covid<NUMBER> clinical presentation infection virus sarscov<NUMBER> <NUMBER> diagnosis currently based detection rna virus via nucleic acid amplification test naat according corman et al <NUMBER> rtpcr sensitivity specificity <NUMBER> provided sample taken proper timely technique choice perfect samples use rtpcr still debate wenling et al <NUMBER> analyzed samples bronchoalveolar lavage fluid sputum nasal swabs fibrobronchoscopy brush biopsy pharyngeal swabs stools blood rtpcr bronchoalveolar lavage fluid demonstrated highest positive rates <NUMBER> followed sputum <NUMBER> recent studies suggest use rtpcr stools virus attack bowel <NUMBER> according ai et al <NUMBER> combined use computed tomography ct pcr increase diagnostic sensitivity however ct often available territorial settings primary care screening purposes according eltholoth et al <NUMBER> rtpcr limitations screening diagnosis covid<NUMBER> test difficult use community high number falsenegatives observed detection specific igm igg antibodies sarscov<NUMBER> possible strategy diagnose infection immune response triggered infection currently investigation similarly longterm modification antibodies levels cannot known moment use fast performing validated serological assay requested different authors xiao <NUMBER> hick <NUMBER> also national health commission state administration traditional chinese medicine suggests use serological test igm igg covid<NUMBER> confirm negative results emblematic example came recent italian experience patient zero negative tests performed onset symptoms namely pharyngonasal swab rtpcr serological test <NUMBER> observations support idea two negative serological tests necessary rule infection quantitative analysis available following procedure respected two paired serum samples taken patient suspected diagnosis covid<NUMBER> patients clinical symptomology suggestive disease close contacts patients known positive test sarscov<NUMBER> infection baseline serum taken early possible within incubation period contact convalescent serum taken <NUMBER> weeks last contact positive serumspecific igm specific igg antibody title recovery phase<NUMBER> times higher acute phase used diagnostic criteria suspected patients negative naat igm usually measurable <NUMBER> days symptom onset igg detectable <NUMBER> days patient symptomatic fact optimal timing convalescent sample needs still established compared naat serological test appears suitable screening purposes population recent study jin et al <NUMBER> emphasizes utility serological test wide cohort also positive patients probability pretest high bai et al <NUMBER> used igm define negative positive case wide samples general population encouraged use serological test also asymptomatic patients confine spread outbreak also consistent interesting article li et al <NUMBER> recommends use serological surveys determine incidence subclinical infections test however may limitations avoid falsepositives crossreactivity antigen used serological test come properly purified sarscov<NUMBER> according meyer et al <NUMBER> following whos recommendations right choice appropriate purification antigens essential obtain validated serological tests fact crossreactivity coronaviruses challenging therefore recent testsvalidated laboratories isolated viruscan used serum antibody determination methods include among others colloidal gold immunochromatography elisa enzymelinked immunosorbent assay chemiluminescence immunoassay xiang et al <NUMBER> recently compared elisa gica colloidal goldimmunochromatographic assay high sensitivity specificity without significant difference h<NUMBER>ha <NUMBER> enhance accuracy diagnosis liu et al <NUMBER> suggested using rtpcr first days infection use serological test alone disease monitoring li et al <NUMBER> described results use rapid serological test <NUMBER> patients test sensitivity <NUMBER> specificity <NUMBER> diagnosis sarscov<NUMBER> immune response firsttime infection needs time grow symptoms occur organism preparing fight first days infection immunoassay negative indeed crossreactivity detected subjects previous coronaviruses infection <NUMBER> similar level precision reported cassaniti et al letter editor authors endorse use colloidal gold rapid test emergency settings triage patients suspected covid<NUMBER> <NUMBER> nevertheless recommendation remains controversial inconsistencies within results presented sampling methods data processing patients targeted study hand recently long qx et al emphasized importance serological testing clinical epidemiological settings <NUMBER> rapid test sarscov<NUMBER> colloidal goldbased immunochromatographic strip assay zhang et al <NUMBER> demonstrated eukaryotic spike proteins expressed rs<NUMBER> rsrbdmfc appropriate prokaryotic nucleocapsid proteins covid<NUMBER> serological diagnosis gica sandwich used detect total antibodies powerful complement current standard rnabased tests prepared six recombinant proteins including three spike proteins rs<NUMBER> rsrbd rsrbdmfc three n nucleocapsid proteins rn rn<NUMBER> rn<NUMBER> protein transmembrane protein three protein fragments prepared using eukaryotic expression system three n proteins prepared using prokaryotic expression system preliminary evaluation indirect elisa revealed three proteins rs<NUMBER> rsrbd rsrbdmfc superior performance lower background higher optical densit values three n proteins however antigenicity proteins n proteins could confirmed study influence prokaryotic expression method used produce n proteins difficult predict speculated difference due relatively high sensitivity early response antigen compared n antigen patients covid<NUMBER> thus n proteins antigenicity studied expression eukaryotic system future zhang et al <NUMBER> selected two recombinant proteins highest elisa titers rs<NUMBER> rsrbdmfc develop sandwichformat gica strip detect total antibodies igm igg hcov<NUMBER> gica colloidal gold immunochromatography assay simple rapid serological method especially suitable timely diagnosis largescale sample screening performance gica strip evaluated <NUMBER> clinical samples showed rapid <NUMBER> min highly sensitive <NUMBER> specific <NUMBER> diagnosing covid<NUMBER> rtpcrnegative patients clinically confirmed covid<NUMBER> positive ct recent study showed sensitivity total antibody igm igg test higher igm igg test <NUMBER> vivadiag™ kit example colloidal gold rapid test produced jiangsu medomics medical technologies may another potential candidate reliable rapid <NUMBER> min testing test based lateral flow qualitative immunoassay rapid determination presence absence antisarscov<NUMBER>igm antisarscov<NUMBER>igg human specimens whole blood serum plasma test reported based utilization antihuman igg antiigm recombinant antigen representing receptorbinding domain covid<NUMBER> spike protein mk<NUMBER> developed purified medomics recombinant antigen transient transfected cell culture purified protein affinity chromatography sizeexclusion chromatography sec <NUMBER> design antigen based published sarscov<NUMBER> sequence strip test composed nitrocellulose membrane mouse antihumanigm monoclonal antibody mouse antihumanigg monoclonal antibody antirabbitigg immobilized different positions g lines control line c line respectively testing <NUMBER> µl specimen added sample port followed addition sample dilution buffer blood samples move forward along test device sprayed mixture aunpcovid<NUMBER> recombinant antigen conjugate aunprabbitigg sample contains igm antibodies antibodies bind virus antigen labeled colloidal gold form sandwich complex coated antihuman igm monoclonal antibody igm line line igm line appear purplish red prompting covid<NUMBER> igm antibody positive sample contains igg antibodies antibodies bind virus antigen labeled colloidal gold form sandwich complex coated antihuman igg monoclonal antibody igg line igg line appear purplered showing covid<NUMBER> igg antibody positive either line igg igm show color negative result displayed test device also contains quality control line c whether test line quality control line c display test evaluated two operators picture taken currently gold standard identification covid<NUMBER> positive negative subjects however commonly adopted standard rtpc carried methods suggested <NUMBER> therefore selected articles data set control rtpcr carried selected groups people certainly negative eg healthy rtpcr negative volunteers affected covid<NUMBER> rtpcr positive symptomatic patients data test validation derived li <NUMBER> capello <NUMBER> paradiso <NUMBER> cassaniti <NUMBER> well data provided manufacturer provided producer alpha pharma inc bitonto bari <NUMBER> italy available httpswwwapsit article paradiso <NUMBER> possible deduce data referring igm noted specificity high studies table <NUMBER> trials included patients enrolled early stage pandemics known exposure sarscov<NUMBER> symptoms covid<NUMBER> ie healthy volunteers contact asymptomatic negative rtpcr patients could reasonably considered true negative subjects starting assumption basically false positives recorded nevertheless peculiarity infection epidemiology pandemic negative rtpcr negative medical history cannot rule possible sarscov<NUMBER> infection even asymptomatic patients would difficult compare results test gold standard aimed assess sensitivity sensibility test thus research protocols future consider specific features infection way spreads among population immune response host disease reason comparison rtpcr alone enough establish effectiveness quantitative qualitative serologic tests besides longtime persistence immunoglobulins serum immunized persons addressed well absence viral rna sites swabs give negative pcr results healed immunized patients table <NUMBER> shows sensitivity specificity data colloidal gold rapid test versus rtpcr oropharyngeal swab published individual articles cassanitia column computed based data reported article relative igm still reasons collected sensitivity values may vary widely among different studies consequently present cannot establish mean sensitivity value addition variations possibly determined time testing eligibility criteria uniform different studies case high precision indicates absence analytical errors determined crossreactivity also reported authors <NUMBER> better understand variability sensitivity better assess accuracy test considered results igg igm testing separately performed analysis via meta analytic approach evaluate heterogeneity effect size results shown forest plots figure <NUMBER> better understand variability sensitivity better assess accuracy test considered results igg igm testing separately performed analysis via meta analytic approach evaluate heterogeneity effect size results shown forest plots figure <NUMBER> igg figure <NUMBER> igm igg figure <NUMBER> odds ratios found significant fixed p <NUMBER> random effects p <NUMBER> heterogeneity high cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic accounting variations due actual heterogeneity chance <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> performing second metaanalysis data shown using pooled cassaniti igg data find substantial differences fixed effects found p <NUMBER> whereas random effects obtained p <NUMBER> cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> better understand variability sensitivity better assess accuracy test considered results igg igm testing separately performed analysis via meta analytic approach evaluate heterogeneity effect size results shown forest plots figure <NUMBER> igg figure <NUMBER> igm igg figure <NUMBER> odds ratios found significant fixed p <NUMBER> random effects p <NUMBER> heterogeneity high cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic accounting variations due actual heterogeneity chance <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> performing second metaanalysis data shown using pooled cassaniti igg data find substantial differences fixed effects found p <NUMBER> whereas random effects obtained p <NUMBER> cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> igg figure <NUMBER> odds ratios found significant fixed p <NUMBER> random effects p <NUMBER> heterogeneity high cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic accounting variations due actual heterogeneity chance <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> performing second metaanalysis data shown using pooled cassaniti igg data find substantial differences fixed effects found p <NUMBER> whereas random effects obtained p <NUMBER> cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> addition igm figure <NUMBER> odds ratio found significant fixed random effects p <NUMBER> cases heterogeneity less high igg cochrans q got <NUMBER> p <NUMBER> thus significant heterogeneity even keeping p <NUMBER> significance cutoff suggested higgins et al given low number studies <NUMBER> i<NUMBER> statistic found <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> furthermore igm performed second metaanalysis data shown using pooled cassaniti igm data fixed random effects found p <NUMBER> cochrans q <NUMBER> p <NUMBER> i<NUMBER> statistic <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> metaanalyses revealed high inconsistency least broad confidence interval i<NUMBER> statistic given ratio qdq accounts degrees freedom system eg number metaanalyzed studies minus one case q one keeps i<NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> reason adding study metaanalysis potentially decrease inconsistency studies case however heterogeneity observed therefore inconsistency also explained differences patient selection timing test timelapse time <NUMBER>the moment possible contact infectionto time test performed would therefore advisable produce clinical protocols could standardize procedure classification patients including time possible exposure prevalence disease population time onset symptoms type timing tests performed subjects fact heterogeneity sensitivity observed previous studies may depend different settings different timing would advisable serially test patients recording evaluating immune response dynamics time complexity diseasewhose fine clinical immunological epidemiological features mostly unknown still investigationswe cannot rely results test alone make diagnosis forecast clinical evolution disease single patient well epidemiological dynamics community common practice investigate hypothesis trial designed aimed assessing main outcome single intervention exposure factor specific population means research protocol consider one variable time better cases basic pool parameters time also implies already know big picture concentrate fine details may lead different outcomes comes covid<NUMBER> however concede completely unexplored territory clinical epidemiological longterm implications impossible evaluate predict moment scientific community joining forces fight virus every group study focuses specific aspects disease lot pieces therefore missing brief time almost impossible portray complexity whole picture amount data still limited well research settings experimental scenarios addition publications subject reasonably fasttracked skipping bypassing traditional processes research paper normally goes published papers reports posted letters editor often reporting findings thatalthough accuraterepresent limited number observations specific groups specific conditions contrary better understand virus find useful hints fight disease must consider whole picture every individual factor influence results study table <NUMBER> summarize independent variables theoretically addressed study proper interpretation experimental observation evaluation outcome intervention table <NUMBER> prototypic examples independent variables considered clustering results evaluating outcomes wellknown disease variables known therefore cannot estimate priori whether cannot affect outcome design research protocol accordingly setting inclusion exclusion criteria covid<NUMBER> weight every variable affecting outcome experimental observation intervention generally unknown demographic environmental feature thus want understand efficacy test integrate result outcomes investigation relevant information clinical presentation signs symptoms medical examination laboratory investigation imaging epidemiological background patients medical history name time possible contact epidemiological context behaviors actions events may increased chances exposure assessment risk profile patient secondary personal professional conditions could increase chance exposure assessment risk possible exposure secondary circumstances possible contact positive cases besides know virus behaves human body still must consider may clinical features analytes peculiarities come investigations may pathognomonic disease table <NUMBER> summarizes typical symptomdescribed date imaging laboratory findings suggest diagnosis prognosis covid<NUMBER> although specific fever dyspnea cough common presentations disease well lymphocytopenia increased lactate dehydrogenase role interleukin <NUMBER> interleukin <NUMBER> suppressor inflammation recently studied <NUMBER> suggestingas already observed immunomodulatorsthat immune response host may cause complication disease <NUMBER> even particular interest research purposes modification clinical scores used assess patients conditions also used corroborate diagnosis possible outcome infection table <NUMBER> clinical laboratory imaging findings commonly found patients sarscov<NUMBER> infection symptoms fever temperature ≥ <NUMBER> • c cough sputum shortness breath myalgia fatigue diarrhea nausea vomiting conjunctivitis anosmia dysgeusia hypertension heart failure coronary heart disease diabetes kidney failure cancer chronic obstructive lung disease immunodeficiency stroke cerebrovascular accident gastrointestinal disease transplant white blood cell count lymphocyte count hemoglobin platelet count albumin creatinine altast lactate dehydrogenase highsensitivity cardiac troponin prothrombin time ddimer il<NUMBER> il<NUMBER> il<NUMBER> il <NUMBER> il<NUMBER> tnfα ccl<NUMBER> ccl<NUMBER> ccl<NUMBER> ip<NUMBER> mcp<NUMBER> procalcitonin creactive protein ph lactate vitamin score curb<NUMBER> quicksofa sofa apache ii imagine findings consolidation groundglass opacity bilateral pulmonary infiltration histoand cytopathological findings sign inflammation alveolar damage exudate lymphocyte multinucleated giant cells bottom line must consider sarscov<NUMBER> incognita know yet new infection know long period virus perpetuate human organism cause chronic sequelae remain dormant decades relapses reinfected cause secondary disease microbiological factors well genetic external factors affect virulence virus seropositive patients researching covid<NUMBER> record many data possible means must collect even information may practical use moment may appear irrelevant purpose study therefore cannot produce research protocols based evaluation clinical performance test especially test aimed screen patients population diagnosis follow contrary must gather possible available information stratify population better understand test works different scenarios level uncertainty rises consider unicity virus time cannot establish patient population exposed virus fact address complexity must become aware cannot rely simplified model produce usable results point view major issue scarcely addressed research papers field produced remains inceptions point figure <NUMBER> specific timeline presented interpretation test rests inception point time <NUMBER> httpswww researchgatenetpublication<NUMBER>howtodesignagoodcaseseries httpsbooksgoogle itbooksiduwzndwaaqbajpgpa<NUMBER>lpgpa<NUMBER>dq<NUMBER>inceptionpoint<NUMBER>clinical methodologysourceblotslx<NUMBER>su<NUMBER>yxydsigacfu<NUMBER>u<NUMBER>wkkmakhky<NUMBER>xhzuus<NUMBER>nitln<NUMBER>lyg hlitsaxved<NUMBER>ahukewjfqqomqivpahwbaqkhyhhbf<NUMBER>q<NUMBER>aewdxoecakqaqv onepageq<NUMBER>inception<NUMBER>point<NUMBER>clinical<NUMBER>methodologyffalse considered select particular lapse time depending category patients tested covid<NUMBER> belong people possible exposure virus based epidemiological context andor medical history people belong mainly general population specific group table <NUMBER> interpretation test rests inception point time <NUMBER> httpswwwresearchgatenetpublication<NUMBER>howtodesignagoodcaseseries httpsbooksgoogleitbooksiduwzndwaaqbajpgpa<NUMBER>lpgpa<NUMBER>dq<NUMBER>inceptionp oint<NUMBER>clinicalmethodologysourceblotslx<NUMBER>su<NUMBER>yxydsigacfu<NUMBER>u<NUMBER>wkkmakhky<NUMBER>xhzuus<NUMBER>nitln<NUMBER>lyghlitsaxved<NUMBER>ahukewjfqqomqivpahwbaqkhyhhbf<NUMBER>q<NUMBER>aewdxoec akqaqvonepageq<NUMBER>inception<NUMBER>point<NUMBER>clinical<NUMBER>methodologyffalse considered select particular lapse time depending category patients tested covid<NUMBER> belong <NUMBER> people possible exposure virus based epidemiological context andor medical history people belong mainly general population specific group <NUMBER> highrisk groups healthcare workers ridders may increased risk exposition significant viral load <NUMBER> people incidentally underwent test several reasons related clinical reasons <NUMBER> patients developed mild severe symptoms covid<NUMBER> according risk exposure category pretest positive probability difference considered administration test <NUMBER> suggests measures needed longterm defining protocols needed designing study tailored given categories people using correct protocol fact weapon fight infection indeed detailed clear protocol proposed study stratify patients outcomes table read extension figure <NUMBER> define patients history table <NUMBER> table <NUMBER> table summarizes main possible outcomes covid<NUMBER> suggests measures needed longterm defining protocols needed designing study tailored given categories people using correct protocol fact weapon fight infection indeed detailed clear protocol proposed study stratify patients outcomes table read extension figure <NUMBER> define patients history according risk exposure category pretest positive probability difference considered administration test based argumentations better understand clinical epidemiological potentiality serological testing hereby present template strongly suggest use design study diagnostic tools broadly every research protocol aimed investigate covid<NUMBER> research protocol based template addressing complexity aimed mainly investigate possible use rapid test evaluation disease population specific conditions considered although result rapid diagnostic test offers binary information positive negative igm positive negative igg result crucial assessing patient complexity disease considered moreover provide useful tool continuous screening highrisk populations implementation public health programs however advised information coming test alone worthless consider whole picture according criteria classified patients tested according possible inception point therefore possible clinical scenario produced different groups based exposure risk exposure selection criteria immune response different tests used detect infection criteria summarized table <NUMBER> table <NUMBER> different classification patients enrolled study different clusters represent different clinical epidemiological scenarios information coming clinical history patient combined results test modification time serve portray picture possible interpretation test according different phases per figure <NUMBER> timeline exposurerisk classification people known close contact b people clear history close contacts c people constantly exposed randomized population ii high exposition subjects iii incidental diagnosis see text iv symptomatic patients data <NUMBER> clinical criteria <NUMBER> serological testing <NUMBER> molecular testing <NUMBER> pathognomonic laboratory findings <NUMBER> pathognomonic instrumental findings classification allows evaluation upper lower limits timelapse place inception point group considered figure <NUMBER> aside selected limited cases fact cannot establish exact time infection yet still gather valuable information evaluate results test different clusters populations consider specific purpose patients routinely attending primary care facilities outpatient department general practitioners survey health center communitywe might apply similar scheme also acute settings however consider peculiarity territorial emergency asymptomatic patients unconsciously spread infection characteristics primary care department patients followedup longer period purpose enrolled patients would classified according groups presented table <NUMBER> demographic features addition available information recent past medical history recorded particular focus preand postcovid<NUMBER> results laboratory testing investigations see table <NUMBER> behaviors medical conditions may increase risk becoming infected becoming seriously ill patients serially tested colloidal gold vivadiag™ covid<NUMBER> igmigg rapid test suggested frequency weekly shorter interval may suggested highrisk settings patient enrolled study would perform rtpcr test beginning study symptomatic patients regularly tested six months estimated time contagion investigators record symptoms medical investigation together date onset resolution primary outcomes <NUMBER> establish accordance test clinical features disease assess test results change time different clusters patients summarized table <NUMBER> establish reliability serologic rapid test detect sarscov<NUMBER> infection therefore sensitivity specificity integration anamnestic clinical laboratory molecular imaging criteria considered gold standard secondary outcome comparison serological rapid test rtpcr commonly used make etiological diagnosis covid<NUMBER> fact cannot classify patients according results single test positive negative patients moreover immune response host still unknown well level immunity secondary infection thus negative positive status cannot assessed cannot established result test serological response interpreted information coming clinical reports consequently drafting conclusions data analysis end study must consider following considerations test positive even presence negative pcr patient considered positive treated according clinical picture igm alone positive serological test shows recent infection even patient developed symptoms yet hand test positive igg alone patient asymptomatic result used epidemiological purposes recent investigations <NUMBER> however show inconsistent response igm igg different patients seroconversion immunoglobulin classes reach <NUMBER> window period test negative symptomatic patient high exposure risk serological test routinely repeated considering window period time <NUMBER> infection production circulating antibodies even rapid tests designed reduce measure errors avoid false negative essential follow producers instructions avoid procedural mistakes reason chose research protocol test based easy procedure already use diseases also limited settings laboratories poor resources autodiagnostic kits test also easy perform read minimally trained personnel nevertheless yesorno tests available given characteristic covid<NUMBER> unlikely created future clinical assessment patients remains crucial implies medical history correctly collected clinical signs must accurately recorded increase chance making proper diagnosis prognosis management plan lastly data collected shared researchers prompt studies consequently whole dataset always made available protocol dubs first research trial clinicaltrialsgov identifier nct<NUMBER> available httpclinicaltrialsgovct<NUMBER>shownct<NUMBER> aimed evaluating immune response negative patients covid<NUMBER> outbreak plus clinical performance test early detection infection reliability test patients develop clinical signs covid<NUMBER> trial preliminary unpublished data match observations reported table <NUMBER> showing good correspondence research studies also suggesting role serological test screening asymptomatic patients <NUMBER> novel coronavirus pandemic showing weak idea global health worldwide emergency asks needs prompt answers original solutions early diagnosis coronavirus remains major issue proper screening strategy improve design implementation workable public health models aimed confine virus reduce devastating effect population therefore paramountalso considering clinical complexity new diseaseto develop accurate userfriendly kits help doctors healthcare workers make diagnosis covid<NUMBER> thus molecular scientists must frontrunners race virus providing expertise unique research capability field investigated quick detection approach targeting viral igm igg antibodies colloidal goldbased immunochromatographic icg strip assay comparison realtime rtpcr testing advantages icg strip viral antibody detection obvious first sensitivity icg strip comparable especially <NUMBER> days onset detection capacity nuclear acidnegative clinically diagnostic patients impressive therefore icg strips highly recommended utilized supplementary diagnostic approach clinical applications icg strip also widely adopted areas diagnostic capacity limited secondary icg strip assay operational ready use timesaving assay finished within <NUMBER> min without specialized equipment third unlike oral swab sampling may cause stimulated retching coughing increases exposure risk laboratory technicians blood collection could avoid unnecessary risk reduce operation steps may cause aerosol fourth detection antibodies may also indicate disease recovery immunoglobulins among important soldiers battle viruses patients initially detected viruspositive gradually became negative detectable igg igm disease progression may considered recovered battle noteworthy icg strip provide qualitative results serological elisa assay viral antibody offered quantitative antibody titer regarded superior alternation point last least strip used community surveillance therefore design public health strategies aimed confine dissemination virus contain ongoing epidemic call whatever restrictions measures needed reduce spread disease timely manner conclusion main advantages serological test higher accuracy detecting sarscov<NUMBER> infection even asymptomatic patients onset symptoms test performed significant amount time suspect day contagion simpler way use allows operators minimal training screen high number people fewer sampling mistakes finally reduces exposure health workers performing test virus taking account background particular long results <NUMBER> speculate serological tests although needing thoroughly studied could indispensable weapons frontline doctors work decentralized setting rapid answers therefore crucial gather possible information every time patient tested assessed understand better infection immune response work build risk classes individual population profiles could help clinicians health policymakers define better strategy fight infection spread disease allowing time people society safely go back normal regular life finally endorse foster proactive collaboration among molecular researchers clinicians creation multicentric studies aimed produce tools used weapons war invisible enemy may undermine future humankind <NUMBER> triplereassortant swine influenza virus human swine avian genomes identified usa <NUMBER> ten years later humans found infected influenza viruses <NUMBER> novel human influenza h<NUMBER>n<NUMBER> virus caused worldwide respiratory disease outbreak april <NUMBER> major transmission route influenza virus via respiratory droplets released coughing <NUMBER>e<NUMBER> influenza virus replicates epithelial cells upper respiratory tract destroys host cells spreading infect cells clinical manifestations influenza fever headache myalgia fatigue rhinorrhea sore throat cough impact influenza outbreaks much higher children adults healthy adults recover <NUMBER>e<NUMBER> days <NUMBER>e<NUMBER> influenza ah<NUMBER>n<NUMBER> predominant serotype <NUMBER>e<NUMBER> season whereas ah<NUMBER>n<NUMBER> <NUMBER> virus still cocirculated ah<NUMBER>n<NUMBER> influenza b strains <NUMBER> pandemic influenza ah<NUMBER>n<NUMBER> outbreak resulted <NUMBER> deaths <NUMBER> countries <NUMBER> <NUMBER> <NUMBER> conventional diagnostic testing influenza virus included virus incubation nucleic acid amplification test virus incubation first method used diagnose virus infections takes <NUMBER> days amplify virus host cells nucleic acid amplification test sensitive method detect virus infection pretreatment sample including virus isolation nucleic extraction still requires <NUMBER> day methods suitable rapid screening influenza virus <NUMBER> vitro diagnostic devices ivds play crucial roles disease diagnosis rapid convenient properties diagnostic accuracy ivds dependent sensitivity specificity previous study evaluated <NUMBER>m rapid detection test respiratory syncytial virus found sensitivity specificity device <NUMBER> <NUMBER> respectively <NUMBER> april <NUMBER> study conducted iregbu et al <NUMBER> performance dual path platform testing kits revealed sensitivity <NUMBER> specificity <NUMBER> contrast study shrivastava et al <NUMBER> reported commercial dengue ns<NUMBER> antigen kit sensitivity <NUMBER> <NUMBER> clinical samples studies reported sensitivity influenza ivds fluivds detecting influenza previous studies used four commercialized rapid test kits <NUMBER>e<NUMBER> fluivd rapid test kits based immunochromatographic tests type ivd designed easy fast operation enables physicians obtain results primary influenza screening sites fluivd rapid test kits classified lowrisk class device according medical device regulation risk assessment taiwan applied approved taiwan food drug administration fda premarket approvals via fast tract pathway exempt substantial performance review study collected taiwanfdaapproved fluivds taiwanese market evaluated performance standard antigens prepared viral cultures purified hemagglutinins used evaluate analytical sensitivity specificity fluivds results represent actual responses rapid test kits provided references future amendments regulations fluivds purchased directly manufacturers local distributors <NUMBER>e<NUMBER> different lots product name lot number manufacturing country fluivd listed tables <NUMBER> <NUMBER> appearance products labels fluivds compared information licenses including chinese english names license numbers name manufacturer address manufacturer expiration dates sensitivity assayed described previously modifications <NUMBER> sensitivity collected fluivds specified ha concentrations ccid <NUMBER> ha standards consisting influenza antigens acalifornia<NUMBER> h<NUMBER>n<NUMBER> avictoria<NUMBER> h<NUMBER>n<NUMBER> bbrisbane<NUMBER> diluted individually <NUMBER>e<NUMBER> ngml <NUMBER>e<NUMBER> ngml <NUMBER>e<NUMBER> ngml respectively dilution buffer provided fluivds additionally influenza taiwan<NUMBER> h<NUMBER>n<NUMBER> ataiwan<NUMBER> h<NUMBER>n<NUMBER> viruses prepared infected rhabdomyosarcoma rd cells diluted concentrations <NUMBER>e<NUMBER> ccid <NUMBER> ml <NUMBER>e<NUMBER> ccid <NUMBER> ml respectively minimum essential medium gibco grand island ny usa sensitivity assay fluivd including positive negative controls carried following instructions j u r n l f f n r u g n l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> e<NUMBER> <NUMBER> <NUMBER> operation manuals two independent welltrained technicians performed experiments hcovoc<NUMBER> prepared infected mrc<NUMBER> cells extract containing <NUMBER> â <NUMBER> ccid <NUMBER> ml virus used evaluate specificity fluivds experimental protocol carried accordance operation manuals fluivds two independent welltraining researchers carried experiments fluivds classified class <NUMBER> medical devices indicating license could easily obtained document reviews therefore quality fluivds needs investigated monitored taiwan suspected influenza patients immediately tested fluivds primary screening site epidemics areas therapeutic strategies divided two parts based test results test result positive patient exhibits influenzalike symptoms patient immediately administered antiviral drugs osletamivir tamiflu continuously monitored flu pcr test kits however negative test results indicate patient common cold antiviral drug treatment given use fluivds plays crucial role controlling influenza epidemics hence falsepositive outcomes may cause inappropriate administration osletamivir could lead future challenges prevention influenza prior <NUMBER> several commercial fluivd rapid test kits approved taiwan however influenza ah<NUMBER>n<NUMBER> pandemics <NUMBER> taiwan fda issued many licenses similar products thus aimed examine analytical sensitivity specificity flu aivds used taiwan total <NUMBER> products <NUMBER> fluivd licenses collected seven domestic <NUMBER> imported fluivds product labels <NUMBER> samples comply regulations taiwan fda example unsatisfactory product labels lacked product name andor license number packaging buffer containers products package insert package inserts indicate sensitivity product percentage unsatisfactory product labels domestic imported kits <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively based reaction principles detecting targets collected samples grouped ha viral particles fluivds belonging ha group evaluated analytical sensitivity world health organization international standard influenza antigens acalifornia<NUMBER> h<NUMBER>n<NUMBER> avictoria<NUMBER> h<NUMBER>n<NUMBER> bbrisbane<NUMBER> shown table <NUMBER> seven products three fluivd licenses aec manufactured usa spain used ha concentrations sensitivity label analytical sensitivity fluivds ah<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> flu b <NUMBER>e<NUMBER> ngml <NUMBER> ngml <NUMBER> ngml respectively ah<NUMBER>n<NUMBER> detection products j u r n l f f n r u g n l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> e<NUMBER> <NUMBER> <NUMBER> b displayed higher analytical sensitivity product c sensitivity results ah<NUMBER>n<NUMBER> flu b identical samples obtained seven products three domestic fluivds def <NUMBER> products eight fluivds gen imported china uk finland singapore usa korea ccid <NUMBER> labels past <NUMBER> years type taiwan<NUMBER> h<NUMBER>n<NUMBER> type ataiwan<NUMBER> h<NUMBER>n<NUMBER> two main strains influenza outbreak taiwan hence two virus strains used influenza viral particle standards ccid <NUMBER> test <NUMBER> averages ah<NUMBER>n<NUMBER> ah<NUMBER>n<NUMBER> sensitivity log <NUMBER> <NUMBER> ae <NUMBER> ccid <NUMBER> ml log <NUMBER> <NUMBER> ae <NUMBER> ccid <NUMBER> ml respectively fig <NUMBER> unbroken broken dotted lines represent mean mean ae <NUMBER> standard deviation sd mean ae <NUMBER> sd sensitivity tests respectively ah<NUMBER>n<NUMBER> sensitivity products within mean ae <NUMBER> sd fig <NUMBER>a ah<NUMBER>n<NUMBER> sensitivity however products e l fell mean ae <NUMBER> sd range fig <NUMBER>b seven products five imported fluivds test sensitivity labeling therefore ha concentrations used determine sensitivities table <NUMBER> sensitivities seven samples h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> flu b <NUMBER>e<NUMBER> ngml <NUMBER>e<NUMBER> ngml <NUMBER>e<NUMBER> ngml respectively previous researchers used clinical specimens monitor clinical performance fluivds study drexler et al <NUMBER> found binaxnow influenza ab rapid test kits poor clinical sensitivity sensitivity <NUMBER> pandemic h<NUMBER>n<NUMBER> <NUMBER> virus <NUMBER> positive cases <NUMBER> polymerasechainreactionconfirmed cases study uyeki et al <NUMBER> also showed quickvue influenza þ b test low sensitivity <NUMBER> detection influenza b viruses center disease control prevention screened <NUMBER> specimens positive results novel influenza h<NUMBER>n<NUMBER> using directigen ez flu þ b obtained sensitivity <NUMBER> <NUMBER> assumed one reasons discrepancies human epidemic strains influenza viruses used fluivds match current influenza virus outbreak strains pandemic influenza virus strains varied year year country country example influenza atexas<NUMBER> strain used master influenza virus strain develop monoclonal antibodies binaxnow influenza ab rapid test however major virus strain caused influenza outbreak taiwan type ataiwan<NUMBER> h<NUMBER>n<NUMBER> type ataiwan<NUMBER> <NUMBER> h<NUMBER>n<NUMBER> fluivds failed mention master influenza virus strain used preparations therefore inappropriate master influenza virus strains used fluivd preparations may contribute low detection sensitivity moreover studies shown analytical sensitivity directly reflect clinical sensitivity patient specimens analytical sensitivity influenza h<NUMBER>n<NUMBER> detection seasonal influenza although clinical performances poor <NUMBER> <NUMBER> manufacturers j u r n l f f n r u g n l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> e<NUMBER> <NUMBER> <NUMBER> follow recommendations annually pandemic influenza virus strains used preparation fluivds order improve quality also suggest class level fluivds taiwan government regulations elevated government monitor quality ivds using lot release system furthermore taiwan fda establish reference proficiency panel evaluate vitro fluivds near future patients suffering respiratory illness cough asthma emphysema usually diagnosed acute respiratory tract infections viruses influenza virus coronavirus respiratory syncytial virus commonly cause respiratory tract infections <NUMBER> several studies conducted specificity test realtime polymerase chain reaction analysis different respiratorytractinfectionrelated viruses <NUMBER> <NUMBER> specificity fluivds played important role selective interaction influenza b viruses according epidemiological studies hcov caused <NUMBER> common colds adults oc<NUMBER> common <NUMBER> hence used common hcovoc<NUMBER> determine specificity fluivds study result showed fluivds crossreacted hcovoc<NUMBER> suggesting good specificity table <NUMBER> conclusion seven domestic <NUMBER> imported fluivds collected analyze sensitivity specificity analytical sensitivity fluivds ah<NUMBER>n<NUMBER> ah<NUMBER>n<NUMBER> flu b <NUMBER>e<NUMBER> ngml <NUMBER> ngml <NUMBER> ngml respectively average sensitivity ah<NUMBER>n<NUMBER> ah<NUMBER>n<NUMBER> fluivds log <NUMBER> <NUMBER> ae <NUMBER> ccid <NUMBER> ml log <NUMBER> <NUMBER> ae <NUMBER> ccid <NUMBER> ml respectively products crossreacted hcovoc<NUMBER> results could provide information future policymaking strategies preparedness seasonal pandemic influenza table <NUMBER> e specificity results influenza vitro diagnostic devices crossreactivity specificity rate human coronavirsoc<NUMBER> <NUMBER> <NUMBER> j u r n l f f n r u g n l <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> e<NUMBER> <NUMBER> <NUMBER> cov merscov sarscov<NUMBER> temperate regions endemic hcovs usually display winter seasonality although hcov<NUMBER>e detected sporadically throughout year <NUMBER> endemic hcovs globally distributed maintained human population sarscov pandemic came end <NUMBER> httpswwwwhointcsrresources publicationscdscsraro<NUMBER>pdfua<NUMBER> accessed <NUMBER> february <NUMBER> less year first reported case contrast human cases caused merscov continue reported time writing seven years first reported case laboratoryconfirmed mers cases occurred eastern mediterranean region majority saudi arabia unlike endemic hcovs sarscov merscov maintained zoonotic reservoirs sars mers outbreaks driven part superspreading events individuals directly infected disproportionally large number contacts <NUMBER> sarscov<NUMBER>caused coronavirus disease <NUMBER> covid <NUMBER> epidemic originated wuhan china market sold exotic animals consumption based genetic relatedness betacoronaviruses sarscov<NUMBER> likely zoonotic reservoir however precise source sarscov<NUMBER> initially infected humans remains confirmed sarscov<NUMBER> appears substantially contagious sarscov table <NUMBER> distribution sarscov<NUMBER> different mammalian species unknown interesting question susceptibility farm animals pets role epidemiologic cycle angiotensinconverting enzyme <NUMBER> ace<NUMBER> receptor shares similarity human ace<NUMBER> <NUMBER> infections caused endemic hcovs incubation period <NUMBER> days associated mild upper respiratory symptoms common cold endemic hcovs among frequent cause upper respiratory tract infections lower respiratory tract infections bronchiolitis pneumonia rare following incubation period usually <NUMBER> days patients infected sarscov often present symptoms fever headache myalgias respiratory symptoms including cough dyspnoea usually develop several days week illness onset atypical pneumonia respiratory deterioration occur <NUMBER> cases incubation period clinical course mers similar sars exception higher proportion cases progressing respiratory deterioration distress incubation period clinical course sarscov<NUMBER> infection probably similar sars li et al first reported mean incubation period <NUMBER> days <NUMBER> fever cough frequently reported early course illness <NUMBER> <NUMBER> infections also characterized dyspnoea respiratory distress positive chest xray <NUMBER> lower respiratory symptoms often develop <NUMBER> week onset initial symptoms <NUMBER> globally <NUMBER> cases <NUMBER> deaths due sarscov reported casefatality ratio approximately <NUMBER> httpswwwwhointcsrsarsen whoconsensuspdf accessed <NUMBER> february <NUMBER> september <NUMBER> november <NUMBER> <NUMBER> laboratoryconfirmed cases mers <NUMBER> deaths httpswwwwhointemergenciesmerscoven accessed <NUMBER> february <NUMBER> mers casefatality rate <NUMBER> triple sars persons <NUMBER> year age group highest risk primary cases short time emergence december <NUMBER> <NUMBER> march <NUMBER> sarscov<NUMBER> reported <NUMBER> countries time writing situation evolving rapidly <NUMBER> confirmed cases reported globally <NUMBER> china <NUMBER> deaths china <NUMBER> casefatality rate <NUMBER> deaths outside china countries continents outside china south korea iran europe particularly italy experienced high number covid<NUMBER> cases httpswwwwhointemergenciesdiseasesnovelcoro navirus<NUMBER>situationreports accessed <NUMBER> march <NUMBER> mortality rates vary widely depend age patients underlying risk factors denominator definitionhospitalized cases symptomatic cases moderate severe cases etc study adult patients mean age <NUMBER> <NUMBER> chronic illnesses sarscov<NUMBER> pneumonia admitted intensive care unit icu <NUMBER> died within <NUMBER> days <NUMBER> contrast study hospitalized patients median age <NUMBER> years across beijing showed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> cases severe <NUMBER> mild fatality rate <NUMBER> <NUMBER> mortality highest older persons median age <NUMBER> years <NUMBER> <NUMBER> treatment severe hcov infections supportive although randomized doubleblinded control clinical trial conducted gilead drug remdesivir <NUMBER> based one study focused children total <NUMBER> children aged <NUMBER> month <NUMBER> years reported china paediatric cases laboratoryconfirmed sarscov<NUMBER> infection mild cases deaths reported <NUMBER> first <NUMBER> months current outbreak covid<NUMBER> spread rapidly throughout china caused varying degrees illness death rate <NUMBER> patients often presented without fever many abnormal radiologic findings <NUMBER> chinese centers disease control prevention team analysed <NUMBER> patient records <NUMBER> laboratoryconfirmed cases <NUMBER> suspected cases <NUMBER> clinically diagnosed cases <NUMBER> asymptomatic cases confirmed cases <NUMBER> illnesses severe included pneumonia shortness breath <NUMBER> critical disease marked respiratory failure septic shock multiorgan failure overall casefatality rate <NUMBER> <NUMBER> deaths included study majority people age <NUMBER> older underlying medical conditions httpwwwcidrapumnedunewsperspective <NUMBER>moreoutbreakdetailsemergecovid<NUMBER>casestop<NUMBER> accessed <NUMBER> february <NUMBER> must appreciated matter accurate fast laboratory testing methods diagnosis viral pneumonias caused sarscov<NUMBER> involves collecting correct specimen patient right time endemic hcovs detected variety upper lower respiratory sources including throat nasal nasopharyngeal np sputum bronchial fluid <NUMBER> <NUMBER> <NUMBER> wang et al reported oropharyngeal op swabs n <NUMBER> used much frequently np swabs n <NUMBER> china covid<NUMBER> outbreak however sarscov<NUMBER> rna detected <NUMBER> op swabs significantly lower np swabs <NUMBER> <NUMBER> us centers disease control prevention cdc recommends collecting upper respiratory np swab collection op specimen lower priority collected combined tube np swab httpswwwcdcgovcoronavirus <NUMBER>ncovlabguidelinesclinicalspecimenshtml accessed <NUMBER> march <NUMBER> swab specimens placed universal viral transport medium nasopharyngeal aspirates also suitable specimens detection hcovs sensitive detection sarscov merscov sarscov<NUMBER> collection testing upper lower respiratory samples sputum bronchoalveolar lavage fluid bal recommended <NUMBER> however collection sputum particularly bal via bronchoscopy increases biosafety risk healthcare workers creation aerosol droplets proper use personal protective equipment ppe healthcare workers important bronchoscopy highly technical procedure requiring welltrained staff may available many parts world upper respiratory specimens easy collect thereby increasing access testing patients mild symptoms resource limited settings sarscov merscov rna also detected stool urine blood specimens although generally less reliably respiratory specimens <NUMBER> <NUMBER> <NUMBER> exception sarscov rna consistently detected feces two weeks symptom onset <NUMBER> <NUMBER> sensitive detection endemic hcovs upper respiratory specimens collected within first days symptom onset dynamics rna shedding mers sars patients may reflect specimen source severity illness well underlying risk factors among hospitalized patients require ventilator support merscov rna levels upper respiratory tract usually peaked first week symptom onset among eventual fatal cases requiring ventilation rna levels lower respiratory tract specimens peaked weeks <NUMBER> <NUMBER> <NUMBER> similar shedding patterns seen sarscov rna positive rates peaked upper respiratory tract specimens <NUMBER> days symptom onset steadily declined rna positive rates lower respiratory tract specimens remained higher throughout <NUMBER> weeks onset illness <NUMBER> one study diabetes associated prolonged merscov rna shedding respiratory tract <NUMBER> viral pneumonias typically result production purulent sputum thus nasopharyngeal swabwash usually collection method used obtain specimen testing nasopharyngeal specimens may miss early infection deeper specimen may need obtained bronchoscopy alternatively repeated testing used time likelihood sarscov<NUMBER> present nasopharynx increases selfcollected saliva specimens tested positive <NUMBER> <NUMBER> covid<NUMBER> patients suggesting promising noninvasive specimen diagnosis monitoring infection control sarscov<NUMBER> infections <NUMBER> time writing little data performance upper vs lower respiratory tract specimens detection sarscov<NUMBER> <NUMBER> serum another source detection sarscov<NUMBER> however <NUMBER> patients hospitalized pneumonia detectable rna serum <NUMBER> specimens collected laboratory testing hcovs maintained refrigerated temperature <NUMBER> h frozen −<NUMBER>°c httpswwwcdcgovcoronavirus <NUMBER>ncovlabguidelinesclinicalspecimenshtml accessed <NUMBER> march <NUMBER> rectal specimens reported positive patients infected sarscov<NUMBER> <NUMBER> patients travel exposure history symptoms suggest possible infection highrisk novel agent sarscov merscov initial handling specimen performed biosafety level <NUMBER> bsl<NUMBER> conditions specimen aliquot rendered noninfectious lysis another method virus isolation routinely performed situation httpswwwasmorg articlespolicylaboratoryresponsenetworklrnsentinellevelc accessed <NUMBER> february <NUMBER> us cdc biosafety guidelines state routine diagnostic testing specimens suspected confirmed sarscov<NUMBER> patients handled bsl<NUMBER> laboratory using standard precautions httpswwwcdc govcoronavirus<NUMBER>ncovlablabbiosafetyguidelineshtml accessed <NUMBER> march <NUMBER> isolation hcovs cell culture routinely performed diagnostic purposes due lack permissive cell lines time results labour expertise requirements lack commercial antisera culture confirmation table <NUMBER> sarscov merscov sarscov<NUMBER> grow primary monkey cells cell lines vero llcmk<NUMBER> cell culture performed suspect cases routine diagnostic laboratories biosafety reasons <NUMBER> <NUMBER> <NUMBER> <NUMBER> however virus isolation cell cultures critical obtain isolates characterization support development vaccines therapeutic agents rapid antigen tests would theoretically provide advantage fast time results lowcost detection hcovs likely suffer poor sensitivity based experience method influenza flu viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> prepeer reviewed article diao et al reported fluorescence immunochromatographic assay accurate rapid early simple method detecting nucleocapsid protein sarscov<NUMBER> np swab diagnosis covid<NUMBER> httpswwwmedrxivorgcontent<NUMBER> <NUMBER>v<NUMBER> accessed <NUMBER> march <NUMBER> incorporation colloidal goldlabeled immunoglobulin g igg detection reagent approach may increase sensitivity rapid antigen tests respiratory viruses <NUMBER> monoclonal antibodies specifically sarscov<NUMBER> preparation novel approaches concentrate antigen amplify detection phase needed methods clinical utility sona nanotech halifax canada developing quickresponse lateralflow test screen covid<NUMBER> patients targeting produce results <NUMBER> min httpssonananocomsonadevelopsrapidscreeningtestforcoronavirus accessed <NUMBER> february <NUMBER> timing specimen collection viral titres highest may improve diagnostic sensitivity rapid antigen tests hcovs <NUMBER> serological assays routinely used diagnosis hcov infections due lack commercial reagents let alone commercial reagents vetted clinical trials regulatory review process <NUMBER> <NUMBER> table <NUMBER> serological assays hand important understanding epidemiology emerging hcovs including burden role asymptomatic infections particularly important antibody detection diagnosis cases novel emerging hcovs sarscov merscov <NUMBER> <NUMBER> situations affected patients may test positive viral rna particularly early phase disease retrospectively shown developed immune response sarscov<NUMBER> identified especially rapid antigen testing andor molecular assays neither available stable serology used supplementary diagnostic tool recent study demonstrated igm igg antibodies detected <NUMBER> days onset <NUMBER> patients infected sarscov<NUMBER> infection authors recommended use serology facilitate diagnosis sarscov<NUMBER> infections np swab specimen collected inappropriately molecular assays performed unsatisfactorily <NUMBER> china six serology devices received urgent approval national medical products administration nmpa <NUMBER> march <NUMBER> table <NUMBER> proper specimen handling storage important maintain integrity specimens performance serologic tests randomamplification deepsequencing approaches played critical role identifying merscov sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> clinical diagnostic application genetic heterogeneity hcovs precludes single panhcov molecular assay <NUMBER> <NUMBER> <NUMBER> <NUMBER> table <NUMBER> pancov assays use degenerate primers <NUMBER> utilize multiple primer sets <NUMBER> others employ single set nondegenerate primers <NUMBER> current molecular respiratory panels detect endemic hcovs hcovnl<NUMBER> hcovhku<NUMBER> hcovoc<NUMBER> hcov<NUMBER>e require multiple sets pcr oligonucleotides <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> cases tested negative endemic hcovs included molecular respiratory panels <NUMBER> china time revising eleven molecular devices shanghai zj biotech shanghai geneodx biotech bgi biotech wuhan mgi tech da gene sansure biotech shanghai biogerm medical biotech capitalbio chengdu beijing applied biological technologies maccura biotechnology wuhan easydiagnosis biomedicine received urgent approval nmpa characteristics contrasted table <NUMBER> variable performance reported devices <NUMBER> <NUMBER> registration certificates clearly indicated certificate urgent supplemental diagnosis pneumonia caused sarscov<NUMBER> additional multicentre clinical trial data needed extension one year among one mgi tech uses ngs technique detect pathogens given specimen including sarscov<NUMBER> one innovita uses isothermal amplification followed chip detection nine devices incorporated realtime pcr technique hydrolysis probes nucleic acids get extracted separated reagents systems extracts transferred realtime pcr thermocycler eg abi <NUMBER> fast dx realtime pcr instrument nucleic acid amplification detection several rtpcr protocols detection sarscov<NUMBER> rna posted world health organization httpswwwwhointemergencies diseasesnovelcoronavirus<NUMBER>technicalguidance laboratoryguidance accessed <NUMBER> march <NUMBER> three protocols listed us cdc developed developed rtpcr diagnostic panel universal detection sarslike betacoronaviruses specific detection sarscov<NUMBER> <NUMBER> three separate rtpcr reactions target n gene one primerprobe set detects betacoronaviruses two sets specific sarscov<NUMBER> <NUMBER> assays must positive report presumptive positive sarscov<NUMBER> httpswwwfdagov media<NUMBER>download accessed <NUMBER> march <NUMBER> specimen types included upper lower respiratory specimens np op swabs sputum lower respiratory tract aspirates bal nasopharyngeal washaspirate nasal aspirate charité algorithm berlin germany begins two rtpcr assays detect e rdrp genes subgenus sarbecovirus sarscov sarscov<NUMBER> batassociated betacoronaviruses assays must positive advance next step testing algorithm second step consists <NUMBER> <NUMBER> <NUMBER> naat monoplex specifichcov high sensitivity specificity special species potential quantification <NUMBER> h diagnosis detection differentiation limited typing research <NUMBER> <NUMBER> naat multiplex high sensitivity specificity covering pathogens filmarray rp ez cliawaived <NUMBER> h diagnosis detection differentiation limited typing research <NUMBER> <NUMBER> <NUMBER> <NUMBER> naat poct rapid safe good sensitivity specificity cliawaived diagnosis detection limited differentiation research <NUMBER> <NUMBER> note eia enzyme immunoassay ifa immunofluorescent assay naat nucleic acid amplification test clia clinical laboratory improvement act sarscov<NUMBER> specific rtpcr targets rdrp <NUMBER> <NUMBER> exclusivity testing showed alphacoronaviruses covnl<NUMBER> −<NUMBER>e betacoronaviruses hcovoc<NUMBER> hcovhku<NUMBER> merscov detected httpswwwwhointdocsdefaultsource coronaviruseprotocolv<NUMBER>pdfsfvrsna<NUMBER>ef<NUMBER>c<NUMBER> accessed <NUMBER> february <NUMBER> university hong kong li ka shing faculty medicine protocol uses two assays n gene screening assay followed orf<NUMBER>b assay confirmation detect subgenus sarbecovirus <NUMBER> <NUMBER> since sarscov circulating humans currently cases positive considered sarscov<NUMBER> infected cases exclusivity testing showed <NUMBER>e oc<NUMBER> mers <NUMBER>e hku<NUMBER> nl<NUMBER> oc<NUMBER> yielded negative results httpswwwwhointdocsdefaultsourcecoronavirusepeirisprotocol<NUMBER>pdf sfvrsnaf<NUMBER>aac<NUMBER> accessed <NUMBER> february <NUMBER> three novel coronaviruses highly contagious fast safe simple use diagnostic devices performed near point care poc figure <NUMBER> shown impact patient management control infectious disease epidemics <NUMBER> extremely desirable poc biosafety facility limited table <NUMBER> several manufactures spending efforts generate devices poc testing poct <NUMBER> id now™ previously alere influenza b assay abbott san diego ca cleared us fda direct use np swabs firstever clinical laboratory improvement amendments cliawaived nucleic acidbased test january <NUMBER> <NUMBER> <NUMBER> similarly xpert® xpress flursv cepheid sunnyvale ca cobas® liat® flu ab rsv roche molecular systems pleasanton ca assays integrated nucleic acid extractionindependent devices recently received fda clearance cliawaiver simultaneous detection identification flua flub rsv nasopharyngeal swabs <NUMBER> filmarray® respiratory ez panel biofire salt lake city ut far far cliawaived syndromic panel covers set <NUMBER> respiratory viral bacterial pathogens including classical coronavirus species <NUMBER> considering increased levels mortality infectivity associated three novelcoronavirus outbreaks randomaccess safe simple tests offer fast accurate detection identification likely immediate impact prompt clinical epidemiological decisions <NUMBER> <NUMBER> lysis buffer used inactivate infectivity specimens testing run poc biosafety cabinet available fast nearpatient poct could help efficiently triage suspected cases novel coronavirus helping focus limited resources enabling appropriate use quarantine handful diagnostics developers striving bring fast sarscov<NUMBER> tests market soon possible hopes ultimately assisting ongoing outbreak china molecular diagnostic tests use development cepheid hibergene dublin ireland cepheid advantages molecular poct space already instruments placed china mobidiag meanwhile may offer additional benefits multiplex test coronavirus flu viruses httpswww genomewebcompcrdiagnosticsfirmsrushdeveloprapidpointcaretestsnovelcoronavirusxkea<NUMBER>sgzy <NUMBER>x accessed <NUMBER> february <NUMBER> mjl ywt employees cepheid commercial manufacturer xpert xpress sarscov<NUMBER> test figure <NUMBER> evolutions molecular testing procedures pointofcare test poct devices incorporate nucleic acid extraction amplification detection together integrated sealed cartridge making simple rapid safe endpoint pcr dna detected measured completion pcr amplification requiring postpcr processing realtime pcr closedtube system dna detected measured exponential phase amplification december <NUMBER> outbreak severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> started wuhan china <NUMBER> coronavirus disease <NUMBER> rapidly spread countries well <NUMBER> first infected patient netherlands detected <NUMBER> th february <NUMBER> <NUMBER> accurate diagnostics fundamental fight increasing pandemic moreover hospitals would benefit rapid detection virus infection patients acutely present hospitals respiratory symptoms suspected covid<NUMBER> time delay establishment diagnosis increases logistic challenges causes stagnation patient flow emergency departments patients unable transferred appropriate hospital wards intensive care units icus results diagnostic tests still pending <NUMBER> nucleic acid amplification tests nats gold standard high specificity although sensitivity may depend timing disease presentation sampling location severity illness <NUMBER> nevertheless usually takes <NUMBER> <NUMBER> hours laboratorybased results become available depending specific nat platforms laboratory organisation therefore numerous lateral flow immunochromatographic assays lfas introduced market countries stocked rapid tests lfas detect presence igm igg sarscov<NUMBER> study aimed assess diagnostic performance lfas compare enzymelinked immunosorbent assay elisa nats suspected covid<NUMBER> patients patients presenting teaching hospital netherlands eligible march <NUMBER> <NUMBER> april <NUMBER> <NUMBER> respiratory symptoms suspected respiratory tract infection patients sampled oral cavity subsequently nasal cavity using nasopharyngeal swab tested nats cases sputum samples tested persisting clinical suspicion covid<NUMBER> despite negative nat nasopharyngeal swabs nats performed according national reference method established international collaboration <NUMBER> ceivd kit genefindertm covid<NUMBER> plus realamp kit using sample result platform elite ingenius® institutional review board waived need informed consent tests performed samples acquired routine clinical care irb protocol number <NUMBER> according hospital procedure patients informed possibility optout objections use leftover material research improve validate diagnostic testing procedures study conducted accordance helsinki declaration revised <NUMBER> first pilot phase <NUMBER> natpositive <NUMBER> natnegative patients retrospectively selected six lfas performed heparin plasma samples obtained upon hospital presentation figure s<NUMBER> corresponded dates molecular testing lfas included boson biotech cellex dynamiker biotechnology orient gene biotech prometheus bio wantai rapid test visible band either igg igm unspecified ig indicative positive result second based sensitivity specificity results pilot study best performing lfa evaluated extended cohort randomly selected patients third lfa prospectively tested consecutive patients april <NUMBER> april <NUMBER> fourth specificity additionally tested historical control group randomly selected sera <NUMBER> adult patients september <NUMBER> sarscov<NUMBER> circulating time finally samples also analysed wantai sarscov<NUMBER> ab elisa kit detects total antibodies interpreted according manufacturers instructions clinical information reference standard results unavailable performers lfas elisa analyses performed using sas <NUMBER> cary north carolina compared groups using nonparametric tests continuous variables chisquare test fishers exact test categorical variables appropriate pvalues <NUMBER> considered statistically significant pilot study sensitivity characteristics lfa heterogenous ranging <NUMBER> <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> table <NUMBER> decided continue orient gene biotech covid<NUMBER> iggigm rapid test ogbrt highest sensitivity total <NUMBER> patients including <NUMBER> pilot study retrospectively selected march <NUMBER> march <NUMBER> subsequently <NUMBER> consecutive patients prospectively included april <NUMBER> april <NUMBER> total <NUMBER> patients included median age <NUMBER> years interquartile range iqr <NUMBER> <NUMBER> <NUMBER> male <NUMBER> <NUMBER> admitted icu within <NUMBER> hours median creactive protein crp upon hospital presentation <NUMBER> iqr <NUMBER> mgl table s<NUMBER> median time symptom onset sample collection <NUMBER> iqr <NUMBER> days ogbrt overall sensitivity <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> specificity <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> table <NUMBER> sensitivity increased <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> patients least seven days symptoms <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> patients crp <NUMBER> mgl upon presentation however significant difference patients requiring icu figure s<NUMBER> randomly selected historical control sera lfa elisa specificity <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively lfa showed weak igg line one sample study shows sensitivity lfa low patients suspected covid<NUMBER> presenting hospital improved patients least seven days symptoms crp levels <NUMBER> mgl upon presentation specificity lfas elisa high fulfilling frequently used criterium least <NUMBER> elisa higher sensitivity compared lfas several countries including spain united kingdom purchased one lfas however study findings underline cautiousness required considering implementation tests interestingly cellex rapid test currently rapid diagnostic test fda approved performed less ogbrt pilot study another rapid test reported sensitivity <NUMBER> acute patients referred emergency department <NUMBER> studies showed higher sensitivities lfas <NUMBER> unspecified patient groups time disease onset testing missing information regarding timing sampling <NUMBER> <NUMBER> test performance characteristics provided manufacturers higher observed study related different selection positive negative controls study primarily included consecutive patients presenting hospital represents clinical practice clinical sensitivity ie diagnosing covid<NUMBER> upon hospital presentation rather analytical sensitivity ie detecting presence antibodies moment observed higher sensitivity patients least seven days symptoms line findings studies <NUMBER> <NUMBER> study limitations consider study included wide comparison six different lfas elisa nats tests available market nevertheless lfas elisa limited sensitivity suggesting antibody production always detectable least yet detectable early phase infection second nat reference standard remains suboptimal remains possible cases actual infections missed patients nats positive sputum negative nasopharynx whereas majority patients tested nasopharyngeal swabs third subgroup patients admitted icu limited precluding definite conclusions group conclusion high specificity lfas may contribute rapidly confirm covid<NUMBER> accelerate decisionmaking emergency rooms routing appropriate hospital wards yet negative lfa results unreliable exclude covid<NUMBER> due limited sensitivity tests therefore lfa tests cannot replace molecular diagnostics acute care settings used additional triage tool improvement hospital logistics expected limitations carefully considered authors declare conflicts interest middle east respiratory syndrome mers first reported saudi arabia <NUMBER> patients respiratory samples severe pneumonia leading acute respiratory distress syndrome death <NUMBER> since september <NUMBER> <NUMBER> countries reported cases mers notified <NUMBER> laboratoryconfirmed cases least <NUMBER> deaths end august <NUMBER> <NUMBER> mers coronavirus merscov novel virus corresponding author email addresses samykassemvetkfsedueg samy kasem<NUMBER>yahoocom kasem belongs family coronaviridae genus betacoronavirus causes disease <NUMBER> humantohuman transmission appears limited family health care settings <NUMBER> general significant proportion cases suspected result zoonotic transmission serological evidence merscov infection dromedaries reported saudi arabia united arab emirates uae oman qatar jordan pakistan africa <NUMBER> <NUMBER> <NUMBER> addition merscov rna detected nasal swabs dromedaries qatar oman saudi arabia egypt uae <NUMBER> <NUMBER> <NUMBER> <NUMBER> moreover widespread circulation different genetic variants merscov camels geographic clustering human camel merscov sequences <NUMBER> <NUMBER> <NUMBER> study mers prevalence rates relation locations seasons investigated livestock markets slaughterhouses saudi arabia moreover sensitivity specificity bionote ® rapid merscov ag test assessed compared realtime reverse transcriptase pcr rtrtpcr study conducted december <NUMBER> august <NUMBER> ministry environment water agriculture mewa riyadh saudi arabia total <NUMBER> dromedary camels examined including <NUMBER> animals livestock markets jeddah algandria altoki arar najran <NUMBER> animals south riyadh slaughterhouse table <NUMBER> two swabs collected camel one viral transport media copan italia italy examined rtrtpcr second swab buffer rapid merscov ag test collected nasal swabs dromedaries viral transport media transferred riyadh veterinary laboratory within <NUMBER> h collection investigated merscov rna rtrtpcr camels less two years age considered young two years old considered adult majority camels slaughterhouses young less <NUMBER> year age sampling procedures approved ethics committee mewa saudi arabia ® rapid merscov ag test kit qualitative test performed samples according manufacturing protocol briefly camel nasal swabs transferred directly tube containing assay diluents test strip placed test tube arrows strip pointing results read <NUMBER> min test considered negative control c line appeared whereas considered positive test line control line c appeared absence control line c test considered invalid merscov rnas extracted nasal samples qiagen viral rna extraction kit according manufacturers protocol qiagen gmbh hilden germany rtrtpcr targeting upstream gene upe merscov used screening <NUMBER> confirmation done using open reading frame orf <NUMBER>a <NUMBER> l extracted rna subjected rtrtpcr using upe primers using lightmix molecular dx merscov upe kits roche according manufacturers protocol positive samples upe assay confirmed orf<NUMBER>a previously described <NUMBER> investigate genetic relationship ten merscov isolates strains whose genomes available genbank wholegenome ten positive rtrtpcr samples riyadh <NUMBER> jeddah <NUMBER> ion torrent sequenced according primeramplicon combinations <NUMBER> sequencing reactions described earlier <NUMBER> evolution analysis based full genome sequencing merscov carried mega<NUMBER> evolutionary distances estimated means neighborjoining method based kimura <NUMBER>parameter method bootstrap analyses performed <NUMBER> repeat samples data sets <NUMBER> data collected study animals entered microsoft excel sheet imported statistical package social sciences spss windows ® version <NUMBER> spss inc chicago illinois statistical analyses appropriate variable association merscov prevalence camels study variables location season age analyzed using <NUMBER>tailed chisquare test logistic regression model statistical significance considered p ≤ <NUMBER> results rapid merscov ag assay showed positive samples merscov <NUMBER> jeddah livestock market <NUMBER> algandria <NUMBER> altoki <NUMBER> najran <NUMBER> south riyadh slaughterhouse positive samples recorded northern boundaries table <NUMBER> general prevalence mers infection camels animal markets slaughterhouses rapid screening assay showed <NUMBER> merscov rna detection rate rtrtpcr nasal swabs showed <NUMBER> positive samples merscov rna jeddah market <NUMBER> samples alganderia market <NUMBER> altoki market <NUMBER> northern boundaries market <NUMBER> najran market <NUMBER> south riyadh slaughterhouse table <NUMBER> general prevalence mers infection camels animal markets slaughterhouses rtrtpcr <NUMBER> genomic sequences obtained ten camels nasal samples assembled merscov genomic sequences obtained genbank analysis showed complete similarity merscov camel isolates merscov sequences recovered human cases fig <NUMBER> rapid merscov ag assay used examine <NUMBER> camel nasal swabs compared rtrtpcr <NUMBER> nasal swabs positive rapid screening assay showing rapid specificity <NUMBER> addition <NUMBER> nasal samples negative rapid assay compared rtrtpcr showed rapid assay sensitivity <NUMBER> table <NUMBER> result revealed high prevalence rate mers infection winter months ranging <NUMBER> altoki livestock market may <NUMBER> <NUMBER> najran market <NUMBER> alganderia market <NUMBER> altoki market january <NUMBER> <NUMBER> jeddah market <NUMBER> south riyadh slaughterhouse prevalence mers infection showed decreased pattern summer months ranging <NUMBER> altoki livestock market august <NUMBER> <NUMBER> south riyadh slaughterhouse august <NUMBER> <NUMBER> arar livestock market overall prevalence mersciv rna dromedaries summer mothers juneaugust lower either rapid assay <NUMBER> rtrtpcr <NUMBER> comparison higher prevalence rates winter months decembermay rapid assay <NUMBER> rtrtpcr <NUMBER> table <NUMBER> prevalence rates merscov rna significantly higher young animals <NUMBER> years age indicating increased infection young camels high rates positive samples recorded either rapid assay <NUMBER> rtrtpcr <NUMBER> merscov rna prevalence rates lower dromedaries <NUMBER> years age either rapid assay <NUMBER> rtrtpcr <NUMBER> table <NUMBER> dromedary camels likely primary source middle east respiratory syndrome virus merscov infection humans routes direct indirect zoonotic transmission yet unknown study prevalence rates merscov investigated dromedaries livestock markets slaughterhouse saudi arabia study based screening nasal swab samples bionote ® rapid merscov ag test kit realtime pcr assay targeting upe orf<NUMBER>a genes characterizing genetic diversity merscov genome sequences presented study showed high rates merscov infection among dromedary camels livestock markets slaughterhouses saudi arabia overall prevalence mers infection camels livestock markets slaughterhouses rtrtpcr <NUMBER> previous studies reported prevalence <NUMBER> merscov infection alahsa province slaughterhouse <NUMBER> also high proportion <NUMBER> dromedaries <NUMBER> shed merscov rna central doha animal market adjoining slaughterhouse qatar <NUMBER> egypt merscov rna prevalence nasal swabs slaughterhouses <NUMBER> among <NUMBER> camels <NUMBER> analysis obtained data based season demonstrated high mers infection rates winter months varied <NUMBER> altoki livestock market <NUMBER> south riyadh slaughterhouse prevalence mers infection showed decreased pattern summer months varied <NUMBER> altoki livestock market <NUMBER> arar livestock market general prevalence rate mers infection camels winter months rtrtpcr <NUMBER> summer months <NUMBER> addition analysis data based age showed young camels <NUMBER> years age higher prevalence merscov rna <NUMBER> compared adult camels <NUMBER> years age <NUMBER> indicating increased rates merscov infection young camels results agreement previous reports showed merscov infection camels recorded winter season young age camels appear highest risk merscov infection <NUMBER> <NUMBER> <NUMBER> sequences merscov genome aligned reference sequences obtained genbank phylogenetic analysis performed using mega<NUMBER> genetic analysis revealed fig <NUMBER> evolutionary analysis full genome sequences ten merscov isolates recovered camels using mega<NUMBER> ten merscov camel samples aligned merscov reference strains retrieved genbank analysis inferred using neighborjoining method distance calculations computed using kimura <NUMBER>parameter method sequences current study indicated solid circle complete identity camel merscov isolates riyadh jeddah regions mers isolates recovered human patients similarity merscov sequences recovered camels human patients indicating increased risk potential zoonosis camels act intermediate hosts transmitting virus humans results consistent many previous studies <NUMBER> <NUMBER> <NUMBER> performance commercial rapid merscov ag assay detect merscov antigen compared mers upe open reading frame <NUMBER>a orf<NUMBER>a realtime reverse transcriptase pcr rtrtpcr assay camel nasal swabs data showed <NUMBER> camel nasal swabs tested <NUMBER> merscov positive <NUMBER> negative ica <NUMBER> positive <NUMBER> negative upe orf<NUMBER>a realtime rtpcr therefore sensitivity specificity ica compared realtime rtpcr <NUMBER> <NUMBER> respectively previous reports recorded sensitivity screening quality ica assay found <NUMBER> <NUMBER> respectively compared rtrtpcr also reported ica less sensitive detection merscov antigen <NUMBER> <NUMBER> tcid<NUMBER> upe realtime pcr <NUMBER> <NUMBER> tcid<NUMBER> difference assay sensitivities might regarded release subgenomic rna onset cytopathogenic effect cpe cell culture including upe target fragment previously reported <NUMBER> <NUMBER> <NUMBER> also rapid merscov ag assay cannot detect merscov loads <NUMBER> <NUMBER> ct value <NUMBER> previous report pointed merscov rtrtpcr assay specific assay molecular studies variety animal species human <NUMBER> <NUMBER> overall rapid screening tests less sensitive confirmatory tests however advantages using rapid screening tests high throughput rapid turnaround time without requirements sample preparation use special equipment therefore ica considered satisfactory used screening camel herds merscov antigen across animal markets slaughterhouses followed confirmatory test positive samples conclusion high prevalence merscov infection among dromedary camels livestock markets slaughterhouses especially winter months young age animals considered highrisk areas zoonosis especially peoples professional contact live camels bodies addition locations drivers merscov circulation funding sources acute respiratory tract infections rtis considered forgotten pandemic remain leading cause cause mortality children worldwide bryce et al <NUMBER> spite public health prevention measures advanced therapeutics incidence rates rtis united states varied little past <NUMBER> years monto et al <NUMBER> etiologic diagnosis remains challenging lack broad based rapid accurate diagnostic tools leads overprescribing antibiotics delayed definitive diagnosis potential increased complications ineffective epidemic control molecular diagnostic assays greatest potential impacting clinical practice infectious agents viruses conventional microbiologic methods ie culture provide timely results ratcliff et al <NUMBER> nucleic acid amplification tests naats developed multiple individual viruses liolios et al <NUMBER> utility clinical settings extended availability single platform systems simultaneously detect multiple pathogens liao et al <NUMBER> pabbaraju et al <NUMBER> raymond et al <NUMBER> wu et al <NUMBER> electrospray ionization mass spectrometry following broadrange reverse transcriptionpcr rtpcresims one single system platforms potential rapidly detect semiquantify different pathogens simulatenously date studies rtpcremims restricted evaluation individual respiratory bacteria viruses ie streptococcus coronavirus sars adenovirus russell et al <NUMBER> influenza viruses sampath et al <NUMBER> detailed characterization eg resistance gene recognition genotyping organism capacity rtpcremims broad range detection rapid turnaround may provide useful tool clinicians health care settings aid early diagnosis rtis aimed <NUMBER> demonstrate capacity rtpcresims platform identify subtype multiple respiratory viruses nasopharyngeal aspirates npas <NUMBER> examine performance characteristics rtpcresims platform pilot hospitalbased retrospective proof concept study seven clinically relevant viral pathogens coronavirus respiratory syncytial virus rsv influenza b parainfluenza type <NUMBER> <NUMBER> adenovirus coronavirus sars obtained zeptometrix given concentrations buffalo ny pooled negative npas tested rtpcresims used mockup experiments determine limit detection lod serial <NUMBER>fold dilutions <NUMBER> <NUMBER> genome copieswell <NUMBER>x <NUMBER> <NUMBER> <NUMBER> genome copiesml spiked negative nasopharyngeal aspirates npa concentration repeated five times indepentently ensure precision lod determined least concentration five five repeats detected rtpcresims clinical samples derived patients presented suspected respiratory tract infection tertiary inner city teaching hospital according standardized collection procedure may <NUMBER> november <NUMBER> excess clinical samples stored <NUMBER>°c nucleic acid extraction microbiology database queried standard clinical virological results including rapid immunochromatographic tests influenza rsv binex inverness bedford uk direct fluorescent antibody staining tests d<NUMBER> ultra dfa respiratory virus id kit diagnostic hybrids athens oh rapid shell vial culture identification rmix diagnostic hybrids athens oh roller tube culture hemadsorption tests figure <NUMBER> routine pcr testing performed clinical virology laboratory two negative npas clinical virology obtained match positive sample month collection study approved johns hopkins university institutional review board samples processed total nucleic acid extraction using thermo kingfisher waltham robot according ambion abi foster city ca magmax viral kit extraction protocol samples processed dedicated investigator kc masked clinical virology laboratory results time processing onestep rtpcr performed <NUMBER>ul reaction mix consisting <NUMBER> u amplitaq gold applied biosystems foster city ca <NUMBER> mm tris ph <NUMBER> <NUMBER> mm kcl <NUMBER> mm mgcl<NUMBER> <NUMBER> mbetaine <NUMBER> mmmix datp dgtp dctp dttp bioline usa inc randolph <NUMBER> mm dithiothreitol <NUMBER> ng sonicated polya dna sigma corp st louis mo <NUMBER> ng random hexamers rt invitrogen corp carlsbad ca <NUMBER> u superasin ambion corp austin tx <NUMBER> ng t<NUMBER> gene <NUMBER> protein roche diagnostics corp indianapolis <NUMBER> u superscript iii invitrogen corp carlsbad ca <NUMBER> mm sorbitol sigma corp <NUMBER> nm specific pcr primer rtpcr cycling conditions <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min followed <NUMBER> cycles <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> seconds <NUMBER>°c annealing temperature increasing <NUMBER>°c cycle rtpcr continued <NUMBER> additional cycles <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> seconds <NUMBER>°c <NUMBER> seconds rtpcr cycle ended final extension <NUMBER> min <NUMBER>°c followed <NUMBER>°c hold rtpcr used rna dna virus amplification assay performed using ibis t<NUMBER> respiratory virus surveillance ii kit ibis biosciences inc carlsbad ca designed detect subtype viruses seven groups conventional viruses rsv influenza b parainfluenza types <NUMBER> adenoviridae type af viruses conventionally identified clinical virology laboratory coronaviridae human bocavirus human metapneumovirus researchuseonly kit <NUMBER> primer pairs distributed <NUMBER>well plate well contained one pair primers viruses two primer sets <NUMBER> sets primers influenza viruses plate able test six patient samples specimen tested <NUMBER> wells ibis t<NUMBER> platform performed automated postpcr desalting esims signal acquisition spectral analysis data reporting analyze rtpcr product described previously briefly steps follows <NUMBER> ul aliquots pcr reaction desalted purified using weak anion exchange protocol described elsewhere ward et al <NUMBER> accurate mass <NUMBER> ppm highresolution mdm<NUMBER> fullwidth halfmaximum mass spectra acquired sample using highthroughput esims protocols described previously sampath et al <NUMBER> sample approximately <NUMBER> ul analyte solution consumed <NUMBER>second spectral acquisition raw mass spectra postcalibrated internal mass standard deconvolved monoisotopic molecular masses unambiguous base compositions derived exact mass measurements complementary singlestranded oligonucleotides semiquantitative results pathogens obtained comparing peak heights internal pcr calibration internal mass standard present every pcr well <NUMBER> molecules also treated internal positive control well negative control implemented batch processing sterile viral transport media well clinical virology laboratory perform pcr tests routinely respiratory viruses accordingly samples clinical virology laboratory rtpcr esims agree enough remaining volume <NUMBER>ul sent viracor lees summit mo identification another pcrbased platform luminex respiratory assay austin tx able detect viruses rtpcresims could detect except human bocavirus pabbaraju et al <NUMBER> sample throughput rtpcresims included using one kingfisher extraction robot one janus automated dispensing robot four eppendorf thermocyclers one t<NUMBER> cleanup injection automation system evaluated primary analysis evaluating performance rtpcresims standard clinical virology laboratory results used reference test figure <NUMBER> describes number subjects one npa sample evaluated number evaluable results operationally defined purposes primary secondary performance evaluation number individual evaluable results could compared one another since npa sample could yield test results culture rtpcrmsesi negative single positive multiple viral detections figure <NUMBER> secondary analysis combined clinical virology laboratory results secondary ie luminex pcrbased results reference test samples containing viruses hospitals clinical virology laboratory protocol available ie bocavirus coronavirus detection excluded primary analysis included secondary analysis viral agent could detected luminex rtpcrbased method ie viruses except bocavirus confidence intervals sensitivity specificity based exact binomial probabilities twosample wilcoxon mannwhitney test used comparing viral load clinical virology positive group negative group mocked npa samples seven viruses groups detected successfully rtpcresims level <NUMBER> copieswell figure <NUMBER> rtpcresims sensitive detecting adenovirus least sensitive detecting rsv lod <NUMBER> <NUMBER> genome copieswell respectively figure <NUMBER> exclusion overall agreement <NUMBER> <NUMBER> confidence interval ci <NUMBER> sensitivity specificity excluding nonconventional viruses jhu identification protocols <NUMBER> coronavirus <NUMBER> metapneumovirus <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively table <NUMBER> among <NUMBER> samples results available first accuracy analysis <NUMBER> samples found disagree rtpcresims clinical virology laboratory individual pathogens identified clinical virology rtpcresims detected <NUMBER> rsv <NUMBER> adenovirus <NUMBER> parainfluenza <NUMBER> influenza viruses table <NUMBER> rtpcresims also successfully subtyped eight influenza five influenza b two parainfluenza type <NUMBER> <NUMBER> parainfluenza type <NUMBER> identified clinical virology well seven adenovirus types b c clinical virology protocol subtype misssubtyped one parainfluenza type <NUMBER> one parainfluenza type <NUMBER> identified virology laboratory parainfluenza type <NUMBER> parainfluenza type <NUMBER> respectively median storage time <NUMBER> months range <NUMBER> viral load semiquantifiable rtpcresims ranged <NUMBER> <NUMBER> copies ml viral loads rtpcresims positive samples clinical virology negative group significantly lower clinical virology positive group median <NUMBER> vs <NUMBER> copiesml respectively p<NUMBER> figure <NUMBER> among <NUMBER> original samples results disagreement rtpcresims conventional virology assays jhu protocols <NUMBER> <NUMBER> sufficient volume sent another pcrbased method <NUMBER> confirmed rtpcresims results including <NUMBER> positive conventional viruses <NUMBER> influenza <NUMBER> rsv <NUMBER> parainfluenza two coronavirus <NUMBER> metapneumovirus detection detectable conventional clinical virology protocols confirmed well overall agreement sensitivity specificity secondary analysis available samples <NUMBER> <NUMBER>ci<NUMBER> <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> <NUMBER>ci <NUMBER> respectively table <NUMBER> time first result sample preparation detection rtpcresims <NUMBER> hours <NUMBER> hours rna extraction <NUMBER> hours rtpcr <NUMBER> hours processing esims estimated throughput rtpcresims <NUMBER> samples <NUMBER> technicians <NUMBER> working hours represented <NUMBER> pcr reactions study hospitalbased retrospective pilot proofofconcept study designed demostrate capacity determine performance novel rtpcresims platform mockup samples previously frozen clinical samples compared clinical virology assays study showed novel assay rapid able detect subtype multiple respiratory pathogens hospital <NUMBER> accuracy compared conventional clinical virology assays study also indicated pathogens detectable traditional clinical virology methods could successfully detected rtpcresims platform rtpcresims platform several advantages including rapid turnaround time detailed pathogen characterization ie relative semiquantification typing subtyping species versus conventional culture methods current common diagnostic methods clinical virology laboratory culturebased may take days yield results laborintensive expensive anzueto et al <NUMBER> although rapid antigen tests offer faster detection times individual lower sensitivity specificity limits clinical utility sole methodology ginocchio <NUMBER> rtpcresims platform capability detect multiple pathogens efficiently high sensitivity well ability determine quantity pathogens would potential biomarkers infection course severity however prospective validation study needed determine clinical performance assay determining performance novel assays similar problems appeared discordant analysis results new assays reference standard tests researchers confirmed result novel assays discordant conventional culture rapid antigen test another multiplex rtpcr assays liolios et al <NUMBER> pabbaraju et al <NUMBER> remains controversial regarding examine potentially accurate novel assay versus current alloyed standard doring et al proposed clinical evidence infections included validation novel nucleic acid test doring et al <NUMBER> however study design permit detailed clinical data collection recognize several limitations design first operation rtpcresims performed almost year initial tests done clinical virology utilizing excess npa obtained clinical virology resulted specimens processed year collecting patients although effect length storage npa shown minimal within <NUMBER> months ward et al <NUMBER> impact longer periods storage remains unknown ward et al demonstrated multiple freezing thawing cycles significantly alter concentrations measured prior freezing influenza samples ward et al <NUMBER> frisbie et al indicated influenza rna could degrade <NUMBER>°c freezer may result loss sensitivity frisbie et al <NUMBER> second limitation could send every specimen secondary analyses due insufficient volume samples inherent limitation retrospective design used however since almost half discordant results verified another pcrbased method <NUMBER> <NUMBER> might little impact estimate future study merited perform parallel comparison every sample another reference tests eg another pcr based method order better characterize performance platform thirdly could test performance rtpcresims every subtype clinical revelant respiratory viruses design study viral subtypes demonstrated pilot study ie parainfluenza type <NUMBER> <NUMBER> adenovirus type df study required determine performance novel platform lastly performed five repeats lod experiment utilized <NUMBER> detection <NUMBER> criteria determine lod <NUMBER> detection rule generally applied lod studies althought fewer repeats study may limitation precision lods <NUMBER> detection still considered conservative estimate pilot study could provide evidence futher studies conclusion demonstrated innovative rtpcresims technology could rapidly accurately detect subtype viruses identified conventional virological methods detection conventional viruses missed clinical virology unconventional viruses required additional confirmatatory testing determine performance characteristics rtpcresims method promising diagnostic platform rapid identification conventional unconventional viruses merits prospective evaluation diagnostic algorithm used clinical virology laboratory detect respiratory viruses mainly divided respiratory season nonrespiratory season respiratory season defined october following january october november rsv december january influenza immunochromatographic assays used respiratory season sole screening test rsv influenza stop testing algorithm results positive respiratory panel cocktail dfa tests serve adenovirus influenza b parainfluenza type <NUMBER> rsv stop testing algorithm results positive nonrespiratory season screened negative immunochromatographic assays respiratory season well bocavirus detectable clinical virology laboratory another pcrbased platform excluded n<NUMBER> excluding <NUMBER> coronavirus <NUMBER> humane metapneumovirusdetections clinical virology laboratory protocol detect <NUMBER> included primary performance analysis table <NUMBER> twentyfive samples clinical virology laboratory rtpcresims agree clinical virology laboratory protocol detect sufficient volume left sent another pcrbased assay secondary analysis seven clinically relevant viral pathogens coronavirus respiratory syncytial virus rsv influenza b parainfluenza type <NUMBER> <NUMBER> adenovirus coronavirus sars spiked pooled negative npas tested rtpcresims determine limit detection lod five repeats serial <NUMBER>fold dilutions <NUMBER> <NUMBER> copieswell <NUMBER>x <NUMBER> <NUMBER> copiesml rtpcresims sensitive detecting adenovirus lod <NUMBER> copieswell least sensitive detecting rsv lod <NUMBER> copies well one copieswell approximate <NUMBER> copiesml overall agreement sensitivity specificity excluding nonconventional viruses jhu identification protocols <NUMBER> <NUMBER> <NUMBER> respectively excluding <NUMBER> viruses <NUMBER> coronavirus <NUMBER> bocavirus <NUMBER> metapneumovirus detected rtpcresims clinical virology identification protocols diagn microbiol infect dis author manuscript available pmc <NUMBER> february <NUMBER> acute respiratory tract infections rtis considered forgotten pandemic remain leading cause allcause mortality children worldwide bryce et al <NUMBER> spite public health prevention measures advances therapeutics incidence rates rtis united states varied little past <NUMBER> years monto ullman <NUMBER> etiologic diagnosis remains challenging lack broadbased rapid accurate diagnostic tools leads overprescribing antibiotics delayed definitive diagnosis potential increased complications ineffective epidemic control molecular diagnostic assays greatest potential impacting clinical practice infectious agents viruses conventional microbiologic methods ie culture provide timely results ratcliff et al <NUMBER> nucleic acid amplification tests developed multiple individual viruses liolios et al <NUMBER> utility clinical settings extended availability single platform systems simultaneously detect multiple pathogens liao et al <NUMBER> pabbaraju et al <NUMBER> raymond et al <NUMBER> wu tang <NUMBER> electrospray ionization mass spectrometry following broadrange reverse transcription polymerase chain reaction rtpcresims one single system platforms potential rapidly detect semiquantify different pathogens simultaneously date studies rtpcr emims restricted evaluation individual respiratory bacteria viruses ie streptococcus coronavirus sars adenovirus russell et al <NUMBER> influenza viruses sampath et al <NUMBER> detailed characterization eg resistance gene recognition genotyping organism capacity rtpcremims broadrange detection rapid turnaround may provide useful tool clinicians health care settings aid early diagnosis rtis aimed <NUMBER> demonstrate capacity rtpcresims platform identify subtype multiple respiratory viruses nasopharyngeal aspirates npas <NUMBER> examine performance characteristics rtpcresims platform pilot hospitalbased retrospective proofofconcept study seven clinically relevant viral pathogens coronavirus respiratory syncytial virus rsv influenza b parainfluenza types <NUMBER> <NUMBER> adenovirus coronavirus sars obtained zeptometrix given concentrations buffalo ny pooled negative npas tested rtpcresims used mockup experiments determine limit detection lod serial <NUMBER>fold dilutions <NUMBER> <NUMBER> genome copywell <NUMBER> × <NUMBER> <NUMBER> <NUMBER> genome copiesml spiked negative npas concentration repeated <NUMBER> times independently ensure precision lod determined least concentration <NUMBER> <NUMBER> repeats detected rtpcresims clinical samples derived patients presented suspected rti tertiary innercity teaching hospital according standardized collection procedure may <NUMBER> november <NUMBER> excess clinical samples stored −<NUMBER>°c nucleic acid extraction microbiology database queried standard clinical virologic results including rapid immunochromatographic tests influenza rsv binex inverness bedford uk direct fluorescent antibody staining tests d<NUMBER> ultra dfa respiratory virus id kit diagnostic hybrids athens oh rapid shell vial culture identification rmix diagnostic hybrids athens oh roller tube culture hemadsorption tests fig <NUMBER> routine pcr testing performed clinical virology laboratory two negative npas clinical virology obtained match positive sample month collection study approved johns hopkins university institutional review board samples processed total nucleic acid extraction using thermo kingfisher waltham robot according ambion abi foster city ca magmax viral kit extraction protocol samples processed dedicated investigator kc masked clinical virology laboratory results time processing onestep rtpcr performed <NUMBER>μl reaction mix consisting <NUMBER> u amplitaq gold applied biosystems foster city ca <NUMBER> mmoll tris ph <NUMBER> <NUMBER> mmoll kcl <NUMBER> mmoll mgcl <NUMBER> <NUMBER> moll betaine <NUMBER> mmoll mix datp dgtp dctp dttp bioline usa randolph <NUMBER> mmoll dithiothreitol <NUMBER> ng sonicated polya dna sigma st louis mo <NUMBER> ng random hexamers rt invitrogen carlsbad ca <NUMBER> u superasin ambion austin tx <NUMBER> ng t<NUMBER> gene <NUMBER> protein roche diagnostics indianapolis <NUMBER> u superscript iii invitrogen <NUMBER> mmoll sorbitol sigma <NUMBER> nmoll specific pcr primer rtpcr cycling conditions <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER> min followed <NUMBER> cycles <NUMBER>°c <NUMBER> <NUMBER>°c <NUMBER> <NUMBER>°c <NUMBER> <NUMBER>°c annealing temperature increasing <NUMBER>°c cycle rtpcr continued <NUMBER> additional cycles <NUMBER>°c <NUMBER> <NUMBER>°c <NUMBER> <NUMBER>°c <NUMBER> rtpcr cycle ended final extension <NUMBER> min <NUMBER>°c followed <NUMBER>°c hold rtpcr used rna dna virus amplification assay performed using ibis t<NUMBER> respiratory virus surveillance ii kit ibis biosciences carlsbad ca designed detect subtype viruses <NUMBER> groups conventional viruses rsv influenza b parainfluenza types <NUMBER> adenoviridae types af viruses conventionally identified clinical virology laboratory coronaviridae human bocavirus human metapneumovirus researchuseonly kit <NUMBER> primer pairs distributed <NUMBER>well plate well contained one pair primers viruses <NUMBER> primer sets <NUMBER> sets primers influenza viruses plate able test <NUMBER> patient samples specimen tested <NUMBER> wells ibis t<NUMBER> platform performed automated postpcr desalting esims signal acquisition spectral analysis data reporting analyze rtpcr product described previously briefly steps follows <NUMBER>μl aliquots pcr reaction desalted purified using weak anion exchange protocol described elsewhere ward et al <NUMBER> accurate mass <NUMBER> ppm highresolution mdm<NUMBER> <NUMBER> fullwidth halfmaximum mass spectra acquired sample using highthroughput esims protocols described previously sampath et al <NUMBER> sample approximately <NUMBER> μl analyte solution consumed <NUMBER>s spectral acquisition raw mass spectra postcalibrated internal mass standard deconvolved monoisotopic molecular masses unambiguous base compositions derived exact mass measurements complementary singlestranded oligonucleotides semiquan fig <NUMBER> diagnostic algorithm clinical virology laboratory respiratory samples diagnostic algorithm used clinical virology laboratory detect respiratory viruses mainly divided respiratory season nonrespiratory season respiratory season defined october following january october november rsv december january influenza immunochromatographic assays used respiratory season sole screening test rsv influenza stop testing algorithm results positive respiratory panel cocktail dfa tests serve adenovirus influenza b parainfluenza types <NUMBER> rsv stop testing algorithm results positive nonrespiratory season screened negative immunochromatographic assays respiratory season well rsv respiratory syncytial virus flu influenza b viruses piv parainfluenza virus hsv herpes simplex virus cmv cytomegalovirus hmpv human metapneumovirus dfa direct fluorescent antibody test cpe cytopathic effect rbc red blood cells id identified titative results pathogens obtained comparing peak heights internal pcr calibration internal mass standard present every pcr well <NUMBER> molecules also treated internal positive control well negative control implemented batch processing sterile viral transport media well clinical virology laboratory perform pcr tests routinely respiratory viruses accordingly samples clinical virology laboratory rtpcr esims agree enough remaining volume <NUMBER> μl sent viracor lees summit mo identification another pcrbased platform luminex respiratory assay austin tx able detect viruses rtpcresims could detect except human bocavirus pabbaraju et al <NUMBER> sample throughput rtpcresims included using <NUMBER> kingfisher extraction robot <NUMBER> janus automated dispensing robot <NUMBER> eppendorf thermocyclers <NUMBER> t<NUMBER> cleanup injection automation system evaluated primary analysis evaluating performance rtpcresims standard clinical virology laboratory results used reference test fig <NUMBER> describes number subjects one npa sample evaluated number evaluable results operationally defined purposes primary secondary performance evaluation number individual evaluable results could compared one another npa sample could yield test results culture rtpcrmsesi negative single positive multiple viral detections fig <NUMBER> secondary analysis combined clinical virology laboratory results secondary ie luminex pcrbased results reference test samples containing viruses hospitals clinical virology laboratory protocol available ie bocavirus coronavirus detection excluded primary analysis included secondary analysis viral agent could detected luminex rtpcrbased method ie viruses except bocavirus confidence intervals cis sensitivity specificity based exact binomial probabilities twosample wilcoxon mannwhitney test used comparing viral load clinical virologypositive group negative group mocked npa samples <NUMBER> viruses groups detected successfully rtpcresims level <NUMBER> copieswell fig <NUMBER> rtpcresims fig <NUMBER> flow diagram patient recruitment analysis bocavirus detectable clinical virology laboratory another pcrbased platform excluded n <NUMBER> exclusion <NUMBER> coronavirus <NUMBER> human metapneumovirus detections clinical virology laboratory protocol detection <NUMBER> included primary performance analysis table <NUMBER> twentyfive samples clinical virology laboratory rtpcresims agree clinical virology laboratory protocol detect sufficient volume left sent another pcrbased assay secondary analysis sensitive detecting adenovirus least sensitive detecting rsv lod <NUMBER> <NUMBER> genome copieswell respectively total <NUMBER> examinable results <NUMBER> npa samples collected clinical virology previously frozen repository march <NUMBER> november <NUMBER> identified excluding bocavirus detection unexaminable clinical virology diagnostic algorithm secondary pcrbased assay fig <NUMBER> exclusion overall agreement <NUMBER> <NUMBER> ci <NUMBER> sensitivity specificity excluding nonconventional viruses johns hopkins university jhu identification protocols <NUMBER> coronavirus <NUMBER> metapneumovirus <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively table <NUMBER> among <NUMBER> samples results available first accuracy analysis <NUMBER> samples found disagree rtpcresims clinical virology laboratory individual pathogens identified clinical virology rtpcresims detected <NUMBER> rsv <NUMBER> adenovirus <NUMBER> parainfluenza <NUMBER> influenza viruses table <NUMBER> rtpcresims also successfully subtyped <NUMBER> influenza <NUMBER> influenza b <NUMBER> parainfluenza type <NUMBER> <NUMBER> parainfluenza type <NUMBER> identified clinical virology well <NUMBER> adenovirus types b c clinical virology protocol subtype missubtyped <NUMBER> parainfluenza type <NUMBER> <NUMBER> parainfluenza type <NUMBER> fig <NUMBER> lod rtpcresims respiratory viruses npa mockup samples seven clinically relevant viral pathogens coronavirus respiratory syncytial virus rsv influenza b parainfluenza types <NUMBER> <NUMBER> adenovirus coronavirus sars spiked pooled negative npas tested rtpcresims determine lod <NUMBER> repeats serial <NUMBER>fold dilutions <NUMBER> <NUMBER> copieswell <NUMBER> × <NUMBER> <NUMBER> <NUMBER> copiesml rtpcr esims sensitive detecting adenovirus lod <NUMBER> copieswell least sensitive detecting rsv lod <NUMBER> copieswell one copywell approximate <NUMBER> copiesml overall agreement sensitivity specificity excluding nonconventional viruses jhu identification protocols <NUMBER> <NUMBER> <NUMBER> respectively excluding <NUMBER> viruses <NUMBER> coronavirus <NUMBER> bocavirus <NUMBER> metapneumovirus detected rtpcresims clinical virology identification protocols identified virology laboratory parainfluenza type <NUMBER> parainfluenza type <NUMBER> respectively median storage time <NUMBER> months range <NUMBER> viral load semiquantifiable rtpcresims ranged <NUMBER> n<NUMBER> <NUMBER> copiesml viral loads rtpcresimspositive samples clinical virologynegative group significantly lower clinical virologypositive group median <NUMBER> <NUMBER> vs n<NUMBER> <NUMBER> copiesml respectively p <NUMBER> total examinable results <NUMBER> fig <NUMBER> among <NUMBER> original samples results disagreement rtpcresims conventional virology assays jhu protocols <NUMBER> <NUMBER> sufficient volume sent another pcrbased method <NUMBER> confirmed rtpcresims results including <NUMBER> positive conventional viruses <NUMBER> influenza <NUMBER> rsv <NUMBER> parainfluenza two coronavirus <NUMBER> metapneumovirus detection detectable conventional clinical virology protocols confirmed well overall agreement sensitivity specificity secondary analysis available samples <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively table <NUMBER> time first result sample preparation detection rtpcresims <NUMBER> h <NUMBER> h rna extraction <NUMBER> h rtpcr <NUMBER> h processing esims estimated throughput rtpcresims <NUMBER> samples <NUMBER> technicians <NUMBER> working hours represented <NUMBER> pcr reactions study hospitalbased retrospective pilot proofofconcept study designed demonstrate capacity determine performance novel rtpcr esims platform mockup samples previously frozen clinical samples compared clinical virology assays study showed novel assay rapid able detect subtype multiple respiratory pathogens hospital <NUMBER> accuracy compared conventional clinical virology assays study also indicated pathogens detectable traditional clinical virology methods could successfully detected rtpcresims platform rtpcresims platform several advantages including rapid turnaround time detailed pathogen characterization ie relative semiquantification typing subtyping species versus conventional culture methods current common diagnostic methods clinical virology laboratory culturebased may take days yield results laborintensive expensive anzueto niederman <NUMBER> although rapid antigen tests offer faster detection times individual lower sensitivity specificity limit clinical utility sole methodology ginocchio <NUMBER> rtpcresims platform capability detect multiple pathogens efficiently high sensitivity well ability determine quantity pathogens would potential biomarkers infection course severity however prospective validation study needed determine clinical performance assay determining performance novel assays similar problems appeared discordant analysis results new assays reference standard tests researchers confirmed result novel assays discordant conventional culture rapid antigen test another multiplex rtpcr assay liolios et al <NUMBER> pabbaraju et al <NUMBER> remains controversial regarding examine potentially accurate novel assay versus current alloyed standard doring et al <NUMBER> proposed clinical evidence infections included validation novel nucleic acid test however study design permit detailed clinical data collection recognize several limitations design first operation rtpcresims performed almost year initial tests done clinical virology utilizing excess npa obtained clinical virology resulted specimens processed year collecting patients although effect length storage npa shown minimal within <NUMBER> months ward et al <NUMBER> impact longer periods storage remains unknown ward et al <NUMBER> demonstrated multiple freezingthawing cycles significantly alter concentrations measured freezing influenza samples frisbie et al <NUMBER> indicated influenza rna could degrade −<NUMBER>°c freezer may result loss sensitivity second limitation could send every specimen secondary analyses insufficient volume samples inherent limitation retrospective design used however almost half discordant results verified another pcrbased method <NUMBER> <NUMBER> might little impact estimate future study merited perform parallel comparison every sample another reference test eg another pcrbased method better characterize performance platform third could test performance rtpcresims every subtype clinically relevant respiratory viruses design study viral subtypes demonstrated pilot study ie parainfluenza types <NUMBER> <NUMBER> adenovirus types df study required determine performance novel platform lastly performed <NUMBER> repeats lod experiment utilized <NUMBER> detection <NUMBER> criteria determine lod <NUMBER> detection rule generally applied lod studies although fewer repeats study may limitation precision lods <NUMBER> detection still considered conservative estimate pilot study could provide evidence studies conclusion demonstrated innovative rtpcresims technology could rapidly accurately detect subtype viruses identified conventional virologic methods detection conventional viruses missed clinical virology unconventional viruses required additional confirmatory testing determine performance characteristics rtpcresims method promising diagnostic platform rapid identification conventional unconventional viruses merits prospective evaluation end <NUMBER> pneumonia unknown cause detected wuhan china first <NUMBER> reported country office china january <NUMBER> th <NUMBER> chinese health <NUMBER> authorities world health organization officially announced discovery <NUMBER> novel coronavirus first named <NUMBER>ncov officially termed sarscov<NUMBER> virus <NUMBER> belonging coronavirus family differs viruses sarscov responsible <NUMBER> sars outbreak <NUMBER> merscov responsible ongoing outbreak began <NUMBER> <NUMBER> middle east <NUMBER> sarscov<NUMBER> virus responsible infectious respiratory disease called covid<NUMBER> <NUMBER> coronavirus disease infection mainly results pneumonia upperlower <NUMBER> respiratory tract infection symptoms covid<NUMBER> infection appear incubation <NUMBER> period approximately <NUMBER> days <NUMBER> common symptoms onset covid<NUMBER> <NUMBER> illness fever cough fatigue others include headache sore throat even acute <NUMBER> respiratory distress syndrome leading respiratory failure <NUMBER> since emergence covid<NUMBER> china end last year sarscov<NUMBER> virus <NUMBER> caused large global outbreak become major worldwide public health issue <NUMBER> declared outbreak global health emergency end january <NUMBER> <NUMBER> april <NUMBER> th <NUMBER> world health organization announced total global deaths <NUMBER> covid<NUMBER> surpassed <NUMBER> <NUMBER> globally april <NUMBER> th <NUMBER> <NUMBER> cases <NUMBER> covid<NUMBER> confirmed <NUMBER> patients died estimated <NUMBER> billion <NUMBER> people ordered remain home governments take extreme measures <NUMBER> protect populations <NUMBER> due rapid spread increasing number covid<NUMBER> cases caused new <NUMBER> coronavirus sarscov<NUMBER> rapid accurate detection virus andor disease increasingly <NUMBER> vital control sources infection prevent progression disease <NUMBER> besides main priority finding efficient treatment one important <NUMBER> research questions targets diagnosis covid<NUMBER> currently realtime rtpcr assay <NUMBER> goldstandard method detect sars ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint study approved local ethics committee march <NUMBER> th <NUMBER> informed <NUMBER> consent obtained participant <NUMBER> study population consisted adult patients visiting infectious disease department <NUMBER> centre hospitalier regional orléans france march <NUMBER> th <NUMBER> april <NUMBER> th <NUMBER> <NUMBER> department receives patients whose symptoms headache fatigue fever <NUMBER> respiratory signs suggest covid infection diagnosis requested date <NUMBER> onset symptoms declared patient age collected inclusion according <NUMBER> severity disease patients rtpcr positive either hospitalized infectious <NUMBER> diseases ward devoted treat covid<NUMBER> infected patients invited regular <NUMBER> medical visits outpatient consultation fingertip blood samples performed various <NUMBER> stages followup even clinical cure order collect samples convalescent <NUMBER> patients <NUMBER> nasopharyngeal np swab specimens collected patients trained surveillance <NUMBER> officers polyestertipped flexible aluminumshafted applicator microtest m<NUMBER>rt remel <NUMBER> inserted one nostrils resistance felt nasopharynx rotated <NUMBER> <NUMBER> degrees withdrawn swabbing swab applicator cut absorbent <NUMBER> swab placed vial containing <NUMBER> ml viral transport media vials immediately <NUMBER> shipped via triple packaging system virology unit located building <NUMBER> hospital stored necessary <NUMBER>°c <NUMBER> hours testing <NUMBER> whole blood samples taken fingertip lancet used prick side <NUMBER> fingertip let large drop suspended blood form blood sample collected <NUMBER> <NUMBER> µl capillary micropipette filled automatically sample expelled <NUMBER> squeezing micropipette bulb deposit blood appropriate well test <NUMBER> cassette retesting performed patient previous test negative <NUMBER> rtpcr testing sarscov<NUMBER> performed unit virology chr orléans nucleic acid <NUMBER> extraction performed automated ez<NUMBER> qiagen sarscov<NUMBER> iggigm antibody test kits covidpresto ® covidduo ® <NUMBER> targeting antibodies specific nprotein sarscov<NUMBER> manufactured <NUMBER> marketed aazlmb <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint tests conducted site clinical staff physicians nurses according <NUMBER> manufacturers instructions health workers involved study received twohours training <NUMBER> session type test prior beginning study <NUMBER> covidpresto ® covidduo ® lateral flow immunechromatographic assays <NUMBER> figs <NUMBER> <NUMBER> tests use antihuman igm antibody test line igm antihuman igg <NUMBER> antibody test line igg rabbit igg control line c immobilized nitrocellulose strip <NUMBER> conjugate recombinant covid<NUMBER> antigens labeled colloidal gold also integrated <NUMBER> strip specimen added sample well followed assay buffer igm igg <NUMBER> antibodies present bind covid<NUMBER> conjugates forming antigenantibodies <NUMBER> complex complex migrates nitrocellulose membrane capillary action complex <NUMBER> meets line corresponding immobilized antibody antihuman igm andor antihuman <NUMBER> igg complex trapped forming burgundy colored band confirms reactive test <NUMBER> result result read within <NUMBER> minutes two independent operators <NUMBER> control line burgundy sample negative control line <NUMBER> appear test invalid repeated new cassette ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint overall <NUMBER> patients symptoms covid<NUMBER> went hospital diagnostic <NUMBER> included study <NUMBER> rtpcr performed patients <NUMBER> positive n<NUMBER> based results <NUMBER> two subgroups defined <NUMBER> patients negative <NUMBER> patients positive rt<NUMBER> pcr results fig <NUMBER> interestingly among patient samples collected two different times elderly woman <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> considering distribution igm igg patterns among patients positive <NUMBER> rdt test igm first antibodies detected systematically present <NUMBER> positive patients onset symptoms <NUMBER> <NUMBER> days ago n<NUMBER> covid<NUMBER> presto ® population n<NUMBER> covidduo ® igm appeared first stayed prevalent <NUMBER> <NUMBER> days viral infection igg became frequent figs <NUMBER> <NUMBER> <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> evaluate sensitivity rdts based positive rtpcr results mix <NUMBER> syndromes imagining findings rna detection <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint results present study highlight two major points firstly assessed rdt <NUMBER> sensitivity elisa tests increases duration symptom onset moreover <NUMBER> showed direct antibody typing whole blood sensitive immunoassay performed <NUMBER> serum retrospective way secondly diagnostic tests either qualitative <NUMBER> quantitative help diagnose past infection elimination virus immune <NUMBER> system thus combining rtpcr antibody detection allows largely diagnose covid<NUMBER> <NUMBER> people regardless delay infection diagnosis <NUMBER> currently extent time kinetics humoral response sarscov<NUMBER> <NUMBER> known widely accepted igm usually first responded antibody providing first <NUMBER> line defense viral infections prior generation adaptive high affinity igg <NUMBER> responses serving robust long term immunity able study <NUMBER> humoral response individual level patients could tested <NUMBER> population level patterns igmigg results obtained positive tests <NUMBER> covidduo ® made possible perceive switch first production igm <NUMBER> later onset igg coincided observations covidpresto ® determine whether person already infected sarscov<NUMBER> serologic tests <NUMBER> needed assess response vaccine candidates map levels immunity <NUMBER> communities rapid tests particularly interesting low resource settings <NUMBER> bedside locations lab tests less obvious <NUMBER> <NUMBER> <NUMBER> ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> authors report conflicts interest authors alone responsible content <NUMBER> writing paper ccbynd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint nfections upper lower respiratory tract caused diversity pathogens viral bacterial communityacquired respiratory tract infections leading cause hospitalization responsible substantial morbidity mortality especially infants elderly immunocompromised patients etiological agent infections differs greatly according season age patient highest prevalences respiratory syncytial virus rsv children influenza virus adults rapid microbiological diagnosis respiratory infection important ensure appropriate antimicrobial therapy effective implementation isolation precautions <NUMBER> last decade many conventional diagnostic methods culture antigen detection assays replaced molecular assays diagnosing respiratory tract infections multiplex realtime pcr assays developed implemented routine diagnostic application detecting wide variety pathogens <NUMBER> assays shown high sensitivity specificity limited number fluorophores used per reaction resulted need run several realtime pcr assays cover broad range relevant pathogens commercial assays using multiplex ligationdependent probe amplification mlpa dual priming oligonucleotide system dpo microarray technology developed overcome problem able detect <NUMBER> viruses simultaneously <NUMBER> <NUMBER> applications mentioned require nucleic acid extraction prior amplification routine diagnostics methods suited batchwise testing turnaround time ϳ<NUMBER> <NUMBER> h decrease time result enable random access testing syndromic diagnostic assays developed assays combine nucleic acid extraction amplification detection single cartridge per sample suitable decentralized even pointofcare testing poct time result ͻ<NUMBER> h novel rapid diagnostic cartridgebased assay detection respiratory tract pathogens using eplex system fig <NUMBER> developed genmark diagnostics inc carlsbad ca eplex respiratory pathogen panel rp panel based electrowetting technology digital microfluidic technology droplets sample reagents moved efficiently within network contiguous electrodes eplex cartridge enabling rapid thermal cycling short time result following nucleic acid extraction amplification detection identification performed using esensor detection technology fig <NUMBER> previously applied xt<NUMBER> system <NUMBER> current study performance syndromic rp panel compared laboratorydeveloped realtime pcr assays using clinical specimens previously submitted diagnosis respiratory pathogens <NUMBER> positive clinical specimens contained total <NUMBER> respiratory pathogens detected laboratorydeveloped realtime pcr assays table <NUMBER> shown table <NUMBER> <NUMBER> nonnasopharyngeal nonnps specimens comprised <NUMBER> total <NUMBER> respiratory pathogens testing samples rp panel resulted overall agreement <NUMBER> <NUMBER> targets <NUMBER> specimens prior discrepant analysis specimens containing single pathogen detected targets concordant <NUMBER> specimens samples coinfection pathogens could identified <NUMBER> <NUMBER> <NUMBER> case <NUMBER> <NUMBER> <NUMBER> pathogens present respectively eight <NUMBER> discordant targets pcr ϩ rp ϫ positive result threshold cycle c values ͼ<NUMBER> fig <NUMBER> retesting third assay confirmed <NUMBER> <NUMBER> realtime pcrpositive targets human bocavirus hbov n ϭ <NUMBER> rhinovirus rv n ϭ <NUMBER> parainfluenza virus type <NUMBER> piv<NUMBER> n ϭ <NUMBER> human coronavirus hcov oc<NUMBER> n ϭ <NUMBER> hcov <NUMBER>e n ϭ <NUMBER> hcov hku<NUMBER> n ϭ <NUMBER> human metapneumovirus hmpv n ϭ <NUMBER> two unresolved pcr ϩ rp ϫ results consisted two hmpvpositive samples c values <NUMBER> <NUMBER> rp panel yielded positive result <NUMBER> specimens laboratorydeveloped test ldt remained negative pcr ϫ rp ϩ including <NUMBER> additional pathogens previously undetected ldt <NUMBER> positive specimens one influenza h<NUMBER>n<NUMBER> <NUMBER> virus detected influenza virus ldt table <NUMBER> seven <NUMBER> additional targets could confirmed including three rventerovirus ev confirmed rv two piv<NUMBER> one hbov hcov nl<NUMBER> one selected negative samples tested positive human adenovirus hadv rp panel could confirmed discrepant testing negative specimens tested negative rp panel well middle east respiratory syndrome coronavirus merscov isolates could detected rp panel testing <NUMBER>fold dilution series isolates shown merscov c value ͻ<NUMBER> laboratorydeveloped realtime pcr assay could detected using rp panel detection c value ͼ<NUMBER> achievable reproducible every instance <NUMBER> specimens quality control molecular diagnostics qcmd <NUMBER> respiratory ii pilot external quality assessment eqa study panel <NUMBER> detected full agreement content reported qcmd table <NUMBER> <NUMBER> falsenegative tested specimens contained hcov nl<NUMBER> one coinfection hmpvpositive sample specimens tested laboratorydeveloped realtime pcr assay well found positive hcov nl<NUMBER> c values <NUMBER> qnostics evaluation panel consisted <NUMBER> samples including <NUMBER> different respiratory pathogens one negative sample table <NUMBER> rp panel detected <NUMBER> specimens agreement content whereas hadv type <NUMBER> chlamydophila pneumoniae detected realtime pcr detection specimens performed confirm presence respective pathogen specimen found positive hadv c value <NUMBER> c pneumoniae c value <NUMBER> hybridized molecule exposed another sequencespecific probe bound solid phase gold electrode upon binding two molecules ferrocene comes close proximity gold electrode electron transfer measured using genmarks esensor technology eplex system occur b performance eplex rp panel assessed retrospective testing <NUMBER> clinical respiratory specimens obtained <NUMBER> <NUMBER> comprising five different types specimens although rp panel ce vitro diagnostic ceivd cleared detection respiratory pathogens nps swabs included range alternate sample types obtained tested respiratory pathogens diagnostic setting including total <NUMBER> respiratory nonnps specimens different pathogens table <NUMBER> shown rp panel able accurately detect pathogens different types specimens assay showed <NUMBER> concordance ldt sputum samples preprocessing sputasol introduced initial <NUMBER> tested specimens since <NUMBER> falsenegative result found resolved retesting sputasol pretreatment studies need determine frequency preprocessing sputum samples efficiently running rp panel specimens inclusion study previously tested two different sites using systems validated assays although initial setups ldt assays <NUMBER> <NUMBER> minor adjustments assays use different pcr platforms may affect performance ldts therefore limitation study comparison results rp panel results routine multiplex realtime pcr showed agreement <NUMBER> <NUMBER> pathogens tested targets c value ͼ<NUMBER> rp panel showed good detection rates regard lower viral bacterial loads well fig <NUMBER> although performance rp panel appeared excellent using tested specimens study piv<NUMBER> n ϭ <NUMBER> c pneumoniae n ϭ <NUMBER> number clinical specimens could analyzed low proper assessment assay limitation study <NUMBER> different specimens rp panel identified <NUMBER> pathogens detected routine testing pcr ϫ rp ϩ addition one influenza virus detected ldt could detected influenza h<NUMBER>n<NUMBER> <NUMBER> virus rp panel one selected negative samples shown contain hadv pcr ϫ rp ϩ targets detected copathogens positive targets samples pcr ϫ rp ϩ targets found samples obtained <NUMBER> institute discrepant analysis small number ldtnegative specimens n ϭ <NUMBER> included study since main objective study determine performance rp panel detecting respiratory pathogens although limitation current study believe issue addressed extensively upcoming prospective clinical studies owing lack clinical specimens containing merscov dilutions two different culture isolates tested study dilutions c values ͻ<NUMBER> shown laboratorydeveloped realtime pcr assay could detected consistently noted realtime pcr assay developed research use yet validated clinical use assessment rp panel using eqa samples qcmd qnostics showed results line results obtained clinical specimens total <NUMBER> targets included eqa samples could detected using rp panel showing c values ͼ<NUMBER> n ϭ <NUMBER> <NUMBER> n ϭ <NUMBER> tested realtime pcr rp panel eplex system enables rapid testing used diagnostic system either laboratory decentralized setting closer patient assay turned rapid straightforward perform compared routine testing handson time rp panel low ͻ<NUMBER> min whereas handson time routine testing <NUMBER> <NUMBER> min depending nature number samples tested overall run time platforms also favor eplex system takes approximately <NUMBER> min nucleic acid extraction amplification hybridization detection whereas routine testing takes <NUMBER> h <NUMBER> min using different systems multiple realtime pcr assays multiplex important advantage eplex system possibility random access testing compared batchwise testing current diagnostic realtime pcr approach relatively short turnaround time potential randomly load run <NUMBER> specimens eplex system suitable testing stat samples require immediate testing contrast ldts c values represent quantitative indicator eplex system generates qualitative results c value dependent many different factors sample type course infection therefore differ greatly even within single patient hence qualitative result eg identification pathogen major factor patient management costs reagents per sample relatively high eplex compared ldt however taking account handson time technicians clinical benefit rapid results assay likely costeffective studies evaluating rapid diagnostic assay respiratory pathogens filmarray respiratory panel biofire diagnostics salt lake city ut already shown impact rapid diagnostics respiratory pathogens since decreased duration antibiotic use length hospitalization time isolation delivering financial savings <NUMBER> <NUMBER> although rp panel eplex system potential clinical studies remain conducted fulfill potential conclusion study shows excellent performance genmark eplex rp panel comparison laboratorydeveloped realtime pcr assays detection respiratory pathogens multiple types clinical specimens eqa samples system provides large amount useful diagnostic data within short time frame minimal handson time helping reduce laboratory costs labor deliver faster result clinician order aid appropriate antimicrobial therapy therefore syndromebased diagnostic assay could used rapid diagnostic testing many different settings clinical specimens selected study previously submitted tested prospectively diagnosis respiratory infections either specialist virology center royal infirmary edinburgh rie medical microbiology laboratory leiden university medical center lumc specimens selected using laboratory information management system corresponding institute without prior selection based c value ethical approval study granted medical ethical committee provided anonymized samples used diagnostic testing labdeveloped tests short routine testing method consisted total nucleic acid extraction nuclisens easymag system ϳ<NUMBER> min biomérieux basingstoke united kingdom magna pure lc system ϳ<NUMBER> min <NUMBER> h <NUMBER> min depending number samples roche diagnostics almere netherlands rie lumc respectively input volume <NUMBER> l per specimen elution volume <NUMBER> l used specimen types amplification detection performed realtime pcr using abi <NUMBER> fast thermocycler <NUMBER> h applied biosystems paisley united kingdom biorad cfx<NUMBER> thermocycler ϳ<NUMBER> h <NUMBER> min biorad veenendaal netherlands rie lumc respectively realtime pcr assays tested updated versions needed primers probes described previously <NUMBER> <NUMBER> rp panel original clinical specimens retrieved storage ϫ<NUMBER>°c thawed room temperature vortexing <NUMBER> l specimen pipetted sample delivery device buffer provided manufacturer <NUMBER> <NUMBER> sputum samples preprocessing done using sputasol oxoid basingstoke united kingdom according manufacturers procedures exception washing sputum incubation <NUMBER>°c <NUMBER> min shaker <NUMBER> rpm gentle mixing specimen buffer sample delivery device mixture dispensed cartridge using sample delivery port subsequently closed sealing cap scanning barcode eplex rp panel cartridge barcode corresponding sample cartridge inserted available bay eplex system test started automatically ran approximately <NUMBER> min single cartridge rp panel able detect <NUMBER> respiratory pathogens including differentiation subtypes influenza virus parainfluenza virus respiratory syncytial virus rsv table <NUMBER> internal controls extraction bead delivery movement within cartridge present well amplification digestion hybridization dna rna targets every specimen tested sample detection report created comprising results targets internal controls results targets reported positive detected internal control fails noted detection report samples retested new cartridge discrepant testing case discrepant results discordant sample retested either new eplex cartridge realtime pcr positive rp panel negative pcr ϩ rp ϫ laboratorydeveloped realtime pcr assay case pcr ϫ rp ϩ results unresolved discrepancies additional testing third pcr assay different primers probe performed final resolution one many challenges containing spread <NUMBER> covid<NUMBER> ability identify asymptomatic cases <NUMBER> result spreading virus close contacts study <NUMBER> passengers diamond princess cruise ship forced <NUMBER> temporary quarantine early outbreak covid<NUMBER> <NUMBER> estimated asymptomatic proportion among infected <NUMBER> cases <NUMBER> <NUMBER>cri <NUMBER>−<NUMBER> <NUMBER> therefore actual <NUMBER> number sarscov<NUMBER>infected individuals may much <NUMBER> higher currently accounted based positive test <NUMBER> results <NUMBER> accurate convenient rapid testing wide<NUMBER> spread deployment aid eliminating silent spread <NUMBER> covid<NUMBER> asymptomatic viral carriers table <NUMBER> section <NUMBER> <NUMBER> supporting information table s<NUMBER> <NUMBER> table <NUMBER> section <NUMBER> <NUMBER> supporting information <NUMBER> rtpcr tests constantly evolving improved detec<NUMBER> tion methods automated procedures example <NUMBER> eplex sarscov<NUMBER> test developed genmark diagnostics <NUMBER> inc <NUMBER> uses true sampletoanswer solution eplex instru<NUMBER> ment detect sarscov<NUMBER> nasopharyngeal swabs test <NUMBER> cartridge contains reagents magnetic solidphase extraction rtpcr creates cdna copy specific segment viral rna converted dsdna exponentially amplified although rtpcr widely used method <NUMBER> detecting sarscov<NUMBER> infections disadvantage <NUMBER> requiring expensive laboratory instrumentation highly skilled <NUMBER> laboratory personnel take days generate results <NUMBER> result number companies laboratories around <NUMBER> globe working improve efficiency <NUMBER> timeliness rtpcr technologies develop various <NUMBER> techniques <NUMBER> <NUMBER> isothermal nucleic acid amplification rtpcr <NUMBER> requires multiple temperature changes cycle involving <NUMBER> sophisticated thermal cycling equipment <NUMBER> isothermal nucleic <NUMBER> acid amplification alternative strategy allows ampli<NUMBER> fication constant temperature eliminates need <NUMBER> thermal cycler therefore several methods based prin<NUMBER> ciple developed shown table <NUMBER> step <NUMBER> <NUMBER>′end viral rna reverse transcriptase bip primer initiate conversion rna cdna step <NUMBER> end dna polymerase b<NUMBER> primer continue generate second cdna strand displace release first cdna strand step <NUMBER> fip primer binds released cdna strand dna polymerase generates complementary strand step <NUMBER> f<NUMBER> primer binds <NUMBER>′ end dna polymerase generates new strand displacing old strand lamp cycling produces various sized doublestranded looped dna structures containing alternately inverted repeats target sequence detected dna indicator dye reagents primers master mix containing reverse transcriptase dna polymerase strand displacing activity dntps buffers <NUMBER> platform distinctive high testing throughput <NUMBER> <NUMBER> tests <NUMBER> h capability simultaneously <NUMBER> screen common respiratory viruses whose symptoms <NUMBER> overlap covid<NUMBER> using patient sample <NUMBER> collection vial <NUMBER> initial step involves hybridization viral rna <NUMBER> target specific capture probe additional oligonu<NUMBER> cleotide containing t<NUMBER> promoter primer captured <NUMBER> onto magnetic microparticles application magnetic <NUMBER> field captured rna target hybridized t<NUMBER> pro<NUMBER> moter primer reverse transcribed complementary <NUMBER> cdna rnase h activity reverse transcriptase sub<NUMBER> sequently degrades target rna strand hybrid <NUMBER> rna−cdna duplex leaving singlestranded cdna <NUMBER> includes t<NUMBER> promoter additional primer used gen<NUMBER> erate doublestranded dna subsequently tran<NUMBER> scribed rna amplicons t<NUMBER> rna polymerase <NUMBER> new rna amplicons reenter tma process allowing <NUMBER> exponential amplification process generate billions <NUMBER> rna amplicons less <NUMBER> h detection process <NUMBER> involves use singlestranded nucleic acid torches <NUMBER> hybridize specifically rna amplicon real time <NUMBER> torch conjugated fluorophore quencher <NUMBER> torch hybridizes rna amplicon fluorophore able <NUMBER> emit signal upon excitation <NUMBER> <NUMBER> crisprbased assays clustered regularly interspaced <NUMBER> short palindromic repeats crispr represents family <NUMBER> nucleic acid sequences found prokaryotic organisms <NUMBER> bacteria sequences recognized cut set <NUMBER> bacterial enzymes called crisprassociated enzymes exem<NUMBER> plified cas<NUMBER> cas<NUMBER> cas<NUMBER> certain enzymes <NUMBER> cas<NUMBER> cas<NUMBER> families programmed target <NUMBER> cut viral rna sequences <NUMBER> <NUMBER> two companies mammoth biosciences sherlock <NUMBER> biosciences established crispr pioneer scientists <NUMBER> independently exploring possibility using gene<NUMBER> editing crispr methodology detection sarscov<NUMBER> <NUMBER> sherlock method developed sherlock biosciences <NUMBER> uses cas<NUMBER> capable excising reporter rna sequences <NUMBER> response activation sarscov<NUMBER>specific guide rna <NUMBER> <NUMBER> detectr assay mammoth biosciences relies <NUMBER> cleavage reporter rna cas<NUMBER>a specifically detect <NUMBER> viral rna sequences e n genes followed iso<NUMBER> thermal amplification target resulting visual readout <NUMBER> fluorophore <NUMBER> crisprbased methods depicted <NUMBER> figure <NUMBER> require complex instrumentation <NUMBER> read using paper strips detect presence <NUMBER> sarscov<NUMBER> virus without loss sensitivity specificity <NUMBER> sarscov<NUMBER> allows potential contact tracing molecular <NUMBER> epidemiology studies viral evolution metagenomics <NUMBER> approaches sequenceindependent single primer <NUMBER> amplification sispa provide additional checks sequence <NUMBER> divergence dual technique particularly relevant <NUMBER> sarscov<NUMBER> assessment rate mutation detect <NUMBER> possible recombination human coronaviruses <NUMBER> implications vaccine development <NUMBER> antiviral efficacy <NUMBER> amplicon metagenomics minion based sequencing <NUMBER> used moore et al <NUMBER> rapidly within <NUMBER> h <NUMBER> sequence genome sarscov<NUMBER> micro<NUMBER> biome nasopharyngeal swabs obtained patients <NUMBER> covid<NUMBER> isaric <NUMBER>c consortium <NUMBER> amplicon<NUMBER> based system group chose <NUMBER> primer binding sites con<NUMBER> served regions sarscov<NUMBER> genome sequentially <NUMBER> amplify roughly <NUMBER> bp fragments approximately <NUMBER> bp <NUMBER> overlapping region primer sets used gen<NUMBER> erate <NUMBER> amplicons cdna subsequently <NUMBER> sequenced using minion <NUMBER> nextgeneration shotgun metagenomics sequencing plat<NUMBER> form developed illumina ability <NUMBER> detect presence multiple strains coronaviruses <NUMBER> also comprehensively examine multiple pathogenic organi<NUMBER> sms present complex sample illumina metagenomics <NUMBER> workflow involves sample preparation using truseq ribo<NUMBER> zero gold rrna depletion kit library preparation using truseq <NUMBER> stranded total rna sequencing using illumina benchtop <NUMBER> <NUMBER> rtpcrbased viral rna detection widely <NUMBER> used diagnosis covid<NUMBER> cannot used monitor <NUMBER> progress disease stages cannot applied <NUMBER> broad identification past infection immunity <NUMBER> serological testing defined analysis blood serum <NUMBER> plasma operationally expanded include testing <NUMBER> saliva sputum biological fluids presence <NUMBER> immunoglobulin igm immunoglobulin g igg <NUMBER> antibodies test plays important role epidemiology <NUMBER> vaccine development providing assessment shortterm <NUMBER> days weeks longterm years permanence trajectories <NUMBER> antibody response well antibody abundance <NUMBER> diversity igm first becomes detectable serum days <NUMBER> lasts couple weeks upon infection followed <NUMBER> switch igg thus igm indicator early stage infec<NUMBER> tion igg indicator current prior infection <NUMBER> igg may also used suggest presence postinfection <NUMBER> immunity recent years sophistication sensitivity <NUMBER> immunological assays increased detection <NUMBER> antibodies also application antibodies <NUMBER> primarily monoclonal antibodies detection pathogen<NUMBER> derived antigens tests huge potential epide<NUMBER> miology covid<NUMBER> <NUMBER>−<NUMBER> test results impacted <NUMBER> least three situations <NUMBER> subset subjects positive <NUMBER> result molecular genetic assays sarscov<NUMBER> infection <NUMBER> seronegative due lag antibody production following <NUMBER> infection <NUMBER> subjects may seropositive yet negative <NUMBER> molecular genetic assay results reflecting clearance earlier <NUMBER> milder infection <NUMBER> limitation sensitivity specificity <NUMBER> assays last issue particularly important even <NUMBER> small percentage false positive results due low specificity <NUMBER> cross reaction may lead misleading predictive antibody <NUMBER> prevalence among given population may unde<NUMBER> sirable impact socioeconomic decisions overall <NUMBER> public confidence results <NUMBER> <NUMBER> determination sarscov<NUMBER> exposure relies largely <NUMBER> detection either igm igg antibodies <NUMBER> specific various viral antigens including exclusively <NUMBER> spike glycoprotein s<NUMBER> s<NUMBER> subunits receptorbinding <NUMBER> domain nucleocapsid protein methodology <NUMBER> determinations includes traditional enzymelinked immu<NUMBER> nosorbent assay elisa immunochromatographic lateral flow <NUMBER> assay neutralization bioassay specific chemosensors <NUMBER> formats brings advantages speed multiplexing <NUMBER> automation disadvantages trained personnel dedicated <NUMBER> laboratories complementary antibodydetecting <NUMBER> methods rapid antigen tests wherein antibodies <NUMBER> used detect presence viral antigens serological <NUMBER> samples development highthroughput serology tests <NUMBER> current focus major diagnostic companies <NUMBER> fda <NUMBER> granted eua status first serology test qsarscov<NUMBER> <NUMBER> iggigm rapid test manufactured cellex inc april <NUMBER> <NUMBER> <NUMBER> <NUMBER> continues allow clinical laboratories com<NUMBER> mercial manufacturers launch serology tests without <NUMBER> eua <NUMBER> elisa microwell platebased assay technique designed <NUMBER> detecting quantifying substances peptides pro<NUMBER> teins antibodies hormones test qualitative <NUMBER> quantitative time results typically <NUMBER>−<NUMBER> h <NUMBER> case sarscov<NUMBER> shown figure <NUMBER>a plate wells neutralization assays deter<NUMBER> mine ability antibody inhibit virus infection cul<NUMBER> tured cells resulting cytopathic effects viral replica<NUMBER> tion assay patient samples whole blood serum <NUMBER> plasma diluted added decreasing concentrations <NUMBER> cell cultures neutralizing antibodies present <NUMBER> levels measured determining threshold <NUMBER> able prevent viral replication infected cell <NUMBER> cultures time results neutralization assays <NUMBER> typically <NUMBER>−<NUMBER> days recent advances reduced <NUMBER> hours <NUMBER> type testing requires cell culture facilities <NUMBER> case sars coronavirus biosafety level <NUMBER> bsl<NUMBER> <NUMBER> laboratories despite limitations determination neu<NUMBER> tralizing antibodies important short term <NUMBER> therapeutic application convalescent plasma long <NUMBER> term vaccine development biosensor tests rely converting <NUMBER> specific interaction biomolecules measurable readout <NUMBER> via optical electrical enzymatic methods surface <NUMBER> plasmon resonance spr technique measures inter<NUMBER> ference incident light solid boundary due local <NUMBER> disturbances adsorption antibody antigen <NUMBER> sprbased biosensor developed diagnosis <NUMBER> sars using coronaviral surface antigen scvme anchored <NUMBER> onto gold substrate <NUMBER> spr chip lower limit detec<NUMBER> tion <NUMBER> ngml antiscvme antibodies within <NUMBER> min <NUMBER> recently pathsensors inc announced canary bio<NUMBER> sensor detect novel sars coronavirus platform <NUMBER> utilizes cellbased immunosensor couples capture <NUMBER> virus signal amplification provide result <NUMBER>−<NUMBER> min <NUMBER> biosensor slated available research purposes <NUMBER> may <NUMBER> <NUMBER> <NUMBER> <NUMBER> rapid antigen test complementary molecular <NUMBER> genetic assays rapid antigen tests allow detection <NUMBER> viral antigens <NUMBER> <NUMBER> shown figure <NUMBER>b tests rely <NUMBER> specific monoclonal antibodies provide mechanism <NUMBER> capture viral antigens analytical sample assays <NUMBER> restricted particular format examples include <NUMBER> colorimetric enzyme immunoassay sarscov <NUMBER> <NUMBER> <NUMBER> enhanced chemiluminescent immunoassay sarscov <NUMBER> <NUMBER> <NUMBER> recently fluorescence lateral flow assay <NUMBER> <NUMBER> detection sarscov<NUMBER> nucleocapsid protein table <NUMBER> <NUMBER> provides collection current available serological immuno<NUMBER> logical assays covid<NUMBER> diagnosis complete list simi<NUMBER> lar assays provided supporting information table s<NUMBER> <NUMBER> past months witnessed rapid progress <NUMBER> diagnostic kit development covid<NUMBER> race continues <NUMBER> develop even efficient laboratory techniques cost<NUMBER> effective pointofcare test kits deployed mass <NUMBER> quantities report provides broad survey molecular <NUMBER> genetic assays serological immunological tests <NUMBER> identification covid<NUMBER> infection rtpcr <NUMBER> dominant technique detection viral rna <NUMBER> nucleic acid assays including isothermal amplification assays <NUMBER> hybridization microarray assays ampliconbased metagenomics <NUMBER> sequencing cuttingedge crisprrelated technologies <NUMBER> also development resulted approved <NUMBER> tests <NUMBER> efficiency testing also significantly <NUMBER> improved report also provides trend analysis journal <NUMBER> articles related covid<NUMBER> diagnostic techniques <NUMBER> number fda euaapproved tests available covid<NUMBER> <NUMBER> diagnosis keeps growing many new tests still <NUMBER> various stages development ultrarapid test kits point<NUMBER> ofcare tests major focus development order speed <NUMBER> response time treatment eliminate need <NUMBER> elaborate laboratory equipment waiting time involved <NUMBER> testing approved laboratories <NUMBER> urgent need accurate rapid diagnosis sarst<NUMBER> <NUMBER> cov<NUMBER> infection remains critical global healthcare systems <NUMBER> continue operate course covid<NUMBER> pan<NUMBER> demic particular serological immunological testing <NUMBER> infected asymptomatic symptomatic individuals <NUMBER> close contacts expected high demand addition <NUMBER> role complementary molecular genetic testing confirm <NUMBER> suspected cases type testing would provide valuable <NUMBER> information course degree immune response <NUMBER> well durability immunity infected indi<NUMBER> viduals participants vaccine clinical trials results <NUMBER> tests may assist epidemiological assessment <NUMBER> used manage return normal activities however <NUMBER> many questions regarding serological tests remain addressed <NUMBER> including degree sensitivity specificity finally <NUMBER> remains confirmed presence antibodies <NUMBER> sarscov<NUMBER> indeed correlates immunity virus <NUMBER> summary significant progress made devel availability pathogenspecific treatment options respiratory tract infections rtis increased need rapid diagnostic tests besides retrospective studies improved labbased detection methods intensified search new viruses since beginning twentyfirst century led discovery several novel respiratory viruses among human bocavirus hbov human coronaviruses hcovhku<NUMBER> nl<NUMBER> human metapneumovirus hmpv rhinovirus type c rvc human polyomaviruses kipyv wupyv additionally new viruses like sars coronavirus sarscov mers coronavirus merscov novel strains influenza virus b recently sars coronavirus <NUMBER> sarscov<NUMBER> emerged although clinical presentation may similar among different viruses associated symptoms may range mild cold severe respiratory illness thus require fast reliable diagnosis increasing number commercially available rapid pointofcare tests pocts respiratory viruses illustrates need kind tests also problem ie majority assays significant limitations review summarize recently published characteristics pocts discuss implications treatment rtis second key aspect work description new innovative diagnostic techniques ranging biosensors novel portable current labbased nucleic acid amplification methods potential future use pointofcare settings prototypes methods already exist ideas still experimental give outlook expected next generation pocts keywords virus diagnostics innovative approaches biosensors bedside testing poct commercial pointofcare tests introduction respiratory viruses influenza viruses iav human respiratory syncytial virus rsv wellknown circulate worldwide associated significant morbidity mortality iuliano et al <NUMBER> shi et al <NUMBER> hand emerging infectious diseases according definition hitherto unknown rare rapidly spreading either number cases geographically <NUMBER>a last <NUMBER> years addition emergence novel influenza coronaviruses advances molecular detection methods led discovery new respiratory viruses already circulating worldwide jartti et al <NUMBER> <NUMBER> human metapneumovirus hmpv discovered van den hoogen et al <NUMBER> outbreaks severe acute respiratory syndrome coronavirus sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov since april <NUMBER> sarscov<NUMBER> since december <NUMBER> highlight danger emerging zoonotic highly pathogenic respiratory viruses fouchier et al <NUMBER> zaki et al <NUMBER> <NUMBER>c two coronaviruses human coronaviruses hcov nl<NUMBER> hku<NUMBER> discovered <NUMBER> <NUMBER> respectively van der hoek et al <NUMBER> woo et al <NUMBER> <NUMBER> allander et al described new member family parvoviridae human bocavirus hbov allander et al <NUMBER> two new human polyomaviruses ki wu kipyv wupyv first discovered <NUMBER> allander et al <NUMBER> gaynor et al <NUMBER> although often detected samples role causality respiratory illness still discussion reviewed jartti et al <NUMBER> <NUMBER> human rhinovirus group c rvc introduced newly sequenced strains differed significantly existing groups b lee et al <NUMBER> finally avian influenza viruses aiv iav h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> crossed species barrier infect humans several times last years reviewed kim et al <NUMBER> labbased techniques still dominate field virus diagnostics classical methods virus cultures electron microscopy serology complemented nucleic acid amplification tests naats sequencing including next generation sequencing different antigen detection methods today clinical settings naats replaced virus cultures gold standard due high specificity faster turnaround times absence limitations posed need susceptible cell lines fox <NUMBER> contrast labbased tests pointofcare tests pocts performed site sample collection eg bedside physicians office emergency department provide results usually <NUMBER> h basile et al <NUMBER> vos et al <NUMBER> furthermore require little handson time specific laboratory training critical steps automated single device latter may range handheld benchtop size designed highthroughput sample processing pocts fast diagnostic tests performed laboratories provide results within <NUMBER> h may called nearpocts prompt identification causative pathogen may help responsible healthcare professional choosing appropriate treatment take right decisions outbreak situations regarding hospitalization quarantine brendish et al <NUMBER> review provide brief overview currently available pocts diagnosis emerging new respiratory viruses along advantages limitations discuss recently published approaches techniques potential use future pocts diagnosis commonly encountered respiratory viruses iav influenza b virus ibv rsv many commercially available pocts nearpocts different sensitivities specificities virus available supplementary table <NUMBER> however recent metaanalysis demonstrated three newer generation rapid multiplex polymerase chain reaction systems mpcrs biomérieuxbiofire r filmarray r rp nanosphere verigene r rv test hologic genprobe prodesse assays highly accurate though usually expensive may provide important diagnostic information early identification iav ibv rsv huang h et al <NUMBER> rabold waggoner <NUMBER> diagnosis emerging novel viruses including hbov rvc coronaviruses eg hcovhku<NUMBER> hcovnl<NUMBER> sarscov<NUMBER> well specific subtypes aiv h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> reassortant iav strains remains challenging schuster williams <NUMBER> <NUMBER>a diagnosis viruses based molecular techniques performed specialized referral centers recently increased interest using pocts settings emergency departments although implementation might hampered need specific training bouzid et al <NUMBER> naats higher sensitivity immunochromatographic assays generally require higher degree technical skills training drancourt et al <NUMBER> polymerase chain reaction pcr remains gold standard technique diagnosis aiv subtypes recommends utilization rapid tests avian flu diagnosis <NUMBER> monne et al <NUMBER> schuster williams <NUMBER> rvc typically detected nasopharyngeal specimens using reverse transcriptase pcr rtpcr specific species serotypes identified seminested pcrs sequencing bochkov et al <NUMBER> jartti et al <NUMBER> schuster williams <NUMBER> diagnosis hbov based detection specific igm antibody along <NUMBER>fold increase igg titer low igg avidity indicative seroconversion adaptive immune response requires several hours even days develop thus utility tests acute settings limited soderlundvenermo et al <NUMBER> hbov dna persists airway secretions months acute infection quantitative pcr along serology currently preferred diagnostic methods christensen et al <NUMBER> viral dnaemia mrna detection via rtpcr antigen immunodetection assays shown promising results studies define sensitivity specificity applicability clinical practice needed soderlundvenermo et al <NUMBER> christensen et al <NUMBER> christensen et al <NUMBER> christensen et al <NUMBER> proencamodena et al <NUMBER> xu et al <NUMBER> detection kipyv wupyv found secretion symptomatic asymptomatic patients based pcr serology testing neske et al <NUMBER> touze et al <NUMBER> jartti et al <NUMBER> sarscov<NUMBER> hcovnl<NUMBER> hku<NUMBER> well hmpv diagnosis based primarily rtpcr methods van den hoogen et al <NUMBER> nichols et al <NUMBER> jartti et al <NUMBER> <NUMBER>a data available fluorescent antibody rapid cultures enzyme immunoassay eia diagnostic tests coronaviruses nl<NUMBER> hku<NUMBER> whereas fluorescent antibody assays may utility hmpv nichols et al <NUMBER> jartti et al <NUMBER> hmpv specifically multiplex ligationdependent probe amplification mlpa nasopharyngeal swab high sensitivity specificity rates <NUMBER> <NUMBER> respectively reijans et al <NUMBER> panda et al <NUMBER> hoppe et al <NUMBER> available tests extinct sarscov include antibody testing using eia rtpcr tests respiratory blood stool specimens cdc <NUMBER> detection merscov epicenter arabian peninsula united states centers disease control prevention cdc recommend sampling lower respiratory tract realtime rtpcr rrtpcr testing specific primers since appears sensitive testing upper respiratory tract specimens <NUMBER>bc cdc <NUMBER> naats proven highly accurate easily scalable tests large outbreaks novel emerging viruses like sarscov<NUMBER> pandemic rapid genome sequencing analysis accommodates fast development reliable inhouse commercially available naats reagents shortly outbreak onset cdc <NUMBER> <NUMBER>b biosensors reliable costeffective way detect specific pathogens pointofcare settings different types sensors rapid identification respiratory viruses developed recently using goldcoated array carbon electrodes authors able detect merscov spike protein picogram range within <NUMBER> min layqah eissa <NUMBER> electrochemical assay based competitive binding merscov antibody either virus sample immobilized antigen electrode measured reduced peak current chip theory technique easily expanded simultaneously detect multiple viruses however diagnostic performance needs validated use patient samples different types biosensors aiv detection use nanobio hybrid materials reviewed lee et al <NUMBER> one approaches dna probe coupled fieldeffect transistor enabled detection target dna <NUMBER> fm lin et al <NUMBER> another sensitive technique based surface plasmon resonance spr biomolecules bound metal surface lead reduction reflection incident light beam tang et al <NUMBER> chang et al <NUMBER> new antibody recombinant aiv h<NUMBER>n<NUMBER> authors able reach detection limit hundred copies per ml nasal fluid within <NUMBER> min processing time although still experimental characteristics approach render promising candidate future rapid poct capillary convective pcr ccpcr reagents circulate across temperature gradient simple capillary tube allows run times shorter <NUMBER> min chou et al <NUMBER> together selfmade dipstick detection method principle already used test nonrespiratory viruses like hepatitis c virus zhang et al <NUMBER> zhang et al <NUMBER> zhou et al integrated method <NUMBER> kg device automation detection different iav strains zhuo et al <NUMBER> although fast sensitive manual rna extraction limits use poct far hardick et al presented another portable naat device detection iav also ibv rsv merscov based rtpcr microfluidic cards likewise lacks automated nucleic acid extraction hardick et al <NUMBER> alternatively nucleic acidbased techniques giant magnetoresistive gmr biosensors function comparable enzymelinked immunosorbent assay use magnetic labels instead enzymes fluorophores coupled detection antibodies hall et al <NUMBER> sensor wu et al constructed handheld device connection computer smartphone able detect iav h<NUMBER>n<NUMBER> purified disrupted virus solutions wu et al <NUMBER> although h<NUMBER>n<NUMBER> strains circulating already since <NUMBER> human population smith et al <NUMBER> method likely adaptable emerging aivs use appropriate capture antibodies designing prototype lateral flow assay approximately <NUMBER> us huang et al proved simultaneous detection iav ibv swab samples possible low costs huang et al <NUMBER> however sensitivity prototype needs significant improvements used clinical conditions instead constructing completely new apparatus cui et al used commercially available glucose test strips together specifically designed glucosebearing substrates test cleavage activity iav neuraminidase spiked samples cui et al <NUMBER> although majority presented approaches prototypes focuses detection influenza viruses theoretically applied emerging new viruses minor changes comparison pcrs isothermal naats require complex devices working extracted nucleic acids reverse transcription strand invasionbased amplification rtsiba reverse transcription loopmediated isothermal amplification rtlamp two examples used detect eg hmpv song et al <NUMBER> iav eboigbodin et al <NUMBER> merscov huang p et al <NUMBER> wang et al went integrate seven rtlamp assays microfluidic chip multiplex detection different respiratory viruses device weighing <NUMBER> kg another chipbased system named iroad uses reverse transcriptionbased recombinase polymerase amplification rtrpa able rapidly identify iav different hcovs respiratory viruses extracted nucleic acids koo et al <NUMBER> development new laboratory pointofcare diagnostic tests influenza rsv emerging respiratory viruses taken pace recent years healthcare professionals hospital managers laboratory directors need update reevaluate best practices regularly advancement diagnostic capabilities may change way identify document communicate respiratory viral infections future along developments expectations patients healthcare professionals may change well ie patients want know responsible pathogen clinical prognosis development specific antiviral therapies vaccines new diagnostic algorithms needed ensure highest quality care containing costs viewpoint quality care clinical management timely infection control ability act upon results future likely belong portable cliawaived rapid diagnostic tests take <NUMBER> min key criterion evaluation diagnostic tests clinical utility ie ability identify current culprit patients symptoms distinguish relevant pathogens bystander pathogens research needed correlate clinical outcomes laboratory data second concern correct timing diagnostic testing regards patients course illness sensitivity positive predictive value diagnostic test depend specimen quality virus load usually higher children early course illness duration viral shedding patients immune status future diagnostic algorithms need consider factors addition epidemiology viruses respective season region initial criticism pocts directed toward lack sensitivity high degree variability test results early studies <NUMBER> flu pandemic reported sensitivities influenza pocts ranging <NUMBER> <NUMBER> test kit rath et al <NUMBER> published evaluation studies entirely clear whether pocts performed bedside whether samples sent laboratory would constitute nearpoct methodological inconsistencies also impaired value metaanalyses comparing pointofcare performance different commercial tests chartrand et al <NUMBER> reported performance differences also hint fact training experience staff performing test impact procedural concerns pronounced earlystage lateral flow strip tests result read manually secondgeneration antigen pocts modern molecular pocts achieve significantly higher reproducibility sensitivity automation key steps process <NUMBER> fda implemented new performance regulations setting new sensitivity thresholds required pocts maintain approval fda <NUMBER> result several influenza pocts taken market role regulators setting quality standards pocts cannot underestimated zhang et al <NUMBER> azar landry <NUMBER> addition reliability poct result handson time timetoresult still critical useracceptance bedside expected future pocts robust easier use majority acute respiratory infections ari viral origin infections common reasons inappropriate antibiotic use harris et al <NUMBER> tief et al <NUMBER> studies raised expectation expanded use virus diagnostics pointofcare may help limit use antibiotics bonner et al <NUMBER> european health action plan amr european parliament <NUMBER> oneill report tackling drugresistant infections globally oneill <NUMBER> point rapid diagnostics key instrument tackling amr including pocts antimicrobial stewardship programs might increase acceptance physicians ability direct right treatment right patient right time facilitates precision medicine future advanced virus diagnostics may combined biomarker pocts prediction individuallevel host responses target treatment likely benefit major obstacle expanding use pocts cost fact pocts would impactful settings majority early treatment decisions made current pricing schemes however seem high broadscale testing community emergency departments addition pricing reimbursement strategies need reconsidered even hospital emergency rooms percapita standard reimbursements disincentivize use virus diagnostics patients ari uptodate economic models needed clarify costeffectiveness different types pocts steepest increase antimicrobial resistance observed lowmiddle income countries lmic whopaho <NUMBER> lmic portable pocts multimodality known emerging pathogens simple labbased instrumentation nominimal need cold chain refrigeration reagents may likely succeed none currently commercially available pocts covers viruses discussed tables <NUMBER> <NUMBER> supplementary table <NUMBER> date holds true new technologies well however conceivable techniques may adapted respiratory viruses shown usefulness practice especially biosensors potential wider spectrum applications also encounter major limitation naats pocts extraction nucleic acids ali et al <NUMBER> tests even less obvious complications like stability plastic materials required chemicals overcome future highly specific nucleic acidbased pocts ideal poct fulfill assured criteria world health organization applicable resourcelimited settings mabey et al <NUMBER> currently likely true tests based lateral flow immunochromatography coming improvements eg miniaturization battery capacity may facilitate use test principles basile et al <NUMBER> economic benefits pocts better outcomes patients still discussed likely tests gain importance decreasing processing costs improved robustness cs pn planned structured edited manuscript pn searched literature integrated contributions pn br pf ea st participated writing first draft manuscript subsequent revisions br pf contributed equally work authors critically read reviewed approved submitted final version manuscript authors would like thank escmid study group respiratory viruses esgrev providing platform interaction authors supplementary material article found online httpswwwfrontiersinorgarticles<NUMBER>fcimb <NUMBER>fullsupplementarymaterial covid<NUMBER> infectious disease caused recently discovered novel coronavirus new virus caused disease unknown outbreak began wuhan china december <NUMBER> covid<NUMBER> pandemic announced march <NUMBER> affecting many countries globally <NUMBER> covid<NUMBER> appear many symptoms fever fatigue dry cough anorexia myalgia muscle ache dyspneashortness breath expectoration coughing spitting material lungs bronchi trachea sputum pharyngalgia diarrhea loose watery stoolsnausea dizziness headache vomiting abdominal pain respiratory system symptoms common onset disease pneumonia appears frequent serious manifestation infection characterized primarily fever cough dyspnea bilateral infiltrates chest imaging <NUMBER> <NUMBER> diagnosis researchers define gold standard lateral methods overwhelm pandemic via early diagnosis disadvantages high duration rtpcr reverse transcription polymerase chain reaction low sensitivity antigenantibody tests high radiation exposure computer tomography ct since methods many disadvantages rapid diagnosis prescreening test crucial keep population wellbeing physicians labor important factor fight novel coronavirus addition decision support systems dss improved artificial intelligence ai machine learning methods timesaving activities physicians rapid analysis chest xray cxr scans ct infection rate mortality rate machine learning methods helpful tools researchers trying build tools prescreening covid<NUMBER> study defines deployed environment <NUMBER> rapid evaluation mortality rate cxr scans via machine learning tools analysis explained study submitted work euvsvirus hackathon <NUMBER> article goes follows sec <NUMBER> discusses diagnosis methods disadvantages sec <NUMBER> reveals algorithms detail sec <NUMBER> evaluation algorithm deployed platform sec <NUMBER> concludes work rtpcr gold standard diagnose covid<NUMBER> <NUMBER> necessary keep mind enough studies evaluate accuracy predictive values tests sensitivity testing depends precise rtpcr assay type specimen duration illness testing study china <NUMBER> samples collected <NUMBER> patients bronchoalveolar lavage fluid positive results <NUMBER> <NUMBER> patients <NUMBER> percent specimens upper respiratory tract fewer positive results <NUMBER> pharyngeal swabs <NUMBER> positive results <NUMBER> percent <NUMBER> nasal swabs <NUMBER> positive results <NUMBER> percent researchers study suggest testing specimens multiple sides may improve sensitivity <NUMBER> according statement study necessary studies evaluating rtpcr tests second diagnostic tool defined literature ct according study wuhan china <NUMBER> patients chest ct <NUMBER> percent sensitivity based positive rtpcr results researchers suggest chest ct could primary tool diagnose covid<NUMBER> unfortunately specificity <NUMBER> percent words <NUMBER> <NUMBER> patients false positive <NUMBER> ct scan pediatric patients also avoided due radiation <NUMBER> besides problem resources diagnose sufficient literature machine learning methods also applied diagnosis ct images <NUMBER> <NUMBER> used supporting clinicians decisions however applied large number samples exploit speed ai interpretation therefore lateral rapid diagnostic tools required preelimination steps according statement pneumonia common clinical manifestation fatal outcomes inspiration solution order diagnose pneumonia cxr appears useful tool diagnose community acquired pneumonia fact gold standard clinical evaluation microbiologic test results <NUMBER> unfortunately covid<NUMBER> cxr limitations study <NUMBER> patients patients abnormality cxr even positive initial rtpcr cxr may normal early mild disease <NUMBER> test used frequently due low radiation exposure health systems governments also enough xray scan devices satisfy population spite cxr lowcost diagnostic tool healthcare chest xrays used frequently keep mind study limitations researchers stated inspires second part solution researchers also publish ai architectures according detection covid<NUMBER> patients <NUMBER> <NUMBER> evaluating fact cxr enough speak certain diagnosis supporting parameter provided physician conditions ai catch condition study parameter defined mortality rate shows risk mortality person infected covid<NUMBER> disease people higher risk severe illness highrisk covid<NUMBER> people <NUMBER> years older people live nursing home longterm care facility also people ages underlying medical conditions particularly well controlled including people chronic lung disease moderate severe asthma serious heart conditions immunocompromised many conditions cause person immunocompromised including cancer treatment smoking bone marrow organ transplantation immune deficiencies poorly controlled hiv aids prolonged use corticosteroids immune weakening medications people severe obesity body mass index bmi <NUMBER> higher diabetes chronic kidney disease undergoing dialysis liver disease <NUMBER> risk evaluation parameter direct patients diagnostic services identify patients risk <NUMBER> proposed solution prescreening covid<NUMBER> <NUMBER> mantiscovid hybrid platform proposed via study evaluation platform two outputs screening group patients prediction risk covid<NUMBER> via cxr mortality rate two parameters used decision support system direct patient highly sensitive tests case <NUMBER> mantiscovid httpsscanmantiscopecomlangen <NUMBER> httpseuvsvirusorg <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint mantiscovid cannot catch covid<NUMBER> patient via ai elimination cxr physician change approaching style patient via evaluating mortality rate patient symptoms negative test results higher mortality rate population advised follow patient closely advise evaluated clinicians although forecasting mortality rate easy due dependence many conditions tried estimate mathematical model linear regression terms <NUMBER> parameters via using open datasets patients <NUMBER> system works cloud web page physician access system available computations system designed scattered millions people provide scalability via cloud flow diagram platform seen fig <NUMBER> system two types forecasting mortality rate cxr posteroanterior pa chest view via ai elimination methods used implement processing flow forecasting mortality rate given following details development open source datasets used python code data synthesis grouping sets given <NUMBER> dataset used compute mortality rate open source covid<NUMBER> survival calculator mortality rate dataset modeled linear regression method connecting <NUMBER> parameters <NUMBER> chosen mortality rate factors age sex height weight health conditions asthma carcinoma chronic kidney disease compromised immune system coronary heart disease chronic obstructive lung disease diabetes hiv positive hypertension high blood pressure chronic illness blood type smoking type discarded mortality rate adjustment parameters obtain minimum dataset methods used obtain linear regression model mortality rate open source libraries associated python scikitlearn <NUMBER> presentation cxr pa patient elimination ai platform three types ai algorithms available check whether person risky flow diagram seen fig <NUMBER> sequence direct role detect risk xray scans aim hybrid module used certain diagnosis due low sensitivity occurring via pa chest view used decision support system clinician first model generated classify whether input image xray image model trained via dataset containing cxr pa scans <NUMBER> images images <NUMBER> images <NUMBER> <NUMBER> dataset divided training <NUMBER> percent test <NUMBER> percent sets image detected besides xray image algorithms processed warns user check uploaded image keras library used generate convolutional neural network cnn architecture starting point classifier <NUMBER> input layer <NUMBER> convolutional filters size <NUMBER>x<NUMBER> inserted rectified linear unit relu activation function inputs accepted <NUMBER>x<NUMBER> redgreenblue rgb colors makes input shape <NUMBER>x<NUMBER>x<NUMBER> max pooling layers <NUMBER> hidden layers inserted <NUMBER>x<NUMBER> filter convolution hidden layer contains <NUMBER> convolutional filters size <NUMBER>x<NUMBER> relu activation functions addition maxpooling layer <NUMBER>x<NUMBER> filters flatten operation applied fully connected layer added <NUMBER> units relu activation function later dropout technique applied rate <NUMBER> avoid overfitting finally fully connected layer used unit sigmoid function <NUMBER> image xray image <NUMBER> otherwise classifier ai middle revealing whether patient risky covid<NUMBER> pneumonia trained model modified version alexnet <NUMBER> according open datasets strengthened currently obtained covid<NUMBER> patients day day <NUMBER> dataset split train <NUMBER> test <NUMBER> validation <NUMBER> enable platform evaluation totally contains <NUMBER> normal <NUMBER> covid<NUMBER> <NUMBER> pneumonia patient data <NUMBER> ai architecture object classifier training batch sizes given fig <NUMBER> last part defined object detection case detection lung opacity parts associated bacteria type pneumonia ai neural network trained tiny version look yolo <NUMBER> mark single objects cxr pa images anomaly named lung opacity dataset used part annotated cxr pa obtained open source datasets <NUMBER> system presented paper contains <NUMBER> different machine learning techniques provide rapid analysis cxr pa view mortality rate evaluation algorithms evaluated one one allocated data evaluation results seen within following details <NUMBER> linear regression model forecast mortality rate evaluation contains allocated <NUMBER> patient data gathered open source dataset mean squared error standard deviation actual predicted values computed <NUMBER> <NUMBER> respectively fig <NUMBER> shows details actual predicted values via testing <NUMBER> conditions <NUMBER> binary classifier check whether uploaded image xray scan evaluation contains additional <NUMBER> xray <NUMBER> random images used evaluation binary classifier algorithm correctly predicted values xray scans random samples given <NUMBER> <NUMBER> separately observed averaged accuracy <NUMBER> percent <NUMBER> classifier separate covid<NUMBER>pneumonianormal patients part contains randomly selected <NUMBER> patient data separated via ai algorithm sensitivity risky patient detection covid<NUMBER>pneumonia <NUMBER> percent sensitivity detection normal patients <NUMBER> percent confusion matrix seen following fig <NUMBER> main objective detection risky patients high accuracy system conditions improved via gathering patient data known covid<NUMBER> certainly lesion detection bacteria type xray scans part contains randomly selected <NUMBER> patient data analyzed via ai algorithm evaluation criterion comparing number lesions real annotated predicted xray scans allocated dataset divided three groups <NUMBER> lesions <NUMBER> image <NUMBER> lesion <NUMBER> image lesion <NUMBER> image detected actual number lesions groups given <NUMBER> ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> mantiscovid cloudbased prescreening platform would useful elimination nonrisky patients coronavirus pandemic since algorithms developed evaluated using open source data platforms system needs evaluated via clinical perspective legal authorities platform internetbased prediagnosis tool verified via universities covid<NUMBER> diagnosis however physician would also use tool assistant scan diagnose patients due rapid diagnosis requirement prevent spreading coronavirus fact gold standards used diagnose covid<NUMBER> patients also high false alarm rates epidemiology disease fully known future work clinical validation internetbased platform start known legal authorities state art ai architectures used increase sensitivity specificity platform integration platform continue chest anteroposterior ap views chest ct ultrasound images providing novel ai architectures infection rate novel coronavirus would also evaluated usage tracking patients locations coronavirus pandemic platform would also used scanning society terms mortality rate xray scans illnesses symptoms studies identify case fatality rate infection rate case proper data collected train ai ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccbync <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> named world health organization <NUMBER> causing covid<NUMBER> <NUMBER> march <NUMBER> <NUMBER> <NUMBER> cases laboratory confirmed <NUMBER> death china based ccdc reported sarscov<NUMBER> enveloped rna virus widely distributed humans mammals birds cause respiratory intestinal liver neurological diseases <NUMBER> <NUMBER> six coronaviruses known cause disease humans sarscov<NUMBER> novel rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint coronavirus never found humans common symptoms people infected sarscov<NUMBER> virus include respiratory symptoms fever cough severe cases infection lead pneumonia severe acute respiratory syndrome <NUMBER> <NUMBER> known routes corona virus disease<NUMBER> transmission respiratory droplets contact transmission aerosol fecaloral transmission require clarification <NUMBER> sarscov<NUMBER> infection early diagnosis particularly important prolong survival patients also ensure safety population <NUMBER> clinical practice detection methods rapidly updated due deepening understanding covid<NUMBER> nucleic acid testing chest ct confirmation epidemiological history clinical manifestations important bases diagnosis novel coronavirus pneumonia <NUMBER> <NUMBER> <NUMBER> <NUMBER> however nucleic acid testing operator restrictions timeconsuming easy pollution high cost comparison coronavirus antigen detection method advantages rapid convenient sarscov antigen detected <NUMBER> day appearance clinical symptoms <NUMBER> clinical practice nucleic acid test antibody assay employed diagnostic suspected acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> infections use sarscov<NUMBER> antigen diagnosis successfully developed theoretically viral antigen specific marker virus precedes antibody appearance within infected people therefore detection viral antigen play rapid screening effect achieve purpose early diagnosis report fluorescence immunochromatographic assay detecting nucleocapsid protein sarscov<NUMBER> nasopharyngeal swab sample urine within <NUMBER> minutes evaluated significance diagnosis covid<NUMBER> study design total <NUMBER> participants suspected sarscov<NUMBER> infection <NUMBER> centers including general hospital central theater command wuhan n<NUMBER> peoples hospital wuhan pulmonary hospital，hubei maternal child rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed participants medical records <NUMBER> participants wuhan <NUMBER> participants chongqing collected retrospectively analyzed nucleic acid test sarscov<NUMBER> specimen collected nasopharyngeal swab collected participants extraction nucleic acids samples performed high pure viral nucleic acid kit described manufacturer da gene co ltd extracted nucleic acid samples tested viruses bacteria polymerase chain reaction pcr using abi prism <NUMBER> light cycler <NUMBER> realtime pcr system accordance manufacturer instructions realtime reverse transcription pcr rtpcr assay used detect viral rna targeting sarscov<NUMBER> orf<NUMBER>ab n gene region sarscov<NUMBER> test device developed based principle fluorescence immunochromatographic assay composed sample pad conjugate pad nitrocellulose membrane absorbent pad supporting plastic cassette fig <NUMBER>a goat antirabbit igg antibodies <NUMBER>mgml mouse antinucleocapsid protein sarscov<NUMBER> monoclonal antibody m<NUMBER>mgml dotted nitrocellulose membrane volume <NUMBER> μl form control line test line respectively rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint conjugates carboxylatemodified polystyrene europium iii chelate micro particles antinucleocapsid protein sarscov<NUMBER> monoclonal antibody m<NUMBER> rabbit igg <NUMBER> μgml spotted conjugation pad volume <NUMBER> μl fully assembled immunochromatographic strip sealed plastic cassette fig <NUMBER>b sample well test device stored dry environment room temperature ready experiment help capillarity absorbent pad sample buffer containing sarscov<NUMBER> nucleocapsid protein could combined iiiconjugated m<NUMBER> antibody captured m<NUMBER> antibody test line iiiconjugated rabbit igg could captured control line resulting fluorescent band test control lines respectively fluorescent results read immunofluorescence analyzer cutoff value determined testing <NUMBER> nasal swab samples healthy people calculated mean value fluorescence signal plus <NUMBER> sd nucleocapsid protein detection procedure nasopharyngeal swab samples urine diluted mixed well <NUMBER>μl saline solution <NUMBER>μl added sample well test card tenminute reaction immediately inserted card immunofluorescence analyzer fig <NUMBER>d authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint study enrolled <NUMBER> participants based diagnostic criteria suspected sarscov<NUMBER> infection participants underwent <NUMBER> nucleic acid tests results nucleic acid test verified <NUMBER> covid<NUMBER> nucleic acid test kits shown fig <NUMBER>a performed nucleocapsid protein n antigen detection sarscov<NUMBER> nasopharyngeal swab samples parallel nucleic acid test multiple centers shown figure <NUMBER> among <NUMBER> patients covid<NUMBER> nucleic acid positive results <NUMBER> sarscov<NUMBER> n antigen positive positive rate <NUMBER> meanwhile among <NUMBER> patients covid<NUMBER> nucleic acid negative results <NUMBER> n antigen negative positive rate <NUMBER> order investigate sensitivity specificity antigen detection methods clinical perspective study selected ct value ≤<NUMBER> ≤<NUMBER> higher virus titer nucleic acid positive group ct value <NUMBER> used nucleic acid negative group results showed positive coincidence rate sensitivity <NUMBER> negative coincidence rate specificity <NUMBER> total coincidence rate accuracy <NUMBER> ct value≤<NUMBER> nucleic acid positive group ct value <NUMBER> nucleic acid negative group fig<NUMBER>a addition positive coincidence rate sensitivity <NUMBER> negative coincidence rate specificity <NUMBER> total coincidence rate accuracy <NUMBER> ct value≤ <NUMBER> nucleic acid positive group ct value <NUMBER> nucleic acid negative group fig<NUMBER>b noteworthy study cohort earliest patient fever <NUMBER> days identified n antigen detection performed n antigen detection sarscov<NUMBER> urine one parallel rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint nucleic acid test nasopharyngeal swab samples day interesting <NUMBER> <NUMBER> <NUMBER> participants diagnosed covid<NUMBER> detected n antigen urine table <NUMBER> current epidemic situation covid<NUMBER> still remains severe quickly spread china <NUMBER> countries early diagnosis critical prevent spreading clinical treatment practice nucleic acid test antibody assay employed diagnostic suspected sarscov<NUMBER> infections use novel coronavirus antigen diagnosis successfully developed virus sarscov<NUMBER> nucleic acid rtpcr test become standard method diagnosis sarscov<NUMBER> infection due high detection rate <NUMBER> however nucleic acid test results sometimes unstable take long appear false negative false positive moreover igm igg antibody detection method used diagnosing relative higher positive rate <NUMBER> however virusspecific antibody usually produced <NUMBER> weeks infection theoretically viral antigen specific marker virus precedes antibody appearance within infected people previous study patients severe acute respiratory syndrome sars test n antigen sarscov achieved sensitivity <NUMBER> <NUMBER> first <NUMBER> days <NUMBER> days onset respectively pointed antigen detection high true positive rate false negative rate used early diagnostic marker sars <NUMBER> day clinical onset <NUMBER> authors also indicate n antigen sarscov high sensitivity rate early stage sars could useful early diagnosis sars <NUMBER> indicate antigen detection play important role early diagnosis therefore detection viral antigen play rapid screening effect achieve purpose early diagnosis report fluorescence immunochromatographic assay detecting nucleocapsid protein sarscov<NUMBER> nasopharyngeal swab sample urine within <NUMBER> minutes evaluated significance diagnosis double blind rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint evaluation clinical trial nucleic acid test golden standard found nucleic acid detection rate <NUMBER> detection rate n antigen sarscov<NUMBER> <NUMBER> <NUMBER> separately depending ct value <NUMBER> nucleocapsid protein positive negative participants accord nucleic acid test importantly earliest patient <NUMBER> days fever identified method findings indicate n antigen assay accurate rapid early simple diagnosis method covid<NUMBER> implies n antigen detection method guarantee early diagnosis hospitals also used largescale screening community additional preliminary study revealed <NUMBER> diagnosed patients nucleic acid assay nasopharyngeal swab detected nucleocapsid antigen urine day coincides finding sarscov<NUMBER> invading kidney test n antigen urine might diagnostic value <NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint among participants nucleic acid detection ct value ≤<NUMBER> table <NUMBER> nucleocapsid antigen urine compared nucleic acid assay nasopharyngeal swab table <NUMBER> examination nucleocapsid antigen urine compared nucleic acid assay nasopharyngeal swab <NUMBER> <NUMBER>f <NUMBER> nucleic acid assay nasopharyngeal swab positive patients exhibits nucleocapsid antigen positive urine day <NUMBER> nucleic acid assay positive patient exhibited nucleocapsid antigen positive urine rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint coronavirus disease <NUMBER> infectious illness caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> chen l et al <NUMBER> hu et al <NUMBER> <NUMBER> january <NUMBER> world health organization declared outbreak covid<NUMBER> global public health emergency international concern zheng et al <NUMBER> incidence covid<NUMBER> increased drastically three million cases reported worldwide causing <NUMBER> deaths baud et al <NUMBER> clinical manifestation covid<NUMBER> ranges mild illnesses fever cough dyspnea lifethreatening syndromes including pneumonia acute respiratory distress syndrome even death bedford et al <NUMBER> bernheim et al <NUMBER> covid<NUMBER> high transmission capability making prevention control difficult chen et al <NUMBER> specific antiviral treatment vaccine covid<NUMBER> early prompt diagnosis important reduce risk lifethreatening complications mortality appropriate health care lee et al <NUMBER> xiao torok <NUMBER> advances poc testing chipbased eg polydimethylsiloxane pdms biosensors paperbased biosensors eg lateral flow test strips threedimensional <NUMBER>d paperbased microfluidic biosensors developed rapid diagnosis infectious diseases yew et al <NUMBER> zhang et al <NUMBER> widely used detect antibodies antigens nucleic acids crude samples saliva sputum blood based upon colorimetric fluorescent electrochemical detection approaches choi et al <NUMBER> tang et al <NUMBER>a yee et al <NUMBER> offer many advantages affordable sensitive specific userfriendly rapid robust equipmentfree deliverable end users assured tomás et al <NUMBER> result obtained fast simple manner allows rapid decisionmaking hence minimizes risk humantohuman transmission view escalating demand rapid diagnosis covid<NUMBER> mini review summarizes recent progress developing poc biosensors covid<NUMBER> highly desirable review article recent advances poc biosensors including chipbased paperbased biosensors detection covid<NUMBER> infection reviewed advantages biosensors along commercially available covid<NUMBER> biosensors summarized finally existing challenges future perspectives developing robust fully integrated poc biosensors covid<NUMBER> briefly discussed general two types rapid poc tests detect covid<NUMBER> infections nucleic acid antibody ab tests sheridan <NUMBER> nucleic acid test usually performed detecting presence virus patients sputum saliva nasal secretions snot zhifeng et al <NUMBER> test good detecting virus early stage infection even symptoms appear hand antibody test strip iggigm test performed collecting patient blood samples contain antibodies virus general <NUMBER> days initial infection virus triggers immune response stimulates production igm igg blood fight virus thevarajan et al <NUMBER> antibodies detected patient plasma serum whole blood existing poc biosensors commercial products covid<NUMBER> summarized table <NUMBER> fact compared existing poc biosensors quantitative realtime polymerase chain reaction qrtpcr gold standard covid<NUMBER> shows higher clinical sensitivity specificity <NUMBER> <NUMBER> respectively et al <NUMBER> clinical sensitivity specificity commercial poc biosensor ie iggigm lateral flow test strip <NUMBER> <NUMBER> respectively poc biosensors potentially used covid<NUMBER> sampletoanswer chipbased biosensors paperbased biosensors materialbased biosensors figure <NUMBER> briefly discussed following sections chipbased biosensors broadly used pointofcare diagnosis infectious diseases mainly made pdms polymethyl methacrylate pmma zarei <NUMBER>a zhang et al <NUMBER> biosensors allow automated precise manipulation fluid flow small volume samples able minimize reagent consumption enables high throughput analysis dincer et al <NUMBER> nasseri et al <NUMBER> pdms chipbased biosensors particular attracted scientific interest due biocompatibility high transparency costeffectiveness nayak et al <NUMBER> explored antibodies nucleic acid detection monitoring infectious diseases darwish et al <NUMBER> recent studies focused development sampletoanswer platform nucleic acid testing sensitive specific antibody assays example study developed sampletoanswer labonadisc biosensor loo et al <NUMBER> pdmsbased biosensor consists multiple channels allows automated nucleic acid extraction isothermal amplification loopmediated isothermal amplification lamp real time signal detection syto<NUMBER> dye used detection binds doublestranded dna lamp reaction emits green fluorescence intensity fluorescence signal indicates amount target detected biosensor selfcontained performing sample heating chemical lysis extraction amplification processes entire sampletoanswer processes take ∼<NUMBER> h platform portable size biosensor relatively large requires improvement biosensor readily customized detect covid<NUMBER> viruses near future recently one group integrated digital amplification process sampletoanswer chipbased biosensor quantify nucleic acids simplifies entire process nucleic acid testing yin et al <NUMBER> biosensor integrates nucleic acid extraction multiplex digital recombinase polymerase amplification rpa fluorescence detection single biosensor mainly made pdms layers glass slide supporting substrate specific primer mixture reaction solution rpa except magnesium acetate added onto three different detection areas lyophilized sample added cell lysed nucleic acids bind magnetic beads following washing elution steps reagents passively driven digital rpa area using vacuumbased selfpriming approaches isothermal amplification followed fluorescent imaging fluorescence probe labeled carboxyfluorescein fam detectable uv light fluorescence signal intensity proportional concentration amplicons biosensor could achieve three main steps nucleic acid testing within <NUMBER> min without requiring complex instrument control systems integrated biosensor shows immense potential rapidly accurately detect covid<NUMBER> patient samples besides fluorescence signal detection colorimetric detection approach also used chipbased biosensors output isothermal amplification eg lamp visualized colorimetric indicators eg calcein hydroxynaphthol blue hnb interact amplicons byproducts ie pyrophosphate seok et al <NUMBER> quyen et al <NUMBER> wang et al <NUMBER> calcein binds manganese ions quench fluorescence complex interacts pyrophosphate express fluorescent signal dou et al <NUMBER> hnb changes color violet sky blue upon reacting pyrophosphate improve portability functionality chipbased biosensors one developed automated portable sampletoanswer biosensor coupled smartphone colorimetric detection pathogens consists microfluidic structure layer hydrophilic layer pdms hydrophobic layer glass substrate biosensor able purify pathogens specific affinity reagent preconjugated magnetic beads ii conduct lysis low temperatures iii perform lamp iv quantify results based colorimetric signals hnb used indicator visual dye amplicons mentioned lamp reaction changes color lamp products violet sky blue entire process <NUMBER> min automatically performed monitored using smartphone future work include storing reagents chip make applicable remote settings paperbased biosensors attracted significant attention use poc testing compared chipbased biosensors owing costeffectiveness biodegradability well easeoffabrication functionalization modification böhm et al <NUMBER> choi et al <NUMBER> characteristics able achieve rapid onsite poc testing remote settings tang et al <NUMBER>b lateral flow test strips particular widely used detection covid<NUMBER> designed detect igg igm patient whole blood serum plasma samples sheridan <NUMBER> test strip generally consists sample pad add patient samples ii conjugate pad containing covid<NUMBER> antigen conjugated gold nanoparticles goldcovid<NUMBER> goldrabbit igg iii nitrocellulose membrane consists control line coated goat antirabbit igg igg test line coated antihuman igg igm test line coated antihuman igm well iv absorbent pad absorbs waste sheridan <NUMBER> presence igm andor igg patient samples antibodies react goldcovid<NUMBER> antigen form complex moves across nitrocellulose membrane interact antiigm andor igg respective test line goldrabbit igg turn reacts antirabbit igg coated control line produce visible red color positive igm negative igg positive lines indicate primary acute infection positive igg negative igm shows secondary later stage infection du et al <NUMBER> li et al <NUMBER> apart antibody testing lateral flow test strips sampletoanswer capability used nucleic acid testing could potentially detect covid<NUMBER> nucleic acids respiratory samples instance group introduced fully integrated paperbased biosensor involves three main steps nucleic acid testing ie nucleic acid extraction lamp detection producing colorimetric signal detected lateral flow test strip rodriguez et al <NUMBER> however integrated biosensor requires external heat block amplification simplify platform poc applications small portable heater developed combination fourlayered paperbased sampletoanswer biosensor choi et al <NUMBER>a biosensor consists fast technology analysis fta card glass fiber nucleic acid extraction choi et al <NUMBER>a graphenebased biosensors kampeera et al <NUMBER> black phosphorusbased biosensors kumar et al <NUMBER> offer tremendous potential identifying managing spread covid<NUMBER> rapid onsite analysis performed using smartphone appropriate health management lamp along integrated lateral flow test strip visual detection functional layer separated hydrophobic polyvinyl chloride substrates control fluid flow one layer another simplify processes semiautomated fully disposable integrated paperbased biosensor developed tang et al <NUMBER>c integrated biosensor consists paperbased valve spongebased reservoir extract nucleic acids crude samples portable battery heater integrated platform isothermal amplification ie helicase dependent amplification hda well lateral flow test strip colorimetric detection proposed biosensor allows board reagent storage use sponges equipmentfree isothermal amplification significantly simplifies user steps recently lateral flow test strip combined paper folding technologies sample preparation lamp lateral flow detection reboud et al <NUMBER> integrated test strip consists buffer chambers regulate fluid flow acetate films prevent sample evaporation filter paperbased valves prevent lamp reagent mixing reagents lateral flow test strip integrated technology suitable use resourcelimited settings test crude samples eg sputum offering great potential rapidly detect nucleic acids covid<NUMBER> <NUMBER> min besides lateral flow test strips several <NUMBER>d paperbased microfluidic biosensors developed detect proteins nucleic acids poc xia et al <NUMBER> lam et al <NUMBER> biosensors usually detect targets based fluorescence colorimetric detection approaches metal ions eg magnesium calcium silver used <NUMBER>d paperbased microfluidic biosensors react base purine pyrimidine double stranded dna form stable complex show fluorescent signal upon uv irradiation example fully integrated foldable biosensor encapsulated agarose developed longterm reagent storage multiplex fluorescence detection biosensor consists reaction zone detection zone agarose carries lamp reagents silver nitrate reaction indicator deposited stored reaction detection zones least <NUMBER> days sample added reaction zones closed adhesive sealing film avoid sample evaporation placed portable heater amplification following amplification process sealing film removed detection zone folded soaked reaction zone uv light used visualize reaction amplicons silver ions brown color intensity test zone increased along increased concentration amplicons biosensor simple user friendly expected detect covid<NUMBER> nucleic acids patient samples recently new alternative fuchsin explored detection dna amplicons based upon colorimetric detection approach using <NUMBER>d paperbased microfluidic biosensor absence dna amplicons addition sodium sulfite molecule fushsin produces fushsin leucosulfonic acid leucofushsin colorless presence dna amplicons aldehyde groups dna bind sulfonate groups bond hydrogen sulfite central c atom broken producing fuchsin chromophoric structure appears purple signals mello de campos vidal <NUMBER> proposed biosensor composed sample zone reaction zone detection zone detection zone consists paper strips fuchsin stained lines briefly sample injected sample zone sealed adhesive sealing film prevent sample evaporation reaction zone folded bind sample zone biosensor turned upside enable flow sample sample zone reaction zone biosensor heated hot plate <NUMBER> • c <NUMBER> min lamp lamp sealing film peeled hydrochloric acid injected reaction zone sodium sulfite subsequently added changes fuchsinstained line color observed unlike abovementioned biosensors biosensor produces simple colorimetric signals detectable naked eyes without requiring external readers shows promising rapid diagnosis covid<NUMBER> infections poc apart developing chipbased paperbased biosensors materialbased biosensors textilebased filmbased carbonbased biosensors also introduced potential use covid<NUMBER> parrilla et al <NUMBER> afsahi et al <NUMBER> mogha et al <NUMBER> developed improve functionality detection sensitivity existing biosensors providing promising choices practical use textilebased biosensors threadbased fabricbased clothbased biosensors developed simple fabrication processes improved assay performance one study incorporated polysiloxanes tunable hydrophobicity threadbased biosensors delay fluid flow lateral flow assay improve detection sensitivity choi et al <NUMBER>a similar conventional lateral flow test strip fluidic delay thread increases interactions gold nanoparticlesantibodies aunpab targets optimum conditions increase interactions produces aunpabtarget complexes showing <NUMBER>fold sensitive unmodified biosensors biosensor simpletofabricate highly sensitive shows immense potential detecting igg igm covid<NUMBER> patients appropriate health monitoring addition textilebased biosensors filmbased biosensors developed detect infectious microorganism crude samples instance filmbased biosensor introduced consists transparent polyester film substrate sample chamber cover reaction chamber waste chamber kukhtin et al <NUMBER> microarray <NUMBER>hydroxyethylmethacrylamide gel elements synthesized incorporation oligonucleotides gels polymerization uv irradiation gel elements covalently attached substrate briefly sample master mix first introduced chambers capillary action promotes uniform filling chamber amplification subsequently performed wash buffer introduced pressure leads waste waste chambers lastly fluorescent imaging analysis performed flexible film substrate used study offers several advantages poc testing allows covalent attachment gel without pretreatment processes ii low background fluorescence iii transparent properties allows optical inspection iv able withstand thermal cycling compatible amplification processes flexible film allows easy fabrication userfriendly costs ∼<NUMBER> times less substrates ie glass demonstrating potential detecting covid<NUMBER> virus patient samples apart <NUMBER>d materials graphene black phosphorus also integrated biosensors poc diagnosis could potentially used covid<NUMBER> testing jin et al <NUMBER> choi et al <NUMBER>b liu et al <NUMBER> example recent study introduced portable graphenebased electrochemical biosensor highly sensitive poc testing kampeera et al <NUMBER> graphenebased electrodes constructed screenprinting mainly due low cost ease fabrication high production rate screenprinted graphene electrodes spge synthesized either substituting carbon graphene incorporating graphene carbon paste spge reported show superior electrochemical properties commonly used screenprinted carbon electrodes spce higher electron transfer rate larger electrochemical surface area nucleic acid extraction lamp performed using simple heating block interaction spge amplicons results shift cathodic current stems intercalation redox probe doublestranded dna phenomenon enables quantification lamp product portable mini potentiostat used combination spge onsite detection next step integration extraction platform proposed biosensor make portable userfriendly besides graphene black phosphorus bp phosphorenebased biosensors also extensively explored medical diagnosis qian et al <NUMBER> ge et al <NUMBER> luo et al <NUMBER> bp displays excellent electrochemical properties enhances assay sensitivity selectivity owing inherent redox properties example recent study reported development labelfree electrochemical biosensor aptamerfunctionalized bp nanostructured electrode kumar et al <NUMBER> bp nanosheets coated polyllysine pll allows functionalization bp antiabaptamers aptamers immobilized onto nanosheets via coulomb interaction aptamers pll presence target antigens causes direct oxidization iron ii iron iii electrode surface mechanism electron transfer compared reduced graphene oxide rgo bpbased biosensors show higher detection sensitivity specificity achieving detection limit pg level compared ng level achieved rgo biosensors proposed biosensor would allow highly sensitive detection igg igm coronavirus patient blood samples summary review article discusses poc biosensors made pdms paper flexible materials textile film carbon nanosheets rapid diagnosis covid<NUMBER> costeffectiveness simplicity rapidity portability biosensors play crucial role poc applications antibody tests suitable detect late stage infections nucleic acid tests detect presence nucleic acids viruses early stage infection showing higher sensitivity specificity antibody tests however current nucleic acid tests require three key steps ie nucleic acid extraction amplification detection involving complicated processes antibody tests fact commercial poc biosensors covid<NUMBER> paperbased biosensors lateral flow test strips antibody detection igg igm produce colorimetric signal antibody tests display lower specificity compared nucleic acid tests helped shortening turnaround time rapid diagnosis allowing fast decision making future work include specificity improvement combination tests rapid nucleic acid tests confirm test result recent studies integrated sampletoanswer processes single biosensor detect nucleic acids pathogens human antibodies pathogens could explored detect covid<NUMBER> infections addition current works also attempted improve detection sensitivity simplicity performance biosensors assay sensitivity enhanced enzymebased signal enhancement et al <NUMBER> sample concentration moghadam et al <NUMBER> much simpler fluidiccontrol strategies choi et al <NUMBER>b nucleic acid tests particular involves three key steps simplified integrated single biosensor poc use biosensors discussed review show immense potential developed selfcontained platform detection covid<NUMBER> infections outside laboratory particularly remote settings developing areas future studies focus simplifying user steps incorporating key steps single biosensor minimal cost loo et al <NUMBER> capability storing reagents chip vital eliminate requirement large storage equipment deng jiang <NUMBER> whereas multiplexing capability biosensors would increase throughput dincer et al <NUMBER> compared detection approaches fluorescence electrochemical detection approaches colorimetric detection represents common approach mainly due simplicity ability observe signal naked eyes biosensors produce colorimetric signals enable visual detection without requiring extra tools uv lamp would helpful rapid onsite diagnosis chan et al <NUMBER> yang et al <NUMBER> quantification provides accurate readout achieved using smartphone apps could performed untrained users poc settings future studies improve function smartphone specific smartphone apps enable onsite data analysis allowing data storage track patient health status roda et al <NUMBER> wang et al <NUMBER> liang et al <NUMBER> xu et al <NUMBER> additionally incorporating portable power sources batteries biosensors would significantly advance functionality especially rural areas electricity supply limited zarei <NUMBER>b short emerging poc biosensors aforementioned capabilities could rapidly identify spread covid<NUMBER> guide appropriate health care playing key role managing outbreak author confirms sole contributor work approved publication coronaviruses cov large family viruses common people many animal species including camels cattle cats bats animal coronaviruses rarely infect humans spread people exceptions middle east respiratory syndrome merscov severe acute respiratory syndromecoronavirus sarscov sarscov<NUMBER> cause ongoing covid<NUMBER> pandemic sarscov<NUMBER> virus novel coronavirus characterized linear positivesense singlestranded rna genome <NUMBER>kb <NUMBER> similarity sarscov genome <NUMBER> <NUMBER> <NUMBER> moreover high level homology sarslike coronavirus isolated bats pangolins suggesting first originated bats pangolins intermediate hosts humans <NUMBER> strong similarity sarscov<NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint sequences european chinese patients suggests recent single emergence virus animal reservoir wwwgisaidorg two million reported cases <NUMBER> confirmed deaths time writing see httpswwwworldometersinfocoronavirus covid<NUMBER> currently main challenge human beings worldwide italy positive cases <NUMBER> <NUMBER> th april <NUMBER> rated second worldwide country highest number deaths <NUMBER> mainly <NUMBER> age group thus possible contributing factor influencing mortality rate could overall population age ie oldest european country around <NUMBER> elderly residents related comorbidity however high rate infection specific italian geographical areas eg lombardy region might exclusively related age moment vaccine approved specialized treatment drugs investigation clinical trials existing repurposed drugs ie remdesivir hydroxychloroquine alphainterferon ifn several novel agents targeting key virushost interactions <NUMBER> despite common symptoms onset covid<NUMBER> disease fever cough tiredness high clinical heterogeneity fact covid<NUMBER> infection shows different clinical manifestation based patient age health conditions ie status patients immune system gender addition variable mortality rates responses treatment likely associated yet elucidated host genetic contribution although country knows real number covid<NUMBER> infected people totally aware infection status tested people anyway seems established overall number people positive molecular testing ie confirmed cases total number infected people expected much higher consequence lack data predicting covid<NUMBER>s spread rate infection results global impact public health concern world health organization classifies confirmed case person laboratory confirmation covid<NUMBER> infection httpswwwwhointdocsdefaultsourcecoronavirusesituationreports<NUMBER>sitrep<NUMBER>covid<NUMBER>pdfsfvrsn<NUMBER>e<NUMBER>b<NUMBER> reliable test data therefore necessary better assess validity information related pandemic spread positive cases deaths immune individuals moreover apparent lack systematic testing protocol countries represents main source discrepancies mortality rates testing covid<NUMBER> performed follows viral test ie establish whether individual currently infected b serology ie prove host immune antibodies response virus known serological test effective tool target immune population also date viral spread population <NUMBER> far europe comprehensive detailed regularly updated data available selected countries iceland estonia rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint httpsourworldindataorgcovidtesting however many nations including italy accurate epidemiological data serological testing present evaluation contribute filling gap increasing knowledge covid<NUMBER> pandemic italy decided carry survey employees one national research hospital irccsburlo garofolo located trieste northeastern italy overall number <NUMBER> employees recruited tested viral antibody tests short timeframe one week order minimize possible biases study design multivariate analysis including covid<NUMBER> personal work risk exposures well healthy status including covid<NUMBER> related symptoms performed extremely interesting results obtained study detailed suggesting first time efficacy combined testing strategy monitor covid<NUMBER> spread highlighting immune specific reactive people represent quite high number geographic area survey carried part mandatory covid<NUMBER> integrated healthmedical high exposure risk hr occupation frontline healthcare professionals eg intensive care unit emergency department nurses performing daily procedures patients healthcare operators providing medical transport patients transport biological material medium exposure risk mr occupation nonfrontline healthcare professionals laboratory personnel collecting handling specimens patients low exposure risk lr occupation administrative staff hospital rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity presence sarscov<NUMBER> tested using neoplextm covid<NUMBER> detection kit assay according manufacturers instruction qualitative vitro assay allows simultaneous detection n rdrp genes <NUMBER>novel coronavirus genome respiratory specimens using realtime reverse transcription polymerase chain reaction rtpcr genematrix inc republic korea regards evaluation immune response covid<NUMBER> comparison choose best rapid kit carried comparing three commercially available ones wantai sars presence band considered positive p signal detectable slightly <NUMBER> minutes recommended test considered study borderline b kit performance declared sensitivity <NUMBER> specificity <NUMBER> tests recommended serum volume added specimen well individual test cassettes followed addition supplied buffer accordance manufacturers instructions addition simple quantification amount signal antibodies test performed using image j quantification tool httpsimagejnihgovijdocstoolshtml statistical analyses performed r v<NUMBER> httpswwwrprojectorg quantitative variables described median interquartile range iqr categorical variables expressed numbers employees percentages wilcoxon test used compare continuous variables antibody groups regarding categorical variables chisquared test rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity fishers exact test used appropriate investigation healthcare professional categories logistic regression model adjusted sex age exposure risk used assess possibility risk increase antibody presence category medical doctors performed tests twotailed statistical significance set pvalue <NUMBER> overall <NUMBER> volunteer employees recruited enrolled study filling dedicated questionnaire underwent nasopharyngeal oropharyngeal swabs plus venipuncture antibody test supplementary table <NUMBER> age range <NUMBER> years old sex distribution <NUMBER> women <NUMBER> males supplementary table <NUMBER> dividing employees according risk exposure <NUMBER> individuals included hr group <NUMBER> <NUMBER> mr lr ones respectively strongly positive antibodies p results obtained <NUMBER> females nine males <NUMBER> <NUMBER> females <NUMBER> males gave borderline data b <NUMBER> overall positiveborderline pb category represents <NUMBER> whole sample negative n ones <NUMBER> cohort reported table <NUMBER> median age significantly lower individuals pb antibody compared individuals n antibody ie wilcoxon test pvalue<NUMBER> apart one individual pb subjects negative presence virus nasopharingealoropharingeal tests moreover show sign symptom sampling time proportion <NUMBER> referred absence sign symptom <NUMBER> questions answered medical questionnaire last three months ie true asymptomatic finally among pb subjects referring presence least one signsymptom medical history questionnaire statistical significant association detected cold conjunctivitis chisquared test pvalue <NUMBER> pvalue <NUMBER> respectively matter fact last three months <NUMBER> <NUMBER> pb subjects suffered cold conjunctivitis respectively table <NUMBER> moreover suggestive association pb category muscular pain also observed chisquared test pvalue<NUMBER> association antibody test detected including relationship presence absence flu vaccination season <NUMBER> looking distribution pb n subjects three risk categories hr mr lr statistically significant association found particular expected pb individuals mainly belong hr group <NUMBER> <NUMBER> <NUMBER> mr group <NUMBER> <NUMBER> <NUMBER> proportion <NUMBER> characterizes lr group <NUMBER> <NUMBER> difference statistically rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint significant chisquared test pvalue<NUMBER> see table <NUMBER> also investigated health care occupation category logistic regression data suggest medical doctor statistically significant risk factor pb antibody test or<NUMBER> pvalue<NUMBER> model adjusted sex age exposure risk table <NUMBER> moreover despite females frequent among healthcare professionals males represented within medical doctor group <NUMBER> vs <NUMBER> chisquared test pvalue <NUMBER> thus searched presence possible association sex results antibody test without finding significant evidence negative results also obtained looking correlation presenceabsence antibodies reported performance invasive manoeuvres aerosol bronchoalveolar lavage intubation swabs patients suggesting proper accurate use individual protection devicesdpi protective measurements hr trained personnel finally twelve hr employees two males ten females age range <NUMBER> years old underwent antibody test second time three ten days later median valuesix previously reported contact covid<NUMBER> case intensity antibody band first assessment showed median value <NUMBER> interquartile range iqr <NUMBER> one individual intensity <NUMBER> second assessment subject showed antibody intensity <NUMBER> remaining <NUMBER> subjects <NUMBER> decrease intensity two assessments repeated quite short time statistically significant wilcoxon test paired data pvalue<NUMBER> considering intrinsic limitation chromatography rapid test rapid decay detectable antibodies documented subjects regards swab test one individual <NUMBER> resulted positive subject female <NUMBER> years old belonging hr occupation resulted positive either presence virus well antibodies three days sampling presented mild covid<NUMBER> clinical features cold nose stuffiness dysgeusia anosmia last three months report sign symptom covid<NUMBER> outbreak initially began china spread many countries rapid diffusion italy number confirmed cases increasing every day complicate situation evidence median incubation period covid<NUMBER> approximately five days generally people develop symptoms <NUMBER> days extensive measures reduce persontoperson transmission covid<NUMBER> required control current outbreak testing window onto pandemic spread without way understanding rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> another interesting finding work medical doctors represent healthcare category frequently associated presence antibodies sarscov<NUMBER> or<NUMBER> rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg <NUMBER> <NUMBER> <NUMBER> probably due peculiar medical methodological approaches pediatric patients including parents prone amplifying person person contact moreover presence similar proportion pb subjects among doctors performing invasive manoeuvres might suggest proper accurate use dpi protective measurements hr trained personnel conclusion survey study provides first time insight extent infection immune status italian health care workers population ie motherchild research hospital strengthening hypothesis quite large proportion asymptomatic mild symptomatic people developed specific immune response covid<NUMBER> consequence critical issue aroused wide concern immune subjects reinfected cohort studies convalescent sarscov patients revealed specific igg antibodies neutralizing antibodies peaked month four onset disease decreased gradually throughout two years followup <NUMBER> samples turned negative <NUMBER> light preliminary findings study despite obtained small series subjects n <NUMBER> indicate possible presence rapid decay antibodies amount strengthening urgent need introduction antibodies quantitative test perform conjunction nasooral pharyngeal swab way apart preexisting health conditions potentially predisposing sarscov<NUMBER> eg obesity hypertension chronic respiratory disease compromised immune status believe might protecting predisposing genetic variants genes ace<NUMBER> tmprss<NUMBER> dpp<NUMBER> recently described potentially modulating covid<NUMBER> illness <NUMBER> <NUMBER> <NUMBER> <NUMBER> answers huge implications diffusion infection since experts believe continue spread across world waves hitting populationcountry several times reason present data demonstrated necessity start future epidemiological activities aimed increasing number subjects tested molecular serological assays following universal monitoring protocol moreover introduction accurate precise methods measuring antibodies ie elisa assay sarscov<NUMBER> help better classifying pb individuals understanding pandemic spread rights reserved reuse allowed without permission certified peer review authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted april <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint dataset completely anonymized made available chief medical officer team testing employees motherchild research hospital irccsburlo garofolo conducted within surveillance program established italian prime minister decree require ethical approval consent form prepared chief medical officer team signed participants authors declare competing interests quality amongst factors influence diagnostic test performance review outline performance outcomes key tests used diagnose covid<NUMBER> considerations modulate performance safety healthcare workers collecting samples laboratory safety aspects experimental approaches detection volatile organic compounds exhaled breath mass spectrometry studies different sample types methods signal amplification utility novel approaches discussed countryspecific indications criteria testing evolved rapidly updated information emerges epidemic progresses recommendations guided phase epidemic available resources generally speaking testing covid<NUMBER> currently considered anyone symptoms acute respiratory tract infection upper lower without systemic symptoms fever fatigue myalgia<NUMBER> mild disease testing directs need selfisolation identification new cases contact tracing testing contacts epidemic progresses forecasted limited testing capacity testing may directed specific subgroups enhanced risk poor outcome clinical setting covid<NUMBER> form part differential diagnosis acute respiratory presentation including infectious causes pneumonia eg bacterial influenza viral pneumonia pneumocystis pneumonia tuberculosis tb acute exacerbations asthma chronic obstructive pulmonary disease copd acute pulmonary embolism cardiac failure conditions relevant investigations depend clinical context likely include pulmonary imaging relevant laboratory investigations blood cultures interrogation urine lower respiratory tract specimens rule viral mycobacterial fungal bacterial cause clinical laboratory parameters may suggest viral infection may include pyrexia acute malaise myalgia lymphopenia c reactive protein crp unhelpful distinguishing covid<NUMBER> infections procalcitonin elevated severe covid<NUMBER> secondary bacterial infection <NUMBER> <NUMBER> early disease procalcitonin may distinguish covid<NUMBER> bacterial infections viral diseases data awaited confirm supposition underlying asthma copd presence pulmonary infiltrates may favour respiratory infectionrelated cause though cardiac cause must also considered differential common sample types sent testing usually means reverse transcription polymerase chain reaction rtpcr nasopharyngeal oropharyngeal samples obtained swab placed viral transport medium already considerable shortage reagents swabs meaning dry swabs sent laboratory centres dry swabs less costly conducive communitybased testing data urgently required determine comparative sensitivity dry swabs compared using viral transport medium taking account time sample acquisition sample processing samples lower respiratory tract including sputum tracheal aspirate bronchial washings bronchoalveolar lavage may also sent patients covid<NUMBER> disease samples lower respiratory tract likely test positive discussed viral rna also detected stool <NUMBER> cases blood <NUMBER> cases <NUMBER> rarely urine recent data infections special contexts cruise liners <NUMBER> close contacts covid<NUMBER> patients <NUMBER> demonstrated sarscov<NUMBER>specific rtpcr may positive early phase disease viral shedding asymptomatic phase early prodromal phase considerable <NUMBER> <NUMBER> present screening asymptomatic individuals rtpcr constrained limited testing capacity need focus public health efforts resources symptomatic persons symptomatic individuals <NUMBER> patients mild symptoms requiring hospitalisation depending age presence risk factors <NUMBER> symptomatic persons may require admission hospital respiratory complications individuals enhanced risk category may one risk factors including age greater <NUMBER> years comorbidities history significant tobacco smoking underlying immunocompromising illnesses <NUMBER> <NUMBER> mild disease especially early stages rtpcr false negative rate <NUMBER> <NUMBER> <NUMBER> <NUMBER> metaanalysis reported single test <NUMBER> days post symptom development <NUMBER> false negative rate using nasopharyngeal swab <NUMBER> throat swab<NUMBER> ai et al reported false negative rate <NUMBER> cohort <NUMBER> hospitalised patients estimated median interval initial negative test subsequent positive rtpcr result <NUMBER> ± <NUMBER> days <NUMBER> selection studies reported false negative rates <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> notably patients required five repeat tests positive result ascertained <NUMBER> false negativity phenomenon may due several factors including low viral load detection limit assay low sample volume cellular mass acquisition sampling location upper versus lower respiratory tract sample degradation transport storage sample processing methodology timing sampling relation stage disease rtpcr positivity may progressively increase course disease <NUMBER> test accuracy depend quality specimen collected <NUMBER> since shown specimens lower respiratory tract higher viral load hence likely test positive specimens upper respiratory tract <NUMBER> <NUMBER> nasopharyngeal specimens better yield compared oropharyngeal samples <NUMBER> <NUMBER> hospitalised patients severe disease wang et al found sensitivity <NUMBER> bronchoalveolar lavage fluid <NUMBER> sputum <NUMBER> nasal swabs sensitivity ranged <NUMBER> <NUMBER> pharyngeal swabs faeces blood urine <NUMBER> given considerations negative test upper respiratory tract specimen repeated <NUMBER> days optimal timing unclear lower respiratory tract specimen obtained exclude false negative result clinical suspicion high <NUMBER> viral shedding asymptomatic early prodromal minimally symptomatic individuals resolution symptoms help us explain rapid extensive spread covid<NUMBER> patients severe diseases including lower respiratory tract infection also individuals mild disease high viral loads detected often several days resolution symptoms <NUMBER> significance remains unclear though recent data limited number patients suggest rtpcr positivity necessarily mean shedding infectious virus symptom resolution <NUMBER> <NUMBER> unclear whether patients whose symptoms resolved continue detectable viral rna respiratory samples transmit infection furthermore symptoms resolved especially given limited testing capacity remains unclear patients may discharged icu general ward setting hospital community setting especially individuals highrisk profiles living household thus clearly defined guidelines safe social mixing occur symptoms resolved healthcare workers safety must taken account collecting sputum ideally performed infectioncontrolled environment open air ambulant patients currently rtpcr imperfect gold standard diagnosis covid<NUMBER> development molecular detection assays facilitated sequencing sarscov<NUMBER> <NUMBER> assay consists two principal steps viral rna extraction patient specimens performed manually using automated platforms ii reverse transcription pcr amplification using specific primers specific probes realtime detection see figure <NUMBER> overview use robotic systems allows increased throughput rna extraction pcr setup current resource constraints trained personnel reagents necessity rapidly deliver test outcomes diagnostic laboratories skipping postextraction rna quality quantification check costly labourintensive several sarscov<NUMBER> targets used include envelope e nucleocapsid n rnadependent rna polymerase rdrp genes two large open reading frames orf<NUMBER>aorf<NUMBER>b rnase p <NUMBER> generally least two target genes need identified sarscov<NUMBER> confirmation however interpretation algorithms differ respect number genes need detected test considered positive protocols results interpreted indeterminate negative one genes detected whereas others identification one gene used screening test subsequent genes serves confirmatory test<NUMBER> laboratory perspective multiplexing targets allows better efficiency shorter turnaround times optimal management laboratory consumables <NUMBER> vogel et al evaluated nine primerprobe sets <NUMBER> confirmed pair detection efficiency <NUMBER> differences ability differentiate true negatives positives patients low viral load sets led inconclusive results due nonspecific background amplification including initial sets issued usa cdc subsequent rectification viral evolution nucleotide substitutions may emerge could affect primerprobe binding regions could alter sensitivity pcr indeed potentially problematic mismatch rdrpsarsr reverse primer already confirmed threshold cycle ct value target gene remains quantitative end point ascertain viral load depending kit used value generally lies <NUMBER> range<NUMBER> control nonspecific pcr inhibition internal positive amplification control eg sarscov<NUMBER> egene rna sarscov frankfurt <NUMBER> rna included assay whilst negative control interrogates contamination sample preparation digital pcr dpcr used perform quality assurance verification rtpcr<NUMBER> dpcr involves partitioning sample many individual parallel pcr reactions allowing even single molecule amplified millionfold using technique sensitivity significantly improved <NUMBER> rtpcr <NUMBER> rtdpcr<NUMBER> moreover <NUMBER> close contacts inconclusive conventional rtpcr likely targets interest detected dpcr positive overall sensitivity specificity diagnostic accuracy rtdpcr <NUMBER> <NUMBER> <NUMBER> respectively moreover higher sensitivity rtdpcr translated detection viral rna longer periods compared conventional rtpcr convalescing patients rtdpcr sensitive suitable detecting low viral loads accessibility limited complexity system cost implications inability multiplex target genes interest <NUMBER> several automated rapid nucleic acid amplification tests recently received fda approval emergency use cepheids xpert xpress sarscov<NUMBER> run gene xpert platform detects multiple gene targets provide result within <NUMBER> min<NUMBER> abbotts rapid covid<NUMBER> test run abbott id device provide results within <NUMBER> min <NUMBER> former may convenient countries like south africa extensive gene xpert infrastructure technology lends onsite pointofcare testing using portable xpert platforms like xpert edge rtpcr currently remains imperfect gold standard rapid confirmation sarscov<NUMBER> infection ongoing genetic evolution virus highlights need closely monitor review methodology based emerging data possible better stagespecific reference standard may emerge incorporating immunoassay results limited testing capacity remains challenge widespread surveillance testing south africa expanding testing services researchbased laboratories fraught challenges including need accreditation laboratories sanas south africa personnel hpcsa south africa capacity shortfalls compounded international countrywide shortage kits reagents severe reduction international freight shipping capacity however implementation rapid automated molecular testing xpert xpress sarscov<NUMBER> helpful enough cartridges procured several antigenbased immunoassays developed detect antibodies serum plasma<NUMBER> one assay recently fda approved foundation innovative new diagnostics website lists <NUMBER> companies either making made assays <NUMBER> rapid lateral flow assay lfa based others enzymelinked immunosorbent assay elisalike tests formats antigen impregnated test line plasticplate surface detect human igg igm sometimes also iga antibodies meanwhile rapid capture assays detect viral antigens nasopharyngeal aspirates also developed evaluated tandem despite proliferation different testing devices kits emerging hardly independent validation data specific assays work optimally therefore sensitivity specificity predictive values individual tests different contexts remain unknown webbased resource developed lists assays approved use specific countries<NUMBER> tests purchased specific countries already found meet expectations <NUMBER> spain one worst hit european nations health authorities purchased thousands rapid serological tests biotech company china later found sensitivity <NUMBER> south african companies already produced iterations lfa platforms currently evaluated one concern test specificity four common human coronaviruses cause third common cold episodes poorly designed antibody tests may crossreact preexisting anticoronavirus antibodies high fig <NUMBER> overview sarscov<NUMBER> rtpcr based detection viral rna extraction performed nasopharyngeal oropharyngeal specimens using manual automated platform rtpcr performed twostep assay extracted rna first reverse transcribed make complementary dna cdna cdna amplified second step fluorescence results <NUMBER>′ <NUMBER>′ exonuclease cleavage fluorescently labelled targetspecific probe enabling dna amplification pcr cycle manual automated false positivity rates may erroneously indicate disease without covid<NUMBER> resulting wasted public health contact tracing efforts unnecessary anxiety even worse unintended exposure individuals covid<NUMBER> testing centres wards hospitalised suboptimal sensitivity lfa formats without signal amplification step potential concern often lfa depending context may suboptimal sensitivity compared elisabased assays however extent applies covid<NUMBER> remains seen several recent papers describe longitudinal antibody responses patients covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> broadly speaking igm responses tend become detectable <NUMBER> days onset symptoms <NUMBER> <NUMBER> robust responses generally develop second week illness <NUMBER> <NUMBER> given considerations antibodybased tests recommended used first line diagnosis within first days symptoms evidence combining antibody rtpcr data early phase disease may useful may incremental benefit though studies required however south african health product regulatory agency agencies recently indicated based guidance south african national institute communicable diseases serological testing suitable diagnosis acute sarscov<NUMBER> infection limited epidemiological surveys least data becomes available indeed undisputed role immunoassays surveillance studies may guide public health planning define trajectory epidemic potential role targeting vaccination certain subgroups investigated suggested immunoassays could identify previously infected recovered healthcare workers essential workers could potentially return work assumption immune reinfection whether case long immunity lasts covid<NUMBER> remains unclear thus validity concept immunity passports remains unclear<NUMBER> currently data diagnostic management prognostic considerations may different hivinfected versus uninfected persons hivinfected patients presenting respiratory tract infection general possibilities outlined considered including considering pcp tb differential diagnosis although well documented widely appreciated <NUMBER> <NUMBER> communityacquired pneumonia acute lower respiratory tract infection subsaharan africa parts asia due mycobacterium tuberculosis <NUMBER> <NUMBER> <NUMBER> proportion even higher hivinfected persons <NUMBER> <NUMBER> also possible covid<NUMBER> infection may unmask subclinical tb hivinfected uninfected persons hand particularly hivinfected persons covid<NUMBER> pneumonia like case influenza <NUMBER> may associated poorer prognosis hospitalised patients tb whether sarscov<NUMBER> viral load higher hivinfected persons therefore rtpcr sensitivity better remains unclear hivuninfected persons coinfection one pathogen already documented eg coinfection covid<NUMBER> influenza andor bacterial organisms <NUMBER> possible coinfection one pathogen may frequent hivinfected persons advanced immunosuppression unanswered questions resolved data become available rapidly spreading covid<NUMBER> pandemic exposed capacity weaknesses healthcare laboratory testing systems although mainstay testing remains rtpcr several drawbacks including significant false negative rate early course disease assay cost lack assay simplicity requirement complex laboratory infrastructure emerging shortage reagents including rna extraction kits likely worsen already many centres using dry nasopharyngeal swabs shortage viral transport medium antibodybased immunoassays developed although limited role early diagnosis symptomatic patients incremental benefit rtpcr assays role applications including surveillance targeting individuals vaccination redeployment workforce investigation viral diseases continue pose serious threat public health world witnessed several viral epidemics past twenty years include severe acute respiratory syndrome coronavirus recently outbreak pneumonia unknown etiology detected wuhan city hubei province china reported china country office world health organization december <NUMBER> <NUMBER> national health commission china reported outbreak associated exposures one seafood market wuhan city etiological agent atypical pneumonia isolated january <NUMBER> <NUMBER> chinese authorities novel coronavirus <NUMBER>ncov genetic sequence novel coronavirus identified shared countries develop specific diagnostic kits january <NUMBER> <NUMBER> subsequently ministry public health thailand ministry health labour welfare japan republic korea reported first imported case labconfirmed <NUMBER>ncov <NUMBER> january <NUMBER> january <NUMBER> january <NUMBER> <NUMBER> respectively subsequently international committee taxonomy viruses termed sarscov<NUMBER> due similarity symptoms induced sars february <NUMBER> <NUMBER> announced disease caused new virus covid<NUMBER> acronym coronavirus disease <NUMBER> march <NUMBER> <NUMBER> declared disease pandemic march <NUMBER> <NUMBER> reported <NUMBER> case <NUMBER> death occurred worldwide <NUMBER> coronavirus cov belongs coronaviridae family order nidovirale cov singlestranded rna viruses þssrna spike glycoprotein envelope giving crownlike appearance seen electron microscope subfamily orthocoronavirinae four genera covs alphacoronavirus betacoronavirus deltacoronavirus gammacoronavirus furthermore genus betacoronavirus divides five subgenera lineages bats rodents considered genetic sources alpha betacoronavirus avian species represents genetic sources delta gammacoronavirus <NUMBER> date seven human coronaviruses hcov identified lineage betacoronavirus hcovoc<NUMBER> hcovhku<NUMBER> well alphacoronavirus hcov<NUMBER>e hcovnl<NUMBER> causes common colds selflimiting respiratory infections contrast b lineage betacorona virus causes sarscov<NUMBER> sarscov<NUMBER> covid <NUMBER> c lineage betacorona virus causes merscov responsible recent epidemics variable clinical severity pulmonary extrapulmonary involvement associated significant increase mortality <NUMBER> covid<NUMBER> singlestranded positive sense rna virus diameter <NUMBER>e<NUMBER> nm round elliptic shape however often exists pleomorphic form rna genome contains <NUMBER> nucleotides encoding <NUMBER> amino acids shares <NUMBER> sequence identity suggesting recent host shift humans <NUMBER> <NUMBER> like covs sensitive ultraviolet rays heat besides viruses effectively inactivated lipid solvents including chloroform ether <NUMBER> ethanol peroxyacetic acid chlorinecontaining disinfectant chlorhexidine inactivate virus <NUMBER> <NUMBER> coronaviruses naturally hosted bats believed human coronaviruses derived bat reservoir <NUMBER> <NUMBER> genomic sequence studies covid<NUMBER> identified nearly <NUMBER> <NUMBER> <NUMBER> similarity merscov sarscov<NUMBER> bat sarsrelated coronavirus respectively <NUMBER>e<NUMBER> specific route transmission human natural reservoirs still yet known however studies suggests pangolin could intermediate mammalian hosts since spike protein sarcov<NUMBER> nearly identical one virus isolated pangolin believed pangolins could provided partial spike gene sarscov<NUMBER> infect mammals <NUMBER> <NUMBER> recent study also shown development new variations functional sites receptorbinding domain spike sarscov<NUMBER> viruses pangolin likely caused due either natural selection mutations recombination <NUMBER> nevertheless human infected virus could also transmitted humantohuman respiratory droplets aerosols coughing sneezing like respiratory pathogens including sarscov<NUMBER> sarscov<NUMBER> also uses angiotensin converting enzyme ii ace<NUMBER> receptors like sarscov <NUMBER> incubation period covid<NUMBER> could vary <NUMBER> days <NUMBER> days based data chinese cdc longest time infection symptoms <NUMBER> days <NUMBER> ci <NUMBER>e<NUMBER> days chinese epidemic also doubled every seven days average patient transmits infection additional <NUMBER> individuals suggesting basic reproduction number r<NUMBER> r naught <NUMBER> bit lesser compared r<NUMBER> sarscov<NUMBER> epidemic nearly <NUMBER> <NUMBER>e<NUMBER> <NUMBER> <NUMBER> epidemiological transmission difference characteristics sarscov<NUMBER> mers covid<NUMBER> summarized table <NUMBER> recent study genetic analysis sarscov<NUMBER> genomes n ¼ <NUMBER> found virus evolving two major types designated l two different snps l type prevalent <NUMBER> aggressive spread quickly seen early stages outbreak wuhan type <NUMBER> ancestral version evolutionarily older less aggressive appears frequency l type decreased early january <NUMBER> hypothesized change selective pressure might change behavior virus thought coercive human interventions may placed severe selective pressure l type mutate type conversely type might increased also due relatively weaker selective pressure <NUMBER> ultrarapid development viral epidemics strongly suggest urgent need understanding viral dynamics cope public health emergency covid<NUMBER> may variety symptoms patient covid<NUMBER> may present usual triad suspect fever dry cough dyspnea may classified asymptomatic symptomatic carrier infective state mild prodrome profusely symptomatic depending upon immunity status patients reports conjunctivitis gastrointestinal symptoms like diarrhea vomiting nausea abdominal pain critically ill may present without fever abdominal pain anorexia dyspnea less common symptoms gastrointestinal anosmia dysgeusia <NUMBER> overall case fatality rate varied <NUMBER> <NUMBER> average <NUMBER> poor prognostic epidemiological risk factors include older age male sex smokers associated comorbidities including obesity hypertension diabetes chronic pulmonary diseases cardiovascular disease chronic kidney disease number risk factors severity presentation <NUMBER> depending clinical features covid<NUMBER> patients generally divided mild moderate severe critical <NUMBER> mild covid<NUMBER> low grade fever cough malaise rhinorrhea sore throat without hemoptysis nausea vomiting diarrhea without radiological features pneumonia absence mental changes b moderate covid<NUMBER> fever respiratory symptoms including dry cough shortness breath may emerge along radiological features <NUMBER> c severe covid<NUMBER> dyspnea respiratory frequency <NUMBER>minute blood oxygen saturation <NUMBER> pao<NUMBER>fio<NUMBER> ratio <NUMBER> andor lung infiltrates <NUMBER> lung field within <NUMBER>e<NUMBER> h critical covid<NUMBER> usually develops <NUMBER> days patients mildmoderatesevere covid<NUMBER> features acute respiratory distress syndrome ards requiring mechanical ventilation along presence multiorgan dysfunction failure metabolic acidosis coagulation dysfunction differences clinical features sarscov<NUMBER> sarscov<NUMBER> merscov summarized table <NUMBER> <NUMBER>e<NUMBER> hemogram leukopenia especially lymphopenia <NUMBER> cases mild thrombocytopenia however leukocytosis also reported <NUMBER> <NUMBER> researchers suggested neutrophiltolymphocyte ratio nlr independent risk factor severe illness nlr <NUMBER> considered threshold progression severe illness covid<NUMBER> patients inflammatory markers serum procalcitonin normal initially may increase severity increase creactive protein crp lactate dehydrogenase ldh sgot troponin rule non coronary false positive refer table <NUMBER> ddimer ferritin creatine kinase esr <NUMBER> crp may used track severity disease severe critically ill patients may high levels inflammatory markers interleukin il<NUMBER> il<NUMBER> il<NUMBER> tumor necrosis factor tnfa poor laboratory prognostic factors include high ddimer lymphopenia thrombocytopenia crp <NUMBER> however findings may always concur contacttravel historyclinical symptoms table <NUMBER> summarizes important investigations prognostic factors <NUMBER> <NUMBER> serology blood sampling much easier swab sampling oropharynx nasopharynx two kinds serological test detect covid<NUMBER> enzyme linked immunesorbent assay elisa b immunochromatography card test elisa considered better compared card test due higher sensitivity elisa sensitivity <NUMBER> card test sensitivity <NUMBER> specificity <NUMBER> however card test convenient cheaper offers rapid turnover <NUMBER> elisa based rp<NUMBER> nucleoprotein detect igm igg sarscov<NUMBER> although elisa quick turn time however may false positive results due n nucleocapsid proteins sarscov<NUMBER> <NUMBER> <NUMBER> cross reactivity expected sarscov<NUMBER> infection since <NUMBER> homology genetic sequence sarscov<NUMBER> hence protein transmembrane glycoprotein spike elisa developed specific sarscov<NUMBER> reversetranscriptase polymerasechainreaction rtpcr rtpcr genomic sequencing wherever available gold standard confirmatory test covid<NUMBER> overall sensitivity rtpcr nearly <NUMBER> <NUMBER> false negative rate sensitivity decreases <NUMBER> day <NUMBER>to <NUMBER> postsymptoms nearly <NUMBER> day <NUMBER> <NUMBER> day <NUMBER> <NUMBER> rtpcr specimen collection upperlower respiratory tract sputum bronchoalveolar lavage samples performed strict precautions taken early symptom onset obtain high virus concentrations <NUMBER> noted rtpcr may take hours <NUMBER> days reporting second sample different viral gene may needed initial test negative moreover rtpcr may false negative times eg low viral load early phase late phase disease mutation covid<NUMBER> virus technical difficulties collection samples similarly result may falsepositive influenza respiratory pathogens either case important remain vigilant issues rtpcr incorrect sample collection processing potential risk health care workers due aerosol transmission beside delayed report delivery requirement expertise setup laboratory cost <NUMBER> although serology rtpcr complimentary however since antibodies appear early <NUMBER>day postsymptoms estimated igmelisa detect cases rtpcr day <NUMBER> illness <NUMBER> another study reported higher sensitivity <NUMBER> rtpcr first week compared serological test <NUMBER> however second week serological test higher sensitivity rtpcr collectively suggest ideally combine modalities test increase sensitivity early detection diagnosis covid<NUMBER> <NUMBER> <NUMBER> indeed combined igmelisa plus rtpcr shown detect <NUMBER> cases versus <NUMBER> single rtpcr <NUMBER>e<NUMBER> available evidence <NUMBER>e<NUMBER> put things perspective logical well advisable superseding recommendation e rapid screening table <NUMBER> differences epidemiological characteristics sarscov<NUMBER> sarscov<NUMBER> merscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> summary important investigations prognostic factors <NUMBER> <NUMBER> sarscov<NUMBER> carriers symptomatic asymptomatic combined igmiggelisa may offer better utility sensitivity compared either igmor iggelisa test alone b symptomatic subjects contacts assessed rapid antibody testing first positive rtpcr done confirmatory test c highly suspicious cases undergo rtpcr first even rapid antibody tests negative antibody test negative initially retested <NUMBER>e<NUMBER> days bronchoscopy bronchoalveolar lavage bal may done sputum sample cannot obtained rule alternative diagnosis tuberculosis bacterial fungal pneumonias remove bronchial mucous plugs strict precautions taken bal avoid aerosol infections sensitivity positivity rates rtpcr patients sarscov<NUMBER> different specimen lowest urine <NUMBER> highest bal <NUMBER> summarized table <NUMBER> <NUMBER> radiological examination includes chest xray cxr computed tomography ct pointofcare lung sonography done case case basis avoid pulmonary function test chances droplet infection may high cxr findings nonspecific normal initial phases patchy unilateral bilateral involvement lobarmultilobarbilateral consolidation <NUMBER> ct changes four stages early stage ground glass opacities ggo subpleural distribution involving mainly lower lobes b progressive stage multilobe distribution ggo bilateral consolidation airspaces fig <NUMBER> c peak stage dense consolidation almost cases fig <NUMBER> absorption stage denotes ggo without crazy paving pattern sonography lungs may helpful done bedside reduces movement patient different department irregular pleural lines consolidation subpleural areas areas white lung thick b lines <NUMBER> table <NUMBER> shows summarizes differences radiological findings sarscov<NUMBER> sarscov<NUMBER> merscov <NUMBER> <NUMBER> <NUMBER> <NUMBER> isolation main stay prevention vaccine covid<NUMBER> currently phase <NUMBER> trial recently mrna<NUMBER> vaccine targets spike protein coronavirus manufactured vaccine research center moderna unit national institute allergy infectious diseases usa trial began <NUMBER> march kaiser permanente washington health research institute seattle washington total <NUMBER> males females aged <NUMBER> <NUMBER> participants divided three cohorts administered <NUMBER> mg mcg <NUMBER>mcg <NUMBER>mcg dose <NUMBER> days apart presently treatment covid<NUMBER> supportive prevention way reduce community transmission convalescent sera covid<NUMBER> positive patients approved fda severe critical patients <NUMBER> although antiviral therapy drugs till time writing proven work substantially covid<NUMBER> humans smallscale studies claimed benefit chloroquine hydroxychloroquine less severely ill patients drugs also tried include lopinavirritonavir remdesivir favipiravir oseltamivir ribavirin interferon beta tocilizumab abidol <NUMBER> multiple rcts currently undergoing agents results eagerly awaited table <NUMBER> specimen positivity sarscov<NUMBER> descending order <NUMBER> sarscov<NUMBER> infectious sarscov<NUMBER> merscov infections covid<NUMBER> generally mild selflimiting however even asymptomatic carriers may spread infection newer possibilities fecooral transmission also speculated rapid diagnostic tests helpful screening diagnosing covid<NUMBER> patients trials specific antiviral drugs vaccine currently underway curb pandemic meanwhile isolation containment way prevention contracting covid<NUMBER> hereby declare conflict interest related article world experiencing expansive spread severe acute respiratory syndromecoronavirus <NUMBER> sarscov<NUMBER> global pandemic first reported december <NUMBER> <NUMBER> wuhan china began cases pneumonia unknown etiology identified novel coronavirus january <NUMBER> <NUMBER> coronavirus disease <NUMBER> covid<NUMBER> illness comes sarscov<NUMBER> named pandemic world health organization march <NUMBER> <NUMBER> <NUMBER> time ravaged much china epidemic accelerating time first reported case first <NUMBER> cases <NUMBER> days took <NUMBER> days next <NUMBER> cases <NUMBER> days following <NUMBER> cases <NUMBER> days subsequent <NUMBER> cases march <NUMBER> <NUMBER> <NUMBER> cases <NUMBER> deaths world attributed directly covid<NUMBER> <NUMBER> cases <NUMBER> deaths united states <NUMBER> <NUMBER> increase respectively <NUMBER> days remember <NUMBER> month ago march <NUMBER> <NUMBER> cases united states <NUMBER> every region globe currently impacted covid<NUMBER> <NUMBER> enormous strain pandemic placing health care systems across world palpable testing capacity supply chains personal protective equipment ppe specimen collection swabs supplies equipment including ventilators requiring hospital care new approaches needed scale testing covid<NUMBER> reduce needs ppe specimen collection swabs allow testing sarscov<NUMBER> outside health care facilities new cases covid<NUMBER> infection casualties continue multiply mixed messages abound public health world urgently recommended covid<NUMBER> prevention measures questioned vast hard follow invasive lifestyle damaging economy public health experts either sidelined covid<NUMBER> response decisions found odds much information presented political leadership united states country currently largest number covid<NUMBER> cases president trump extended initial <NUMBER>day national slow called social distancing april <NUMBER> <NUMBER> attempt reduce spread virus <NUMBER> states like california illinois new york implemented statewide “stayathome” ordinances states implemented less restrictive measures statewide measures <NUMBER> determining proper scale timing measures critical controlling spread covid<NUMBER> numbers lives lost believe best public health evidence must inform activities three priority areas stop pandemic <NUMBER> coordinated consistent stayathome orders across multiple jurisdictions including potential nationwide mandates <NUMBER> rapid scaleup sarscov<NUMBER> testing <NUMBER> improved health care capacity respond public health consensus limiting number contacts persons slow covid<NUMBER> transmission community give time health care systems respond substantial approaches government order stay home except food medical needs although multiple theoretical practical models stayathome orders travel restrictions could slow covid<NUMBER> transmission clear consistency implementation communication key policies effective implemented coordinated manner across large geographic regions people commonly move remain multiple examples public health interventions uniformly implemented instance city atlanta georgia quickly implemented several local variations stayathome recommendations multiple city county levels comprise metropolitan area yet statewide recommendation implemented several weeks later meant people told come work one atlanta county order lived continued congregate public places patchwork response unique united states illustrates underlying lack understanding use public health measures slow transmission infectious diseases inconsistency implementing public health measures also created substantial amounts public confusion fodder social media conspiracy theories hyperpartisanship distrust experts covid<NUMBER> first true global pandemic social media era offering new opportunities rapid distribution accurate public health information millions people unfortunately critical public health communications actions take protect oneself covid<NUMBER> easy differentiate inaccurate even dangerously wrong information correct information well reasoned delivered consistent messaging pillars behavior change including changing people’s transmissionrelated behaviors response covid<NUMBER> <NUMBER> social media one predominant ways people get information public health must find better ways communicate mitigation plans forums decisions covid<NUMBER> mitigation policies must informed best epidemiologic information requires rapid scaleup covid<NUMBER> testing require rapid development new diagnostic tests laboratory capacity testing supply chains health care personnel collect specimens novel testing strategies development including use rapid diagnostic tests serological tests selfcollected specimens improve ability screen large number people quickly give us new understanding extent exposure disease recovery information vital epidemiologic modeling support informationdriven decision making appropriate timing scope response also rapidly growing number examples innovative approaches implementing covid<NUMBER> testing including examples successful largescale screening programs like driveup testing south korea thousands tests delivered day <NUMBER> changing course covid<NUMBER> disease heavily impacted countries united states require massive scaleup testing compared conducted date instance united states rate total covid<NUMBER> testing point <NUMBER> tests per <NUMBER> million people <NUMBER> overall since january <NUMBER> <NUMBER> <NUMBER> admittedly dismal response testing focus mainly severely ill rate testing meet needs health care sector response much less needs better understand covid<NUMBER> epidemiology way make control measures effective testing least <NUMBER> million us residents every week <NUMBER> population phase pandemic additionally need shorter time test results better guide care isolation decisions must find new ways reaching people testing without overburdening already taxed health care systems control movement scaleup covid<NUMBER> testing successful truncating covid<NUMBER> pandemic reducing lives lost immediate commitment resources improve capacity health care sector respond reports multiple countries already impacted covid<NUMBER> predict health care capacity rapidly exceeded transmission grows current predictions covid<NUMBER> transmission ability health care sector respond certainly require coordination efforts increase capacity hospital beds ventilators protective equipment clinicians use protecting health safety health care workers vital health us workings health care system needs high level commitment safety health care professionals providing tools prevent nosocomial covid<NUMBER> infections although implicitly means making sure health care workers appropriate ppes also come form telemedicine virtual care trends chatbots capitalize advances technology provide care patients outside hospital setting time hospitalization needed form care protects health care workforce maximizes scope care provided less impact hospital setting global public health response covid<NUMBER> successful rapidly generate best data inform decisions political leaders regarding resources policies slow transmission improve response unprecedented global public health crisis require strong political commitment courage also innovation capacity timing scale inconceivable <NUMBER> months ago right quickly directly change long covid<NUMBER> us many people die critical sciencebased information guide public health strategies leaders listen best information much public health making changes improve human life without much announcement impossible determine number lives saved due epidemiologic research yet unquestionable discipline saved millions lives implementation interventions preventative programs training understand use data protect communities needed also responsibility use skills wisely steadfast way bend whim politics instead affirms know loudly needed highlights still need determine quickly accurately possible protect world december <NUMBER> increasing number pneumonia cases appeared wuhan hubei state china thorough analytical studies accomplished epidemiologists demonstrated spread disease might related wuhan south china seafood market <NUMBER> dedicated indepth studies using highthroughput sequencing revealed new betacoronavirus called <NUMBER> novel coronavirus <NUMBER>ncov <NUMBER> january <NUMBER> world health organization renamed virus sarscov<NUMBER> disease covid<NUMBER> <NUMBER> despite attempts limit spread virus within city rapidly disseminated states china may due movement preceding lunar chinese new year <NUMBER> within weeks infection spread many countries worldwide january <NUMBER>th many countries including japan south korea thailand reported first cases next day first case confirmed usa virus continued spread first case recorded philippines february <NUMBER>nd france february <NUMBER>th iran february <NUMBER> st february <NUMBER>th first case appeared italy many countries europe reported first cases <NUMBER> considering largely increasing cases throughout world world health organization announced global pandemic march <NUMBER>th <NUMBER> <NUMBER> may <NUMBER>th <NUMBER> eastern european summer time covid<NUMBER> affected <NUMBER> countries <NUMBER> <NUMBER> <NUMBER> confirmed cases <NUMBER> <NUMBER> deaths <NUMBER> coronaviruses covs comprise heterogeneous group enveloped positive sense singlestranded rna viruses owned names due <NUMBER> nm long surface spikes look like corona equal crown latin cause many diseases including respiratory gastrointestinal heart neurological pathologies variable severity among animals humans <NUMBER> depending available data bats may initial hosts covid<NUMBER> may transmitted humans pangolin <NUMBER> wild animals <NUMBER> confronted huanan seafood market disseminated human human transmission current data showed incubation period <NUMBER> days range <NUMBER> days high probability asymptomatic transmission <NUMBER> severe acute respiratory syndrome sars considered first pandemic infection related coronavirus started china <NUMBER> <NUMBER> due new sarscov coronavirus disseminated <NUMBER> countries <NUMBER> due travel movement throughout world affecting <NUMBER> patients casefatality rate <NUMBER> sars disappeared nosocomial transmission sarscov common bats considered primary reservoir although unproven actual source intermediary source considered civet cats wet markets guangdong <NUMBER> second coronavirusrelated outbreak middle east respiratory syndrome mers caused merscov mers appeared april <NUMBER> first identified humans kingdom saudi arabia ksa contact camels camel products considered cause human infection mers continued emerge reemerge <NUMBER> december <NUMBER> total <NUMBER> laboratoryconfirmed cases merscov infection including <NUMBER> deaths <NUMBER> mortality reported <NUMBER> countries <NUMBER> covid<NUMBER> outbreak brings back memories spanish flu pandemic <NUMBER> caused h<NUMBER>n<NUMBER> strain influenza virus pandemic caused fifty million deaths worldwide mortality rate ranged <NUMBER> <NUMBER> <NUMBER> death toll associated covid<NUMBER> highly surpasses two coronaviruses sarscov merscov outbreak still ongoing represents considerable threat global public health economies <NUMBER> many respiratory viruses diagnosis relies two main compartments clinical manifestations fever fatigue dry cough dyspnea gastrointestinal symptoms paraclinical diagnostic tools vary polymerase chain reaction pcr computed tomography ct <NUMBER> rapid accurate diagnosis vital pandemic one side rapidity may enhance management effectiveness accelerate application suitable isolation measures leading less contiguity hand coupling rapidity less costly procedures may permit especially lowincome countries examinations applied thus faster effective communityscale management review shed light established diagnostic methods applied help manage outbreak furthermore intend include underdevelopment techniques may potentially useful context practical intent work provide realistic perspective diagnosis covid<NUMBER> reviewing different biological radiological pathological aspects disease diagnosis end searched research articles reviews letters types publications needed research included major data bases search engines trying include much possible novel high value information patients confirmed covid<NUMBER> developed fever symptoms acute lower respiratory tract illness dry cough dyspnea rapid global spread virus limited testing capacity may preclude testing patients suspected covid<NUMBER> therefore crucial set priorities criteria conducting confirmation laboratory tests highpriority individuals include hospitalized patients especially critically ill patients unexplained respiratory failure symptomatic health care workers features respiratory illness symptomatic individuals underlying chronic health conditions risk factors severe disease <NUMBER> undertreatment soontobetreated cancer autoimmune disorders patients may high risk covid<NUMBER> receiving chemotherapy immunecomprising treatments group high risk individuals may also include patients tobetransplanted organ hematopoietic stem cell patients must screened using pcr applying aforementioned treatments case test impossibility put quarantine <NUMBER> days prior treatment initiation <NUMBER> <NUMBER> <NUMBER> least patients meet testing criteria undergo testing sarscov<NUMBER> outbreak likely preferences specific activities change outbreak seems changes create global economic burden <NUMBER> sarscov virus bought world output <NUMBER> billion initial estimates indicate economic impact covid<NUMBER> outbreak might much significant maybe around <NUMBER> billion <NUMBER> year lockdown take globes economy approximately <NUMBER> cost <NUMBER> trillion furthermore high death toll pandemic considered firstly humanitarian disaster also economic burden estimate value lost lives <NUMBER> million per life <NUMBER> many low middleincome countries covid<NUMBER> test cost exceeds government per head health spending may impose restrictions applicability test example countries test costs around <NUMBER> whereas health per head expenditure around <NUMBER> <NUMBER> even highincome european countries testing cost around <NUMBER> euros limited capacity per laboratory individual suspected infection specific criteria may accepted conduct test necessity find simpler affordable diagnostic tools <NUMBER> due high infection rate rapid accurate diagnostic methods urgently needed identify isolate treat patients soon possible reduces mortality spread risk infection population laboratoryconfirmed sarscov<NUMBER> infection requires detection viral nucleic acid respiratory tract samples use realtime reversetranscription polymerase chain reaction rrtpcr assay whereas clinicalradiological diagnosis based symptoms exposures chest imaging <NUMBER> significance rrtpcr assay demonstrated fact currently considered determining factor hospitalization decisions isolation individual patients <NUMBER> however yet determined whether considered gold standard early diagnosis guidelines nhs guidance covid <NUMBER> testing preferred molecular assay screeningtesting technique <NUMBER> highly conserved abundantly expressed genes considered attractive targets sarscov<NUMBER> rtpcr assays structural spike nucleocapsid n genes nonstructural rnadependent rna polymerase rdrp gene open reading frame orf<NUMBER>ab encodes replicase polyprotein <NUMBER>ab required viral rna replication transcription <NUMBER> study conducted chu et al described two rtpcr assays detect orf<NUMBER>b n regions viral genome separately results reported assays sensitive specific sarbecoviruses furthermore n gene rtpcr assay found sensitive detecting <NUMBER>ncov rna different respiratory samples sputum throat swab <NUMBER> recommended use specific primers probes orf<NUMBER>ab n gene regions targets test positive case would considered confirmed infection covid<NUMBER> <NUMBER> <NUMBER> cycle threshold values ctvalue rrtpcr determine copy number sarscov<NUMBER> rna specimen ctvalue less <NUMBER> defined positive test ctvalue <NUMBER> defined negative test medium viral load defined ctvalue <NUMBER> less <NUMBER> may require confirmation repeating test <NUMBER> study conducted chan et al three novel rtpcr assays targeting rnadependent rna polymerase rdrphelicase hel spike nucleocapsid n genes sarscov<NUMBER> developed assays compared reported rdrpp<NUMBER> assay used many laboratories europe among three novel assays covid <NUMBER> rdrphel assay lowest limit detection highest analytical sensitivity <NUMBER> detection probability furthermore covid<NUMBER> rdrphel assay significantly sensitive established rdrpp<NUMBER> assay detection viral rna respiratory tract specimens nasopharyngeal aspirateswab throat swab nonrespiratory tract specimens saliva plasma detected viral rna <NUMBER> additional specimens tested negative rdrp p<NUMBER> assay contrast significant difference sensitivity two assays sputum fecesrectal swabs exclusivity testing showed covid<NUMBER> rdrphel assay crossreact human sarscov whereas rdrpp<NUMBER> assay showed crossreactivity sarscov cell culture probes rdrphel assay developed contain <NUMBER> nucleotide differences human sarscov whereas probe rdrpp<NUMBER> assay contained three nucleotide differences <NUMBER> charité algorithm berlin germany uses twostep assay confirm covid<NUMBER> infection first step linescreening assay detects envelope e gene subgenus sarbecovirus second step confirmatory assay sarscov<NUMBER> specific rtpcr assay targets rdrp crossreactivity alphacoronaviruses betacoronaviruses detected <NUMBER> another method established university hong kong detect subgenus sarbecovirusu uses ngene screening assay followed confirmatory orf<NUMBER>b assay positive patients considered sarscov<NUMBER> confirmed cases none sarbecoviruses previously detected humans sars eliminated humans last reported human sars case detected <NUMBER> <NUMBER> retrospective study conducted chen et al total <NUMBER> patients diagnosed covid<NUMBER> results showed clinical progression covid<NUMBER> patients presented two phases first phase represented fever cough fatigue systemic symptoms course phase upper respiratory specimens tested rtpcr viral rna majority patients showed positive results sarscov<NUMBER> second week disease progression symptoms began relieve patients parallel half patients showed pcr negative results upper respiratory tract samples estimated median duration negative reversetranscriptase pcr tests upper respiratory tract samples <NUMBER> days proportion <NUMBER> patients story direct contact confirmed covid<NUMBER> cases patients asymptomatic positive rtpcr results throatswab samples asymptomatic patients pcr turned negative two days <NUMBER> <NUMBER> <NUMBER> admission <NUMBER> strongly thought involving various specimens multiple sites could lower false negatives improve sensitivity important issue collect samples testing actual guidelines current public health england guidance <NUMBER> suggest samples upper respiratory tract question remains whether significant difference sensitivity nasopharyngeal np nasal oropharyngeal op throat throat swabs may appear uncomfortable patients could induce coughing lingual swabs comfortable consider achieve comparable results total positive rate rrtpcr throat swab samples reported <NUMBER> initial presentation <NUMBER> <NUMBER> cohort study conducted ye et al showed positive rate throat swabs <NUMBER> higher lingual swabs <NUMBER> detection covid<NUMBER> difference seen samples taken single experienced nurse results indicate standardized sampling nurse could improve detection rate <NUMBER> another cohort yang et al examined <NUMBER> throat swabs <NUMBER> nasal swabs <NUMBER> hospitalized covid<NUMBER> patients reported positive test rates favor nasopharyngeal specimen nasal swabs mild severe cases different time points illness onset day <NUMBER> <NUMBER> <NUMBER> unfortunately significance calculation performed results contrast another german smaller study wolfel et al conducted <NUMBER> covid<NUMBER> patients discernible difference viral loads detection rates comparing nasal throat swabs <NUMBER> <NUMBER> urine specimens tested negative <NUMBER> notably raises concerns ruling covid<NUMBER> based combined pharyngeal nasal swabs obtained single time point based limited available data quality possible assess sensitivity test enough data performing nasal throat swabs hand may recommended possible collect lower respiratory tract specimen form sputum appears highly sensitive specimens noninvasive exam <NUMBER> sensitivity also depend technical issues related testing performance delay illness onset methods sampling <NUMBER> symptomatic covid<NUMBER> patients viral rna may detected nasopharyngeal swab early <NUMBER> day symptoms initiation positivity starts decline week <NUMBER> subsequently becomes undetectable <NUMBER> shown fig <NUMBER> live coronavirus sheds high concentrations nasal cavity even asymptomatic infected individuals thus detected pcr symptoms initiation <NUMBER> gastrointestinal symptoms diarrhea nausea vomiting frequently reported patients infected sarscov<NUMBER> sometimes alone alongside general respiratory manifestations many studies confirmed presence live virus stool samples thus stool samples also diagnostic furthermore worth studying whether stool specimen collection may eventually reduce medical staff infections compared respiratory swabs specimens study conducted xiao <NUMBER> regarding collection samples worth mentioning pcr samples general obtained dacron polyester flocked swabs reach laboratory soon possible collection <NUMBER> study conducted zhang et al revealed <NUMBER> confirmed covid<NUMBER> patients positive stool sample viral nucleic acid shown accuracy fecal specimen detection may equivalent oropharyngeal swabs results <NUMBER> another publication zhang et al enrolled three pediatric patients mild covid<NUMBER> infection results suggested long existence viruses feces patients recovered soon negative sarscov<NUMBER> nucleic acid throat swab specimens three remained positive fecal specimens within <NUMBER> days recovery discharge <NUMBER> chen et al found <NUMBER> laboratoryconfirmed covid<NUMBER> patients tested positive sarscov<NUMBER> rna stool specimens furthermore consistency zhang et al positivity stool samples associated presence gastrointestinal symptoms severity illness proportion <NUMBER> patients remained positive viral rna feces pharyngeal swabs turned negative concerning duration viral shedding feces found <NUMBER> days <NUMBER> negative conversion pharyngeal swabs <NUMBER> long existence viral rna feces indicate fecaloral route may serve alternative infection route suggested replication virus gastrointestinal tract may consistent respiratory tract <NUMBER> <NUMBER> <NUMBER> finding raise concerns whether patients negative respiratory swabs truly virusfree sampling additional body sites needed therefore may important routinely detect viral rna stool specimens covid<NUMBER> patients hospitalization recovery stage perform transmissionbased precautions patients negative conversion viral rna feces according reports date patients showed positive results viral rna pharyngeal swabs reversibly anal swabs turned negative <NUMBER> rapid detection sarscov<NUMBER> considered urgent priority contain pandemic rrtpcr used standard method confirm infection may considered timeconsuming procedure samples testing must carried central laboratories advanced equipment leads time consumed consequently time needed get results may take hours <NUMBER> <NUMBER> days depending country <NUMBER> loopmediated isothermal amplification lamp assay isothermal nucleic acid amplification technique high specificity efficiency rapidity lamp showed advantages rrtpcr simplified sample preparation one single protocol hence results obtained less hour furthermore diagnostic sensitivity tests based lampreaction assays higher <NUMBER> compared rrtpcr avian influenza pandemic lamp assay showed success rapid detection h<NUMBER>n<NUMBER> virus assay used point care devices <NUMBER> may suggest lamp assay could candidate pointofcare device application rapid detection covid<NUMBER> strongly thought serological testing approach surveillance covid<NUMBER> takes <NUMBER> weeks positivity onset infection serum samples tested using enzymelinked immunosorbent assay elisa study conducted zhao et al enrolled total <NUMBER> confirmed cases covid<NUMBER> use rrtpcr samples respiratory track reported seroconversion sequentially appeared total antibody ab igm igg median time <NUMBER> <NUMBER> <NUMBER> days respectively besides presence antibodies <NUMBER> among patients first week illness rapidly increased <NUMBER> <NUMBER> <NUMBER> respectively since day <NUMBER> onset may conclude total antibody sensitive igm igg detecting sarscov<NUMBER> infection contrast positive rate rna decreased <NUMBER> <NUMBER> <NUMBER> samples collected day <NUMBER> <NUMBER> <NUMBER> days <NUMBER> <NUMBER> thus antibody detection essential supplement rna detection illness course probably combining rna antibody detections may significantly improve sensitivity pathogenic diagnosis covid<NUMBER> patients p <NUMBER> even early phase <NUMBER>week since onset p <NUMBER> moreover results revealed correlation clinical severity antibody titer <NUMBER>week illness onset higher titer ab independently associated worse clinical outcome p <NUMBER> <NUMBER> cases nucleic acid amplification test naat assay negative strong doubt epidemiological link covid<NUMBER> infection travel highly infected areas etc paired serum samples acute convalescentphase could support diagnosis crossreactivity coronaviruses challenging commercial noncommercial serological tests currently development evaluation <NUMBER> simple pointofcare device developed detect igm igg antibodies sarscov<NUMBER> virus blood samples within <NUMBER> min provides possibility identify significant number infected patients mainly asymptomatic carriers prevent virus spread depending clinical studies validate clinical efficacy uses overall testing sensitivity <NUMBER> specificity <NUMBER> test commercially available <NUMBER> accuracy furthermore igmigg combined assay showed advantages single igm igg test better utility sensitivity used rapid screening sarscov<NUMBER> carriers symptomatic asymptomatic hospitals clinics test laboratories <NUMBER> antibodies test could also impact since available massive population lockdown strategy used massive immune confirmation especially asymptomatic mildly symptomatic patients longer represent threats others case seroconversion impact attributed point care poc devices terms management infections epidemics several manufactures made efforts build devices poc testing samples ordinarily nasal throat swab many poc devices use molecular testing rapid pcr testing using nucleic acid fluorescent probes <NUMBER> cartridge genexpert <NUMBER> machine cepheid <NUMBER> results could obtained within <NUMBER> min claimed <NUMBER> cartridge m<NUMBER> <NUMBER> machine abbott <NUMBER> time obtain results approximately <NUMBER> min claimed <NUMBER> cartridge vivalytic <NUMBER> machine bosch <NUMBER> time obtain results <NUMBER> min claimed respistrip <NUMBER> coris bioconcept <NUMBER> immunebased test using monoclonal antibodies nucleocapsid protein tests results obtained within <NUMBER> min claimed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> apparently abnormally high values procalcitonin pct associated <NUMBER>fold higher risk severe sarscov<NUMBER> infection <NUMBER> <NUMBER> ci <NUMBER> furthermore seems serial procalcitonin measurements may play key role predicting evolution towards severe form disease possible explanation production sustainability release procalcitonin extrathyroidal source reinforced il<NUMBER>β tumor necrosis factor tnfα il<NUMBER> time synthesis inhibited interferon infg usually high viral infection result surprising procalcitonin concentration seems normal noncomplicated covid<NUMBER> patients tend climb higher severe forms <NUMBER> recent publication sarscov<NUMBER>specific cd<NUMBER> cd<NUMBER> cells responses measured covid<NUMBER> cases using flow cytometry among approaches sarscov<NUMBER>specific cd<NUMBER> cell seen covid<NUMBER> cases cd<NUMBER> cell responses seen thus flow cytometry could present potential covid<NUMBER> diagnosis alongside potential laboratory indicators like pct etc worth noting preexisting sarscov<NUMBER>crossreactive cell responses healthy donors indicating potential preexisting immunity human population <NUMBER> <NUMBER> rrtpcr test plays crucial role diagnosis covid<NUMBER> falsenegative results recorded initial diagnosis highlights importance recruiting additional techniques diagnosis management criteria national health commission china published <NUMBER>th version diagnosis treatment program recommends use radiologic techniques diagnosis management sarscov<NUMBER> infection <NUMBER> <NUMBER> study ai et al results shown table <NUMBER> demonstrated high sensitivity ct scan conventional rapid practical diagnostic method screening managing critical cases epidemic areas also <NUMBER> cases eventually improved followup scans turning rrtpcr results negative recommends use ct scan followup however study revealed many limitations including low specificity due falsepositive cases common imaging characteristics viral pneumonia <NUMBER> recent retrospective study li et al including <NUMBER> patients covid<NUMBER> two patients adenovirus diagnosed rrtpcr low rate <NUMBER> covid<NUMBER> misdiagnosis detected missed cases however ct features initial examination overlapped ct features sars mers including consolidation septal thickening <NUMBER> another study <NUMBER> patients fang et al revealed <NUMBER> sensitivity ct compared <NUMBER> sensitivity rtpcr <NUMBER> common ct features according multiple reported cases bilateral groundglass opacities patchy consolidation mainly located along bronchial bundle reactive thickened adjacent pleura mild bronchiectasis lymphadenopathy pleural effusion detected reports <NUMBER> <NUMBER> <NUMBER> <NUMBER> study chung et al revealed <NUMBER> normal findings <NUMBER> groundglass opacity <NUMBER> groundglass opacity consolidation <NUMBER> two lobes involved <NUMBER> bilateral disease <NUMBER> besides comprehensive review european society radiology defined ct features covid<NUMBER> common findings groundglass opacity ggo <NUMBER> multifocal patchy consolidation <NUMBER> considered indicator disease progression reticular pattern thickened interstitial septa crazy paving pattern ends acute interstitial inflammatory alveolar edema bronchiolectasis defined gelatinous mucousfilled bronchi background airless lung pleural thickening fewer commonly pleural effusion subpleural curvilinear lines fibrosis small bubblelike aircontaining space bubble sign less common features small multifocal nodules halo sign refers nodules surrounded ground glass atoll sign reversed halo sign focal ground glass opacity ggo surrounded ringshaped consolidation <NUMBER> <NUMBER> similar findings described another study <NUMBER> patients patchy bilateral ggo <NUMBER> unilateral involvement <NUMBER> <NUMBER> furthermore according retrospective study comparing ct features deceased recovered patients air bronchogram extensive multifocal consolidations common mortality group suggests worse prognosis abnormalities <NUMBER> one retrospective cohort studies including <NUMBER> patients wuhan common abnormal pattern ct scan ggo <NUMBER> mainly involving right lower lobe illdefined margins <NUMBER> air bronchograms <NUMBER> interlobular septal thickening <NUMBER> cases demonstrated bilateral involvement <NUMBER> peripheral distribution <NUMBER> slightly predominating right lower lobe less common features bronchiectasis <NUMBER> cystic changes <NUMBER> although previous cases didnt demonstrate features lymphadenopathy pleural effusion study included five patients lymphadenopathy <NUMBER> four patients pleural effusion <NUMBER> study revealed asymptomatic patients could also present abnormalities ct scan abnormalities showed rapid increase within two weeks symptom onset followed gradual decrease third week results highly suggested clinical course disease correlates radiological evolution however features specific covid<NUMBER> also present pneumonia caused viruses bacteria <NUMBER> multicenter recent retrospective study total <NUMBER> patients china united states radiologists compared ct abnormalities covid<NUMBER> noncovid<NUMBER> pneumonia results revealed noncovid<NUMBER> pneumonia likely manifest air bronchogram <NUMBER> compared <NUMBER> covid<NUMBER> pleural thickening <NUMBER> vs <NUMBER> pleural effusion <NUMBER> vs <NUMBER> central peripheral distribution <NUMBER> vs <NUMBER> lymphadenopathy <NUMBER> vs <NUMBER> covid<NUMBER> pneumonia likely manifest ggo <NUMBER> vs <NUMBER> noncovid <NUMBER> fine reticular opacity <NUMBER> vs <NUMBER> reverse halo sign <NUMBER> vs <NUMBER> vascular thickening <NUMBER> vs <NUMBER> bilateral peripheral distribution <NUMBER> vs <NUMBER> <NUMBER> another study dai et al conducted another comparison ct manifestations covid<NUMBER> pneumonia viral types pneumonia common bacterial pneumonia according findings common bacterial pneumonia manifested multiple consolidations involving lung parenchyma bronchial wall thickening centrilobular nodules covid<NUMBER> pneumonia characterized bilateral ggos progressing massively clinical course crazy paving pattern diffuse consolidations even whitelung appearance advanced stage viral pneumonias highattenuation reticular patterns interstitial inflammation atelectasis localized pulmonary edema <NUMBER> however studies required order evaluate accuracy ct scan define diagnostic role covid<NUMBER> patients complement clinical laboratory results pandemic rapid accurate diagnosis plays vital role coupling rapid detection high sensitivity viral infection may allow better control viral spread provides faster effective communityscale management according results recent studies chest ct abnormalities identified patients prior detection viral rna upper respiratory specimens endemic areas <NUMBER> <NUMBER> <NUMBER> study <NUMBER> patients wuhan underwent rrtpcr testing chest ct evaluation covid<NUMBER> investigators found chest ct achieved higher sensitivity diagnosis covid<NUMBER> compared initial rrtpcr pharyngeal swab samples results showed indicated <NUMBER> patients positive rrtpcr results <NUMBER> positive chest ct scans patients negative rrtpcr results <NUMBER> n <NUMBER> positive chest ct findings besides analysis serial rrtpcr assays ct scans performed mean interval initial negative positive rrtpcr results determined <NUMBER> ae<NUMBER> days initial positive subsequent negative rrtpcr result <NUMBER> ae <NUMBER> days using rrtpcr results reference standard sensitivity specificity accuracy chest ct diagnosing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively <NUMBER> low specificity may related etiologies causing similar ct findings consistency previous study fang et al reported sensitivity chest ct higher rrtpcr <NUMBER> vs <NUMBER> respectively <NUMBER> addition retrospective analysis conducted chunqin long et al showed sensitivity ct examinations <NUMBER> <NUMBER> <NUMBER> patients positive presentation whereas sensitivity initial rrtpcr <NUMBER> <NUMBER> patients positive second rrtpcr round three patients positive result three positive third round rrtpcr <NUMBER> findings indicate among others rrtpcr repeated avoid misdiagnosis results rrtpcr tests must cautiously interpreted may affected various external factors including sampling operations specimens source sampling timing different periods disease development performance detection kits number factors could lead negative result infected individual including poor quality specimen containing insufficient patient material specimen collected late early infection timeline specimen handled shipped appropriately technical reasons inherent test eg virus mutation pcr inhibition case strong clinical geographical doubt negative test especially upper respiratory tract sampling second test conducted preferably lower respiratory tract <NUMBER> although ct wellrecognized firstline radiologic investigation covid<NUMBER> recent studies american college radiology suggest using cxr firstline tool decrease risk crosscontamination caused ct suites well minimize economic burden radiology departments increase availability service <NUMBER> retrospective cohort study wong et al <NUMBER> patients covid<NUMBER> infection confirmed rrtpcr cxr sensitivity <NUMBER> compared <NUMBER> rrtpcr <NUMBER> ct common findings bilateral peripheral consolidation lower zone dominance showed highest peak <NUMBER> days symptom onset ground glass opacities less common features interestingly six patients study revealed chest xray abnormalities confirming positivity rrtpcr however due low sensitivity cxr compared ct evidence needed support use initial screening <NUMBER> <NUMBER> pathological aspects covid<NUMBER> essential issues studies recently revealed pathological characteristics covid<NUMBER> demonstrating importance histological diagnosis however best knowledge complete autopsy pathological report recorded yet xu et al first autopsied lung extrapulmonary organs deceased <NUMBER>yearold male diagnosed covid<NUMBER> infection associated acute respiratory distress syndrome ards findings demonstrated endstage diffuse injury <NUMBER> tian et al reported earlystage changes studying samples biopsies two patients underwent surgical resection lung adenocarcinoma accidentally diagnosed early phase covid<NUMBER> pneumonia <NUMBER> early pathological manifestations included proteinaceous exudate pulmonary edema inflammatory clusters multinucleated giant cells vascular congestion reactive epithelial hyperplasia suspected viral inclusions endstage pathological changes included fibromyxoid exudate diffuse alveolar damage hyaline membrane formation addition presence atypical pneumocytes characterized amphophilic granular cytoplasm large nuclei prominent nucleoli identified viral inclusions studies literature review pathological features severe acute respiratory syndrome sars middle east respiratory syndrome mers covid<NUMBER> found share multiple pathological characteristics however subsequent systematic autopsy might better explain clinicpathological features covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> recently interesting approved animal study performed golden syrian hamsters inoculated sarscov<NUMBER> isolated laboratoryconfirmed covid<NUMBER> patient hong kong several tissue organs dissected underwent histological examination tracheal tissue examination revealed epithelial desquamation focal cilia loss mononuclear infiltration microscopic examination infected lungs revealed formation hyaline membranes mononuclear cell infiltration large multinucleated syncytial bodies alveolar lumens filled cellular debris hemorrhage also proliferation marker ki<NUMBER> extensively expressed bronchiolar cells demonstrating marked cellular proliferation furthermore multiple extrapulmonary organ tissues studied reduction spleen size markedly observed red white pulp depletion decrease size number follicles pale eosinophilic lymph sinus ectasia observed mesenteric bronchial lymph nodes interestingly intestinal mucosa highly affected demonstrating increased mononuclear cell infiltration lamina propria massive necrosis epithelial cells pathological changes revealed possible explanation extrapulmonary symptoms disease <NUMBER> covid<NUMBER> relatively new disease thus opportunities must explored order find effective mean diagnosis prevention treatment efforts may also benefit new technologies including molecular biology radiology techniques maybe also artificial intelligence medical applications <NUMBER> rapidity accessibility may also represent important objectives new researches meanwhile strict wellapplied measures prevention detection could help enhancing virus detectability <NUMBER> importantly combination wellconducted clinical examination adequate laboratory tests adapted radiological exams still potent arsenal disease ta received honorarium biotest france sas rs si ms aa declare conflict interests manuscript recent outbreak novel coronavirus covid<NUMBER> generated global concern given rapid spread multiple countries possible fatal progression infection initially many patients reported exposure large seafood animal market wuhan china suggesting animaltoperson transmission virus however since many patients reported exposure animal markets indicating persontoperson transmission occurring currently vaccine targeted therapeutic covid<NUMBER> covid<NUMBER> difficult diagnose early infection patients remain asymptomatic present nonspecific flulike clinical symptoms including fever cough shortness breath symptoms may appear <NUMBER> days <NUMBER> weeks exposure <NUMBER> quantitative reverse transcription pcr qrtpcr covid<NUMBER> serum respiratory samples currently standard diagnostic molecular testing however requires expensive equipment trained personnel reverse transcription loopmediated isothermal amplification rtlamp onestep nucleic acid amplification method based pcr technology used diagnose infectious diseases <NUMBER> rtlamp several advantages including high specificity sensitivity done less hour work various ph temperature ranges advantageous clinical samples <NUMBER> reagents relatively low cost stable room temperature previously used method detect zika virus clinical serum urine samples well mosquitos <NUMBER> <NUMBER> study describes rtlamp methodology detect covid<NUMBER> simulated patient samples <NUMBER> minutes test could used pointofcare field local personnel rapid diagnosis individuals optimal treatment isolation rapid contact tracking well investigation outbreaks unknown respiratory diseases rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity sharing influenza data gisaid epiflu database blast global alignment tool <NUMBER> <NUMBER> rtlamp primers also compared coronaviruses using blast global alignment tool determine specificity percent mismatch using method percent mismatch calculated using following equation rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint establish optimal conditions rtlamp using covid<NUMBER> pcrstandard designed nucleotide <NUMBER> covid<NUMBER> wuhanhu<NUMBER> complete genome mn<NUMBER> several primer sets ranges temperatures <NUMBER>°c incubation times <NUMBER> mins tested best amplification results obtained <NUMBER> ° c <NUMBER> minutes indicated banding pattern electrophoresis gel fig <NUMBER> positive reactions containing sybr green could observed naked eye color change orange yellow fig <NUMBER>top <NUMBER> order determine lower detection limit rtlamp reaction covid<NUMBER> dilution series ranging <NUMBER> fg <NUMBER> ng covid<NUMBER> amplified fig <NUMBER> limit detection approximately equivalent <NUMBER> fg dilution series run parallel qrtpcr using primers targeted region covid<NUMBER> genome qrtpcr ct values dilution series reported supplemental table <NUMBER> demonstrate clinical utility system covid<NUMBER> detection spiked various human specimens covid<NUMBER> middle east respiratory syndrome mers betacoronavirus england<NUMBER> btcov murine hepatitis virus mhv mers btcov mhv spiked samples used test specificity rtlamp assay spiked specimens included serum urine saliva oropharyngeal swabs nasopharyngeal swabs wanted verify substances present samples would interfere rtlamp samples directly used rtlamp without performing nucleic acid rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint isolation samples containing covid<NUMBER> mers btcov mhv positive rtlamp reactions indicating specificity reaction covid<NUMBER> fig <NUMBER> furthermore rtlamp could successfully completed using human serum urine saliva oropharyngeal swabs nasopharyngeal swabs sequence rtlamp primers also compared aligned sequences various strains severe acute respiratory syndrome coronaviruses sars coronaviruses commonly associated common cold human coronavirus strains <NUMBER>e nl<NUMBER> hku<NUMBER> oc<NUMBER> coronaviruses <NUMBER> nucleotide mismatch rtlamp primers making highly unlikely would give positive rtlamp result supporting specificity assay covid<NUMBER> table <NUMBER> given viruses prone genetic mutation likewise examined rtlamp primers mismatch <NUMBER> different isolated strains covid<NUMBER> various locations <NUMBER> mismatch strains examined suggesting rtlamp primers would identify <NUMBER> strains covid<NUMBER> examined supplemental table <NUMBER> given rapid emergence covid<NUMBER> severe complications result including acute respiratory distress syndrome ards pneumonia improved diagnostic options fast reliable easy affordable required critical since covid<NUMBER> infection rapidly progress hospital admission ards <NUMBER> days covid<NUMBER> infection fatal <NUMBER> conventional qrtpcr specific sensitive must done trained personnel specialized equipment qualified laboratory since disease spreading rapidly centralized labs may trouble keeping testing demands may need alternative approach qrtpcr kits available feasibility study demonstrated rtlamp allows rapid detection covid<NUMBER> variety rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint common human specimens collected clinical testing including serum urine saliva oropharyngeal swabs nasopharyngeal swabs currently clinical testing covid<NUMBER> done central testing laboratories may take one days study sought improve upon developing potential pointofcare test pointofcare testing several advantages emerging infectious diseases like covid<NUMBER> must easy use inexpensive fast require little laboratory infrastructure maintaining sensitivity specificity rtlamp meets requirements therefore large value screening testing covid<NUMBER> potentially exposed populations sought determine rtlamp assay worked range different samples might collected clinical setting possible noninvasive screening tool important since may feasible collect serum patients especially patients critically sick dehydrated elderly children neonates personnel trained collecting blood specimens may also available furthermore biological samples may contain chemicals inhibit nucleic acid assays sample tested directly without first isolating rna rtlamp worked human sample types tested samples several individuals previously demonstrated rtlamp zikv require prior rna isolation samples <NUMBER> <NUMBER> thus used unprocessed urine serum samples study saves considerable time reduced costs rtlamp assay covid<NUMBER> urine samples gave stronger rtlamp signals serum samples spiked identical amounts covid<NUMBER> however amount virus present infected individual likely vary different biological specimens time course infection furthermore observed faint background banding gel electrophoresis oropharyngeal swabs suggesting may factor specimen results however due specificity primers believe interfere correct interpretation rtlamp reaction especially since covid<NUMBER> spiked sample correctly identified color change fluorescence rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint primers designed conserved span covid<NUMBER> sequence found <NUMBER> isolated covid<NUMBER> strains sequence also divergent related coronavirus sars given isolated strains covid<NUMBER> thus far shown little genetic differences anticipate rtlamp detect covid<NUMBER> level confidence qrtpcr covid<NUMBER> rtlamp assay highly specific give positive result mers btcov mhv significant mismatch numerous strains sars common cold associated human coronoavirus strains <NUMBER>e nl<NUMBER> hku<NUMBER> oc<NUMBER> tested range temperatures <NUMBER>°c <NUMBER>°c temperatures gave comparable results indicating rtlamp reaction large temperature range optimal temperate <NUMBER> ° c also tested range incubation times <NUMBER> minutes optimal time detection rtlamp products <NUMBER> minutes however covid<NUMBER> rtlamp products detectable uv light excitation banding patterns gels little <NUMBER> minutes study several limitations first covid<NUMBER> biosafety level <NUMBER> laboratory unable work directly virus infected samples experiments presented used nucleotide oligo covid<NUMBER> corresponding genbank mn<NUMBER> sequence similarly unable directly test related coronaviruses instead used nucleotide oligos region viruses however represent proofoffeasibility assay primers evaluated specificity blasting related coronavirus sequences although rtlamp reactions highly specific quantitative test however groups working improving read outs rtlamp assays including use smartphoneintegrated sensors make interpretation assay even userfriendly <NUMBER> rtlamp reactions higher rate false positives compared qrtpcr experience template negative control reactions negative control samples samples containing coronaviruses also took rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint precautions lateral work flow experiments included thermolabile uracildna glycosylase udg reactions prevent possible carryover contamination previous reactions study powered determine sensitivity clinical population lastly rapidly developing area study information presented time publication represent authors best knowledge time understanding covid<NUMBER> continues develop information may change describe fast robust assay detection covid<NUMBER> <NUMBER> minutes simple assay could used outside central laboratory various types biological samples assay completed individuals without specialty training equipment may provide new diagnostic strategy combatting spread covid<NUMBER> pointofrisk rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint authorfunder granted medrxiv license display preprint perpetuity authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint early <NUMBER> world health organization declared global health emergency due outbreak new coronavirus initially called <NUMBER>ncov later called sarscov<NUMBER> causing severe acute respiratory syndrome corona virus disease <NUMBER> covid <NUMBER> <NUMBER> zoonotic coronavirus causes severe forms acute respiratory distress syndrome cases occur mild symptoms <NUMBER> <NUMBER> may <NUMBER> overall case fatality <NUMBER> <NUMBER> deaths <NUMBER> confirmed cases reported americas <NUMBER> <NUMBER> deaths <NUMBER> confirmed cases ecuador <NUMBER> <NUMBER> deaths <NUMBER> confirmed cases according official bulletins world health organization <NUMBER> covid<NUMBER> serological tests igg igm developed several methodologies immunoenzymatic assay elisa chemiluminescence electro chemiluminescence fluorescent lateral flow immunoassays immunochromatography one different variable performance relation clinical moment used well whether developed detect spike n nucleocapsid antigens former apparently sensitive<NUMBER> none tests used diagnosis population screening disease considering antibodies appear <NUMBER>th <NUMBER>th day disease onset <NUMBER> laboratory tests detect antibodies sarscov<NUMBER> including rapid immunodiagnostic tests need validation determine accuracy reliability since double risk first one falsely label people infected seronegative second one people infected falsely labeled seropositive errors serious consequences addition necessary ensure tests distinguish infections caused sarscov<NUMBER> caused human coronaviruses cross reaction <NUMBER> rapid development associated market urgency meant tests solid clinical validation makes show divergences sensitivity specificity use <NUMBER> ecuador <NUMBER> rapid tests various brands methodologies authorized health authorities far <NUMBER> present study evaluates sample immunofluorescent immunochromatographic rapid tests show agreement relation chemiluminescence diagnostic test evaluation assay performed establish performance five rapid tests <NUMBER> immunochromatographic <NUMBER> immunofluorescent tests igg igm serology sarscov<NUMBER> evaluation performed comparing yhloiflash<NUMBER> ™ chemiluminescent analyzer medical laboratory iso <NUMBER> <NUMBER> certification iso <NUMBER> <NUMBER> accreditation city quito device previously verified according clsi ep<NUMBER> a<NUMBER> cv <NUMBER> repeatability <NUMBER> intermediate precision within manufacturers recommendations <NUMBER> <NUMBER> <NUMBER> additional performance characteristics shown table <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> results obtained rapid tests compared reports chemiluminescent analyzer using panel <NUMBER> serum samples patients received laboratory analysis routine samples taken venepuncture anterior side elbow using multipleextraction device vacuette® vacuette® <NUMBER>g needle bd vacuntainer® tube clot activator gel separator serum collection samples mixed gentle inversion <NUMBER> tubes vertically placed rack <NUMBER> minutes room temperature centrifuged <NUMBER>g <NUMBER> minutes samples free hemolysis lipemia jaundice signals obtained automated analyzer igg igm classified positive <NUMBER> au ml <NUMBER> igg <NUMBER> igm <NUMBER> <NUMBER> evaluation clinical performance qualitative results rapid tests compared obtained chemiluminescence dichotomized positives <NUMBER> au ml negative <NUMBER> ua ml total <NUMBER> rapid tests compared <NUMBER> immunochromatographic <NUMBER> fluorescent immunoassay stateoftheart reference standard study state sensitivity specificity predictive values demonstration agreement defining subjects dichotomous criterion positive negative calculating complex repeatability global percentage agreements percentage positive agreements negative agreements together corresponding <NUMBER> confidence interval complemented cohens kappa test measure agreement discriminates agreements chance <NUMBER> obtained data microsoft excel database created subsequent refining analysis means jasp® software luminescent chemo signals detected samples expressed means standard deviations concordance provided percentages accompanied corresponding confidence interval cohens kappa index <NUMBER> research committee faculty medical science central university ecuador review study conclude ethical approval required samples patient used context clinical diagnoses exist intervention affect clinical decision patients integrity ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint characterization au ml igg igm au ml positive negative samples shown table <NUMBER> table <NUMBER> summarizes concordance findings diagnostic tests evaluated n <NUMBER> reference chemoluminescence ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> given epidemiological urgency growing demand tests could contribute management sarscov pandemic high demand diagnostic tests including immunoassays rapid development commercialization limited validation clinical samples <NUMBER> given important penetration rapid tests mostly immunochromatographic ecuador received marketing authorization ministry public health <NUMBER> present study evaluated concordance tests luminescent chemoimmunological analysis using patients samples received laboratory seroprevalence evaluations best agreement positive negative agreements seen immunofluorescent assay igg contrast particularly good kappa index <NUMBER> without positive disagreements negative disagreement <NUMBER> contrasts immunochromatographic methods kappa index <NUMBER> best disagreements negative findings ≈<NUMBER> positive cases ≈<NUMBER> igm concordance behavior hand reflects weak moderate kappa concordance value kappa <NUMBER> <NUMBER> negative disagreements reaching <NUMBER> positives <NUMBER> without evaluated test reaching kappa performance equal greater <NUMBER> variations found may due type antigens used development assay apparently according several publications oriented nucleocapsid antigens would seem sensitive oriented host binding protein rbds would specific <NUMBER> great variation agreement percentages found draw attention problems diagnostic certainty serological tests associated crossreactions coronaviruses added low proportion negative agreements impact erroneous screening subject epidemiological surveillance may overestimate population rate considered immune fact <NUMBER> far studies show people recovered infection antibodies virus however persons low levels neutralizing antibodies blood therefore evaluated whether presence detectable antibodies sarscov<NUMBER> confers immunity subsequent infection <NUMBER> serological studies used clinical epidemiological context diagnostic tests <NUMBER> <NUMBER> given high demand supply market rapid serological tests evaluation panels serologically positive negative samples established chemiluminescence electro chemiluminescence essential authorize extensive use populations use required recommended carried trained technicaloperational personnel supervision professionals laboratory medicine ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> since emergence novel respiratory virus sarscov<NUMBER> december <NUMBER> region wuhan china virus spread rapidly world causing pandemic coronavirus disease covid<NUMBER> <NUMBER> adequate diagnosis sarscov<NUMBER> infection essential prompt therapeutic management patients control epidemic establishment infection control measures even though rtqpcr considered reference method screening diagnosis sensitivity method may vary depending quality origin sample time infection viral load <NUMBER> <NUMBER> <NUMBER> january <NUMBER> world health organization declared covid<NUMBER> outbreak public health emergency international concern shortly thereafter called research invitro diagnostics use community level <NUMBER> response several serological tests including enzymelinked immunosorbent assay elisa chemiluminescence immunoassay clia lateral flow rapid testing development already entered market foundation innovative new diagnostics find httpswwwfinddxorg lists <NUMBER> rapid covid<NUMBER> antibody tests communauté européenne ce marked <NUMBER> detection igg igm iga antibodies sarscov<NUMBER> play complementary role rtqpcr test diagnosis covid<NUMBER> assessing immune status individuals moreover serological data enable gathering important epidemiological information providing realistic data spread epidemic morbidity mortality addition detection antibodies sarscov<NUMBER> play key role determining appropriate lockdown exit strategies vaccine development <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> however data concerning performance assays scarce <NUMBER> <NUMBER> purpose study therefore assess performance ce marked assays available belgiumthree lateral flow rapid tests two quantitative automated immunoassaysfor detection sarscov<NUMBER> igg igm iga antibodies retrospective study included <NUMBER> residual sera patients healthy volunteers laboratoire hospitalier universitaire de bruxelles universitair laboratorium brussel lhubulb microbiology statistical analysis performed spps software receiver operator characteristic roc curve constructed used comparisons area curve auc roc curves cohen kappa index calculated agreement analysed assays p value <NUMBER> considered statistically significant sensitivity specificity positive predictive value ppv negative predictive value npv calculated serological test sensitivity specificity obtained quantitative elisa clia serological assays summarized table <NUMBER> overall elisa assay showed higher sensitivity clia <NUMBER> versus <NUMBER> respectively j u r n l p r e p r f contrast specificity clia igm <NUMBER> greater observed elisa iga <NUMBER> tests showed similar specificities igg <NUMBER> clia <NUMBER> elisa shown table <NUMBER> first week onset symptoms elisa iga analysis significantly sensitive clia igm p <NUMBER> although notstatistically significant higher sensitivity also observed elisa igg results lateral flow assays easily interpretable unambiguous coloured reading igg lines colour intensity line regions correlated concentration sarscov<NUMBER> antibodies cases igm line presented slight difficulty reading commercial lateral flow tests predicted manufacturer results obtained ten minutes less cases tests performed study provided valid results overall sensitivity similar around <NUMBER> without significant differences three tests table <NUMBER> however sensitivity igm significant lower p <NUMBER> labon time compared quickzen avioq assays avioq lateral flow test showed three false positive results concomitant igm igg reactivity three samples previous epidemic period without known confounding factor contrast false positive results observed among pool <NUMBER> sera containing antibodies potential cross reactivity globally significant differences observed specificity values three tests positive predictive value <NUMBER> quickzen labon time <NUMBER> avioq assays shown table <NUMBER> similarly serological quantitative assays elisa j u r n l p r e p r f clia sensitivity three lateral flow assays increased second week onset symptoms achieved similar values <NUMBER> <NUMBER> <NUMBER> days table <NUMBER> shows percentage agreement five immunoassays overall best agreement observed clia labon time assays <NUMBER> cohen kappa index <NUMBER> two lateral flow assays labon time avioq <NUMBER> cohen kappa index <NUMBER> absence agreement five serological assays observed first week following symptom onset lessened <NUMBER> days symptom onset assays achieving <NUMBER> <NUMBER> agreement serological testing complementary test covid<NUMBER> diagnosis strategic vehicle second phase pandemic necessary epidemiological study lockdown exit programmes immunoassays could provide identification noncontagious potentially protected individuals support progressive deconfinement strategies process gradually restoring safe economic social activity <NUMBER> <NUMBER> different types serological tests available market could applied massive testing challenge world currently facing fully automated clia elisa assays allow quantitative determination antibodies sarscov<NUMBER> clinical laboratories increased screening capacity study elisa iggiga tested fully automated microtiter plate analyser workflow elisa tests depends analyser used laboratory capacity <NUMBER> tests per <NUMBER> hours contrast clia iggigm assays fully automated randomaccess tests technology allows <NUMBER> tests per hour depending platform used results delivered <NUMBER> minutes performance maglumi iggigm tests successfully evaluated padoan et al showing reliability immunoassays assessing immunological response sera covid<NUMBER> patients tests show takes least <NUMBER> days reach <NUMBER> sensitivity igg <NUMBER> positive rate igm <NUMBER> another study compared maglumi iggigm euroimmun iggiga <NUMBER> sensitivity observed maglumi igg <NUMBER> days following onset symptoms authors reported lower sensitivity maglumi igm <NUMBER> compared euroimmun iga <NUMBER> <NUMBER> current study maglumi iggigm tests also showed overall lower sensitivity euroimmun iggiga test <NUMBER> vs <NUMBER> contrast specificity increased <NUMBER> mean days since symptom onset population tested study <NUMBER> days median <NUMBER> days explain lower sensitivity maglumi iggigm tests study compared literature obka et al <NUMBER> also described higher sensitivity observed j u r n l p r e p r f euroimmun iga test euroimmun igg test <NUMBER> vs <NUMBER> particularly evident two first weeks symptom onset less specificity former test <NUMBER> vs <NUMBER> recently many commercial lateral flow assays developed celabelled study three also evaluated results showed global sensitivity specificity npv ppv equivalent elisa iggiga clia iggigm tests addition excellent concordance five immunoassays tested study observed <NUMBER> days onset symptoms similar results reported li et al showing good sensitivity <NUMBER> specificity <NUMBER> rapid test large cohort patient samples china observed similar performances serum plasma fingerstick blood <NUMBER> rapid serological tests performed laboratory used pointofcare tests poct latter provide accurate results within <NUMBER> <NUMBER> minutes equivalent sensitivity specificity quantitative automated immunoassays particularly two weeks onset symptoms opportunity test outside clinical laboratory lateral flow assay makes possible reach larger population groups without saturating capacity laboratories poct may play important role largescale testing order evaluate herd immunity sarscov<NUMBER> however mistakes interpretation results situations control trained staff must taken consideration reason development automated reader devices could help reduce errors increase sensitivity addition device could support transmission results public health institution provide realtime information seroprevalence population level still awaiting results large seroprevalence studies community wu et al report detection rate around <NUMBER> sarscov<NUMBER> igg asymptomatic subjects singlecentre investigation <NUMBER> causal relationship humoral response illness severity still unclear zhao et al revealed strong positive correlation clinical severity antibody titres two weeks illness onset <NUMBER> yongchen et al highlight complementary role immunoassays rtqpcr diagnosis covid<NUMBER> particularly critical patients negative rtqpcr observed seronegative asymptomatic patients four weeks positive rtqpcr results <NUMBER> current study two asymptomatic patients tested seronegative immunoassays <NUMBER> days positive rtqpcr result studies asymptomatic patients necessary understand better humoral responses population understand role real herd immunity determining lockdown exit strategies study limitations first retrospective study performed residual samples lack fresh serum could impact accuracy results second reliable gold standard serological tests currently available comparative studies little literature exists concerning comparison immunoassay j u r n l p r e p r f methods sarscov<NUMBER> detection furthermore criteria assessing time illness onset recovered medical records may contain imprecisions due subjectivity perception symptoms timing conclusion study shows accurate equivalent performance five serological antibody assays tables table <NUMBER> analytical objective describe implementation technological support important optimizing clinical management covid<NUMBER> pandemic health system confirmed prior current cases covid<NUMBER> incident command center established early crisis helped identify electronic health record ehr based tools support clinical care outline design implementation ehr based rapid screening processes laboratory testing clinical decision support reporting tools patientfacing technology related covid<NUMBER> ehr useful tool enable rapid deployment standardized processes uc san diego health built multiple covid<NUMBER>specific tools support outbreak management including scripted triaging electronic checkin standard ordering documentation secure messaging realtime data analytics telemedicine capabilities challenges included need frequently adjust build meet rapidly evolving requirements communication adoption coordinating needs multiple stakeholders maintaining highquality prepandemic medical care ehr essential tool supporting clinical needs health system managing covid<NUMBER> pandemic novel coronavirus covid<NUMBER> initially identified december <NUMBER> case pneumonia wuhan china since become global pandemic affecting greater <NUMBER> countries around world<NUMBER> world health organization declared outbreak pandemic march <NUMBER> <NUMBER> called coordinated mechanisms support preparedness response infection across health sectors <NUMBER> march <NUMBER> executive office united states proclaimed pandemic national emergency <NUMBER> incidence covid<NUMBER> continues rise healthcare systems rapidly preparing adapting increasing clinical demands <NUMBER> <NUMBER> inherent operational management pandemic era modern medicine leveraging capabilities electronic health record ehr useful developing tools support standard management patients <NUMBER> technologybased tools effectively support institutions pandemic facilitating immediate widespread distribution information tracking transmission realtime creating virtual venues meetings daytoday operations perhaps importantly offering telemedicine visits patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ebola outbreak <NUMBER> attention brought use ehr potential public health tool <NUMBER> unfortunately despite recent ebola epidemic infrastructure outbreak management present many united states health systems ehr applications <NUMBER> facing pandemic many institutions working rapidly develop supportive reliable informatics infrastructure order prepare managing exponential increase covid<NUMBER>infected patients however literature describe informatics tools required successfully manage novel infection lacking discuss rapid development implementation ehr configuration necessary outbreak management within large regional public academic health center setting new pending covid<NUMBER> cases detail specific informatics tools built support health systems efforts prepare current pandemic challenges associated task university california san diego health ucsdh large regional academic health system encompassing two acute care hospitals outpatient primary specialty medical surgical care emergency patient care ucsdh also one five academic medical centers within broader <NUMBER>campus university california system ucsdh utilizes commercially available electronic health record ehr epic verona wi also hosts <NUMBER> affiliate physicians across <NUMBER> medical groups ehr san diego county served quarantine site chinese expatriots cruise ship passengers also experienced community spread covid earlier much us <NUMBER> incident command center established ucsdh february <NUMBER> <NUMBER> <NUMBER>hour monitoring adaptation rapidly evolving conditions recommendations local state federal global scale assessment institutional current state revealed need develop rapid screening process hospitalbased ambulatory testing new orders clinical decision support reportinganalytics tools enhancementexpansion current patientfacing technology guidance incident command center clinical informatics team prioritized projects related covid<NUMBER> enable expedited build implementation response pandemic configured ehr technologybased tools listed table <NUMBER> awareness training novel resources clinicians staff distributed via variety communication channels concurrence important epidemiologic policy health safety information incident command center health system leadership one first needs health system development rapid effective multimodal covid<NUMBER> screening process including telephone calls direct email ehr messaging inperson encounters protocolized triage system developed embedded multiple ehr templates could rapidly updated screening guidance evolved table <NUMBER> instructions easily accessed call centers triage nurses allowing provide guidance patients regarding requirements home isolation appropriate locations obtain covid<NUMBER> testing visit emergency department order limit exposures relieve burden physical healthcare locations automated email notifications sent patients prior clinic appointments indicating persons fever andor new cough call health system proper triage presenting health care facility travel symptoms screening questions added registrationcheckin process figure <NUMBER> ehr configured require complete documentation front desk staff ensuring patients seen acute elective care across institution receive screening ehr templates used frontline staff adhere standardized screening script positive screening questions acute ambulatory care settings triggered provider alert clinical decision support offering appropriate guidance subsequent clinical care including testing isolation orders needed facilitate next steps set tools ehr rapidly adjusted based evolving recommendations constructed order panels ehr inpatient emergency department ambulatory settings included defaulted prepopulated covid<NUMBER> lab order appropriate isolation orders options additional laboratory testing imaging studies ucsdh elected use inhouse covid<NUMBER> testing patients hospital emergency department covid<NUMBER> tests obtained ambulatory urgent care settings sent reference laboratory due initial existing limitations testing capacity engineering correct order appear correct setting essential avoid confusion process failures additionally modifications made existing respiratory pathogen panel several tests noncovid<NUMBER> coronaviruses already present system order avoid confusion clinicians patients tests clearly labeled delineate covid<NUMBER> coronaviruses unrelated current pandemic noncovid<NUMBER> coronavirus clinical decision support moment ordering provided including screening criteria information specimen acquisition requirements personal protective equipment expectations test result turnaround time easy review addition series questions added covid<NUMBER> orders requiring ordering provider document testing criteria met patient build construct allowed rapid editing maintain alignment operational needs screening requirements lab handling processes frequently changed following initial implementation similar covid<NUMBER> ordering workflows instituted occupational health department prepare potential increased healthcare worker exposures better respond rapidly evolving care needs outbreak ucsdh assembled sevenperson ambulatory covid team act team members included two infectious disease physicians three primary care physicians community care physician lead epidemiology expert ambulatory chief medical information officer two nurses used secured messaging platform smp within ehr enable rapid ability monitor evolving current state health system key request incident command center enterprise reporting team constructed series easily accessible reports within ehr use incident command center infection control key organizational leaders reports automatically distributed accessible mobile devices used inform operational decisions expanding testing capacity patient isolation procedures geographic cohorting patients monitor adherence patient screening processes also created covid<NUMBER> operational dashboard realtime data number patients tested test results bed availability intensive care unit availability ventilator units volume ambulatory visits figure <NUMBER> addition ucsdh previously granted broad access ehr selfservice analytics tool key personnel create ad hoc reports items use isolation testing frequency ucsdh prioritized moving inperson clinic visits telemedicinebased visits appropriate order avoid unnecessary patient staff exposure prior advent covid<NUMBER> outbreak ucsd already developed implemented telemedicine infrastructure use multiple outpatient clinics response federal government loosening telehealth requirements local desire convert existing outpatient visits video expanded access outpatient areas created online selfguided learning videos conduct virtual patient care figure <NUMBER> <NUMBER> <NUMBER> addition repurposed existing ambulatory ehr optimization team provide assistance onboarding clinical areas enhancing telemedicine capacity within <NUMBER> hours executive proclamation national emergency <NUMBER> unique health employees trained telemedicine <NUMBER> video visits scheduled <NUMBER> patients ucsdh use patient portal functionality within ehrtethered patient portal epic mychart allows patients utilize video visit capability described addition scheduling appointments secure messaging care team viewing downloading test results <NUMBER> aforementioned modification display names preexisting coronavirus assay ensured noncovid coronavirus lab results displayed patients noncovid<NUMBER> early operational decision made delay release positive covid<NUMBER>specific test results allow ucsdh directly contact inform patients however elected immediately post negative covid<NUMBER> test results mychart testing volume made challenging contact tested patients timely fashion describe series ehr enhancements designed support rapid deployment new policies procedures protocols across healthcare system response covid<NUMBER> pandemic within span weeks magnitude outbreak within united states became clear healthcare leaders local state federal levels <NUMBER> <NUMBER> institution faced growing number known suspected covid<NUMBER> cases well variety patient care operational needs related pandemic recognized importance ehr technologybased tools enabling adjunct accelerated process design implementation development multidisciplinary task force involving institutional leaders infectious disease infection prevention specialists technology experts critical first step addressing hospitalspecific concerns developing open productive communication <NUMBER> <NUMBER> <NUMBER> initial needsbased assessment done current state determine necessary operational processes outbreak management existing informatics structure support processes gaps needed bridged timely fashion allowed us expediently configure ehr support covid<NUMBER> outbreak management detailed report information serve assist governments regional health systems combatting outbreak however knowledge reports detailed specific tools within ehr developed leveraged support efforts public health response covid<NUMBER> modern era essentially processes mentioned rely heavily technology individual health systems direct interfacing ehr therefore summarized recent efforts enhance informatics infrastructure recent examples utilizing technology public health crisis taiwan national health insurance database integrated immigration customs data generate realtime alerts clinic visits aid case identification <NUMBER> online questionnaires utilized risk stratify travelers low risk citizens automatically sent health declaration border pass highrisk individuals quarantined home remotely monitored development symptoms mobile device applications <NUMBER> healthcare systems houston texas developed remote communication channels physicians emergency responders assist triaging <NUMBER> virtual home visits high risk individuals remote icu monitoring also employed reduce hospitalstaff contact patients suspected confirmed cases covid<NUMBER> <NUMBER> multiple institutions across united states transitioned telemedicine effort reduce emergency room visits remote triaging <NUMBER> telemedicine already proved useful epidemiological emergencies including use live video counseling patients virtual patient monitoring mobile applications symptom observation <NUMBER> telemedicine used setting emergency medicine triage patients decrease rate discharge without complete treatment proper followup reduce number inperson visits subsequent risk transmission infection <NUMBER> <NUMBER> additional application early symptom identification triaging mitigation strategy potential delays access healthcare <NUMBER> previously observed wuhan china initial outbreak covid<NUMBER> <NUMBER> patients hospitalized least <NUMBER> days illness <NUMBER> enhancing existing ehr platforms tools triaging screening symptoms potential identify symptomatic patients earlier decrease physical burden healthcare systems <NUMBER> institution much informatics framework support outbreak balancing need focus pandemic maintaining highquality healthcare operations unrelated novel infection order provide service aspects community finally frequently changing landscape pandemic often daily guideline protocol updates generally require approval multiple stakeholders within large complex health system presented challenges maintaining rapid project momentum significant mitigation strategy challenges establishment services enabled realtime identification failures successes focus evolving needs feedback subsequent interventions covid<NUMBER> pandemic highlighted importance multidisciplinary team approach medical care building cohesive systems capable sustaining unanticipated trials face covid<NUMBER> pandemic healthcare systems best prepare following guidelines recommendations set forth federal global institutions electronic health record associated technologies vital requisite tools supporting outbreak management leveraged full potential hope experiences developing tools helpful health systems facing challenge  novel severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first reported late <NUMBER> cause coronavirus disease rapid global spread exponential growth pandemic wave stretched limits available healthcare intensive care unit capacity since initial notification outbreak december <NUMBER>st global response transitioned initial policy active case finding containment increasingly complex package confinement measures including closures schools implementation travel restrictions physical distancing measures present given global circulation sarscov<NUMBER> consensus elimination virus longer feasible longerterm strategies needed strike balance economically socially damaging near lockdown approaches full release control measures wide agreement latter situation rapid resurgence would likely modeled epidemic peaks potentially exceeding current healthcare capacity <NUMBER> socalled exit strategy defined transition current approach focuses entirely flattening peak covid<NUMBER> emergence curve transition phase restrictions gradually lifted gradual lifting control measures require active surveillance allow early detection new cases clusters coupled contact tracing quarantine likely combined continued physical distancing recommendations enhanced protection atrisk severe disease key knowledge gap level duration protective immunity population large specific groups including persons different clinical severity <NUMBER> assess extent virus circulation community likelihood protection reinfection crucial need add serology testing algorithms required performance serological assay depend specific aim testing may either population screening general population atrisk populations diagnostic support recently showed antibodies directed s<NUMBER> subunit sarscov<NUMBER> spike protein specifically receptor binding domain rbd within s<NUMBER> subunit strongly correlate virus neutralization <NUMBER> likelihood predicting protective antibody responses thus increase using either s<NUMBER> antigens rbd assay specificity serological tools detecting antibodies sars cov<NUMBER> might hampered presence antibodies circulating coronaviruses population thus testing cross reactivity crucial selecting appropriate assay specific purpose decision making include available knowledge antibody specificities kinetics functions <NUMBER> limited knowledge antibody kinetics emerging virus infections always challenge design validation serological assays outbreak recent studies covid<NUMBER> patients shown hospitalized patients patients mild disease seroconversion rates reach <NUMBER> <NUMBER> days antibody levels may correlate clinical severity <NUMBER> line observations middle east respiratory syndrome coronavirus merscov infection antibody responses varied depending disease severity mild asymptomatic infections resulting weaker immune responses <NUMBER> therefore meaningful interpretation serological assays extrapolation results population screening sufficient samples persons mild asymptomatic disease included validation studies study compare three platforms widely used diagnostic laboratories three rapid tests four elisas high throughput chemiluminescent assay clia used address different needs individualized home testing supplement diagnostics population screening analyze performance correlation inhouse virus neutralization assay <NUMBER> currently gold standard assessing protective immunity sars cov<NUMBER> patient diagnostics serological testing support clinical diagnostic workup mostly requested hospitalized patients example sars cov<NUMBER> rna diagnostic testing remains negative patient despite strong clinical suspicion patients whose samples symptomatic phase collected patients antibody testing valuable hospitalized weeks pcr test continues positive increasing cycle threshold values patients detection virus neutralizing antibodies help decision stop using personal protective equipment patients usually serological results interpreted laboratory staff possibility test followup sera perform confirmation serological testing comparing laboratory assays patients different severity stages disease overall patients tested <NUMBER> days postonset disease rbd antigen based wantai total ig assay performed best fig <NUMBER> table <NUMBER> igg assays targeting antigen euroimmun liaison lacked sensitivity hospitalized patients sample set included early timepoints s<NUMBER> based iga assay euroimmun contrast good sensitivity showed best quantitative relationship specifically neutralizing titers higher <NUMBER> prnt<NUMBER> units upon rbd ig assay becomes nonlinear iga testing detect early memory iga responses thus useful addition igg assays possible relevance quantitative antibody measurements need assessed results longerterm patient followup studies become available alternative prnt<NUMBER> use surrogate virus neutralization test sars cov<NUMBER> recently produced genscript usa allows direct quantification extensive studies performance however yet published despite differences sensitivity laboratory assays sufficient positive predictive value ppv covid<NUMBER> hospitalized patients assuming expected seroprevalence population ≥<NUMBER> table <NUMBER> using serology adjunct rtpcr testing monitor clinical course illness application sole diagnostic howeverfor instance primary care seroprevalence much lowerwill challenging illustrated variation ppv assays seroprevalence estimate <NUMBER> level currently observed netherlands <NUMBER> addition specialized elisa assays used laboratory settings wide range rapid diagnostic tests rdt put market triggering question whether used patient care triage medical care facility selected three rdts following criteria <NUMBER> preferably targetting spike sarscov<NUMBER> <NUMBER> least european conformity ce marking authorization <NUMBER> sufficient production capacity rdts provide qualitative yesno results allow quantification definition cutoff neutralization fig <NUMBER>fh three rdts sufficient ppv high seroprevalence scenarios implies might role rdts used individual patient sufficiently high pretest probability add pcr based diagnostics high negative predictive value npv rdts low seroprevalence scenario could offer opportunities use test general population aim rule presence sars cov<NUMBER> antibodies table <NUMBER> population screening population screening pandemic phase requires highly specific assay assure acceptable ppv populations low seroprevalence <NUMBER> additionally reasonable sensitivity table <NUMBER> condition met wantai elisas euroimmun igg elisa euroimmun iga liaison clia analyzer performed less well specificities <NUMBER> testing serum samples persons exposed range viruses table <NUMBER> <NUMBER> led low ppvs respectively <NUMBER> <NUMBER> euroimmun iga clia analyzer low prevalence settings wantai total ig continued perform reasonably well tested specimen obtained patients mild moderate severe disease patients detectable antibodies prnt<NUMBER> day <NUMBER> supplementary data severity disease affect range detected neutralizing titers sensitivity selected assays table <NUMBER> supplementary data due limitations sample volumes mild patients equally tested assays addition future studies recommended address performance alternative high throughput assays like roche elecsys antisarscov<NUMBER> abbott sarscov<NUMBER> igg correlation neutralization rdts specificities varied <NUMBER> <NUMBER> table <NUMBER> although overall performance cellex assay <NUMBER> specificity hampered low sensitivity <NUMBER> generally use selected rdt recommended population screening estimated seroprevalence mostly <NUMBER> ppv low reliable interpretation table <NUMBER> final question population screening whether antibody measurements correlate functional antibodies protect population subsequent exposure analyses samples testing positive wantai ig elisa od ratio <NUMBER> detectable levels neutralizing antibodies suggests thatusing cutoffin assay could used indicate presence neutralizing antibodies exact kinetics functionality antibodies offering protection remains determined conclusion presented data support decision making use serology either individual patient care populationlevel serological testing conclude aim detecting protective antibodies rbd based wantai elisa best overall performance including potential set cutoff indicating presence protective antibodies global performance selected rdts robust enough counter personalized testing population blood samples specimen used study collected delivered diagnostic laboratory patient diagnostics following predefined covid<NUMBER> research protocol determine specificity assays used welldefined panel <NUMBER> serum plasma samples <NUMBER> individuals exposed human coronaviruses hcov<NUMBER>e nl<NUMBER> oc<NUMBER> sars mers range respiratory viruses sensitivity calculated using total <NUMBER> sera <NUMBER> individuals netherlands covid<NUMBER> confirmed rtpcr antibodies detected prnt<NUMBER> disease severity varied <NUMBER> mild nonhospitalized <NUMBER> moderate hospitalized <NUMBER> severe admitted intensive care unit specimen taken different timepoints postonset disease supplementary data fig <NUMBER> specimen stored −<NUMBER>°c use variation number samples tested per assay caused fact validation part acute diagnostic response first phase covid<NUMBER> pandemic initially set <NUMBER> patient sera tested assays sera mostly collected hospitalized patients involved three sera mild patients assess performance assays population screening important involve sera mild patients increased number tested sera wantai elisas liaison rdts selection assays based best overall performance wantai elisas first analyses likely application liaison rdts population screening exact number specimen tested per assay varied due availability serum figure <NUMBER> depicts outcome assays per time interval analyses mild patients shown table <NUMBER> source data found supplementary data <NUMBER> ethics declarations use specimen approved erasmus mc medical ethical committee mec approval <NUMBER> allows use clinical data leftover material specimen delivered laboratory diagnostics unless patients declared opted scheme addition erasmus mc institutional research committee regulated covid<NUMBER> patients admitted erasmus mc asked permission use clinical data leftover patient material covid<NUMBER> research purposes patients refused excluded analyses elisa four selected elisas performed according manufacturers protocol <NUMBER> wantai sarscov<NUMBER> total ig igm elisas beijing wantai biological pharmacy enterprise co ltd china elisas coated rbd antigen <NUMBER> euroimmun antisarscov<NUMBER> igg iga elisa assays euroimmun medizinische labordiagnostika ag lübeck germany euroimmun elisas coated s<NUMBER> antigen diasorin liaison xl liaison xl diasorin saluggia italy semiautomated system using chemiluminescent immunoassay clia technology detection ab human samples assay based s<NUMBER> s<NUMBER> coating antigens assays performed following manufacturers protocol rapid antibody test rapid tests evaluated <NUMBER> rapid sars cov<NUMBER> antibody igmigg test intec utilizing nucleocapsid protein antigen test lots s<NUMBER> gj<NUMBER> <NUMBER> qsarscov<NUMBER> iggigm cassette rapid test gica cellex inc utilizing spike nucleocapsid protein test lot <NUMBER>wi<NUMBER>c <NUMBER> covid<NUMBER> iggigm rapid test cassette whole bloodserumplasma orient gene healgen test lot <NUMBER> utilizing spike nucleocapsid protein three tests based immunochromatography detection igg igm specific sars cov<NUMBER> human whole blood venous fingerstick serum plasma performed tests following manufacturers instructions sample tested one test readout positivenegative interpreted two operators parallel prnt <NUMBER> inhouse plaquereduction neutralization test prnt<NUMBER> used reference study virus neutralization assays gold standard coronavirus serology tested serum plasma samples neutralizing capacity sarscov<NUMBER> german isolate gisaid id epiisl <NUMBER> european virus archive global <NUMBER>v<NUMBER> prnt<NUMBER> previously described okba et al <NUMBER> statistical analysis outcome commercial testing correlated functional antibody measurements assess likelihood predicting protective antibody responses results different elisas rdts compared detected prnt<NUMBER> sensitivity calculations prnt<NUMBER> positive samples used calculations specificity calculated using cross reactive panel nonsars cov<NUMBER> sera graphs made using graphpad prism version <NUMBER> httpswwwgraphpadcom predictive values calculated three scenarios <NUMBER> seroprevalence general population <NUMBER> seroprevalence highrisk subpopulation <NUMBER> seroprevalence confirmed highly suspect covd<NUMBER> hospitalized patients reporting summary information research design available nature research reporting summary linked article source data provided paper data available corresponding author upon reasonable requests source data provided paper received <NUMBER> may <NUMBER> accepted <NUMBER> june <NUMBER> accurate timely diagnosis acute viral respiratory tract infections rtis important individual patients management decisions well appropriate infection control remains challenging clinicians laboratorians mahony <NUMBER> many clinical virology laboratories still rely labour intensive timeconsuming diagnostic algorithms incorporate antigen culturebased methods mahony <NUMBER> molecular diagnostic assays hold great potential impact infectious disease diagnosis clinical management particularly viral infections conventional methods ie antigen culture based methods provide timely highly accurate results ratcliff et al <NUMBER> many rapid nucleic acid amplification tests developed identify individual virus liolios et al <NUMBER> utility molecular diagnostics clinical settings may best realized single system diagnostic platforms simultaneously detect multiple pathogens liao et al <NUMBER> pabbaraju et al <NUMBER> raymond et al <NUMBER> wu tang <NUMBER> electrospray ionization mass spectrometry following broadrange reverse transcriptionpcr rtpcresims one single system diagnostic platforms potential detect rapidly also identify quantify multiple pathogens simultaneously date studies rtpcremims restricted detection individual respiratory bacteria viruses ie streptococcus coronavirus sars adenovirus russell et al <NUMBER> algorithm clinical reference diagnostic test clinical virology laboratory respiratory samples diagnostic algorithm used clinical virology laboratory detect respiratory viruses mainly divided respiratory season nonrespiratory season respiratory season defined october following january october november rsv december january influenza immunochromatographic assays used respiratory season sole screening test rsv influenza stop testing algorithm results positive respiratory panel cocktail dfa tests serve adenovirus influenza b parainfluenza types <NUMBER> rsv stop testing algorithm results positive nonrespiratory season screened negative immunochromatographic assays respiratory season well rsv respiratory syncytial virus piv parainfluenza virus hsv herpes simplex virus cmv cytomegalovirus hmpv human metapneumovirus dfa direct fluorescent antibody test cpe cytopathic effect rbc red blood cells influenza viruses sampath et al <NUMBER> detailed characterization eg resistance gene recognition genotyping organism capacity rtpcremims broad range simultaneous multiple pathogen detection rapid turnaround may translate useful tool clinicians health care settings aid early diagnosis respiratory tract infections hospitalbased pilot study conducted one season respiratory infections compare performance characteristics rtpcresims platform versus conventional virologic procedures identification multiple clinically relevant respiratory viruses nasopharyngeal aspirate samples collected emergency department patients presenting acute respiratory illnesses patients visiting adult paediatric emergency departments tertiary care innercity hospital december <NUMBER> <NUMBER> may <NUMBER> <NUMBER> assessed eligibility eligible patients operationally defined patients suspected acute upper respiratory tract infection emergency physicians ordered nasopharyngeal aspirate testing approached consecutively recruited eligible patients identified dedicated study coordinators daily review nasopharyngeal aspirate testing order lists emergency department sought informed consent person still hospital telephone already discharged either emergency department inpatient setting least three separate attempts different periods different days attempt contact informed consent potentially eligible subjects resulted <NUMBER> participation rate clinical information obtained chart review derive patient demographic variables hospitalization related respiratory tract infection episode length stay hospital days admitted samples maintained clinical virology laboratory frozen −<NUMBER> • c standard virologic procedures completed part standard laboratory protocol study approved johns hopkins university institutional review board nasopharyngeal aspirate tests ie rapid immunochromatographic testing binax inverness bedford uk influenza viruses rsv respiratory season direct fluorescent antibody testing d<NUMBER> ultra dfa respiratory virus id kit diagnostic hybrids athens oh shell vial culture identification rmix diagnostic hybrids athens oh adenovirus influenza viruses parainfluenza viruses rsv tube culture adenovirus influenza viruses parainfluenza viruses human mpv rsv hsv cmv enterovirus hemadsorption inhibition testing processed according standardized algorithm fig <NUMBER> clinical virology laboratory virologic identification routine pcr testing performed clinical virology laboratory samples processed total nucleic acid extraction using thermo kingfisher waltham robot according ambion abi foster city ca magmax viral kit extraction protocol pcr wells amplified onestep rtpcr cycle protocol protocol developed support rtpcr conventional pcr equally primer pairs used rtpcr performed <NUMBER> l reaction mix consisting <NUMBER> u amplitaq gold applied biosystems foster city ca <NUMBER> mm tris ph <NUMBER> <NUMBER> mm kcl <NUMBER> mm mgcl <NUMBER> <NUMBER> betaine <NUMBER> mm mix datp dgtp dctp dttp bioline usa inc randolph <NUMBER> mm dithiothreitol <NUMBER> ng sonicated polya dna sigma corp st louis mo <NUMBER> ng random hexamers invitrogen corp carlsbad ca <NUMBER> u superasin ambion corp austin tx <NUMBER> ng t<NUMBER>gene<NUMBER> protein roche diagnostics corp indianapolis <NUMBER> u superscript iii invitrogen corp carlsbad ca <NUMBER> mm sorbitol sigma corp <NUMBER> nm primer following rtpcr cycling conditions used <NUMBER> • c <NUMBER> min <NUMBER> • c <NUMBER> min <NUMBER> • c <NUMBER> min <NUMBER> • c <NUMBER> min followed <NUMBER> cycles <NUMBER> • c <NUMBER> <NUMBER> • c <NUMBER> <NUMBER> • c <NUMBER> <NUMBER> • c annealing temperature increasing <NUMBER> • c cycle reverse transcription pcr continued <NUMBER> additional cycles <NUMBER> • c <NUMBER> <NUMBER> • c <NUMBER> <NUMBER> • c <NUMBER> rtpcr cycle ended final extension <NUMBER> min <NUMBER> • c followed <NUMBER> • c hold assay performed using ibis t<NUMBER> respiratory virus surveillance ii kit ibis biosciences inc carlsbad ca designed detect subtype viruses seven groups conventional viruses respiratory syncytial virus rsv influenza b parainfluenza types <NUMBER> adenoviridae types af viruses identifiable conventionally coronaviridae human bocavirus human metapneumovirus rtpcr products analysed using ibis t<NUMBER> universal biosensor platform ibis biosciences inc carlsbad ca performs automated postpcr desalting esims signal acquisition spectral analysis data reporting described previously briefly steps follows pcr desalted purified using weak anion exchange protocol described elsewhere jiang hofstadler <NUMBER> accurate mass <NUMBER> ppm highresolution mdm <NUMBER> fwhm mass spectra acquired sample using highthroughput esims protocols sampath et al <NUMBER> sample approximately <NUMBER> l analyte solution consumed <NUMBER>s spectral acquisition raw mass spectra postcalibrated internal mass standard deconvolved monoisotopic molecular masses unambiguous base compositions derived exact mass measurements complementary singlestranded oligonucleotides detailed information software used interrogate amplicon mass viruses identification described elsewhere calibrant consists specially designed nucleic acid sequence similar distinguishable potential sequence amplified well internal positive control negative control implemented batch processing sterile viral transport media clinical virology laboratory institution perform pcr tests routinely respiratory viruses accordingly samples clinical virology laboratory rtpcresims agree sufficient volume <NUMBER> l available sent viracor lees summit mo identification another pcrbased platform luminex respiratory assay austin tx designed detect viruses rtpcresims could detect except human bocavirus pabbaraju et al <NUMBER> sample throughput determination rtpcresims included using one kingfisher extraction robot one janus automated dispensing robot four eppendorf thermocyclers simultaneously one t<NUMBER> cleanup injection automation system primary analysis evaluating performance rtpcresims conventional virology laboratory results used reference standard fig <NUMBER> describes number subjects one nasopharyngeal aspirate sample evaluated also included figure number evaluable results operationally defined purposes primary secondary performance evaluation number individual evaluable results could compared one another since nasopharyngeal aspirate sample could yield test results culture rtpcrmsesi negative single positive multiple viral detections secondary analysis clinical virology laboratory results secondary ie luminex pcrbased results combined reference test samples containing viruses clinical virology laboratory protocol available ie bocavirus coronavirus detection excluded primary analysis included secondary analysis viral agent could detected luminex rtpcrbased method ie viruses except bocavirus confidence intervals sensitivity specificity based exact binomial probabilities subgroup analysis performed detect difference performance among paediatric adult patients december <NUMBER> <NUMBER> june <NUMBER> <NUMBER> <NUMBER> patients eligible <NUMBER> <NUMBER> recruited among consented patients younger <NUMBER> years age n <NUMBER> <NUMBER> male n <NUMBER> <NUMBER> african american n <NUMBER> <NUMBER> hospitalized n <NUMBER> <NUMBER> supplementary table <NUMBER> common reason patients participating study inability reach subjects eg wrong telephone numbers registry inability connect telephone call median storage time nasopharyngeal aspirates <NUMBER> months range <NUMBER> table <NUMBER>a <NUMBER> evaluable results secondary analysis table <NUMBER>b <NUMBER> subjects multiple viruses detected table <NUMBER> <NUMBER> coronavirus detections sufficient volume sent <NUMBER> nd rtpcr fig <NUMBER> flow diagram recruitment performance analysis process bocavirus detectable clinical virology laboratory secondary rtpcr based platform excluded <NUMBER> subjects bocavirus detection <NUMBER> bocavirus detection excluding bocavirus coronavirus detections clinical virology laboratory protocol detect <NUMBER> included primary performance analysis table <NUMBER> six coronavirus <NUMBER> samples clinical virology laboratory rtpcresims agree sufficient volume left sent secondary rtpcr based assay secondary analysis <NUMBER> patients <NUMBER> evaluable results primary analysis among <NUMBER> positive detections tested clinical virology laboratory found shell vial culture n <NUMBER> <NUMBER> followed immunochromatographic tests n <NUMBER> <NUMBER> detected <NUMBER> <NUMBER> influenza viruses <NUMBER> <NUMBER> <NUMBER> rsv <NUMBER> isolated viral culture described <NUMBER> bocaviruses excluded <NUMBER> specimens bocavirus <NUMBER> bocavirus detections samples multiple detections well <NUMBER> coronavirus samples primary analysis exclusions overall agreement rtpcresims conventional virology <NUMBER> <NUMBER> ci <NUMBER> sensitivity specificity <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> respectively table <NUMBER>a table <NUMBER> total evaluable results <NUMBER> fig <NUMBER> <NUMBER> evaluable results primary analysis findings rtpcresims disagreed clinical virology <NUMBER> sufficient volume together <NUMBER> coronavirus positive specimens rtpcresims protocol clinical virology laboratory sent evaluation secondary pcrbased method luminex total <NUMBER> samples twentyone <NUMBER> <NUMBER> rtpcresims results confirmed luminex including <NUMBER> conventional viruses detections <NUMBER> influenza <NUMBER> rsv <NUMBER> adenovirus <NUMBER> coronavirus detections detectable conventional clinical virology overall agreement sensitivity specificity secondary analysis available samples <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> respectively table <NUMBER>b results individual pathogens shown table <NUMBER>b accuracy rtpcresims differ significantly adult paediatric patients time first result sample preparation detection rtpcresims <NUMBER> h<NUMBER> h dnarna extraction <NUMBER> h rtpcr <NUMBER> h processing esims estimated throughput rtpcresims <NUMBER> samples <NUMBER> technicians working <NUMBER> h hospitalbased pilot study designed describe preliminary performance novel rtpcresims platform versus current diagnostic algorithm used clinical virology laboratory clinical specimens findings demonstrate assay high throughput able detect simultaneously type multiple clinically relevant respiratory pathogens nasopharyngeal aspirates patients suspected viral infections <NUMBER> accuracy compared conventional clinical virology laboratory testing study also shows pathogens detectable conventional clinical virology methods could detected successfully rtpcresims platform advantages rtpcresims platform conventional testing include rapid turnaround capacity detect multiple respiratory pathogens simultaneously high throughput provision detailed pathogen characterization ie semiquantitation typing subtyping species commonly used diagnostic methods less wellequipped clinical virology laboratories culturebased may take days yield results labourintensive costly anzueto niederman <NUMBER> although rapid antigen tests offer faster detection times individual pathogen clinical utility limited pathogenic agent usually known priori tests suboptimal sensitivity specificity ginocchio <NUMBER> demonstrated study rapid antigen tests detected small proportions influenza rsv clinical specimens suboptimal sensitivity restricts wider utilization rapid tests clinical settings compared diagnostic algorithms used commonly hospitals fig <NUMBER> rtpcresims platform provides straightforward approach identification clinically relevant respiratory viruses may serve diagnostic adjunct ultimately data demonstrating capacity rtpcresims platform type subtype shown comes pilot gaydos <NUMBER> viral load quantitation capacity assay detailed performed separate pilot study group demonstrating readouts viral genome copywell rtpcresims correlate positively type detection method employed clinical virology chen et al <NUMBER> methods evaluating performance novel assays potentially accurate current reference tests remain controversial researchers employ similar assays ie secondary pcr based assay confirm findings novel assays discordant conventional culture rapid antigen test liolios et al <NUMBER> pabbaraju et al <NUMBER> others propose using adjunctive clinical data reference doring et al <NUMBER> although retrospective study design permit detailed clinical data collection reference secondary analysis performed using secondary pcr assay however secondary pcr assay still perfect diagnosing every type respiratory virus clinical samples result two four adenovirus detections luminex assay poor sensitivity detect pabbaraju et al <NUMBER> able confirmed study may underestimated performance rtpcresims platform adenoviruses subgroup analysis differences found performance characteristics platform among different clinical subgroups study population hypothesized could due small sample size pilot however specimens clinical virology laboratory negative groups found contain significantly lower viral load rtpcresims platform compared positive group data presented could explained better sensitivity nucleic acid amplification tests mahony <NUMBER> studies confirm performance among patients different demographic characteristics merited current study several important limitations although optimal design determine whether candidate assay performs potentially better gold standard third confirmatory test done every sample limited volume excess nasopharyngeal aspirate samples precluded type detailed evaluation accordingly readers cautioned interpret results secondary analysis carefully since could overestimating performance assay hadgu et al <NUMBER> reason specimens bocavirus detected rtpcresims could confirmed another limitation rtpcresims testing excess nasopharyngeal aspirate samples performed several months initial clinical samples obtained tested clinical virology although effect length storage nasopharyngeal aspirates shown minimal within <NUMBER> months ward et al <NUMBER> another study suggests nucleic acid degradation may associated −<NUMBER> • c storage frisbie et al <NUMBER> impact longer periods storage remains unknown furthermore majority study population comprised paediatric patients <NUMBER> years age limits generalizability findings adult population future validation performance rtpcresims platform adult population necessary lastly ibis t<NUMBER> respiratory virus surveillance ii kit designed detect rhinovirus one prevalent respiratory viruses however modified respiratory virus surveillance kit development include rhinovirus accuracy reliability type platform merits studies using prospective clinical respiratory specimens conclusion innovative rtpcresims technology could detect viruses identified conventional virology methods rapidly accurately allowed identification mixed pathogens clinical specimens detection conventional viruses missed clinical virology algorithm unconventional viruses required additional confirmatory testing evaluate performance characteristics assay rtpcresims method promising diagnostic platform rapid identification conventional unconventional viruses merits prospective evaluation accurate timely diagnosis acute viral respiratory tract infections rtis important individual patients management decisions well appropriate infection control remains challenging clinicians laboratorians mahony <NUMBER> many clinical virology laboratories still rely labour intensive timeconsuming diagnostic algorithms incorporate antigen culturebased methods mahony <NUMBER> molecular diagnostic assays hold great potential impact infectious disease diagnosis clinical management particularly viral infections conventional methods ie antigen culture based methods provide timely highly accurate results ratcliff et al <NUMBER> many rapid nucleic acid amplification tests developed identify individual virus liolios et al <NUMBER> utility molecular diagnostics clinical settings may best realized single system diagnostic platforms simultaneously detect multiple pathogens liao et al <NUMBER> pabbaraju et al <NUMBER> raymond et al <NUMBER> wu tang <NUMBER> electrospray ionization mass spectrometry following broadrange reverse transcriptionpcr rtpcresims one single system diagnostic platforms potential detect rapidly also identify quantify multiple pathogens simultaneously date studies rtpcremims restricted detection individual respiratory bacteria viruses ie streptococcus coronavirus sars adenovirus russell et al <NUMBER> influenza viruses sampath et al <NUMBER> detailed characterization eg resistance gene recognition genotyping organism capacity rtpcremims broad range simultaneous multiple pathogen detection rapid turnaround may translate useful tool clinicians health care settings aid early diagnosis respiratory tract infections hospitalbased pilot study conducted one season respiratory infections compare performance characteristics rtpcresims platform versus conventional virologic procedures identification multiple clinically relevant respiratory viruses nasopharyngeal aspirate samples collected emergency department patients presenting acute respiratory illnesses patients visiting adult paediatric emergency departments tertiary care innercity hospital december <NUMBER> <NUMBER> may <NUMBER> <NUMBER> assessed eligibility eligible patients operationally defined patients suspected acute upper respiratory tract infection emergency physicians ordered nasopharyngeal aspirate testing approached consecutively recruited eligible patients identified dedicated study coordinators daily review nasopharyngeal aspirate testing order lists emergency department sought informed consent person still hospital telephone already discharged either emergency department inpatient setting least three separate attempts different periods different days attempt contact informed consent potentially eligible subjects resulted <NUMBER> participation rate clinical information obtained chart review derive patient demographic variables hospitalization related respiratory tract infection episode length stay hospital days admitted samples maintained clinical virology laboratory frozen <NUMBER>°c standard virological procedures completed part standard laboratory protocol study approved johns hopkins university institutional review board nasopharyngeal aspirate tests ie rapid immunochromatographic testing binax inverness bedford uk influenza viruses rsv respiratory season direct fluorescent antibody testing d<NUMBER> ultra dfa respiratory virus id kit diagnostic hybrids athens oh shell vial culture identification rmix diagnostic hybrids athens oh adenovirus influenza viruses parainfluenza viruses rsv tube culture adenovirus influenza viruses parainfluenza viruses human mpv rsv hsv cmv enterovirus hemadsorption inhibition testing processed according standardized algorithm figure <NUMBER> clinical virology laboratory virologic identification routine pcr testing performed clinical virology laboratory samples processed total nucleic acid extraction using thermo kingfisher waltham robot according ambion abi foster city ca magmax viral kit extraction protocol pcr reaction wells amplified onestep rtpcr cycle protocol protocol developed support rtpcr conventional pcr equally primer pairs used rtpcr performed <NUMBER>ul reaction mix consisting <NUMBER>u amplitaq gold applied biosystems foster city ca <NUMBER>mm tris ph <NUMBER> <NUMBER>mm kcl <NUMBER>mm mgcl<NUMBER> <NUMBER>m betaine <NUMBER>mm mix datp dgtp dctp dttp bioline usa inc randolph <NUMBER>mm dithiothreitol <NUMBER>ng sonicated polya dna sigma corp st louis mo <NUMBER>ng random hexamers invitrogen corp carlsbad ca <NUMBER>u superasin ambion corp austin tx <NUMBER>ng t<NUMBER>gene<NUMBER> protein roche diagnostics corp indianapolis <NUMBER>u superscript iii invitrogen corp carlsbad ca <NUMBER>mm sorbitol sigma corp <NUMBER>nm primer following rtpcr cycling conditions used <NUMBER>°c <NUMBER>min <NUMBER>°c <NUMBER> min <NUMBER>°c <NUMBER>min <NUMBER>°c <NUMBER>min followed <NUMBER> cycles <NUMBER>°c <NUMBER>seconds <NUMBER>°c <NUMBER>seconds <NUMBER>°c <NUMBER>seconds <NUMBER>°c annealing temperature increasing <NUMBER>°c cycle reverse transcription pcr continued <NUMBER> additional cycles <NUMBER>°c <NUMBER>seconds <NUMBER>°c <NUMBER>seconds <NUMBER>°c <NUMBER>seconds rtpcr cycle ended final extension <NUMBER>min <NUMBER>°c followed <NUMBER>°c hold assay performed using ibis t<NUMBER> respiratory virus surveillance ii kit ibis biosciences inc carlsbad ca designed detect subtype viruses seven groups conventional viruses respiratory syncytial virus rsv influenza b parainfluenza types <NUMBER> adenoviridae types af viruses identifiable conventionally coronaviridae human bocavirus human metapneumovirus rtpcr products analysed using ibis t<NUMBER> universal biosensor platform ibis biosciences inc carlsbad ca performs automated postpcr desalting esims signal acquisition spectral analysis data reporting described previously briefly steps follows pcr reaction desalted purified using weak anion exchange protocol described elsewhere jiang hofstadler <NUMBER> accurate mass <NUMBER>ppm highresolution mdm<NUMBER> fwhm mass spectra acquired sample using highthroughput esims protocols sampath et al <NUMBER> sample approximately <NUMBER>ul analyte solution consumed <NUMBER>second spectral acquisition raw mass spectra postcalibrated internal mass standard deconvolved monoisotopic molecular masses unambiguous base compositions derived exact mass measurements complementary singlestranded oligonucleotides detailed information software used interrogate amplicon mass viruses identification described elsewhere calibrant consists specially designed nucleic acid sequence similar distinguishable potential sequence amplified well internal positive control negative control implemented batch processing sterile viral transport media clinical virology laboratory institution perform pcr tests routinely respiratory viruses accordingly samples clinical virology laboratory rtpcresims agree sufficient volume <NUMBER>ul available sent viracor lees summit mo identification another pcrbased platform luminex respiratory assay austin tx designed detect viruses rtpcr esims could detect except human bocavirus pabbaraju et al <NUMBER> sample throughput determination rtpcresims included using one kingfisher extraction robot one janus automated dispensing robot four eppendorf thermocyclers simultaneously one t<NUMBER> cleanup injection automation system primary analysis evaluating performance rtpcresims conventional virology laboratory results used reference standard figure <NUMBER> describes number subjects one nasopharyngeal aspirate sample evaluated also included figure number evaluable results operationally defined purposes primary secondary performance evaluation number individual evaluable results could compared one another since nasopharyngeal aspirate sample could yield test results culture rtpcrmsesi negative single positive multiple viral detections secondary analysis clinical virology laboratory results secondary ie luminex pcrbased results combined reference test samples containing viruses clinical virology laboratory protocol available ie bocavirus coronavirus detection excluded primary analysis included secondary analysis viral agent could detected luminex rtpcrbased method ie viruses except bocavirus confidence intervals sensitivity specificity based exact binomial probabilities subgroup analysis performed detect difference performance among paediatric adult patients december <NUMBER> <NUMBER> june <NUMBER> <NUMBER> <NUMBER> patients eligible <NUMBER> <NUMBER> recruited among consented patients younger <NUMBER> years age n<NUMBER> <NUMBER> male n<NUMBER> <NUMBER> african american n<NUMBER> <NUMBER> hospitalized n<NUMBER> <NUMBER> table <NUMBER> common reason patients participating study inability reach subjects eg wrong telephone numbers registry inability connect telephone call median storage time nasopharyngeal aspirates <NUMBER> months range <NUMBER> <NUMBER> patients <NUMBER> evaluable results primary analysis among <NUMBER> positive detections tested clinical virology laboratory found shell vial culture n<NUMBER> <NUMBER> followed immunochromatographic tests n<NUMBER> <NUMBER> detected <NUMBER> <NUMBER> influenza viruses <NUMBER> <NUMBER> <NUMBER> rsv <NUMBER> isolated viral culture described <NUMBER> bocaviruses excluded <NUMBER> specimens bocavirus <NUMBER> bocavirus detections samples multiple detections well <NUMBER> coronavirus samples primary analysis exclusions overall agreement rtpcresims conventional virology <NUMBER> <NUMBER> ci <NUMBER> sensitivity specificity <NUMBER> <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> respectively table <NUMBER>a sensitivity rtpcresims individual pathogens follows <NUMBER> parainfluenza <NUMBER> influenza viruses <NUMBER> rsv <NUMBER> adenovirus table <NUMBER>a rtpcresims successfully typed pathogens including <NUMBER> influenza one influenza b four parainfluenza type <NUMBER> one adenovirus type <NUMBER> matched findings clinical virology six adenovirus type c adenovirus clinical virology laboratory protocol type rtpcresi ms detected multiple virus detections <NUMBER> samples table <NUMBER> total evaluable results <NUMBER> figure <NUMBER> <NUMBER> evaluable results primary analysis findings rtpcresims disagreed clinical virology <NUMBER> sufficient volume together <NUMBER> coronavirus positive specimens rtpcresims protocol clinical virology laboratory sent evaluation secondary pcrbased method luminex total <NUMBER> samples twentyone <NUMBER> <NUMBER> rtpcresims results confirmed luminex including <NUMBER> conventional viruses detections <NUMBER> influenza <NUMBER> rsv <NUMBER> adenovirus <NUMBER> coronavirus detections detectable conventional clinical virology overall agreement sensitivity specificity secondary analysis available samples <NUMBER> <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> ci<NUMBER> <NUMBER> <NUMBER> ci<NUMBER> respectively table <NUMBER>b results individual pathogens shown table <NUMBER>b accuracy rtpcresims differ significantly adult paediatric patients time first result sample preparation detection rtpcresims <NUMBER> hours <NUMBER> hour dnarna extraction <NUMBER> hours rtpcr <NUMBER> hours processing esims estimated throughput rtpcresims <NUMBER> samples <NUMBER> technicians working <NUMBER> hours hospitalbased pilot study designed describe preliminary performance novel rtpcresims platform versus current diagnostic algorithm used clinical virology laboratory clinical specimens findings demonstrate assay high throughput able detect simultaneously type multiple clinically relevant respiratory pathogens nasopharyngeal aspirates patients suspected viral infections <NUMBER> accuracy compared conventional clinical virology laboratory testing study also shows pathogens detectable conventional clinical virology methods could detected successfully rtpcresims platform advantages rtpcresims platform conventional testing include rapid turnaround capacity detect multiple respiratory pathogens simultaneously high throughput provision detailed pathogen characterization ie semiquantitation typing subtyping species commonly used diagnostic methods less wellequipped clinical virology laboratories culturebased may take days yield results labourintensive costly anzueto niederman <NUMBER> although rapid antigen tests offer faster detection times individual pathogen clinical utility limited pathogenic agent usually known priori tests suboptimal sensitivity specificity ginocchio <NUMBER> demonstrated study rapid antigen tests detected small proportions influenza rsv clinical specimens suboptimal sensitivity restricts wider utilization rapid tests clinical settings compared diagnostic algorithms used commonly hospitals figure <NUMBER> rtpcresims platform provides straightforward approach identification clinically relevant respiratory viruses may serve diagnostic adjunct ultimately data demonstrating capacity rtpcresims platform type subtype shown comes pilot study group <NUMBER> <NUMBER> novel h<NUMBER>n<NUMBER> influenza viruses detections confirmed additional state laboratory testing using centers disease control prevention novel h<NUMBER>n<NUMBER> influenza pcr typing method supporting role platform surveillance clinical public health settings gaydos <NUMBER> viral load quantitation capacity assay detailed performed separate pilot study group demonstrating readouts viral genome copywell rtpcresims correlate positively type detection method employed clinical virology chen <NUMBER> methods evaluating performance novel assays potentially accurate current reference tests remain controversial researchers employ similar assays ie secondary pcr based assay confirm findings novel assays discordant conventional culture rapid antigen test liolios et al <NUMBER> pabbaraju et al <NUMBER> others propose using adjunctive clinical data reference doring unertl heininger <NUMBER> although retrospective study design permit detailed clinical data collection reference secondary analysis performed using secondary pcr assay however secondary pcr assay still perfect diagnosing every type respiratory virus clinical samples result two four adenovirus detections luminex assay poor sensitivity detect pabbaraju et al <NUMBER> able confirmed study may underestimated performance rtpcresims platform adenoviruses subgroup analysis differences found performance characteristics platform among different clinical subgroups study population hypothesized could due small sample size pilot however specimens clinical virology laboratory negative groups found contain significantly lower viral load rtpcresims platform compared positive group data presented could explained better sensitivity nucleic acid amplification tests mahony <NUMBER> studies confirm performance among patients different demographic characteristics merited current study several important limitations although optimal design determine whether candidate assay performs potentially better gold standard third confirmatory test done every sample limited volume excess nasopharyngeal aspirate samples precluded type detailed evaluation accordingly readers cautioned interpret results secondary analysis carefully since could overestimating performance assay hadgu dendukuri hilden <NUMBER> reason specimens bocavirus detected rtpcresims could confirmed another limitation rtpcresims testing excess nasopharyngeal aspirate samples performed several months initial clinical samples obtained tested clinical virology although effect length storage nasopharyngeal aspirates shown minimal within <NUMBER> months ward et al <NUMBER> another study suggests nucleic acid degradation may associated <NUMBER>°c storage frisbie et al <NUMBER> impact longer periods storage remains unknown furthermore majority study population comprised paediatric patients <NUMBER> years age limits generalizability findings adult population future validation performance rtpcresims platform adult population necessary lastly ibis t<NUMBER> respiratory virus surveillance ii kit designed detect rhinovirus one prevalent respiratory viruses however modified respiratory virus surveillance kit development include rhinovirus accuracy reliability type platform merits studies using prospective clinical respiratory specimens conclusion innovative rtpcresims technology could detect viruses identified conventional virology methods rapidly accurately allowed identification mixed pathogens clinical specimens detection conventional viruses missed clinical virology algorithm unconventional viruses required additional confirmatory testing evaluate performance characteristics assay rtpcresims method promising diagnostic platform rapid identification conventional unconventional viruses merits prospective evaluation refer web version pubmed central supplementary material diagnostic algorithm used clinical virology laboratory detect respiratory viruses mainly divided respiratory season nonrespiratory season respiratory season defined october following january october november rsv december january influenza immunochromatographic assays used respiratory season sole screening test rsv influenza stop testing algorithm results positive respiratory panel cocktail dfa tests serve adenovirus influenza b parainfluenza type <NUMBER> rsv stop testing algorithm results positive nonrespiratory season screened negative immunochromatographic assays respiratory season well rsv respiratory syncytial virus piv parainfluenza virus hsv herpes simplex virus cmv cytomegalovirus hmpv human metapneumovirus dfa direct fluorescent antibody test cpe cytopathic effect rbc red blood cells bocavirus detectable clinical virology laboratory secondary rtpcr based platform excluded <NUMBER> subjects bocavirus detection <NUMBER> bocavirus detection excluding bocavirus coronavirus detections clinical virology laboratory protocol detect <NUMBER> included primary performance analysis table <NUMBER>a six coronavirus <NUMBER> samples clinical virology laboratory rtpcresims agree sufficient volume left sent secondary rtpcr based assay secondary analysis na available one coronavirus isolation detected conventional virology reference test adenovirus excludes one coronavirus detection insufficient volume send secondary pcr method establishing rapid widespread testing coronavirus disease <NUMBER> covid<NUMBER> essential containing pandemic reopening society current gold standard test measures viral nucleic acids extracted clinical swabs quantitative reverse transcription polymerase chain reaction qrtpcr assay requires trained medical personnel specialized instrumentation supplylimited reagents significant technical labor isothermal nucleic acid amplification tests alternative conventional pcr methods require expensive instruments trained personnel perform reaction quantify results specifically loopmediated isothermal amplification lamp simultaneous reversetranscription rtlamp allows rapid sensitive detection nucleic acids within one hour easily interpretable colorimetric assay requires heat source <NUMBER> several groups around world currently developing lampbased protocols detection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus causing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sensitivity lamp compares well limitofdetection qrtpcr purified rna samples may achieve higher sensitivity crude clinical samples <NUMBER> robustness lamp bst polymerase pcr inhibitors makes especially wellsuited widely used pathogen detection unpurified samples <NUMBER> confers major potential advantage current testing protocols enables skipping cost labor reagentconsuming step rna extraction saliva promising sample expanding facilitating testing due ease safety noninvasive nature collection relatively high viral load <NUMBER> <NUMBER> recognizing benefits fda approved saliva collection preservation device downstream covid<NUMBER> testing direct comparison saliva nasopharyngeal np swabs individuals revealed saliva samples provided consistent sensitive results covid<NUMBER> detection <NUMBER> salivabased methods however still employ rna extraction followed qrtpcr sought establish optimize simple lampbased assay qualitative detection sarscov<NUMBER> virus directly saliva without rna extraction step develop assay first compared performance five sets recently developed lamp primer sets targeting different regions sarscov<NUMBER> genome <NUMBER> used commercially available neb colorimetric enzyme mix perform lamp reactions quantitative vitro transcribed rna standards corresponding regions targeted lamp primers <NUMBER> neb gene na <NUMBER> lamb et al <NUMBER> primers targeting nucleocapsid gene n orf<NUMBER>ab regions respectively highest sensitivity lowest rates false positives wateronly control supplementary figure <NUMBER> demonstrating specificity sarscov<NUMBER> primers crossreactivity mers coronavirus controls primer sets prioritized testing next validated primer sets rna standards heatinactivated viral particles spiked water human saliva simulate clinical samples figure <NUMBER>a across sets lamp primers rna particles saliva strongly inhibited lamp detection sarscov<NUMBER> compared water fig <NUMBER>b particles weakly inconsistently detected saliva whereas detection water par detection rna fig <NUMBER>c suggests presence inhibitor saliva rather inaccessibility particleassociated rna observed time sensitivity colorimetric assay especially saliva many samples tinting yellow prolonged incubation lamp reaction longer <NUMBER> minutes found <NUMBER>minute incubation provided reliable readout values indicate number viral genome equivalents per reaction purpleframed boxes indicate <NUMBER>minute reactions blackframed boxes indicate <NUMBER>hour reactions b quantification comparison approximate limits detection viral genome equivalents per reaction compared rna type water saliva primer sets limit detection recorded lowest value clear colorimetric change magenta yellow inconclusive undetected values recorded detected quantification comparison approximate limits detection viral genome equivalents per reaction compared rna type water saliva primer sets pvalues indicate onesided ttests saliva greater water inconclusive nondetected values excluded neutralize otherwise reduce inhibitors human saliva tested several approaches demonstrated improve viral rna detection crude samples including saliva <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tested simple dilution particlecontaining saliva water various heat chemical treatments first found dilution saliva water enabled sensitive detection sarscov<NUMBER> particles using lamp figure <NUMBER>a top heat treatment <NUMBER>˚c <NUMBER> minutes followed <NUMBER>˚c <NUMBER> minutes improved lamp sensitivity fig <NUMBER>a middle identical heating steps plus addition proteinase k increased lamp sensitivity relative dilution alone fig <NUMBER>a bottom markedly heat treatment importantly found combined heating steps proteinase k treatment improved sarscov<NUMBER> particle detection undiluted human saliva samples fig <NUMBER>b conferred consistent limit detection order <NUMBER> <NUMBER> particles per reaction experimented additional heat chemical pretreatments including hudson protocol heating unextracted diagnostic samples obliterate nucleases <NUMBER> various detergents conditions decreased assay sensitivity interfered colorimetry supplementary figure <NUMBER>a c also varied amount crude sample input lamp reaction found adding <NUMBER> µl direct saliva compatible assay increased volume improve sensitivity supp fig <NUMBER>d figure <NUMBER> dilution heat proteinase k treatments improve sarscov<NUMBER> detection saliva dilution particlecontaining saliva water improved lamp detection least two orders magnitude undetectable <NUMBER> <NUMBER> particles per reaction heat treatment heat treatment plus proteinase k increased lamp sensitivity <NUMBER> <NUMBER> viral genome equivalents per reaction p <NUMBER> onesided ttests compared dilution alone replicate <NUMBER> used lamb et al primers gave nearly identical results neb gene na primers b heat treatment heat treatment plus proteinase k treatments increased lamp sensitivity undetectable <NUMBER> <NUMBER> viral genome equivalents undiluted saliva reactions purpleframed indicate <NUMBER>minute reactions w water saliva improve accuracy assay sought multiplex lamp primer sets single reaction combining primers potentially increase sensitivity additive signals simultaneous amplification reactions <NUMBER> <NUMBER> including multiple primer sets also confer diagnostic robustness mutations arise sarscov<NUMBER> genome <NUMBER> nonspecific primer interactions however could result potential false positives compared pairwise combinations neb gene na primers four primer sets targeting various regions across sarscov<NUMBER> genome encouragingly pairs primer sets outperformed neb gene na primer set alone apparent increase spurious background amplification supplementary figure <NUMBER> next tested whether multiplexing primer sets could improve signal detection untreated heat chemical treated particlecontaining saliva figure <NUMBER>a found heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes alone gave marked improvement sarscov<NUMBER> particle detection saliva fig <NUMBER>b p <NUMBER>e<NUMBER> twosided ttest effect consistent across primer sets heat treatment plus proteinase k improved assay sensitivity compared heat alone p <NUMBER> twosided ttest multiplexed primer sets slightly improved sensitivity assay pushing limit detection order <NUMBER> <NUMBER> particles per reaction sensitivity multiplexed lamp assay would detect vast majority covid positive samples based reported saliva viral loads median <NUMBER> <NUMBER> <NUMBER> <NUMBER> per ul <NUMBER> <NUMBER> viral loads peak around day zero symptom onset lamp would accuracy critical timepoint <NUMBER> benchmark performance extractionfree protocol qrtpcr performed qrtpcr using cdc gene n<NUMBER> probe set directly untreated treated simulated saliva samples found qrtpcr similar sensitivity lamp crude samples reliably detecting sarscov<NUMBER> samples <NUMBER> <NUMBER> particles per reaction fig <NUMBER>c <NUMBER> <NUMBER> particles reliably detected assay observed strong improvements cycle thresholds ct using either heat alone heat plus proteinase k p <NUMBER>e<NUMBER> twotailed paired ttests results provide evidence saliva pretreatment significantly increase sensitivity viral rna detection ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> heat treatment improves lod p <NUMBER>e<NUMBER> ttest twotailed vs untreated proteinase k treatment improves heat treatment p <NUMBER> ttest twotailed vs heat multiplexed primers may slightly improve limit detection <NUMBER> <NUMBER> particles reaction c qrtpcr crude lysate neb gene na reactions showed similar increase sensitivity either heat proteinase k treatment p <NUMBER>e<NUMBER> either treatment <NUMBER>tailed paired ttest proteinase k improve qrtpcr sensitivity n neb gene na obtained saliva samples collected day zero hospital admission six presumptive covid<NUMBER> positive individuals one sample excluded viscosity prevented pipetting five aliquoted <NUMBER> tubes either treatment heat inactivation <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes heat treatment plus proteinase k following pretreatment rtlamp reaction performed neb gene na primers photographs taken <NUMBER> <NUMBER> <NUMBER> minutes track colorimetric shifts time figure <NUMBER>a aliquot <NUMBER> <NUMBER> viral particles saliva used positive control <NUMBER> minutes <NUMBER> five samples clearly positive heat plus proteinase k treated samples fig <NUMBER>a bottom right positive negative controls positive negative reactions <NUMBER>minute timepoint allowing interpretable readout assay untreated samples showed positivity samples <NUMBER> heatalone indicated clear positivity samples <NUMBER> differences may reflect altered ratios free viral rna particleassociated ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rna samples could differentially affected heat treatment proteinase k treatment protects free rna inactivating nucleases releases particlebound rna incorporating quantitative colorimetric decomposition analysis enhance sensitivity interpretability borderline samples future experiments <NUMBER> corresponding goldstandard qrtpcr results samples instead performed qrtpcr cdc n<NUMBER> probe directly untreated treated samples along positive negative controls qrtpcr results qualitatively concordant rtlamp results identifying <NUMBER> clear positives samples <NUMBER> ct <NUMBER> fig <NUMBER>b sample <NUMBER> tested negative lamp treatments qrtpcr attempt purify rna saliva sample unsuccessful may indicate rna degradation prior lamp qrtpcr work needed establish best practices upstream handling saliva specimens toward end shown lamp reaction compatible samples te buffer <NUMBER> mm tris <NUMBER> mm edta diluted hudson buffer <NUMBER> mm tcep <NUMBER> mm edta rnasecure supplementary figure <NUMBER>a lamp pretreatment regimens significantly improved nucleic acid detection qrtpcr fig <NUMBER>c heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k outperformed untreated samples p <NUMBER> p <NUMBER> respectively proteinase k significantly improve sensitivity compared heat alone extrapolation viral loads clinical saliva samples comparing quantitative positive control yielded estimates <NUMBER> x <NUMBER> <NUMBER> <NUMBER> x <NUMBER> <NUMBER> particles per µl demonstrates sensitivity assay real clinical samples validation optimization additional positive negative saliva specimens necessary clinical assay deployment ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> enable significant scaleup testing capacity using lamp assay human saliva adapted protocol <NUMBER>well plate format spectrophotometric plate scanning assay provided unbiased quantitative interpretation initial plate scanning implemented normalize baseline differences induced variation ph across human saliva samples heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k enabled sensitive detection viral particles human saliva samples <NUMBER> <NUMBER> particles per reaction detection <NUMBER> <NUMBER> even <NUMBER> <NUMBER> particles per reaction figure <NUMBER>a assay quantitative least four orders magnitude quantification limitofdetection assay validation clinical specimens ongoing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rtlamp assay adapted highthroughput <NUMBER>well plate format quantitative absorbance readout achieving limit detection <NUMBER> <NUMBER> particles per reaction saliva samples absorbance <NUMBER> nm yellow <NUMBER> nm red wavelengths measured lamp reaction normalized negative controls heat <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k prok two biological replicates run triplicate isothermal lamp wellsuited pointofcare testing requires heatsource sought avoid <NUMBER> ˚c heating step make saliva pretreatment compatible single isothermal heat source whereas mild heat treatment consisting <NUMBER> ˚c <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes enable sensitive detection sarscov<NUMBER> undiluted saliva sup figure <NUMBER>b <NUMBER>˚ c treatment <NUMBER> minutes saliva diluted <NUMBER> either te <NUMBER> mm tris <NUMBER> mm edta dilute hudson buffer <NUMBER> mm tcep <NUMBER> mm edta improved detection sup fig <NUMBER>b addition rnasecure nonenzymatic ribonuclease inhibitor require heatinactivation boosted assay sensitivity <NUMBER> <NUMBER> viral particles per reaction sup fig <NUMBER>b sarscov<NUMBER> samples treated thermolabile version proteinase k inactivated incubation <NUMBER>˚ <NUMBER> minutes detected sensitive fashion sup fig <NUMBER>c finally found guanidine hydrochloride <NUMBER> mm compatible lamp reaction rnasecure primer multiplexing provided enhancements sensitivity sup <NUMBER>d pretreatment methods enable use saliva lamp reactions using single heat step simplifying pointofcare testing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint proposed approach combines three promising avenues enable rapid widespread covid<NUMBER> detection <NUMBER> colorimetric rtlamp <NUMBER> selfcollected saliva specimens <NUMBER> compatibility crude saliva samples without rnaextraction approach solves two major bottlenecks massively scaling covid<NUMBER> nucleic acid testing sample acquisition rna extraction enables test results less hour viral shedding likely begins several days prior onset symptoms viral load peaks period <NUMBER> colorimetric rtlamp directly saliva would enable rapid frequent testing preor asymptomatic carriers enabling isolation prior unwitting viral transmission testing critical curtailing ongoing pandemic due ease use rapid amplification nucleic acids high specificity arising use six primers high tolerance reaction inhibitors <NUMBER> rtlamp widely used pathogen detection sensitive diagnostic assays developed viruses including zika <NUMBER> assays developed sarscov<NUMBER> several groups including <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speed cost turnaround time simple colorimetric readout make rtlamp effective solution ramping testing require specialized equipment training performing interpreting assay rtlamp especially wellsuited pointofcare detection sample acquisition currently limited reliance np swabs need carefully performed trained healthcare worker require use ppe midnasal swabs promising alternative np swabs selfadministered contain high viral loads <NUMBER> <NUMBER> <NUMBER> however due potential swab shortages instead focused expectorated saliva due ease collection high viral load <NUMBER> work adds growing body evidence saliva facilitate adoption widespread testing several groups optimizing workarounds avoid rna extraction step pcr based sarscov<NUMBER> testing maintaining sensitivity <NUMBER> <NUMBER> <NUMBER> <NUMBER> demonstrated variety saliva pretreatment protocols enable sensitive detection sarscov<NUMBER> rtlamp qrtpcr rna saliva likely comprises mixture free particleassociated rna capsid release rna nuclease inactivation heat chemicals may damage free viral rna careful balance must achieved maximize sensitivity despite requiring brief inactivation <NUMBER>˚c proteinase k treatment release viral rna inactivate ribonucleases inhibitors saliva worked well increase sensitivity rtlamp qrtpcr alternatively te buffer guanidine hudson buffer rnasecure allowed us perform heat step isothermal lamp reaction conditions maintaining high assay sensitivity version protocol compatible pointofcare testing proofofconcept validation actual clinical samples suggests high sensitivity current assay detect sarscov<NUMBER> directly treated saliva optimizations may improve assay sensitivity robustness daily screening employees especially healthcare workers feasible approach due rapid turnaround low complexity low cost viral loads correlated transmission weakly infectious carriers risk false negative results also true current gold standard colorimetric rtlamp saliva broad potential increase covid<NUMBER> screening speed capacity demonstrated adaptation assay platebased format similar approaches others validated clinical samples deployed disease surveillance adapted home testing pointofcare use <NUMBER> <NUMBER> summary optimized rtlamp reaction conditions enable sensitive sarscov<NUMBER> detection unpurified saliva samples optimization overcomes burden rna extraction reagent need sophisticated instrumentation time labor bottlenecks current gold standard nucleic acidbased tests assay deployed pointofcare test centralized laboratory facility nonexhaustive current optimizations enabled reliable detection <NUMBER> <NUMBER> viral genomes per reaction simulated saliva samples using conditions observed high performance assay limited number clinical saliva specimens without rna extraction lamp reactions performed following new england biolabs recommended protocol using warmstart colorimetric lamp <NUMBER>x master mix neb massachusetts usa m<NUMBER>l <NUMBER> µl reactions <NUMBER> µl lamp master mix <NUMBER> µl <NUMBER>x primer mix <NUMBER> µm f<NUMBER> b<NUMBER> <NUMBER> µm forward inner primer fip backward inner primer bip <NUMBER> µm loop forward lf loop backward lb primers <NUMBER> <NUMBER> nmol scale idt <NUMBER> µl nucleasefree water <NUMBER> µl samples lamp reactions incubated <NUMBER>˚c using biorad dna engine thermocyclers <NUMBER> minutes photographs taken cell phone cameras samples laid white sheets paper ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> vitro transcribed rna standards prepared described <NUMBER> httpswwwprotocolsioviewgenerationofsarscov<NUMBER>rnatranscriptstandardsbdv<NUMBER>i<NUMBER>e brief gblocks idt corresponding sarscov<NUMBER> regions targeted lamp primer sets pcr amplified vitro transcribed using megashortscript t<NUMBER> transcription kit thermofisher rna products columnpurified using monarch rna cleanup kit neb quantified using qubit heat inactivated sarscov<NUMBER> particles acquired cdc bei resources particle stock concentrations <NUMBER> x <NUMBER> <NUMBER> particles per µl <NUMBER> µl particles resuspended <NUMBER> µl water saliva make <NUMBER> <NUMBER> particles µl stock alternatively <NUMBER> µl particles added <NUMBER> µl saliva make <NUMBER> <NUMBER> particles µl stocks individually aliquoted reduce freezethaw dna plasmid coronavirus controls corresponding sarscov<NUMBER> mers obtained idt plasmid dna solutions ncovn control severe acute respiratory syndrome coronavirus <NUMBER> isolate wuhanhu<NUMBER> complete genome genbank nc<NUMBER> mers control middle east respiratory syndromerelated coronavirus isolate knih<NUMBER> complete genome genbank mk<NUMBER> hudson heating unextracted diagnostic samples obliterate nucleases <NUMBER> performed described using tcep <NUMBER> mm edta <NUMBER> mm final concentrations mild heat treatment consisting <NUMBER> ˚c <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes employed neutral ph tcep also investigated still caused instant colorimetric shift lamp reactions diluted tcepedta compatible lamp ability inactivate nucleases lyse viral particles remains validated proteinase k neb p<NUMBER>s added saliva <NUMBER> volume <NUMBER> µl <NUMBER> µl saliva <NUMBER> <NUMBER> dilutions proteinase k water te also used concentrations effective <NUMBER> dilutions used ongoing experiments performed heat inactivation proteinase k <NUMBER> minutes <NUMBER>˚c also tested thermolabile proteinase k neb p<NUMBER>s samples incubated <NUMBER> ˚c <NUMBER> minutes followed proteinase k inactivation <NUMBER> ˚c <NUMBER> minutes rnasecure <NUMBER>x thermofisher am<NUMBER> added reactions <NUMBER>x optimizations observed low levels te buffer effective preventing negative control samples tinting yellow prolonged lamp ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> reactions pulse spin microfuge improved reliability viral detection across various batches saliva qrtpcr reactions performed according cdc eua guidelines using taqpath <NUMBER> step rtqpcr master mix gc thermo a<NUMBER> ncovn<NUMBER> probe form <NUMBER>ncov ruo kit idt reactions performed quantstudio <NUMBER> <NUMBER> realtime pcr systems thermofisher using crude lysate input <NUMBER> µl used input match lamp protocol assay scaleup performed <NUMBER>well plate format biorad <NUMBER> well skirted pcr plate minor modifications lamp reaction <NUMBER> µl saliva samples used <NUMBER> µl total volume reactions heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes proteinase k treatment identical single tube format rnasin promega included samples samples run technical triplicate dilution utilizing biotek epoch microplate spectrophotometer sample plates scanned prior heating designated preread establish background due variations color related individual saliva samples heating <NUMBER> ˚c <NUMBER> minutes plate read second time designated postread read takes approximately <NUMBER> minute reader software returns endpoint absorbance <NUMBER> nm <NUMBER> nm wavelengths measure positive negative reaction results respectively analytically ratio <NUMBER> nm <NUMBER> nm computed preand postread scans well preread ratio subtracted postread ratio establish background subtracted value mean standard deviation background subtracted negative controls saliva pbs computed <NUMBER> wells across plate replicate adjusted absorbance ratio computed taking ratio sample average negative control value background subtracted sample ratio background subtracted negative control ratio neborf<NUMBER>aaf<NUMBER> ctgcacctcatggtcatgtt neborf<NUMBER>aab<NUMBER> agctcgtcgcctaagtcaa neborf<NUMBER>aafip gagggacaaggacaccaagtgtatggttgagctggtagcaga neborf<NUMBER>aabip ccagtggcttaccgcaaggttttagatcggcgccgtaac ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> saliva samples collected day zero hospital admission six presumptive covid<NUMBER> positive individuals saliva samples diluted <NUMBER> phosphate buffered saline facilitate pipetting frozen samples thawed heattreated <NUMBER>˚c <NUMBER> minutes inactivate majority live virus <NUMBER> samples refrozen samples thawed ice prior lamp qrtpcr reactions ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review establishing rapid widespread testing coronavirus disease <NUMBER> covid<NUMBER> essential containing pandemic reopening society current gold standard test measures viral nucleic acids extracted clinical swabs quantitative reverse transcription polymerase chain reaction qrtpcr assay requires trained medical personnel specialized instrumentation supplylimited reagents significant technical labor isothermal nucleic acid amplification tests alternative conventional pcr methods require expensive instruments trained personnel perform reaction quantify results specifically loopmediated isothermal amplification lamp simultaneous reversetranscription rtlamp allows rapid sensitive detection nucleic acids within one hour easily interpretable colorimetric assay requires heat source <NUMBER> several groups around world currently developing lampbased protocols detection severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> virus causing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sensitivity lamp compares well limitofdetection qrtpcr purified rna samples may achieve higher sensitivity crude clinical samples <NUMBER> robustness lamp bst polymerase pcr inhibitors makes especially wellsuited widely used pathogen detection unpurified samples <NUMBER> confers major potential advantage current testing protocols enables skipping cost labor reagentconsuming step rna extraction saliva promising sample expanding facilitating testing due ease safety noninvasive nature collection relatively high viral load <NUMBER> <NUMBER> recognizing benefits fda approved saliva collection preservation device downstream covid<NUMBER> testing direct comparison saliva nasopharyngeal np swabs individuals revealed saliva samples provided consistent sensitive results covid<NUMBER> detection <NUMBER> salivabased methods however still employ rna extraction followed qrtpcr sought establish optimize simple lampbased assay qualitative detection sarscov<NUMBER> virus directly saliva without rna extraction step develop assay first compared performance five sets recently developed lamp primer sets targeting different regions sarscov<NUMBER> genome <NUMBER> used commercially available neb colorimetric enzyme mix perform lamp reactions quantitative vitro transcribed rna standards corresponding regions targeted lamp primers <NUMBER> neb gene na <NUMBER> lamb et al <NUMBER> primers targeting nucleocapsid gene n orf<NUMBER>ab regions respectively highest sensitivity lowest rates false positives wateronly control supplementary figure <NUMBER> demonstrating specificity sarscov<NUMBER> primers crossreactivity mers coronavirus controls primer sets prioritized testing next validated primer sets rna standards heatinactivated viral particles spiked water human saliva simulate clinical samples figure <NUMBER>a across sets lamp primers rna particles saliva strongly inhibited lamp detection sarscov<NUMBER> compared water fig <NUMBER>b particles weakly inconsistently detected saliva whereas detection water par detection rna fig <NUMBER>c suggests presence inhibitor saliva rather inaccessibility particleassociated rna observed time sensitivity colorimetric assay especially saliva many samples tinting yellow prolonged incubation lamp reaction longer <NUMBER> minutes found <NUMBER>minute incubation provided reliable readout values indicate number viral genome equivalents per reaction purpleframed boxes indicate <NUMBER>minute reactions blackframed boxes indicate <NUMBER>hour reactions b quantification comparison approximate limits detection viral genome equivalents per reaction compared rna type water saliva primer sets limit detection recorded lowest value clear colorimetric change magenta yellow inconclusive undetected values recorded detected quantification comparison approximate limits detection viral genome equivalents per reaction compared rna type water saliva primer sets pvalues indicate onesided ttests saliva greater water inconclusive nondetected values excluded neutralize otherwise reduce inhibitors human saliva tested several approaches demonstrated improve viral rna detection crude samples including saliva <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> tested simple dilution particlecontaining saliva water various heat chemical treatments first found dilution saliva water enabled sensitive detection sarscov<NUMBER> particles using lamp figure <NUMBER>a top heat treatment <NUMBER>˚c <NUMBER> minutes followed <NUMBER>˚c <NUMBER> minutes improved lamp sensitivity fig <NUMBER>a middle identical heating steps plus addition proteinase k increased lamp sensitivity relative dilution alone fig <NUMBER>a bottom markedly heat treatment importantly found combined heating steps proteinase k treatment improved sarscov<NUMBER> particle detection undiluted human saliva samples fig <NUMBER>b conferred consistent limit detection order <NUMBER> <NUMBER> particles per reaction experimented additional heat chemical pretreatments including hudson protocol heating unextracted diagnostic samples obliterate nucleases <NUMBER> various detergents conditions decreased assay sensitivity interfered colorimetry supplementary figure <NUMBER>a c also varied amount crude sample input lamp reaction found adding <NUMBER> µl direct saliva compatible assay increased volume improve sensitivity supp fig <NUMBER>d figure <NUMBER> dilution heat proteinase k treatments improve sarscov<NUMBER> detection saliva dilution particlecontaining saliva water improved lamp detection least two orders magnitude undetectable <NUMBER> <NUMBER> particles per reaction heat treatment heat treatment plus proteinase k increased lamp sensitivity <NUMBER> <NUMBER> viral genome equivalents per reaction p <NUMBER> onesided ttests compared dilution alone replicate <NUMBER> used lamb et al primers gave nearly identical results neb gene na primers b heat treatment heat treatment plus proteinase k treatments increased lamp sensitivity undetectable <NUMBER> <NUMBER> viral genome equivalents undiluted saliva reactions purpleframed indicate <NUMBER>minute reactions w water saliva improve accuracy assay sought multiplex lamp primer sets single reaction combining primers potentially increase sensitivity additive signals simultaneous amplification reactions <NUMBER> <NUMBER> including multiple primer sets also confer diagnostic robustness mutations arise sarscov<NUMBER> genome <NUMBER> nonspecific primer interactions however could result potential false positives compared pairwise combinations neb gene na primers four primer sets targeting various regions across sarscov<NUMBER> genome encouragingly pairs primer sets outperformed neb gene na primer set alone apparent increase spurious background amplification supplementary figure <NUMBER> next tested whether multiplexing primer sets could improve signal detection untreated heat chemical treated particlecontaining saliva figure <NUMBER>a found heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes alone gave marked improvement sarscov<NUMBER> particle detection saliva fig <NUMBER>b p <NUMBER>e<NUMBER> twosided ttest effect consistent across primer sets heat treatment plus proteinase k improved assay sensitivity compared heat alone p <NUMBER> twosided ttest multiplexed primer sets slightly improved sensitivity assay pushing limit detection order <NUMBER> <NUMBER> particles per reaction sensitivity multiplexed lamp assay would detect vast majority covid positive samples based reported saliva viral loads median <NUMBER> <NUMBER> <NUMBER> <NUMBER> per ul <NUMBER> <NUMBER> viral loads peak around day zero symptom onset lamp would accuracy critical timepoint <NUMBER> benchmark performance extractionfree protocol qrtpcr performed qrtpcr using cdc gene n<NUMBER> probe set directly untreated treated simulated saliva samples found qrtpcr similar sensitivity lamp crude samples reliably detecting sarscov<NUMBER> samples <NUMBER> <NUMBER> particles per reaction fig <NUMBER>c <NUMBER> <NUMBER> particles reliably detected assay observed strong improvements cycle thresholds ct using either heat alone heat plus proteinase k p <NUMBER>e<NUMBER> twotailed paired ttests results provide evidence saliva pretreatment significantly increase sensitivity viral rna detection ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> heat treatment improves lod p <NUMBER>e<NUMBER> ttest twotailed vs untreated proteinase k treatment improves heat treatment p <NUMBER> ttest twotailed vs heat multiplexed primers may slightly improve limit detection <NUMBER> <NUMBER> particles reaction c qrtpcr crude lysate neb gene na reactions showed similar increase sensitivity either heat proteinase k treatment p <NUMBER>e<NUMBER> either treatment <NUMBER>tailed paired ttest proteinase k improve qrtpcr sensitivity n neb gene na obtained saliva samples collected day zero hospital admission six presumptive covid<NUMBER> positive individuals one sample excluded viscosity prevented pipetting five aliquoted <NUMBER> tubes either treatment heat inactivation <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes heat treatment plus proteinase k following pretreatment rtlamp reaction performed neb gene na primers photographs taken <NUMBER> <NUMBER> <NUMBER> minutes track colorimetric shifts time figure <NUMBER>a aliquot <NUMBER> <NUMBER> viral particles saliva used positive control <NUMBER> minutes <NUMBER> five samples clearly positive heat plus proteinase k treated samples fig <NUMBER>a bottom right positive negative controls positive negative reactions <NUMBER>minute timepoint allowing interpretable readout assay untreated samples showed positivity samples <NUMBER> heatalone indicated clear positivity samples <NUMBER> differences may reflect altered ratios free viral rna particleassociated ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rna samples could differentially affected heat treatment proteinase k treatment protects free rna inactivating nucleases releases particlebound rna incorporating quantitative colorimetric decomposition analysis enhance sensitivity interpretability borderline samples future experiments <NUMBER> corresponding goldstandard qrtpcr results samples instead performed qrtpcr cdc n<NUMBER> probe directly untreated treated samples along positive negative controls qrtpcr results qualitatively concordant rtlamp results identifying <NUMBER> clear positives samples <NUMBER> ct <NUMBER> fig <NUMBER>b sample <NUMBER> tested negative lamp treatments qrtpcr attempt purify rna saliva sample unsuccessful may indicate rna degradation prior lamp qrtpcr work needed establish best practices upstream handling saliva specimens toward end shown lamp reaction compatible samples te buffer <NUMBER> mm tris <NUMBER> mm edta diluted hudson buffer <NUMBER> mm tcep <NUMBER> mm edta rnasecure supplementary figure <NUMBER>a lamp pretreatment regimens significantly improved nucleic acid detection qrtpcr fig <NUMBER>c heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k outperformed untreated samples p <NUMBER> p <NUMBER> respectively proteinase k significantly improve sensitivity compared heat alone extrapolation viral loads clinical saliva samples comparing quantitative positive control yielded estimates <NUMBER> x <NUMBER> <NUMBER> <NUMBER> x <NUMBER> <NUMBER> particles per µl demonstrates sensitivity assay real clinical samples validation optimization additional positive negative saliva specimens necessary clinical assay deployment ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> enable significant scaleup testing capacity using lamp assay human saliva adapted protocol <NUMBER>well plate format spectrophotometric plate scanning assay provided unbiased quantitative interpretation initial plate scanning implemented normalize baseline differences induced variation ph across human saliva samples heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k enabled sensitive detection viral particles human saliva samples <NUMBER> <NUMBER> particles per reaction detection <NUMBER> <NUMBER> even <NUMBER> <NUMBER> particles per reaction figure <NUMBER>a assay quantitative least four orders magnitude quantification limitofdetection assay validation clinical specimens ongoing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> rtlamp assay adapted highthroughput <NUMBER>well plate format quantitative absorbance readout achieving limit detection <NUMBER> <NUMBER> particles per reaction saliva samples absorbance <NUMBER> nm yellow <NUMBER> nm red wavelengths measured lamp reaction normalized negative controls heat <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes without proteinase k prok two biological replicates run triplicate isothermal lamp wellsuited pointofcare testing requires heatsource sought avoid <NUMBER> ˚c heating step make saliva pretreatment compatible single isothermal heat source whereas mild heat treatment consisting <NUMBER> ˚c <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes enable sensitive detection sarscov<NUMBER> undiluted saliva sup figure <NUMBER>b <NUMBER>˚ c treatment <NUMBER> minutes saliva diluted <NUMBER> either te <NUMBER> mm tris <NUMBER> mm edta dilute hudson buffer <NUMBER> mm tcep <NUMBER> mm edta improved detection sup fig <NUMBER>b addition rnasecure nonenzymatic ribonuclease inhibitor require heatinactivation boosted assay sensitivity <NUMBER> <NUMBER> viral particles per reaction sup fig <NUMBER>b sarscov<NUMBER> samples treated thermolabile version proteinase k inactivated incubation <NUMBER>˚ <NUMBER> minutes detected sensitive fashion sup fig <NUMBER>c finally found guanidine hydrochloride <NUMBER> mm compatible lamp reaction rnasecure primer multiplexing provided enhancements sensitivity sup <NUMBER>d pretreatment methods enable use saliva lamp reactions using single heat step simplifying pointofcare testing ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint proposed approach combines three promising avenues enable rapid widespread covid<NUMBER> detection <NUMBER> colorimetric rtlamp <NUMBER> selfcollected saliva specimens <NUMBER> compatibility crude saliva samples without rnaextraction approach solves two major bottlenecks massively scaling covid<NUMBER> nucleic acid testing sample acquisition rna extraction enables test results less hour viral shedding likely begins several days prior onset symptoms viral load peaks period <NUMBER> colorimetric rtlamp directly saliva would enable rapid frequent testing preor asymptomatic carriers enabling isolation prior unwitting viral transmission testing critical curtailing ongoing pandemic due ease use rapid amplification nucleic acids high specificity arising use six primers high tolerance reaction inhibitors <NUMBER> rtlamp widely used pathogen detection sensitive diagnostic assays developed viruses including zika <NUMBER> assays developed sarscov<NUMBER> several groups including <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> speed cost turnaround time simple colorimetric readout make rtlamp effective solution ramping testing require specialized equipment training performing interpreting assay rtlamp especially wellsuited pointofcare detection sample acquisition currently limited reliance np swabs need carefully performed trained healthcare worker require use ppe midnasal swabs promising alternative np swabs selfadministered contain high viral loads <NUMBER> <NUMBER> <NUMBER> however due potential swab shortages instead focused expectorated saliva due ease collection high viral load <NUMBER> work adds growing body evidence saliva facilitate adoption widespread testing several groups optimizing workarounds avoid rna extraction step pcr based sarscov<NUMBER> testing maintaining sensitivity <NUMBER> <NUMBER> <NUMBER> <NUMBER> demonstrated variety saliva pretreatment protocols enable sensitive detection sarscov<NUMBER> rtlamp qrtpcr rna saliva likely comprises mixture free particleassociated rna capsid release rna nuclease inactivation heat chemicals may damage free viral rna careful balance must achieved maximize sensitivity despite requiring brief inactivation <NUMBER>˚c proteinase k treatment release viral rna inactivate ribonucleases inhibitors saliva worked well increase sensitivity rtlamp qrtpcr alternatively te buffer guanidine hudson buffer rnasecure allowed us perform heat step isothermal lamp reaction conditions maintaining high assay sensitivity version protocol compatible pointofcare testing proofofconcept validation actual clinical samples suggests high sensitivity current assay detect sarscov<NUMBER> directly treated saliva optimizations may improve assay sensitivity robustness daily screening employees especially healthcare workers feasible approach due rapid turnaround low complexity low cost viral loads correlated transmission weakly infectious carriers risk false negative results also true current gold standard colorimetric rtlamp saliva broad potential increase covid<NUMBER> screening speed capacity demonstrated adaptation assay platebased format similar approaches others validated clinical samples deployed disease surveillance adapted home testing pointofcare use <NUMBER> <NUMBER> summary optimized rtlamp reaction conditions enable sensitive sarscov<NUMBER> detection unpurified saliva samples optimization overcomes burden rna extraction reagent need sophisticated instrumentation time labor bottlenecks current gold standard nucleic acidbased tests assay deployed pointofcare test centralized laboratory facility nonexhaustive current optimizations enabled reliable detection <NUMBER> <NUMBER> viral genomes per reaction simulated saliva samples using conditions observed high performance assay limited number clinical saliva specimens without rna extraction lamp reactions performed following new england biolabs recommended protocol using warmstart colorimetric lamp <NUMBER>x master mix neb massachusetts usa m<NUMBER>l <NUMBER> µl reactions <NUMBER> µl lamp master mix <NUMBER> µl <NUMBER>x primer mix <NUMBER> µm f<NUMBER> b<NUMBER> <NUMBER> µm forward inner primer fip backward inner primer bip <NUMBER> µm loop forward lf loop backward lb primers <NUMBER> <NUMBER> nmol scale idt <NUMBER> µl nucleasefree water <NUMBER> µl samples lamp reactions incubated <NUMBER>˚c using biorad dna engine thermocyclers <NUMBER> minutes photographs taken cell phone cameras samples laid white sheets paper ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> vitro transcribed rna standards prepared described <NUMBER> httpswwwprotocolsioviewgenerationofsarscov<NUMBER>rnatranscriptstandardsbdv<NUMBER>i<NUMBER>e brief gblocks idt corresponding sarscov<NUMBER> regions targeted lamp primer sets pcr amplified vitro transcribed using megashortscript t<NUMBER> transcription kit thermofisher rna products columnpurified using monarch rna cleanup kit neb quantified using qubit heat inactivated sarscov<NUMBER> particles acquired cdc bei resources particle stock concentrations <NUMBER> x <NUMBER> <NUMBER> particles per µl <NUMBER> µl particles resuspended <NUMBER> µl water saliva make <NUMBER> <NUMBER> particles µl stock alternatively <NUMBER> µl particles added <NUMBER> µl saliva make <NUMBER> <NUMBER> particles µl stocks individually aliquoted reduce freezethaw dna plasmid coronavirus controls corresponding sarscov<NUMBER> mers obtained idt plasmid dna solutions ncovn control severe acute respiratory syndrome coronavirus <NUMBER> isolate wuhanhu<NUMBER> complete genome genbank nc<NUMBER> mers control middle east respiratory syndromerelated coronavirus isolate knih<NUMBER> complete genome genbank mk<NUMBER> hudson heating unextracted diagnostic samples obliterate nucleases <NUMBER> performed described using tcep <NUMBER> mm edta <NUMBER> mm final concentrations mild heat treatment consisting <NUMBER> ˚c <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes employed neutral ph tcep also investigated still caused instant colorimetric shift lamp reactions diluted tcepedta compatible lamp ability inactivate nucleases lyse viral particles remains validated proteinase k neb p<NUMBER>s added saliva <NUMBER> volume <NUMBER> µl <NUMBER> µl saliva <NUMBER> <NUMBER> dilutions proteinase k water te also used concentrations effective <NUMBER> dilutions used ongoing experiments performed heat inactivation proteinase k <NUMBER> minutes <NUMBER>˚c also tested thermolabile proteinase k neb p<NUMBER>s samples incubated <NUMBER> ˚c <NUMBER> minutes followed proteinase k inactivation <NUMBER> ˚c <NUMBER> minutes rnasecure <NUMBER>x thermofisher am<NUMBER> added reactions <NUMBER>x optimizations observed low levels te buffer effective preventing negative control samples tinting yellow prolonged lamp ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted may <NUMBER> <NUMBER> reactions pulse spin microfuge improved reliability viral detection across various batches saliva qrtpcr reactions performed according cdc eua guidelines using taqpath <NUMBER> step rtqpcr master mix gc thermo a<NUMBER> ncovn<NUMBER> probe form <NUMBER>ncov ruo kit idt reactions performed quantstudio <NUMBER> <NUMBER> realtime pcr systems thermofisher using crude lysate input <NUMBER> µl used input match lamp protocol assay scaleup performed <NUMBER>well plate format biorad <NUMBER> well skirted pcr plate minor modifications lamp reaction <NUMBER> µl saliva samples used <NUMBER> µl total volume reactions heat treatment <NUMBER>˚ <NUMBER> minutes <NUMBER>˚ <NUMBER> minutes proteinase k treatment identical single tube format rnasin promega included samples samples run technical triplicate dilution utilizing biotek epoch microplate spectrophotometer sample plates scanned prior heating designated preread establish background due variations color related individual saliva samples heating <NUMBER> ˚c <NUMBER> minutes plate read second time designated postread read takes approximately <NUMBER> minute reader software returns endpoint absorbance <NUMBER> nm <NUMBER> nm wavelengths measure positive negative reaction results respectively analytically ratio <NUMBER> nm <NUMBER> nm computed preand postread scans well preread ratio subtracted postread ratio establish background subtracted value mean standard deviation background subtracted negative controls saliva pbs computed <NUMBER> wells across plate replicate adjusted absorbance ratio computed taking ratio sample average negative control value background subtracted sample ratio background subtracted negative control ratio neborf<NUMBER>aaf<NUMBER> ctgcacctcatggtcatgtt neborf<NUMBER>aab<NUMBER> agctcgtcgcctaagtcaa neborf<NUMBER>aafip gagggacaaggacaccaagtgtatggttgagctggtagcaga neborf<NUMBER>aabip ccagtggcttaccgcaaggttttagatcggcgccgtaac ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted may <NUMBER> <NUMBER> saliva samples collected day zero hospital admission six presumptive covid<NUMBER> positive individuals saliva samples diluted <NUMBER> phosphate buffered saline facilitate pipetting frozen samples thawed heattreated <NUMBER>˚c <NUMBER> minutes inactivate majority live virus <NUMBER> samples refrozen samples thawed ice prior lamp qrtpcr reactions ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review rapid testing respiratory viruses become widely appreciated clinical laboratory virusspecific indirect fluorescent antibody ifa spot enzyme immunoassay eia kits become commercially available quantitative tests eia timeresolved fluoroimmunoassay trfia improved tests proven greater sensitivity ifa trfia performed monoclonal antibodies shown greater sensitivity even similarly constructed eia tests reviewed hierholzer et al <NUMBER> mclntosh et al <NUMBER> others described monoclonal trfia tests influenza adenovirus respiratory syncytial virus parainfluenza l<NUMBER> mumpsvirus enteroviruses responsible acute hemorrhagic conjunctivitis halonen et al <NUMBER> walls et al <NUMBER> hierholzer et al <NUMBER> hierholzer et al <NUMBER> hierholzer et al <NUMBER> hierholzer et al <NUMBER> brown et al <NUMBER> siitari <NUMBER> bucher et al <NUMBER> coronaviruses another group viruses cause widespread respiratory infections thus included trfia battery rapid viral diagnosis four recognized human coronavirus strains two characterized associated upper occasionally lower respiratory tract disease ifa eia tests strains called human coronavirus hcv <NUMBER>e hcvoc<NUMBER> described applied epidemiologic surveys good success mcintosh et al <NUMBER> isaacs et al <NUMBER> macnaughton et al <NUMBER> present report describe production monoclonal antibodies hcv<NUMBER>e hcvoc<NUMBER> describe use ifa eia trfia emphasis trfia highlysensitive rapid antigen test prototype strain hcv<NUMBER>e initially obtained dorothy hamre university chicago shkzwi<NUMBER> passage level hamre procknow <NUMBER> maintained variety human embryonic lung diploid fibroblast cell lines eg wi<NUMBER> ru<NUMBER> mrc<NUMBER> helf hlf present studies commenced strain <NUMBER>e <NUMBER> x plaque purification helf cells shkzwi<NUMBER>rushelf<NUMBER> hlf <NUMBER> passage hierholzer <NUMBER> kemp et al <NUMBER> prototype hcvoc<NUMBER> obtained ken mcintosh national institutes health adaptation human embryonic tracheal organ culture suckling mouse brain smb hetssmb v passage level mcintosh et al <NUMBER> study oc<NUMBER> adapted human embryonal rhabdomyosarcoma rd cells suggested schmidt et al <NUMBER> schmidt kenny <NUMBER> oc<NUMBER> used het<NUMBER>smb<NUMBER>rd<NUMBER> passage level throughout study xhlfe xro <NUMBER> working stock passages <NUMBER>e oc<NUMBER> respectively made fortified maintenance medium consisting rpmi<NUMBER> <NUMBER> fetal calf serum incubated roller rocker platform <NUMBER>°c <NUMBER> <NUMBER> h postadsorption previously described hierholzer <NUMBER> flasks harvested <NUMBER> cycles freezethawing stored aliquots crude working stocks preparation test antigens antibody production due extreme lability coronaviruses association biological activities intact virions aliquot used tests run manner minimize exposure virus ambient temperatures kaye et al <NUMBER> hierholzer <NUMBER> hierholzer tannock <NUMBER> prototype wild strains respiratory viruses obtained reference virus collection maintained <NUMBER>°c used study without passage nasopharyngeal aspirates positive <NUMBER>e oc<NUMBER> obtained department virology university turku identified eia tests hyperimmune rabbit guinea pig antisera made purified virions halonen et al <NUMBER> mertsola et al <NUMBER> specimens positive respiratory viruses obtained cdc diagnostic service prior studies halonen et al <NUMBER> halonen et al <NUMBER> hierholzer et al <NUMBER> hierholzer et al <NUMBER> specimens stored <NUMBER>°c <NUMBER> dilution pbs containing <NUMBER> fcs <NUMBER> tween<NUMBER> <NUMBER> merthiolate halonen et al <NUMBER> antisera polyclonal hyperimmune antiserums used eia formats prepared adult rabbits guinea pigs mice chickens immunization crude virus supernatants purified virions previously described kaye et al <NUMBER> hierholzer et al <NUMBER> hierholzer <NUMBER> halonen et al <NUMBER> production monoclonals production monoclonal antibodies human coronaviruses problematic usual prevalence latent murine coronaviruses mouse hepatitis viruses mouse colonies strong antigenic crossreactions oc<NUMBER> many strains mhv reviewed robb bond <NUMBER> macnaughton <NUMBER> siddell et al <NUMBER> hierholzer tannock <NUMBER> thus mouse colonies carefully monitored eia serologic evidence mhv infection organon teknika corp durham nc well eia infection murine viruses ensure adventitious viruses would compromise oc<NUMBER> monoclonals monoclones <NUMBER>e oc<NUMBER> viruses prepared previously described hierholzer et al <NUMBER> <NUMBER>e balbc mice immunized crude virus supernatants hlf cultures frozenthawed <NUMBER> x clarified <NUMBER> x g <NUMBER> min <NUMBER>°c immunizing antigen infectivity titer <NUMBER> tcidsoml <NUMBER> days hlf microneutralization system see oc<NUMBER> mice immunized smb seed stock <NUMBER> x freezethawing clarification <NUMBER> <NUMBER> x g <NUMBER> min <NUMBER>°c remove maximum amount cellular debris retaining full infectivity kaye et al <NUMBER> preparation infectivity titer <NUMBER> <NUMBER> ldoml <NUMBER> days suckling mice inoculated ic <NUMBER> ml virus dilution spleen cells immunized mice fused sp<NUMBER>agl<NUMBER> myeloma cells atcc crl<NUMBER> presence <NUMBER> peg <NUMBER> ml basic optimem medium <NUMBER>°c plus <NUMBER> ml melted polyethylene glycol<NUMBER> <NUMBER> bdh ltd poole uk filtersterilized hybridoma cells selectively grown standard media hybrid cells screened antibody production tissue culture eia procedure anderson et al <NUMBER> <NUMBER>e hlf cells <NUMBER> <NUMBER> cells per well <NUMBER> eagles mem<NUMBER> fcs growth medium added wells <NUMBER>well tissue culture plates <NUMBER> costar cambridge entire rows alternately supplemented <NUMBER> <NUMBER> rpmi<NUMBER> fcs maintenance medium cell control wells infected standard dose <NUMBER>e working stock virus <NUMBER> <NUMBER> maintenance medium give minimal cpe <NUMBER> days incubation <NUMBER>°c co<NUMBER> plates washed <NUMBER> × see eia methods fixed <NUMBER> pl <NUMBER> acetone<NUMBER> pbs <NUMBER> rain <NUMBER>°c airdried stored protective plastic <NUMBER>°c needed testing <NUMBER> pl pbsgt diluent see eia methods added wells <NUMBER> pi supernatant hybridoma wells added virus well cell control well test incubated <NUMBER> h <NUMBER>°c moist chamber plates washed <NUMBER> × <NUMBER> pl goat antimouse peroxidase <NUMBER> kirkegaard perry laboratories gaithersburg md <NUMBER> dilution pbsgt added test incubated <NUMBER> h <NUMBER>°c <NUMBER> × wash step <NUMBER> <NUMBER> tmb see eia methods added reacted <NUMBER> min ambient temperature stopped <NUMBER> <NUMBER> <NUMBER> sulfuric acid read spectrophotometrically <NUMBER> nm monoclones hcvoc<NUMBER> screened similar manner oc<NUMBER> working stock virus infecting rd cells seeded <NUMBER> <NUMBER> cellswell positive cultures cloned limiting dilutions screened specific antibody mouse ascitic fluids prepared cells subsequent second cloning clarified centrifugation <NUMBER> × g <NUMBER> min <NUMBER>°c pooled stored <NUMBER>°c ascitic fluidderived monoclonal antibodies tested eia procedure cell culture supernatants except titrated higher dilutions antibodies mouse ascitic fluids characterized previously described hierholzer et al <NUMBER> antibody subclass determined commercial eia kit ifa assays utilized hlf rd cell cultures appropriate incubation following inoculation <NUMBER> days <NUMBER>°c hemagglutination ha hemagglutinationinhibition hi tests oc<NUMBER> done standard procedures using human chicken erythrocyte suspensions ambient temperature hierholzer et al <NUMBER> hierholzer et al <NUMBER> biotinylation antibody igg purified labeled <NUMBER> mgml concentration enzo biotin reagent ebp<NUMBER> enzo biochemical inc new york ny western blots coronaviruses grown hlf rd cells appropriate medium <NUMBER> <NUMBER> fcs <NUMBER> h cytopathology evident monolayers washed incubated briefly pbs remove nonviral proteins cultures harvested <NUMBER> x freezethaws light centrifugation viral proteins supernatant fluids solubilized electrophoresed reducing nonreducing conditions identified blotting technique tsang et al <NUMBER> microneutralization test serum neutralization sn tests <NUMBER>e oc<NUMBER> carried hlf rd cells respectively <NUMBER>well flatbottom styrene microculture plates costar <NUMBER> cambridge working stock passages <NUMBER> starting dilutions first titrated replicas <NUMBER> growth medium gm rpmi<NUMBER> <NUMBER> fcs lglutamine penicillin streptomycin <NUMBER>fold dilution series using autodiluter cetus propette model <NUMBER> perkinelmercetus corp norwalk ct cell control passages titrated <NUMBER> rows plate <NUMBER> ml cell suspension <NUMBER> x <NUMBER> cellsml added per well entire plate plate gently agitated mixing wrapped plastic film incubated <NUMBER> days <NUMBER>°c <NUMBER> co<NUMBER> humidity reading cells stained immersion <NUMBER> min fixativestain solution consisting <NUMBER> g crystal violet <NUMBER> ml <NUMBER> ethanol <NUMBER> ml <NUMBER> wtwt formaldehyde <NUMBER> ml distilled water <NUMBER> mi <NUMBER> phosphatebuffered saline ph <NUMBER> final concentrations <NUMBER> formaldehyde <NUMBER> crystal violet final ph <NUMBER> endpoints read wells showed <NUMBER> stained area ie uninfected cells present uninoculated cell control wells rows <NUMBER> virus titer thus defined asthe reciprocal highest dilution virus showing <NUMBER> <NUMBER> staining <NUMBER> days dilution called <NUMBER> u virus<NUMBER> ml sn tests carried replicas <NUMBER> rows <NUMBER> <NUMBER> serum control wells untreated antibody samples <NUMBER> starting dilution diluted gm <NUMBER>fold series <NUMBER> ml virus dilution containing <NUMBER> u virus<NUMBER> ml added well first <NUMBER> rows <NUMBER> ml gm added well last <NUMBER> rows plates incubated room temperature <NUMBER> h cells added test mixed incubated stained virus backtitration done determine actual dosage virus test serum titer defined reciprocal highest dilution serum inhibiting <NUMBER> u virus <NUMBER> days eia procedures modifications previously described hierholzer et al <NUMBER> eia format <NUMBER> allmonoclonal test designed parallel used trfia closely possible required use biotinylated igg eia carried <NUMBER>well polystyrene microtiter plates purified monoclonal igg diluted carbonate buffer ph <NUMBER> capture antibody overnight incubation <NUMBER>°c plates washed <NUMBER> pbs ph <NUMBER>° tween<NUMBER> specimen npa virus culture added <NUMBER> dilution pbsgt diluent <NUMBER> pbs ph <NUMBER> <NUMBER> gelatin <NUMBER> tween<NUMBER> trfia antigen diluent plates incubated washed next biotinylated detector antibody diluted pbsgt added test incubated washed test finally developed streptavidinperoxidase tmb substrate absorbance read <NUMBER> nm eia reader eia format <NUMBER> virus optimal polyclonal test derived hyperimmune antisera steps format <NUMBER> except capture antibody polyclonal igg detector antibody igg biotinylation different species antiserum different species igg tried detector followed appropriate antispecies iggperoxidase conjugate diluent detector tried <NUMBER> normal goat serum <NUMBER> normal species serum needed reduce background signal diluent used conjugate purification europium labeling monoclonal antibodies mouse ascitic fluids done described hierholzer et al <NUMBER> oneincubation trfia procedure also done described therein briefly purified monoclonal igg diluted optimal concentration ph <NUMBER> carbonate buffer added wells <NUMBER>well polystyrene strips icn biomedicals inc horsham pa <NUMBER>pl volumes adsorbed overnight ambient temperature moist chamber wells washed <NUMBER> × aqueous <NUMBER> nac<NUMBER> tween<NUMBER> wells saturated <NUMBER> pl <NUMBER> gelatin difco detroit mi <NUMBER> tris<NUMBER> nac<NUMBER> nan<NUMBER> buffer ph <NUMBER> overnight incubation ambient temperature removing excess volume leaving <NUMBER> lwell strips could stored sealed plastic <NUMBER> years <NUMBER>°c point loss activity test wells washed <NUMBER> × <NUMBER> <NUMBER> antigen eudetector antibody added appropriate wells antigen npa culture suspensions diluted <NUMBER> specimen diluent consisting <NUMBER> mm tris ph <NUMBER> <NUMBER> nacl <NUMBER> nan<NUMBER> <NUMBER> gelatin <NUMBER> tween<NUMBER> <NUMBER>tm dtpa <NUMBER> bsa eulabeled detector antibody diluted appropriate concentration diluent strips incubated <NUMBER> h <NUMBER>°c moist chamber washed <NUMBER> x <NUMBER> <NUMBER> per well enhancement solution added th<NUMBER> plates gently agitated shaker <NUMBER> min ambient temperature placed fluorometer counting fluorometer programmed take mean coefficient variation cv <NUMBER> reagent blanks take mean cv duplicates triplicates specimen minus reagent blanks analyzed printed data computing mean standard deviation sd negative specimens run test used mean <NUMBER> sds cutoff value positive specimens hierholzer et al t<NUMBER> <NUMBER> mouse ascitic fluids monoclonals possessed useable homologous titers eia considered use trfia protein specificity clones determined western blots first blots reacted electrophoresed viral proteins hyperimmune rabbit antisera <NUMBER>e mouse guinea pig rabbit antisera oc<NUMBER> followed appropriate antispecies peroxidase confirm presence coronavirus proteins test lanes schmidt kenny <NUMBER> hierholzer tannock <NUMBER> arpin talbot <NUMBER> replicate lanes reacted individual monoclonals followed antimouse peroxidase eleven <NUMBER>e oc<NUMBER> monoclonals suitable eia titers directed nucleoprotein n mean molecular weight <NUMBER> kda reducing gels table <NUMBER> characterization labeling data antibodies listed table <NUMBER> also typespecific eia titers <NUMBER> <NUMBER> purification euigg molar ratios varied <NUMBER> <NUMBER> indicating acceptable labeling antibody ifa titers <NUMBER>e monoclonals ranged <NUMBER> <NUMBER> oc<NUMBER> antibodies <NUMBER> <NUMBER> crossreaction serotypes reactions large panel heterologous viruses prototype plus <NUMBER> strains parainfluenza <NUMBER> <NUMBER> <NUMBER> <NUMBER> measles mumps respiratory syncytial virus groups b influenza b herpes simplex <NUMBER> <NUMBER> adenovirus <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> polio <NUMBER> coxsackie a<NUMBER> b<NUMBER> echo <NUMBER> none coronavirus monoclonals neutralizing activity ie li<NUMBER> antibody titer <NUMBER> tcidsos virus per <NUMBER> ml none oc<NUMBER> monoclonals possessed hi activity ie <NUMBER> antibody titer <NUMBER> ha units virus<NUMBER> ml hcv<NUMBER>e exhibit ha activity therefore <NUMBER>e mabs tested hi lack sn eia titers expressed loglo highest dilution antibody whose absorbance values exhibit pn ratio <NUMBER> <NUMBER>eor oc<NUMBER>infected cells respectively absorbance value uninfected cell controls constitutes n hi activities low ifa titers consistent characterization antibodies antin monoclonal eia format <NUMBER> virus using antibodies trfia optimized checkerboard titrations also biotinylated purified antibodies tested possible combinations eia optimal monoclonal eia formats antigen detection given table <NUMBER> <NUMBER>e several capturedetector combinations reasonably sensitive detecting virus sensitive combination one chosen best trfia format antibody <NUMBER>c capture <NUMBER>a detector gave mean od values <NUMBER> <NUMBER>e virus hlf cultures <NUMBER> oc<NUMBER> smb rd cultures <NUMBER> negative hlf rd cell controls mean pn value <NUMBER> second best format <NUMBER>a capture<NUMBER>a detector gave mean negative od value <NUMBER> mean pn <NUMBER>e <NUMBER> oc<NUMBER> virus optimal format <NUMBER> also found trfia monoclonal <NUMBER>f capture <NUMBER>d detector combination gave mean od values <NUMBER> oc<NUMBER> virus rd cultures <NUMBER> <NUMBER>e virus hlf cultures <NUMBER> negative rd cell controls mean pn value <NUMBER> another format <NUMBER>d capture<NUMBER>d detector gave similar values <NUMBER> mean pn oc<NUMBER> cultures <NUMBER> panel heterologous viruses tested ifa also tested direct eia antigen coating wells followed monoclonal antibody antimouse peroxidase diluent capture antibodies ph <NUMBER> carbonate buffer incubated overnight <NUMBER>°c antigen diluted trfia antigen diluent incubation <NUMBER> h <NUMBER>°c diluent detector antibodies developing system pbsgt <NUMBER> phosphatebuffered saline ph <NUMBER> <NUMBER> gelatin <NUMBER> tween<NUMBER> throughout except <NUMBER>e polyclonal test required <NUMBER> normal goat serum added pbsgt steps incubation <NUMBER> h <NUMBER>°c developing system format <NUMBER> incubated <NUMBER> rain ambient temperature format <NUMBER> incubated <NUMBER> h <NUMBER>°c coronavirus monoclonals uniformly negative thus typespecific polyclonal eias format <NUMBER> also optimized shown table <NUMBER> much less utility higher background signals lower serum antibody levels polyclonal <NUMBER>e tests relatively high backgrounds lowered slightly addition normal goat serum detector side formats thus optimal <NUMBER>e test guinea pig capture antibody gave mean od values <NUMBER> <NUMBER>e cultures <NUMBER> oc<NUMBER> cultures <NUMBER> negative cell controls presence <NUMBER> normal goat serum mean pn <NUMBER> none oc<NUMBER> tests improved addition normal serum detector antibodies thus oc<NUMBER> test mouse capture antibody gave similar positive od values <NUMBER> mean pn ratio <NUMBER> test typespecific <NUMBER>e test results show viruses cell culture supernatants allmonoclonal format sensitive polyclonal test antigen detection limited testing npa specimens confirmed optimallysensitive tests described monoclonal tests superior polyclonal tests oneincubation trfia formatted coronaviruses testing combinations monoclonals serial dilutions tissue culture isolates npa specimens optimization utilized checkerboard titrations capture antibodies <NUMBER> <NUMBER> <NUMBER> <NUMBER> gwell detector antibodies <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ngwell concentration capture antibody optimal concentration detector antibody determined pn ratio representative positive negative samples obtain greatest sensitivity trfia system background mean <NUMBER> reagent system controls automatically subtracted samples run test background measured fluorescence values known negative specimens tested parallel positive specimens thus pn value mean replicate tests positive specimen divided mean negative specimens tested replicates run pn values used ascertain best format trfia table <NUMBER> <NUMBER> mabs evaluated study <NUMBER> found useable either capture detector position trfia <NUMBER>e virus clone <NUMBER>c capture position <NUMBER> gwell clone <NUMBER>a detector position <NUMBER> ngwell gave mean pn value <NUMBER> <NUMBER>e cultures <NUMBER> oc<NUMBER> cultures mean pn <NUMBER> <NUMBER>e clinical specimens <NUMBER> oc<NUMBER> specimens l<NUMBER>diluted test samples signals <NUMBER>e cultures ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> mean<NUMBER> <NUMBER> cps mean negatives<NUMBER> cps <NUMBER>e clinical specimens <NUMBER> <NUMBER> mean <NUMBER> <NUMBER> cps oc<NUMBER> virus clone <NUMBER>f capture position <NUMBER> gwell clone <NUMBER>d detector position <NUMBER> ngwell gave mean pn value <NUMBER> oc<NUMBER> cultures <NUMBER> <NUMBER>e cultures mean pn <NUMBER> oc<NUMBER> clinical specimens <NUMBER> <NUMBER>e specimens l<NUMBER>diluted test samples signals oc<NUMBER> cultures ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> mean <NUMBER> <NUMBER> cps mean italics denotes optimal test system direct detection trfia negatives <NUMBER> cps oc<NUMBER> clinical specimens <NUMBER> <NUMBER> <NUMBER> mean <NUMBER> <NUMBER> cps <NUMBER>c<NUMBER>a format thus sensitive test <NUMBER>e cell cultures clinical specimens <NUMBER>f<NUMBER>d format sensitive oc<NUMBER> cultures specimens tests sensitive next best combinations clones <NUMBER>a<NUMBER>a <NUMBER>e <NUMBER>f<NUMBER>d lower detector concentration oc<NUMBER> eia tests optimized trfia formats coronaviruses <NUMBER>e oc<NUMBER> typespecific tested panel heterologous viruses used ifa eia tests determine doseresponse curves optimized trfia formats working stock cultures <NUMBER>e hlf cells oc<NUMBER> rd cells clarified concentrated <NUMBER>fold ultrafiltration purified glyceroltartrate gradients <NUMBER> <NUMBER> xg hierholzer <NUMBER> hierholzer et al <NUMBER> visible band whole virus <NUMBER> density position harvested dialyzed confirmed coronavirus electron microscopy measured total protein lowry method titrated <NUMBER>fold dilution series trfia shaminoculated cell control cultures virus treated <NUMBER> density position harvested gradients harvests titrated trfia identical fashion cps values samples constituted negative values averaged cutoff calculations cutoff point defined mean <NUMBER> standard deviations negative samples <NUMBER> <NUMBER> cps <NUMBER>e oc<NUMBER> respectively purified <NUMBER>e sample protein content <NUMBER> gml fluorescence value <NUMBER> dilution <NUMBER> <NUMBER> cps oc<NUMBER> sample higher protein content <NUMBER> tgml higher fluorescence value <NUMBER> dilution <NUMBER> <NUMBER> <NUMBER> cps higher background loglog relationship signaltoantigen concentration optimized tests shown fig <NUMBER> allmonoclonal trfia threshold detection <NUMBER>l ngwell <NUMBER> ngml <NUMBER>e virus <NUMBER> ngwell <NUMBER> ngml oc<NUMBER> virus correspond <NUMBER> × <NUMBER> <NUMBER> x <NUMBER> virions per well respectively using optimum reagents dilutions described trfia compared eia formats <NUMBER> <NUMBER> testing original clinical specimens table <NUMBER> <NUMBER>e comparative evaluation included <NUMBER> <NUMBER>epositive specimens <NUMBER> oc<NUMBER>positive specimens <NUMBER> negative specimens seven negative specimens positive adenovirus rsv parainfluenza types <NUMBER> <NUMBER> thus important controls study remaining specimens negative recognized virus culture trfia specimens tested <NUMBER> dilution specimen diluent none negative specimens positive three tests several positive specimens failed detected eia tests cases absorbance values slightly eia cutoff value <NUMBER> specimens <NUMBER> <NUMBER>e <NUMBER> oc<NUMBER> detected monoclonal eias also detected respective polyclonal eias furthermore minimally positive trfia suggesting specimens deteriorated point eia tests sufficiently sensitive detect viruses thus trfia sensitive tests detecting <NUMBER> <NUMBER>e oc<NUMBER> clinical specimens considered positive initial polyclonal eias carried fresh specimens compared <NUMBER> <NUMBER> detected monoclonal eias <NUMBER> <NUMBER> respectively detected polyclonal eias due small number coronavirus specimens available however numbers must considered provisional fluorescent antibody tests first rapid antigen tests developed respiratory viruses still widely used clinical laboratories successfully applied human respiratory coronaviruses well mcintosh et al <NUMBER> enzyme immunoassays become even important rapid viral diagnosis eia sensitive ifa therefore critical test compare new test halonen et al <NUMBER> halonen et al <NUMBER> grandien et al <NUMBER> hornsleth et al <NUMBER> hughes et al <NUMBER> hierholzer et al <NUMBER> takimoto et al <NUMBER> mcintosh et al <NUMBER> thus study included optimized eia tests monoclonal polyclonal antibodies direct comparison optimized trfia tests monoclonal antibodies shown previously trfia polyclonal antibodies sensitive detecting respiratory virus antigens rapid antigen tests halonen et al <NUMBER> halonen et al <NUMBER> subsequent studies monoclonal antibodies revealed even greater sensitivities detecting influenzavirus walls et al <NUMBER> adenovirus hierholzer et al <NUMBER> enterovirus <NUMBER> coxsackie a<NUMBER> viruses eye swabs hierholzer et al <NUMBER> respiratory syncytial virus parainfluenza type <NUMBER> viruses parainfluenza type <NUMBER>a b mumps viruses hierholzer et al <NUMBER> directly clinical specimens present study describe monoclonal antibodies human respiratory coronaviruses useable similarlyconstructed allmonoclonal trfia formats like directantigen trfia tests tests also highly useful identifying viruses cell culture supernatants coronavirus <NUMBER>e sensitive eia monoclonal assay using clone <NUMBER>c capture antibody clone <NUMBER>a detector oc<NUMBER> virus monoclonal assay clone <NUMBER>f capture clone <NUMBER>d detector tests detected virus <NUMBER> <NUMBER>eand <NUMBER> oc<NUMBER>positive clinical specimens respectively trfia hand detected virus <NUMBER> <NUMBER>eand <NUMBER> oc<NUMBER>containing specimens detection rates may change additional experience formatted tests numbers original specimens known eiapositive available testing low accurate determination culturepositive coronavirus specimens owing extreme lability viruses reactive monoclonal antibodies made study directed n nucleoprotein typespecific possess neutralizing activity consistent known biological functions coronavirus proteins reviewed schmidt et al <NUMBER> schmidt <NUMBER> hierholzer tannock <NUMBER> antin antibodies hcvoc<NUMBER> also exhibit hi activity resides peplomers hcv<NUMBER>e possess ha activity thus <NUMBER>e antibodies could tested hi titers hierholzer et al <NUMBER> antin monoclonals addition antie<NUMBER> envelope antie<NUMBER> peplomer antibodies typespecific studies well arlene collins ernesto denardin suny buffalo ny personal communication <NUMBER> fleming et al <NUMBER> furthermore probes pcr primers based n gene sequences <NUMBER>e oc<NUMBER> also successfully used typespecific diagnostic tests kamahora et al <NUMBER> myint et al <NUMBER> myint et al <NUMBER> stewart et al <NUMBER> thus findings utility n protein trfia tests consistent tests based highly conserved protein gene optimized trfia formats described herein wellsuited detection coronavirus types <NUMBER>e oc<NUMBER> directly clinical specimens identification virus isolates recovered cell culture successful muchneeded epidemiologic studies role viruses upper lower respiratory disease late <NUMBER> cluster cases viral pneumonia unknown aetiology reported wuhan hubei province china new viral pneumonia covid<NUMBER> coronavirus disease <NUMBER> caused novel sarscov<NUMBER> severe acute respiratory syndrome coronavirus<NUMBER> spread rapidly developed global pandemic within three months initial detection <NUMBER> <NUMBER> <NUMBER> among symptoms covid<NUMBER> often include fever dry cough resemble respiratory illnesses caused viruses bacteria <NUMBER> <NUMBER> <NUMBER> <NUMBER> due overlapping manifestations clinical diagnosis becomes problematic especially seasonal flu <NUMBER> confirmation covid<NUMBER> depends detection sarscov<NUMBER> nucleic acid reversetranscriptase polymerase chain reaction rtpcr <NUMBER> million cases covid<NUMBER> <NUMBER> countries territories <NUMBER> human deaths reported <NUMBER> <NUMBER> april <NUMBER> due limited testing many geographical regions clear total number actual covid<NUMBER> cases much higher number confirmed ones confirmed covid<NUMBER> cases patients symptomatic showing fever dry cough pneumonia also atypical symptoms gastrointestinal manifestations well anosmia ageusia however virus detected completely asymptomatic individuals eg recent study italy showing <NUMBER> laboratoryconfirmed cases lacked symptoms <NUMBER> knowledge concerning actual number asymptomatic vs symptomatic infections still limited true potentially growing herd immunity almost data available date present study evaluated commercially available assay covid<NUMBER> iggigm rapid test cassette zhejiang orient gene biotech co ltd huzhou zhejiang china developed detection sarscov<NUMBER>specific antibodies capillary blood samples serum <NUMBER> pcrconfirmed covid<NUMBER> patients convalescents capillary blood samples <NUMBER> healthy volunteers without known history sarscov<NUMBER> infection covid<NUMBER> included study anonymous blood donor sera healthy adults n <NUMBER> <NUMBER> serum samples babies <NUMBER> months collected <NUMBER> uppsala academic hospital used negative controls clinical samples deposited uppsala biobank anonymized used accordance local ethical guidelines used informed consent according swedish biobank law allows anonymized diagnostic patient samples used purposes similar original sampling <NUMBER> samples covid<NUMBER> confirmed individuals well <NUMBER> negative controls <NUMBER> healthy volunteers unique individuals samples analyzed anonymously test run according manufacturers instructions covid<NUMBER> iggigm rapid test cassette whole bloodserumplasma product model gccov<NUMBER>a lot <NUMBER> zhejiang orient gene biotech co ltd huzhou zhejiang china <NUMBER> briefly <NUMBER> µl serum one drop capillary blood added test slide followed <NUMBER> µl buffer provided kit results read <NUMBER> min max <NUMBER> min naked eye tests control line changed color regarded valid <NUMBER> <NUMBER> <NUMBER> cassettes function line observed igm andor igg test considered positive intensity color judged none <NUMBER> negative sera healthy blood donors tested igm positive assay one tested igg positive <NUMBER> <NUMBER> <NUMBER> confidence level <NUMBER> tables <NUMBER> <NUMBER> single iggpositive sample reanalyzed remained igg positive second test none <NUMBER> serum samples <NUMBER> months old babies tested positive either igm igg none <NUMBER> healthy volunteers without known history sarscov<NUMBER> infectioncovid<NUMBER> tested positive igm igg altogether <NUMBER> <NUMBER> <NUMBER> samples pcrconfirmed covid<NUMBER> patients tested igm positive <NUMBER> tested <NUMBER> igg positive tables <NUMBER> <NUMBER> patients grouped two groups depending time onset disease testing seven ten patients first group <NUMBER> days <NUMBER> patients second group <NUMBER> days tested igm positive nine ten patients first group <NUMBER> days <NUMBER> patients second group <NUMBER> days tested igg positive figure <NUMBER> statistical difference two groups neither igm igg seropositivity samples igm positive also igg positive assay sensitivity specificity accuracy based results described summarized tables <NUMBER> <NUMBER> assay showed sensitivity <NUMBER> <NUMBER> <NUMBER> <NUMBER> igm igg respectively assay showed overall specificity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> false positive igm igg respectively using pcrpositive cases true positives accuracy test <NUMBER> <NUMBER> <NUMBER> <NUMBER> igm igg respectively positive negative predictive values likelihood case given positive test result likelihood healthy given negative test result igm <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively study evaluated commercial rapid test detection sarscov<NUMBER>specific igm igg evaluation samples covid<NUMBER> cases obtained disease convalescence previously confirmed pcr used true positives means pcrpositive cases antibodies may yet time develop potential cases immune defects possible negative igm igg results fact true negatives case one included patients actual sensitivities higher ie evaluated samples known contain detectable levels sarscov<NUMBER>specific igm andor igg optimal evaluation assay sensitivity gold standard sarscov <NUMBER>specific antibodies would needed however unfortunately available date according manufacturer specificity evaluated <NUMBER> pcrnegative samples found <NUMBER> igm igg sensitivity evaluated covid<NUMBER> cases calculated <NUMBER> igm <NUMBER> igg results li et al <NUMBER> indicated overall testing sensitivity <NUMBER> <NUMBER> specificity results showed lower sensitivity igm similar sensitivity igg specificities results two evaluations recent study three chinese covid<NUMBER> cases found seroconversions occurred <NUMBER> <NUMBER> days onset symptoms <NUMBER> however larger studies detailed kinetics antibody responses eg iga igm igg neutralizing antibodies urgently needed better understanding dynamics immune response covid<NUMBER> results study showed detectable igm igg patients day <NUMBER> patients seroconversion seems occur later impact early late seroconversion case severity known must explored interestingly igm positives igg positive generally igm produced first later switch towards igg production <NUMBER> studies sarscov suggest igm igg often develop around time <NUMBER> <NUMBER> results line figure <NUMBER> detailed studies longterm sequential samples patients needed may worth looking whether problem test constant finding within immune response sarscov<NUMBER> false igm positive samples indicating high specificity test one false positive igg result observed one healthy adult blood donor sample retested result consistent indicating crossreaction another coronavirus serological crossreactions earlier observed sarscov sarscov<NUMBER> <NUMBER> human coronaviruses nl<NUMBER> oc<NUMBER> <NUMBER>e hku<NUMBER> globally endemic epidemic <NUMBER> may possible reaction represented crossreaction due previous infection one human cov nl<NUMBER> shown use receptor angiotensinconverting enzyme <NUMBER> ace<NUMBER> sarscov sarscov<NUMBER> <NUMBER> may indicate potential crossreactive epitopes common covs causative agents common colds known detail estimates <NUMBER> cases could caused covs <NUMBER> specificity sensitivity igg detection rapid test evaluated well line recently reported enzymelinked immunosorbent assay elisa specificity sensitivity <NUMBER> <NUMBER> study showed satisfactory performance rapid test limited compared clinical cases pcrpositivity next step necessary compare assay serological tests contrast li et al <NUMBER> found less indications using test clinical diagnosis nevertheless might contribute detecting potential asymptomatic infections well getting notion magnitude spread different geographical areas might key taking appropriate decisions policies forward high negative predictive value indicates rapid test useful detecting past infections possible immunity may crucial restoring social functions lockdown diseases infectious disease clinic uppsala university hospital janina krambrich phd student department medical biochemistry microbiology uppsala university sweden doctoral studies concern molecular epidemiology overwintering strategies japanese encephalitis virus bengt rönnberg phd working researcher laboratory clinical microbiology uppsala university hospital zoonosis science center uppsala university main research focus development diagnostic assays studies zoonotic viruses dario akaberi phd student department medical biochemistry microbiology uppsala university sweden doctoral studies mainly concern research antivirals flaviand coronaviruses mouna esmaeilzadeh md phd medical doctor neuroscientist karolinska institutet sweden one founders scilife clinic <NUMBER> pioneering medical clinic within preventive personalized medicine using technologies magnetic resonance imaging genetic sequencing map prevent diseases addition md phd masters degree philosophy university oslo stockholm university erik salaneck associate professor infectious diseases department medical sciences uppsala university responsible physician high consequence infectious diseases infectious diseases clinic uppsala university hospital johanna lindahl veterinary epidemiologist working zoonosis science centre uppsala university affiliations international livestock research institute ilri nairobi kenya swedish university agricultural sciences johanna graduated swedish university agricultural sciences phd working japanese encephalitis virus vietnam since phd focusing research food safety vectorborne zoonotic emerging infectious diseases developing countries mainly east africa south southeast asia åke lundkvist phd professor virology one founders zoonosis science center uppsala university work focuses basic virological pathogenetic ecological epidemiological studies zoonotic viruses vectors hosts new virus able spread person person infecting contacts easily sustained efficient way called pandemic novel coronavirus <NUMBER>ncov fulfills definitions strongly end year <NUMBER> wuhan city china cradled first case novel coronavirus europe america deadly effects threaten whole world named <NUMBER>ncov epidemic disease february <NUMBER> <NUMBER> coronavirus disease <NUMBER>ncov new member severe acute respiratory syndrome coronavirus family sarscov labeled sarscov<NUMBER> <NUMBER> spike surface binding receptors see figure <NUMBER> sarscov<NUMBER> presents covid<NUMBER> symptoms fever sore throat following pneumonia severe acute respiratory distress <NUMBER> respiratory symptoms specific form many isolated cases ie existence covid<NUMBER> may appear first clinical symptoms <NUMBER> rapid spreading nature coronavirus serious respiratory effects humans make diagnosis covid<NUMBER> urgent situation <NUMBER> today health specialists use reverse transcription polymerase chain reaction rtpcr test detection nucleic acid forms stem sarscov<NUMBER> process respiratory specimens oropharyngeal swabs nasopharyngeal sampling collected important issue receipt place specimens operation categorically open malfunctions expert mistakes <NUMBER> besides operation procedure pcr test timeconsuming process patient isolated nonsuitable circumstances hours getting test results addition types tests low detection rate <NUMBER> <NUMBER> hence times need repeated make confirmation <NUMBER> figure <NUMBER> threedimensional medical image representing shape coronavirus <NUMBER> able procure atmosphere patients could get quick treatment care crucial task fight covid<NUMBER> fastspreading essence pandemic patients apply health center batches point need rapid diagnosis methods important issue monitoring sarscov<NUMBER> infections diagnose another option visualization using radiological images instance chest xrays computed tomography ct former studies prove covid<NUMBER> causes abnormalities visible chest xrays ct images form groundglass opacities strong suggestion diagnostic radiological images could first step monitoring covid<NUMBER> <NUMBER> although radiological images based diagnostic faster way also advances pcr testing terms detection rate earlier stages covid<NUMBER> backbone system need experts comprehending images intrinsically artificial intelligence ai based diagnostic options encourage experts gain rapid accurate explication xray images way detection covid<NUMBER> <NUMBER> motivation several studies literature including analysis conducted aibased diagnostic covid<NUMBER> help radiological images <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> authors propose transfer learning model processes dataset including ct images covid<NUMBER> infected patients obtain test accuracy <NUMBER> study <NUMBER> indicates threeclass model distinguish covid<NUMBER> influenzaa viralbased pneumonia healthy cases segmentationbased study reaches <NUMBER> accuracy value ct images dataset <NUMBER> authors propose rapid ai development cycle using deep learningbased ct image analysis heretofore mentioned studies literature use nonpublic datasets developing deep learningbased diagnostic covid<NUMBER> studies <NUMBER> <NUMBER> provides public datasets including covid<NUMBER> xray images infected patients <NUMBER> authors propose combined public dataset besides deep learning model called covidnet detection covid<NUMBER> covidnet architecture relies tailored convolutional neural network cnn model uses chest xrays inputs authors reach test accuracy <NUMBER> restricted covid<NUMBER> class images study use dataset <NUMBER> able outperform existing covidnet accuracy detecting covid<NUMBER> addition several studies consider covid<NUMBER> detection using chest xrays <NUMBER> <NUMBER> <NUMBER> <NUMBER> detailed preprocessed dataset study captures flag specially designed deep learning model usage deep learning models medical image processing analysis challenging topic ai field <NUMBER> <NUMBER> <NUMBER> authors propose cnn model pneumonia detection authors study <NUMBER> propose vessel extraction fundus images <NUMBER> expert system proposed brain tumor detection highresolution brain magnetic resonance images end study use specially designed deep learning model called squeezenet first proposed <NUMBER> proposed deep learning model diagnostic covid<NUMBER> based squeezenet architecture smaller structure compared wellknown pretrained network designs <NUMBER> <NUMBER> study introduce covid<NUMBER> detection ai model covidiagnosisnet based deep squeezenet bayes optimization view obtain higher accuracy rate hyperparameter optimization deep learning models crucial task <NUMBER> backbone proposed model ie dataset public dataset detailed <NUMBER> differently study <NUMBER> perform multiscale augmentation process overcome imbalance problem proposed public dataset since focus covid<NUMBER> diagnosis perform detailed offline augmentation process limited number covid<NUMBER> infected chest xrays patients help offline welldefined augmentation process bayessqueezenet proposed diagnostic model covid<NUMBER> outperforms covidnet <NUMBER> reaching test accuracy <NUMBER> building model first perform detailed augmentation obtaining augmented dataset data split generated shuffled database form train validation test datasets manage training process deep squeezenet performing bayes optimization validation phase time training best model determined final network design tested separate test dataset package developments proposed deep bayes squeezenet obtains higher detection rate diagnosis covid<NUMBER> using chest xray images herein describe contributions proposed model listed <NUMBER> presents novel model rapid diagnostic covid<NUMBER> based deep bayessqueezenet called covidiagnosisnet <NUMBER> overcomes imbalance problem public dataset multiscale offline augmentation performed <NUMBER> proposes easy implement deep learning network embedded mobile systems could aid health experts stable diagnosis covid<NUMBER> control current epidemic composition rest article follows section <NUMBER> describes materials methods details proposed deep bayessqueezenet along model components ie squeezenet architecture bayesian optimization dataset description section <NUMBER> presents explanation design experiments evaluation criteria findings comparison subsection draw big picture study stands among stateoftheart methods finally section <NUMBER> briefs conclusion study cnn models achieve humanlike accuracies image classification problems due selflearning abilities superior classification results multiclass problems convolution network occurs chain convolution layer conv rectified linear unit relu activation functions pooling layers pool batch normalization operation cnns coordinated versions multilayer perceptrons neuron layer related neurons next layer layers convolute inputs kernels filters convolutions increase across whole visual field processes compose complex patterns using smaller simpler patterns depending hierarchical patterns therefore hierarchical network structure provides highlevel feature maps reduced computation complexity improved generalization ability <NUMBER> <NUMBER> <NUMBER> considering types characteristics bayesian optimization based deep squeezenet architecture diagnostic covid<NUMBER> disease xray images proposed paper main purpose framework provide distinctive visual properties well rapid diagnostic system able classify properties new covid<NUMBER> xray images method may also helpful clinicians may quickly decided treatment plan use depending type infection following sections describe proposed method deep squeezenet architecture bayesian optimization dataset description offline augmentation techniques detail overall architecture deep bayessqueezenet based rapid diagnostic system presented first stage offline augmentation method utilized raw input xray images due uneven sample distributions method preferred smaller classes fewer sample numbers order increase size classes transformation factor augmentation augmented dataset divided three subsets train validation test sets train validation sets set input training optimization stage test set used testing input training optimization stage squeezenet convolution network utilized uses squeeze expands layers fire modules construct smaller effective cnn architecture squeezenet pretrained cnn model pretrained ilsvrc<NUMBER> challenge imagenet dataset <NUMBER> <NUMBER> supporting dataset completely different xray images squeezenet model needs finetuned classify covidx classes order obtain best decisionmaking model cnn network optimized bayesianbased method sequential design strategy training validation error used update optimization process finally best squeezenet model obtained used decisionmaking process test set obtained best network model classifies infection classes classification performances determined squeezenet convolution network executes better performance alexnet <NUMBER>x fewer parameters <NUMBER> <NUMBER> <NUMBER> squeezenet consists fifteen layers five different layers two convolution layers three max pooling layers eight fire layers one global average pooling layer one output layer softmax architecture network given figure <NUMBER> dimensions rgb channels input images generalized convolution max pooling applied convolution layer convolutes weights small regions input volumes <NUMBER>×<NUMBER> kernels convolution layer performs elementwise activation function positive part argument squeezenet utilizes fire layers constructed squeeze expansion phases convolution layers output tensor scale input fire consistent squeeze phase uses filter size <NUMBER>×<NUMBER> whereas expansion uses filters size <NUMBER>×<NUMBER> <NUMBER>×<NUMBER> firstly input tensor h×w×c passes squeeze number convolution equal c<NUMBER> number input tensor channels first phase data passes expansions depth data expanded c<NUMBER> output tensor depth squeeze expansion phases connected relu units squeeze operation compresses depth expansion increases depth keeping feature size finally expansion outputs stacked depth dimension input tensor concatenate operation figure <NUMBER> summarizes fire layer suboperations assuming fm c define feature maps channels output layer fy squeeze operation kernel w expressed <NUMBER> squeeze outputs defined weighted combination table <NUMBER> presents detailed layer configuration squeezenet architecture motivation designing squeezenet architecture covid<NUMBER> diagnosis network provides three main advantages <NUMBER> <NUMBER> <NUMBER> network efficient fewer parameters <NUMBER> applications developed network easy move require less communication <NUMBER> model size less <NUMBER> mb easy implement embedded systems hyperparameters key role machine learning deep learning algorithms inasmuch parameters tightly managing acts training algorithms affect performance models significantly therefore optimization hyperparameters crucial task especially comes deep learning medical image processing general exist two ways hyperparameters optimization called manual automatic searching manual searching name suggests looks hyperparameters hand hence manual searching requires expertise unfortunately dealing big data many model parameters tuning even expertise may insufficient <NUMBER> <NUMBER> handle difficulties manually searching automatic searching alternatives take place literature grid search random search algorithms considered topic nevertheless still problems remaining methods curse dimensionality unavailability highly efficient performance timeconsuming operations <NUMBER> <NUMBER> tuning hyperparameters optimization problem objective function latent unknown words blackbox function name suggests stemming bayesian theorem bayesian optimization efficient algorithm dealing kind optimization problem <NUMBER> <NUMBER> bayesian optimization relies typical kind approximation dealing unknown function requires approximation help known samples ie prior knowledge like concept posteriori probability food algorithm observations generated model evaluations outputs online learning means bayesian optimization need training process training model trace function knowledge learned data center bayesian optimization algorithm main purpose obtain related hyperparameters make learning outline maximum <NUMBER> mathematical expression consider global maximization minimization problem black box unknown function stands searching space caused nature bayes theorem <NUMBER> bayesian optimization calculates posteriori probability model aid learned data posteriori probability proportional likelihood observations multiplication prior probability <NUMBER> reflects main behavior bayesian optimization <NUMBER> brief bayesian optimization searches best model amid many point one recall crossvalidation method however hard find best model many samples prelisted hundreds alternatives thus bayesian optimization accelerates operation reducing computational cost need expertise guess outputs though <NUMBER> flow clarify two basic parts algorithm <NUMBER> updates posterior distribution <NUMBER> maximizes acquisition function bayesian optimization process continues repeatedly defined maximum iteration value reached alternatively also quitted catches threshold value difference actual value obtained optimal value <NUMBER> <NUMBER> declared general detection method covid<NUMBER> disease rtpcr testing identifies sarscov<NUMBER> rna sputum nasopharyngeal swab however rtpcr testing long time complex process troublesome <NUMBER> another detection method chest radiography imaging due abnormalities chest xray images patients infected covid<NUMBER> <NUMBER> <NUMBER> therefore selected distinctive public dataset including chest xray images respond need rapid disease diagnosis system <NUMBER> order compose special covid<NUMBER> dataset two different publicly available datasets combined covid chest xray dataset <NUMBER> kaggle chest xray pneumonia dataset <NUMBER> obtained covidx dataset <NUMBER> consists main purpose selection covidx dataset public available accessible researchers extensible therefore studies based database may helpful diagnosis treatment covid<NUMBER> cases classification process classical machine learning deep learning algorithms imbalance ratio class distribution dataset huge impact performances models study <NUMBER> order evaluate quantitative performance proposed method evaluation metrics accuracy acc correctness cor completeness com specificity spe f<NUMBER> score matthew correlation coefficient mcc statistically computed confusion matrix acc measures classification performance cor gives rate truly classified xray images among classes com defines truly detected negative images spe represents correctly classified rate opposite disease classes f<NUMBER> harmonic average gives combination cor com mcc measures quality classification performance according confusion matrix selected evaluation metrics defined define number correctly classified diseases number correctly classified opposite classes number incorrectly classified diseases number misclassified diseases respectively classification procedure proves determines robustness effectiveness generalization ability proposed method using aforementioned evaluation metrics experimental setup firstly perform offline augmentation raw covidx dataset preprocessing augmented dataset divided three packages training validation testing sets triple split dataset packages formed <NUMBER> training <NUMBER> validation <NUMBER> testing training validation datasets designed bayesian optimizationbased online learning structure bayesian contribution model needs validation result minimize objective function error bayesian optimizationbased online training process reach best network model implement testing phase separate test dataset obtained best model evaluated input images resized <NUMBER>×<NUMBER> pixel size transformed rgb <NUMBER>bit depth meantime dataset packages shuffled overcome negative effect overfitting thus reach robust decisionmaking performance classification infected patient cases training process minibatch size given <NUMBER> images normalized mean subtracting operation proposed deep bayessqueezenet includes bayesian optimization training stage validation process objective function optimization process given figure <NUMBER> seen function evaluation ends <NUMBER> iterations model saturation end <NUMBER> th iteration minimum observed objective achieved construct best model optimized parameters ie initial learning rate initiallearnrate momentum l<NUMBER> regularization listed table <NUMBER> along iterations model result run time observedestimation values objective function optimization process clearly seen catching five different best models bayesian optimization points model <NUMBER>th iteration selected best model training process obtained best model parameters used proposed deep bayessqueezenet network highlighted table <NUMBER> order evaluate effectiveness augmentation improvement first present raw dataset results aim prove negative effect imbalance distributions raw dataset performance noted tune squeezenet best model parameters regular training process retraining testing processes performed train test packages related dataset please see table <NUMBER> figure <NUMBER> demonstrates confusion matrix test process retrained squeezenet confusion matrix presentation accuracies errors row columns given percentage value lower right cells respectively accuracy rates column show us correctness value class accuracy values row state single accuracy values classes shown figure <NUMBER> false classification rate appears majorly within normal pneumonia pneumonia class achieves nearly perfect classification whereas covid class <NUMBER> accuracy within <NUMBER> table <NUMBER> second phase experiments performing augmented dataset testing process phase proposed deep bayessqueezenet model obtained bayesian optimization approach validated separate test dataset noted obtained best model trained augmented dataset overcome abovementioned imbalance effects well achieving rapid system covid<NUMBER> diagnosis robust sustainable structure figure <NUMBER> presents confusion matrix test phase order analyze performance comparison experiments raw dataset augmented one report increase rates performance values figure <NUMBER> sharp bounce experienced normal class boosting <NUMBER> times focus model concentrate performance covid detect <NUMBER> times boosting pneumonia class decreasing percentage <NUMBER> considering accuracy value overall accuracy rate also performance increasing rate <NUMBER> overall accuracy rate also performance increase rate <NUMBER> activation mapping also defines bias regions training images first column figure <NUMBER> defines original input images second column includes heat map images predicted samples class activation mappings examined figure <NUMBER> proposed deep bayessqueezenet low model size easy implement hardware deployments shown table <NUMBER> model size proposed network less <NUMBER> times lower compared alexnet inspiration squeezenet architecture overall experimental results show proposed model significant robust performance value covid<NUMBER> patient cases study proposes complete compact solution using chest xray images rapid diagnosis figure <NUMBER> class activation mapping visualization proposed deep bayessqueezenet sample images covid b normal c pneumonia misclassified prediction coronavirus disease <NUMBER> announced outbreak february <NUMBER> <NUMBER> <NUMBER> due covid<NUMBER> outbreak early diagnosis disease become key topic clinicians radiologists world ai techniques regarding image classification approaches help early diagnose disease considering ai cnn methods achieve better faster results compared traditional diagnosis methods paper rapid robust efficient covid<NUMBER> diagnosis method namely deep bayessqueezenet proposed proposed method performs xray images multiclass normal pneumonia covid order evaluate proposed cnn model general performance comparison study stateofart methods given section model evaluations related studies depend multiclass classification chest xray images various ai techniques table <NUMBER> shows comparison results related studies uses similar datasets amid performance metrics table <NUMBER> gives model outperforms similar studies use chest xrays diagnosis covid<NUMBER> although seems performance values achieved study <NUMBER> whole performance proposed method study better table <NUMBER> performance values listed studies given terms covid<NUMBER> class accuracy chowdhury et al <NUMBER> overall accuracy study covid<NUMBER> class accuracy stays behind proposed method farooq hafeez <NUMBER> obtain accuracy covid<NUMBER> class study outperforms overall accuracy addition test dataset study includes eight samples covid<NUMBER> best knowledge proposed model reveals excellent classification performance covid<NUMBER> diagnosis chest xrays proposed model great advantage owning practical network architecture robust stable operation nature including fewer parameters network favorable embedded systems among existing deep learning models rapid diagnosis method key role control infectious diseases pandemic situations like date covid<NUMBER> limitations rtpcr nucleic acidbased test modules reveal need fast alternative methods able serve frontline experts make reach quick accurate diagnosis study propose aibased decisionmaking system including recognition input xray images roof practical deep learning model study important attempt including easy implement deep learning model accuracy performance <NUMBER> among normal pneumonia covid cases <NUMBER> single recognition covid<NUMBER> among classes difficult days global covid<NUMBER> pandemic model strong potential build tool design covid<NUMBER> monitoring would like note rtpcr test method detect sarscov<NUMBER> still important however proved also undeniable shortcomings along rtpcr test method listed follows <NUMBER> possible methodology lacks <NUMBER> strict dependence level disease timing <NUMBER> possibility collecting specimens mistaken localizations <NUMBER> response time delay <NUMBER> <NUMBER> model working deep learningbased practical structure early stage detections covid<NUMBER> cases could done manage control pandemic disease medical image processing deep learning methods preferred many areas becoming important especially interpretation radiological images model extremely satisfactory even initial results opens door implementation comprehensive product work mobile appeal enduser backbone model deep bayessqueezenet decisionmaking system covid<NUMBER> diagnosis xray images squeezenet much less model size stateoftheart deep learning model inspired wellknown alexnet practical structure generalization performance squeezenet preferable embedded applications improve squeezenet structure bayes optimization algorithm build robust sustainable learning model bayesian optimization helps us build bestperformed model validation dataset diagnosis system trained using public dataset proposed <NUMBER> augmented form separate test independent train validation sets performs experiments experimental results also present performance boosting augmentation contribution dataset preprocessing thus model training performed rich image set xrays covid<NUMBER> comprehensive literature research date studies use similar public datasets detected evaluate model proposed diagnosis model covid<NUMBER> using xray images deep bayessqueezenet outperforms competitors believe increased training dataset expected get higher results works aim plan model able work mobile appealing health care experts diagnosis covid<NUMBER> addition possibility presenting diagnostic system solution medical image processing cases also explored since severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> first emerged wuhan china <NUMBER> december <NUMBER> spread quickly across world developed pandemic <NUMBER> <NUMBER> <NUMBER> world health organization announced new name disease coronavirus disease covid<NUMBER> <NUMBER> march <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> cases confirmed <NUMBER> countries regions date rapid spread sarscov<NUMBER> caused considerable harm public health economy <NUMBER> <NUMBER> clinical manifestations covid<NUMBER> include fever dry cough fatigue approximately half infected patients developed severe pneumonia nearly onethird patients develop acute respiratory distress syndrome <NUMBER> <NUMBER> <NUMBER> however currently specific treatment covid<NUMBER> due obstacle collecting highquality throat swab samples different stages infection nucleic acid test sarscov<NUMBER> showed high false negative rate difficult identify quarantine infected individuals effectively break spread chain curb infection therefore urgent need develop sensitive diagnostic method rapidly identify sarscov<NUMBER> infected patients high accuracy jiajia xie chengchao ding contributed equally work currently viral nucleic acid realtime polymerase chain reaction rtpcr test based patient nasopharyngeal throat swabs standard method clinical diagnosis covid<NUMBER> despite crucial role identifying sarscov<NUMBER> infection patients start epidemic limitations method soon became obvious example one recent study demonstrated rtpcr showed positive test rate <NUMBER> total <NUMBER> specimens significant number false negative cases <NUMBER> accepted igm early immunoglobulin response virus invasion igg highest opsonization neutralization activities humoral immune response previous studies reported igmigg seroconversion start early <NUMBER> days onset sars infection <NUMBER> patients admitted hospital due fever respiratory symptoms nasopharyngeal throat swabs used respiratory pathogen testing serum levels igmigg antibodies targeting sarscov<NUMBER> tested upon patient admission medical history clinical symptoms appeared asked time interval clinical symptoms antibody testing recorded detail physical findings hematological biochemical results also collected patients enrolled study diagnosed according <NUMBER>th edition guideline diagnosis treatment covid<NUMBER> established chinas national health commission including patients epidemic history clinical characteristics chest computed tomographic ct scan laboratory findings patients covid<NUMBER> severe illness defined one following criteria respiratory distress respiratory frequency rp equal <NUMBER>min b pulse oximeter oxygen saturation less equal <NUMBER> rest c oxygenation index arterial partial pressure oxygeninspired oxygen fraction pao <NUMBER> fio <NUMBER> less equal <NUMBER> mm hg clinical characteristics compared severe nonsevere cases study approved ethics committee first affiliated hospital ustc retrospective observational study informed consent obtained presence sarscov<NUMBER> detected using rtpcr viral rna extracted nasopharyngeal throat swabs using antihuman igg igm assays purchased yhlo biological technology co ltd shenzhen china patients igg igm antibodies sarscov<NUMBER> envelope e protein nucleocapsid n protein serum samples measured using chemiluminescence immunoassay cutoff value positive result <NUMBER> samples values greater equal <NUMBER> auml considered positive sarscov<NUMBER> infection categorical variables presented numbers continuous measurements medians interquartile range iqr antibody concentration reported geometric mean sd continuous variables analyzed using mannwhitney test unpaired test correlation igm igg quantitative detection hematological profiles analyzed using pearson correlation graphpad prism <NUMBER> used statistical analyses twosided α value less <NUMBER> considered statistically significant igmigg antibody levels nucleic acid test results summarized table <NUMBER> interestingly differences laboratory findings groups severe nonsevere covid<NUMBER> symptoms included higher neutrophil counts neutrophil percentage neu fibrinogen level lower lymphocyte counts lymphocyte percentages lym p <NUMBER> figure <NUMBER> median ddimer level increased group severe symptoms difference significant procalcitonin hypersensitive creactive protein levels normal range majority patients table <NUMBER> statistical analysis performed using mannwhitney test p values indicate differences severe nonsevere patients p <NUMBER> considered statistically significant abbreviation covid<NUMBER> coronavirus disease p <NUMBER> p <NUMBER> p <NUMBER> p <NUMBER> table <NUMBER> figure <NUMBER>d study analyzed clinical features immunological characteristics <NUMBER> patients covid<NUMBER> despite negative nucleic acid test results patients showed high specific igg concentrations suggesting sarscov<NUMBER> infection <NUMBER> patients <NUMBER> developed severe illness required intensive care common symptoms fever cough chest tightness consistent previous studies <NUMBER> <NUMBER> <NUMBER> compared patients nonsevere symptoms patients severe illness group numerous laboratory abnormalities higher neutrophil counts neu fibrinogen levels lower lymphocyte counts lower lym igm lower igg higher patients severe symptoms addition weak correlation igm neu noted findings suggest patients severe illness group might experience longer virus exposure time develop severe inflammatory response currently nucleic acid test based individual nasopharyngeal throat swabs standard diagnostic method covid<NUMBER> although rtpcr method sensitive effective still suffers limitations laborintensive f g u r e <NUMBER> analysis igmigg findings severe nonsevere groups kinetic analysis igmigg antibodies severe nonsevere groups b differences total igm levels severe nonsevere groups c differences total igg levels severe nonsevere groups correlation igm neu patients severe group antibody concentration presented geometric mean sd analyzed using unpaired test correlation igmigg hematological profiles analyzed using pearson correlation statistical analyses performed using graphpad prism <NUMBER> p <NUMBER> p <NUMBER> considered statistically significant neu neutrophil percentage sd standard deviation <NUMBER> january <NUMBER> world health organization declared sarscov<NUMBER> global public health emergency <NUMBER> covid<NUMBER> originated wuhan province china led bans travel public gatherings negatively impacted world economy <NUMBER> <NUMBER> covid<NUMBER> characterized high morbidity low mortality therefore representing great threat particularly immunocompromised elderly people individuals preexisting health problems data far suggest virus case fatality rate around <NUMBER> <NUMBER> thus several times severe typical seasonal influenza severity falling somewhere <NUMBER> <NUMBER> <NUMBER> <NUMBER> influenza pandemics <NUMBER> appears lower sars <NUMBER> middle east respiratory syndrome <NUMBER> <NUMBER> addition average person infected covid<NUMBER> spreads disease efficiently two three others exponential rate increase also strong evidence virus transmitted infected individuals asymptomatic experiencing mild symptoms <NUMBER> turns complicates containment disease control measures compared diseases caused coronaviruses like middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov thus far covid<NUMBER> caused approximately ten times many cases sarscov quarter time <NUMBER> unlike merscov camel intermediate carrier sarscov civet cat intermediate carrier source covid<NUMBER> remains unknown according <NUMBER> <NUMBER> recent studies suggested intermediate carriers could snakes <NUMBER> pangolins <NUMBER> bats speculated reservoir host <NUMBER> median incubation period covid<NUMBER> four days range <NUMBER> days longest incubation period observed <NUMBER> days <NUMBER> particularly covid<NUMBER> infected individuals develop obvious clinical symptoms <NUMBER> <NUMBER> long incubation period asymptomatic infections imply huge risk community transmission sarscov<NUMBER> <NUMBER> <NUMBER> rapid point care tests required detect virus suspected cases community clinics hospitals possibly househouse testing among measures stopping spread covid<NUMBER> availability reliable aggressive testing presently samples collected suspected cases presenting community clinics hospitals processed centralized clinical laboratory expensive pcr equipment technical expertise available turnaround time results <NUMBER> h delays turnaround time could lead anxiety continued spread virus since selfisolation absolutely assured testing standard realtime rtpcr centralized clinical laboratory <NUMBER> however point care covid<NUMBER> test help reduce anxiety eliminate prolonged turnaround time reduce spread virus point care device rapid robust costeffective used onsite field necessarily require trained personnel operate <NUMBER> crucial urgently needed detection sarscov<NUMBER> importance testing reduce spread outbreak like covid<NUMBER> shown dramatically control infectious diseases <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> turns complicates containment disease control measures compared diseases caused coronaviruses like middle east respiratory syndrome merscov severe acute respiratory syndrome sarscov thus far covid<NUMBER> caused approximately ten times many cases sarscov quarter time <NUMBER> unlike merscov camel intermediate carrier sarscov civet cat intermediate carrier source covid<NUMBER> remains unknown according <NUMBER> <NUMBER> recent studies suggested intermediate carriers could snakes <NUMBER> pangolins <NUMBER> bats speculated reservoir host <NUMBER> median incubation period covid<NUMBER> four days range <NUMBER> days longest incubation period observed <NUMBER> days <NUMBER> particularly covid<NUMBER> infected individuals develop obvious clinical symptoms <NUMBER> <NUMBER> long incubation period asymptomatic infections imply huge risk community transmission sarscov<NUMBER> <NUMBER> <NUMBER> rapid point care tests required detect virus suspected cases community clinics hospitals possibly househouse testing among measures stopping spread covid<NUMBER> availability reliable aggressive testing presently samples collected suspected cases presenting community clinics hospitals processed centralized clinical laboratory expensive pcr equipment technical expertise available turnaround time results <NUMBER> h delays turnaround time could lead anxiety continued spread virus since selfisolation absolutely assured testing standard realtime rtpcr centralized clinical laboratory <NUMBER> however point care covid<NUMBER> test help reduce anxiety eliminate prolonged turnaround time reduce spread virus point care device rapid robust costeffective used onsite field necessarily require trained personnel operate <NUMBER> crucial urgently needed detection sarscov<NUMBER> importance testing reduce spread outbreak like covid<NUMBER> shown dramatically control infectious diseases <NUMBER> <NUMBER> <NUMBER> figure <NUMBER> importance rapid testing infectious diseases controlling outbreak yaxis represents number cases xaxis indicates period detection response red color represents number cases without intervention like testing yellow color drop cases due intervention drastically reducing response rate unlike graph left hand side <NUMBER> since outbreak covid<NUMBER> regulatory bodies like us food drug administration fda fasttracked covid<NUMBER> diagnostics including isothermal amplification technology platform like nicking enzymeassisted reaction near emergency use authorization led increased uptake covid<NUMBER> diagnostics commercial companies research institutions inhouse development tests clinical laboratories tests largely based pcr technology however technology completely amenable onsite field conditions addition introduction rapid immunoassay coupled lateral flow strip point care test developed test detect either sarscov<NUMBER> antigens antibodies like igm igg developed virus testing method advantage absolutely reducing turnaround figure <NUMBER> importance rapid testing infectious diseases controlling outbreak yaxis represents number cases xaxis indicates period detection response red color represents number cases without intervention like testing yellow color drop cases due intervention drastically reducing response rate unlike graph left hand side <NUMBER> since outbreak covid<NUMBER> regulatory bodies like us food drug administration fda fasttracked covid<NUMBER> diagnostics including isothermal amplification technology platform like nicking enzymeassisted reaction near emergency use authorization led increased uptake covid<NUMBER> diagnostics commercial companies research institutions inhouse development tests clinical laboratories tests largely based pcr technology however technology completely amenable onsite field conditions addition introduction rapid immunoassay coupled lateral flow strip point care test developed test detect either sarscov<NUMBER> antigens antibodies like igm igg developed virus testing method advantage absolutely reducing turnaround time less <NUMBER> min highly cost effective likely less sensitive specific based experience influenza viruses rapid immunoassay <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> alternative comparable technology pcr required enable timely detection sarscov<NUMBER> technology also comparable rapid immunoassay regarding providing point care testing less <NUMBER> min cost effective review provides brief description common isothermal technologies loopmediated amplification recombinase polymerase amplification could potentially deployed point care tests community clinics hospitals technologies proven potential replace pcr especially resource limited settings characterized inadequate expertise infrastructure pcr setup limited publications application isothermal technologies testing covid<NUMBER> studies demonstrated comparability pcr iat amplification nucleic acids constant temperature require thermocycling like pcr different strategies achieving amplified products table <NUMBER> demonstrated point care testing already reviewed extensively <NUMBER> technologies identified game changer <NUMBER> improve turnaround time results ease use diagnostic tools covid<NUMBER> new molecular diagnostic tools using iat developed used point care unlike pcr need performed skilled personnel central laboratory iat requires little training performed community clinics hospitals means frontline workers like nurses medical doctors perform covid<NUMBER> test needed point care iat technologies offer high sensitivity specificity compared pcr <NUMBER> <NUMBER> <NUMBER> mainly due strand displacement enzymes commonly used technologies example loopmediated amplification lamp near uses bacillus stearothermophilus dna polymerase dna polymerase bacillus subtilis used recombinase polymerase amplification rpa polymerase activity noted improved sensitivity efficiency additionally use iat less expensive comparable pcrbased test example estimates affordability less usd <NUMBER> per test less usd <NUMBER> per piece equipment <NUMBER> <NUMBER> <NUMBER> several isothermal technologies commercialized used diagnosis human infectious diseases including malaria tuberculosis viral hepatitis chlamydia gonorrhea <NUMBER> using lamp rpa strand displacement amplification helicase displacement amplification among platforms loopmediated amplification widely applied <NUMBER> peer reviewed publications reported utilized lamp detection human infectious diseases extensively reviewed <NUMBER> <NUMBER> <NUMBER> however uptake lamp diagnostic tool covid<NUMBER> slow particularly point care yet lamp rpa near recently emerged potential technologies could obviate need pcr used community clinics hospitals order identify symptomatic asymptomatic individuals potentially reducing spread covid<NUMBER> excitedly near recently approved emergency use authorization us fda detection sarscov<NUMBER> test referred id now™ covid<NUMBER> abbott laboratories illinois il usa lamp reaction mechanism simply involves nucleic acids unwinding amplification elongation approach described animation eiken chemical httploopamp eikencojpelampanimhtml really helpful understanding principle works essentially lamp uses bst dna polymerase stranddisplacement activity coupled two inner primers fip bip outer primers f<NUMBER> b<NUMBER> recognizes six separate regions dna template additional loop primers lf lb may added speed reaction binding amplifying newly formed loop amplicons reaction additional primers enhance sensitivity specificity reaction figure <NUMBER> lamp reactions incubated constant temperature ranging <NUMBER> • c time amplification positive lamp result less <NUMBER> min <NUMBER> lamp near also compatible detectionamplification rna templates directly bst <NUMBER> dna polymerase new england biolabs melbourne australia reverse transcriptase reaction <NUMBER> lamp positive reaction determined visually quantified based turbidity colorimetry fluorimetry insoluble byproduct magnesium pyrophosphate formed lamp reaction seen naked eye cloudiness figure <NUMBER>a <NUMBER> recently endpoint detection improved using calcein fluorescein complex fluoresces visible color change presence magnesium pyrophosphate figure <NUMBER>b <NUMBER> <NUMBER> nucleic acid intercalating dyes including sybr green added detect visible color change quantify loop amplicons formed detection system allows realtime monitoring reaction using isothermal equipment equipped fluorescence detectors commercial equipment optimized highly adaptable across wide range iat including near lamp rpa figure <NUMBER>c paucity literature application iat covid<NUMBER> diagnosis studies far showed onestep rtlamp test comparable rtqpcr lin yu et al <NUMBER> showed rtlamp test could detect synthesized rna equivalent <NUMBER> copies sarscov<NUMBER> virus clinical sensitivity <NUMBER> <NUMBER> samples validated rtqpcr test targeted orf<NUMBER>ab region virus could performed <NUMBER> min renfei lu et al <NUMBER> targeted rdrp gene showed limit detection <NUMBER> copies synthesized sarscov rna <NUMBER> sensitivity <NUMBER> determined rtqpcr <NUMBER> min addition test cross react <NUMBER> clinical samples positive respiratory viruses like enterovirus respiratory syncytial virus b groups parainfluenza viruses type <NUMBER> influenza ac human rhinovirus human metapneumovirus adenovirus bocavirus human coronavirus strains unlike studies laura lamb et al <NUMBER> detected <NUMBER> fg sarscov<NUMBER> fragments used simulated patient samples spiking saliva urine serum oropharyngeal nasopharyngeal swabs fragments synthetic sarscov<NUMBER> without extractions reaction test time less <NUMBER> min highly specific cross react mers betacoronavirus england<NUMBER> murine hepatitis virus spiked patient samples schematic representation loopmediated amplification reaction principle unlike pcr primer design lamp characterized four different primers specifically designed recognize six distinct regions target dna forward inner primer fip consists f<NUMBER> region <NUMBER>end f<NUMBER>c region <NUMBER>end f<NUMBER> primer forward outer primer consists f<NUMBER> region complementary f<NUMBER>c region template sequence backward inner primer bip made b<NUMBER> region <NUMBER>end b<NUMBER>c region <NUMBER>end b<NUMBER> primer backward outer primer consists b<NUMBER> region complementary b<NUMBER>c region template sequence regards lamp reaction amplification begins f<NUMBER> region fip anneals f<NUMBER>c region target dna initiates complementary strand synthesis f<NUMBER> primer anneals f<NUMBER>c region target extends displacing fip linked complementary strand displaced strand forms loop <NUMBER>end provides template bip b<NUMBER> anneals b<NUMBER>c region template dna synthesis initiated results formation complementary strand opening <NUMBER>end loop subsequently b<NUMBER> anneals b<NUMBER>c region target dna extends displacing bip linked complementary strand forms dumbbellshaped dna nucleotides added <NUMBER>end f<NUMBER> bst dna polymerase extends opens loop <NUMBER>end dumbbellshaped dna converted stemloop structure b initiates lamp cycling second stage lamp reaction amplicons formed mixture stemloop cauliflowerlike structures multiple loops <NUMBER> lamp positive reaction determined visually quantified based turbidity colorimetry fluorimetry insoluble byproduct magnesium pyrophosphate formed lamp reaction seen naked eye cloudiness figure <NUMBER>a <NUMBER> recently endpoint detection improved using calcein fluorescein complex fluoresces visible color change presence magnesium pyrophosphate figure <NUMBER>b <NUMBER> <NUMBER> nucleic acid intercalating dyes including sybr green added detect visible color change quantify loop amplicons formed detection system allows realtime monitoring reaction using isothermal equipment equipped fluorescence detectors commercial equipment optimized highly adaptable across wide range iat including near lamp rpa figure <NUMBER>c regards lamp reaction amplification begins f<NUMBER> region fip anneals f<NUMBER>c region target dna initiates complementary strand synthesis f<NUMBER> primer anneals f<NUMBER>c region target extends displacing fip linked complementary strand displaced strand forms loop <NUMBER>end provides template bip b<NUMBER> anneals b<NUMBER>c region template dna synthesis initiated results formation complementary strand opening <NUMBER>end loop subsequently b<NUMBER> anneals b<NUMBER>c region target dna extends displacing bip linked complementary strand forms dumbbellshaped dna nucleotides added <NUMBER>end f<NUMBER> bst dna polymerase extends opens loop <NUMBER>end dumbbellshaped dna converted stemloop structure b initiates lamp cycling second stage lamp reaction amplicons formed mixture stemloop cauliflowerlike structures multiple loops <NUMBER> amplification nucleic acids using rpa faster lamp <NUMBER> • c less <NUMBER> rpa employs recombinase proteins forms complex primers scan homologous sequences unwind double stranded template figure <NUMBER> <NUMBER> <NUMBER> amplified products either monitored real time sandwiched lateral flow strip two commonly used detection systems possible unique probes design except internal modifications figure <NUMBER> <NUMBER> usually test design diagnostic developer determines choice probe exo probe used realtime monitoring nfo suitable lateral flow strip recombinase proteins monitoring devices including lateral flow strips commercially available companies like twistdx cambridge uk hence developer needs design screen primers probe targets pathogen choice interestingly pcr primers could also adopted rpa assay development unlike lamp primers date study demonstrated using technology covid<NUMBER> diagnosis rpa deployed last ebola virus outbreak declared global public health epidemic <NUMBER> recombinase polymerase amplification schematic representation begins binding recombinase t<NUMBER> uvsy uvsx green diamonds orange circles respectively forward reverse primers forms complex search homologous sequences double stranded dna strand exchange reaction occurs homology found single strand binding proteins ssb t<NUMBER> gp<NUMBER> protein brown circles aligns unwound dna strand allowing dna polymerase bacillus subtilis pol bsu green circles initiate template amplification using two primers forming two double stranded dna repetition cycle leads exponential amplification near driven two enzymes nicking endonuclease dna polymerase reaction buffer deoxyribonucleotide triphosphate primers linear amplification dna template achieved amplification eventually leads exponential increase amplified products <NUMBER> coupled fluorometer briefly near reaction occurs <NUMBER> °c involves five steps dna template hybridized primers conjugated nicking endonucleases restriction site cleaving double stranded dna b <NUMBER>′ end primer dna polymerase extends nucleotides forming double stranded dna c nicking endonucleases identifies restriction site primers nicked one strands exposing <NUMBER>′end figure <NUMBER> recombinase polymerase amplification schematic representation begins binding recombinase t<NUMBER> uvsy uvsx green diamonds orange circles respectively forward reverse primers forms complex search homologous sequences double stranded dna strand exchange reaction occurs homology found single strand binding proteins ssb t<NUMBER> gp<NUMBER> protein brown circles aligns unwound dna strand allowing dna polymerase bacillus subtilis pol bsu green circles initiate template amplification using two primers forming two double stranded dna repetition cycle leads exponential amplification near driven two enzymes nicking endonuclease dna polymerase reaction buffer deoxyribonucleotide triphosphate primers linear amplification dna template achieved amplification eventually leads exponential increase amplified products <NUMBER> coupled fluorometer briefly near reaction occurs <NUMBER> • c involves five steps dna template hybridized primers conjugated nicking endonucleases restriction site cleaving double stranded dna b <NUMBER> end primer dna polymerase extends nucleotides forming double stranded dna c nicking endonucleases identifies restriction site primers nicked one strands exposing <NUMBER> end dna polymerase extends nicked site employing uncleaved strand template new double stranded dna displacing former strand another cycle dna synthesis restriction site recovered newly synthesized double stranded dna e steps continuously amplified targeted dna template via cleavage extension recovery figure <NUMBER> probe annealed double stranded dna <NUMBER>′ block dark blue prevents extension escherichia coli endonuclease iv nfo exonuclease iii exo recognizes cleaves tetrahydrofuran thf residue indicated arrow within probe detaching <NUMBER>′end block process helps integration amplified products bsu polymerase elongation <NUMBER>′end hydroxide regarding nfo amplification fluorophore labeled amplicons example fluorescein amidites biotin dyes detected visually using lateral flow strips sandwich format allows fluorophore bright orange captured antifluorophore conjugated gold nanoparticles also detect second label like biotin purple binding streptavidin detection line b regarding exo amplification fluorescent signals generated exonuclease iii exo pink cuts thf site like nfo separating fluorophore bright orange quencher red c lateral flow coupled rpa nfo reaction performed within broad range temperatures top positive test observed visibly <NUMBER> min bottom <NUMBER> exo fluorescent signals detected realtime device t<NUMBER>iso equipment twistdx cambridge uk probe annealed double stranded dna <NUMBER> block dark blue prevents extension escherichia coli endonuclease iv nfo exonuclease iii exo recognizes cleaves tetrahydrofuran thf residue indicated arrow within probe detaching <NUMBER> end block process helps integration amplified products bsu polymerase elongation <NUMBER> end hydroxide regarding nfo amplification fluorophore labeled amplicons example fluorescein amidites biotin dyes detected visually using lateral flow strips sandwich format allows fluorophore bright orange captured antifluorophore conjugated gold nanoparticles also detect second label like biotin purple binding streptavidin detection line b regarding exo amplification fluorescent signals generated exonuclease iii exo pink cuts thf site like nfo separating fluorophore bright orange quencher red c lateral flow coupled rpa nfo reaction performed within broad range temperatures top positive test observed visibly <NUMBER> min bottom <NUMBER> exo fluorescent signals detected realtime device t<NUMBER>iso equipment twistdx cambridge uk figure <NUMBER> schematic representation nicking enzymeassisted reaction unlike pcr primers near primers uniquely designed successful reaction primer three regions restriction site <NUMBER>′gagtcnnnn<NUMBER> example nt bstnbi stabilizing region targetbinding region complementary target nucleic acid strand first forward primer primer <NUMBER> anneals template <NUMBER> targetbinding region extended <NUMBER>′ end dna polymerase results formation intermediate strand complementary template <NUMBER> step time nicking endonuclease recognizes asymmetric restriction site <NUMBER>gagtc<NUMBER>′ cleaves strand four base pairs recognized sequence introduces new nick site step ii nick site dna polymerase initiates another extension displace intermediate strand generated step step iii iv displaced strand template <NUMBER> carries targetbinding sequence complementary reverse primer primer <NUMBER> dna polymerase extends <NUMBER>′ end primer step vi nicking endonuclease recognizes cleaves restriction site polymerase enzyme extends displaces initial template strand template <NUMBER> nick site recovered step vii ix another cycle starting step target template exponentially amplified repeating cycle events <NUMBER> potential new diagnostic technology usually demonstrated matched existing wellestablished technology covid<NUMBER> iat considered acceptable diagnostic purposes community clinics hospitals research must demonstrate diagnostic sensitivity specificity common practice also consider factors make ideal diagnostic test setting criteria guide implementation rapid molecular test rapid clinical decision test safety usage medical doctors nurses nonlaboratory staff quick result patient visit cost effectiveness compared pcr technology iat like lamp near rpa potential fulfil majority criteria studies urgently needed order validate technologies covid<NUMBER> diagnosis spite advantages iat lack internal inhibition control could result duplication reactions testing addition complexity primer design lamp test example prove difficult target site selection resolution <NUMBER> figure <NUMBER> schematic representation nicking enzymeassisted reaction unlike pcr primers near primers uniquely designed successful reaction primer three regions restriction site <NUMBER> gagtcnnnn<NUMBER> example nt bstnbi stabilizing region targetbinding region complementary target nucleic acid strand first forward primer primer <NUMBER> anneals template <NUMBER> targetbinding region extended <NUMBER> end dna polymerase results formation intermediate strand complementary template <NUMBER> step time nicking endonuclease recognizes asymmetric restriction site <NUMBER> gagtc<NUMBER> cleaves strand four base pairs recognized sequence introduces new nick site step ii nick site dna polymerase initiates another extension displace intermediate strand generated step step iii iv displaced strand template <NUMBER> carries targetbinding sequence complementary reverse primer primer <NUMBER> dna polymerase extends <NUMBER> end primer step vi nicking endonuclease recognizes cleaves restriction site polymerase enzyme extends displaces initial template strand template <NUMBER> nick site recovered step vii ix another cycle starting step target template exponentially amplified repeating cycle events <NUMBER> potential new diagnostic technology usually demonstrated matched existing wellestablished technology covid<NUMBER> iat considered acceptable diagnostic purposes community clinics hospitals research must demonstrate diagnostic sensitivity specificity common practice also consider factors make ideal diagnostic test setting criteria guide implementation rapid molecular test rapid clinical decision test safety usage medical doctors nurses nonlaboratory staff quick result patient visit cost effectiveness compared pcr technology iat like lamp near rpa potential fulfil majority criteria studies urgently needed order validate technologies covid<NUMBER> diagnosis spite advantages iat lack internal inhibition control could result duplication reactions testing addition complexity primer design lamp test example prove difficult target site selection resolution <NUMBER> normally respiratory samples collected either nasopharyngeal oropharyngeal swabs viral transport medium processed class ii iii biologic safety cabinet <NUMBER> level containment feasible community clinics hospital collecting swab samples directly lysis buffer containing inactivating agent like guanidinium nondenaturing detergent would suitable direct testing iat like lamp guanidinium detergents able inactivate viable coronavirus prevent rna degradation respectively <NUMBER> <NUMBER> <NUMBER> combined personal protective equipment latex hand gloves laboratory coat appropriate face mask eye goggle makes sarscov<NUMBER> iat testing safe nonlaboratory personnel clinics hospitals lamp already shown possess ability withstand inhibitory substances present cellbased clinical samples associated complex primer assembly dna complementary strand <NUMBER> unlike lamp rpa yet demonstrate direct detection target clinical samples means rpa could probably inhibited cellbased samples respiratory samples covid<NUMBER> free cells suggesting rpa potential directly test type sample example rpa demonstrated directly test urine samples chlamydia trachomatis <NUMBER> however heating respiratory samples avoided prevent rna degradation could impact outcome iat test outcome presently least two different targets sarscov<NUMBER> required confirmation covid<NUMBER> avoid cross reaction potential endemic coronaviruses genetic drift sarscov<NUMBER> <NUMBER> targets could envelope e helicase hel transmembrane structural proteins envelope glycoproteins spike nucleocapsid n <NUMBER> <NUMBER> <NUMBER> speciesspecific accessory genes required viral replication rnadependent rna polymerase rdrp hemagglutininesterase open reading frames orf<NUMBER>a orf<NUMBER>b <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> studies sarscov<NUMBER> still evolving extent virus mutations still clear notwithstanding ideal nucleic acid test design include least one conserved region one specific region order mitigate effects sarscov<NUMBER> genetic drift virus evolves within new populations <NUMBER> us centers disease control recommends two nucleocapsid protein targets n<NUMBER> n<NUMBER> <NUMBER> recommends first line screening e gene test followed confirmatory test using rdrp gene <NUMBER> iat costeffective efficient multiplex test targeting two genes appropriate clinical decision date published rtlamp tests evaluate sarscov<NUMBER> using two target genes however rtlamp studies commercialization iat urgently required help prevent spread virus community level high expectation diagnostic developers iat hold promise reduce spread covid<NUMBER> resource limited settings central laboratories far away transmission disease lamp near rpa potentials simplicity sensitivity specificity quick result demonstrated incorporation technologies like lateral flow strip portable detection reader iat shows ability easily amenable different detection platforms notwithstanding clinical evaluation expected multiplexing targeted genes order assess capability iat confirm diagnosis covid<NUMBER> like pcr pair primer required rpa reaction making assay design relatively easy however multiplexing ability yet fully explored notwithstanding rpa used multiplex food pathogens like staphylococcus aureus vibrio parahaemolyticus salmonella enteritidis coupled lateral flow strip test line intensities quantified using test strip reader <NUMBER> useful see recent strategy deployed sarscov<NUMBER> multiplexing well currently urgent demand tests could confirmed cases covid<NUMBER> screening helpful know extent contribution lamp near rpa regard however lamp used multiplexed influenza b <NUMBER> genie ii fluorometer detection platform figure <NUMBER>c device shows amplification signals time completion reaction real time sample melting temperature tm also shown device mahony james et al <NUMBER> employed tm strategy differentiation influenza b easily differentiated tm overlap strategy could deployed sarscov<NUMBER> multiplexing well require technical training point care testers without background nucleic acid testing advantage realtime rtpcr testing amplification analysis done simultaneously closed system reduce falsepositive results commonly linked amplicons capacity test process <NUMBER> samples among nucleic acids tests integration sample preparation amplification detection single platform challenge especially sample preparation <NUMBER> result sample preparation still processed isolation amplification detection test applications interestingly rtlamp could directly performed clinical samples without rna extractions demonstrated published covid<NUMBER> rtlamp studies <NUMBER> <NUMBER> <NUMBER> throughput <NUMBER> samples gene ii fluorometer used amplification detection could slow testing process considering high demand covid<NUMBER> test point care addition inclusion thermolabile uracildna glycosylase ung lamp reactions could help prevent crosscontamination samples already demonstrated laura lamb et al <NUMBER> approach simply works introducing uridine triphosphate utp reaction along thymidine triphosphate ttp nucleoside triphosphates amplification utp replaces ttp creating mix utp ttp amplicons utp amplified products cleaved ung prevent reamplified next cycle introduction ung isothermal reactions especially coupled lateral flow strips makes system suitable point care nonlaboratory staff may proficient enough handle nucleic acid testing current covid<NUMBER> pandemic continues urgent point care tests like id now™ covid<NUMBER> abbott laboratories illinois il usa comparable standard rtpcr needed lamp near rpa potentials reduce spread sarscov<NUMBER> diagnostic developers scientific community commercial companies required make contributions regard importantly review limited rapidly developing area regards covid<NUMBER> diagnosis presented information time publication iat sarscov<NUMBER> testing may keep evolving pandemic n december <NUMBER> cluster patients pneumonia unknown cause reported wuhan china <NUMBER> causative pathogen subsequently identified severe acute respiratory syndromerelated coronavirus<NUMBER> sarscov<NUMBER> <NUMBER> newly described betacoronavirus virus recognized etiologic agent covid<NUMBER> disease seventh known coronavirus infect humans <NUMBER> since recognition covid <NUMBER> exponential rise number cases worldwide <NUMBER> april <NUMBER> world health organization reported <NUMBER> <NUMBER> cases <NUMBER> countries areas territories <NUMBER> reasons rapid spread include high transmissibility virus <NUMBER> <NUMBER> especially among asymptomatic minimally symptomatic carriers <NUMBER> <NUMBER> apparent absence crossprotective immunity related viral infections delayed public health response measures <NUMBER> <NUMBER> age presence comorbid illnesses increase risk death among persons covid<NUMBER> <NUMBER> <NUMBER> clinical manifestations covid<NUMBER> children less severe compared adults yet age younger <NUMBER> year seems increase risk critical illness <NUMBER> current casefatality rate estimates range <NUMBER> <NUMBER> region seem substantially higher <NUMBER> mortality rate seasonal influenza <NUMBER> <NUMBER> <NUMBER> however current estimates covid<NUMBER> casefatality rates probably inflated preferential testing many countries persons severe manifestations risk death <NUMBER> <NUMBER> germany south korea casefatality rates less <NUMBER> probably extensive testing revealed large denominator mild illness <NUMBER> estimated widescale travel restrictions china undiagnosed sarscov<NUMBER> represented infection source <NUMBER> documented cases <NUMBER> observations underscore critical importance ample accurate diagnostic testing pandemic review current array tests sarscov<NUMBER> highlight gaps current diagnostic capacity propose potential solutions articles including human subjects published <NUMBER> present included articles languages english french excluded screened results title abstract relevant information starting articles found search used snowball search strategy scanning useful references similar articles retrieving considered relevant furthermore experts consulted additional literature guidelines resources international organizations used appropriate search last updated <NUMBER> april <NUMBER> primary goal epidemic containment reduce disease transmission reducing number susceptible persons population reducing basic reproductive number r<NUMBER> number modulated factors duration viral shedding infectiousness organism contact matrix infected susceptible persons <NUMBER> given lack effective vaccines treatments <NUMBER> currently available lever reduce sarscov<NUMBER> transmission identify isolate persons contagious deployment sarscov<NUMBER> testing varied widely across globe asian countries illustrated power preparedness flexible isolation systems intensive case finding south korea dramatically slowed epidemic implementing unprecedented testing effort <NUMBER> using innovative measures south korea performed <NUMBER> <NUMBER> tests <NUMBER> tests per million persons <NUMBER> weeks first case identified <NUMBER> <NUMBER> singapore used broad case definition aggressive contact tracing isolation <NUMBER> moreover identify infected persons meeting case definition singapore screened patients pneumonia influenzalike illnesses hospitals primary care settings severely ill patients intensive care deaths possible infectious cause <NUMBER> taiwan hong kong used similar approaches <NUMBER> countries rapidly deployed resourceintensive strategies prioritized aggressive testing isolation interrupt transmission <NUMBER> <NUMBER> face widespread transmission role diagnostic testing contingent type testing available resources required testing time obtain results example rapidly identifying cases among hospitalized patients remains high priority properly allocate personal protective equipment prevent nosocomial spread subsequent community transmission <NUMBER> <NUMBER> likewise specific treatment decisions enrollment ongoing clinical trials require prompt diagnosis despite remarkable speed accurate diagnostic tests developed made available sarscov<NUMBER> <NUMBER> current tools partially meet several clinically relevant needs figure <NUMBER> illustrates different indications diagnostic testing among persons proven suspected covid<NUMBER> important consideration clinical decision test result help inform test designs must account several parameters whether test detects infection directly virus indirectly host antibodies test turnaround time ability perform many tests time throughput need minimum number specimens testing batching ability perform test lowinfrastructure settings cruise ships remote communities potential use point care depends test complexity us food drug administration fda categorizes diagnostic tests complexity waived tests available use point care whereas moderateand highcomplexity tests must performed laboratory intended use also determines specimen types ideal feasible finally important recognize acceptable diagnostic accuracy test may vary according use case example sensitivity specificity requirements assay used confirm results screening test need stringent method used standalone diagnosis pool persons tested already enriched true infections foundation innovative new diagnostics published detailed assessment priority use cases considered test developers policymakers <NUMBER> response rapidly evolving covid<NUMBER> pandemic countries used different testing approaches depending testing capacity public health resources spread virus community united states diagnostic testing indications capacity limited beginning outbreak largely regulatory hurdles use new tests expand access testing fda released policies allow laboratories use validated assays timely manner <NUMBER> <NUMBER> march centers disease control prevention cdc removed restrictive testing criteria recommending clinicians use judgment determine whether test performed <NUMBER> testing capacity remains suboptimal <NUMBER> implementation recommendation remains challenge cdc still recommends priority testing <NUMBER> groups hospitalized covid<NUMBER> pandemic demonstrates essential role diagnostics control communicable diseases laboratorybased molecular assays detecting sarscov<NUMBER> respiratory specimens current reference standard covid<NUMBER> diagnosis pointofcare technologies serologic immunoassays rapidly emerging early massive deployment sarscov<NUMBER> diagnostics case finding helped curb epidemic several countries urgent clinical public health needs drive unprecedented global effort increase testing capacity diagnostic testing sarscov<NUMBER> patients presentations compatible covid<NUMBER> symptomatic persons risk poor outcomes persons close contact someone suspected confirmed covid<NUMBER> within <NUMBER> days illness onset history travel affected area <NUMBER> patients evaluated molecular diagnostic test described later cdc recommend testing asymptomatic persons although realtime reverse transcriptase polymerase chain reaction rtpcrbased assays performed laboratory respiratory specimens cornerstone covid<NUMBER> diagnostic testing several novel complementary diagnostic methods developed evaluated <NUMBER> figure <NUMBER> depicts adequacy principal assay types used proposed covid<NUMBER> <NUMBER> key use cases among patients diagnosed covid<NUMBER> occurrence concomitant viral infections reported range <NUMBER> <NUMBER> greater <NUMBER> <NUMBER> result possible rule sarscov<NUMBER> infection merely detecting another respiratory pathogen current diagnostic strategy recommended cdc identify patients covid<NUMBER> test samples taken respiratory tract assess presence <NUMBER> several nucleic acid targets specific sarscov<NUMBER> <NUMBER> nasopharyngeal specimen preferred choice swabbased sarscov<NUMBER> testing oropharyngeal midturbinate anterior nares samples also acceptable <NUMBER> <NUMBER> samples obtained using flocked swab available enhance collection release cellular material swabs aluminum plastic shaft preferred swabs contain calcium alginate wood cotton avoided may contain substances inhibit pcr testing ideally swabs transferred universal transport medium immediately sample collection preserve viral nucleic acid samples taken sputum endotracheal aspirates bronchoalveolar lavage also may sent directly microbiology laboratory processing may greater sensitivity upper respiratory tract specimens <NUMBER> inadequate sample collection may result falsenegative test specimen collection samples undergo rna extraction followed qualitative rtpcr target detection united states cdc developed widely used sarscov<NUMBER> assay kit contains pcr primerprobe sets <NUMBER> regions viral nucleocapsid gene n<NUMBER> n<NUMBER> human rnase p gene ensure rna extraction successful assay differs world health organization primerprobe sets target sarscov<NUMBER> rnadependent rna polymerase rdrp envelope e genes <NUMBER> assays high analytic sensitivity specificity sarscov<NUMBER> minimal crossreactivity circulating strains coronaviruses use cycle threshold less <NUMBER> criterion positivity cdc kit may used state public health laboratories laboratories determined state qualified clinical laboratories meet regulatory requirements test well suited one use case epidemiologic surveillance may completely inadequate another rapid screening symptomatic patients allocation personal protective equipment test results enable specific clinical decision test developers policymakers clinicians need consider respect intention testing population tested specifically possible moment use cases placed green gray bar best met nucleic acid amplification tests whereas detection hostderived antibodies directed sarscov<NUMBER> crucial surveillance epidemic forecasting determination sarscov<NUMBER> immunity sarscov<NUMBER> severe acute respiratory syndromerelated coronavirus<NUMBER> clinical laboratories improvement amendment clia perform highcomplexity testing <NUMBER> dozens laboratories applied emergency use authorization eua fda laboratorydeveloped assays <NUMBER> fda also granted eua several commercial assays <NUMBER> expanding ability clinical laboratories use platforms table lack established reference standard use differing sample collection preparation methods incomplete understanding viral dynamics across time course infection hamper rigorous assessment diagnostic accuracy many newly introduced sarscov<NUMBER> assays <NUMBER> serum urine usually negative presence viral nucleic acid regardless illness severity <NUMBER> importance ability rtpcr assays rule covid<NUMBER> basis upper respiratory tract samples obtained single time point remains unclear conversely patient positive test result several authorities recommended obtaining least <NUMBER> negative upper respiratory tract samples collected intervals <NUMBER> hours longer document sarscov<NUMBER> clearance <NUMBER> <NUMBER> lowcomplexity rapid results within <NUMBER> hour molecular diagnostic tests respiratory viral infections clia waived fda approved use outside laboratory nonlaboratory personnel include cartridgebased assays platforms include abbott id abbott laboratories biofire filmarray biomé rieux cobas liat roche diagnostics genexpert cepheid <NUMBER> rapid pointofcare assays sarscov<NUMBER> instruments critical expand pointofcare testing xpert xpress sarscov<NUMBER> test cepheid received fda eua performed genexpert platform already widely used tuberculosis hiv testing especially lowand middleincome countries capacity might useful scale testing across world well settings rapid results point care would medium green cells currently available tools well adapted intended uses within use case terms diagnostic accuracy format turnaround time light green cells assays available projected short term useful important limitations use example current rtpcr assays may yield falsenegative results persons incubation phase low viral load dark green cells assay type meet needs use case naat nucleic acid amplification test poc point care rtpcr reverse transcriptase polymerase chain reaction assumes assays development currently undergoing regulatory evaluation prove accurate † utility antibody detection assays diagnosing acute infections probably limited around time symptom onset viral shedding transmission risk seem highest thus although tests may role among persons presenting late course infection potential misuse high diagnostic testing sarscov<NUMBER> enable clinical decisions although testing throughput may limiting factor tests detect respiratory syncytial virus influenza virus antigens immunoassay directly clinical specimens commercially available decades low complexity may provide results within minutes point care <NUMBER> current tools influenza respiratory syncytial virus suffer suboptimal sensitivity rule disease <NUMBER> <NUMBER> challenge would probably exist sarscov<NUMBER> tests would need implemented clear guidance correct interpretation prototypes tests novel coronaviruses received regulatory approval <NUMBER> <NUMBER> development <NUMBER> monoclonal antibodies nucleocapsid protein sarscov<NUMBER> generated might form basis future rapid antigen detection test <NUMBER> serologic tests identify antibodies iga igm igg sarscov<NUMBER> clinical specimens blood saliva enzymelinked immunosorbent assays may less complex molecular tests potential used diagnosis certain situations <NUMBER> however utility diagnosing acute infections probably limited around time symptom onset viral shedding transmission risk seem highest <NUMBER> antibody responses infection take days weeks reliably <NUMBER> negative results would exclude sarscov<NUMBER> infection particularly among recent exposure virus crossreactivity antibody nonsarscov<NUMBER> coronavirus proteins also potential problem whereby positive results may result past present infection human coronaviruses <NUMBER> serologic assays might relevant scenarios patients present medical care late complications disease rtpcr may falsely negative viral shedding drops time <NUMBER> development serologic assays accurately assess prior infection immunity sarscov<NUMBER> essential epidemiologic studies ongoing surveillance vaccine studies potentially risk assessment health care workers immunoassays already market countries diagnostic accuracy optimal use remain undefined optimal use diagnostic imaging biomarkers nonmicrobiologic tests rapidly evolving many centers evaluated utility chest imaging diagnosis chest radiography bilateral pneumonia frequently reported feature range <NUMBER> <NUMBER> common unilateral focus <NUMBER> <NUMBER> computed tomography regarded sensitive radiography several cohort studies reporting patients <NUMBER> <NUMBER> ground glass opacities features commonly reported covid<NUMBER> chest computed tomography include peripheral distribution fine reticular opacities vascular thickening <NUMBER> compared serial nasopharyngeal sampling chest computed tomography may sensitive rtpcr test single time point diagnosis covid<NUMBER> <NUMBER> <NUMBER> addition artificial intelligence may help distinguish covid<NUMBER> etiologic agents communityacquired pneumonia <NUMBER> however findings completely specific covid<NUMBER> exclude coinfection alternative diagnosis <NUMBER> common laboratory features reported patients covid<NUMBER> include decreased albumin <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> elevated creactive protein <NUMBER> ci <NUMBER> <NUMBER> elevated lactate dehydrogenase levels <NUMBER> ci <NUMBER> <NUMBER> lymphopenia <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> biomarkers reported include increased erythrocyte sedimentation rates elevated aspartate aminotransferase alanine aminotransferase creatinine kinase levels leukopenia leukocytosis increased bilirubin creatinine levels <NUMBER> <NUMBER> <NUMBER> findings surprising biomarkers represent inflammatory host response sarscov<NUMBER> early markers endorgan dysfunction similar seen patients sepsis <NUMBER> biomarker combination biomarkers currently exists sensitive specific enough establish diagnosis covid<NUMBER> pragmatically predict clinical course face public health emergency important first steps expand testing capacity include relaxing streamlining regulatory requirements procedures local public health laboratories academic diagnostic laboratories united states rapidly enabled perform euagranted commercial assays laboratorydeveloped tests using research useonly reagents <NUMBER> university research laboratories could also add capacity although concerns exist regarding quality control absence protocols managing clinical specimens flexibility regarding nucleic acid extraction methods amplification instruments using cdc protocols introduced <NUMBER> national agencies expeditiously making materials test development validation available clinical laboratories diagnostic test manufacturers safely evaluating clinically stable persons covid<NUMBER> traditional health care access points resource intensive slow risks exposing staff infection many jurisdictions enabling innovative testing venues external tents drivethrough phone booth testing well home assessment teams expedite specimen collection limiting potential exposures <NUMBER> telemedicine combined athome nasal swab selftesting also proposed <NUMBER> importance jurisdictions without universal health care coverage policy solutions must introduced eliminate financial barriers testing uninsured underinsured patients efforts increase accessibility testing multiple use cases need coupled appropriate public health interventions isolate infected persons contacts nasopharyngeal swabs recommended specimen molecular analysis sudden demand flocked nasopharyngeal swabs viral transport medium generated pandemic put enormous pressures supply chain capacities products <NUMBER> march <NUMBER> cdc made oropharyngeal midturbinate nasal swabs acceptable specimen types nasopharyngeal swabs available <NUMBER> earlymorning posterior oropharyngeal saliva samples coughed clearing throat also assessed useful specimen types would require use swab <NUMBER> cdc released standard operating procedure laboratories create viral transport medium <NUMBER> solutions also may used viral transport medium unavailable including phosphatebuffered saline liquid amies normal saline <NUMBER> fda provided review diagnostic testing sarscov<NUMBER> guidance web site alternative materials collect transport samples rtpcr sarscov<NUMBER> assays <NUMBER> diagnostic value molecular testing nonrespiratory specimens currently unclear although excellent tools exist diagnosis symptomatic patients wellequipped laboratories important gaps remain screening asymptomatic persons incubation phase well accurate determination live viral shedding among patients convalescence phase inform deisolation decisions figure <NUMBER> critical advance solutions require less wellequipped laboratories curb pandemic globally foundation innovative new diagnostics find others created online resources collate rapidly evolving set assays various stages development proof concept full regulatory approval <NUMBER> <NUMBER> simple antigenbased tests sensitive enough might useful lowerresource home settings inform quarantine spatial distancing measures patients without severe illness contacts novel technologies clustered regularly interspersed short palindromic repeats crisprbased diagnostics used develop rapid simple lowcost portable temperaturestable assays deployment field nontraditional resourcelimited settings airports border crossings <NUMBER> <NUMBER> <NUMBER> technologies might deployed lowerresource settings standardized example might possible leverage existing loopmediated isothermal amplification testing networks established diseases human african trypanosomiasis surveillance <NUMBER> critical considerations diagnostics used epidemic diseases public health importance include quality assurance regulatory frameworks surrounding testing mature regulatory agencies developed mechanisms account emergencies fdas eua stream pragmatic solutions must found facilitate widescale independent evaluation emerging tests initially need elaborate biosafety precautions inconsistent recommendations application across regions severely hampered covid<NUMBER> testing although continue evolve current recommendations canada united states acknowledge nonpropagative work molecular testing may performed containment level <NUMBER> conditions found routine diagnostic laboratories provide specific guidance diagnostic testing specimens conducted outside biosafety level <NUMBER> laboratory rapid respiratory testing performed point care <NUMBER> covid<NUMBER> pandemic dramatically highlighted essential role diagnostics control communicable diseases intensive diagnostics deployment probably contributed success countries controlling transmission urgent clinical public health needs drive unprecedented global effort increase sarscov<NUMBER> testing capacity finally blinding speed covid<NUMBER> spread illustrates need preparedness longterm investments diagnostic testing disclosures dr cheng reports grants canadian institute health research mcgill interdisciplinary initiative infection immunity conduct study manuscript written submitted offered position scientific advisory board gen<NUMBER>e lifesciences position unrelated submitted work dr papenburg reports grants personal fees bd diagnostics seegene abbvie personal fees cepheid grants medimmune sanofi pasteur janssen pharmaceuticals hoffmanla roche outside submitted work dr kanjilal reports grants phast diagnostics outside submitted work dr libman reports grants geosentinel network outside submitted work dr yansouni reports nonfinancial support biomé rieux outside submitted work authors named disclosed conflicts interest disclosures also viewed wwwacponlineorgauthorsicmjeconflictofinterestforms domsnumm<NUMBER> among coronaviruses emergence severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov caused threats public health <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> end december <NUMBER> another zoonotic human coronavirus emerged wuhan hubei province china <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> initially <NUMBER> patients clinical manifestations pneumonia fever difficulty breathing chest radiographs bilateral lung infiltrative lesions observed <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients clinically tested negative merscov sarscov <NUMBER> abrupt increase cases viral pneumonia unknown etiology led chinese authorities report situation world health organization december <NUMBER> <NUMBER> <NUMBER> <NUMBER> ongoing scientific investigations initially proposed interim name novel virus <NUMBER>ncov later covid<NUMBER> designated official name disease <NUMBER> following thorough assessment phylogeny taxonomy established practice international committee taxonomy viruses ictv formally recognized virus related sarscovs designated virus sarscov<NUMBER> <NUMBER> sarscov<NUMBER> falls genus betacoronavirus sequence homology <NUMBER> coronaviruses discovered humans bats wild animals instance sarscov bat sarslike cov <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> due increase risk potential spread virus countries weaker health systems declared sarscov<NUMBER> outbreak disease public health emergency international concern <NUMBER> owing current disease situation novel coronavirus may remarkably become third coronavirus posing significant threats public health worldwide impediment spread transmission disease requires rapid reliable identification especially areas limited laboratory capacity concurrently hospitals identification causative agents recurrent acute respiratory infections requires routine confirmatory diagnosis quantitative realtime polymerase chain reaction qrtpcr recent years loopmediated isothermal amplification lamp method includes exponential amplification specific nucleic acid sequences constant temperature widely utilized rapid detection virusspecific genes <NUMBER> <NUMBER> specificity sensitivity method generally comparable conventional pcr qrtpcr lamp assays merged reverse transcription steps developed detection rna viruses including sarscov merscov influenza respiratory viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> present study singletube reverse transcription loopmediated isothermal amplification rtlamp assay developed detection sarscov<NUMBER> nucleocapsid n gene colorimetric visualization study aimed develop rapid simple sensitive molecular detection assay novel coronavirus differentiate currently circulating human coronaviruses including oc<NUMBER> <NUMBER>e nl<NUMBER> merscov well respiratory viruses method enables detection sarscov<NUMBER> within <NUMBER> min excluding rna extraction detection limit <NUMBER> <NUMBER> rna copies close qrtpcr furthermore combining amplification process colorimetric detection assay suitable rapid simple diagnosis within poorly equipped primary hospitals laboratories situations urgent diagnosis needed rtlamp primers designed detection sarscov<NUMBER> based upon already available sequences global initiative sharing influenza data gisaid wwwgisaidorg sequences aligned using clc genomics workbench <NUMBER> qiagen usa conserved region identified target n gene sequence genbank accession nc<NUMBER> position <NUMBER> used template designing rtlamp primers identify efficient primer set seven sets specific rtlamp primers initially designed using primerexplorer v<NUMBER> eiken chemical co ltd tokyo japan programme based upon published sequence n gene primer sets included two external primers forward outer primer f<NUMBER> backward outer primer b<NUMBER> two internal primers forward inner primer fip backward inner primer bip two loop primers backward loop primer lb forward loop primer lf primers synthesized bionics inc republic korea table <NUMBER> represents detailed information regarding designed primer sets <NUMBER> contributing laboratories gratefully acknowledged sharing sequences metadata gisaid designing primers assay supplementary table <NUMBER> initially primers containing t<NUMBER> rna polymerase promoter designed using betacovwuhanhu<NUMBER> <NUMBER> gisaid epiisl<NUMBER> sequence sarscov<NUMBER> sarscovhku<NUMBER> genbank accession ay<NUMBER> sequence outsourced bionics inc republic korea t<NUMBER>flagged pcr product synthesized vitro transcription details sequence primers used rna synthesis provided supplementary table <NUMBER> artificial sarscov<NUMBER> sarscov rna synthesized using megascript® kits invitrogen usa following manufacturers instructions rna recovered lithium chloride precipitation stored −<NUMBER>°c till use quantification rna transcript rna copy number using endmemo dnarna copy number calculator httpendmemocombiodnacopynum php calculated quantitated using qubit rna hs assay kit thermo fisher scientific inc massachusetts usa following manufacturers instructions endpoint diluted rna confirmed qrtpcr moreover betacovkoreanmc<NUMBER> betacovkoreanmc<NUMBER> viruses propagated passaged twice vero cells vero cells maintained dulbeccos modified eagles medium dmem gibcoinvitrogen carlsbad ca usa containing <NUMBER> fetal bovine serum fbs <NUMBER> antibiotics incubated <NUMBER>°c <NUMBER> co <NUMBER> intact viral rna extracted using rneasy mini kit qiagen usa followed manufacturers instructions viral rna stored −<NUMBER>°c till use complete experimental work sarscov<NUMBER> conducted enhanced biosafety level <NUMBER> bl<NUMBER> facility chungbuk national university approved korea center disease control table <NUMBER> rna template <NUMBER> μl extracted virus synthesized rna added master mix rtlamp reaction performed <NUMBER>°c detection limit determination performed processing tenfold serially diluted <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> synthesized viral rnas rtlamp concomitantly samples subjected qrtpcr according shared protocol developed national institute infectious diseases japan showed one highest sensitivities comparison study <NUMBER> <NUMBER> briefly sarscov<NUMBER> qrtpcr performed using itaq universal probes onestep kit biorad hercules ca usa conditions including reverse transcription <NUMBER>°c <NUMBER> min initial denaturation <NUMBER>°c <NUMBER> min <NUMBER> cycles denaturation <NUMBER>°c <NUMBER> annealing <NUMBER>°c <NUMBER> min using cfx<NUMBER> touchtm realtime pcr detection system biorad hercules ca usa cycle threshold ct values qrtpcr analysis determined based upon set baseline threshold value <NUMBER> ct values qrtpcr results analysis determined based upon set baseline threshold value <NUMBER> validated standard curve graph generated serially diluted copies templates correlation coefficient value <NUMBER> evaluate time efficiency developed assay optimization rtlamp reaction done varying reaction time points <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> min using determined limit concentration viral rna ten repeats rtlamp reaction performed using determined viral rna concentrations incubations <NUMBER> <NUMBER> min comparison detection limit qrtpcr also determined performing ten repeats reaction using <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rna copies positive rtlamp reactions resulted colour change phenol red ph indicator pink yellow due decreased ph presence extensive dna polymerase activity thus results could directly observed naked eye results rtlamp reactions also confirmed <NUMBER> agarose gel electrophoresis sensitivity developed rtlamp assay detect sarscov<NUMBER> confirmed using cell propagated cultures sarscov<NUMBER> grown passaged twice vero cells intact viral rna tenfold serially diluted <NUMBER> −<NUMBER> processed parallel testing rtlamp assay qrtpcr serially diluted rna <NUMBER> μl mixed optimized master mix subjected rtlamp assay described previously <NUMBER> determine specificity optimized rtlamp assay targeting sarscov<NUMBER> assay tested across threepanel sets different rna samples extracted patients nasal swabs andor cellpropagated isolates respiratory diseasecausing agents rtlamp crosstested panel set rna samples related coronaviruses includes human coronavirus <NUMBER>e <NUMBER>e human coronavirus nl<NUMBER> nl<NUMBER> human coronavirus oc<NUMBER> oc<NUMBER> middle east respiratory syndrome coronavirus merscov tested using developed rtlamp assay optimized rtlamp assay also tested panel human infecting avian influenza viruses rna samples acalifornia<NUMBER> h<NUMBER>n<NUMBER>pdm aperth<NUMBER> h<NUMBER>n<NUMBER> bbrisbane<NUMBER> victoria lineage bphuket<NUMBER> yamagata lineage highly pathogenic avian influenza viruses including h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> h<NUMBER>n<NUMBER> low pathogenic avian influenza viruses including h<NUMBER> h<NUMBER>∼h<NUMBER> also tested reactivity <NUMBER> furthermore panel set respiratory diseasecausing viruses including adenovirus adv parainfluenza virus piv human metapneumovirus mpv human bocavirus hbov human rhinovirus hrv sarscov<NUMBER> qrtpcr performed following protocol used optimization sensitivity assay viruses used panel also confirmed viral rna using onestep rtpcr using specific primers detailed information primers pcr conditions used panel viruses presented supplementary table <NUMBER> fourteen nasal swabs collected covid<NUMBER> patients national medical center republic korea processed viral rna extraction purified rna used clinical evaluation rtlamp assay comparison qrtpcr method described agreement two tests also evaluated using cohens kappa twentyeight sequences sarscov<NUMBER> deposited gisaid aligned designed oligonucleotide primer sets target conserved region ngene sequence exhibited zero mismatches highly conserved region specifically position <NUMBER> <NUMBER> figure <NUMBER>a b performed rtlamp assay using vitro transcribed <NUMBER> μl <NUMBER> ngml rna <NUMBER> × <NUMBER> <NUMBER> number copies sarscov<NUMBER> n gene successful rtlamp reaction results colorimetric reaction includes change colour phenol red ph indicator pink yellow figure <NUMBER>c moreover successful amplifications indicated typical ladderlike pattern electrophoresed <NUMBER> agarose gel figure <NUMBER>c optimize rtlamp determine limit detection tenfold serial dilution rna transcript <NUMBER> × <NUMBER> <NUMBER> <NUMBER> × <NUMBER> <NUMBER> per reaction used template rtlamp <NUMBER>°c <NUMBER> min figure <NUMBER>a qrtpcr figure <NUMBER>b assays standard curve qrtpcr associated linear regression created using graphpad prism supplementary figure <NUMBER> serial dilution rtlamp assay able detect <NUMBER> <NUMBER> copies per reaction ten repetitions rtlamp assay containing <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rna copies per reaction resulted <NUMBER> <NUMBER> <NUMBER> detection rate respectively qrtpcr detected <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> rna copies <NUMBER> <NUMBER> <NUMBER> rna copies per reaction figure <NUMBER>a b nonetheless compared rtlamp qrtpcr method consistently detected tenfold lower <NUMBER> <NUMBER> rna copies across ten reactions qrtpcr mean ct<NUMBER> supplementary table <NUMBER> discerning optimal reaction time rtlamp assay clear colorimetric change evident <NUMBER> min clarity colorimetric change <NUMBER> min hard discern eye however ladderlike pattern exhibited agarose gel electrophoresis figure <NUMBER>c assessment <NUMBER> <NUMBER> min incubation times showed <NUMBER> positive detection <NUMBER> <NUMBER> copies rna per reaction observed time points across ten repetitions <NUMBER> <NUMBER> copies per reaction positive detection rate <NUMBER> <NUMBER> min <NUMBER> <NUMBER> min across ten repetitions moreover ten repetitions rtlamp observed possess equal detection rate <NUMBER> detecting <NUMBER> <NUMBER> rna copies time points figure <NUMBER>d terms overall time efficiency excluding rna extraction qrtpcr takes <NUMBER> min complete obtain results figure <NUMBER>e rtlamp assay developed present study shown capability sensitive detection within <NUMBER> min similar <NUMBER> min incubation hence succeeding evaluation rtlamp assay set <NUMBER> min incubation time point sensitivity rtlamp assay tested detect intact viral rna extracted cell culture supernatants two isolates covid<NUMBER> patients sensitivity observed tenfold lower qrtpcr similar rtlamp assay performed using synthesized rna assays able detect sarscov<NUMBER> reaction intact viral templates used figure <NUMBER>a b interestingly sarscov<NUMBER> positive samples confirmed assays qrtpcr rtlamp reactions able detect intact viral rna concentration range <NUMBER> −<NUMBER> <NUMBER> −<NUMBER> dilutions significantly qrtpcr exhibited tenfold <NUMBER> −<NUMBER> higher detection rate two intact viral rna samples mean ct values observed across three repetitions indicated figure <NUMBER> c detection limit rtlamp determined using ten repetitions serially diluted templates <NUMBER> −<NUMBER> <NUMBER> −<NUMBER> <NUMBER> −<NUMBER> <NUMBER> <NUMBER> min incubation figure <NUMBER> e f <NUMBER> detection observed ten replicates rna diluted <NUMBER> −<NUMBER> patient isolates regardless incubation period however rna samples <NUMBER> −<NUMBER> concentrations observed lower detection rate <NUMBER> <NUMBER> min <NUMBER> <NUMBER> min incubation moreover ten replicates similar serially diluted templates <NUMBER> −<NUMBER> <NUMBER> −<NUMBER> <NUMBER> −<NUMBER> subjected qrtpcr demonstrated tenfold higher detection rate agreement rtlamp results using synthesized rna template supplementary table <NUMBER> examined specificities sarscov<NUMBER> rtlamp assay coronaviruses human coronaviruses oc<NUMBER> nl<NUMBER> <NUMBER>e merscov influenza viruses respiratory diseasecausing viruses amplification observed rtlamp assay viral rna panel related coronaviruses figure <NUMBER>a upper panel confirmed gel electrophoresis figure <NUMBER>a middle panel presence viral rna confirmed samples rtpcr gel electrophoresis shown lower panel figure <NUMBER> since signs symptoms sarscov<NUMBER> similar influenza virus infection panel highly pathogenic avian influenza viruses human infectious influenza viruses tested figure <NUMBER> b crossreactivity observed rtlamp either colorimetric detection agarose gel electrophoresis similar results obtained developed rtlamp assay tested using panel avian influenza viruses figure <NUMBER>c results suggest developed assay high specificity sarscov<NUMBER> viruses tested manifest andor cause respiratory clinical signs symptoms evaluation rtlamp assay using clinical specimens total <NUMBER> clinical samples evaluated comprised <NUMBER> positive nasal swab specimens collected previously diagnosed patients covid<NUMBER> national medical center republic korea <NUMBER> nasal swab specimens collected outbreak previously confirmed hospital respiratory diseasecausing viruses addition <NUMBER> samples confirmed respiratory diseasecausing viruses collected prior outbreak also evaluated collected specimens <NUMBER> <NUMBER> samples observed react positively rtlamp assay table <NUMBER> <NUMBER> samples <NUMBER> respiratory samples covid<NUMBER> patients <NUMBER> negative samples used evaluation two <NUMBER> samples observed show positive reaction table <NUMBER> using qrtpcr confirmed specimens exhibited falsepositive reaction rtlamp data shown also tested <NUMBER> respiratory samples qrtpcr results revealed collected specimens showed positive amplification ct value ranging <NUMBER> <NUMBER> results developed rtlamp assay showed calculated sensitivity <NUMBER> specificity <NUMBER> suggests primers used assay used sensitive specific early detection method identify sarscov<NUMBER> cases rtlamp method primers designed target nucleocapsid n protein gene utilized general gene encoding n protein found abundant expression subgenomic mrna sgmrna infection <NUMBER> <NUMBER> <NUMBER> coronavirus n protein lacks glycosylation site possesses distinctly unaltered immunological characteristics <NUMBER> hence protein selected main target nucleic acid amplification apart abundant throughout infection gene encoding n protein highly conserved among coronavirus structural proteins based upon reported pairwise patristic distances ppd value differences emergence sarscov<NUMBER> ppd <NUMBER> completely independent sarscov ppd <NUMBER> emerged <NUMBER> <NUMBER> hence explains specific merscov sarscov primers limitedly detect virus supports primers utilized rtlamp assay highly specific sarscov<NUMBER> n gene limit detection revealed developed assay highly capable detection nearly sensitive qrtpcr demonstrated rtlamp assay specific sarscov<NUMBER> possesses rare crossreactivity viruses manifest similar respiratory disease moreover assay discriminate currently cocirculating common human coronaviruses merscov data presented supports rtlamp specific qrtpcr detecting sarscov<NUMBER> silico figure <NUMBER> addition rtlamp assay using synthesized rna sarscov n gene showed positive amplification <NUMBER> <NUMBER> rna copies per reaction across three repetitions result shows <NUMBER>fold lower cross reactivity compared sarscov<NUMBER> n gene <NUMBER> <NUMBER> rna copies supplementary figure <NUMBER> furthermore using cohens kappa level agreement qrtpcr rtlamp revealed almost perfect agreement kappa value <NUMBER> <NUMBER> supports high sensitivity specificity results obtained clinical evaluation using assays generally rtlamp methodology regarded new generation diagnostics <NUMBER> however along advantages tool may also technical shortcomings falsepositive single readout sensitivity aerosol contaminants assay manipulations <NUMBER> inclusion rna extraction step also limits assay genuinely used bedside testing patients lamp methodologies able develop assay without need conduct rna extraction utilized onestep syringe filter system <NUMBER> <NUMBER> even though optimized assay false positive reactions envisioned developed rtlamp assay utilized primary screening method rapid detection sarscov<NUMBER> hence positive reactions may subjected subsequent confirmatory diagnosis qrtpcr would best interest developed assay optimized using realtime amplification order hasten time reaction minimize false positive reactions rtlamp would ideal pointofcaretest covid<NUMBER> limitations met future studies summary developed rtlamp assay use clinical laboratories support preliminary detection sarscov<NUMBER> suspected patients especially testing abundant number samples high sensitivity specificity assay simple methodology low cost time efficient singletube isothermal colorimetric method require expensive equipment declaration public health international concerns sarscov<NUMBER> method would significantly contribute public health responses disease control countries providing preliminary counter detection measures especially limited laboratory capacities coronaviruses frequent causes respiratory neurological diseases human six major species known cause respiratory neurological diseases human <NUMBER> species include severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov less virulent species hku<NUMBER> oc<NUMBER> nl<NUMBER> <NUMBER>e <NUMBER> unknown pneumonia widely broke word genetic sequencing isolates obtained patients pneumonia identified previously unknown coronavirus <NUMBER>ncov <NUMBER> recently denoted covid<NUMBER> <NUMBER> based genomic characteristics coronavirus figure <NUMBER> current diagnostic tests coronavirus include rtpcr rrtpcr realtime reverse transcription pcr rtlamp reverse transcription loopmediated isothermal amplification well realtime rtlamp <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> epidemiology aetiology clinical characteristics covid<NUMBER> recently described detail <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> current diagnostic covid<NUMBER> includes detection virus genomic techniques using either pcrbased method deep sequencing <NUMBER> <NUMBER> <NUMBER> within days chinese researchers releasing sequence virus <NUMBER> january scientists developed pcrbased tests detect novel coronaviruses covid<NUMBER> patients <NUMBER> although diagnostic test kits approved low efficiency low accuracy test kits makes severe situation difficult keep increasing number patients april <NUMBER> <NUMBER> <NUMBER> million confirmed cases <NUMBER> death worldwide however detection methods heavily rely presence viral genome sufficient amounts site sample collection amplified missing timewindow viral replication provide false negative results similarly incorrect sample collection limit usefulness qpcrbased assay false negative diagnosis grave consequences specially stage pandemic allowing infected patients spread infection hampering efforts contain spread virus <NUMBER> additional screening methods detect presence infection despite lower viral titres beneficial ensure timely diagnosis infected patients therefore urgently needs develop diagnostic method simple quick high accuracy diagnose emerging pathogen infectious discovery recently advance biology clustered regularly interspaced short palindromic repeats crispr crisprassociated cas proteins led rapidly research expansion recently molecular diagnostics figure <NUMBER> development crisprcas based systems genome editing acknowledge efforts different fields past <NUMBER> years <NUMBER> crispr locus first discovered <NUMBER> described arranged highly homologous repeats spacers escherichia coli <NUMBER> subsequent sentinel discoveries unveiled functions mechanisms crisprcas system setting new era crisprcas mediated adaptive immunity <NUMBER> <NUMBER> <NUMBER> first application crisprcas<NUMBER> technology revolutionised field gene editing targeting mammalian cells accelerating advance novel applications crisprcas systems basic sciences clinical medicine <NUMBER> <NUMBER> crisprcas<NUMBER>based tools firstly used detect zike virus <NUMBER> <NUMBER> methicillinresistant staphylococcus aureus <NUMBER> <NUMBER> discovery rnaguided rnatargeting crispr effector cas<NUMBER>a <NUMBER> subsequently founded cas<NUMBER>a <NUMBER> set stage crisprcas<NUMBER> orand cas<NUMBER> based nucleic acid detection used clinical diagnosis <NUMBER> recently crisprcas<NUMBER> based sherlock protocols described prof feng zhang et al provides rapid accurate diagnostic assay emerging <NUMBER> novel coronavirus covid <NUMBER> pneumonia therefore crisprcas based technology good potential application fast accurate portable diagnostic assay emerging infectious disease crisprcas systems act rnaguided dna rnatargeting technique confer prokaryotes heritable adaptive immunity foreign genetic elements including bacteriophages plasmids bacteria archaea <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> excellent comprehensive reviews summarised main processes crisprcasmediated immunity include adaptation crrna maturation interference <NUMBER> based composition interference complex crisprcas systems divided class <NUMBER> crisprcas systems types iii iv class <NUMBER> crisprcas systems iicas<NUMBER> vcas<NUMBER> vicas<NUMBER> <NUMBER> <NUMBER> class <NUMBER> crisprcas systems utilise crrna together multieffector complex recognise cleave target sequence whereas class <NUMBER> systems utilise single multidomain cas protein together crrna interference <NUMBER> <NUMBER> <NUMBER> <NUMBER> date class <NUMBER> crisprcas systems widely used genome editing accurate rapid diagnosis infectious diseases <NUMBER> <NUMBER> <NUMBER> <NUMBER> crisprcas<NUMBER>a cas<NUMBER>a cas<NUMBER>b recently applied develop practical sensitive detection assays human pathogens including bacteria virus <NUMBER> <NUMBER> <NUMBER> <NUMBER> type ii crisprcas<NUMBER> based technology reported several groups infectious disease diagnostics <NUMBER> <NUMBER> <NUMBER> pardee et al developed novel method combine crisprcas<NUMBER> isothermal amplification technique called nasba nucleic acid sequencebased amplification differentiate zikv strains singlebase discrimination <NUMBER> investigators exploited dsdna intermediate nasba amplification process serve substrate cas<NUMBER> endonuclease sgrnacas<NUMBER> complex cleave resulting dsdna resulting truncated fulllength dna fragments formed upon cas<NUMBER> cleavage without strainspecific pam respectively fulllength strands truncated dna fragments triggered toehold switch leading colour change distinguish different strains guk et al developed method detect methicillinresistant staphylococcus aureus mrsa via combination crisprcas<NUMBER> fishdna fluorescent situ hybridization <NUMBER> method dcas<NUMBER>sgrna complex targets recognises target meca gene associated methicillin resistance mrsa <NUMBER> dcas<NUMBER> induce dna cleavage dcas<NUMBER>sgrna complex recognises target dna sequence detected fish corresponding fluorescence intensity reflects concentration mrsa easy detect mrsa detection concentration <NUMBER> cfuml rapid distinguish aureus isolates presence absence meca gene however new meca homologue mecalga<NUMBER> shared <NUMBER> nucleotide homology meca <NUMBER> results possible false negative results using method meanwhile detection meca gene specific mrsa small proportion methicillinsusceptible staphylococcus aureus mssa meca gene large proportion mrsa strains lack meca <NUMBER> <NUMBER> combination crisprcas<NUMBER> optical dna mapping also applied identify bacterial antibiotic resistance genes <NUMBER> assay cas<NUMBER>grna complex specifically recognises cleaves nucleic acid sequences resistance genes fluorescent dye yoyo<NUMBER> netropsin independently selectively binds resulting dna based atrich regions resulting difference emission intensity allows detect different resistance genes identification crisprcas<NUMBER> systems type v expand crisprcas arsenal genomic editing <NUMBER> cpf<NUMBER> characterised firstly renamed cas<NUMBER>a <NUMBER> c<NUMBER>c<NUMBER> cas<NUMBER>b <NUMBER> type v members identified subsequently <NUMBER> <NUMBER> <NUMBER> chen et al reported technique named detectr dna endonucleasetargeted crispr trans reporter provides straightforward platform molecular diagnostics <NUMBER> detectr achieves attomolar sensitivity dna detection combination activation nonspecific singlestranded deoxyribonuclease cas<NUMBER>a ssdnase isothermal amplification enables fast specific detection virus patient samples assay crrnacas<NUMBER>a complex binds target dna induces indiscriminate cleavage ssdna coupled fluorescent reporter author used detectr differentiate different types human papillomavirus cultured human cells clinical samples within <NUMBER> h <NUMBER> addition another technique combines crisprcas<NUMBER> fluorescencebased pointofcare poc system recently reported rapid detection accurate african swine fever virus asfv <NUMBER> method cas<NUMBER>acrrna detects binds targeting dna cas<NUMBER>a crrnadna complex becomes activated degrades fluorescent ssdna reporter author used method detect asfv detection limit <NUMBER> mm within <NUMBER> h detection limit <NUMBER> fm achieved <NUMBER> h incubation several subtypes type vi crisprcas<NUMBER> systems reported serve potential tools rna editing <NUMBER> <NUMBER> <NUMBER> generally type vi crisprcas<NUMBER> systems contain single effector protein designated cas<NUMBER>a combines crrna form crrnaguided rnatargeting crispr effector complex cleave ssrna rather dna <NUMBER> <NUMBER> <NUMBER> first platforms based type vi crisprcas<NUMBER> systems termed sherlock specific highsensitivity enzymatic reporter unlocking integrates isothermal rpa recombinase polymerase amplification reverse transcription rtrpa nuclease activity cas<NUMBER>a <NUMBER> crrnacas<NUMBER>a complex specifically binds cleaves target nucleic acid well nontarget rna coupled fluorescent reporter provides fluorescent signal rapid realtime detection pathogen even low concentrations using sherlock gootenberg et al identified escherichia coli pseudomonas aeruginosa differentiated bacteria mycobacterium tuberculosis klebsiella pneumoniae staphylococcus aureus clinical isolates k pneumoniae possess different drugresistant gene including new delhi metallobetalactamase<NUMBER> resistance ndm carbapenemase kpc distinguished moreover powerful applications sherlock allowed discrimination targets differed single base pair successfully distinguished targets african american strains zikv different serotypes denv five healthrelated gene alleles human saliva various cancerrelated mutations suspensions cellfree dna several important characteristics including estimated cost reagents materials less <NUMBER> per test paperbased test used reagents stable detection performed within <NUMBER> h make feasible use revised method based sherlock termed sherlockv<NUMBER> simultaneously detect one dna target three ssrna targets single reaction <NUMBER> modified method cas<NUMBER> together csm<NUMBER> auxiliary crisprtype iii associated nuclease <NUMBER> <NUMBER> increase <NUMBER>fold signal sensitivity <NUMBER> method applied detect specific nucleic acid high sensitivity takes less <NUMBER> min accuratly detects zika virus dengue virus synthetic dsdna <NUMBER> moreover myhrvold et al developed novel technique based sherlock together hudson heating unextracted diagnostic samples obliterate nucleases <NUMBER> allows pathogen detection directly bodily fluids patient without nucleic acid extraction method high sensitivity detection identify dengue virus saliva whole blood serum patient samples within <NUMBER> h recently protocol detection covid<NUMBER> using crisprbased sherlock described feng zhang et al figure <NUMBER> author mentioned test performed starting rna isolated patient samples read using dipstick less hour protocol provide reference researchers interested advancing diagnostics system covid<NUMBER> emerging infectious disease limitation overall performance characteristics traditional diagnostic methods makes novel molecular tools quickly integrated clinical use tremendous advances novel methods associated pcr dna sequencing allow rapidly identified pathogen emerging infectious diseases facilitate timely treatment infections however ideal diagnostic reagent characterised rapid reliable inexpensive easytouse perhaps nonspecific dna cleavage observed crisprcas type ii cas<NUMBER> v cas<NUMBER> vi cas<NUMBER> systems provides promising advance crisprbased diagnostics emerging infectious diseases three different techniques based class ii crisprcas systems applied combination crispr cas based system technique achieve described applications diagnosis although urgent need fast accurate inexpensive tests possibility crisprcas based diagnosis may set novel stage terms accuracy speed detection emerging advanced techniques based diagnostic methods require careful validation field testing guarantee functionality severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> new type coronavirus belonging genus β <NUMBER> mar <NUMBER> world health organization declared coronavirus disease <NUMBER> covid<NUMBER> pandemic <NUMBER> viral culture pcr gold standards diagnosis sarscov<NUMBER> infection <NUMBER> however takes hours detect nucleic acid days isolate virus addition specialized instrument expertise required rapid diagnosis sarscov<NUMBER> infection rapid antigen detection rad tests qualitative determination sarscov<NUMBER> antigen available rad tests detect viral antigen immobilized coated sarscov<NUMBER> antibody device test results rad interpreted without specialized instrument available within <NUMBER> minutes hence rad tests relieve workload diagnostic hospitals laboratories improve turnaround time however according role rad tests antigen detection sarscov<NUMBER> needs evaluated recommended clinical diagnosis <NUMBER> purpose evaluation assess diagnostic use commercially available biocredit covid<NUMBER> ag test aim first part study assess limit detection lod rad test rtpcr viral culture second part evaluate performance rad test detecting sarscov<NUMBER> virus different types respiratory specimens sarscov<NUMBER> culture isolate strain hcov<NUMBER>hong kongvm<NUMBER> first sarscov<NUMBER> case detected hong kong used perform serial tenfold dilution determine lod different assays evaluated commercially available rad kit hong kong time starting evaluation biocredit covid<NUMBER> ag diagnosis sarscov<NUMBER> infection intended use biocredit covid<NUMBER> ag kit nasopharyngeal swab specimen npa ts nps ts sputum throat saliva either eluted vtm suspended pbs test carried modified sample processing methods recommended sample volume biocredit covid<NUMBER> ag kit <NUMBER> ul unify sample volume <NUMBER> ul sample volume used evaluated two sample processing methods based nature samples less viscous samples samples need preparation <NUMBER> ul sample added directly sample well device swab provided kit used collect samples swab immersed provided assay diluent tube subsequent procedures carried according manufacturers instructions effort compare performance two sample processing methods ie methods handling less viscous viscous samples lod determined using serial tenfold dilution virus results compared rtpcr viral culture j u r n l p r e p r f lod rad test <NUMBER> fold less sensitive viral culture <NUMBER> ul sample added directly sample well device rad <NUMBER> <NUMBER> viral culture <NUMBER> <NUMBER> pcr sensitive assay detecting sarscov<NUMBER> virus <NUMBER> <NUMBER> rad test marked differences sensitivity using provided swab transfer sample assay diluent tube adding <NUMBER> ul suspension sample well fold difference two rad sample processing method least <NUMBER> fold table <NUMBER> seemed related volume sample used dilution effect assay diluent tube shown table <NUMBER> figure <NUMBER> rad test detected <NUMBER> <NUMBER> realtime rtpcrpositive high viral load samples covid<NUMBER> patients however detected <NUMBER> normal viral load samples crossreactivity test using virus isolates tested negative rad test study determined performance characteristics rad test limitations study include fact employed modified sample processing method perform rad test added sample directly sample well device instead using swab provided kit collect samples immerse swab provided assay diluent tube add suspension sample well device however capable determining viral load dependent effect sensitivity j u r n l p r e p r f offering density specificity enables rapid assessment lung lesions latter offering better spatial specificity allows clinicians directly evaluate transverse lung sections well surrounding tissues vasculature <NUMBER> chest radiography generally first test ordered patients suspected suffering sars mers covid<NUMBER> advancing technology artificial intelligence ai system could surve reliable support <NUMBER> radiographs <NUMBER> sars patients found exhibit abnormalities <NUMBER> consolidation <NUMBER> groundglass opacity ggo <NUMBER> <NUMBER> <NUMBER> similarly <NUMBER> mers patients exhibit radiographic abnormalities <NUMBER> ggo <NUMBER> consolidation <NUMBER> bronchovascular markings <NUMBER> air bronchogram <NUMBER> diffuse reticulonodular patterning <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> covid<NUMBER> patients chest radiographic abnormalities observed <NUMBER> patients <NUMBER> ggo <NUMBER> consolidation <NUMBER> pneumothorax <NUMBER> <NUMBER> <NUMBER> <NUMBER> significant differences rates radiographic abnormalities among three coronavirus infections p <NUMBER> spatial location lesions coronavirus pneumonia patients also important diagnostic prognostic consideration sars patients exhibited unilateral bilateral involvement <NUMBER> <NUMBER> cases respectively <NUMBER> <NUMBER> patients exhibiting single multiple infiltration respectively lower lung susceptible infection <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> unilateral bilateral involvement observed <NUMBER> <NUMBER> mers patients respectively <NUMBER> <NUMBER> patients similarly exhibiting single multiple infiltration respectively interstitial infiltration detected <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> unilateral bilateral involvement detected <NUMBER> <NUMBER> covid<NUMBER> patients respectively patients exhibiting single multiple interstitial infiltration <NUMBER> <NUMBER> <NUMBER> cases respectively lower lung susceptible infection <NUMBER> patients <NUMBER> <NUMBER> <NUMBER> results suggest covid<NUMBER> mers commonly associated bilateral lung involvement relative sars whereas sars mers associated similar infiltration rates overall extant radiographic data suggest chest radiography aid diagnosis coronavirus pneumonia although still potential misdiagnosis ct scans important affected patients table <NUMBER> ct scans increasingly common diagnostic tools owing recent advances lowdose highresolution imaging techniques similar chest radiography ai system involving <NUMBER> <NUMBER> ct scans <NUMBER> sars patients found exhibit abnormalities <NUMBER> exhibiting ggo <NUMBER> exhibiting consolidation <NUMBER> exhibiting interlobular septal thickening <NUMBER> exhibiting crazy paving pattern <NUMBER> exhibiting parapneumonic effusion <NUMBER> <NUMBER> <NUMBER> contrast <NUMBER> mers patients found exhibit ct abnormalities <NUMBER> ggo <NUMBER> consolidation <NUMBER> pleural effusion <NUMBER> interlobular septal thickening <NUMBER> ct scans offer excellent spatial specificity effectively used assess lesion variability radiographic scans ct scans sars patients identified <NUMBER> <NUMBER> lesions unifocal multifocal respectively <NUMBER> <NUMBER> unilobar multilobar respectively <NUMBER> unilateral <NUMBER> bilateral <NUMBER> exhibiting lower lobe involvement <NUMBER> exhibiting peripheral subpleural involvement <NUMBER> <NUMBER> <NUMBER> contrast <NUMBER> mers lesions found unilateral remaining <NUMBER> bilateral <NUMBER> exhibiting lower lobe involvement <NUMBER> peripheral subpleural <NUMBER> <NUMBER> unifocal multifocal lung lesions observed <NUMBER> <NUMBER> covid<NUMBER> patients respectively unilobar multilobar lesions detected <NUMBER> <NUMBER> patients respectively <NUMBER> <NUMBER> exhibiting unilateral bilateral involvement respectively addition <NUMBER> exhibiting lower lobe involvement <NUMBER> exhibiting peripheral subpleural involvement <NUMBER> exhibiting central involvement <NUMBER> <NUMBER> <NUMBER> line chest radiographic findings results suggest mers covid<NUMBER> associated diffuse disease sars potentially due underlying differences pathological mechanisms diseases overall data suggest ct scans offer markedly higher diagnostic efficacy relative chest radiography p <NUMBER> however ct scans cannot reliably identify infections article protected copyright rights reserved associated specific virus reliably differentiate viruses <NUMBER> even owing excellent diagnostic utility ct scans primary mode imaging examination patients suspected coronavirus pneumonia present guidelines indicate formal sarscov<NUMBER> diagnosis dependent upon results laboratory examinations swab test qpcr analyses <NUMBER> however laboratory testing timeand resourceintensive test kits swabs available sufficient quantities areas rapid viral spread diagnostic approaches also hampered potential falsenegative results due laboratory errors lack sufficiently highquality sample analysis <NUMBER> <NUMBER> order aid precise diagnostic evaluation patients coronavirus pneumonia herein compared extant data pertaining abnormal ct findings qpcr results disease context significant differences ct qpcr findings observed mers patients owing relatively limited literature surrounding emerging virus p <NUMBER> significant differences ct qpcr results observed sars covid<NUMBER> cases p <NUMBER> p <NUMBER> table <NUMBER> qpcr analyses achieve <NUMBER> specificity <NUMBER> <NUMBER> <NUMBER> order require access sufficient viral specimen bronchoalveolar lavage fluid balf samples associated <NUMBER> viral positivity rate one study sputum samples associated lower positivity rate <NUMBER> <NUMBER> nasal swab detection rates lower still <NUMBER> <NUMBER> <NUMBER> may consequence number different factors pertaining sample collection methodology timing sample transport sample testing parameters lower respiratory samples potential offer greater diagnostic sensitivity even nasopharyngeal oropharyngeal qpcr tests yield negative results serological testing also used followup approach clinically suspected disease <NUMBER> also vital clinicians implement appropriate infection control strategies patients suspected disease including patients exhibit negative qpcr findings exhibit imaging signs consistent coronavirus pneumonia <NUMBER> single swabbased test also sufficient reliably rule possibility infection study mers patients <NUMBER> patients found positive single swab test <NUMBER> found positive following two consecutive swabs <NUMBER> positive following three consecutive swab tests <NUMBER> initial negative test results high risk falsenegative findings repeated testing therefore essential order ensure appropriate patient quarantine management respect ct scans relatively low rates covid<NUMBER> misdiagnosis <NUMBER> suggest radiologic diagnoses may reliable means quickly detecting cases coronavirus pneumonia facilitate rapid effective patient quarantine management <NUMBER> ai study related ct scan achieved test accuracy <NUMBER> <NUMBER> ci <NUMBER> sensitivity <NUMBER> <NUMBER> ci <NUMBER> specificity <NUMBER> <NUMBER> ci <NUMBER> receiver operating characteristic accepted article roc auc <NUMBER> precisionrecall pr auc <NUMBER> concluded ai assistance improved radiologists performance distinguishing covid<NUMBER> noncovid<NUMBER> pneumonia chest ct <NUMBER> scans may also value patients initially exhibit negative pcr findings example xie et al <NUMBER> reported five patients negative sarscov<NUMBER> initial qpcr tests exhibited typical covid<NUMBER> ct findings including ggo consolidation patients isolated subsequent repeated qpcr testing eventually confirmed five patients infected sarscov<NUMBER> <NUMBER> similarly research conducted ai et al <NUMBER> revealed positive chest ct findings detected <NUMBER> symptomatic patients negative qpcr findings serial rtpcr ct scans patients suggested mean interval <NUMBER> ± <NUMBER> days initial negative qpcr positive qpcr findings <NUMBER> comprehensive strategy reached higher sensitivity <NUMBER> retrospective study table <NUMBER> <NUMBER> ct scans expose patients higher radiation doses relative risks benefits exposure must determined radiologists clinicians context severe pandemic disease ct scans valuable tool may essential order accurately quickly identify isolate covid<NUMBER> patients however combination laboratory testing imaging essential order accurately identify covid<NUMBER> patients confidence ct scans ordered patients negative qpcr results nonetheless suspected suffering coronavirus pneumonia patients test positive sarscov<NUMBER> infection small risk falsepositive diagnosis essential strictly isolated individuals order limit ability virus spread vulnerable communities summary present review surveyed results prior studies sars mers covid<NUMBER> patients effort establish diagnostic approaches efficacious coronavirus pneumonia found ct scans associated higher detection rates qpcr tests nonetheless important clinicians utilize combination imaging laboratory findings inform diagnostic process patients rapidly identified quarantined thus stemming spread deadly pandemic viruses article protected copyright rights reserved rtpcr reverse transcriptionpolymerase chain reaction qpcr realtime quantitative reverse transcriptionpolymerase chain reaction one study related serological test mers lack data disease since spread rapidly around world cases currently reported <NUMBER> countries five continents <NUMBER> disease features give rise great concern including poorly understood epidemiology pathogenesis absence definitive diagnostic tests specific treatments incubation period allows rapid spread along international airtravel routes incompletely understood pattern nosocomial transmission mounting evidence certain source cases make special contribution rapid spread infection disturbing concentration cases previously healthy hospital staff initial case fatality <NUMBER> initially unclear causal agent <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> developing emergency plans contain outbreak prevent international spread worked principle unidentified causal agent could lead exceptionally dangerous outbreak rapid development scientific knowledge would needed reduce opportunities sars establish endemicity identification causal agent development diagnostic test given paramount importance overall containment strategy <NUMBER> <NUMBER> view epidemiologists virologists long causal agent remained unknown specific interventions agent available specialists infectious disease control would forced resort control tools isolation quarantine members global influenza surveillance network <NUMBER> national influenza centres <NUMBER> countries four collaborating centres already increased vigilance novel influenza virus reports received early february <NUMBER> guangdong province china <NUMBER> cases five deaths caused atypical pneumonia unknown cause <NUMBER> laboratory analyses influenza viruses reported negative <NUMBER> feb <NUMBER> influenza network activated emergency pandemic response plans receiving report department health hong kong confirming presence avian influenza virus subtype h<NUMBER>n<NUMBER> boy aged <NUMBER> years whose family travelled fujian province china january <NUMBER> laboratories influenza network ruled influenza virus strains known causes pneumonia samples taken hanoi singapore hong kong sars looked increasingly like new disease epidemiological evidence suggested persontoperson transmission major route <NUMBER> causative agent maintained pathogenicity transmissibility sars could become first severe new disease <NUMBER>st century global epidemic potential exception aids new diseases emerged past two decades established endemicity new geographical areas features limit capacity pose major threat international public health example avian influenza nipah virus hendra virus hanta virus establish efficient humantohuman transmission <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> diseases escherichia coli o<NUMBER>h<NUMBER> variant creutzfeldtjakob disease depend food vehicle transmission <NUMBER> <NUMBER> diseases west nile fever rift valley fever spread new geographical areas require vector part transmission cycle associated low mortality although frequently occur highrisk groups elderly immunocompromised people comorbidity <NUMBER> <NUMBER> still others neisseria meningitidis w<NUMBER> ebola marburg crimeancongo haemorrhagic fevers strong geographical foci <NUMBER> <NUMBER> although outbreaks ebola haemorrhagic fever associated case fatalities <NUMBER> uganda <NUMBER> democratic republic congo persontoperson transmission requires close physical exposure infected blood bodily fluids <NUMBER> severe acute respiratory syndrome new disease human beings first recognised late february <NUMBER> hanoi vietnam severity disease combined rapid spread along international airtravel routes prompted set network scientists <NUMBER> laboratories around world try identify causal agent develop diagnostic test network unites laboratories different methods capacities rapidly fulfil postulates establishing virus cause disease results shared real time via secure website microscopy pictures protocols testing pcr primer sequences also posted findings discussed daily teleconferences progress facilitated sharing laboratories samples test materials network identified new coronavirus consistently detected samples sars patients several countries conclusively named causative agent sars strain unlike known member genus coronavirus three diagnostic tests available limitations march <NUMBER> <NUMBER> day issued emergency travel advice response sars set network scientists <NUMBER> leading laboratories around world expedite identification causative agent sars rapidly develop robust reliable diagnostic test network modelled partly global influenza network however urgency increasingly seen publichealth emergency called rapid adaptation meet unique needs ensure virtual collaboration laboratories approached telephone throughout weekend march <NUMBER> <NUMBER> objective secure participation laboratories outstanding experience detection wide range viruses microorganisms history collaboration international investigations coordinated access sars samples capacity fulfil six criteria kochs postulates required establish virus cause disease <NUMBER> laboratories asked join agreed work according set rules confidentiality data rules specified data information shared among members research project would used advance project collaborative way specific scientific data could shared outside network approval laboratory data information originated avoid discrepancies official national case notification laboratory information data cases samples treated separately epidemiological information open sharing among academic competitors required trust willingness work together collaboration continued daily teleconferences use secure website post electron microscopy pictures candidate viruses protocols testing phylogenetic trees pcr primer sequences results various diagnostic tests arrangements allow simultaneous analyses samples patient several laboratories different approaches realtime sharing results laboratories areas sars cases including canada germany france hong kong uk usa singapore regularly exchange samples despatch materials laboratories netherlands japan initially spared sars cases early april laboratories beijing guangdong province china joined network march <NUMBER> <NUMBER> network laboratories reported available samples reviewed past planned intervention strategies catalogued available laboratory experience capacities initially bacterial viral rickettsia chlamydia pathogens primarily associated respiratory disease pathogens respiratory symptoms might secondary targeted detection methods used include light electron microscopy immunohistochemistry animal inoculation bacterial cellculture isolation techniques serology pcr analyses march <NUMBER> participating laboratories germany reported paramyxovirus singaporean origin electron microscopy isolated respiratory samples sars patient frankfurt directly linked singapores index case simultaneously chinese university hong kong shared equivocal results generic specific human metapneumovirus pcr primers samples patients developed sars contact hong kongs index case pcr primers tested three additional patients findings positive human metapneumovirus sequences primers shared electronically networks secure website next day singapore laboratory noted pleiomorphic virus electron microscopy respiratory samples sars patients rotterdam laboratory human metapneumovirus first discovered sent car frankfurt overnight obtain samples sars patients <NUMBER> japanese laboratory reported negative results pcr bronchoalveolar lavage serum antibody obtained index case hanoi laboratory found evidence influenza b viruses respiratory syncytial virus parainfluenza viruses human metapneumovirus nipah virus hendra virus hanta virus lassa ebola marburg crimeancongo haemorrhagic fever viruses march <NUMBER> human metapneumovirus primers tested four additional laboratories chinese university hong kong found paramyxoviruslike particles respiratory samples rotterdam laboratory detected human metapneumovirus samples frankfurt rotterdam laboratory sent test kits human metapneumovirus singapore hong kong laboratories shared via website phylogenetic tree isolated paramyxovirus laboratory canada shipped convalescent sera rotterdam testing isolates daily conference call singapore laboratory reported round pleomorphic structures samples scientists germany hong kong described similar findings march <NUMBER> teleconference laboratory rotterdam established respiratory samples cluster tested germany singapore patients negative human metapneumovirus pcr laboratory also isolated agent caused cytopathogenic effect vero monkey kidney cell lines laboratories uk also detected h<NUMBER>n<NUMBER> influenza virus two suspected sars cases laboratory canada detected human metapneumovirus pcr samples two patients provided electronmicroscopy picture small virus particles around <NUMBER> nm seen bronchoalveolar lavage time german laboratory isolated agent vero cells murine cell line l<NUMBER> laboratories also ruled presence respiratory pathogens influenza b viruses respiratory syncytial virus parainfluenza viruses type <NUMBER> <NUMBER> <NUMBER> adenovirus rhinovirus enterovirus human metapneumovirus mycoplasma pneumoniae chlamydia pneumoniae later day scientists hong kong university sent email indicating isolated agent two patients sars agent isolated continuous rhesus monkey kidney cells produced cytopathogenic effect indicating growth virus addition immunofluorescence assay virusinfected cells done blinded trial sera sars patients rising antibody titres new virus isolate contrast sera blood donors taken long disease emerged hong kong antibody virus furthermore viruslike particles cytoplasm cell membrane seen thin electron microscopic sections infected cells findings proved turning point search sars causative agent march <NUMBER> laboratory usa isolated virus caused cytopathogenic effect vero e<NUMBER> cells patient thailand showed presence coronaviruslike particles electron microscopy size <NUMBER> nm samples patient us laboratory found positive pcr signals primers picornavirus later identified rhinovirus government virus unit hong kong us laboratory sent electron microscopy pictures coronaviruslike particles posted website simoultaneously laboratories canada paris chinese university detected paramyxovirus human metapneumovirus electron microscopy pcr various samples singapore laboratory detected human metapneumovirus test kit supplied rotterdam scientists government virus unit hong kong provided laboratory usa convalescent sera laboratory canada found particles <NUMBER> nm size electron microscopy posted phylogenetic tree human metapneumovirus sequences secure website march <NUMBER> laboratory usa confirmed classification coronavirus based coronaviruslike sequence pcramplified product posted initial primers amplification website government virus unit hong kong tested inhouse coronavirus primers found coronavirus rna two eight samples usa laboratory reported presence coronavirus postmortem kidney samples hong kong also developed immunofluorescence assay detection seroconversion trials nonhuman primates started intratracheal infection nasopharyngeal swabs taken singapore hong kong laboratories paris canada found coronavirus respiratory samples electron microscopy pcr respectively suckling mice hamsters inoculated <NUMBER> days previously pasteur unit lyon samples frankfurt hanoi described still healthy remained laboratories germany japan singapore isolated cytopathogeniceffectcausing agent vero cells laboratories uk detected specific pcr four pneumovirus sequences respiratory samples probable suspected cases consistent human metapneumovirus march <NUMBER> <NUMBER> coronavirus detected pcr electron microscopy laboratories laboratories germany hong kong developed shared refined primers detected new coronavirus german laboratory pcr products sequenced two matched protein level polymerase gene known coronaviruses several laboratories reported coronavirus particles electron microscopy respiratory samples faeces sequencing new coronavirus began laboratories germany rotterdam hong kong german laboratory hong kong university laboratory posted website first phylogenetic trees group collectively discovered new coronavirus <NUMBER> march <NUMBER> <NUMBER> hong kong university made available virus isolate members network monkey trials continued first coronavirus isolates obtained hong kong university us laboratory reported negative results antibodies new coronavirus large numbers blooddonor serum samples virus antibodies rna pcr however consistently detected increasing numbers sars patients many network laboratories laboratory japan received samples singapore hong kong identified new coronavirus also confirmed seroconversions also developed pcr primers immunofluorescence assay system igm hong kong university reported <NUMBER> <NUMBER> paired sera patients clinically typical sars showed rising titres antibody new coronavirus detected rna faeces five ten sars patients government virus unit hong kong reported consistently positive pcr new coronavirus faeces sars patients days <NUMBER> <NUMBER> onset clinical signs laboratory germany found rna new coronavirus conjunctival liquid one patient day onset clinical symptoms human metapneumovirus continued detected samples sars cases various countries suggests sars might caused coinfection two viruses coronavirusprimers used various laboratories resulting increasing number positive samples parallel human metapneumovirus isolated found pcr various samples patients canada april <NUMBER> <NUMBER> netherlands laboratory monkeys infected new coronavirus human metapneumovirus bothfirst coronavirus followed metapneumovirus animals infected coronavirus alone developed fullblown disease animals infected human metapneumovirus developed mild rhinitis monkeys infected coronavirus metapneumovirus develop serious disease monkeys infected metapneumovirus alone basis findings network scientists collectively agreed coronavirus alone cause symptoms sars seen human beings however coinfection agents including chlamydia human metapneumovirus could result severe clinical course elisa tests developed laboratory usa detected antibodies day <NUMBER> onset clinical signs hong kong university laboratory reported indirect fluorescence detection antibodies igm day <NUMBER> additional mice hamster infection trials started pasteur unit lyon invitro ribavirin efficacy trials began rotterdam germany laboratory japan began human interferon efficacy trials chinese laboratory beijing continued report chlamydia postmortem samples sars patients april <NUMBER> <NUMBER> month network began function participating laboratories collectively announced conclusive identification new coronavirus causative agent sars announcement made based results monkey studies done netherlands laboratory virus found many sars patients several countries virus causes cytopathogenic effect two cell lines vero cells fetal rhesus kidney cells electron microscopy cell culture respiratory samples sars patients show coronaviruslike particles immunofluorescent assays serum convalescent patients detect cells infected virus cell culture reactivity new coronavirus could detected serum several hundreds nonsars individuals usa canada hong kong generic coronavirus primers detect new coronavirus rna cell culture samples sars patients specific primers developed several laboratories currently compared sensitivity hyperimmune sera transmissible gastroenteritis virus feline infectious peritonitis virus <NUMBER>e human coronavirus react virus antigen cell culture partial sequencing new coronavirus several laboratories confirmed affiliation genus coronavirus shown dissimilarities known members belonging three existing groups genus three diagnostic tests available limitations since elisa detects antibodies reliably day <NUMBER> onset clinical symptoms cannot used detect cases potentially spread infection others second test immunofluorescence assay detects antibodies reliably day <NUMBER> infection various versions realtime blockbased pcr tests currently developed improve low sensitivity reduce number falsenegative test results existing tests used individually combination confirm disease suspected probable sars cases work needed reliable easytouse sensitive tests become available countries work towards objective continuing proceeding rapid pace laboratory contributed substantially rapid identification characterisation new coronavirus associated sars <NUMBER> <NUMBER> <NUMBER> lower respiratory tract infections lrtis cause significant hospitalization among children <NUMBER> years old <NUMBER> <NUMBER> although infections usually relatively mild children develop respiratory failure necessitating mechanical ventilation admission paediatric intensive care unit picu aetiology severe lrti often difficult establish however majority lrtis young age group believed caused respiratory viruses detection respiratory viruses two conventional methods commonly used viral culture direct immunofluorescence dif assays addition third method based molecular techniques become available namely realtime pcr specifically realtime pcr format provides rapid results within clinically relevant period time allows quantitative virus detection postpcr processing needs performed moreover compared standard format pcr risk contamination strongly reduced realtime pcr rendering falsepositive results realtime pcr highly unlikely <NUMBER> currently guidelines regarding viral tests appropriate young children lrti picu <NUMBER> conventional detection methods several disadvantages dif direct immunofluorescence hmpv human metapneumovirus lrti lower respiratory tract infection pcr polymerase chain reaction picu paediatric intensive care unit piv parainfluenzavirus rsv respiratory syncytial virus rt reverse transcriptase compared realtime pcr viral culture considered gold standard detection respiratory viruses limitation detect small number furthermore yield viral culture depends quality sampling correct transport storage samples type cells used addition technique turnaround time several days weeks therefore unable guide initial patient management results dif assays available rapidly shown improve patient outcome less antibiotic use shorter hospital stay <NUMBER> <NUMBER> <NUMBER> unfortunately dif assay less sensitive culture detection certain pathogens pcr shown sensitive conventional techniques fast <NUMBER> <NUMBER> <NUMBER> <NUMBER> additional advantages pcr include ability identify multiple viruses simultaneously detect viral atypical pathogens cannot cultured dif commercially available example coronaviruses human metapneumovirus hmpv chlamydia pneumoniae mycoplasma pneumoniae rapid sensitive testing broad range respiratory viruses vital picu improve understanding severe viral respiratory infections furthermore used guide cohorting strategies may protect critically ill children guide initial therapy finally evaluation viral tests may future importance antiviral therapy becomes widely available present study conventional methods viral culture dif compared realtime pcr ability detect respiratory viruses young children lrti admitted picu secondary objectives describe presence viral pathogens bacterial infection lrti patients picu children aged <NUMBER> years admitted picu wilhelmina childrens hospital lrti enrolled one winter season december <NUMBER> may <NUMBER> wilhelmina childrens hospital tertiary university hospital <NUMBER> bed picu facility serves referral centre central part netherlands patients eligible admission diagnosis probable bronchiolitis probable pneumonia respiratory failure exclusion criteria primary cardiac central origin respiratory failure overt sepsis time admission study described conducted part normal patient care therefore according medical ethical research council institution need patient consentethical approval sputa andor nasopharyngeal aspirates obtained eligible patients viral testing viral culture dif realtime pcr assays addition sputum blood samples available cultured processed accordance standard microbiological procedures sputum samples taken standardized manner sterile transtracheal aspiration intubated children material obtained used immediate viral culture rsv influenzaviruses parainfluenzaviruses pivs <NUMBER> picornaviruses adenoviruses herpesviruses llcmk<NUMBER> rd rhela hep<NUMBER>c cells cultures examined twice weekly development cytopathological effect positive cultures virus identified immunofluorescence monoclonal antibodies rsv types b influenzaviruses b piv <NUMBER> adenoviruses dako glostrup denmark rhinoviruses identified using acid lability tests material subjected dif assays detect respiratory syncytial virus rsv influenzaviruses piv <NUMBER> adenoviruses using imagen kits dako accordance manufacturers recommended protocol remaining material used realtime pcr testing nucleic acids extracted using total nucleic acid protocol magna pure lc nucleic acid isolation system roche diagnostics basel switzerland sample eluted <NUMBER> µl buffer sufficient realtime pcr analyses cdna synthesized using multiscribe reverse transcriptase rt random hexamers applied biosystems foster city ca usa <NUMBER> µl reaction mixture contained <NUMBER> µl eluted rna <NUMBER> µl <NUMBER> × rt buffer <NUMBER> mmoll mgcl <NUMBER> <NUMBER> µmoll deoxynucleoside triphosphate <NUMBER> µmoll random hexamer <NUMBER> u rnase inhibitor per microlitre applied biosystems incubation <NUMBER> minutes <NUMBER>°c rt carried <NUMBER> minutes <NUMBER>°c followed rt inactivation <NUMBER> minutes <NUMBER>°c detection viral atypical pathogens performed parallel using realtime pcr assays specific following rsv b influenzavirus b piv <NUMBER> rhinoviruses adenoviruses human coronavirus oc<NUMBER> nl<NUMBER> <NUMBER>e hmpv mycoplasma pneumoniae chlamydia pneumoniae realtime pcr procedures performed described previously <NUMBER> <NUMBER> <NUMBER> briefly samples assayed duplicate <NUMBER> µl reaction mixture containing <NUMBER> µl cdna <NUMBER> µl <NUMBER> × taqman universal pcr master mix applied biosystems <NUMBER> nmoll forward reverse primers <NUMBER> nmoll probes samples spiked extraction internal control virus murine encephalomyocarditis virus rna virus phocine herpes virus dna virus monitor efficient extraction amplification essentially described previously <NUMBER> patients medical records reviewed clinical data demographic data following clinical characteristics outcomes extracted entered standardized forms gestational age underlying disease length picu stay need mechanical ventilation death five criteria used classify presence bacterial infection admission picu stay new infiltrate chest radiograph increased need supplemental oxygen fever temperature <NUMBER>°c greater increased infectious parameters creactive protein <NUMBER> mgl andor white blood cell count <NUMBER> × <NUMBER> <NUMBER> l positive bacterial culture blood sputum purpose study bacterial infection possible bacterial infection proven bacterial infection defined presence fewer two two three three criteria respectively analysis continuous variables unpaired test used compare means categorical variables analyzed using twotailed fishers exact test twentysix picu patients met inclusion criteria one patient admitted positive rsv test result outside hospital testing performed institution another patient diagnosed bacterial pneumonia subjected virus tests insufficient material obtained third patient perform respiratory tests consequently <NUMBER> patients included subsequent analysis median age patients <NUMBER> months majority referred outside hospital table <NUMBER> picu patients formed heterogeneous group many patients underlying conditions resulting preterm birth birth defects patients stayed picu median <NUMBER> days <NUMBER> <NUMBER> patients needed mechanical ventilation two patients study group died one child suffered bronchiolitis progressive bronchospasms end could controlled second child complex underlying conditions eliminating treatable causes including lrti patient died central hypoventilation viral culture identified respiratory virus six picu patients rsv adenovirus detected four two patients respectively table <NUMBER> dif assay appeared sensitive detect respiratory viruses viral culture population identifying virus <NUMBER> <NUMBER> patients including six patients diagnosed viral culture realtime pcr detected total <NUMBER> respiratory viruses <NUMBER> <NUMBER> patients positive results found conventional techniques confirmed realtime pcr rsv single common respiratory virus found detected <NUMBER> <NUMBER> patients addition rhinovirus found six <NUMBER> patients influenzavirus adenovirus coronavirus detected three <NUMBER> children piv<NUMBER> hmpv found one patient <NUMBER> piv<NUMBER> piv<NUMBER> atypical pathogens mycoplasma pneumoniae chlamydia pneumoniae could detected lrti patients eight <NUMBER> children one virus detected six children dual infection one triple one quadruple respiratory virus infection rsv detected seven eight children infected multiple viruses including three patients infected coronavirus <NUMBER> children single infection nine rsv five patients infection rhinovirus n <NUMBER> influenzavirus n <NUMBER> adenovirus n <NUMBER> hmpv n <NUMBER> present study conventional methods viral culture dif compared realtime pcr ability detect respiratory viruses young children admitted picu lrti use realtime pcr increased diagnostic yield <NUMBER> <NUMBER> viruses found conventional methods confirmed realtime pcr whereas conventional methods double infections found realtime pcr revealed multiple virus infections <NUMBER> patients high diagnostic yield pcr compared conventional techniques agreement findings others conducting medline search <NUMBER> september <NUMBER> search terms lrti pcr rsv respiratory viruses identified <NUMBER> hospitalbased paediatric studies compared pcr conventional techniques two respiratory viruses <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> pcr found excellent sensitivity studies conventional methods considered reference standard <NUMBER> summary studies showed pcr increased diagnostic yield <NUMBER> compared conventional techniques however studies selected patients basis respiratory test results rather selecting patients admission diagnosis exceptions include studies conducted weinberg coworkers <NUMBER> jennings colleagues <NUMBER> weinberg coworkers <NUMBER> tested samples <NUMBER> hospitalized children selected patients admission diagnoses new vaccine surveillance network pcr assays used test rsv influenzaviruses piv <NUMBER> viral culture <NUMBER> <NUMBER> specimens positive compared <NUMBER> <NUMBER> positive specimens pcr jennings colleagues <NUMBER> enrolled <NUMBER> hospitalized children using case definition acute respiratory infection performed viral diagnostics broad range viruses pcr identified <NUMBER> additional viruses adding total <NUMBER> viruses found <NUMBER> <NUMBER> children <NUMBER> clinical relevance detection respiratory viruses rhinovirus coronavirus matter debate rhinovirus <NUMBER> coronavirus <NUMBER> well recognized causes common cold hand increasing evidence also important causes severe lower respiratory disease rhinovirus infections reported elderly adults lrti pneumonia <NUMBER> <NUMBER> immunocompromised patients <NUMBER> <NUMBER> coronavirus infection also reported cases lrti <NUMBER> <NUMBER> <NUMBER> <NUMBER> realtime pcr provide insight role played viruses aetiology lrti high yield pcr compared conventional techniques could theoretically result contamination however using realtime pcr likelihood falsepositive results caused carryover contamination reduced minimum achieved use modified nucleotides dutp uracildna glycosylase ung control contamination pcrbased amplification cdna well closedtube detection system <NUMBER> addition procedures dnarna isolation amplification several negative controls included monitor possible falsepositive findings additional advantage realtime pcr standardformat pcr allows highthroughput screening patient samples presence many different pathogens realtime pcr assays included testing rsv influenzaviruses pivs also rhinoviruses adenoviruses recently discovered hmpv <NUMBER> coronaviruses oc<NUMBER> <NUMBER>e newly identified coronavirus nl<NUMBER> <NUMBER> atypical pathogens mycoplasma pneumoniae chlamydia pneumoniae thus realtime pcr allows maximal detection multiple viral atypical infections children lrti negligible risk falsepositive results picu patients studied found high prevalence multiple viral infections <NUMBER> including triple even quadruple infections previous studies detection multiple infections varied considerably ranging <NUMBER> <NUMBER> low prevalence found studies using pcr rsv influenzaviruses pivs <NUMBER> <NUMBER> contrast high prevalence found studies included broad range respiratory viruses including rhinovirus adenovirus coronavirus hmpv <NUMBER> interestingly latter study coronaviruses identified part multiple virus infections three four accordance findings prevalence possible proven bacterial infection study group high <NUMBER> fact almost half children diagnosed possible bacterial infection indicates difficulty precluding diagnosis addition previous studies showed viral infection may pave way bacterial infection <NUMBER> study compared viral diagnostic methods similar population picu patients report prevalence bacterial infections compare finding studies <NUMBER> contrast high prevalence possible proven bacterial infection found study group demonstrate infections atypical pathogens mycoplasma pneumoniae chlamydia pneumoniae speculated atypical pathogens play important role children severe lrti small study group included study represents limitation allow us find association clinical characteristics multiple infections furthermore samples negative conventional methods positive realtime pcr could confirmed using true gold standard standard respiratory viruses exist problem encountered studies respiratory viruses finding realtime pcr increases yield viral diagnoses picu patients lrti implications clinical practice rapidity sensitivity realtime pcr test results help clinician initiate appropriate cohorting strategies prevent critically ill children nosocomial viral infections reliable rapid viral test result also taken account prescribing discontinuing antibiotic treatment study designed determine antibiotic treatment lrti picu warranted high percentage possible proven bacterial infections viral lrti patients indicates antibiotic treatment poses dilemma picu clinical impact high prevalence multiple virus infections detected picu remains unclear associated different clinical characteristics research larger numbers patients agematched control groups needed determine real clinical impact multiple infections determine whether use realtime pcr prevents unnecessary antibiotic treatment however realtime pcr offers rapid sensitive highly reliable new technique may improve understanding epidemiology severe lrtis realtime pcr broad range respiratory viruses found highly sensitive children severe lower respiratory tract infection picu addition realtime pcr increased diagnostic yield positive samples twofold compared conventional methods viral culture dif whereas conventional methods identified multiple infections realtime pcr found prevalence multiple infections <NUMBER> realtime pcr rapid sensitive technique able guide initial patient cohorting strategies therapy picu • realtime pcr detection respiratory viruses sensitive reliable method picu patients lrti increases diagnostic yield compared conventional methods • realtime pcr allows detection multiple viral infections found <NUMBER> patients study identified using conventional methods • rapidity sensitivity realtime pcr test results help clinician initiate appropriate cohorting strategies prevent critically ill children acquiring nosocomial viral infections urgent need rapid diagnosis sarscov<NUMBER> infected covid<NUMBER> patients even immune response occur asymptomatic carriers critical making decisions public health measures movement restrictions quarantine duration nucleic acid testing detecting viral rna feasible practical method currently common method nucleic acid diagnosis based real time rtpcr drosten et al <NUMBER> mackay et al <NUMBER> espy et al <NUMBER> example bgi china httpswwwbgicomkit us cdc httpswwwcdcgovcoronavirus <NUMBER>ncovabouttestinghtml provide reagents primers probes support rtpcr diagnosis sarscov<NUMBER> although realtime rtpcr sensitive reliable timeconsuming <NUMBER> h requires specific detection device instrument limits broad application current huge demand global pandemic address challenge fast simpletooperate test kit would highly desirable test virus infected patients could identified early stage quarantined prevent spread infection whilst noninfected individuals could carry life usual ideally test kit mobile without need complicated instrument test result read naked eye hence used airports railway stations hospitals particularly regional hospitals medical centres rural areas loopmediated isothermal amplification lamp rapid technology dna amplification notomi et al <NUMBER> tomita et al <NUMBER> applied pathogen detection virus bacteria malaria thai et al <NUMBER> boehme et al <NUMBER> mori notomi <NUMBER> law et al <NUMBER> reboud et al <NUMBER> lamp reaction generally takes place constant temperature target dna amplified <NUMBER> min tomita et al <NUMBER> lamp method employs <NUMBER> <NUMBER> primers bind six regions target dna specificity extremely high notomi et al <NUMBER> tomita et al <NUMBER> since lamp method needs one constant temperature usually <NUMBER>°c device simple initially lamp uses <NUMBER> primers notomi et al <NUMBER> tomita et al <NUMBER> later found addition two loop primers shorten half time required original lamp reaction nagamine et al <NUMBER> availability warmstart rtx reverse transcriptase new england biolabs uk makes possible combine reverse transcription lamp one reaction since sarscov<NUMBER> rna virus length <NUMBER> kb wang et al <NUMBER> single reaction reverse transcription rt lamp together significantly shorten reaction time without dna purification step rt thus rapid detection sarscov<NUMBER> achieved work developed covid<NUMBER> diagnosis kit rapid detection sarscov<NUMBER> using onestep reverse transcription loopmediated isothermal amplification rtlamp whole reaction short <NUMBER> min constant <NUMBER>°c detection limit <NUMBER> copies viral rna per ml sample simple colour change indication visualized naked eye confirm result viral rna amplification kits validated <NUMBER> clinical covid<NUMBER> samples new technique also provide rapid feasible approach detection various virus specificity o<NUMBER> s<NUMBER> n<NUMBER> n<NUMBER> primers amplify synthesized dna sarscov<NUMBER> designed four sets lamp primers o<NUMBER> s<NUMBER> n<NUMBER> n<NUMBER> target rna encoding orf<NUMBER>ab spike glycoprotein two regions nucleocapsid protein sarscov<NUMBER> respectively fig s<NUMBER> set <NUMBER> primers table <NUMBER> sarscov<NUMBER> single stranded rna virus length <NUMBER> kb orf<NUMBER>ab <NUMBER>kb long encoding replicase polyprotein woo et al <NUMBER> o<NUMBER> primers designed cover conversed region <NUMBER>end viral rna orf<NUMBER>ab fig s<NUMBER> s<NUMBER> primers target gene encodes spike glycoprotein key sarscov<NUMBER> virus bind human ace<NUMBER> protein invade human cells menachery et al <NUMBER> cui et al <NUMBER> walls et al <NUMBER> n gene nucleocapsid protein <NUMBER>ʹend viral rna conserved sarslike coronavirus cui et al <NUMBER> sampling rna extraction processes viral rna might attacked rnase degrading <NUMBER>ʹto <NUMBER>ʹ designed n<NUMBER> n<NUMBER> ensure detection <NUMBER>ʹend viral rna sarscov<NUMBER> even though partially degraded targeted sarscov<NUMBER> rna fragments four sets primers fig s<NUMBER> table <NUMBER> <NUMBER> bp long enough targeted <NUMBER> primers short enough achieve rapid amplification experiments lamp rtlamp experiments carried three biological replicates results consistent verify specificity first tested primers using synthetic target dna sarscov<NUMBER> n<NUMBER> n<NUMBER> primers able amplify dna fragments n gene human genomic dna fig <NUMBER>a b adding fluorescent dye provided neb new england biolabs uk positive results visualized directly pcr tubes uv exposure fluorescent intensity amplificationpositive tubes stronger amplificationnegative tubes although fluorescence background also present negative tubes fig <NUMBER>a b fluorescent readouts consistent results electrophoresis gel however fluorescent signal background might cause ambiguous reading requires fluorescent sensitive instrument analyse result changed colorimetric reading later study similarly o<NUMBER> s<NUMBER> primers also specifically amplify synthesized dna fragments orf<NUMBER>ab gene gene respectively unable amplify human genomic dna fig <NUMBER>c addition human genomic dna viral dna reaction mixture interfere amplification performance lane <NUMBER> fig <NUMBER>a b lane <NUMBER> fig <NUMBER>c essential using rtlamp detect viral rna human sample lamp reaction time experiments <NUMBER> min positive amplification products obtained even <NUMBER> copies synthetic viral dna fragment template <NUMBER> min using s<NUMBER> primers lane <NUMBER> fig <NUMBER>d demonstrating lamp reaction rapid sensitive rtlamp sensitivity amplify synthesized rna sarscov<NUMBER> assess potential rtlamp detecting rna virus sarscov<NUMBER> tested performance primers synthesized rna fragments n gene gene orf<NUMBER>ab gene obtained vitro transcription appendix s<NUMBER> shows reverse transcription lamp integrated one single rtlamp reaction specifically amplify viral rna fragments fig <NUMBER> evaluated sensitivity rtlamp diluting copy number rna target <NUMBER> <NUMBER> copies per reaction total <NUMBER> reaction solution examined efficiency sampling reaction mixture <NUMBER> <NUMBER> <NUMBER> min reaction started shows <NUMBER> copies target rna amplified detectable level using n<NUMBER> primers within <NUMBER> min whilst requires <NUMBER> min using n<NUMBER> primers fig <NUMBER>ac sensitivity efficiency rtlamp also tested s<NUMBER> o<NUMBER> primers shown figure <NUMBER> <NUMBER> copies gene rna detected using s<NUMBER> primers <NUMBER> min whilst detection limit using o<NUMBER> primers <NUMBER> copies orf<NUMBER>ab gene rna <NUMBER> min results suggest rtlamp sensitive enough detect viral rna within <NUMBER>min reaction sensitivity <NUMBER> copies <NUMBER> reaction <NUMBER> copies viral rna per ml employing primers n<NUMBER> s<NUMBER> also observed higher copies rna shorter time needed obtain products fig <NUMBER> copy number rna <NUMBER> per reaction amplification result observed short <NUMBER> min fig <NUMBER> since resultreporting using fluorescent dye requires specific instrument fig <NUMBER> also tried read results using naked eye since nucleic acid amplification releases pyrophosphate hydrogen ion decreases ph reaction solution sensitive ph indicator used show positive negative result rtlamp tanner et al <NUMBER> poole et al <NUMBER> hence rtlamp result fig <NUMBER> show colorimetric rtlamp assay reliably detect n genes sarscov<NUMBER> viral rna colour change could indicate number target sequence semiquantitatively fig <NUMBER> colorimetric reading dependent ph change rtlamp however clinical application many factors might interfere ph change example patient sample conditions different introducing uncertain factors ph change rtlamp reaction addition viral rna sarscov<NUMBER> might eluted various buffers might compatible rtlamp reaction could significantly affect colorimetric reading fig s<NUMBER> overcome uncertainty ensure reliability diagnosis results also designed another set fip primers <NUMBER>ʹend conjugated fluorescent fam <NUMBER>carboxyfluorescein table <NUMBER> figure <NUMBER> shows application <NUMBER>ʹfamfip primers able display colorimetric fluorescent readings results consistent comparing results rtqpcr rtlamp shows rtlamp able detect viral rna c <NUMBER> rtqpcr table <NUMBER> suggesting rtlamp visually colour change reading sensitive onestep process nucleic acid detection using rtlamp cell samples processed one single step obtain nucleic acid amplification heating cells temperature rtlamp <NUMBER>°c lyse cells virus release rna study tested onestep process using human episomal induced pluripotent stem cells ipscs suspended <NUMBER> saline figure <NUMBER> shows nucleic acids bactin gene ipsc cells directly amplified using rtlamp within <NUMBER> min <NUMBER> min purified human rna amplified showing colour change fig <NUMBER>a however <NUMBER> min tube human cells changed colour whilst tube without human cells blank water control remained unchanged pink colour fig <NUMBER>b onestep process sensitive enough detect human <NUMBER> cells per <NUMBER>ll reaction onestep process took <NUMBER> min longer rtlamp rna takes <NUMBER> min time lyse cells release nucleic acids result suggests possible use one single step achieve detection specific nucleic acids cells test needed validate practical feasibility clinical swab samples containing sarscov<NUMBER> described fast simpletooperate method diagnose covid<NUMBER> applied rtlamp achieve rapid testing sarscov<NUMBER> using different primers o<NUMBER> s<NUMBER> n<NUMBER> n<NUMBER> target orf<NUMBER>ab gene gene n gene showed <NUMBER> min reaction could detect <NUMBER> copies target rna per <NUMBER> reaction <NUMBER> copies per ml figs <NUMBER> <NUMBER> however extreme sensitivity also doubleedged sword carryover contamination common lamp reactions usually cause false positive results hsieh et al <NUMBER> et al <NUMBER> also observed carryover contamination rtlamp reactions performed several times laboratory suspect aerosol formed rtlamp products able spread everywhere laboratory contaminating labcoats pipettes reagents materials equipment used next reaction thus clinical use components required rtlamp reaction need prepared separate laboratory space good practice molecular biology colorimetric display testing outcome easy without need expensive complicated instrument however colour change rtlamp reaction based ph indicator phenol red tanner et al <NUMBER> poole et al <NUMBER> elution buffers various rna extraction kits significantly affect result hence experiments including clinical tests rna samples eluted dnasernasefree water ensure rna elution buffer minimal impact ph indication rtlamp reactions viral rna clinical tests work well match results rtqpcr tube <NUMBER> samples negative suggesting rna human bactin gene transcript amplified samples fig <NUMBER> fourprimer design human bactin poon et al <NUMBER> might require longer reaction time <NUMBER> min rtlamp assay future better human control applied example primers human rnase gene used positive control ultimate aim develop enclosed device integrates rna extraction purification reverse transcription rt loopmediated isothermal amplification lamp detect sarscov<NUMBER> virus directly throat swab sample wellknown colony pcr done directly using cells huang et al <NUMBER> heating cells cause cell lysis nucleic acid release used template amplification nucleic acids tested onestep rtlamp nucleic acid amplification worked well fig <NUMBER> advantage temperature <NUMBER>°c rtlamp able lyse cells cell lysis pure water low salt affect reaction rtlamp preliminary work suggests possible combine rna extraction rt lamp one single step significantly simplify detection process shorten detection time current criteria test china <NUMBER> copies ml à<NUMBER> preliminary results onestep rtlamp meet requirement proving practicability rtlamp diagnosing covid<NUMBER> first step towards developing accessible diagnostic kit testing crucial getting treatment need also curb spread disease within region face global shortage testing kits amid global pandemic work vital address need clinical practice well extend towards homebased personal diagnostic system proofofconcept work possible develop simple low cost onestep testing kit used screen individuals sarscov<NUMBER> virus table <NUMBER> eight positive samples labelled p eight negative samples labelled n components test kit listed experimental procedures three tubes rtlamp assay <NUMBER> <NUMBER> <NUMBER> order left right tube <NUMBER> <NUMBER> separately contain o<NUMBER> n<NUMBER> primers targeting orf<NUMBER>ab gene n gene sarscov<NUMBER> tube <NUMBER> contain human bactin primers tube <NUMBER> <NUMBER> positive samples turned yellow whilst negative samples remained pink <NUMBER>minute reaction results rtlamp method consistent results conventional rtpcr table <NUMBER> fig s<NUMBER> pointofcare testing poct need onsite rapid test infection operated easily minimal training without risk getting infected existing methods detect sarscov<NUMBER> either based detecting virus rna using reverse transcription realtime polymerase chain reaction rtqpcr technologies based specific igm igg patients blood generated several days infection currently tests would require laboratory specific machines operated skilled scientists technicians take least <NUMBER> h perform ultimate goal development rapid <NUMBER> min enclosed test device onestep operation detection sarscov<NUMBER> virus multiple sites viral rna detected ensure specificity sensitivity internal control embedded prevent false positives false negatives study pave way move forward rapid largescale screening diagnosis patients exhibiting suspected symptoms tested early stages human episomal ipsc line purchased thermo fisher uk used source human genomic dna rna shenzhen luohu peoples hospital authorized chinese cdc detection clinical samples sarscov<NUMBER> virus clinical samples sampled clinical throat swab stored transported virus transport media vtm virus deactivation steps done following standard guidelines detection nucleic acid sarscov<NUMBER> clinical samples research rapid diagnostic technique covid<NUMBER> using clinical samples approved ethical committee shenzhen luohu peoples hospital four sets lamp primers designed targeting orf<NUMBER>ab n genes sarscov<NUMBER> published ncbi <NUMBER> à à ct cycle threshold e e gene envelop protein ic rnase gene internal control n n gene nucleocapsid protein orf<NUMBER>ab orf<NUMBER>ab gene genbank nc<NUMBER> primers designed using lamp primer designing software primerexplorer http primerexplorerjpe tomita et al <NUMBER> six primers including forward primer f<NUMBER> backward primer b<NUMBER> forward inner primer fip backward inner primer bip forward loop primer lf backward loop primer lb designed accelerate lamp reaction nagamine et al <NUMBER> table <NUMBER> shows primer sequences used work experiments <NUMBER>ʹend fip primers labelled fam carry mock experiment also designed four dna fragments containing t<NUMBER> promoter vitro transcription appendix s<NUMBER> designed primers dna fragments well <NUMBER>ncovnpositive control plasmid ordered integrated dna technologies idt uk dna fragments n orf<NUMBER>ab target genes synthesized idt reconstituted <NUMBER> ng µl à<NUMBER> according manufacturers instruction copy number target gene determined molecular weight diluted <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> copies µl à<NUMBER> subsequent experiments t<NUMBER>n t<NUMBER>s t<NUMBER>o dna synthesized idt reconstituted <NUMBER> ng µl à<NUMBER> according manufacturers instruction dna sequences subjected vitro transcription using hiscribe tm t<NUMBER> high yield rna synthesis kit new england biolabs uk transcription products purified using rneasy mini kit qiagen uk concentration quality rna measured using nanodrop copy number target rna determined molecular weight diluted <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> copies µl à<NUMBER> subsequent experiments human wholegenome purified human ipsc cells using fast dna tm spin kit mp biomedicals followed followed dna cleanup kit new england biolabs uk human wholerna purified human ipscs using rneasy mini kit qiagen uk equipment laminarflow cabinet working bench sprayed rnasezap tm prior experimental work filtered pipette tips used prevent crosscontamination experiments lamp rtlamp run least three replicates <NUMBER>x primer mix fip <NUMBER> µm bip <NUMBER> µm f<NUMBER> <NUMBER> µm b<NUMBER> <NUMBER> µm lf <NUMBER> µm lb <NUMBER> µm made reactions lamp rtlamp reactions carried using warmstart tm <NUMBER> µl reaction mixture <NUMBER> mastermix <NUMBER> µl <NUMBER> primer mix <NUMBER> µl dnarna target <NUMBER> µl dnase rnasefree molecular grade water <NUMBER> µl mixed homogeneously centrifuged <NUMBER> lamp rtlamp performed thermocycler <NUMBER>°c <NUMBER> min colour change observed directly naked eye gel electrophoresis performed confirm result lamp rtlamp human cells equipment laminarflow cabinet working bench sprayed rnasezap tm prior experimental work filtered pipette tips used prevent crosscontamination human episomal ipscs obtained thermo fisher scientific uk dissociated <NUMBER> mm edta ph <NUMBER> thermo fisher scientific sterile pbs cells counted resuspended diluted <NUMBER> <NUMBER> <NUMBER> cells µl à<NUMBER> sterile <NUMBER> nacl sigmaaldrich solution <NUMBER> bactin primer mix fip <NUMBER> µm bip <NUMBER> µm f<NUMBER> <NUMBER> µm b<NUMBER> <NUMBER> µm made reactions lamp rtlamp carried using warmstart tm colorimetric lamp <NUMBER> master mix dna rna new england biolabs neb onestep amplification nucleic acids cells <NUMBER> µl <NUMBER> nacl first heated <NUMBER>°c <NUMBER> min <NUMBER>µl reaction mixture <NUMBER> mastermix <NUMBER> µl <NUMBER> primer mix <NUMBER> µl boiled cell sample <NUMBER> µl dnase rnasefree molecular grade water <NUMBER> µl prepared hand cell lamp experiments cells directly added lamp reaction reagents <NUMBER>µl reaction mixture <NUMBER> mastermix <NUMBER> µl <NUMBER> primer mix <NUMBER> µl <NUMBER> nacl solution without ipscs <NUMBER> µl dnase rnasefree molecular grade water <NUMBER> µl prepared lamprtlamp performed thermocycler <NUMBER>°c <NUMBER> <NUMBER> min colour change observed directly naked eye respiratory specimens throat swabs collected patients immediately placed sterile tubes containing <NUMBER> ml vtm health gene technologies ningbo china total <NUMBER> clinic samples collected patients swab samples deactivated heating <NUMBER>°c <NUMBER> min biosafety level <NUMBER> bsl <NUMBER> medical laboratory shenzhen luohu peoples hospital china rna extracted swab samples using rna extraction kit health biomed china smart labassist<NUMBER> platform taiwan advanced nanotech inc taoyuan china avoid interference te buffer rtlamp reaction rna eluted rnasefree dnase water conventional rtqpcr sarscov<NUMBER> commercial <NUMBER>ncov rtpcr kit shanghai zj biotech china used determine samples positive negative sarscov<NUMBER> virus abi <NUMBER> realtime pcr system thermo fisher scientific inc waltham usa according manufacturers instructions <NUMBER> reaction mixture contained <NUMBER> rna template <NUMBER> <NUMBER>ncov rt pcr buffer <NUMBER> rtqpcr enzyme mix thermal cycling condition <NUMBER> min <NUMBER>°c reverse transcription <NUMBER> min <NUMBER>°c pcr initial activation <NUMBER> cycles <NUMBER> <NUMBER>°c <NUMBER> <NUMBER>°c rtlamp assays clinical samples performed premixed test kits test kit consists three tubes <NUMBER> <NUMBER> <NUMBER> contain o<NUMBER> n<NUMBER> human bactin primers respectively table <NUMBER> three tubes first filled <NUMBER> rnasefree water sigmaaldrich <NUMBER> warmstart colorimetric lamp <NUMBER> master mix new england biolabs uk <NUMBER> <NUMBER>x primer mix test kits first prepared oscar delivered shenzhen luohu peoples hospital ice box detection sarscov<NUMBER> virus <NUMBER> extracted rna patient sample added tube <NUMBER> <NUMBER> <NUMBER> respectively test kit incubated <NUMBER>°c <NUMBER> min sequences simple visual detection products nat protoc <NUMBER> <NUMBER> walls ac park tortorici wall mcguire veesler <NUMBER> structure function antigenicity sarscov<NUMBER> spike glycoprotein cell <NUMBER> <NUMBER> wang c horby pw hayden fg gao gf <NUMBER> novel coronavirus outbreak global health concern lancet <NUMBER> <NUMBER> woo pcy huang lau skp yuen ky <NUMBER> coronavirus genomics bioinformatics analysis virusesbasel <NUMBER> <NUMBER> additional supporting information may found online supporting information section end article appendix s<NUMBER> synthesised dna t<NUMBER> promoter fig s<NUMBER> rna map sarscov<NUMBER> locations four sets primers o<NUMBER> s<NUMBER> n<NUMBER> n<NUMBER> target regions encoding orf<NUMBER>ab spike protein n protein fig s<NUMBER> impact virus transport media reading rtlamp results tubes contain n<NUMBER> primers warmstart colorimetric lamp master mix tubes incubated <NUMBER>°c <NUMBER> min sensitivity specificity computed possible combinations <NUMBER> <NUMBER> rdts <NUMBER>c <NUMBER> evaluated parallel algorithm individual sensitives rdts ranged <NUMBER> <NUMBER> general increasing trend across categories days since pcr confirmation total <NUMBER> possible combinations rdts used parallel computated combinations <NUMBER> rdts improved sensitivities <NUMBER> demonstrate use rdts combinations improve overall sensitivity approach used wider range combination rdts may yield combinations give sensitivities diagnostics relevance mass testing low resource setting ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> novel coronavirus causes coronavirus disease <NUMBER> covid<NUMBER> respiratory illness responsible covid<NUMBER> pandemic<NUMBER> sarscov<NUMBER> specific antibodies produced days weeks infection virus strength antibody response depends several factors including age nutritional status severity disease certain medications infections like hiv suppress immune system <NUMBER> antibody responses demonstrated sarscov<NUMBER> prevalence <NUMBER> patients first <NUMBER> days illness rapidly increased <NUMBER> <NUMBER> <NUMBER> total ab igm igg respectively since day <NUMBER> onset<NUMBER> evidence early acquisition sars cov<NUMBER> antibodies strengthen idea use rdts mid late convalescent postrecovery phases disease rapid diagnostic tests require testing equipment may stored room temperature easy operate cheap also rapid screening time approximately <NUMBER> minutes attributes make rdts attractive mass testing poor performance currently available sars cov<NUMBER> antibody rdts world health organization recommends use rdt tests research surveillance settings study aimed using <NUMBER> rdts test algorithm determine improve performance terms sensitivity specificity prospective study total <NUMBER> samples tested covid <NUMBER> rapid diagnostic kit negative samples retrieved sample archives january <NUMBER> inventory national biorepository positive samples obtained confirmed positive patients genexpert admitted masaka mbarara regional referral hospitals categorized day confirmed positive follows category <NUMBER> days <NUMBER> samples category b <NUMBER> days <NUMBER> samples category c <NUMBER> days <NUMBER> samples category <NUMBER> days <NUMBER> samples ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint whole blood collected commercially available anticoagulant edta tubes samples transported cphl testing per cphl standard operating procedures plasma separated aliquoted <NUMBER> vials stored according cphl standard operating procedures study included <NUMBER> rdts provided different laboratory suppliers wanted product evaluated testing rapid diagnostic test kits carried central public health laboratories cphl lateral flow immune chromatographic assay <NUMBER> covid<NUMBER> kits use anti human igm antibody test line igm antihuman igg test line igg igg control line immobilized nitrocellulose strip burgundy colored conjugate pad contains colloidal gold conjugated recombinant covid<NUMBER> antigen conjugated colloid gold covid<NUMBER> conjugate specimen followed buffer added igm igg present bind covid<NUMBER> conjugates making antigen antibody complex complex migrates nitrocellulose membrane capillary action total <NUMBER> rapid diagnostic kits verified <NUMBER> μ l aliquot plasma used rapid diagnostic test kits results read <NUMBER> minutes following manufacturers instructions kit inserts results recorded paperbased study record form srf dated initiated laboratory technologist reviewed another laboratory technologist data entered microsoft excel paperbased study record form srf <NUMBER> <NUMBER> table used compute sensitivity specificity negative positive predictive values ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> table <NUMBER> ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> table <NUMBER> table showing computed sensitives <NUMBER> combinations <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> two <NUMBER> combinations rdts sensitivities <NUMBER> <NUMBER> specificity tested parallel selected ccby <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint observed sensitivity individual kits ranging <NUMBER> however sensitivity improved time since confirmed pcr similar findings<NUMBER> used kits combinations <NUMBER> overall sensitivity improved <NUMBER> best combination provide evidence use rdts algorithm may improve performance diagnosis covid<NUMBER> work required explore additional rdts combinations tested parallel series objectives virus infection underevaluated older adults severe acute respiratory infections saris aimed evaluate clinical impact combining pointofcare molecular viral test serum procalcitonin pct level antibiotic stewardship emergency department ed design prospective twincenter cohort study conducted january <NUMBER> march <NUMBER> setting participants older adult patients presented ed saris received rapid molecular test <NUMBER> respiratory viruses pct test measures evaluate clinical impact compared outcomes sari patients experimental cohort propensity scoreematched historical cohort primary outcome proportion antibiotics discontinuation deescalation ed secondary outcomes included duration intravenous antibiotics length hospital stay mortality results total <NUMBER> patients included <NUMBER> patients experimental group <NUMBER> patients control group onefourth <NUMBER> patients experimental group tested positive virus compared controls experimental group significantly higher proportion antibiotics discontinuation deescalation ed <NUMBER> vs <NUMBER> p ¼ <NUMBER> neuraminidase inhibitor uses <NUMBER> vs <NUMBER> p <NUMBER> shorter duration intravenous antibiotics <NUMBER> vs <NUMBER> days p <NUMBER> conclusions implications combining rapid viral surveillance pct test useful strategy early detection potential viral epidemics antibiotic stewardship clustered viral respiratory infections nursing home common patients transferred nursing homes ed may benefit approach ó <NUMBER> amda e society postacute longterm care medicine communityacquired respiratory tract infections among common reasons emergency department ed visits caused viral bacterial pathogens identification pathogen causing symptoms critical rapid institution adequate antiviral antibiotic therapy challenges differentiating viral bacterial pathogens patients viral respiratory infections usually underdetected unnecessary antibacterial agents likely administered therefore laboratory tests providing accurate timely determination infectious agents associated viral respiratory diseases important broad array tests available detect viral respiratory agents rapid antigen tests available influenza b respiratory syncytial virus rsv tests low sensitivity specificity <NUMBER> <NUMBER> authors declare conflicts interest molecular diagnostic tests using polymerase chain reaction pcr method detect rna dna infectious agents show high sensitivity specificity technically challenging time consuming advent sensitive pointofcare poc molecular detection methods made rapid diagnosis respiratory virus infections possible filmarray system biofire diagnostics inc salt lake city ut desktop automated realtime pcr system integrates sample preparation amplification detection analysis <NUMBER> complete process delivers results <NUMBER> hour respiratory panel detect <NUMBER> respiratory viruses <NUMBER> bacterial targets single reaction <NUMBER> initial studies demonstrated poc multiplex pcr systems identified previously underevaluated viral atypical infections ed dyspneic patients additional information rapid respiratory infection testing may also change physicians antibioticprescribing behavior enabling timely appropriate treatment <NUMBER>e<NUMBER> hospital length stay direct medical cost patients identified respiratory pathogens decreased <NUMBER>e<NUMBER> despite availability highly accurate viral testing results discontinuation deescalation antibiotics still raises concerns mixed virusbacteria coinfection especially influenza pneumococcus common older adults <NUMBER> study proposed diagnostic approach combines multiplex pcr respiratory panel procalcitonin pct tests better guide antibiotic treatment pct precursor calcitonin constitutively secreted c cells thyroid gland k cells lungs healthy individuals pct normally undetectable <NUMBER> ngml stimulated endotoxin pct rapidly produced parenchymal tissue throughout body unlike creactive protein pct respond sterile inflammation viral infection <NUMBER> distinctive characteristic makes pct valuable diagnostic marker multiple randomized controlled trials demonstrated pct levels <NUMBER> mgl guide decision withhold antibiotics stop therapy early <NUMBER> <NUMBER> since approval filmarray respiratory panel tests studies evaluated clinical impact implementation multiplex pcr respiratory panel patients less severe acute reparatory illness <NUMBER>e<NUMBER> date study focused older adults severe acute respiratory illness older adults vulnerable respiratory virus infection undifferentiated clinical manifestation bacterial viral infection antibiotic overuse population common study aimed assess impact implementing diagnostic algorithm combines rapid respiratory viral surveillance pct tests older patients presenting ed severe acute respiratory illness conducted prospective cohort study ed <NUMBER> urban medical centers clinical impact evaluated comparison experimental cohort propensity score psematched historical cohort conducted prospective multicenter observational study sample ed patients presenting acute severe respiratory illness eds <NUMBER> urban medical centers participated project annual ed census around <NUMBER> one medical center <NUMBER> study period included january <NUMBER> march <NUMBER> defined preerespiratory panel system implementation period january <NUMBER> december <NUMBER> <NUMBER> months posterespiratory panel system implementation period january <NUMBER> march <NUMBER> <NUMBER> multiplex pcr kits <NUMBER> used rapid pcr respiratory panel system calibration remaining <NUMBER> kits aimed use among study patients however planned end date study could reach target sample size therefore <NUMBER>month extension experimental group made collect sufficient samples trial approved institutional review board human research participating center patients aged <NUMBER> years older presenting ed acute severe respiratory illness eligible inclusion defined case severe acute respiratory illness according world health organizations case definition defined severe acute respiratory illness adults physiciandiagnosed lower respiratory tract infection pulse oxygen saturation spo <NUMBER> presentation less <NUMBER> respiratory rate <NUMBER> breathsmin requirement intubation mechanical ventilation basic demographic clinical information specimens collected day admission episode lower respiratory tract infection defined acute pulmonary disease without acute respiratory failure including pneumonia influenzalike illness acute exacerbation chronic respiratory illness including exacerbation chronic obstructive pulmonary disease asthma bronchiectasis exclusion criteria included patient receiving palliative care declined nasopharyngeal swabbing participants provided written informed consent filmarray respiratory panel biofire diagnostics inc detects <NUMBER> viruses rsv influenza h<NUMBER> h<NUMBER> h<NUMBER> influenza b adenovirus parainfluenza virus <NUMBER>e<NUMBER> rhinovirusenterovirus human metapneumovirus human coronavirus oc<NUMBER> <NUMBER>e nl<NUMBER> hku<NUMBER> <NUMBER> atypical bacteria bordetella pertussis mycoplasma pneumoniae chlamydia pneumoniae collected nasopharyngeal swab using nylon flocked swab immediately placed universal transport media utm study nurse collected samples specimens utm tested according manufacturers instructions blood samples collected within <NUMBER> hours admission pct concentrations measured using immunoluminometric assay detection limit <NUMBER> ngml brahms pctsensitive kryptor thermo fisher scientific brahms gmbh respiratory swab blood samples tested soon received laboratory study period study nurse identified eligible patients explained study protocol treating physicians patients eligible patients received rapid molecular test <NUMBER> respiratory viruses pct test results respiratory panel pct tests communicated treating physicians directly study nurse soon available kept medical records study nurse reminded treating physician recommendation antibiotic treatment based different viral pct testing results detection influenza initiates isolation neuraminidase inhibitor use detection virus elevated serum pct level <NUMBER> ngml may indicate possibility superimposed bacterial infection justify continual use antibacterial treatment patients noneinfluenza virus infection combined antiviral antibacterial treatment patients influenza infection positive result respiratory virus low serum pct level stable clinical manifestation may allow early discontinuation deescalation empiric antibiotics deescalation defined changing narrowerspectrum antibiotic shifting intravenous antibiotics oral form negative respiratory virus test result low serum level pct <NUMBER> ngml would prompt clinicians consider noninfectious causes respiratory distress acute exacerbation obstructive airway disease acute decompensated heart failure fluid overload information regarding laboratory tests antibiotic antiviral therapy administration duration intravenous antibiotic treatment length intensive care unit stays length hospital stay <NUMBER>day mortality obtained electronic health records compared outcome duration intravenous antibiotic use historical cohort similar baseline characteristics clinical presentations clinical impact measured via proportion stopping deescalating antibiotics neuraminidase inhibitor uses ed duration intravenous antibiotics treatment length hospital stay length intensive care unit stays <NUMBER>day mortality overall allcause mortality evaluate clinical impact combining respiratory panel pct testing outcomes patients severe acute respiratory illness established historical cohort including patients presenting ed severe acute respiratory illness january <NUMBER> <NUMBER> december <NUMBER> <NUMBER> database included following demographics clinical presentations presenting viral signs laboratory data image results ed admission medications used ed hospitalization course discharge status used psmatching technique select group patients similar demographics comorbidities diagnoses vital signs laboratory results experimental cohort received respiratory panel pct test increase statistical power analysis performed <NUMBER>to<NUMBER> matching final cohort includes <NUMBER> older adult severe acute respiratory illness patients received respiratory panel pct test <NUMBER> psmatched control patients composite cohort used assess clinical impact rapid respiratory viral surveillance pct tests baseline characteristics summarized using appropriate descriptive statistics categorical variables presented frequency percentage compared using chisquared test continuous variables presented median interquartile range compared nonparametric mannwhitney u tests numbers different respiratory viral isolates mean serum level pct different viral infections shown bar graph select control patients built ps matching ps defined conditional probability tested respiratory panel pct derived logistic regression model included following potential predictors demographics comorbidity presenting vital signs laboratory results admission diagnoses verify balancing baseline covariates ps matching made standardized difference plot ensure minimum differences baseline covariates <NUMBER> groups patients supplementary figure <NUMBER> psmatched cohort compared outcome current cohort psmatched historical cohort using logistic regression model adjusting residual difference baseline covariates statistical analyses performed sas <NUMBER> sas inc cary nc p value <NUMBER> deemed significant total <NUMBER> patients enrolled study <NUMBER> excluded missing data loss followup finally <NUMBER> older adult patients severe acute respiratory illness included study analysis <NUMBER> <NUMBER> patients tested positive respiratory virus patients sick hospitalized demographics presenting vital signs laboratory test results underlying comorbidity experimental control cohorts shown table <NUMBER> experimental cohort mean age <NUMBER> years <NUMBER> males diabetes cancer chronic pulmonary disease leading <NUMBER> comorbidities pneumonia chronic obstructive pulmonary disease acute exacerbation acute respiratory failure prevalent diagnoses control cohort comparable distribution aforementioned characteristics except including fewer patients dementia chronic liver disease experimental group <NUMBER> patients tested positive respiratory virus including <NUMBER> influenza b virus <NUMBER> <NUMBER> rsv <NUMBER> <NUMBER> human rhinovirusenterovirus <NUMBER> <NUMBER> coronavirus <NUMBER> <NUMBER> parainfluenza virus type <NUMBER> <NUMBER> <NUMBER> human metapneumovirus <NUMBER> control group <NUMBER> patients <NUMBER> diagnosed influenza significantly lower experimental group p ¼ <NUMBER> table <NUMBER> <NUMBER> patients tested positive virus <NUMBER> <NUMBER> pct level lower <NUMBER> ngml coronavirus influenza human rhinovirusenterovirus infections higher serum levels pct figure <NUMBER> compared control group patients experimental group antibiotics deescalation <NUMBER> vs <NUMBER> p ¼ <NUMBER> received neuraminidase inhibitor ed <NUMBER> vs <NUMBER> p <NUMBER> shorter duration intravenous antibiotics use although patients experimental group trend antibiotic discontinuation small number patients prevents meaningful comparison neither <NUMBER>day inhospital mortality significantly different <NUMBER> groups account residual covariate difference ps matching performed logistic linear regression adjusting age temperature chronic liver disease dementia results revealed rapid pcr respiratory panel pct testing associated increased odds discontinuing deescalating antibiotics odds ratio <NUMBER> <NUMBER> confidence interval ci <NUMBER> <NUMBER> increased odds neuraminidase inhibitor prescription <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> shorter duration intravenous antibiotics e<NUMBER> <NUMBER> ci e<NUMBER> à<NUMBER> difference length hospital stay <NUMBER>day mortality table <NUMBER> prospective cohort study reports clinical impact rapid molecular diagnosis respiratory pathogens conjunction pct testing older adult patients presenting ed severe acute respiratory illness results showed <NUMBER> older adult severe acute respiratory illness patients respiratory virus infection influenza rsv human rhinovirusenterovirus <NUMBER> leading pathogens demonstrated new diagnostic approach associated increased discontinuation deescalation antibiotics reduced length intravenous antibiotics treatment improved influenza detection antiviral use findings consistent previous studies brendish et al <NUMBER> showed patients receiving respiratory panel testing likely undergo single doses brief courses antibiotics treatment respiratory panel testing also associated reduced length stay improved influenza detection antiviral use however find routine use respiratory panel testing could reduce proportion patients treated antibiotics ascribed initiation antibiotics results pct many patients prepost study showed use respiratory panel decreased time diagnosis respiratory viruses hospital admission rate length stay number chest radiographs duration antimicrobial use <NUMBER> gelfer et al <NUMBER> combined respiratory panel pct tests found significant differences overall antibiotic exposure experimental standardofcare groups nevertheless found significantly fewer patients discharged antibiotics shorter duration therapy subgroup patients positive viral negative pct testing results stressed importance proactive communication antibiotics stewardship team physicians results showed proposed diagnostic approach could reduce intravenous antibiotics treatment duration <NUMBER> days without compromising patient outcomes historically advised complete course intravenous antibiotics treatment despite resolution clinical symptoms however little evidence support practice <NUMBER> <NUMBER> overuse antibiotics associated increased risk clostridioides difficile infection prolonged course intravenous antibiotics may increase risk adverse drug events organ dysfunction mortality <NUMBER> noteworthy identification respiratory virus alone may sufficient reduce antibiotic use concerns regarding mixed virusbacteria coinfection especially influenza pneumococcus infection <NUMBER> low serum level pct may help alleviate concerns mixed infection addition communicating results treating physicians important <NUMBER> <NUMBER> although formal antibiotic stewardship team study nurse communicated results treating physicians promoted antibiotics stewardship another finding underdiagnosis influenza older adult patients older adult patients less likely undergo providerordered influenza test usually lack typical presentation influenzalike illness may present respiratory distress confusion <NUMBER> recent study showed diagnosis influenza based clinical grounds alone associated suboptimal sensitivity <NUMBER> specificity <NUMBER> <NUMBER> effect estimates dichotomous outcomes calculated logistic regression whereas continuous outcomes calculated using quantile regression models adjusted covariates balanced ps matching including age temperature chronic liver disease dementia chronic obstructive pulmonary disease acute exacerbation proposed algorithm respiratory virus infection diagnosis antibiotic stewardship may also implications nursing home nh residents acute respiratory virus infection outbreaks common problem nhs <NUMBER> <NUMBER> recent systematic review reported <NUMBER> <NUMBER> annual incidence influenza rsv infection longterm care facilities <NUMBER> influenza rsv human metapneumovirus third common causative pathogen nh respiratory infection outbreaks <NUMBER> nhs often onsite equipment evaluate suspected infection therefore lower threshold antibiotic prescription common estimated approximately twothirds nh residents received antibiotics year <NUMBER> treatment inappropriate nhs become reservoirs resistant bacteria within community <NUMBER> although present protocol cannot implemented nhs used among severe nh patients transferred ed less severe outbreak nasopharyngeal samples nh residents collected sent contracted laboratories respiratory panel testing early detection acute respiratory infection enables early isolation infected patients early antiviral drug administration prevent contain respiratory virus infection outbreak cost important consideration largescale clinical implementation rapid multiplex pcr testing previous analyses showed rapid multiplex pcr testing costeffective testing strategy detection influenza children <NUMBER> <NUMBER> costeffectiveness respiratory panel testing highly influenced prevalence influenza proportion patients treated antivirals significant improvement influenza diagnosis antiviral treatment study suggests combination respiratory panel pct testing may costeffective study setting speculation however requires future validation results interpreted light several limitations first pct tests used comparison cohort cannot determine impact viral panel pct tests separately second study nurse enrolled patients working hours weekdays selection spectrum bias less likely find significant difference outcomes patients presenting ed different time shifts third postdischarge followup data historical comparison cohort cannot retrieved therefore could compare duration oral antibiotics <NUMBER> cohorts reduction intravenous antibiotic duration alone important shown strong risk factor development resistant bacteria strains fourth generalization results settings taken consideration long hospitalization duration study due old age severe illness low hospitalization cost <NUMBER> <NUMBER> lastly incidence various respiratory viruses may varied across <NUMBER> seasons study period strengths study include older adult population twincenter prospective cohort design simple antibiotic stewardship algorithm comparison psmatched cohort findings study support use rapid multiplex pcr respiratory panels conjunction pct test early diagnosis respiratory viral infection inform optimizing antibiotic use older adult patients presenting ed severe acute respiratory illness respiratory viral infection outbreak common nursing homes performing proposed diagnostic approach patients transferred nhs may enable early detection causative pathogens early isolation infected patients cost per test still high institutions develop protocol prevent indiscriminate testing multiplex pcr provide proactive realtime feedback treating physicians antimicrobial stewardship studies needed assess incremental value multiplex pcr viral testing compared pct testing alone management patients severe acute respiratory infection ed concerns december <NUMBER> china reported first disease case hubei province based <NUMBER> phylogenetic analysis identified novel coronavirus named severe acute <NUMBER> respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> disease spread sarscov<NUMBER> <NUMBER> known covid<NUMBER> declared pandemic world health organization who<NUMBER> <NUMBER> despite global massive efforts control outbreak covid<NUMBER> pandemic still <NUMBER> rise date lack approved medicine vaccine impede escalated management <NUMBER> covid<NUMBER> epidemic absence effective treatment strategy developing affordable <NUMBER> screening rapid diagnosis critically required management <NUMBER> according <NUMBER> immediate priority development pointofcare tests detection <NUMBER> sarscov<NUMBER> early stage improved sensitivity<NUMBER> <NUMBER> currently covid<NUMBER> diagnostic test falls two categories antibody nucleic acid<NUMBER> based detection systems developed immunoassay rapid inefficient detection <NUMBER> pathogen early stage infection<NUMBER> besides currently recommend <NUMBER> use antigenbased rapid diagnostic tests patient care encourages related <NUMBER> research improve performance potential diagnostic utility among nucleic acidbased detection systems considered realtime polymerase <NUMBER> chain reaction rtpcr based method gold standard covid<NUMBER> testing <NUMBER> <NUMBER> sampletoresult time quantitative rtpcr qrtpcr initially <NUMBER> hrs however <NUMBER> constant efforts underway improve turnaround time automation besides <NUMBER> timeconsuming process pcr based tests expensive require sophisticated instruments <NUMBER> expertise <NUMBER> thus technologies reverse transcriptionloopmediated <NUMBER> isothermal amplification rtlamp <NUMBER> genomeediting <NUMBER> explored promising technologies however expected turnaround time would still around <NUMBER> hour <NUMBER> may economical mass screening especially developing countries <NUMBER> nanomaterials based sensing platforms hold promise develop rapid disease diagnostics <NUMBER> however limited use clinical setting due need sophisticated <NUMBER> equipment<NUMBER> <NUMBER> recent attempt use antisensenucleotide capped gold nanoparticles n<NUMBER> gene based covid<NUMBER> detection could game changer<NUMBER> whereas suggested <NUMBER> ngene relatively weak analytical capability compared rdrp gene detect <NUMBER> covid<NUMBER> infection<NUMBER> moreover authors demonstrated covid<NUMBER> detection <NUMBER> cellularmodel system application human samples yet shown <NUMBER> study report first time gold nanoparticles aunps based rapid colorimetric <NUMBER> assay visual eye detection covid<NUMBER> rna human samples designed target rdrp <NUMBER> specific gene target costeffective manner wide application mass screening <NUMBER> field utilized surface plasmon resonance property aunps detect unamplified <NUMBER> covid<NUMBER> rna human samples ability aunps preferentially adsorb ssrnassdna <NUMBER> dsdnadsrna crucial concept assay single doublestranded <NUMBER> oligonucleotides different electrostatic properties provide stability via retaining <NUMBER> natural color aggregation causes color change aunps solution <NUMBER> respectively<NUMBER> <NUMBER> chemicals citrate buffer stabilized aunps <NUMBER> nm diameter purchased alfa aesar <NUMBER> thermo fisher scientific india private limited phosphate buffer saline pbs ph <NUMBER> <NUMBER> nacl procured sigma aldrich <NUMBER> clinical samples nasopharyngeal rna sample covidnegative n<NUMBER> positive <NUMBER> subjects n<NUMBER> used covid<NUMBER> testing subjects done indian used specifically detect presence sarscov<NUMBER> rna assay parallel <NUMBER> measure specificity assay input genomes different source nasopharyngeal <NUMBER> rna covid negative subjects hpv dna cervical cancer positive samples <NUMBER> used negative controls similarly nontemplate control ntc also included measure <NUMBER> background reactivity addition confirm working principle assay different rna template isolated pancreas pancreas specific reg<NUMBER> regenerating islet<NUMBER> derived protein <NUMBER> gene oligo probe <NUMBER>gtgcctatggctcctattgct<NUMBER> used <NUMBER> final reaction mixture combinations denatured <NUMBER>°c <NUMBER> <NUMBER> seconds annealed <NUMBER>°c <NUMBER> seconds cooled room temperature <NUMBER> minutes <NUMBER> subsequently <NUMBER> nm colloidal aunps <NUMBER> nm added assay mixture allowed <NUMBER> develop color <NUMBER> minute <NUMBER> spectral studies measurement sensitivity absorption spectrum assay mixture <NUMBER> recorded range <NUMBER> <NUMBER> nm peak shift <NUMBER> nm known redshift <NUMBER> peak broadening <NUMBER> nm measured characteristic feature salt induced <NUMBER> aggregation using various combinations positive negative controls discussed <NUMBER> previous section specificity reaction aggregation compared assay sensitivity <NUMBER> determined serially diluting input sarscov<NUMBER> rna ivt synthesized <NUMBER> synthetic sarscov<NUMBER> control ncov<NUMBER> control kit applied biosystems ranging <NUMBER> <NUMBER>ng <NUMBER>ng concentrations respectively <NUMBER> result discussion <NUMBER> study report first time development rapid affordable rnabased <NUMBER> assay visual detection sarscov<NUMBER> genome human samples assay <NUMBER> use surface plasmon resonance property gold nanoparticlescolloids aunp targeted <NUMBER> rdrp specific gene sequence sarscov<NUMBER> rdrp essential viral replication <NUMBER> higher analytical power e envelope protein n nucleocapsid protein genes sars<NUMBER> cov<NUMBER> <NUMBER> current established assay saltinduced aggregation color change <NUMBER> gold colloids occurs rdrp oligo probe hybridizes specific target rna sarscov<NUMBER> current escalated demand cost effective easy sensitive diagnostic <NUMBER> covid<NUMBER> test developed using commercially available ncov<NUMBER> synthetic dna <NUMBER> validated using clinical samples covid<NUMBER> subjects confirmed using taqman <NUMBER> based rtpcr method table s<NUMBER> study demonstrated visual change gold <NUMBER> colloid color pink blue rna samples subjects clinically diagnosed <NUMBER> covid<NUMBER> infection hybridize rdrp oligo probe n<NUMBER> simultaneously color remained <NUMBER> pink sarscov<NUMBER> negative samples due absence hybridization n<NUMBER> <NUMBER> assay sarscov<NUMBER> rna human patients ivt synthesized rna added <NUMBER> hybridization buffer containing oligo probe followed denaturation annealing <NUMBER>°c <NUMBER> <NUMBER>s <NUMBER>°c <NUMBER>s respectively cooling room temperature gold colloid <NUMBER> added reaction mixture colloid color changes visible range pink <NUMBER> blue indicate formation hybridized product figure <NUMBER>b c figure <NUMBER> broadening <NUMBER> peak redshift <NUMBER> nm observed spectrum aggregated colloids non<NUMBER> aggregated confirms success developed assay detection unamplified target <NUMBER> unmodified colloids quick facile way principle binding oligo probe specific <NUMBER> target leading change color solution independently verified using different <NUMBER> template rna isolated pancreas tissue pancreas specific gene reg<NUMBER> oligo probe <NUMBER> separate assay assay also resulted similar change color absorption spectra <NUMBER> optimized earlier sarscov<NUMBER> rna rdrp oligo probe established working <NUMBER> principle specificity test figure s<NUMBER> ntc fig <NUMBER>d similar recent approach utilizes thiol capped gold nanoparticles detect n<NUMBER> gene sarscov<NUMBER> gene cellular system<NUMBER> however detection sars<NUMBER> cov<NUMBER> rna human samples ngene reportedly inferior analytical power <NUMBER> rdrp gene<NUMBER> thus would essential know assays performance developed <NUMBER> successfully developed affordable gold nanoparticlesbased colorimetric test <NUMBER> rapid detection sarscov<NUMBER> rna humans assay detect <NUMBER> ng sars<NUMBER> cov<NUMBER> rna turnaround time assay less <NUMBER> minutes moreover <NUMBER> developed test helpful mass screening require sophisticated <NUMBER> equipment validation developed assay using large number clinical samples <NUMBER> underway determine diagnostic accuracy including sensitivity specificity falsepositive <NUMBER> negative rate mixed rna sample reaction mixture denatured <NUMBER>°c <NUMBER> seconds followed annealing <NUMBER>° c <NUMBER> seconds annealing tube kept room temperature <NUMBER> minutes colloidal aunps added pure colloid pink color turns blue vial containing rna sample positive control due saltinduced aggregation upon successful hybridization oligo probe target rna color remained pink absence target rna presence nonspecific target table s<NUMBER> table shows clinical diagnosis subjects based taqman rtpcr analysis rna extracted nasopharyngeal samples analyzed study r espiratory tract infections significant contributor global burden respiratory tract illnesses <NUMBER> million deaths worldwide <NUMBER> <NUMBER> several pathogens including viruses bacteria cause respiratory tract infections clinical presentations often overlap identification underlying pathogen based solely clinical criteria challenging <NUMBER> even though respiratory tract infections selflimited immunocompetent hosts many treated shown recent study highlighting increase unnecessary antibiotic use group <NUMBER> patient groups including immunocompromised patients elderly patients critically ill patients complications respiratory tract infections often occur poor outcomes including increased morbidity mortality <NUMBER> <NUMBER> <NUMBER> thus ability rapidly accurately diagnose respiratory tract infections critical optimal patient care additionally rapid accurate diagnosis essential timely administration antiviral therapy available institution contact droplet precautions prevent health careassociated transmission <NUMBER> <NUMBER> several instruments multiplexed molecular panels currently approved us food drug administration fda rapid sensitive detection viral bacterial respiratory pathogens nasopharyngeal swab nps specimens methods differ based several criteria including degree multiplexing <NUMBER> <NUMBER> targets complexity method moderate high throughput low high turnaround time tat ϳ<NUMBER> h <NUMBER> h <NUMBER> general performance characteristics multiplex panels significantly better conventional methods including viral culture antigen tests replaced methods many laboratories hand increased cost multiplexed molecular panels compared cost conventional methods raised questions costbenefit ratio particularly many viral targets panels specific treatments however given utility rapid diagnosis infections especially immunocompromised patients infection control prevention practices antibiotic stewardship interest multiplexed pcrs remains high genmark respiratory pathogen rp panel qualitative nucleic acid multiplex test recently received us fda clearance use genmarks new eplex instrument eplex rp panel detects <NUMBER> common respiratory pathogens nps specimens viral targets identified adenovirus coronavirus <NUMBER>e hku<NUMBER> nl<NUMBER> oc<NUMBER> human metapneumovirus hmpv human rhinovirusenterovirus hrvev influenza virus influenza h<NUMBER> virus influenza <NUMBER> h<NUMBER> virus influenza h<NUMBER> virus influenza b virus parainfluenza virus <NUMBER> piv<NUMBER> piv<NUMBER> piv<NUMBER> piv<NUMBER> respiratory syncytial virus subtype rsva rsvb bacterial targets identified chlamydia pneumoniae mycoplasma pneumoniae <NUMBER> eplex rp panel sampletoanswer multiplex assay runs singleuse cartridge automates aspects nucleic acid testing including extraction amplification detection combines electrowetting microfluidics genmarks esensor technology based principles competitive dna hybridization electrochemical detection previously described genmark xt<NUMBER> respiratory viral panel <NUMBER> multicenter clinical trial study performance characteristics investigationaluseonly iuo eplex rp panel evaluated using nps specimens collected <NUMBER> sites across united states canada reproducibility evaluated <NUMBER> sites addition assay performance characteristics including assay workflow turnaround time evaluated study population study population included patients ages genders presenting signs andor symptoms upper respiratory tract infection <NUMBER> clinical sites located united states canada residual nps specimens prospectively collected march <NUMBER> august <NUMBER> <NUMBER> sites frozen ϫ<NUMBER>°c future testing prospectively collected september october <NUMBER> <NUMBER> sites tested fresh supplement results prospective collection nps samples positive lowprevalence pathogens retrospectively collected frozen frozen samples thawed pipetted separate aliquots frozen ϫ<NUMBER>°c tested eplex rp biofire rp andor targetspecific pcrbidirectional sequencing needed also lowprevalence pathogens additional contrived samples used evaluate assay performance overall study design nps specimens prospectively retrospectively collected viral transport medium handled processed according nps kit manufacturers instructions either samples collected specifically study separately standardofcare soc purpose residual sample deidentified provided soc completed study approved central quorum review institutional review board andor individual clinical testing site institutional review board samples tested eplex rp panel <NUMBER> <NUMBER> sites compared results testing biofire filmarray respiratory panel version <NUMBER> biomérieux durham nc analytically validated pcr amplification assays followed bidirectional sequencing necessary eg resolution discordant results virus subtyping laboratory corporation america morrisville nc genmark eplex rp panel testing testing eplex rp panel performed according manufacturers instructions using materials kit briefly vortexing <NUMBER> l primary nps sample aspirated sample delivery device sdd provided eplex rp panel kit vortexed entire volume sdd dispensed sample loading port eplex rp panel cartridge cap depressed close port cartridge barcoded scanned eplex instrument inserted available bay fig <NUMBER> upon completion assay run eplex instrument ejected cartridge disposal eplex rp panel report generated comparator method method resolution discordant results comparator method biofire filmarray respiratory panel version <NUMBER> collected samples tested biofire rp detects respiratory viral bacterial targets included eplex rp panel differentiate rsv subtypes b <NUMBER> samples rsv detected biofire rp additionally tested analytically validated pcr amplification assays followed confirmation bidirectional sequencing determine subtype laboratory corporation america morrisville nc results collected samples discordant eplex rp panel comparator method ie false negative fn false positive fp tested analytically validated pcr amplification assays followed bidirectional sequencing described coronaviruses additional repeat testing biofire rp eplex rp panel also conducted part discordantresult resolution reproducibility study three reproducibility panels <NUMBER> pathogens influenza h<NUMBER> virus rsva piv<NUMBER> hmpv coronavirus oc<NUMBER> adenovirus species b <NUMBER> different concentrations moderate <NUMBER>ϫ limit detection lod low <NUMBER>ϫ lod negative nps specimens tested <NUMBER> sites lod studies performed manufacturer data shown reproducibility testing performed <NUMBER> operators <NUMBER> sites operator tested reproducibility panels triplicate <NUMBER> days including <NUMBER> nonconsecutive days using <NUMBER> different cartridge lots resulting <NUMBER> days testing <NUMBER> lots statistical methods positive percent agreement ppa negative percent agreement npa overall percent agreement opa comparator method results expected results determined target detected eplex rp panel ppa calculated <NUMBER> ϫ tpno tp ϩ fn npa calculated <NUMBER> ϫ tnno tn ϩ fp opa calculated <NUMBER> ϫ tp ϩ tnno tp ϩ tn ϩ fp ϩ fn tp truepositive results fn falsenegative results tn truenegative results fp falsepositive results twosided <NUMBER> score confidence interval ci calculated ppa npa opa statistical analysis performed using sas version <NUMBER> workflow turnaround time study time study performed determine time needed perform eplex rp panel test data averaged <NUMBER> samples tested <NUMBER> operators step process sample preparation unloading instrument recorded timed average tat determined patient demographics total <NUMBER> prospectively collected <NUMBER> retrospectively collected <NUMBER> contrived samples eligible testing eplex rp panel approximately <NUMBER> samples collected copanmanufactured utm universal transport medium <NUMBER> collected remel m<NUMBER> m<NUMBER> medium demographic information evaluable prospectively retrospectively collected subject samples provided table <NUMBER> approximately <NUMBER> subjects male median ages <NUMBER> years subjects prospectively collected samples <NUMBER> years subjects retrospectively collected samples prevalences eplex rp panel targets age group two phases prospective collection provided tables s<NUMBER> s<NUMBER> supplemental material assay performance accuracy <NUMBER> samples eligible testing eplex rp panel <NUMBER> invalid results <NUMBER> repeat testing <NUMBER> samples evaluable due final invalid results <NUMBER> prospective samples <NUMBER> contrived sample final validity rate <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> eplex rp panel detected potential respiratory pathogen <NUMBER> <NUMBER> prospectively collected nps specimens tested positivity rate <NUMBER> ppas npas <NUMBER> cis eplex rp panel targets comparator methods provided tables <NUMBER> <NUMBER> separately retrospectively collected samples prospectively collected samples samples combined additional data fresh frozen prospectively collected samples presented table s<NUMBER> supplemental material overall percent agreement eplex rp biofire rp results ͼ<NUMBER> targets tested target positive either <NUMBER> h<NUMBER> n ϭ <NUMBER> h<NUMBER> n ϭ <NUMBER> subtype <NUMBER> samples positive influenza virus target without subtype identified note influenza h<NUMBER> virus detected chlamydia pneumoniae n ϭ <NUMBER> isolates detected study period targets least <NUMBER> specimens pathogen spiked negative nps specimens contrived detected eplex rp data shown discordance resolution results table <NUMBER> demonstrate eplex rp high level agreement biofire rp detected targets nearly samples assay detected targets table <NUMBER> samples targets detected eplex rp detected biofire rp fp counted truepositive samples target detected discordance testing tpd samples targets detected eplex rp detected biofire rp fn counted truenegative samples target detected discordance testing tnd given number discordant samples two panels coronavirus detection additional repeat testing biofire rp eplex rp performed part discordance analysis additional testing demonstrated evidence <NUMBER> prospectively collected samples <NUMBER> codetections least one assays data shown eplex rp panel identified total <NUMBER> prospective samples multiple pathogens detected <NUMBER> prospectively collected samples biofire rp detected total <NUMBER> samples multiple pathogens <NUMBER> prospectively collected samples <NUMBER> samples multiple pathogens detected eplex rp <NUMBER> <NUMBER> two pathogens <NUMBER> <NUMBER> three pathogens <NUMBER> <NUMBER> four pathogens detected <NUMBER> samples codetections <NUMBER> samples <NUMBER> included one pathogens detected biofire rp method comparator method identified total <NUMBER> <NUMBER> codetections one pathogens identified eplex rp panel discordance resolution results included analysis presented table <NUMBER> ii reproducibility <NUMBER> sites performing reproducibility study collected <NUMBER> <NUMBER> results target concentration total <NUMBER> <NUMBER> samples per site moderately positive negative panels percent agreement <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> panel targets lowpositive panel percent agreement <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> <NUMBER> <NUMBER> panel targets remaining adenovirus panel target percent agreement lowpositive panel <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> agreement results shown table <NUMBER> total <NUMBER> <NUMBER> samples yielded valid result upon initial testing upon repeat testing one specimen yielded valid result final validity rate <NUMBER> <NUMBER> ci <NUMBER> <NUMBER> significant sources variability found targets panel across cartridge lots operation days technologistsoperators sites data shown workflow turnaround time study time identification receipt result determined <NUMBER> h <NUMBER> min <NUMBER> handson times hots per sample <NUMBER> min <NUMBER> multicenter clinical study performance characteristics new eplex respiratory pathogen panel genmark eplex instrument estimated measuring agreement results biofire rp commercially available multiplex respiratory panel eplex rp panel recently fda cleared expands available options laboratories interested rapid diagnosis respiratory tract infections using broadly multiplexed molecular assay nps specimens similar biofire rp eplex rp offers large panel viral bacterial respiratory pathogens simple sampletoanswer format minimal handson time rapid turnaround time results molecular diagnostic test methods biofire rp eplex rp potential generate falsepositive falsenegative results confirmed study additional testing targetspecific pcrs bidirectional sequencing unavailability established gold standard prevents true measure correctness requiring use agreement measures nonreference standard instead establish performance characteristics new test <NUMBER> thus data presented study reflect agreement results two platforms spite limitations overall performance eplex rp comparable biofire rp overall percent agreement truepositive truenegative results ͼ<NUMBER> available targets tested line results recent study nijhuis colleagues evaluating performance eplex researchuseonly ruo rp panel compared laboratorydeveloped assays found overall agreement <NUMBER> discordant results occurring primarily samples low pathogen loads estimated using cycle threshold c values ie high c value ͼ<NUMBER> <NUMBER> highest numbers discordant results observed adenovirus coronavirus rhinovirusenterovirus targets finding may explained large diversity genotypes present within groups pathogens prevalence pathogens population tested adenovirus performance diagnostic tests particularly important young children immuno compromised hosts however detection adenovirus challenging study eplex rp detected adenoviruses biofire rp recent report performance biofire rp v<NUMBER> detection adenovirus highlighted decreased sensitivity assay samples low viral loads positive species f <NUMBER> although eplex rp panel detects <NUMBER> genotypes coronaviruses hku<NUMBER> oc<NUMBER> <NUMBER>e nl<NUMBER> results reported without genotyping information currently treatments coronaviruses utility genotyping information may lie value epidemiological studies reports severe coronavirus infections reported immunocompromised hosts indication severity associated particular genotype <NUMBER> similar biofire rp eplex rp detects wide range rhinovirus enteroviruses genotypes given high degree genetic similarity reliably differentiate two species based discordance analysis performed pcr bidirectional sequencing samples positive rhinovirus trend expected given rhinoviruses common cause common cold <NUMBER> overall agreement influenza viruses high prospective collection periods clinical study occurred <NUMBER> <NUMBER> respiratory seasons expected lack clinical specimens positive influenza h<NUMBER> virus <NUMBER> influenza virus infections time period due <NUMBER> h<NUMBER> h<NUMBER> viruses hence evaluation influenza virus h<NUMBER> target performed entirely using contrived nps samples similar biofire rp results instances samples positive influenza virus without subtypes positive influenza virus subtype identified results may caused low virus titers novel influenza virus subtype thus require additional testing limited number samples positive chlamydia pneumoniae evaluation conducted primarily contrived samples performance c pneumoniae similar reported biofire rp clinical study also conducted using primarily contrived samples <NUMBER> chlamydia pneumoniae mycoplasma pneumoniae associated atypical communityacquired pneumonia cap seasonality nonspecific symptoms <NUMBER> therefore inclusion bacteria large multiplex panels potential significantly improve diagnosis cap notable difference eplex rp panel biofire rp absence bordetella pertussisbordetella parapertussis targets among bacterial targets noteworthy unlike bacterial targets panel infection bordetella pertussisb parapertussis relatively specific epidemiology higher incidences typically reported children less <NUMBER> months old recently unvaccinated populations vaccinated patients waning immunity <NUMBER> thus exclusion highly multiplexed respiratory panel may warranted addition utilization singlecopy pertussis toxin promoter target ptxp multiplex panels shown less sensitive detection b pertussis pcr tests targeted multicopy is<NUMBER> insertion sequence <NUMBER> result b pertussis infection suspected fdacleared b pertussis molecular test may appropriate similar broadly multiplexed respiratory panels eplex rp panel allows detection coinfections study coinfections identified <NUMBER> samples human rhinovirusenterovirus common virus detected coinfected specimens importance detecting coinfections highlighted recent study showing viralbacterial coinfection severe cap adults resulted complicated disease course associated complications <NUMBER> studies human rhinoviruses frequently detected association bacterial pathogens hematopoietic stem cell transplant population suggesting commonly detected virus may significant cause severe pneumonia immunocompromised patients <NUMBER> <NUMBER> initial rate invalid results eplex rp <NUMBER> repeat testing resulting final rate invalid results <NUMBER> value falls range rates invalid results reported multiplexed respiratory panels including nanosphere verigene rv <NUMBER> xtag rvp <NUMBER> <NUMBER> biofire rp <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> eplex instrument consists standalone system additional accessories eg computer touch screen making great option spaceconstrained laboratories eplex instrument available configurations ranging one four towers tower containing six randomaccess testing bays supports singleshift <NUMBER> h testing volumes ranging <NUMBER> samples <NUMBER> samples tat less <NUMBER> h hot less <NUMBER> min providing flexible capacity laboratories sizes additional features available system include ability generate customized reports eg statistical trending reports potential bidirectional interface laboratory information systems conclusion eplex rp panel provides rapid sensitive broadly multiplexed sampletoresults option minimal handson time assay performance equivalent biofire filmarray rp targets new fully integrated instrument easily expandable offers great option implementation multiplex assay largervolume laboratories supplemental material article may found httpsdoiorg<NUMBER>jcm <NUMBER> supplemental file <NUMBER> pdf file <NUMBER> mb rapid spread coronavirus disease <NUMBER> covid<NUMBER> many countries causes citizens daily inconvenience even lifethreat elderly population invasion main pathogen severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov human body causes different levels impact various patients one important issues covid<NUMBER> defend virus ability foresee infected targets thus maintain quarantined essentially others saved covid<NUMBER> far routine laboratory test confirm whether infected sarscov<NUMBER>ncov realtime reverse transcription polymerase chain reaction rrtpcr quantitative polymerase chain reaction qpcr certain sequence regions recognize sarscov<NUMBER>ncov rna genome heavy loading rrtpcr qpcr machine handling labor tightpacked instruments well manpower almost every country therefore alternative approaches eagerly waiting developed review article sort stateoftheart novel approaches might applied fast sensitive precise detection sarscov<NUMBER>ncov help routine laboratory testing also improve effective quarantine hunting severe acute respiratory syndrome coronavirus <NUMBER> <NUMBER> novel coronavirus laboratory testing back basic research rapid spread coronavirus disease covid<NUMBER> many countries causes citizens daily inconvenience even lifethreat elderly population invasion main pathogen severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER>ncov human body causes different levels impact various patients one important issues covid<NUMBER> defend virus ability foresee infected targets thus maintain quarantined essentially others saved covid<NUMBER> far routine laboratory test confirm whether infected sarscov<NUMBER>ncov rrtpcr qpcr certain sequence regions recognize sarscov<NUMBER>ncov rna genome heavy loading rrtpcr qpcr machine handling labor tightpacked instruments well man power almost every country therefore alternative approaches eagerly waiting developed review article sort stateoftheart novel approaches might applied fast sensitive precise detection sarscov<NUMBER>ncov help routine laboratory testing also improve effective quarantine hunting coronavirus sarscov<NUMBER> <NUMBER>ncov laboratory testing back basic research coronavirusinduced respiratory disease <NUMBER> covid<NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov outbreak end <NUMBER> wuhan china <NUMBER> soon continuously impacts daily life aspects worldwide alone increasing infected numbers death rates death person versus confirmed cases within selected area seem less <NUMBER> much higher new burst countries aged people dangerous status especially one also served medical history clinical symptoms covid<NUMBER> may found infected patients include fever infrared thermosensor used detect high temperature persons coughing myalgia fatigue productive cough headache hemoptysis even diarrhea patients severe pneumonia difficulty respiration <NUMBER> calculated record china <NUMBER> recently patients found disability distinguish smell andor tests neurological disorder far effective way distinguish healthy one infected targets even flulike symptoms abstract rapid spread coronavirus disease <NUMBER> covid<NUMBER> many countries causes citizens daily inconvenience even lifethreat elderly population invasion main pathogen severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> novel coronavirus <NUMBER>ncov human body causes different levels impact various patients one important issues covid<NUMBER> defend virus ability foresee infected targets thus maintain quarantined essentially others saved covid<NUMBER> far routine laboratory test confirm whether infected sarscov<NUMBER>ncov realtime reverse transcription polymerase chain reaction rrtpcr quantitative polymerase chain reaction qpcr certain sequence regions recognize sarscov<NUMBER>ncov rna genome heavy loading rrtpcr qpcr machine handling labor tightpacked instruments well manpower almost every country therefore alternative approaches eagerly waiting developed review article sort stateoftheart novel approaches might applied fast sensitive precise detection sarscov<NUMBER>ncov help routine laboratory testing also improve effective quarantine keywords clusters regularly interspaced short palindromic repeats fluorescence resonance energy transfer biosensing rapid diagnostic tests realtime reverse transcription polymerase chain reactionquantitative polymerase chain reaction routine laboratory tests severe acute respiratory syndrome coronavirus <NUMBER> novel coronavirus virus detection moreover lots sarscov<NUMBER> infected patients found asymptomatic since one knows already infected becomes infectious others time freely go daily activities unfortunately easily causes covid<NUMBER> transmission situation causes serious problem establishment prevention network every country taiwan avoid falsenegative case requires least three sequential negative tests sarscov<NUMBER> case confirmed negative combined positive negative result influenza virus according taiwan model quarantine suspicious individuals period time according activities contact history confirmed cases efficiently slow transmission covid<NUMBER> however could profoundly disturb daily life large population related cases confirmed positive sarscov<NUMBER> general personal epidemic prevention covid<NUMBER> avoiding contact hands nose eyes droplets primary task foresee sarscov<NUMBER> infected targets isolate selected population advanced treatments keeping others healthy free quarantine one important goals global war sarscov<NUMBER> develop sarscov<NUMBER> detection system accurately identify viral macromolecules either rna genome viral proteins full understanding specific infection process virus first step also benefit development antisarscov<NUMBER> drugs according current data sarscov<NUMBER> virus similar infection route sarscov <NUMBER> <NUMBER> <NUMBER> viruses utilize surface protein angiotensinconverting enzyme <NUMBER> ace<NUMBER> expresses certain types human cells type <NUMBER> alveolar cells receptor spike protein attach host cells <NUMBER> entry attached virus requires endocytosis priming protein host tmprss<NUMBER> serine protease <NUMBER> regulated ap<NUMBER>associated protein kinase <NUMBER> aak<NUMBER> disruption aak<NUMBER> might interrupt entry virus host cells intracellular assembly virus particles <NUMBER> structures several sarscov related proteins including spike proteins main protease sarscov<NUMBER> ace<NUMBER> <NUMBER> <NUMBER> <NUMBER> resolved provide valuable information following development new detection sensors even design antisarscov<NUMBER> drugs review article present available approaches identify sarscov<NUMBER> routine laboratory tests rapid diagnostic tests great application potential help reducing labor routine laboratory test hopefully proper applications tools finally stop fast transmission covid<NUMBER> whole world major laboratory assay confirm whether patients infected sarscov<NUMBER> nucleic acid amplification tests naats realtime reverse transcription polymerase chain reaction rrtpcr method carried hospital disease control center government taiwan method relatively mature since breakout sars <NUMBER> however still takes around <NUMBER> hours get results including <NUMBER> <NUMBER> hours reaction around <NUMBER> hour medical consultations sampling moreover carefully confirm infection three regions sarscov<NUMBER> rna sequences selected assay coding region spike protein orf<NUMBER> orf<NUMBER> shorten reaction time company tried develop new instruments related kits purpose example taqpath covid<NUMBER> combo kit thermo fisher scientific inc xpert xpress sarscov<NUMBER> test cepheid autosat related kit etc improvements may shorten examination reaction within <NUMBER> hours protein level detection time might shortened since excess time needed amplify detected signal hand protein level detection needs precise recognition high sensitivity least two groups claimed detect sarscov<NUMBER> within <NUMBER> minutes <NUMBER> one group guangzhou medical university china developed test patients serum check patients specific antibody sarscov<NUMBER>s antigen since method direct detection sarscov<NUMBER> virus could exist blind spot samples found negative two possible situations clarified one case infected case produced antibody sarscov<NUMBER> yet group genomics research center academia sinica taiwan developed novel sensitive test specific monoclonal antibody mab immunoglobulin g nucleocapsid protein sarscov<NUMBER> mab cross react sars related proteins sarscov middle east respiratory syndrome coronavirus merscov method quickly developed application applying specific mab onto current commercially available test kit replacing antiflu antibody specific mab flu test kit thus rapid diagnostic test kit sarscov<NUMBER> soon produced large demands nevertheless new methods still need clinical trials real samples suspected populations infected cases sampling nasopharyngeal swab sputum lower respiratory track aspirate meantime scientists around world continuously introduced alternative methods detection sarscov<NUMBER> <NUMBER> <NUMBER> <NUMBER> example new powerful geneediting tool clusters regularly interspaced short palindromic repeats crisprs technique applied successfully detect synthetic sarscov<NUMBER> rna sequences <NUMBER> <NUMBER> described latest reports testing reaction restricted within <NUMBER> minutes relatively low cost <NUMBER> proof concept idea emerged also tested real samples confirm detection efficacy recently unique idea combines modified rna amplification reverse transcription enzymatic recombinase amplification rtera fluorescence resonance energy transfer fretbased probe proposed <NUMBER> key new method use fam bhq<NUMBER> fret quenching pair means bhq<NUMBER> quench fluorescence fam located close together specific exonuclease ii recognizing thf site utilized cut doublestrand status due targeted rna sensed rna sarscov<NUMBER> exo fret probe designed located within targeted amplicon cut happens allows restore fam fluorescence since quencher bhq<NUMBER> leaves authors claim sensing limit ultrasensitive detection method low <NUMBER> <NUMBER> × <NUMBER> <NUMBER> rna <NUMBER> descriptions various types detection methods sarscov<NUMBER> rrtpcr still taking heavy works corresponding official confirmation however increased susceptive populations nearly exhaust routine test special invitation <NUMBER> xxxxxx j chin med assoc procedure many countries indeed new emerged approaches potential future rapid diagnostics release heavy loading rrtpcr test specificity efficacy proved clinical trial example antibodybased test developed academia sinica great potential fast exam since adapted commercial flulike test challenge amplification mab ratelimit stage large production kit hand another novel method combining modified rna amplification technique fret quenching concept provide convincing results future usage finally addition example fretbased strategy also applied detect binding sarscov<NUMBER> spike protein human ace<NUMBER> receptor activity sarscov<NUMBER> protease using specific peptide sequence substrate fret pair fluorescent proteins march <NUMBER> <NUMBER> world health organization declared global pandemic due widespread infection novel coronavirus covid<NUMBER> coronavirus disease <NUMBER> caused severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> initial testing protocols us centers disease control prevention cdc covid<NUMBER> detection patients possible infection recommend samples also first sent influenza viruses along respiratory panels detection parainfluenza virus adenovirus human rhinovirus respiratory syncytial virus bordetella pertussis chlamydia pneumoniae mycoplasma pneumoniae <NUMBER> problem testing coinfections suspected patients presence positive upper respiratory pathogen nucleic acid detection rpna test viruses sarscov<NUMBER> may suggest clinicians alternate explanations patients symptoms cdc continues strongly encourage test causes respiratory illness <NUMBER> therefore positive rpna test could potentially lead failure test covid<NUMBER> thereby increasing exposure risks patient coinfection initial investigations patients covid<NUMBER> wuhan china showed low nonexistent rate coinfection respiratory viral pathogens <NUMBER> however recent study presumably cooler climates shown increasing presence coinfections <NUMBER> typically influenza rhinovirus <NUMBER> large variations data lack experience comprehensive testing covid<NUMBER> along respiratory pathogens elected look retrospectively experience testing data could help weighing pros cons strategies algorithms involve respiratory pathogen panels flu testing decision point covid<NUMBER> testing study retrospective analysis data academic medical center <NUMBER> hospitals <NUMBER> urgent care centers san diego california initial <NUMBER> weeks sarscov<NUMBER> testing march <NUMBER> <NUMBER> covid<NUMBER> testing targeted toward highrisk patients following known criteria per cdc guidelines consistent study period patients presenting symptoms concerning covid<NUMBER> infection fever cough shortness breath data queried shared electronic medical record epic using standard structured query language sql queries data col flow diagram virology testing patients first <NUMBER> weeks covid<NUMBER> testing presented figure <NUMBER> main limitation study small sample size lack also simple detection virus pharyngeal swab necessarily imply active infection virus covid<NUMBER> initially causes nonspecific symptoms mild cough myalgia fever <NUMBER> published series far adults influenza common coinfection seen sarscov<NUMBER>positive patients seen single case recent series <NUMBER> sarscov<NUMBER>positive samples northern california showed astounding rate <NUMBER> <NUMBER> <NUMBER> nonsarscov<NUMBER> pathogens <NUMBER> surprising sarscov<NUMBER> added next iteration diagnostic testing assay respiratory pathogens prove useful pandemic unfolds therefore based experience review literature patients respiratory illness need testing sarscov<NUMBER> another respiratory virus one consider testing sarscov<NUMBER> regardless preliminary testing done flu respiratory pathogens new virus continues common cause respiratory infection patient cough dyspnea andor fever suspect covid<NUMBER> regardless preliminary testing results respiratory pathogens course months coronavirus disease <NUMBER> covid <NUMBER> developed global pandemic causing <NUMBER> deaths beginning june <NUMBER> <NUMBER> etiological investigation gene sequencing identified novel rna coronavirus provisionally named severe acute respiratory syndrome coronavirus <NUMBER> sarscov<NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> highly infectious basic reproductive number r<NUMBER> approximately <NUMBER> <NUMBER> sarscov<NUMBER> spreads humantohuman mediated droplets contact highconcentration aerosols closed environment <NUMBER> sarscov<NUMBER> mainly infects upper respiratory tract causes symptoms fever dry cough fatigue progressive dyspnea one major concern healthcare systems discovering early infections incubation period asymptomatic carriers making reliable test critical successful control pandemic currently effective targeted drugs available vaccine covid<NUMBER> early diagnosis early quarantine cutting source infection effective control means pandemic clinical features epidemiological history imageology pathogenic index play vital role diagnosis covid<NUMBER> present nucleic acid test based fluorescence pcr isothermal nucleic acid amplification primarily employed early diagnosis covid<NUMBER> <NUMBER> <NUMBER> however nucleic acid testing requires biosafety laboratory facility skilled personnel therefore unsuitable field screening reach many less wellendowed communities health care systems developing countries furthermore nucleic acid test needs rna extraction reverse transcription gene amplification result analysis complicated operations take least <NUMBER> h second major challenge associated nucleic acid detection high false negative rates <NUMBER> potentially dangerous characteristic given epidemiological consequences unidentified carriers pcr nucleic acid testing highly sensitive early diagnosis sarscov<NUMBER> infection suitable field rapid screenings antibody testing another approach assisting nucleic acid diagnosis <NUMBER> colloidal gold test paper traditional chemiluminesence immunoassay clia enzymelinked immunosorbent assay elisa reagents rapidly developed <NUMBER> currently available antibody tests detect igm orand igg antibodies nucleocapsid spike antigen sarscov<NUMBER> present blood samples <NUMBER> <NUMBER> colloidal gold paper tests rapid easytouse <NUMBER> sensitivity colloidal gold antibody test relatively low compared pcrbased testing critically antibodies generated <NUMBER> days past virus exposure <NUMBER> therefore suitable early screening diagnosis covid<NUMBER> rendering early isolation disrupting transmission impossible previous study reported nanozyme colorimetric strip test ebola virus detection based fe<NUMBER>o<NUMBER> nanozymecatalyzed chromogenic reaction <NUMBER> nanozymes nanomaterials endowed intrinsic enzymemimicking activity <NUMBER> used enzymelabeled probes enzymatic chemiluminescence widely used vitro diagnosis ivd due higher sensitivity wider linear range compared elisa traditional clia based natural protease natural horseradish peroxidase hrp alkaline phosphatase alp characterized poor stability moreover traditional chemiluminescence detection depends large instruments expensive readily available individuals developed nanozymebased chemiluminescence paper test rapid highsensitive portable detection sarscov<NUMBER> spike antigen used cofehemin nanozyme suitable alternative hrp thus combining traditional clia lateral flow assay novel pointofcare approach nanozymebased chemiluminescence paper test considerable benefit early screening suspected sarscov<NUMBER> infections greatly assist minimizing impact largescale screening national healthcare systems especially emerging lowerincome economies inc beijing china pseudosarscov<NUMBER> expressing spike s<NUMBER> protein spike s<NUMBER> elisa reagent sarscov srbd merscov srbd hcovhku<NUMBER> hcovoc<NUMBER> spike protein purchased sino biological inc firstly cofe nanoparticles cofe nps carboxyl modification synthesized hydrothermal method brief fecl<NUMBER>h<NUMBER>o cocl<NUMBER>h<NUMBER>o molar ratio <NUMBER> <NUMBER> dissolved <NUMBER> ml ployethylene glycol next <NUMBER> g sodium acetate naac <NUMBER> g poly acrylic acid added vigorous stirring solution transferred hightemperature autoclave heated <NUMBER>℃ <NUMBER> h synthesized nanoparticles gathered magnetic separation washed ethyl alcohol deionized water subsequently cofe nps prepared added naac solution next hemin mass concentration ratio <NUMBER> dropwise added reaction system continuous stirring <NUMBER> h room temperature cofehemin nanocomposites purified magnetic separation washed described transmission electron microscopy tem images obtained using tecnai sprit microscope instrument operating <NUMBER> kv fei inc america scanning electron microscopy sem images taken su<NUMBER> microscope instrument hitachi japan hydrate particle size cofehemin nanozyme measured using <NUMBER>dpn dynamic light scattering dls instrument uvvis absorbance spectra scanned using u<NUMBER> absorption spectrophotometer hitachi japan wavelength range <NUMBER> nm surface carboxyl group modification characterized using thermo gravimetricdifferential scanning calorimeter tgdsc analysis using sta<NUMBER>f<NUMBER> jupiter netzsch german heating rate <NUMBER>℃min n<NUMBER> protection elemental analysis performed using energy dispersive spectroscopy eds equipped sem microscope instrument peroxidase activity cofehemin nanozyme measured according previously published procedure <NUMBER> brief nanoparticles different concentrations added <NUMBER> ml hacnaac buffer <NUMBER> ph <NUMBER> <NUMBER> µl tmb <NUMBER> µl h<NUMBER>o<NUMBER> <NUMBER> wtvol added cuvette absorbance <NUMBER> nm measured <NUMBER> min temperature <NUMBER>℃ rectiontime curve plotted specific activity sa umg nanozyme calculated chemiluminescence catalytic activity assessed envision multilabel plate reader perkinelmer using liquid autoinjection system luminol substrate maximum chemiluminescent intensities catalyzed cofehemin nanozyme measured different ph temperature pretreatment different concentrations h<NUMBER>o<NUMBER> hrp positive control moreover intermediate reactive oxygen species reaction system monitored using electron spin resonance esr spectroscopy spin trap agent recombinant antigen receptor binding domain sarscov<NUMBER> spike protein srbd located s<NUMBER> subunit <NUMBER> cdna sequence encoding srbd expressed containing nterminal natural signal peptide well <NUMBER>×his tag cterminus transfection hek<NUMBER> cells <NUMBER> days supernatants collected soluble protein sequentially purified using histrap hp column superdex <NUMBER> column concentration srbd protein determined using bca assay kit pierce purity recombinant protein analyzed sdspage aliquoted protein stored <NUMBER>℃<NUMBER>℃ use antispike antibodies generated sorting single memory b cells previously reported <NUMBER> briefly peripheral blood mononuclear cells convalescent covid<NUMBER> patients incubated histagged srbd <NUMBER> nm staining anticd<NUMBER> anticd<NUMBER> anticd<NUMBER>a anticd<NUMBER> anticd<NUMBER> anticd<NUMBER> antihis antibodies antigenspecific memory b cells identified following markers cd<NUMBER> cd<NUMBER> cd<NUMBER>a cd<NUMBER> cd<NUMBER> cd<NUMBER> higg sorted <NUMBER>well pcr plates single cell perwell genes encoding ig vh vl chains amplified <NUMBER>race nested pcr variable regions genes cloned human igg<NUMBER> constant region generate fulllength monoclonal antibodies expressed purified conventional methods antibody binding affinity srbd evaluated biacore <NUMBER>k antisrbd antibody pairs screening using elisa method nanozymebased colorimetric strips <NUMBER> preparation nanozymebased chemiluminescence test paper resembles colloidal gold strip modifications nanozymebased chemiluminescence test paper constituted pvc backing plate absorbing pad sample pad nitrocellulose membrane conjugate pad first detection antibody srbd sdab conjugated nanozyme chemiluminescent probes prepared chemical coupling carboxyl group using edcnhs agents labeled nanozyme probes stored modified tb buffer containing <NUMBER> bsa nanozyme probes dispensed pretreated conjugate pad using biodot dispensing equipment paired capture antibody srbd scab immobilized nitrocellulose membrane <NUMBER> mgml form test line tline well antihuman igg antibody control line cline next conjugate pad nitrocellulose membrane sample pad absorbing pad assembled pvc backing plate followed complete drying <NUMBER>℃ <NUMBER> h paper boards cut <NUMBER> mmwide strips finally strips packed clamp slots stored room temperature solid chemiluminescence substrate excitant dissolve buffer stored plastic ampoule bottles room temperature study rapid nanozymebased chemiluminescence paper test sarscov<NUMBER> spike antigen developed recombinant srbd protein sarscov<NUMBER> used evaluate sensitivity nanozymebased chemiluminescence paper test <NUMBER> µl sample containing srbd protein dilution buffer loaded onto sample pad pseudosarscov<NUMBER> packaged transfecting <NUMBER>t cells hiv<NUMBER>based retroviral vector coding sarscov<NUMBER> spike s<NUMBER> protein luciferase reporter gene pseudovirus titer determined <NUMBER> <NUMBER> virus copiesml spike s<NUMBER> protein expressed pseudovirus quantified <NUMBER> ngml serially diluted pseudovirus detected nanozymebased chemiluminescence test paper according method described virusrelated operations carried inside class ⅱ biological safety cabinet cofehemin nanozyme type nanomaterial possesses peroxidasemimicking activity characterize morphology microstructure cofehemin nanozyme used tem sem analysis shown fig <NUMBER>a b cofehemin nanozymes resemble spherical particles mean diameter approximately <NUMBER>nm dls analysis showed mean hydrated diameter nanozyme spheres approximately <NUMBER> nm fig <NUMBER>c uvvis spectrum detected two absorption peaks nanozyme spheres corresponding characteristic peaks cofe nanoparticles hemin molecules fig <NUMBER>d using absorption spectrum verified hemin modification present surface cofehemin nanozyme analyzed surface carboxyl group modification cofehemin nanozyme using tgdsc fig <NUMBER>e furthermore element composition content analysis eds indicated atomic ratio fe co nanozyme particle <NUMBER> fig <NUMBER>f peroxidase activity cofehemin nanozyme determined specific activity sa umg according established procedures literature <NUMBER> tmb one chromogenic substrates hrp shown fig <NUMBER>a catalytic activity cofehemin tmb chromogenic reaction <NUMBER> umg higher cofe nps <NUMBER> umg fe<NUMBER>o<NUMBER> nps <NUMBER> umg data shown next evaluated chemiluminescence catalytic properties cofehemin nanozyme luminol substrate using envision multilabel plate reader chemiluminescence signals <NUMBER> µg cofehemin hrp captured presence excitant h<NUMBER>o<NUMBER> shown fig <NUMBER>b maximum chemiluminescent intensity cofehemin comparable hrp showing threefold increase cofe nps comparison catalytic chemiluminescence activity fe<NUMBER>o<NUMBER> nps found lower expected cofehemin nanozyme displayed high chemiluminescent catalytic activity maximum intensity exceeds <NUMBER>e<NUMBER> ph range <NUMBER> <NUMBER> demonstrating nanozyme tolerate alkaline conditions fig <NUMBER>c comparison natural hrp achieved maximum catalytic activity luminol substrate ph <NUMBER> significantly decreased ph increased shown fig <NUMBER>d temperature pretreatment <NUMBER> ℃<NUMBER> ℃ <NUMBER> h failed affect catalytic activity cofehemin nanozyme contrast hrp inactivated heat pretreatment <NUMBER>℃ together results clearly showed nanozyme robust hrp especially extreme ph temperature conditions next investigated reaction parameters excitant h<NUMBER>o<NUMBER> cofeheminluminol catalytic system shown fig <NUMBER>e maximum chemiluminescent intensity increased concentration h<NUMBER>o<NUMBER> range <NUMBER> µm <NUMBER> mm reaching plateau phase concentration <NUMBER> mm moreover monitored superoxide anions o<NUMBER>• − signal cofeheminh<NUMBER>o<NUMBER> system alkaline conditions using esr technique fig <NUMBER>f together findings indicated luminol oxidated o<NUMBER>• − radicals derived reaction cofehemin h<NUMBER>o<NUMBER> suggesting possible mechanism nanozymecatalyzed chemiluminescence successfully validating different core parts novel testing platform next designed nanozymebased chemiluminescence paper test <NUMBER> unlikely crossreactivity occur nontarget antigen identify best paired antibodies sarscov<NUMBER> srbd antigen next screened series antispike antibodies using elisa among six antibodies tested clones gh<NUMBER> cb<NUMBER> tp<NUMBER> rp<NUMBER> exhibited high binding activity recombinant srbd protein fig <NUMBER>b manufactured nanozyme probes labeled cb<NUMBER> rp<NUMBER> clones respectively combined probes strips immobilized gh<NUMBER> rp<NUMBER> tp<NUMBER> gh<NUMBER> tp<NUMBER> capture antibodies shown fig <NUMBER>c cb<NUMBER> gh<NUMBER> pair gave best performance srbd detection however clone pairings resulted problematic combinations suggesting antibodies recognize either identical crossed antigenic epitopes thus chose cb<NUMBER> detection antibody gh<NUMBER> capture antibody final antibody pairs nanozymebased chemiluminescence paper test using cb<NUMBER> gh<NUMBER> pair manufactured nanozymebased chemiluminescence test strips detect srbd antigen assess sensitivity test prepared serial dilution srbd protein samples following chromatography procedure room temperature <NUMBER> minutes color signals tline observed naked eyes concentration higher <NUMBER> ngml next added luminol substrate solution chemiluminescent signal instantly captured using ccd smartphone camera dark environment fig <NUMBER>a next analyzed chemiluminescent signal intensity using imagepro plus software calibration curve antigen test plotted shown fig <NUMBER>b analysis showed test detected little <NUMBER> ngml srbd protein detection limit srbd defined x<NUMBER>sd x mean negative control sd standard deviation value linearity test identified ranging <NUMBER> <NUMBER> ngml correlation coefficient <NUMBER> fig <NUMBER>b parallel test using elisa srbd antigen detectable <NUMBER> ngml linear calibration curve ranging <NUMBER> <NUMBER> ngml fig <NUMBER>c sensitivity nanozymebased chemiluminescence paper test srbd protein similar elisa however least <NUMBER>fold enlargement linearity range moreover nanozymebased chemiluminescence paper test specifically recognized sarscov<NUMBER> srbd protein whereas failed detect spike proteins known coronaviruses sarscov merscov hcovhku<NUMBER> hcovoc<NUMBER> fig <NUMBER>d sarscov<NUMBER> shares <NUMBER> similarities sarscov merscov hcovhku<NUMBER> well hcovoc<NUMBER> cause common flu identified genome sequence analysis <NUMBER> clearly demonstrated paper test specific sarscov<NUMBER> spike antigen verify validity paper test actual viral infection collected pseudosarscov<NUMBER> expressing spike protein s<NUMBER> subunit titer pseudosarscov<NUMBER> stock determined <NUMBER>e<NUMBER> virus copiesml using realtime rtpcr gradient dilution series pseudovirus detected nanozymebased chemiluminescence test paper shown fig <NUMBER>a detection limit chemiluminescence paper test pseudosarscov<NUMBER> <NUMBER>e<NUMBER> copyml corresponding <NUMBER> ngml s<NUMBER> protein linearity paper test ranging <NUMBER>e<NUMBER> <NUMBER>e<NUMBER> copyml r <NUMBER> <NUMBER> fig <NUMBER>b parallel test sensitivity elisa reached <NUMBER>e<NUMBER> copyml relatively narrow linear range <NUMBER>e<NUMBER> <NUMBER>e<NUMBER> copyml fig <NUMBER>c present novel sarscov<NUMBER> antigen paper test outperformed traditional paper test hrpbased immunoassay study successfully combined nanozymecatalyzed chemiluminescence lateral immunochromatographic system achieve ultrasensitive well rapid testing sarscov<NUMBER> antigen greatly benefit early screening diagnosis covid<NUMBER> study designed synthesized type peroxidasemimic co cofehemin nanozyme key improving sensitivity paper test moreover synthesis nanozyme relies readily available materials easily scaled without need expensive equipment thus nanozyme material relatively lowcost compared nature hrp produced complex extraction purification therefore overall cost nanozymebased chemiluminescence paper test relatively low compared traditional chemiluminescence nucleic acid testing advantage may reduce costs usually incurred universal screening critically benefit regions low socioeconomic standing study clearly showed test superior currently available detection procedures critical validate accuracy paper test real clinical samples theoretically paper test suitable multiple sample candidates covering throat swab sputum urine saliva serum particular sample preservation buffer time investigation officially authorized reagents rapid testing sarscov<NUMBER> antigen remained unavailable thus comparisons commercial kits test paper clinical sample detection require future investigation lastly proofofprinciple study primarily designed enable qualitative analysis achieved means readily available smartphone technology allow quantitative analysis clinical samples quantitative test developed portable handheld device equipped signal acquisition data analysis function nanozymebased chemiluminescence paper test currently developed conclusion nanozymebased chemiluminescence paper test combines highsensitivity chemiluminescence highspecificity immunoassay short testing time lateral flow chromatography technique due excellent performance remarkable portability lowcost nanozymebased chemiluminescence paper test provide novel pointofcare approach early screening sarscov<NUMBER> infections moreover universal paperbased poct technique promising potential diagnosis application emerging infectious diseases pandemic potential pediatric patients respiratory viruses rvs considered important pathogens acute respiratory tract infections resulting hospitalization acute care visits <NUMBER> <NUMBER> <NUMBER> diagnostic evaluations rvs frequently performed <NUMBER> however diagnostic evaluations rvs rarely performed adult patients viruses cause benign respiratory tract infections <NUMBER> recently advent sensitive molecular techniques clinical cases pneumonia associated variable rvs reported increasing frequency adult patients <NUMBER> <NUMBER> importance rvs adult patients also emphasized wwwkjimorg httpdxdoiorg<NUMBER>kjim<NUMBER> <NUMBER> emergence severe acute respiratory syndrome avian influenza h<NUMBER>n<NUMBER> pandemic influenza h<NUMBER>n<NUMBER> <NUMBER> <NUMBER> near future rv detection tests may considered essential part diagnostic workup adult patients acute respiratory tract infections however physicians treating adult patients yet familiar rv detection tests investigated current utilization multiplex reverse transcriptionpolymerase chain reaction rtpcr test rvs adult patients clinical practice multiplex rtpcr test allows detection large number rvs simultaneously higher sensitivity viral culture <NUMBER> hypothesized utilization data results current multiplex rtpcr tests would helpful identifying benefits problems associated multiplex rtpcr utilization adult patients study performed chungang university hospital <NUMBER>bed tertiary care teaching hospital seoul republic korea adult patients <NUMBER> years age underwent multiplex rtpcr testing january <NUMBER> april <NUMBER> identified electronic medical records chest radiographs reviewed demographic characteristics underlying diseases multiplex rtpcr results presence respiratory symptoms clinical outcomes investigated upper respiratory infection uri defined presence ≥ <NUMBER> following respiratory symptoms cough sputum production rhinorrhea sore throat dyspnea pneumonia defined presence new progressive infiltrate chest radiography plus two following symptoms signs fever sputum production rhinorrhea sore throat dyspnea attending physicians diagnosis pneumonia nonrespiratory infection nri defined neither uri pneumonia patient episode acute infection within <NUMBER> days admission underwent multiplex rtpcr testing episode considered received test communityacquired infection flu season defined january april <NUMBER> january april <NUMBER> flu season determined based weekly surveillance reports influenza respiratory viruses korea centers disease control prevention <NUMBER> study period nasopharyngeal specimens obtained using flocked swab submitted universal transport medium copan brescia italy nasopharyngeal specimens submitted rv<NUMBER> detection january <NUMBER> december <NUMBER> rv<NUMBER> detection january <NUMBER> april <NUMBER> nucleic acids extracted <NUMBER>μl specimens using viral genespin viral dnarna extraction kit intron biotechnology seongnam korea cdnas synthesized extracted rnas cdna synthesis premix seegene seoul korea geneamp pcr system <NUMBER> thermal cycler applied biomaterials foster city ca usa rv<NUMBER> testing performed detect following viruses adenovirus influenza viruses b respiratory syncytial virus rsv human metapneumovirus hmpv human rhinovirus hrv pcr performed using seeplex rv<NUMBER> detection kit seegene according manufacturers instructions geneamp pcr system <NUMBER> thermal cycler applied biomaterials products separated <NUMBER> agarose gels containing <NUMBER> g ethidium bromideml triborateedta buffer visualized ultraviolet light pcr according manufacturers instructions anyplex ii rv<NUMBER> detection kit seegene used detect fourteen types rna viruses two types dna viruses according manufacturers instructions briefly assay conducted final volume <NUMBER> μl containing <NUMBER> μl cdna <NUMBER> μl <NUMBER> × rv primer <NUMBER> μl <NUMBER>methoxypsoralen solution <NUMBER> μl <NUMBER> × master mix cfx<NUMBER> realtime pcr detection system biorad laboratories inc hercules ca usa statistical analyses performed using spss version <NUMBER> spss inc chicago il usa continuous variables compared using student test mannwhitney u test categorical variables compared using chisquare test fisher exact test study period multiplex rtpcr testing performed <NUMBER> respiratory samples <NUMBER> adult patients period rapid influenza antigen detection tests performed <NUMBER> nasopharyngeal swab samples bacterial cultures performed <NUMBER> respiratory samples study hospital thus frequency multiplex rtpcr testing <NUMBER> rapid influenza antigen detection tests <NUMBER> respiratory bacterial cultures mean turnaround time <NUMBER> positive multiplex rtpcr tests <NUMBER> hours sd <NUMBER> range <NUMBER> <NUMBER> turnaround time <NUMBER> hours observed <NUMBER> <NUMBER> <NUMBER> positive tests characteristics <NUMBER> cases summarized table <NUMBER> mean patient age <NUMBER> years half male <NUMBER> <NUMBER> common underlying disease diabetes mellitus <NUMBER> followed chronic lung disease <NUMBER> solid tumor <NUMBER> hematologic malignancy <NUMBER> chronic renal failure <NUMBER> multiplex rtpcr testing performed frequently cases pneumonia <NUMBER> followed uri <NUMBER> nri <NUMBER> majority multiplex rtpcr tests performed admitted patients <NUMBER> communityacquired infections <NUMBER> flu season <NUMBER> patients underwent multiplex rtpcr nri following diseases urinary tract infections acute gastroenteritis acute hepatitis febrile neutropenia meningitis mediastinitis pulmonary tuberculosis mumps chickenpox acute cholangitis escherichia coli bacteremia unknown origin enteric fever clostridium difficile infection acute appendicitis cellulitis cervical lymphadenitis hemorrhagic cystitis cerebrovascular accidents seizure hyperventilation syndrome angina patients nri multiplex rtpcr testing performed due presence fever unknown origin flu nonflu season list detected rvs presented table <NUMBER> rvs identified <NUMBER> <NUMBER> samples <NUMBER> influenza commonly identified <NUMBER> <NUMBER> influenza <NUMBER> vs <NUMBER> p <NUMBER> human coronavirus <NUMBER> vs <NUMBER> p <NUMBER> frequently detected patients uri pneumonia rates rv positivity different patients communityand hospitalacquired infections <NUMBER> vs <NUMBER> p <NUMBER> individual rv difference rates rv positivity communityand hospitalacquired infections <NUMBER> patients nri <NUMBER> <NUMBER> positive multiplex rtpcr results influenza <NUMBER> adenovirus <NUMBER> parainfluenza virus <NUMBER> human enterovirus <NUMBER> hrv <NUMBER> rsv <NUMBER> characteristics <NUMBER> patients pneumonia four duplicates excluded underwent multiplex rtpcr testing compared according pathogen type table <NUMBER> approximately one quarter patients rv infection <NUMBER> <NUMBER> bacterial infection <NUMBER> <NUMBER> respectively nine patients <NUMBER> <NUMBER> bacterialviral coinfections remaining <NUMBER> patients <NUMBER> identified pathogen patients rv infection <NUMBER> rvs influenza <NUMBER> <NUMBER> patients single rv infection without rv infection differ terms baseline characteristics underlying diseases symptoms inhospital mortality except rhinorrhea frequently observed patients single rv infection flu season pa tients coinfected rv bacterium rsv hematologic malignancy common features patients infected single rv inhospital mortality rates higher patients bacterialviral coinfection <NUMBER> without rv infection <NUMBER> single rv infection <NUMBER> multiplex rtpcr testing performed primarily adult patients communityacquired respiratory infections admitted tertiary care center flu season especially patients pneumonia test performed infrequently test results often reported late rvpositive rate <NUMBER> communityacquired infections different hospitalacquired infections <NUMBER> p <NUMBER> rvs identified quarter <NUMBER> <NUMBER> patients pneumonia nearly half patients rvassociated pneumonia rvs influenza <NUMBER> <NUMBER> hospital multiplex rtpcr testing frequently performed adult patients communityacquired respiratory infections admitted flu season thus test primarily used diagnose influenza adult patients especially pneumonia clinicians experienced influenza h<NUMBER>n<NUMBER> pandemic <NUMBER> use multiplex rtpcr diagnostic test influenza infection understandable hospitals perception multiplex rtpcr testing physicians may similar given predominance influenza among rvs presence effective antiinfluenza therapies <NUMBER> therefore multiplex rtpcr test performed diagnose influenza flu season especially considering low sensitivity rapid influenza antigen detection tests <NUMBER> however hospital multiplex rtpcr test performed infrequently compared rapid influenza antigen detection tests additionally test rarely performed outpatient departments study hospital findings understandable given test results available onsite unlike rapid influenza antigen detection test moreover test covered national health insurance south korea relatively expensive <NUMBER> krw compared cost respiratory bacterial culture <NUMBER> krw rapid influenza antigen detection test <NUMBER> <NUMBER> krw consequently infrequent ordering resulted less routine pcr testing clinical laboratory every day three times week hospital may explain turnaround time <NUMBER> hours observed <NUMBER> positive tests fortyeight hours appropriate time period introduction antiinfluenza drugs onset symptoms <NUMBER> considering problems continuous threat influenza infection current utilization multiplex rtpcr testing requires improvement may increase diagnostic sensitivity influenza decrease number patients receive delayed thera py study rv positivity rate communityacquired infections differ hospitalacquired infections differences viral pathogens communityand hospitalacquired infections recent study viral infections patients severe pneumonia requiring intensive care unit admission patients communityacquired pneumonia healthcareassociated pneumonia similar rates rv positivity <NUMBER> vs <NUMBER> similar rv pathogens <NUMBER> regarding findings experts suggest rv infections directly influenced previous healthcare interventions exposure antimicrobial agents rather mirror circulating viruses community <NUMBER> although hospitalacquired infections healthcareassociated infections different similar explanation may applied findings considering frequent detection rvs patients hospitalacquired infection multiplex rtpcr testing limited patients communityacquired respiratory infections test may required patients serious hospitalacquired respiratory infections unknown cause based study findings test may needed hospital rv infection control <NUMBER> although turnaround time may optimal purpose causal role rvs influenza determined adult patients pneumonia effective treatment antiviral agents largely unavailable clinical practice thus detection rvs influenza may regarded unnecessary adult patients pneumonia especially nonflu season considering fact multiplex rtpcr test represented <NUMBER> sputum bacterial culture tests however clinical studies pneumonia associated rvs influenza reported increased infection rates immunocompromised nonimmunocompromised patients <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> additionally antiviral agents recommended severe pneumonia caused rvs influenza especially immunocompromised patients <NUMBER> <NUMBER> study although tests performed diagnosis influenza infection flu season rvs influenza found <NUMBER> <NUMBER> patients rvassociated pneumonia furthermore half <NUMBER> patients bacterialviral coinfection rvs influenza including rsv hmpv hrv detected group coinfected patients higher rates mortality either group single rv infection group without rv infection although association higher mortality may due serious underlying diseases hematologic malignancy <NUMBER> impact bacterial infections group significance rvs influenza neglected clinical significance rsv hmpv hrv adult patients pneumonia recently reported <NUMBER> <NUMBER> <NUMBER> <NUMBER> study suggests rvs influenza considered adult patients pneumonia clinical impact rvs evaluated future clinical studies study <NUMBER> patients nri positive multiplex rtpcr test results clinical presentation rv infection may vary according either pathogenic potential rv degree host immunity rvs respiratory symptoms signs patients rv infection may minimal absent asymptomatic carriers rvs another possible explanation suggested previous study <NUMBER> study several limitations first designed compare clinical management outcomes medical costs patients underwent multiplex rtpcr testing patients thus study include direct evidence clinical usefulness multiplex rtpcr test rvs prior studies shown conflicting results costeffectiveness multiplex rtpcr test <NUMBER> additional studies required multiplex rtpcr test rvs strongly recommended south korea second platform multiplex rtpcr testing changed study period might affected multiplex rtpcr results positivity rates however rv<NUMBER> test performed <NUMBER> <NUMBER> cases third clinical data retrospectively collected unrecognized clinical factors may resulted biases study analysis fourth data cannot generalized centers different characteristics conclusion multiplex rtpcr test performed frequently adult patients admitted communityacquired respiratory infections flu season tertiary care center test performed infrequently reporting test results often delayed utilization multiplex rtpcr testing encouraged effectively diagnose infections influenza rvs inside outside hospital influenza virus influenza viruses segmented rna genomes classified type b c <NUMBER> envelope glycoproteins important targets neutralizing antibody <NUMBER> hemagglutinin h initiates infectivity binding cellular sialic acid residues neuraminidase n protein cleaves newly synthesized virus sialic acid cell surfaces allowing spread virus adjacent cells least <NUMBER> antigenically distinct hemagglutinin h<NUMBER>h<NUMBER> <NUMBER> neuraminidase n<NUMBER>n<NUMBER> molecules influenza identified h<NUMBER>h<NUMBER> viruses cause cases human disease whereas others generally pathogens aquatic birds mammals antigenic variation h n contributes epidemic nature influenza <NUMBER> mechanisms antigenic drift due minor changes neutralizing epitopes h results epidemics necessitates annual adjustment vaccine formulations antigenic shift occurs <NUMBER> influenza viruses exchange h n genes infection host shifts resultant influenza pandemics occurred <NUMBER> h<NUMBER>n<NUMBER> virus <NUMBER> h<NUMBER>n<NUMBER> virus <NUMBER> h<NUMBER>n<NUMBER> virus although annual winter epidemics occur predictably lasting <NUMBER> weeks one locale time onset severity highly variable influenza efficiently transmitted via small particle aerosols generated coughing sneezing <NUMBER>day incubation period facilitates explosive outbreaks closed settings nursing homes table <NUMBER> since <NUMBER> impact influenza elderly population substantial greatest among persons chronic diseases estimated least <NUMBER> <NUMBER> influenzarelated hospitalizations <NUMBER> <NUMBER> influenzarelated deaths united states involve persons aged <NUMBER> years group constitutes <NUMBER> total population <NUMBER> clinical manifestations influenza elderly persons may differ classic influenza ie abrupt fever myalgias headache seen younger adults older persons lower frequency upper respiratory tract symptoms among elderly outpatients cough fever acute onset illness <NUMBER> positive predictive value contrast positive predictive value <NUMBER> young adults <NUMBER> study older adults hospitalized documented influenza cough nearly universal fever temperature <NUMBER>њc seen <NUMBER> <NUMBER> fever altered mental status may signs influenza pneumonia older persons cognitive impairment gastrointestinal complaints fever myalgias help distinguish influenza winter respiratory viruses respiratory syncytial virus rsv table <NUMBER> classic description influenzaassociated lower respiratory tract complications h<NUMBER>n<NUMBER> pandemic <NUMBER> louria et al <NUMBER> described <NUMBER> syndromes <NUMBER> radiographic pneumonia <NUMBER> viral infection followed bacterial pneumonia <NUMBER> rapidly progressive diffuse viral pneumonia <NUMBER> concomitant viralbacterial pneumonia today pure viral pneumonia uncommon perhaps prior infection vaccination induced immunity among older persons well rarity rheumatic heart disease found <NUMBER> highly vaccinated elderly persons ie <NUMBER> community developed influenza season <NUMBER> pneumonia <NUMBER> hospitalized patients influenza radiographic infiltrates whereas equal percentage findings consistent congestive heart failure diseases <NUMBER> true incidence secondary bacterial pneumonia influenza unknown largely difficulties involved accurate diagnosis bacterial infection recent study <NUMBER> bacterial infection identified <NUMBER> hospitalized patients influenza <NUMBER> episode streptococcus pneumoniae bacteremia dual viralbacterial infections severe viral infections alone evidence higher rates intensive care use morbidity rsv rsv secondmost commonly identified cause viral pneumonia older persons first isolated <NUMBER> chimpanzee cold subsequently shown leading cause lower respiratory infections young children rsv rna virus belonging paramyxoviridae family causes characteristic syncytia formation cell culture two major antigenic groups rsv b cause annual winter epidemics respiratory disease temperate climates <NUMBER> unlike influenza virus rsv undergo major periodic antigenic changes yet immunity incomplete reinfection young adults usually produces mild illness however likelihood severe disease pneumonia increases advancing age rsv pneumonia first described older adults <NUMBER>s however appreciated significant pathogen outbreaks infection nursing homes reported <NUMBER>s <NUMBER> rates pneumonia death ranged <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively composite studies indicate ∼<NUMBER> nursing home residents develop rsv infection annually <NUMBER> develop pneumonia rsv infection also problem among elderly persons live community investigators centers disease control prevention linked viral surveillance data national death databases estimated rsv infection accounts ∼<NUMBER> deaths among elderly persons year <NUMBER> study <NUMBER> adults cap rsv <NUMBER> cases thirdmost commonly identified pathogen compared pneumoniae <NUMBER> cases influenza viruses b <NUMBER> cases mycoplasma pneumonia <NUMBER> <NUMBER> found season rsv infection occurred <NUMBER> prospectively monitored healthy elderly persons <NUMBER> highrisk adults pneumonia occurred <NUMBER> infected persons <NUMBER> addition rsv infection accounted <NUMBER> winter discharge diagnoses pneumonia clinical manifestations rsv pneumonia difficult distinguish viral bacterial pneumonias dyspnea cough common <NUMBER> cases unique rsv infection typical rsv illness begins nasal congestion gradually progresses wheezing difficulty breathing compared influenza rsv infection often associated rhinorrhea sputum production wheezing whereas fever gastrointestinal complaints common influenza table <NUMBER> <NUMBER> <NUMBER> chest radiographs typically show patchy bilateral alveolar infiltrates interstitial changes cultureproven cases rsv pneumonia infiltrates tend small illdefined although consolidation described <NUMBER> seventy percent patients rsv pneumonia normal wbc count compared <NUMBER> patients atypical pneumonia <NUMBER> bacterial pneumonia eleven percent <NUMBER> rsvinfected patients may evidence mixed viralbacterial infection human metapneumovirus hmpv hmpv newly described respiratory pathogen identified dutch researchers <NUMBER> young children respiratory illnesses resembling rsv bronchiolitis <NUMBER> hmpv rna virus belonging paramyxoviridae family metapneumovirus genus worldwide distribution universal infection age <NUMBER> years temperate climates virus circulates predominantly winter months overlapping seasonal viruses several studies suggest may significant yeartoyear variation incidence rates <NUMBER> hmpv newly identified virus clinical data still relatively limited studies describe children bronchiolitis pneumonia asymptomatic infection colds asthma exacerbations flulike illnesses documented older children healthy young adults <NUMBER> comprehensive studies hmpv cause cap among adults yet published <NUMBER>year study elderly subjects highrisk adults hmpv infection identified <NUMBER> rtpcr serologic testing used diagnoses <NUMBER> impact greatest among cardiopulmonary diseases ill twice long healthy elderly subjects hospitalized persons <NUMBER> infiltrates noted chest radiographs illness may severe frail elderly subjects evidenced canadian study pneumonia documented <NUMBER> hmpvinfected nursing home residents <NUMBER> clinical characteristics hmpv pneumonia older adults appear distinctive illness due winter respiratory viruses hmpv infection may somewhat less severe rsv infection influenza lower rates mechanical ventilation death noted one study <NUMBER> parainfluenza viruses pivs pivs paramyxoviruses cause croup bronchitis pneumonia young children piv type <NUMBER> infection endemic year round infections due piv types <NUMBER> <NUMBER> tend peak fall months <NUMBER> infection recurs throughout adulthood accounting <NUMBER> acute respiratory illnesses occasional reports pneumonia young adults elderly population piv less well studied rsv pneumonia reported <NUMBER> investigators sweden found <NUMBER> communitydwelling elderly persons pneumonia <NUMBER> acute respiratory tract illness serologic evidence recent infection due piv type <NUMBER> <NUMBER> <NUMBER> prospective studies nursing homes documented piv infection <NUMBER> respiratory illnesses fatal cases bronchopneumonia reported <NUMBER> piv also implicated precursor outbreak invasive pneumococcal disease longterm care facility clinical syndromes characterized fever rhinorrhea cough sore throat distinctive coronaviruses coronaviruses rna viruses derive name crownlike appearance clubshaped surface proteins discovered <NUMBER> second rhinoviruses cause common cold studies human illness limited inability grow virus routine conditions past <NUMBER> decades oc<NUMBER> <NUMBER>e strain infections diagnosed age groups serologic testing <NUMBER> recently <NUMBER> new human strains nl<NUMBER> hku<NUMBER> identified rtpcr <NUMBER> <NUMBER> interest coronaviruses intensified <NUMBER> severe acute respiratory syndrome epidemic spread quickly china proven due novel coronavirus sarscov oc<NUMBER> <NUMBER>e often occur late winter early spring demonstrating <NUMBER>year periodicity <NUMBER> healthy adults infection characterized lowgrade fever malaise nasal symptoms pneumonia reported young children immunocompromised patients elderly persons <NUMBER> <NUMBER> coronaviruses identified rtpcr <NUMBER> elderly persons community acute respiratory illnesses recent dutch study <NUMBER> patients lower respiratory tract symptoms <NUMBER> studies date reported radiographic findings thus frequency coronavirus pneumonia remains unknown rhinoviruses rhinoviruses frequent cause common cold circulate throughout year activity peaks fall spring infections common among persons ages including elderly persons account ∼<NUMBER> respiratory illnesses among communitydwelling elderly individuals <NUMBER> outbreaks also documented longterm care facilities senior daycare centers <NUMBER> <NUMBER> prominent nasal congestion cough constitutional symptoms characterize illnesses role rhinoviruses pneumonia remains somewhat controversial replication restricted core body temperature rhinoviruses dismissed cause pneumonia recent evidence indicates rhinoviruses recovered lower airways experimental challenge cases pneumonia described young children severely immunocompromised patients <NUMBER> comprehensive studies older adults cap using new sensitive molecular techniques yet performed viral diagnostic methods include culture rapid antigen detection rtpcr serologic testing availability sensitivity varying basis specific virus respiratory secretions appropriate testing include nasal swab wash specimens sputum specimens bronchoalveolar lavage fluid samples nasal wash samples preferred sample children difficult obtain frail cognitively impaired elderly persons although slightly less sensitive washes nasal swab samples acceptable alternatives viral culture remains gold standard diagnosis available many clinical laboratories optimal results require prompt transportation specimen ice immediate inoculation influenza relatively hardy grows well culture <NUMBER> days required detection unsatisfactory one must make decisions regarding antiviral therapy culture insensitive diagnosis rsv infection rsv labile adults typically shed low titers pivs rhinoviruses detected culture using standard techniques hmpv coronaviruses special growth requirements necessitating research facilities isolation rapid antigen testing commercially available influenza viruses b rsv offers immediate results cases done point care diagnosis influenza adults tests offer sensitivity <NUMBER> specificity у<NUMBER> many institutions screen patients rapid tests perform culture rapid testing negative allows quick identification many patients sacrificing sensitivity culture given rate falsenegative results rapid tests patients influenza highly suspected epidemics isolated treated antivirals appropriate awaiting culture results <NUMBER> rapid rsv antigen tests useful young children shed high titers virus results disappointing adults compared serologic tests rtpcr sensitivity commercially available tests low <NUMBER> rtpcr sensitive specific diagnosis common respiratory viruses pivotal defining adult disease rsv hmpv rhinoviruses coronaviruses although rapid assays expensive widely available outside major medical centers however multiplex rtpcr hexaplex prodes commercially available diagnosis infection due multiple common respiratory viruses infection respiratory viruses exception sarscov represents reinfection adults presence preexisting antibody precludes single serologic test detect igg antibody igm assays generally useful serologic testing provides retrospective diagnosis у<NUMBER>fold increase specific antibody detected complement fixation eia rhinovirus <NUMBER> serotypes serologic testing impractical diagnosis whereas serologic tests detection hmpv coronavirus available research settings overlapping clinical syndromes diagnosis viral pneumonia requires laboratory confirmation particularly important influenza treatment available infectioncontrol issues arise hospitals nursing homes figure <NUMBER> therefore winter months recommend screening rapid antigen tests patients admitted hospital residents longterm care facilities suspicious clinical syndromes influenza active community recommend screening patients pneumonia rapid tests followed influenza culture results rapid test negative full respiratory viral cultures rtpcr desirable identify viral pathogens resources limited tests may restricted immunocompromised severely ill patients use unproven therapies sometimes attempted retrospective nature serologic testing useful investigation nursing home outbreaks respiratory disease rather individual patient care four antivirals amantadine rimantadine zanamivir oseltamavir approved treatment influenza table <NUMBER> amantadine rimantadine active influenza whereas zanamivir oseltamavir active influenza b agents <NUMBER> effective prophylaxis also reduce illness severity duration symptoms viral shedding given р<NUMBER> h symptom onset uncomplicated influenza cns adverse effects limit utility amantadine elderly population issue resistance develops quickly amantadine rimantadine zanamivir oseltamivir associated fewer adverse effects although zanamivir avoided patients chronic obstructive pulmonary disease asthma bronchospasm <NUMBER> benefit antiviral agents influenza pneumonia unknown placebocontrolled trials pneumonia conducted although definitive data lacking authorities feel reasonable administer antiviral agent elderly patients hospitalized influenza pneumonia treatment rsv pneumonia elderly adults largely supportive antiviral therapy aerosolized ribavirin rsvspecific immunoglobulin approved highrisk infants controlled data available adults <NUMBER> <NUMBER> although general use ribavirin cannot recommended use agent may considered selected cases involving immunocompromised patients anecdotal experience suggests adults undergoing intubation highdose shortduration therapy <NUMBER> mg ml <NUMBER> h given mask <NUMBER> times day better tolerated tent treatment ribavirin vitro activity piv hmpv clinical data involving humans antivirals approved treatment coronavirus rhinovirus infections immunization remains effective means reducing morbidity mortality associated influenza elderly population currently <NUMBER> vaccines available standard trivalent inactivated killed virus vaccine recently introduced live attenuated virus vaccine <NUMBER> studies shown <NUMBER> reduction influenza hospitalization rates good antigenic match vaccine circulating strain <NUMBER> study nearly <NUMBER> communityliving elderly subjects administration trivalent inactivated virus vaccine associated <NUMBER> reduction rate deaths due causes significant reductions rates hospitalization pneumonia influenza cardiac disease stroke compared rates among nonimmunized persons <NUMBER> contrast recent analysis found decrease morbidity mortality rates among older persons even vaccine uptake increased <NUMBER> <NUMBER> <NUMBER> <NUMBER> suggesting better influenza vaccines still needed <NUMBER> although live attenuated virus vaccine efficacious young children adults aged <NUMBER> years vaccine studied older persons <NUMBER> currently licensed rsv vaccines children adults transmission influenza may occur via small particle aerosols thus respiratory isolation patients documented suspected influenza periods high influenza activity appropriate hand washing also important especially patients receiving amantadine rimantadine prevent nosocomial spread drugresistant virus major respiratory viruses spread via fomites large particle droplets therefore respiratory isolation required summary viruses account substantial portion cases respiratory illness pneumonia elderly population diagnostic tests continue improve new agents relative importance known agents may change presently influenza virus h<NUMBER>n<NUMBER> rsv mostcommonly identified viral pathogens older adults viral pneumonia clinical features periods peak activity overlap winter months laboratory confirmation influenza recommended seriously ill institutionalized patients fight infectious diseases caused viruses remains challenging endless task despite tremendous efforts significant advances public healthcare infectious diseases pose significant risk human health led approximately onefourth deaths worldwide <NUMBER> <NUMBER> coronaviruses belong family coronaviridae may cause respiratory neurological diseases <NUMBER> six human coronaviruses hcovs identified namely hcov<NUMBER>e hcovhku<NUMBER> hcovoc<NUMBER> hcovnl<NUMBER> severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> particular sarscov merscov caused pandemic <NUMBER> recently emergence novel coronavirus sarscov<NUMBER> china subsequent worldwide spread challenging global public health community confront novel infectious disease coronavirus disease <NUMBER> <NUMBER> february <NUMBER> <NUMBER> confirmed cases covid<NUMBER> <NUMBER> deaths httpswwwworldometersinfocoronavirus epidemic detections sarscov<NUMBER> rna shown useful early diagnosis covid<NUMBER> would beneficial controling sources infection help patients prevent illness progression rapid accurate detection coronavirus therefore becoming increasingly important advance molecular biology technology nucleic acid detection methods developed rapidly become revolutionary technology virus detection especially method based polymerase chain reaction pcr characterized rapid detection high sensitivity specificity regarded gold standard virus detection novel pcrbased methods also reported enhance specificity sensitivity assay besides several molecular tests employ nonpcrbased methods isothermal nucleic acid amplification loop mediated isothermal amplification lamp nucleic acid sequencebased amplification developed detection coronavirus rna work reviewed various approaches currently available detection coronavirus anticipated assist researchers develop rapid accurate detection techniques pcr enzymatic method produce numerous copies gene separating two strands dna containing gene segment marking location primer using dna polymerase assemble copy alongside segment continuously copy copies widely used amplify minute quantities biologic materials provide adequate specimens laboratory study owing large range applications high sensitivity high sequence specificity pcrbased method become routine reliable technique detecting coronaviruses <NUMBER> <NUMBER> generally coronavirus rna transferred cdna reverse transcription afterwards pcr performed followed detection pcr product specific detection methods instruments among gel visualization sequencing pcr conventional methods detection coronaviruses <NUMBER> <NUMBER> however due timeconsuming process high cost methods commonly used clinical samples realtime reverse transcriptasepcr rtpcr detection currently favored detection coronavirus advantages specific simple quantitative assay moreover realtime rtpcr sensitive conventional rtpcr assay help much diagnosis early infection <NUMBER> <NUMBER> therefore realtime rtpcr assay still predominant method applied detection kinds coronaviruses <NUMBER> <NUMBER> including sarscov<NUMBER> <NUMBER> even massive efforts invested improve realtime rtpcr assay since rtpcr methods prone contamination require timeconsuming sample handling postpcr analysis van elden et al <NUMBER> described taqmanbased realtime rtpcr easily implemented routine diagnostic setting detection hcov moreover improve sensitivity yip et al <NUMBER> designed realtime quantitative rtpcr assay sarscov use <NUMBER> taqman probes instead <NUMBER> probe simple modification using dual taqman probes quantification wide applications areas ultrasensitivity critically required sarscov detection limit <NUMBER> copy rna per reaction clinical detection lack safe stable external positive controls epc could become serious problem diagnosis coronavirus plenty attention focused address problem however problems could well avoided realtime rtpcr assays epc important component yu et al <NUMBER> developed realtime rtpcr assay armored rna used epc detect sarscov detection limit <NUMBER> copiesml meanwhile rapidly mutating nature coronaviruses highlights need accurate detection genetically diverse coronaviruses therefore improve ability detect coronavirus precisely reduce risk eliciting falsenegative results caused genome sequence variations researchers established multiplex realtime rtpcr methods favorable sensitivity multitarget detection coronavirus hadjinicolaou et al <NUMBER> developed realtime rtpcr assay using mismatchtolerant molecular beacons distinguish pathogenic nonpathogenic strains assay incorporated four beacons targeting four genes addition internal positive control validated using clinical samples exhibited target detection ability specificity detection limit <NUMBER> copies per reaction lamp novel isothermal nucleic acid amplification method high efficiency commonly used amplification dnas rnas exhibits great sensitivity high specificity result exponential amplification feature <NUMBER> different target sequences identified <NUMBER> different primers simultaneously respectively <NUMBER> lamp assay rapid require expensive reagents instruments therefore application lamp test might help reduce cost detection coronavirus <NUMBER> herein number lampbased coronavirus detection methods developed applied clinical diagnosis gel electrophoresis commonly used analyze amplified products endpoint detection poon et al <NUMBER> reported simple lamp assay sars diagnosis demonstrated feasibility using technology detection sarscov orf<NUMBER>b region sarscov chosen sars diagnosis amplified lamp reaction presence <NUMBER> primers amplified products analyzed gel electrophoresis detection rates sensitivity sarscov lamp assay similar conventional pcrbased methods pyrc et al <NUMBER> successfully applied lamp detection hcovnl<NUMBER> conducted agarose gel electrophoresis favorable sensitivity specificity cell cultures clinical specimens notably detection limit found <NUMBER> copy rna template per reaction amplification detected precipitation magnesium pyrophosphate fluorescence dye enables methods carried real time monitoring turbidity pyrophosphate fluorescence effectively overcome limitations endpoint detection <NUMBER> useful rtlamp assay diagnosis epidemiologic surveillance human merscov developed way shirato et al <NUMBER> capable detecting <NUMBER> copies merscov rna highly specific crossreaction respiratory viruses thai et al <NUMBER> developed onestep singletube accelerated realtime quantitative rtlamp assay monitored realtime measurement turbidity photometer early rapid diagnosis sarscov clinical samples assay found <NUMBER>fold sensitive conventional rtpcr detection limit <NUMBER> plaque forming units pfu however methods rely nonspecific signal transduction schemes fluorescence dyes intercalation doublestranded dna amplicons solution turbidity due release pyrophosphates polymerization possibility unexpected signals derived primer dimer nonprimer reactions cannot excluded <NUMBER> sequencespecific robust method monitoring lamp isothermal amplification reactions readily separate true signal nonspecific noise would address problem shirato et al <NUMBER> improved rtlamp assay using quenching probe qprobe monitor signal performance standard realtime rtpcr assay detection merscov additionally huang et al <NUMBER> established nucleic acid visualization technique combines rtlamp vertical flow visualization strip rtlampvf detect merscov illustrated fig <NUMBER>a two loop primers lf lb involved isothermal amplification labeled fluorescein isothiocyanate fitc biotin respectively amplification amplicons labeled biotin bind colloidal gold particles conjugated streptavidin form complex subsequently captured antifitc antibody coated text line strip fig <NUMBER>b thus presenting colored line visible naked eye instance merscov rna detected detection limit <NUMBER> copiesml scientists ellingtons group plenty work improve specificity lamp detection make readout simpler reliable replaced intercalating dye typically used monitoring realtime fluorescence toeholdmediated strand exchange reaction termed onestep strand displacement osd applied realtime sequencespecific verification lamp amplicons <NUMBER>e<NUMBER> resulting assays could detect <NUMBER> <NUMBER> pfu <NUMBER>e<NUMBER> pfuml merscov infected cell culture supernatants within <NUMBER>e<NUMBER> min crossreact common human respiratory pathogens <NUMBER> strand exchange signal transductions developed make lamp reaction userfriendly shown fig <NUMBER> combining lamp thermostable invertase du et al directly transduce mers coronavirus templates glucose signals easily read commercial glucometer sensitivity low <NUMBER>e<NUMBER> copiesml equating attomolar low zeptomole <NUMBER> human chorionic gonadotropin hcg also used signal analyte already sensitively detected commercial pregnancy test kits hcg sitespecifically conjugated dna oligonucleotide thereby allowing signal transduction via strand exchange capture signaloff release signalon hcg lamp based virus assay <NUMBER> incorporation engineered hcg reporter protein led lamptohcg signal transduction lowcost commercially available pregnancy test strips assay reliably detected <NUMBER> copies virus templates human serum saliva meanwhile lamp shows optimal performance around <NUMBER> c always limits applications cai et al <NUMBER> developed version lamp used phosphorothioated primers pslamp enable efficient hairpin formation extension termini growing concatamers therefore worked much lower temperatures sensitivity selectivity amplicon detection pslamp <NUMBER> c comparable regular lamp reaction <NUMBER> c rolling circle amplification rca attracted considerable attention nucleic acid determination <NUMBER> <NUMBER> isothermal conditions rca capable <NUMBER> <NUMBER> fold signal amplification circle within <NUMBER> min efficient assay detection sarscov rca set liquid solid phases <NUMBER> presented preliminary results small number clinical respiratory specimens main advantage rca performed isothermal conditions minimal reagents avoids generation falsepositive results frequently encountered pcrbased assays microarray detection method rapid high throughput method coronavirus rna first produce cdna labeled specific probes reverse transcription labeled cdnas loaded well hybridize solidphase oligonucleotides fixed microarray followed series washing steps remove free dnas finally coronavirus rna detected detection specific probes due superiority microarray assay widely used detection coronavirus <NUMBER> shi et al <NUMBER> designed <NUMBER>mer oligonucleotide microarray according sequence tor<NUMBER> successfully applied detection sars coronavirus clinical samples however considering rapid mutation sarscov guo et al <NUMBER> developed microarray detect <NUMBER> single nucleotide polymorphism snp mutations among spike gene sarscov <NUMBER> accuracy sample detection since coronavirus may lead sudden outbreak great significance diagnostic assays able detect wide range coronaviruses deployable near point care poc therefore luna et al <NUMBER> designed nonfluorescent lowcost lowdensity oligonucleotide array detecting whole coronavirus genus sensitivity equal individual realtime rtpcr hardick et al <NUMBER> evaluated novel portable nearpoc diagnostic platform based microarray chip mobile analysis platform map good performance identifying virus acceptable detection limit rnatargeting crispr associated enzyme cas<NUMBER> recently adapted rapid portable sensing nucleic acids <NUMBER> <NUMBER> zhangs group demonstrated cas<NUMBER> programmed target destroy genomes diverse mammalian single stranded rna viruses fig <NUMBER> <NUMBER> developed platform termed sherlock specific highsensitivity enzymatic reporter unlocking combined isothermal preamplification cas<NUMBER> detect single molecules rna dna <NUMBER> detect dengue zika virus singlestranded rna well mutations patient liquid biopsy samples lately protocol covid<NUMBER> entitled protocol detection covid<NUMBER> using crispr diagnostics reported website httpsbroadiosherlockprotocol may provide reference points researchers interested advancing diagnostics system highlighting potential multiplexable portable rapid quantitative detection platform nucleic acids currently diagnosis covid<NUMBER> mainly relies detection coronavirus rna great importance select appropriate detection methods however methods described unique advantages inevitable disadvantages pcr widely used virus identification high sensitivity specificity analysis requires various equipment educated analysts possibly accomplished wellestablished laboratory lamp ultrasensitive nucleic acid amplification method often detect small numbers dna rna templates within roughly hour requirement high temperatures still limits applicability microarray high cost inevitably limits application detection coronaviruses therefore still necessary develop effective practical methods overcome shortcomings existing methods future date considerable efforts made improve detection coronavirus variety improved new approaches developed practical applications several methods usually combined avoid drawbacks using single method much possible short rapid development new technologies methods believe excellent efficient detection methods developed future would provide scientistsclinicians choices time balancing advantages disadvantages various detection assays according specific purposes obtain economical optimal option authors declare conflicts interest fight infectious diseases caused viruses remains challenging endless task despite tremendous efforts significant advances public healthcare infectious diseases pose significant risk human health led approximately onefourth deaths worldwide <NUMBER> <NUMBER> coronaviruses belong family coronaviridae may cause respiratory neurological diseases <NUMBER> six human coronaviruses hcovs identified namely hcov<NUMBER>e hcovhku<NUMBER> hcovoc<NUMBER> hcovnl<NUMBER> severe acute respiratory syndrome coronavirus sarscov middle east respiratory syndrome coronavirus merscov <NUMBER> particular sarscov merscov caused pandemic <NUMBER> recently emergence novel coronavirus sarscov<NUMBER> challenging global public health community confront novel infectious disease coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> february <NUMBER> <NUMBER> confirmed cases <NUMBER> deaths httpswwwworldometersinfocoronavirus epidemic detections sarscov<NUMBER> rna shown useful early diagnosis covid<NUMBER> would beneficial controling sources infection help patients prevent illness progression rapid accurate detection coronavirus therefore becoming increasingly important advance molecular biology technology nucleic acid detection methods developed rapidly become revolutionary technology virus detection especially method based polymerase chain reaction pcr characterized rapid detection high sensitivity specificity regarded gold standard virus detection novel pcrbased methods also reported enhance specificity sensitivity assay besides several molecular tests employ nonpcrbased methods isothermal nucleic acid amplification loop mediated isothermal amplification lamp nucleic acid sequencebased amplification developed detection coronavirus rna work reviewed various approaches currently available detection coronavirus anticipated assist researchers develop rapid accurate detection techniques pcr enzymatic method produce numerous copies gene separating two strands dna containing gene segment marking location primer using dna polymerase assemble copy alongside segment continuously copy copies widely used amplify minute quantities biologic materials provide adequate specimens laboratory study owing large range applications high sensitivity high sequence specificity pcrbased method become routine reliable technique detecting coronaviruses <NUMBER> <NUMBER> generally coronavirus rna transferred cdna reverse transcription afterwards pcr performed followed detection pcr product specific detection methods instruments among gel visualization sequencing pcr conventional methods detection coronaviruses <NUMBER> <NUMBER> however due timeconsuming process high cost methods commonly used clinical samples realtime reverse transcriptasepcr rtpcr detection currently favored detection coronavirus advantages specific simple quantitative assay moreover realtime rtpcr sensitive conventional rtpcr assay helps much diagnosis early infection <NUMBER> <NUMBER> therefore realtime rtpcr assay still predominant method applied detection kinds coronaviruses <NUMBER> <NUMBER> including sarscov<NUMBER> <NUMBER> even massive efforts invested improve realtime rtpcr assay since rtpcr methods prone contamination require timeconsuming sample handling postpcr analysis van elden et al <NUMBER> described taqmanbased realtime rtpcr easily implemented routine diagnostic setting detection hcov moreover improve sensitivity yip et al <NUMBER> designed realtime quantitative rtpcr assay sarscov use <NUMBER> taqman probes instead <NUMBER> probe simple modification using dual taqman probes quantification wide applications areas ultrasensitivity critically required sarscov detection limit <NUMBER> copy rna per reaction clinical detection lack safe stable external positive controls epc could become serious problem diagnosis coronavirus plenty attention focused address problem however problems could well avoided realtime rtpcr assays epc important component yu et al <NUMBER> developed realtime rtpcr assay armored rna used epc detect sarscov detection limit <NUMBER> copiesml meanwhile rapidly mutating nature coronaviruses highlights need accurate detection genetically diverse coronaviruses therefore improve ability detect coronavirus precisely reduce risk eliciting falsenegative results caused genome sequence variations researchers established multiplex realtime rtpcr methods favorable sensitivity multitarget detection coronavirus hadjinicolaou et al <NUMBER> developed realtime rtpcr assay using mismatchtolerant molecular beacons distinguish pathogenic nonpathogenic strains assay incorporated four beacons targeting four genes addition internal positive control validated using clinical samples exhibited target detection ability specificity detection limit <NUMBER> copies per reaction lamp novel isothermal nucleic acid amplification method high efficiency commonly used amplification dnas rnas exhibits great sensitivity high specificity result exponential amplification feature <NUMBER> different target sequences identified <NUMBER> different primers simultaneously respectively <NUMBER> lamp assay rapid require expensive reagents instruments therefore application lamp test might help reduce cost detection coronavirus <NUMBER> herein number lampbased coronavirus detection methods developed applied clinical diagnosis gel electrophoresis commonly used analyze amplified products endpoint detection poon et al <NUMBER> reported simple lamp assay sars diagnosis demonstrated feasibility using technology detection sarscov orf<NUMBER>b region sarscov chosen sars diagnosis amplified lamp reaction presence <NUMBER> primers amplified products analyzed gel electrophoresis detection rates sensitivity sarscov lamp assay similar conventional pcrbased methods pyrc et al <NUMBER> successfully applied lamp detection hcovnl<NUMBER> conducted agarose gel electrophoresis favorable sensitivity specificity cell cultures clinical specimens notably detection limit found <NUMBER> copy rna template per reaction amplification detected precipitation magnesium pyrophosphate fluorescence dye enables methods carried real time monitoring turbidity pyrophosphate fluorescence effectively overcome limitations endpoint detection <NUMBER> useful rtlamp assay diagnosis epidemiologic surveillance human merscov developed way shirato et al <NUMBER> capable detecting <NUMBER> copies merscov rna highly specific crossreaction respiratory viruses thai et al <NUMBER> developed onestep singletube accelerated realtime quantitative rtlamp assay monitored realtime measurement turbidity photometer early rapid diagnosis sarscov clinical samples assay found <NUMBER>fold sensitive conventional rtpcr detection limit <NUMBER> plaque forming units pfu however methods rely nonspecific signal transduction schemes fluorescence dyes intercalation doublestranded dna amplicons solution turbidity due release pyrophosphates polymerization possibility unexpected signals derived primer dimer nonprimer reactions cannot excluded <NUMBER> sequencespecific robust method monitoring lamp isothermal amplification reactions readily separate true signal nonspecific noise would address problem shirato et al <NUMBER> improved rtlamp assay using quenching probe qprobe monitor signal performance standard realtime rtpcr assay detection merscov additionally huang et al <NUMBER> established nucleic acid visualization technique combines rtlamp vertical flow visualization strip rtlampvf detect merscov illustrated fig <NUMBER>a two loop primers lf lb involved isothermal amplification labeled fluorescein isothiocyanate fitc biotin respectively amplification amplicons labeled biotin bind colloidal gold particles conjugated streptavidin form complex subsequently captured antifitc antibody coated text line strip fig <NUMBER>b thus presenting colored line visible naked eye instance merscov rna detected detection limit <NUMBER> copiesml scientists ellingtons group plenty work improve specificity lamp detection make readout simpler reliable replaced intercalating dye typically used monitoring realtime fluorescence toeholdmediated strand exchange reaction termed onestep strand displacement osd applied realtime sequencespecific verification lamp amplicons <NUMBER>e<NUMBER> resulting assays could detect <NUMBER> <NUMBER> pfu <NUMBER>e<NUMBER> pfuml merscov infected cell culture supernatants within <NUMBER>e<NUMBER> min crossreact common human respiratory pathogens <NUMBER> strand exchange signal transductions developed make lamp reaction userfriendly shown fig <NUMBER> combining lamp thermostable invertase du et al directly transduce mers coronavirus templates glucose signals easily read commercial glucometer sensitivity low <NUMBER>e<NUMBER> copiesml equating attomolar low zeptomole <NUMBER> human chorionic gonadotropin hcg also used signal analyte already sensitively detected commercial pregnancy test kits hcg sitespecifically conjugated dna oligonucleotide thereby allowing signal transduction via strand exchange capture signaloff release signalon hcg lamp based virus assay <NUMBER> incorporation engineered hcg reporter protein led lamptohcg signal transduction lowcost commercially available pregnancy test strips assay reliably detected <NUMBER> copies virus templates human serum saliva meanwhile lamp shows optimal performance around <NUMBER> c always limits applications cai et al <NUMBER> developed version lamp used phosphorothioated primers pslamp enable efficient hairpin formation extension termini growing concatamers therefore worked much lower temperatures sensitivity selectivity amplicon detection pslamp <NUMBER> c comparable regular lamp reaction <NUMBER> c rolling circle amplification rca attracted considerable attention nucleic acid determination <NUMBER> <NUMBER> isothermal conditions rca capable <NUMBER> <NUMBER> fold signal amplification circle within <NUMBER> min efficient assay detection sarscov rca set liquid solid phases <NUMBER> presented preliminary results small number clinical respiratory specimens main advantage rca performed isothermal conditions minimal reagents avoid generation falsepositive results frequently encountered pcrbased assays microarray detection method rapid high throughput method coronavirus rna first produce cdna labeled specific probes reverse transcription labeled cdnas loaded well hybridize solidphase oligonucleotides fixed microarray followed series washing steps remove free dnas finally coronavirus rna detected detection specific probes due superiority microarray assay widely used detection coronavirus <NUMBER> shi et al <NUMBER> designed <NUMBER>mer oligonucleotide microarray according sequence tor<NUMBER> successfully applied detection sars coronavirus clinical samples however considering rapid mutation sarscov guo et al <NUMBER> developed microarray detect <NUMBER> single nucleotide polymorphism snp mutations among spike gene sarscov <NUMBER> accuracy sample detection since coronavirus may lead sudden outbreak great significance diagnostic assays able detect wide range coronaviruses deployable near point care poc therefore luna et al <NUMBER> designed nonfluorescent lowcost lowdensity oligonucleotide array detecting whole coronavirus genus sensitivity equal individual realtime rtpcr hardick et al <NUMBER> evaluated novel portable nearpoc diagnostic platform based microarray chip mobile analysis platform map good performance identifying virus acceptable detection limit rnatargeting crispr associated enzyme cas<NUMBER> recently adapted rapid portable sensing nucleic acids <NUMBER> <NUMBER> zhangs group demonstrated cas<NUMBER> programmed target destroy genomes diverse mammalian single stranded rna viruses fig <NUMBER> <NUMBER> developed platform termed sherlock specific highsensitivity enzymatic reporter unlocking combined isothermal preamplification cas<NUMBER> detect single molecules rna dna <NUMBER> detect dengue zika virus singlestranded rna well mutations patient liquid biopsy samples lately protocol covid<NUMBER> entitled protocol detection covid<NUMBER> using crispr diagnostics reported website httpsbroadiosherlockprotocol may provide reference points researchers interested advancing diagnostics system highlighting potential multiplexable portable rapid quantitative detection platform nucleic acids currently diagnosis covid<NUMBER> mainly relies detection coronavirus rna great importance select appropriate detection methods however methods described unique advantages inevitable disadvantages pcr widely used virus identification high sensitivity specificity analysis requires various equipment educated analysts possibly accomplished wellestablished laboratory lamp ultrasensitive nucleic acid amplification method often detect small numbers dna rna templates within roughly hour requirement high temperatures still limits applicability microarray high cost inevitably limits application detection coronaviruses therefore still necessary develop effective practical methods overcome shortcomings existing methods future date considerable efforts made improve detection coronavirus variety improved new approaches developed practical applications several methods usually combined avoid drawbacks using single method much possible short rapid development new technologies methods believe excellent efficient detection methods developed future would provide scientistsclinicians choices time balancing advantages disadvantages various detection assays according specific purposes obtain economical optimal option authors declare conflicts interest <NUMBER> scheme detection rna viruses using cas<NUMBER> figure reproduced permission ref <NUMBER> acute respiratory tract infection leading cause hospital admission children study used broad capture rapid sensitive method multiplex pcr assay detect <NUMBER> different respiratory pathogens including influenza subtypes h<NUMBER> h<NUMBER> h<NUMBER> influenza b parainfluenza types <NUMBER> <NUMBER> <NUMBER> <NUMBER> respiratory syncytial virus rsv groups b adenoviruses human rhinoviruses enteroviruses human metapneumoviruses human coronaviruses oc<NUMBER> <NUMBER>e sarscov chlamydophila pneumoniae legionella pneumophila mycoplasma pneumoniae respiratory specimens <NUMBER> children hospitalized <NUMBER>month period acute respiratory tract infections overall positive rate <NUMBER> twice higher previous reports based conventional methods influenza parainfluenza rsv accounted <NUMBER> noncultivable viruses accounted <NUMBER> positive cases influenza peaked march june influenza b detected january february april parainfluenza prevalent throughout year except april june rsv infections found february september adenovirus multiple peaks whereas rhinovirus coronavirus oc<NUMBER> detected mainly winter early spring rsv infection associated bronchiolitis parainfluenza associated croup otherwise clinical manifestations largely nonspecific general children infected influenza adenovirus mixed viruses higher temperatures view increasing concern unexpected outbreaks severe viral infections rapid multiplex pcr assay acute respiratory infection common cause hospitalization children hong kong review standardised discharge data hong kong government hospitals <NUMBER> <NUMBER> showed acute respiratory infections accounted <NUMBER> paediatric admissions <NUMBER> age <NUMBER> years nelson et al <NUMBER> large spectrum viruses cause respiratory tract infection routine rapid diagnostic method used currently government hospitals hong kong immunofluorescence test nasopharyngeal aspirate method cover upto seven common respiratory viruses influenza b parainfluenzae types <NUMBER> <NUMBER> <NUMBER> respiratory syncytial virus adenovirus method alone aetiological diagnosis made less <NUMBER> cases lam et al <NUMBER> viral culture although carried routinely referent laboratories less helpful patient management long turnaround time inability detect fastidious viruses lack highly sensitive rapid test confirm etiology acute respiratory infection caused greater concern since outbreaks avian influenza h<NUMBER>n<NUMBER> severe acute respiratory syndrome hong kong past outbreaks posed special challenges paediatric practice hospitals suspected cases confined isolation rooms suspected pathogens exlcuded leung et al <NUMBER> aggravated shortfall isolation cubicles also caused great distress children family urgent pcr tests coronavirus infleunza h<NUMBER>n<NUMBER> since become available pneumonia cases severe respiratory distress avian infuenza cases suspected ground history travelling endemic areas contact birds policy selective testing inadequate cover clinical needs along rapid advances molecular diagnostic techniques increasing number multiplex pcr assays respiratory pathogens developed different research groups early comprehensive assessment viral bacterial etiologies gröndahl et al <NUMBER> coiras et al <NUMBER> oosterheert et al <NUMBER> freymuth et al <NUMBER> mahony et al <NUMBER> nolte et al <NUMBER> current study employed multiplex nested pcr assays established recently detection <NUMBER> respiratory viruses atypical bacteria influenza subytpes h<NUMBER> h<NUMBER> h<NUMBER> influenza b parainfluenza types <NUMBER> <NUMBER> <NUMBER> <NUMBER> respiratory syncytial virus groups b adenoviruses human rhinoviruses enteroviruses human metapneumoviruses human coronaviruses oc<NUMBER> <NUMBER> e sarscov chlamydophila pneumoniae legionella pneumophila mycoplasma pneumoniae lam et al <NUMBER> study aimed delineating spectrum respiratory viruses atypical bacteria accounted hospitalization children acute respiratory tract illnesses examined seasonality clinical manifestations infections prospective study examined children <NUMBER> years old admitted universityaffiliated general hospital prince wales hospital acute respiratory infections november <NUMBER> october <NUMBER> prince wales hospital acute hospital situated east new territories hong kong serving approximate population <NUMBER> million <NUMBER> <NUMBER> years old first <NUMBER> children admitted monday tuesday monday public holiday suspected acute respiratory tract infections whose parent provided written consent included study selection monday arbitary diagnostic criteria acute respiratory infection sudden onset <NUMBER> hr one following symptoms signs rhinorrhoea cough sore throat earache hoarseness stridor wheeze dyspnoea without fever paired nasopharyngeal aspirate nasal swab samples taken strict infection control guidance dedicated area trained nurses nasopharyngeal aspirate catheter inserted one nostril depth <NUMBER> cm drawn back applying gentle suction electric suction device heikkinen et al <NUMBER> nasal swab dacron swab plastic shaft copan italy placed <NUMBER> cm opposite nostril rotated three times surface nasal cavity specimens collected viral transport medium kept <NUMBER>c processing specimens subjected respiratory virus detection using immunofluorescence conventional virus culture multiplex nested pcr specimens processed within day collection specimens tested influenza influenza b parainfluenza types <NUMBER> <NUMBER> <NUMBER> respiratory syncytial virus adenovirus direct immunofluorescence using specific antibodies chemicon temecula ca virus culture performed inoculating approximately <NUMBER> ml specimens onto hep<NUMBER> mdck llcmk <NUMBER> cell monolayers adsorption <NUMBER> hr medium replaced corresponding maintenance medium tubes incubated roller drum <NUMBER>c hep<NUMBER> cells <NUMBER>c mdck llcmk <NUMBER> cells hep<NUMBER> tubes incubated <NUMBER> days examined daily cytopathic effects haemadsorption performed day <NUMBER> mdck llcmk <NUMBER> monolayers growth viruses confirmed immunofluorescence using virusspecific antibodies viral rna dna present specimens extracted commercial kit according manufacturers protocol qiaamp minelute virus spin kit qiagen valencia ca rna template mixed <NUMBER> ml random primer <NUMBER> ngml <NUMBER> ml dntps <NUMBER> mm final volume <NUMBER> ml heated <NUMBER>c <NUMBER> min solution equilibrated <NUMBER>c mixed <NUMBER> u rnase <NUMBER> ml <NUMBER>â firststrand buffer <NUMBER> mm dtt <NUMBER> u mmlv superscript iii reverse transcriptase invitrogen carlsbad ca final volume <NUMBER> ml reverse transcription performed <NUMBER>c <NUMBER> min stopped heating <NUMBER> min <NUMBER>c cdnas stored à<NUMBER>c analysis five separate multiplex nested pcr assays used detection <NUMBER> respiratory viruses atypical bacteria multiplex pcr group <NUMBER> comprised influenza influenza b groupspecific subtype h<NUMBER> h<NUMBER> h<NUMBER>specific primers group <NUMBER> comprised parainfluenza viruses type <NUMBER> <NUMBER> <NUMBER> <NUMBER> group <NUMBER> comprised respiratory syncytial virus groups b rhinoviruses enteroviruses group <NUMBER> comprised human coronaviruses oc<NUMBER> <NUMBER>e sarscov human metapneumovirus group <NUMBER> included mycoplasma pneumoniae chlamydophila pneumoniae legionella pneumophila adenovirus details assay procedures performance described previously lam et al <NUMBER> nested pcr assays run fast thermal cycler applied biosystem fast pcr machine foster city ca allow completion <NUMBER>cycle pcr assay within <NUMBER> min compared <NUMBER> min ordinary cyclers standard form demographic data detailed history completed patient soon recruited study additional laboratory results information treatment clinical course final diagnosis retrieved medical records routine immunofluorescence results seven common respiratory viruses available clinicians within one working day multiplex pcr results retained virology laboratory end study paired samples collected <NUMBER> children <NUMBER> years old <NUMBER> boys <NUMBER> girls mean age <NUMBER> months sd <NUMBER> study population represented <NUMBER> children <NUMBER> years old admitted acute respiratory infections study period results comparing diagnostic yield nasopharyngeal aspirates nasal swabs respect different testing methods immunofluorescence isolation multiplex pcr influenza b respiratory syncytial virus parainfluenza <NUMBER> <NUMBER> <NUMBER> adenovirus described previously sung et al press following analyses results multiplex pcr assays covering <NUMBER> respiratory pathogens altogether <NUMBER> <NUMBER> cases least one virus atypical bacteria detected multiplex pcr assays positive rate nasopharyngeal aspirate specimens <NUMBER> higher nasal swab specimens <NUMBER> difference significant p <NUMBER> chi squared test single pathogen detected <NUMBER> children two pathogens detected <NUMBER> children influenza parainfluenza respiratory syncytial virus frequently identified pathogens accounted <NUMBER> positive cases table nineteen patients coinfection two pathogens included three cases metapneumovirus plus mycoplasma two cases adenovirus plus chlamydophila remaining <NUMBER> cases combinations parainfluenza virus mycoplasma pneumoniae rhinovirus metapneumovirus pathogens found commonly among coinfections sarscov influenza h<NUMBER>n<NUMBER> detected study period figure <NUMBER> shows monthly distribution number positive specimen pathogen influenza infection peaked march june influenza b detected january february april parainfluenza virus prevalent throughout year except april june respiratory syncytial virus also prevalent throughout year common february september adenovirus showed multiple peaks active november april rhinovirus coronavirus oc<NUMBER> detected often winter early spring mycoplasma pneumoniae peaked march clinical manifestations discharge diagnoses <NUMBER> children respiratory pathogens identified shown table ii one third cases principal diagnosis upper respiratory tract infection discharge four cases croup <NUMBER> <NUMBER> cases lower respiratory tract infections <NUMBER> cases pneumonia <NUMBER> bronchiolitis twentysix <NUMBER> cases acute gastrointestinal symptoms main feature illness thirteen cases <NUMBER> febrile convulsions eight cases <NUMBER> asthma exacerbation association acute respiratory infection none patients required intensive care ventilatory support duration fever admission <NUMBER> ae <NUMBER> days temperature admission <NUMBER> ae <NUMBER>c total duration fever <NUMBER> ae <NUMBER> days general children infected adenovirus influenza mixed viruses higher temperatures whereas infected respiratory syncytial virus lower degree fever study used multiplex pcr assays assess role <NUMBER> respiratory viruses atypical bacteria cause hospital admission children suspected acute respiratory infections hong kong multiplex pcr assays shown provide much greater sensitivity compared immunofluorescence conventional virus isolation lam et al <NUMBER> sung et al press improved sensitivity together broad coverage allows precise evaluation relative importance pathogens hong kong study one respiratory pathogens found <NUMBER> cases positive rate twice based conventional methods lam et al <NUMBER> concordance previous reports druce et al <NUMBER> weigl et al <NUMBER> respiratory syncytial virus influenza parainfluenza virus identified frequently accounted <NUMBER> positive cases current study population respiratory syncytial virus parainfluenza virus predominant viruses detected infants younger <NUMBER> months old whereas <NUMBER> adenovirus infections occurred children <NUMBER> <NUMBER> years old influenza evenly distributed children <NUMBER> <NUMBER> years old viruses identified frequently included influenza b coronavirus oc<NUMBER> rhinoviruses accounted <NUMBER> positive cases mycoplasma human metapneumovirus accounted <NUMBER> positive cases enterovirus reported circulating widely children juvén et al <NUMBER> tsai et al <NUMBER> identified three cases two single one coinfection previous local study viral etiology acute respiratory infections children carried august <NUMBER> july <NUMBER> using rtpcr detection rhinovirus metapneumovirus coronavirus immunofluorescence culture respiratory viruses showed slightly lower positive rates adenovirus <NUMBER> vs <NUMBER> influenza b <NUMBER> vs <NUMBER> parainfluenza <NUMBER> vs <NUMBER> respiratory syncytial virus <NUMBER> vs <NUMBER> positive rates influenza coronavirus similar whereas positive rate rhinovirus <NUMBER> vs <NUMBER> remarkably higher previous study cheuk et al <NUMBER> discrepancy sung et al rhinovirus detection rates might due differences sensitivity pcr tests used nevertheless studies continued <NUMBER> year seasonal pattern respiratory viral activities might vary different years prospective studies longer duration necessary elucidate epidemiology disease burden associated rhinovirus hong kong exception strong association respiratory syncytial virus infection bronchiolitis parainfluenza croup clinical manifestations viral infections largely nonspecific fever cough main symptoms among <NUMBER> patients positive results <NUMBER> <NUMBER> cases prominent gastrointestinal symptoms appeared overrepresented <NUMBER> human coronavirus oc<NUMBER> infections agreement previous report gastrointestinal symptoms common human coronavirus oc<NUMBER> infections vabret et al <NUMBER> febrile convulsions asthmatic attacks observed <NUMBER> <NUMBER> positive cases respectively line previous reports grü nberg et al <NUMBER> chung wong <NUMBER> notably rhinoviruses detected october december peak months asthma admissions hong kong study <NUMBER> <NUMBER> patients rhinovirus infection asthmatic attack principal diagnosis admission however number rhinovirus positive asthma cases small allow evaluation association line previous report lin et al <NUMBER> current study revealed adenovirus influenza mixed viral infections associated higher fever single viral infections rapid identification aetiology acute respiratory infections essential better decisions usage antiviral agents antibiotics implement proper isolation prevent transmission woo et al <NUMBER> oosterheert et al <NUMBER> regard rapid pcr system used study reduce time required single round pcr <NUMBER> hr <NUMBER> min therefore whole testing process completed within <NUMBER> day rapid turnaround time may alleviate anxiety parents potentially decrease duration hospital stay need isolation cubicles nevertheless noted gain turnaround time achieved rapid pcr system available site hospital clinic multiplex pcr assays major advantages sensitivities specificities general inferior equivalent monoplex pcr assays technical hurdle overcome multiplex pcr recommended routine clinical use certain circumstances examples pathogens great public health concern including sarscov avian influenza positive multiplex pcr result requires testing supplementary assay ascertain infection status practical concern routine use multiplex pcr assays cost however justified view devastating economic human loss sustained outbreaks h<NUMBER>n<NUMBER> influenza <NUMBER> sars <NUMBER> increasing concern repeated unexpected outbreaks viral infections hong kong yuen et al <NUMBER> chan <NUMBER> lee et al <NUMBER> importance establishing sustainable surveillance system monitoring circulating respiratory pathogens disease burden economic impact wide range respiratory infections become increasingly recognized results study support multiplex pcr assays expanded detection spectrum valuable tools surveillance could performed one sentinel hospitals government private clinics one limitation current study bacterial culture nasopharyngeal aspirate sputum performed systematically except bacterial aetiology suspected clinically possible clinical manifestations cases might contributed part coexisting bacterial infections conclusion data generated study expanded knowledge epidemiology respiratory viral infections children hong kong management children severe acute respiratory infections hospital surveillance respiratory viral infections community could greatly enhanced use multiplex pcr assays diagnostics <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> high mortality rate due covid<NUMBER> <NUMBER> deaths spain usa also seriously impacted <NUMBER> <NUMBER> deaths respectively last weeks led exponential increase number cases usa uk iran european union eu however singapore south korea china managed successfully contain spread covid<NUMBER> taking essential measures deal pandemic sarscov<NUMBER> transmitted humans via humananimal contact live animals market wuhan china late december <NUMBER> <NUMBER> chinese researchers found origin bats intermediate hosts sarscov <NUMBER> yet identified <NUMBER> genomic sequence sarscov<NUMBER> <NUMBER> sequence homology human sarscov <NUMBER> bat sarslikecovzxc<NUMBER> <NUMBER> aged population age <NUMBER> years persons decreased immunity chronic diseases hypertension diabetes mellitus cardiovascular diseases lung disease higher risk developing severe covid<NUMBER> infected sarscov<NUMBER> therefore must take special precautions prevent infection stressed need intensive testing suspected cases identify covid<NUMBER> infected people quarantined order avoid spread infection also evident existing realtime reverse transcriptase polymerase chain rtpcr assays unable detect covid<NUMBER> early stages infection reports given false negatives subjects two weeks <NUMBER> <NUMBER> reason false negative results rtpcr could due improper extraction nucleic acid clinical materials insufficient cellular material detection chest computerized tomography ct scan act complementary diagnostic tool enables physicians effectively detect covid<NUMBER> infection several rtpcr falsenegative cases <NUMBER> <NUMBER> therefore need developing better vitro diagnostic ivd assays detect sarscov<NUMBER> infection reliably persons even initial stage specific biomarkers involved early stage covid<NUMBER> infection investigated employed development diagnostics structure sarscov<NUMBER> comprises spikes formed sp figure <NUMBER> sp major glycoprotein mol wt<NUMBER> kda consists two subunits ie s<NUMBER> s<NUMBER> <NUMBER> s<NUMBER> contains receptor binding domain rbd responsible recognizing binding host cell receptor ie angiotensin converting enzyme <NUMBER> receptor ace<NUMBER> found lower respiratory tract <NUMBER> hand s<NUMBER> contains basic elements needed membrane fusion sp common target neutralizing antibodies vaccines aminoterminal s<NUMBER> subunit sp variable immunogenic antigen additionally sarscov<NUMBER> np mol wt<NUMBER> kda abundant viral phosphoprotein produced shed infection template mrna np abundant subgenomic rna np exhibits high immunogenicity detected either serum urine samples first two weeks infection peak viral shedding around ten days infection <NUMBER> large protein detected via sandwich immunoassay furthermore sarscov<NUMBER> contains mp abundant protein complete virion particle ep smallest major structural protein sarscov<NUMBER> involved viral assembly release virions pathogenesis abundant viral phosphoprotein produced shed infection template mrna np abundant subgenomic rna np exhibits high immunogenicity detected either serum urine samples first two weeks infection peak viral shedding around ten days infection <NUMBER> large protein detected via sandwich immunoassay furthermore sarscov<NUMBER> contains mp abundant protein complete virion particle ep smallest major structural protein sarscov<NUMBER> involved viral assembly release virions pathogenesis several serological immunoassays developed ivd companies detection sarscov<NUMBER> viral proteins antibodies serum plasma widely used biomarkers detection sarscov<NUMBER> infection commercial immunoassays rapid lateral flow immunoassay lfia tests automated chemiluminescence immunoassay clia manual elisa formats igm igg antibodies produced suspects <NUMBER>nd week viral infection igm detected patient samples <NUMBER> <NUMBER> days sarscov<NUMBER> infection igg detected <NUMBER> days onwards <NUMBER> igm response occurs earlier igg decreases disappears hand igg persist infection long time may protective role several manual elisa kits also commercially available detection np sp used mainly research widely used ivd assays confirmatory diagnosis covid<NUMBER> based rtpcr employed globally deal pandemic novel robust realtime rtpcr assay developed tibmolbiol germany collaboration various partners <NUMBER>nd week january <NUMBER> <NUMBER> highly specific sarscov<NUMBER> rna crossreact coronaviruses test detects sarscov<NUMBER> rna via envelope e rnadependent rna polymerase rdrp gene assays egene assay used first line screening rdrp gene assay employed confirmatory testing another approach researchers developed onestep rtpcr assays detect orf<NUMBER>b n regions sarscov<NUMBER> <NUMBER> h <NUMBER> min <NUMBER> n gene assay used screening orf<NUMBER>b used confirmatory test however assay involved detection orf<NUMBER>b n regions highly conserved among sarbecoviruses could also bind sarscov closelyrelated viruses authors mentioned could distinguish sarscov<NUMBER> sarscov via sequence analysis positive amplicons rtpcr results positive interest development realtime rtpcr assay detection rdrphelicase h genes sarscov<NUMBER> crossreact human coronaviruses respiratory viruses <NUMBER> due high sensitivity used covid<NUMBER> detection samples low viral loads testing saliva plasma upper respiratory tract samples many rtpcr assays already developed many companies researchers worldwide prominent realtime rtpcr rapid test xpert ® xpress sarscov<NUMBER> test cepheid usa provides results <NUMBER> min using genxpert benchtop system <NUMBER> rapid automated pointofcare poc molecular test enables qualitative detection sarscov<NUMBER> nasopharyngeal swab nasal wash aspirate specimens suspects test requires minute sample preparation employs cepheids xpert ® xpress cartridge technology targets multiple regions viral genome also received food drug administration fda emergency use authorization eua another prominent advance vivalytic covid<NUMBER> test bosch germany <NUMBER> detects sarscov<NUMBER> infection suspects less <NUMBER> h test developed bosch collaboration randox laboratories uk fully automated rapid poc molecular test simultaneously detect sarscov<NUMBER> nine respiratory viruses including influenza b sample taken nose throat suspect using swab placed inside vivalytic cartridge containing assay reagents cartridge plugged small benchtop vivalytic analyzer abbott id now™ covid<NUMBER> test recent breakthrough ivd assay detects sarscov<NUMBER> <NUMBER> min <NUMBER> <NUMBER> molecular poc test utilizes isothermal nucleic acid amplification technology qualitative detection viral rna sarscov<NUMBER> test used location hospitals clinics physicians offices outbreak hotspots covid<NUMBER> requires portable touchscreenoperated instrument ie id lightweight <NUMBER> pounds compact size small toaster employs molecular test rdrp gene take throat nasal nasopharyngeal oropharyngeal swabs samples kit contains <NUMBER> tests positive negative controls swabs sample collection pipettes received fda eua seen remarkable achievement worldwide apart molecular diagnostics numerous lfia based rapid poc tests developed several companies enable detection igm igg antibodies produced suspects response sarscov<NUMBER> infection one prominent rapid tests covid<NUMBER> test developed biomedomics usa detects igm igg antibodies suspects <NUMBER> min <NUMBER> requires minimal sample volume ie <NUMBER> µl fingerpricked blood <NUMBER> µl serumplasma require instrument trained staff thus employed place time especially developing nations limited healthcare resources remote settings assay ideal primary healthcare workers rapid testing covid<NUMBER> suspects another prospective test sarscov<NUMBER> rapid pharmacyt ag germany <NUMBER> employs two drops fingerpricked blood sample suspects provide results <NUMBER> min results obtained rapid test correlated well achieved rtpcr exciting advance dpp covid<NUMBER> igmigg test launched recently chembio diagnostics usa already received fda eua poc rapid lfia test provides results <NUMBER> min using fingerpricked blood sample however distinct feature test rely visual detection naked eye employs optical readout via microreader <NUMBER> <NUMBER> analyzers produced chembio germany <NUMBER> large number rapid igmigg tests developed several ivd companies beijing lepu medical technology sona nanotech jiangsu medomics medical technologies innovita biological technology guangzhou wondfo biotech zhejiang orient gene biotech biomerica xiamen amonmed biotechnology sugentech chil zhenjiang orient gene biotech sure biotech however peerreviewed publications <NUMBER> show accuracy covid<NUMBER> diagnostic results obtained rapid tests respect rtpcr tests rapid tests could used complementary ivd assay existing rtpcr assays could lead much better diagnosis covid<NUMBER> provide additional information immune status suspects however clinical accuracy rapid tests needs stringently evaluated authorized mass screening covid<NUMBER> recent reports many european countries suggest rapid tests covid<NUMBER> procured china show good analytical performance work <NUMBER> covid<NUMBER> cases <NUMBER> <NUMBER> furthermore igm igg could detected suspects two weeks onset infection immense need include biomarkers early stage sarscov<NUMBER> infection developing improved covid<NUMBER> rapid tests exciting development dzlite sarscov<NUMBER> clia igm igg tests developed diazyme usa received fda eua <NUMBER> tests based principle chemiluminescence immunoassay clia run automated diazyme dzlite <NUMBER> plus chemiluminescence analyzer throughput <NUMBER> testsh similarly snibe china developed automated clia tests maglumi clia analyzers detection igg igm patient sample <NUMBER> min <NUMBER> main advantages automated clia analyzers based covid<NUMBER> assays compared rapid lfia tests high throughput samples analyzed ability perform clinical tests biomarkers creactive protein crp also need monitored covid<NUMBER> suspects several ce marked manual elisa kits also developed various ivd manufacturers euroimmun ibl international drg diagnostics gmbh epitope diagnostics target igg igm produced subjects response sarscov<NUMBER> infection prospective ivd assay formats based reverse transcription loopmediated isothermal amplification rtlamp labonachip microfluidics multiplex detection currently investigated researchers would also useful develop automated fully integrated poc ivd assay perform molecular immunological testing single analytical platform ideal ivd assay poc detection covid<NUMBER> near future would smartphonebased poc electrochemical test sarscov<NUMBER> biomarkers similar ihealth align device developed ihealth usa smartphonebased blood glucose monitoring <NUMBER> smartphones omnipresent powered internal battery equipped large storage capacity advanced processing power large screen display moreover global positioning system gps spatiotemporal tagging data internet connectivity capability store processed results internal device memory well secure cloud therefore smartphonebased poc electrochemical device detection sarscov<NUMBER> biomarkers could useful largescale rapid testing covid<NUMBER> suspects pointofneed accurate diagnosis people infected sarscov<NUMBER> essential curb global spread covid<NUMBER> however current rtpcr based diagnostic assays robust still missing several infected cases <NUMBER> <NUMBER> <NUMBER> moreover performed wellequipped central laboratories highly skilled analysts therefore limited utility cannot deployed widely developing nations remote locations regions decentralized laboratories delay diagnosing people passed disease onto many others contributing continued global spread covid<NUMBER> rapid lfia automated clia tests igm igg could complement existing covid<NUMBER> testing rtpcr however need stringently evaluate clinical performance commercial tests used diagnosis covid<NUMBER> biomarker discovery could also play key role identifying novel biomarkers involved early stages sarscov<NUMBER> infection recently developed abbott id now™ covid<NUMBER> test detects sarscov<NUMBER> <NUMBER> min remarkable achievement <NUMBER> <NUMBER> could revolutionize covid<NUMBER> testing ongoing efforts lead reliable robust rapid easytoimplement ivd assays smart diagnostics covid<NUMBER> still significant knowledge gaps health research crucial effective public health response case epidemics signifies need nations invest health research make integral part healthcare antimicrobial resistance amr arguably one greatest threats global human health driven overuse antibiotics <NUMBER> antibiotics prescribed vast majority patients hospitalised acute respiratory illness ari including clinical groups viruses strongly implicated aetiology asthma exacerbations associated respiratory virus infection especially rhinovirus <NUMBER> randomised controlled trials failed demonstrate benefit antibiotic treatment <NUMBER> <NUMBER> additionally large retrospective observational study nearly <NUMBER> <NUMBER> <NUMBER> patients hospitalised exacerbation suggests antibiotic use improve outcome associated higher costs <NUMBER> professional societies strongly discourage use antibiotics asthma exacerbation national guidelines <NUMBER> <NUMBER> despite antibiotic use adults hospitalised exacerbation asthma remains common <NUMBER> <NUMBER> <NUMBER> patients hospitalised exacerbation copd also routinely treated antibiotics despite viruses frequently implicated aetiology <NUMBER> lack high quality evidence benefit patients nonlife threatening exacerbations <NUMBER> several randomised trials biomarkerdirected therapy show antibiotics use safely reduced noncritically ill hospitalised patients exacerbation copd low levels crp procalcitonin <NUMBER> <NUMBER> supporting concept antibiotics currently overused population diagnostic uncertainty regarding aetiology exacerbations airways disease contributes ongoing overuse antibiotics groups uk department health commissioned report antimicrobial resistance specifically noted importance rapid diagnostic tests help combat amr effective antibiotic stewardship recommended <NUMBER> prescribing antibiotics informed diagnostic test one exists <NUMBER> rapid molecular tests respiratory viruses could potentially fulfil need patients hospitalised exacerbation airways disease respoc study large pragmatic randomised controlled trial evaluated clinical impact syndromic ie comprehensive multiplex pcr pointofcare testing poct respiratory viruses adults presenting hospital acute respiratory illness <NUMBER> demonstrated syndromic poct respiratory viruses using fimarray respiratory panel associated several clinical benefits compared routine clinical care laboratory testing including earlier discontinuation antibiotics without increase adverse events subgroup analysis trial suggests antibiotic changes occurred predominantly patients exacerbation airways disease testing positive viruses little difference seen antibiotic use clinical groups patients community acquired pneumonia patients testing negative viruses several observational studies support findings respoc demonstrating reduction unnecessary antibiotics rapid molecular testing respiratory viruses variety clinical setting <NUMBER> <NUMBER> addition post hoc analysis trial suggests rapid turnaround times results seen poct compared laboratory testing critical modifying antibiotic use hospitalised patients <NUMBER> several rapid molecular test platforms respiratory viruses available potential deployment pocts clinical areas use hospitals becoming widespread <NUMBER> however lack evidence inform clinicians hospitals choice multiplex syndromic panels filmarray rp test comprehensive range respiratory viruses platforms test influenza influenza rsv rapid accurate influenza detection clearly priority hospitals periods intense influenza transmission correctly rapidly administer influenza antivirals efficiently utilise infection control facilities addition multiplex syndromic panels expensive uniplex tests influenza currently clear additional clinical value gained testing virus types hospitalised patients analysis examine detail changes antibiotic use associated syndromic molecular poct among patients exacerbation airways diseases determine importance changes antibiotic management occurring due detection noninfluenza viruses study design inclusion exclusion criteria outcome measures baseline population characteristics respoc study previously described original report trial <NUMBER> brief adults presenting emergency department acute medical unit ari recruited presentation randomised <NUMBER> receive poct respiratory viruses using filmarray respiratory panel routine clinical care study approved north west preston regional ethics committee nw<NUMBER> protocol publically available <NUMBER> analysis evaluated patients exacerbation asthma copd treated antibiotics duration antibiotics proportion treated single dose short course defined less <NUMBER> h compared patients testing positive viruses poct testing negative poct control patients patients testing positive viruses poct compared according virus types detected kaplanmeier curves generated duration antibiotic use early discontinuation antibiotics defined receipt less <NUMBER> h antibiotics stopping including received single dose rhinoenterovirus codetected influenza rsv influenza rsv considered dominant patient classified accordingly statistical analyses done using prism version <NUMBER> graphpad software la jolla ca usa stata version <NUMBER> statacorp college station tx usa compared duration antibiotic use groups using median differences kruskalwallis test differences proportions using chi squared test fishers exact test appropriate kaplanmaier curves duration antibiotics generated compared using log rank test <NUMBER> patients exacerbation airways disease poct group <NUMBER> asthma <NUMBER> copd <NUMBER> <NUMBER> received antibiotics <NUMBER> patients exacerbation airways disease control group <NUMBER> asthma <NUMBER> copd <NUMBER> <NUMBER> received antibiotics difference antibiotic use poct control group <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> p <NUMBER> poct group <NUMBER> <NUMBER> patients tested positive respiratory viruses <NUMBER> <NUMBER> received antibiotics <NUMBER> <NUMBER> patients tested negative viruses <NUMBER> <NUMBER> received antibiotics difference antibiotic use poct positive negative patients <NUMBER> <NUMBER>ci <NUMBER> <NUMBER> p <NUMBER> baseline characteristics patients testing positive negative poct control patients well matched including physiological observations laboratory results <NUMBER> <NUMBER> patients control group tested respiratory viruses using laboratory pcr median turnaround time results <NUMBER> h compared <NUMBER> h tested poct p <NUMBER> <NUMBER> <NUMBER> table <NUMBER> testing positive viruses poct received antibiotics <NUMBER> <NUMBER> early discontinuation antibiotics versus <NUMBER> <NUMBER> testing negative <NUMBER> <NUMBER> control patients p <NUMBER> <NUMBER> <NUMBER> median duration antibiotic <NUMBER> days testing positive poct versus <NUMBER> days testing negative poct <NUMBER> days control group p <NUMBER> median duration iv antibiotics <NUMBER> h ie single dose testing positive poct versus <NUMBER> testing negative <NUMBER> h control group p <NUMBER> antibiotic use poct result control patients shown table <NUMBER> kaplanmeier curve analysis duration antibiotics shown fig <NUMBER> although curves three groups poct positive poct negative control becomes similar approximately <NUMBER> days starting antibiotics curves show sharp reduction antibiotic use early testing positive viruses poct p <NUMBER> tested viruses poct <NUMBER> <NUMBER> positive influenza b <NUMBER> <NUMBER> positive rhinoenterovirus <NUMBER> <NUMBER> positive viruses combined rsv parainfluenza <NUMBER> human metapneumovirus human coronavirus fig <NUMBER> <NUMBER> codetections rsv rhinoenterovirus ×<NUMBER> influenza human coronavirus rsv hmpv human coronavirus patients received poc test fig <NUMBER> among positive viruses receiving antibiotics proportion early discontinuation antibiotics different virus types <NUMBER> <NUMBER> influenza <NUMBER> <NUMBER> rhinovirus <NUMBER> <NUMBER> viruses combined p <NUMBER> antibiotic use virus type shown table <NUMBER> higher proportion patients influenza received iv antibiotics compared rhinoenterovirus virus types <NUMBER> vs <NUMBER> <NUMBER> p <NUMBER> median duration iv antibiotic antibiotic different virus types although small numbers individual virus types make definitive statement difficult survival analysis show differences early antibiotic discontinuation virus types p <NUMBER> fig <NUMBER> study shows syndromic molecular poct respiratory viruses adults presenting hospital exacerbation airways disease leads reduction antibiotic use due early discontinuation testing positive viruses viruses detected patients noninfluenza viruses rhinoenterovirus commonly detected single virus type difference rate antibiotic discontinuation different virus types noted respoc study poct lead reduction proportion treated antibiotics compared routine clinical care however unsurprising patients started antibiotics early patient journey admitted hospital often results poct made available reason antibiotics stopped early patients exacerbation airways disease testing positive viruses unknown likely due clinicians feeling detection virus adequately explains acute illness giving confidence bacterial infection unlikely longer needs covered antibiotics combination data crp level radiology results expected rhinoenterovirus frequently detected virus group type virus detected seem influence decision stop antibiotics early although numbers groups small cannot definitively exclude difference suggests patients exacerbation airways disease respiratory virus testing performed pointofcare using comprehensive syndromic multiplex panel rather molecular poct influenza alone would detect majority viruses associated early antibiotic discontinuation could argued many patients study treated antibiotics treated case clinical grounds alone given antibiotic use patients asthma exacerbation already strongly discouraged national society guidelines however despite guidelines inappropriate antibiotic use hospitalised patients asthma remains common <NUMBER> diagnostic uncertainty regarding possibility bacterial infection especially early part hospital admission diagnostic information available likely key driver practice early provision accurate results regarding exacerbation aetiology seems assist rational antibiotic decision making potential alternative complementary strategy biomarkerdirected therapy additional reasons beyond antibiotic stewardship benefits choosing test using comprehensive syndromic poct range respiratory viruses rather poct influenza alone although molecular poct platforms influenza diagnostic accuracy comparable laboratory pcr others demonstrated inferior sensitivity nonindustry sponsored real world studies <NUMBER> potentially reducing usefulness hospital setting missed diagnoses serious consequences including nosocomial transmission influenza although influenza may represent priority hospital infection control teams peak influenza season detection respiratory viruses also important infection control purposes viruses also pose serious risk nosocomial transmission outbreaks especially dangerous immunocompromised patients certain high risk areas haematology wards renal units hospitals twostep testing process adopted patient negative influenza poct tested using multiplex laboratory pcr increasing costs prolonging time result available compared comprehensive syndromic poct regulatory consideration also important rapid diagnostic platforms may able used poct certain countries due regulatory requirements example current filmarray system fully clia waived us significant consideration obviously higher cost associated syndromic panels versus molecular poct influenza clearly need health economic studies provide evidence cost effectives approach considering incremental benefits syndromic testing lower rate readmission seen testing positive viruses versus testing negative control patients reason clear may nonviral exacerbations higher rate subsequent exacerbations even clarity around aetiology exacerbation may reduce readmission although respoc study published randomised controlled trial syndromic respiratory virus testing pointofcare nonrandomised pre post intervention studies suggested similar benefits rapid syndromic respiratory virus testing terms reducing unnecessary antibiotic use paediatric adults patients presenting hospital <NUMBER> <NUMBER> strengths study include randomised nature parent study large overall cohort patients studied pragmatic nature broad generalisability uk international centres limitations include singlecentre trial relatively small numbers patients asthma copd respiratory virus detected although likely generalisable centres cannot rule changes seen dependent processes care uk hospitals also currently uncertain molecular poct respiratory viruses best implemented within nhs health systems potential models include training clinical staff perform testing development dedicated pointofcare testing laboratories staffed technicians located within close acute areas <NUMBER> conclusion syndromic molecular poct respiratory viruses adults exacerbation airways disease associated early discontinuation unnecessary antibiotics testing positive viruses viruses detected noninfluenza viruses difference antibiotic discontinuation different virus types results suggest syndromic molecular poct respiratory viruses favoured poct influenza alone adults exacerbation airways disease university southampton manufactures molecular test platform biofire diagnostics llc salt lake city utah us role study conception design data analysis manuscript preparation corresponding author full access data final responsibility submit publication report independent research supported national institute health research nihr post doctoral fellowship dr tristan clark pdf <NUMBER> views expressed publication authors necessarily nhs national institute health research department health world health organization characterized covid<NUMBER> pandemic <NUMBER>th march <NUMBER> <NUMBER> symptoms covid<NUMBER> induced novel pathogen sarscov<NUMBER> difficult differentiate common infections large proportion infected estimated <NUMBER> cases experience mild disease cough fever <NUMBER> experience moderate disease bilateral pneumonia <NUMBER> develop severe disease <NUMBER> critical disease <NUMBER> recommendation conduct early screening patients identify isolate track infected prevent transmission <NUMBER> reverse transcription polymerase chain reaction rtpcr based methodologies gold standard confirming individual presenting covid<NUMBER> active viral shedding sarscov<NUMBER> <NUMBER> <NUMBER> however ability conduct wide scale testing patients limited number factors including suitable resources rtpcr based testing presence sarscov<NUMBER> addition standard test used <NUMBER> accuracy compared chest ct scan results <NUMBER> may depend specific level viral shedding individual time sample test moreover time sample collection informing patient estimated take many hours several days according systems place complex issues hand hand wideranging symptoms presenting patients discrepant results chest ct symptoms rtpcr results <NUMBER> indicates testing direct presence virus requires significant improvement highly specific tests sarscov<NUMBER> development using crispr <NUMBER> biosensors <NUMBER> <NUMBER> innovative applications require highly specialised equipment resources negatively affect less affluent areas unable access technologies short time frame order contain pandemic therefore global challenge enable screening without need sophisticated equipment resources machine learning ml artificial intelligence ai approaches rapidly developed aid clinical procedures current pandemic predicting specificity new therapies <NUMBER> diagnosing covid <NUMBER> patients radiographic patterns ct scans <NUMBER> current study focused predicting whether person sarscov<NUMBER> positive negative early stage disease approach taken based reported limitation conduct rtpcr tests need quickly differentiate individuals presenting similar symptoms seen covid <NUMBER> common infections dataset used comes public challenge mindstreamai <NUMBER> use ai predict test result sarscov<NUMBER> positivenegative solely full blood counts hospital israelita albert einstein located state sao paulo brazil population <NUMBER> million people <NUMBER> confirmed cases covid <NUMBER> <NUMBER> associated deaths <NUMBER>rd march <NUMBER> hospital publicly released full blood counts <NUMBER> <NUMBER> anonymised patients along rtpcr result sarscov<NUMBER> age quantile symptoms patient history released present evidence patients sarscov<NUMBER> identified random forest ml artificial neural networks ann patients admitted hospital community patients regular ward setting recognition altered immune cell profile allow rapid early screening purely based blood profile data processed study published public forum <NUMBER> part challenge accelerate approaches combat spread sarscov<NUMBER> dataset contains anonymized data patients seen hospital israelita albert einstein são paulo brazil samples collected perform sarscov<NUMBER> rtpcr additional laboratory tests visit hospital data anonymized following best international practices recommendations <NUMBER> clinical data standardized mean zero unit standard deviation data provided included age percentile group outcome rtpcr sarscov<NUMBER> test standard full blood count hematocrit haemoglobin platelets mean platelet volume mpv red blood cells rbc lymphocytes mean corpuscular haemoglobin concentration mchc leukocytes basophils neutrophils mean corpuscular haemoglobin mch eosinophils mean corpuscular volume mcv monocytes red blood cell distribution width rbcdw <NUMBER> full dataset released included <NUMBER> individual patients tested <NUMBER>th march <NUMBER> <NUMBER>rd april <NUMBER> <NUMBER> full blood count results used statistical analysis remaining <NUMBER> results used due lack full blood count data without indepth data timeline tests performed duration infection analysis performed basis severity according location patient within hospital system blood counts four classifications patients community patients admitted hospital regular ward semi intensive unit intensive care unit icu table <NUMBER> patients semiintensive unit icu excluded modelling ensure prediction based early indicators also neutrophils included since reported <NUMBER> patients furthermore exclude age modelling large imbalance positive <NUMBER> vs negative <NUMBER> sarscov<NUMBER> patients community result informative test separately specificity negative patients correctly identified negative sensitivity positive patients correctly identified positive rather solely total accuracy  <NUMBER>class sarscov<NUMBER> positive vs negative classification employ several ml ann network models ml models apply random forest <NUMBER> <NUMBER> <NUMBER> lassoelasticnet regularized generalized linear glmnet models classification random forest classifier based several decision trees classify new object decision tree provides classification input data random forest uses mode classification decide class paper glmnet hand fits traditional logistic model instead using predictors uses regularized path select important variables use logistic regression methods present results <NUMBER>fold cross validation corresponding variable importance plots <NUMBER> furthermore ann <NUMBER> model defined <NUMBER> input parameters three hidden layers trained <NUMBER> epochs classification performance ann model evaluated stratified <NUMBER>fold cross validation performance model expressed terms auc sensitivity specificity accuracy defined follows sensitivity fraction sarscov<NUMBER> positive patients correctly identified specificity fraction sarscov<NUMBER> negative patients correctly identified accuracy total number patients correctly identified lowering threshold detecting sarscov<NUMBER> positive patients sensitivity increase expense specificity hence also look commonly employed auc area receiveroperating characteristics curve curve plotting sensitivity vs <NUMBER>specificity upon changing threshold auc also known wilcoxonmannwhitney statistic probability sarscov<NUMBER> positive patient higher ranked sarscov<NUMBER> negative patient higher auc generally implies better performing model note drawback using accuracy alone unbalanced set mainly sarscov<NUMBER> negative patients case community dataset accuracy high using zero sensitivity significant differences p <NUMBER> <NUMBER> <NUMBER> blood count parameters shown patients regular ward setting tested positive negative sarscov<NUMBER> presence fig <NUMBER> order importance lower p significant increased values sarscov<NUMBER> positive patients mpv rbc lymphocytes hematocrit hemoglobin decreased values eosinophils leukocytes platelets communitypatients found statistically significant differences p <NUMBER> <NUMBER> blood count parameters increased values monocytes mpv leukocytes platelets neutrophils eosinophils show significant decrease sarscov<NUMBER> positive patients among <NUMBER> patients full blood count profiles <NUMBER> admitted regular ward <NUMBER> tested rtpcr positive sarscov<NUMBER> <NUMBER> negative furthermore total <NUMBER> patients admitted hospital <NUMBER> tested positive sarscov<NUMBER> <NUMBER> negative report model predictions sets patients defined ann model regular ward patients produces average classification accuracy <NUMBER> stratified <NUMBER>fold crossvalidation receiver operating characteristic roc curves <NUMBER> folds values area curve auc presented fig <NUMBER>a along average auc <NUMBER> ± <NUMBER> normalized confusion matrix corresponding fold <NUMBER> worst auc value presented fig <NUMBER>b defined ann model community ward produces average classification accuracy <NUMBER> stratified <NUMBER>fold crossvalidation roc curves <NUMBER>folds produce average auc <NUMBER> ± <NUMBER> sensitivity specificity indices estimated <NUMBER> <NUMBER> respectively since imbalance two classes dataset positivenegative <NUMBER> degrades performance defined ann model synthetic minority oversampling technique smote <NUMBER> adapted balancing two classes training dataset stratified <NUMBER>fold crossvalidation technique incorporated repeated <NUMBER> times average accuracy auc sensitivity specificity estimated <NUMBER> <NUMBER> <NUMBER> <NUMBER> respectively roc curves values auc one repetition stratified <NUMBER>fold crossvalidation presented fig <NUMBER>a along average auc <NUMBER> ± <NUMBER> normalized confusion matrix corresponding fold <NUMBER> presented fig <NUMBER>b results implementation random forest glmnet <NUMBER> patients regular ward gives average auc <NUMBER> <NUMBER> fold classification patients community auc <NUMBER> full array sensitivity specificity accuracy values optimal choices cutoff two classifiers given table <NUMBER> table <NUMBER> compared ann random forest glmnet provide insight important variables fig <NUMBER>a b clear indication decision obtained additionally glmnet variable selection providing much smaller stable set variables among <NUMBER> highly correlated predictors analysis top four variables according glmnet corresponded patients community supplementary fig <NUMBER> regular ward supplementary fig <NUMBER> indicated clear recognisable pattern particular note patients regular ward decreased pool leukocytes overall increase red blood cells particular significant decrease eosinophils community patients sarscov<NUMBER> distinctively high levels monocytes low levels leukocytes order enable rapid prediction model clinics <NUMBER> clinicians may want choose two fig <NUMBER>a three fig <NUMBER>b four parameters fig <NUMBER>c monocytesleukocyteseosinophilsplatelets trends supplementary figs <NUMBER> <NUMBER> fig <NUMBER> analysed adding monocytes subtracting leukocytes eosinophils platelets difference indicates little overlap patients test positive negative sarscov<NUMBER> however must noted simple additive formula based normalised data example simple logistic regression lr derived variable monocytes leukocytes eosinophils platelets shows blood characteristic predict sarscov<NUMBER> test outcome average auc <NUMBER> <NUMBER> fold crossvalidation among patients community auc <NUMBER> patients regular ward model predictions ann random forest glmnet formula monocytes leukocytes eosinophils mlep summarized table <NUMBER> table <NUMBER> patients testing sarscov<NUMBER> full blood count tests <NUMBER> patients tested pathogens <NUMBER> patients diagnosed infections note rhinovirus influenza b table <NUMBER> similar presentation many infections covid<NUMBER> may however differentiated clear difference immune response sarscov<NUMBER> using ann model full blood count analysis <NUMBER> patients one tested positive sarscov<NUMBER> least one pathogen patient also tested positive influenza b coronavirus nl<NUMBER> icu addition changing profile immune cells change red blood cells platelets noted order describe profile cells mean changes plotted patients regular ward supplementary fig <NUMBER> developed multiple independent models statistical random forest shallow learning predict sarscov<NUMBER> auc <NUMBER> community <NUMBER> regular ward patients using data collected normalized full blood counts provides initial screen sarscov<NUMBER> positive negative using biomarkers early stage disease presentation screen conducted set data based severity judged location patient hospital admitted regular ward compared admitted hospital icu patients excluded hence models able distinguish altered blood profiles patients later diagnosed pathogens well recognised symptoms covid<NUMBER> accompanied significant change immune response <NUMBER> decreased population leukocytes lymphocytes <NUMBER> <NUMBER> eosinophils <NUMBER> <NUMBER> <NUMBER> found throughout stages infection indeed suggested one case report wuhan eosinopenia together lymphopenia may potential indicator diagnosis <NUMBER> early reports used similar predictive patterns found full blood count parameters suggesting elevated neutrophil lymphocyte ratio could used part diagnosis <NUMBER> study investigated change blood parameters total <NUMBER> patients severe non severe collected together using commonly used ratios used diagnosis viral respiratory diseases neutrophiltolymphocyte ratio derived nlr ratio dnlr neutrophil count divided result wbc count minus neutrophil count platelettolymphocyte ratio lymphocytetomonocyte ratio however parameters commonly alter respect viral infections initiated research identify new ratios distinguish sarscov<NUMBER> pathogens show new simple calculation based leukocytes monocytes eosinophils platelets normalized monocytes leukocytes eosinophils platelets used predict <NUMBER> auc presence sarscov<NUMBER> earlystage community patients validation required determine whether model distinguish fully pathogens although initial small numbers indicate trend positive leukocytes family white blood cells includes neutrophils lymphocytes monocytes eosinophils basophils specific pathogens induce specific responses increase circulating neutrophils monocytes typically increase sepsis part immune defence mechanism several studies indicated ratios different blood cells used predict outcome ratio monocyte neutrophil used determine sepsis severity <NUMBER> platelet monocyte aggregation reported increased patients influenza h<NUMBER>n<NUMBER> <NUMBER> indeed clinical interest using relationship different parameters full blood counts great value interest due simplicity readily measurable parameters yet common clinical use shown neutrophil lymphocyte mean platelet volume platelet count could predict outcome critically ill patients peritonitis pancreatitis bacteremia <NUMBER> results presented clearly demonstrates early prediction infected sarscov<NUMBER> may made relationship monocytes eosinophils leukocytes differentiate pathogen induced infections data analysed report focussed clear early stages order differentiate patients presenting common symptoms prior need icu changes parameters full blood counts easily distinguishable pathogeninduced infections apparent decrease leukocyte population consisting large proportion monocytes observation keeping tools used diagnose severity covid<NUMBER> measurement il<NUMBER> significantly increases throughout progression disease cytokine il<NUMBER> predominantly synthesised monocytes macrophage derive monocytes partly responsible drive immune response deleterious cytokine storm order best understand immune response sarscov<NUMBER> useful compare similar coronaviruses two main example closest known example sars virus directly infects human monocytes produces cytokines attract neutrophils macrophage activated lymphocytes <NUMBER> mers shown increase monocytes il<NUMBER> production <NUMBER> parallel study indicates pathogenesis sarscov<NUMBER> may linked monocytes production il<NUMBER> study analysis monocyte involvement crucial prediction sarscov<NUMBER> infection additionally use ai ml recognise altered pattern key blood parameters useful tool future emergence future coronavirus equally pathogenic contagious decrease platelets patients testing positive sarscov<NUMBER> regular ward opposite observed separate reports patients influenza <NUMBER> subset patients included analysis tested pathogens proportion negative sarscov<NUMBER> positive pathogens including coronaviruses nl<NUMBER> hku<NUMBER> <NUMBER>e influenza b suggests platelet count good indicator predictive model may good way differentiate sarscov<NUMBER> infection influenza suggests potential decreased platelet presence patients concern due link thrombocytopenia increased internal bleeding supports reports increase thrombocytopenia associated higher mortality covid<NUMBER> patients <NUMBER> condition thrombocytopenia may reason recently noted rashes observed patients especially young children <NUMBER> however reports clotting increased covid<NUMBER> patients data show normalised may misleading normalised data also indicates increase platelet size mpv suggests rapid platelet production bone marrow indeed recommended covid<NUMBER> patients administered antiplatelet therapy protect thrombosis <NUMBER> overall highlights difficulty interpreting mean normalised data report first use primary patient data full blood counts test train ann predict patients regular ward well community test positive sarscov<NUMBER> preliminary model trained adapted aim address shortfall direct sarscov<NUMBER> testing methods hospitals enable prediction allows health care providers conduct rapid cheap screening separate patients likely sarscov<NUMBER> early screening allows segregation patients early treatment intervention research receive specific grant funding agencies public commercial notforprofit sectors since december <NUMBER> novel coronavirus sarscov<NUMBER> identified cause pandemic covid <NUMBER> early symptoms overlap common conditions common cold influenza making early screening diagnosis crucial goals health practitioners aim study use machine learning artificial neural network ann simple statistical test identify sarscov<NUMBER> positive patients full blood counts without knowledge symptoms history individuals dataset included analysis training contains anonymized full blood count results patients seen hospital israelita albert einstein são paulo brazil samples collected perform sarscov<NUMBER> rtpcr test visit hospital patient data anonymised hospital clinical data standardized mean zero unit standard deviation data made public aim allow researchers develop ways enable hospital rapidly predict potentially identify sarscov<NUMBER> positive patients find full blood counts random forest shallow learning flexible ann model predict sarscov<NUMBER> patients high accuracy populations regular wards auc <NUMBER> admitted hospital community auc <NUMBER> auc area receiver operating characteristics curve measure model performance moreover simple linear combination <NUMBER> blood counts used auc <NUMBER> patients within community normalised data different blood parameters sarscov<NUMBER> positive patients exhibit decrease platelets leukocytes eosinophils basophils lymphocytes increase monocytes sarscov<NUMBER> positive patients exhibit characteristic immune response profile pattern changes different parameters measured full blood count detected simple rapid blood tests symptoms early stage infection known overlap common conditions parameters full blood count analysed distinguish viral type earlier stage current rtpcr tests sarscov<NUMBER> allow present new methodology potential greatly improve initial screening patients pcr based diagnostic tools limited sarscov<NUMBER> machine learning artificial neural network ann screening full blood count leukocytes monocytes world health organization characterized covid<NUMBER> pandemic <NUMBER> th march <NUMBER> <NUMBER> symptoms covid<NUMBER> induced novel pathogen sarscov<NUMBER> difficult differentiate common infections large proportion infected estimated <NUMBER> cases experience mild disease cough fever <NUMBER> experience moderate disease bilateral pneumonia <NUMBER> develop severe disease <NUMBER> critical disease <NUMBER> recommendation conduct early screening patients identify isolate track infected prevent transmission <NUMBER> reverse transcription polymerase chain reaction rtpcr based methodologies gold standard confirming individual presenting covid<NUMBER> active viral shedding sarscov<NUMBER> <NUMBER> <NUMBER> however ability conduct wide scale testing patients limited number factors including suitable resources rtpcr based testing presence sarscov<NUMBER> addition standard test used <NUMBER> accuracy compared chest ct scan results <NUMBER> may depend specific level viral shedding individual time sample test moreover time sample collection informing patient estimated take many hours several days according systems place complex issues hand hand wideranging symptoms presenting patients discrepant results chest ct symptoms rtpcr results <NUMBER> indicates testing direct presence virus requires significant improvement highly specific tests sarscov<NUMBER> development using crispr <NUMBER> biosensors <NUMBER> innovative applications require highly specialised equipment resources negatively affect less affluent areas unable access technologies short time frame order contain pandemic therefore global challenge enable screening without need sophisticated equipment resources machine learning artificial intelligence approaches rapidly developed aid clinical procedures current pandemic predicting specificity new therapies <NUMBER> diagnosing covid <NUMBER> patients radiographic patterns ct scans <NUMBER> current study focused predicting whether person sarscov<NUMBER> positive negative early stage disease approach taken based reported limitation conduct rtpcr tests need quickly differentiate individuals presenting similar symptoms seen covid <NUMBER> common infections dataset used comes public challenge mindstreamai <NUMBER> use artificial intelligence predict test result sarscov<NUMBER> positivenegative solely complete blood tests hospital israelita albert einstein located state sao paulo brazil population <NUMBER> million people <NUMBER> confirmed cases covid <NUMBER> <NUMBER> associated deaths <NUMBER>rd march <NUMBER> hospital publicly released full blood counts <NUMBER> <NUMBER> anonymised patients along rtpcr result sarscov<NUMBER> age quantile symptoms patient history released present evidence patients sarscov<NUMBER> identified random forest machine learning artificial neural networks ann patients admitted hospital community patients regular ward setting recognition altered immune cell profile allow rapid early screening purely based blood profile data processed study published public forum <NUMBER> part challenge accelerate approaches combat spread sarscov<NUMBER> dataset contains anonymized data patients seen hospital israelita albert einstein são paulo brazil samples collected perform sarscov<NUMBER> rtpcr additional laboratory tests visit hospital data anonymized following best international practices recommendations <NUMBER> clinical data standardized mean zero unit standard deviation data provided included age percentile group outcome rtpcr sarscov<NUMBER> test standard full blood count hematocrit haemoglobin platelets mean platelet volume mpv red blood cells rbc lymphocytes mean corpuscular haemoglobin concentration mchc leukocytes basophils neutrophils mean corpuscular haemoglobin mch eosinophils mean corpuscular volume mcv monocytes red blood cell distribution width rbcdw <NUMBER> full dataset released included <NUMBER> individual patients tested <NUMBER>th march <NUMBER> <NUMBER>rd april <NUMBER> <NUMBER> full blood count results used statistical analysis remaining <NUMBER> results used due lack full blood count data without indepth data timeline tests performed duration infection analysis performed basis severity according location patient within hospital system blood counts four classifications patients community patients admitted hospital regular ward semi intensive care intensive care unit icu table <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients semiintensive intensive care units excluded modelling ensure prediction based early indicators also neutrophils included since reported <NUMBER> patients furthermore exclude age modelling large imbalance positive <NUMBER> vs negative <NUMBER> sarscov<NUMBER> patients community result informative test separately specificity ge negative patients correctly identified negative sensitivity ge positive patients correctly identified positive rather solely total accuracy <NUMBER> complete counts analysed <NUMBER> patients also tested pathogens <NUMBER>class sarscov<NUMBER> positive vs negative classification employ several machine learning artificial network models machine learning models apply random forest <NUMBER> lassoelasticnet regularized generalized linear glmnet models classification random forest classifier based several decision trees classify new object decision tree provides classification input data random forest uses mode classification decide class paper glmnet hand fits traditional logistic model instead using predictors uses regularized path select important variables use logistic regression methods present results <NUMBER>fold crossvalidation corresponding variable importance plots <NUMBER> furthermore artificial neural network ann <NUMBER> model defined <NUMBER> input parameters three hidden layers trained <NUMBER> epochs classification performance ann model evaluated stratified <NUMBER>fold cross validation performance model expressed terms auc sensitivity specificity accuracy defined follows sensitivity fraction sarscov<NUMBER> positive patients correctly identified specificity fraction sarscov<NUMBER> negative patients correctly identified accuracy total number patients correctly identified lowering threshold detecting sarscov<NUMBER> positive patients sensitivity increase expense specificity hence also look commonly employed auc area receiveroperating characteristics curve curve plotting sensitivity vs <NUMBER>specificity upon changing threshold auc also known wilcoxonmannwhitney statistic probability sarscov<NUMBER> positive patient higher ranked sarscov<NUMBER> negative patient higher auc generally implies better performing model note drawback using accuracy alone unbalanced set mainly sarscov<NUMBER> negative patients case community dataset accuracy high using zero sensitivity significant differences p<NUMBER> <NUMBER> <NUMBER> blood count parameters shown patients regular ward setting tested positive negative sarscov<NUMBER> presence figure <NUMBER> order importance lower p significant increased values sarscov<NUMBER> positive patients mpv rbc lymphocytes hematocrit hemoglobin decreased values eosinophils leukocytes platelets communitypatients found statistically significant differences p<NUMBER> <NUMBER> blood count parameters increased values monocytes mpv leukocytes platelets neutrophils eosinophils show significant decrease sarscov<NUMBER> positive patients among <NUMBER> patients complete blood profiles <NUMBER> admitted regular ward <NUMBER> tested rtpcr positive sarscov<NUMBER> <NUMBER> negative furthermore total <NUMBER> patients admitted hospital <NUMBER> tested positive sarscov<NUMBER> <NUMBER> negative report model predictions sets patients defined ann model regular ward patients produces average classification accuracy <NUMBER> stratified <NUMBER>fold crossvalidation receiver operating characteristic roc curves <NUMBER> folds values area curve auc presented figure <NUMBER>a along average auc <NUMBER>±<NUMBER> normalized confusion matrix corresponding fold <NUMBER> presented figure <NUMBER>b results implementation random forest glmnet <NUMBER> patients regular ward gives average auc <NUMBER> <NUMBER> fold classification patients community auc <NUMBER> full array sensitivity specificity accuracy values optimal choices cutoff two classifiers given table <NUMBER> table <NUMBER> compared ann random forest glmnet provide insight important variables figure <NUMBER>a b clear indication decision obtained additionally glmnet variable selection providing much smaller stable set variables among <NUMBER> highly correlated predictors analysis top four variables according glmnet corresponded patients community supplementary figure <NUMBER> regular ward supplementary figure <NUMBER> indicated clear recognisable pattern particular note patients regular ward decreased pool leukocytes overall increase red blood cells particular significant decrease eosinophils community patients sarscov<NUMBER> distinctively high levels monocytes low levels leukocytes order enable rapid prediction model clinics <NUMBER> clinicians may want choose two figure <NUMBER>a three figure <NUMBER>b four parameters figure <NUMBER>c monocytesleukocyteseosinophilsplatelets trends supplementary figure <NUMBER> <NUMBER> figure <NUMBER> analysed adding monocytes subtracting leukocytes eosinophils platelets difference indicates little overlap patients test positive negative sarscov<NUMBER> however must noted simple additive formula based normalised data example simple logistic regression lr derived variable ymonocytes leukocyteseosinophils platelets shows blood characteristic predict covid test outcome average auc <NUMBER> <NUMBER> fold crossvalidation among patients community auc <NUMBER> patients regular ward model predictions ann random forest glmnet formula monocytes leukocyteseosinophils mlep summarized table <NUMBER> table <NUMBER> <NUMBER> patients one tested positive sarscov<NUMBER> least one pathogen patient also tested positive influenza b coronavirus nl<NUMBER> icu addition changing profile immune cells change red blood cells platelets noted order describe profile cells mean changes plotted patients regular ward supplementary figure <NUMBER> developed multiple independent models statistical random forest shallow learning predict sarscov<NUMBER> auc <NUMBER> community <NUMBER> regular ward patients using data collected normalized full blood counts provides initial screen sarscov<NUMBER> positive negative using biomarkers early stage disease presentation screen conducted set data based severity judged location patient hospital admitted regular ward compared admitted hospital icu patients excluded hence models able distinguish altered blood profiles patients later diagnosed pathogens well recognised symptoms covid <NUMBER> accompanied significant change immune response <NUMBER> decreased population leukocytes lymphocytes <NUMBER> eosinophils <NUMBER> <NUMBER> <NUMBER> found throughout stages infection indeed suggested one case report wuhan eosinopenia together lymphopenia may potential indicator diagnosis <NUMBER> early reports used similar predictive patterns found full blood count parameters suggesting elevated neutrophil lymphocyte ratio could used part diagnosis <NUMBER> study investigated change blood parameters total <NUMBER> patients severe non severe collected together using commonly used ratios used diagnosis viral respiratory diseases neutrophiltolymphocyte ratio derived nlr ratio dnlr neutrophil count divided result wbc count minus neutrophil count platelettolymphocyte ratio lymphocytetomonocyte ratio however parameters commonly alter respect viral infections initiated research identify new ratios distinguish sarscov<NUMBER> pathogens show new simple calculation based leukocytes monocytes eosinophils platelets normalized monocytes leukocytes eosinophils platelets used predict <NUMBER> auc presence sarscov<NUMBER> earlystage community patients validation required determine whether model distinguish fully pathogens although initial small numbers indicate trend positive leukocytes family white blood cells includes neutrophils lymphocytes monocytes eosinophils basophils specific pathogens induce specific responses increase circulating neutrophils monocytes typically increase sepsis part immune defence mechanism several studies indicated ratios different blood cells used predict outcome ratio monocyte neutrophil used determine sepsis severity <NUMBER> platelet monocyte aggregation reported increased patients influenza h<NUMBER>n<NUMBER> <NUMBER> indeed clinical interest using relationship different parameters full blood count great value interest due simplicity readily measurable parameters yet common clinical use shown neutrophil lymphocyte mean platelet volume platelet count could predict outcome critically ill patients peritonitis pancreatitis bacteremia <NUMBER> results presented clearly demonstrates early prediction infected sarscov<NUMBER> may made relationship monocytes eosinophils leukocytes differentiate pathogen induced infections data analysed report focussed clear early stages order differentiate patients presenting common symptoms prior need icu changes parameters full blood count easily distinguishable pathogeninduced infections apparent decrease leukocyte population consisting large proportion monocytes observation keeping tools used diagnose severity covid <NUMBER> measurement il<NUMBER> significantly increases throughout progression disease cytokine il<NUMBER> predominantly synthesised monocytes macrophage derive monocytes partly responsible drive immune response deleterious cytokine storm order best understand immune response sarscov<NUMBER> useful compare similar coronaviruses two main example closest known example sars contrast highly infectious highly pathogenic coronaviruses sars mers noted similar effects immune response recently overlaps pathogenesis witnessed sarscov<NUMBER> infections sars virus directly infects human monocytes produces cytokines attract neutrophils macrophage activated lymphocytes <NUMBER> mers shown increase monocytes il<NUMBER> production <NUMBER> parallel study indicates pathogenesis sarscov<NUMBER> may linked monocytes production il<NUMBER> study analysis monocyte involvement crucial prediction sarscov<NUMBER> infection additionally use ai ml recognise altered pattern key blood parameters useful tool future emergence future coronavirus equally pathogenic contagious decrease platelets patients testing positive sarscov<NUMBER> regular ward opposite observed separate reports patients influenza <NUMBER> subset patients included analysis tested pathogens proportion negative sarscov<NUMBER> positive pathogens including coronaviruses nl<NUMBER> hku<NUMBER> <NUMBER>e influenza b suggests platelet count good indicator predictive model may good way differentiate sarscov<NUMBER> infection influenza suggests potential decreased platelet presence patients concern due link thrombocytopenia increased internal bleeding supports reports increase thrombocytopenia associated higher mortality covid <NUMBER> patients <NUMBER> condition thrombocytopenia may reason recently noted rashes observed patients especially young children <NUMBER> however reports clotting increased covid <NUMBER> patients data show normalised may misleading normalised data also indicates increase platelet size mpv suggests rapid platelet production bone marrow indeed recommended covid <NUMBER> patients administered antiplatelet therapy protect thrombosis <NUMBER> overall highlights difficulty interpreting mean normalised data report first use primary patient data full blood counts test train ann predict patients regular ward well community test positive sarscov<NUMBER> preliminary model trained adapted aim address shortfall direct sarscov<NUMBER> testing methods hospitals enable prediction allows health care providers conduct rapid cheap screening separate patients likely sarscov<NUMBER> early screening allows segregation patients early treatment intervention aim study use machine learning artificial neural network ann simple statistical test identify sarscov<NUMBER> positive patients full blood counts without knowledge symptoms history individuals dataset included analysis training contains anonymized full blood count results patients seen hospital israelita albert einstein são paulo brazil samples collected perform sarscov<NUMBER> rtpcr test visit hospital patient data anonymised hospital clinical data standardized mean zero unit standard deviation data made public aim allow researchers develop ways enable hospital rapidly predict potentially identify sarscov<NUMBER> positive patients find full blood counts random forest shallow learning flexible ann model predict sarscov<NUMBER> patients high accuracy populations regular wards auc <NUMBER> admitted hospital community auc <NUMBER> auc area receiver operating characteristics curve measure model performance moreover simple linear combination <NUMBER> blood counts used auc <NUMBER> patients within community normalised data different blood parameters sarscov<NUMBER> positive patients exhibit decrease platelets leukocytes eosinophils basophils lymphocytes increase monocytes sarscov<NUMBER> positive patients exhibit characteristic immune response profile pattern changes different parameters measured full blood count detected simple rapid blood tests symptoms early stage infection known overlap common conditions parameters full blood count analysed distinguish viral type earlier stage current rtpcr tests sarscov<NUMBER> allow present new methodology potential greatly improve initial screening patients pcr based diagnostic tools limited <NUMBER> early sarscov<NUMBER> prediction monocytesleukocyteseosinophils variable auc <NUMBER> <NUMBER> prediction regular ward using machine learning complete blood count auc <NUMBER> <NUMBER> predominance monocytes sarscov<NUMBER> positive patients similar sars mers severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> outbreak governments strived maximize daily testing capacity order facilitate diagnosis isolation cases <NUMBER> although important metric alone sufficient gauge ongoing effectiveness nations response healthcare system may access many tests unless used distributed part coherent testing strategy value limited make case highthroughput testing combined nuanced context specific testing approaches using validated rapid point care diagnostics sarscov<NUMBER>associated respiratory disease covid<NUMBER> highly variable symptoms range mild coryza severe life threatening respiratory compromise <NUMBER> furthermore unascertained proportion individuals develop asymptomatic viraemia <NUMBER> <NUMBER> disease spectrum lead diagnostic management challenges including reliable distinction patients covid<NUMBER> without concern considering best cohort patients within healthcare system lack accurate cohorting subsequent nosocomial spread could lead persistent reservoir infectivity within hospitals detection sarscov<NUMBER> typically via realtime polymerase chain reaction rtpcr gold standard diagnosis covid<NUMBER> however using standard testing approaches time swab clinically actionable result could well <NUMBER> hours especially hospitals without laboratory facilities <NUMBER> therefore unlikely molecular result would available whilst patient emergency department ed setting information could greatest value global biotechnology industry quick recognise gap testing paradigm increasing number rapid pointofcare tests pocts sarscov<NUMBER> entering market pocts likely relatively limited resource therefore strategies developed guide implementation currently without molecular result ed clinicians must assess whether patient might covid<NUMBER> based clinical presentation early case series suggest frequently observed symptoms fever <NUMBER> cough <NUMBER> however dyspnoea <NUMBER> myalgia <NUMBER> headache <NUMBER> also frequently reported <NUMBER> additionally radiographic imaging appears value reaching diagnosis study assessing <NUMBER> cases ct scanning diagnostic sensitivity <NUMBER> positive predictive value <NUMBER> <NUMBER> role clinician consider available variables alongside generating differential diagnosis determine probability given patient covid<NUMBER> probabilistic assessment could used guide deployment pocts previously well patient presets fever cough bilateral infiltrates ct chest high index suspicion covid<NUMBER> scenario rapid molecular confirmation negative positive adds little high pretest probability therefore strong rationale cohorting patient alongside patients covid<NUMBER> furthermore even rapid molecular result available returned negative priori odds posttest probability would still indicate likely covid diagnosis figure <NUMBER> given pretest probability <NUMBER> assuming relatively conservative assay sensitivity <NUMBER> specificity <NUMBER> positive negative results would alter posttest probabilities <NUMBER> <NUMBER> respectively outcomes still indicative likely covid<NUMBER> diagnosis therefore rapid molecular result context limited clinical value frequently however patients cannot clearly differentiated presentation symptomatology may equivocal imaging may inconclusive clinical scenario equipoise pretest probability <NUMBER> situation inherent difficulty knowing best cohort patient poct available could considerable benefit either outcome positive negative notably alters posttest probability one direction allowing clinician make informed decision regarding cohorting management figure <NUMBER> assuming assay sensitivity specificity positive negative results scenario adjusts posttest probabilities <NUMBER> <NUMBER> respectively divergence posttest probabilities may empower clinicians accordingly adjust management strategies indicating context rapid assay represents clinically useful test determining pretest probability traditionally based upon clinical gestalt however formalize strategy risk stratification tools could developed using data prospective observational cohort studies <NUMBER> diagnostic utility specific symptoms findings presentation could combined via bayesian framework generating reliable pretest probabilities indeterminate cases greatest value molecular result rapid poct could deployed similar dynamic risk stratification strategies already widely used ed triaging patients cardiac chest pain workforce accustomed approach <NUMBER> dynamic risk stratification approaches adopted analytical sensitivity specificity incorporated diagnostic test must first established given unprecedented demand sarscov<NUMBER> diagnostics many new assays receiving emergency regulatory approval relatively limited analytical validation <NUMBER> <NUMBER> assays sensitivity increases ability differentiate indeterminate cases figure <NUMBER> poorly validated assays could lead inappropriate cohorting increased nosocomial spread avoidable patient deaths therefore critical assay proposed implementation properly validated clinical setting time writing many countries beginning slow rates infection governments cautiously relaxing social distancing measures caseloads begin fall efforts must made develop assessment testing strategies minimise hospital acquired infections include evidenced based cohorting approaches beginning ed ensuring formal scientifically guided approach triaging patients could improve outcomes control disease spread ultimately reduce scale pandemic recent <NUMBER> h<NUMBER>n<NUMBER> influenza pandemic heighten awareness need improved diagnostic tests respiratory pathogens overlap clinical presentation various respiratory infections possible reliably predict pathogen based clinical signs symptoms moreover rapid diagnostic tests shown reduce length hospital stay costs testing viral respiratory tract infections <NUMBER> <NUMBER> discuss emerging multiplex technologies detect quantify multiple respiratory pathogens single test exhaustive discussion emerging technologies rather overview <NUMBER> technologies applied respiratory pathogens table <NUMBER> note none tests described herein cleared us food drug administration currently available research use brief overview technology presented along published data respiratory virus testing test viewed context clinical utility example method applicable nearpatient testing suited testing clinical laboratory turnaround time result affect utility outpatient andor inpatient diagnostic testing test identify needed pathogens identify less pathogens would needed certain clinical setting finally result alter clinical management lead betterdirected reduced use antiviral therapy antibiotics respplex technology qiaplex technology qiagen involves nucleic acid purification multiplex amplification polymerase chain reaction pcr followed detection using liquidphase beadbased array technology luminex xmap technology allows high degree multiplexing detection <NUMBER> pathogens single test respplex test designed detect bacterial respiratory pathogens whereas respplex ii test detects respiratory viruses pathogen multiplex pcr nested genespecific primers designed included reaction <NUMBER> target specific primers added low concentrations used enrich targets first cycles pcr inner genespecific primers tag sequences recognized universal set primers called superprimers superprimers added higher concentration genespecific primers allows exponential amplification targets present sample reverse superprimer labeled biotin added higher concentration forward superprimer asymmetric pcr yields reverse strands detection eliminates need denature pcr products hybridization probe labeled pcr products detected using capture probe specific target probes covalently coupled colorcoded bead specific target corresponds unique bead color biotinlabeled amplified products detected addition streptavidinphycoerythrin detection occurs luminex instrument unique colored bead recognized laser presence absence phycoerythrinlabeled product determines whether genespecific target present sample unique design resplex ii system allows sensitive specific reproducible amplification multiple targets respplex system used identify viral bacterial pathogens patients symptoms acute respiratory infection <NUMBER> <NUMBER> tests used one study <NUMBER> designed detect <NUMBER> pathogens including common viral bacterial pathogens <NUMBER> respiratory samples tested <NUMBER> <NUMBER> pathogen detected including <NUMBER> <NUMBER> pathogen <NUMBER> <NUMBER> <NUMBER> <NUMBER> viruses also detected direct immunofluorescence testing direct fluorescent antibody dfa influenza b parainfluenza <NUMBER> respiratory syncytial virus rsv respplex test sensitivity <NUMBER> compared dfa adenovirus resplex test sensitivity <NUMBER> compared dfa led reconfiguration adenovirus component test another study showed similar results <NUMBER> sensitivity respplex ii test varied <NUMBER> <NUMBER> compared culture monoplex realtime pcr assays high specificity <NUMBER> although sensitivity pathogens needs improved overall respplex tests potential diagnostic tool ability detect multiple pathogens single test important diagnostic advance provides approach study outcomes clinical significance coinfections respplex system also used detect h<NUMBER>n<NUMBER> influenza virus assay designed target h<NUMBER> h<NUMBER> h<NUMBER> h<NUMBER> h<NUMBER> h<NUMBER> n<NUMBER> n<NUMBER> genes influenza virus well ns genes influenza influenza b viruses test allowed detection genotyping influenza b viruses total <NUMBER> clinical samples tested including <NUMBER> samples human h<NUMBER>n<NUMBER> infection results compared viral culture conventional realtime reversetranscription rt pcr respplex test clinical sensitivity <NUMBER> specificity <NUMBER> <NUMBER> providing rapid method identifying subtyping influenza viruses respplex test detects <NUMBER> bacterial pathogens streptococcus pneumoniae neisseria meningitidis haemophilus influenzae legionella pneumophila mycoplasma pneumoniae chlamydophila pneumoniae used test <NUMBER> formalinfixed paraffinembedded tissue samples fatal cases pneumonia meningitismeningococcemia confirmed immunohistochemistry organismspecific realtime pcr overall respplex test identified <NUMBER> <NUMBER> cases single pathogen <NUMBER> <NUMBER> multiple pathogens <NUMBER> multiplex tests value respiratory specimens formalinfixed paraffinembedded tissue broad differential limited volume specimen advantage resplex ii test identify large number pathogens single test however complex test multiple steps requiring batching specimens turnaround time results <NUMBER> h practical nearpatient testing test needs performed clinical laboratory one significant limitations technology need postamplification manipulation samples greatly increases risk carryover contamination could lead falsepositive results infiniti system autogenomics couples multiplex pcr automated microarray hybridization using infiniti analyzer nucleic acid extraction multiplex conventional rtpcr reaction performed primers specific <NUMBER> respiratory viruses amplification amplicons purified enzymatic step remove unincorporated nucleotides primers subjected proprietary primer extension step within infiniti analyzer step attaches specific tag amplicon also incorporates fluorescentlabeled nucleotides cy<NUMBER>dctp tagged labeled amplicons hybridized antitags immobilized microarray allowing specific identification targets three replicates antitag microarray provide redundancy primer extension tagging hybridization scanning data analysis steps automated performed within infiniti analyzer recent study raymond et al <NUMBER> compared microarray test singletarget quantitative realtime pcr assays <NUMBER> respiratory viruses commonly infect children nasopharyngeal aspirates collected children <NUMBER> years age hospitalized acute respiratory tract infections overall <NUMBER> specimens positive <NUMBER> virus realtime microarray tests <NUMBER> negative viruses methods <NUMBER> samples <NUMBER> <NUMBER> positive realtime tests viruses detected microarray test common viruses detected rsv influenza coronaviruses rhinoviruses enteroviruses multiple viruses found <NUMBER> specimens results compared <NUMBER> methods specimen <NUMBER> concordance sensitivity microarray test <NUMBER> viruses except adenoviruses coronavirus nl<NUMBER> overall single realtime pcr tests sensitive microarray test although latter required fewer manual steps <NUMBER> specimens <NUMBER> h less handson time required throughput higher performance individual realtime tests microarray test requires several steps loading infiniti analyzer designed batching specimens nucleic acid extraction rtpcr enzyme digestion steps take <NUMBER> h infiniti analyzer loaded first result available <NUMBER> h subsequent result requires additional <NUMBER> min based complexity batching time required results technology designed clinical laboratory nearpatient testing jaguar system handy lab recently acquired bd diagnosticsgeneohm couples automated nucleic acid extraction method realtime pcr technology detection multiple respiratory pathogens clinical specimen pipetted specimen tube reagents disposables nucleic acid extraction amplification reactions loaded onto instrument nucleic acid extraction performed individual reagent cartridges loaded jaguar instrument along amplification cartridge remainder test completely automated proprietary extraction method allows rapid efficient purification concentration nucleic acid relatively large specimen volume <NUMBER> <NUMBER> ml elution volume <NUMBER> used resuspend amplification reagents amplification step performed cartridge <NUMBER> <NUMBER> <NUMBER> cm <NUMBER> mm thick cartridge accommodate <NUMBER> reactions reaction volume <NUMBER> small volume allows rapid cycling time hence entire test completed <NUMBER> min system uses realtime pcr multiplexing capabilities limited <NUMBER> targets however jaguar system several advantages automated simple use essentially requiring single pipette step uses realtime pcr postamplification manipulation specimen eliminating risk carryover contamination ease use rapid time result would allow system placed rapidresponse laboratory emergency department provide nearpatient testing results available quickly enough affect clinical management multiplex assay detection influenza influenza b rsv nasopharyngeal specimens developed jaguar system sensitivities detection influenza influenza b rsv <NUMBER> <NUMBER> <NUMBER> respectively compared tissue culture results <NUMBER> overall specificity <NUMBER> <NUMBER>day period <NUMBER> clinical samples tested <NUMBER> positive influenza jaguar assay demonstrated <NUMBER> positive agreement compared laboratorydeveloped molecular tests <NUMBER> falsepositive findings noted <NUMBER> negative agreement <NUMBER> specimens <NUMBER> subtyped found <NUMBER> h<NUMBER>n<NUMBER> detected jaguar test although assay currently designed distinguish influenza subtypes jaguar system required <NUMBER> min technical <NUMBER> h test <NUMBER> specimens filmarray system idaho technologies integrates nucleic acid extraction nested pcr detection data analysis singleuse pouch system automated enables detection numerous viral bacterial respiratory pathogens single test needed reagents assay enclosed singleuse pouch addition water hydrate lyophilized reagents respiratory specimen pouch loaded filmarray instrument rest test completely automated extraction purification nucleic acid nested pcr reaction performed within pouch firststep pcr multiplexed reaction containing primers viral bacterial targets amplicons first pcr diluted second round pcr reactions performed multiwell array well containing single primer set targeting specific pathogen redundancy built array target amplified <NUMBER> separate wells using amplification melt curve analysis filmarray software generates result target system robust detecting low concentration pathogen presence high concentration second pathogen results available <NUMBER> h although nested pcr used system closed risk carryover contamination preliminary studies show filmarray system detects viral pathogens coinfections dfa testing respiratory panel development detects adenoviruses bocaviruses conornaviruses influenza b influenza subtypes novel h<NUMBER> h<NUMBER> h<NUMBER> metapneumonvirus parainfluenza viruses <NUMBER> rsv rhinoviruses well bordetella pertussis c pneumoniae pneumoniae ability detect multiple pathogens within <NUMBER> h simple setup fully automated system raises possibility nearpatient testing filmarray technology emergency department outpatient clinic current instrumentation limited single test per run multiple instruments may needed depending required throughput scalable target analysis routine star technology primeradx integrates conventional pcr capillary electrophoresis providing ability detect large number pathogens <NUMBER> single reaction also unique feature providing quantitative data star similar principle realtime pcr uses amplicon size instead fluorescent probes identify targets nucleic acid extraction multiplex pcr reaction set unique primers specific target thermal cycler amplification reaction capillary electrophoresis device contained iceplex instrument amplification reaction small sample nanoliter master mix subjected capillary electrophoresis sequential sampling every <NUMBER> cycles starting cycle <NUMBER> size separation signal amplicon increases accumulation amplicon plotted time generating amplification curve cycle threshold determined target different target identified based unique size amplicon quantification targets accomplished adding <NUMBER> standards master mix different concentration unique amplicon size standard curve generated plotting cycle threshold values standards known concentration curve used determine concentration targets amplification capillary electrophoresis data analysis steps automated iceplex instrument star technology demonstrate large number pathogens single reaction ability quantify pathogens may prove important distinguishing colonization invasive disease pathogens pneumoniae assay requires <NUMBER> h complete testing performed clinical laboratory samples batched technology therefore designed nearpatient testing instrument closed system minimal risk carryover contamination currently test quantification cytomegalovirus epsteinbarr virus bk virus human herpesviruses <NUMBER> <NUMBER> transplant recipients developed evaluated test respiratory pathogens also planned plexid abbott molecular unique system combines pcr electrospray ionization mass spectrometry esims detect broad array pathogens including bacteria viruses fungi parasites nucleic acid extracted purified clinical specimen multiple pcr reactions performed <NUMBER>well microtiter plates use primers targeting highly conserved regions microbial genome flank variable regions types primers also used sequencebased pathogen identification plates loaded plexid analyzer automates desalting step esims determination base composition data analysis amplified mixture injected electrospray ionization timeofflight mass spectrometer mass amplicon measured mass amplicon possible determine nucleotide base composition ie number g c nucleotides dna molecule requiring base composition forward reverse strands complementary number possibilities reduced single unambiguous solution organisms sample determined comparing base composition observed amplicons database comprising known sequence data wide array pathogens compared culture nucleic acid probe assays limited detection microbes grow targeted assay primer sequences broadbased approach enables identification known emerging unanticipated pathogens plexid system used identify viral respiratory pathogens clinical specimens results compared expanded reference standard including combination antigen detection culture pcr methods plexid system performed well sensitivity <NUMBER> detection influenza b <NUMBER> rsv sensitivity detection adenoviruses parainfluenza viruses coronaviruses <NUMBER> although number specimens pathogens low <NUMBER> pcresi technology used examine samples obtained military recruits outbreaks respiratory disease identified variety bacterial pathogens including h influenzae n meningitidis streptococcus pyogenes <NUMBER> unique technology detect wide array pathogens clinical samples well suited pathogen discovery evaluation emerging pathogens example plexid system able determine mixed lineage swine avian human novel h<NUMBER>n<NUMBER> influenza virus pcresi technology also able identify distinguish diverse collection coronavirus species included acute respiratory syndromeassociated coronavirus <NUMBER> testing completed <NUMBER> h system designed use clinical laboratories adapted highthroughput testing although high cost instrumentation date limited use research studies wide array emerging technologies detection quantification respiratory pathogens directly clinical specimens technologies potential highthroughput testing others allow rapid nearpatient testing studies needed fully elucidate performance characteristics determine ideal clinical application goal identify tests improve diagnostic testing respiratory pathogens affect patient management decisions lead improved patient outcomes appropriate use antivirals antibiotics andor costeffective delivery care coronavirus disease <NUMBER> covid <NUMBER> infectious disease caused severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> first appeared wuhan china december <NUMBER> quickly spread worldwide outbreak declared pandemic march <NUMBER> world health organization responsible pathogen covid<NUMBER> positivesense singlestranded rna virus belonging coronaviridae family <NUMBER> vaccine approved specific treatment currently available <NUMBER> <NUMBER> even many trials progress defined mandatory mobilize research control covid<NUMBER> emergency epidemiological studies clinical characterization management infection prevention control including health care workers protection crucial role quickly identify sick people treat better estimate widely virus spread <NUMBER> knowledge diagnostic tests sarscov<NUMBER> still evolving immune response virus yet fully understood nevertheless wellknown infectious diseases host immunity certainly role fighting pathogen predicting prognosis <NUMBER> realtime reversetranscript polymerase chain reaction realtime rtpcr performed using nasopharyngeal swabs upper respiratory tract specimens ie throat swabs salivary samples commonly used test diagnosis covid<NUMBER> <NUMBER> even widely adopted gold standard method presents limitations <NUMBER> falsenegative results occur due poor quality specimen collected example sample collected inappropriate timing relation illness onset inappropriate specimen handling shipping laboratory department time false positive results due contamination technical errors unlike molecular testing detection immune response virus indirect marker infection development robust serological tests appropriate utilization essential support ongoing public health effort effective epidemic prevention <NUMBER> serological tests could used epidemiologic studies large scale population especially asymptomatic population presenting mild symptoms including ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint healthcare workers <NUMBER> theoretically determine number people exposed virus population reveal disease currently immune however date data published efficiency often controversial <NUMBER> <NUMBER> <NUMBER> immunoglobulin test measures level antibodies produced secreted b lymphocytes immune system tries protect body bacteria viruses etc immunoglobulin igm first antibody body makes fights new infection immunoglobulin g igg starts produced ensure robust longer lasting immunity <NUMBER> literature data report igm igg sarscov start detected <NUMBER> days onset infection persist period <NUMBER> years <NUMBER> <NUMBER> <NUMBER> <NUMBER> similarly first studies antibodies sarscov<NUMBER> show started detected <NUMBER> days <NUMBER> <NUMBER> <NUMBER> rd <NUMBER> th april <NUMBER> <NUMBER> asymptomatic minimally symptomatic healthcare workers submitted qualitative serological tests sarscov<NUMBER> igm igg covid<NUMBER> medical surveillance local health unit bologna order determine immunological state due contacts caused type work done considered much exposed risk infection reason previously submitted rtpcr <NUMBER> individuals already tested positive sarscov<NUMBER> rtpcr nasopharyngeal oropharyngeal samples aim evaluate performances two different ic assays submitting serological testing <NUMBER> healthcare workers previously tested positive sarscov<NUMBER> rtpcr trying find correlation molecular method considered gold standard rapid ic tests actually available finally submitted samples tested positive ic elisaclia assays evaluation ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint health professional workers samples collected collection tube containing edta venepuncture plasma immediately separated centrifugation submitted qualitative rapid serological tests due emergency availability ic testing affected difficulties find kit continuously forced use two different rapid tests two different groups individuals first part surveillance used khb® diagnostic kit sarscov<NUMBER> igmigg antibody colloidal gold second part used cellex qsarscov<NUMBER> iggigm cassette rapid test methods characterized lateral flow chromatographic immunoassay cassette format adequate volume test specimen according manufacturer instructions dispensed sample well specimen migrates capillary action along cassette immediately specimen two three drops sample diluent added area cassette incubated <NUMBER> minutes room temperature possible read result igg andor igm anti sarscov<NUMBER> present bind sarscov<NUMBER> conjugate constituting immunocomplex captured antihuman igg andor igm conjugate presence captured immunocomplex visible due precipitation coloured red band specific antibodies iggigm absent present extremely low concentrations detected test line appear except internal control line samples showed presence igg andor igm rapid testing transferred microbiology department subjected iflashsarscov<NUMBER> iggigm assay clia supplied pantec srl andor antisarscov<NUMBER> igg elisa assay supplied euroimmun italia srl determination igg igm antibody sarscov<NUMBER> remaining plasma stored <NUMBER>°c analysis ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint sampling conducted within surveillance program established emiliaromagna region require ethical approval <NUMBER> samples collected informed consent given statistical significance assessed using fishers exact test pvalue <NUMBER> considered significant showed table n <NUMBER> stratified results according time intercourse positive rtpcr ic testing without distinguishing igg andor igm positivity <NUMBER> <NUMBER> <NUMBER> samples molecular positive result came least one igm andor igg positivity ic assays moreover comparing two ic methods found significant difference p<NUMBER> moreover calculating proportion individuals showing presence antisarscov<NUMBER> igm andor igg ic rtpcr positivity khb showed sensitivity <NUMBER> much lower cellex even showed poor sensitivity <NUMBER> order eliminate possible bias due different tests used different periods calculation pvalue tried compare two ic assays period positive molecular result reducing period comparison first considered tests carried day <NUMBER> day <NUMBER> positive rtpcr literature data sarscov show development antibodies generally reach peak <NUMBER> days onset infection <NUMBER> reduced evaluation period considering ic results obtained <NUMBER> days rtpcr positivity cases significant difference p <NUMBER> used ic methods sensitivity <NUMBER> khb <NUMBER> cellex ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint period evaluation <NUMBER> <NUMBER> days sensitivity <NUMBER> <NUMBER> cellex considered period reduced day <NUMBER> day <NUMBER> rtpcr positivity even methods show great efficiency term sensitivity especially consider assays used screening epidemiological purposes need high sensitivity cellex ic test seems certainly best performances table n<NUMBER> showed specific igg andor igm positivity patterns obtained ic tests authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint system table <NUMBER>b cellex overall percentages concordant patterns ic testing results elisaclia <NUMBER> khb <NUMBER> cellex proving better performance latter anyway noticed khb system showed concordance elisaclia two igmigg samples <NUMBER> total found <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> <NUMBER> <NUMBER> patients seem develop humoral immune response uncertain well still unclear relationship antibody response clinical improvement <NUMBER> reasons reliable test data necessary better assess validity information related pandemic spread term positive cases deaths immune individuals <NUMBER> <NUMBER> <NUMBER> <NUMBER> time apparent lack systematic standardized protocols countries represents main source discrepancies mortality rates ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint study underline necessity using large scale validated testing order guarantee usefulness epidemiological field especially emergencies pandemic covid<NUMBER> lack sufficient time prevents correct validation methods use moreover must consider crossreactivity may occur due structural similarity genomic sequence conservation immunogenic proteins cov species share common structural epitopes reason also important know epitopes tests directed ie n proteinbased serological assays proteinbased assays etc <NUMBER> findings showed great discrepancy molecular ic results probably due poor sensitivity ic assays also found inconsistency immunoglobulins positivity patterns compared ic elisaclia results highlighting absolute necessity assays performance validation marketing use avoid errors results evaluation clinical epidemiological level recently confirmed circular italian ministry health qualitative rapid tests sarscov<NUMBER> antibodies detection need validation third parties relation quality chosen clinical utilization best knowledge available today currently evidence produced third parties <NUMBER> methods still development early make evaluation usefulness current epidemiology purposes <NUMBER> limitation study able calculate specificity ic assays due lack data healthcare professional workers rtpcr negative submitted serological evaluation ccbyncnd <NUMBER> international license made available authorfunder granted medrxiv license display preprint perpetuity certified peer review copyright holder preprint version posted june <NUMBER> <NUMBER> httpsdoiorg<NUMBER> doi medrxiv preprint dynamics underlie rapid spread covid<NUMBER> currently unknown <NUMBER> <NUMBER> <NUMBER> <NUMBER> however lack vaccine herd immunity paucity knowledge concerning humantohuman transmission beginning outbreak potentially important contributing factors <NUMBER> <NUMBER> remarkably many patients covid<NUMBER> may present nonspecific symptoms fever cough sore throat others may remain asymptomatic latter subjects thought significant sources propagate infection population <NUMBER> <NUMBER> <NUMBER> time report cdcs update may <NUMBER> <NUMBER> case count covid<NUMBER> usa stands <NUMBER> cases including <NUMBER> deaths indicating mortality rate <NUMBER> total count cases worldwide stands <NUMBER> cases including <NUMBER> deaths indicating mortality rate <NUMBER> <NUMBER> refer readers reference citation <NUMBER> httpswwwgooglecomsearchsxsrf alekk<NUMBER>cs<NUMBER>rzzv<NUMBER>d<NUMBER>wnlt<NUMBER>uech<NUMBER>msoma <NUMBER>qcovid<NUMBER>casecountworldwide timely update case count regional worldwide holistic approaches interrogating principles early diagnosis early isolation early prevention implemented personal national international levels several governments around globe activated national emergency alert establish infection prevention measures contain propagating effects disease healthcare organizations medical centers provide dynamically updated guidelines best alleviate impact pandemic medical personnel exchange knowledge mechanisms transmission clinical manifestations therapeutic approaches clinical diagnostics research laboratories around world work understand disease mechanisms optimize diagnostic tests develop vaccines prevention however despite incredible efforts multiple levels one certainties nothing yet certain coronaviruses covs become emerging pathogens respiratory disease epidemics prior sarscov<NUMBER> pandemic two epidemics covs occurred past two decades sarscov <NUMBER> middle east respiratory syndrome coronavirus merscov <NUMBER> <NUMBER> <NUMBER> viruses cross species barriers cause humans illness ranging mild upper respiratory infection severe acute respiratory illness mers sars indeed persontoperson transmission sarscov<NUMBER> among close family contacts coworkers even without travel history regular route infection <NUMBER> <NUMBER> covs enveloped positivesense singlestranded rna viruses nucleocapsid crownlike appearance u n e r n e l e c r n c r c p e h e u b f l orthocoronavirinae coronaviridae family classifies four genera covs alphacoronavirus alphacov betacoronavirus betacov deltacoronavirus deltacov gammacoronavirus gammacov <NUMBER> <NUMBER> sarscov<NUMBER> belongs betacov genera like merscov sarscov date seven covs known infect humans cause outbreaks variable clinical severity <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> several sequences sarscov<NUMBER> published <NUMBER> <NUMBER> <NUMBER> resources allowed researchers trace phylogenetic tree recognize strains vary according mutations <NUMBER> <NUMBER> instance recent report angeletti et al suggested spike mutation probably occurred late november <NUMBER> triggered crossing species barriers humans <NUMBER> moreover availability complete genome sarscov<NUMBER> allowed scientists develop diagnostic laboratory tests <NUMBER> <NUMBER> synthesis viral polyprotein <NUMBER>a<NUMBER>ab pp<NUMBER>app<NUMBER>ab viral rna achieved host cells sarscov<NUMBER> genome least six orfs generated specifically frameshift orf<NUMBER>a orf<NUMBER>b guides production <NUMBER>a and<NUMBER>ab polypeptides processed virally encoded proteases producing <NUMBER> nonstructural proteins nsps orfs encode structural proteins including spike membrane envelope e nucleocapsid proteins n accessory protein chains <NUMBER> <NUMBER> <NUMBER> <NUMBER> fig <NUMBER> evolving literature links virulence mechanisms covs including sarscov<NUMBER> nsps structural proteins example nsps able block host innate immunity <NUMBER> envelope e promotes viral assembly release particular information available features spike glycoproteins positioned viral surface covs guide binding host receptors determine host tropism transmission properties <NUMBER> <NUMBER> <NUMBER> monomer trimeric protein contains two subunits s<NUMBER> s<NUMBER> mediating attachment membrane fusion respectively s<NUMBER> subunit utilizes human angiotensinconverting enzyme <NUMBER> hace<NUMBER> important regulator cardiovascular system receptor infect human cells <NUMBER> <NUMBER> <NUMBER> highly conserved s<NUMBER> could selective target antiviral antis<NUMBER> agents contrast spike receptorbinding domain presents <NUMBER> amino acid identity sarscov sarscov<NUMBER>specific structural elements orf<NUMBER>b orf<NUMBER> homology sarscov finally n protein plays important role viral replication research needed determine structural components sarscov<NUMBER> underlie pathogenicity pathogenic mechanism covid<NUMBER> disease complex poorly understood clinical longitudinal studies elucidate underlying mechanisms variety clinical manifestations disease expression ace<NUMBER> lower respiratory tract believed determined natural history sars tropism infect lower respiratory tract <NUMBER> available data indicate sarscov<NUMBER> infection produces uncontrolled immune response host known cytokine storm <NUMBER> main culprit storm interleukin <NUMBER> il<NUMBER> produced activated leukocytes il<NUMBER> execute different actions large number cells tissues also stimulates production acute phase proteins play important roles thermoregulation result severe tissue damage multiorgan dysfunction clinical epidemiologic information used countries determine tested <NUMBER> usa diagnostic testing indications limited beginning outbreak secondary regulatory procedures new tests subsequently fda released policies allow laboratories use validated assays march <NUMBER> <NUMBER> centers disease control prevention cdc removed restrictive testing criteria encouraging clinicians use judgment determine whether test performed present cdc recommends two criteria testing <NUMBER> high priority category includes hospitalized patients symptoms healthcare facility workers residents longterm care facilities congregate living settings symptoms priority category includes persons symptoms suspected covid<NUMBER> infection persons without symptoms prioritized healthcare providers reason including public health monitoring screening according state local plans cdc recommend testing asymptomatic persons person identified person investigation pui covid<NUMBER> recommended clinician immediately adapt infection control prevention ppe measures addition excluding sources respiratory infection decision test based cdc guidance local epidemiological data sampling recommends collecting specimens upper respiratory tracts nasopharyngeal np oropharyngeal op swabs spontaneously breathing patients lower respiratory tract mechanically ventilated patients researchers proven np swab specimen superior op swab specimen examination sarscov<NUMBER> <NUMBER> <NUMBER> higher viral loads detected nasal area throat <NUMBER> therefore np swab preferred sampling method covid<NUMBER> diagnosis upon collection swabs placed immediately sterile transport tube containing <NUMBER> ml either viral transport medium vtm amies transport medium sterile saline <NUMBER> stored <NUMBER>°c potential risks np swabs include <NUMBER> production aerosol sampling impose infection risks healthcare workers <NUMBER> inconsistent quality np swabs collections may lead falsenegative results <NUMBER> patient may experience discomfort sampling procedure aiming address potential risks studies demonstrated efficacy less invasive routes sampling throat wash sputum collection <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> saliva collection shown yield greater detection sensitivity consistency throughout course infection compared patientmatched np samples furthermore saliva could enable selfadministered sample collection accurate largescale sarscov<NUMBER> testing <NUMBER> authors suggested potential value testing fecal respiratory specimens improve test sensitivity <NUMBER> however issue remains debate detection viral rna stool may reflect actual viral replication infection <NUMBER> top priority controlling rapidly evolving sarscov<NUMBER>associatedcovid<NUMBER> developing diagnostic test high performance use viral culture feasible option rapid diagnosis takes <NUMBER> days sarscov<NUMBER> cause obvious cytopathic changes vitro addition virus isolation requires biosafety level<NUMBER> bcl<NUMBER> facilities limited availability many medical centers serology tests yet validated moreover issue crossreactivity sarscov remains solved therefore present positive result nucleic acid testing nat using reverse transcriptionpolymerase chain reaction rtpcr gold standard diagnosing covid<NUMBER> <NUMBER> <NUMBER> <NUMBER> although assay highly specific sensitivity relatively low secondary several factors including viral load virus replication rna isolation method source timing swab collection relation disease stage <NUMBER> therefore optimization mitigate high falsenegative rate crucial goal high priority collection clinical samples subjected rna isolation timeconsuming step also extremely important avoid falsenegative results optimal protocol isolation rna would ideally provide pure rnasefree nucleic acid recover rna quantitatively across range dilutions several protocols rna isolation used different laboratory efficiency rna isolation protocols sarscov<NUMBER> stool samples discussed recent multicenter study <NUMBER> however limited data currently available regarding performance rna extraction methods different types specimens rna isolation clinical sample amplification reverse transcription polymerase chain reaction rtpcr sarscov<NUMBER>specific primers serve search viral rna sequences conserved <NUMBER> patients confirmed covid<NUMBER> diagnosis laboratory evaluation repeated confirm viral clearance prior releasing isolation <NUMBER> conserved abundantly expressed genes structural genes n e nonstructural rnadependent rna polymerase rdrp well orf <NUMBER>ab genes preferred targets sarscov<NUMBER> rtpcr assays <NUMBER> <NUMBER> traditionally two molecular targets included assay avoid potential crossreaction covs well potential genetic drift sarscov<NUMBER> among assays rdrp assay exhibited highest sensitivity <NUMBER> rna copiesreaction <NUMBER> detection probability involves two probes one probes nonspecific would detect covs whereas second probe specific sarscov<NUMBER> rdrp assays used <NUMBER> laboratories europe <NUMBER> <NUMBER> usa cdc recommends assays targeting two nucleocapsid proteins n<NUMBER> n<NUMBER> <NUMBER> recommends initial screening e gene assay followed confirmatory assay using rdrp gene <NUMBER> importantly rdrp assays designed validated using synthetic nucleic acid technology vitro transcription absence sarscov<NUMBER> isolates patient specimens <NUMBER> given high falsenegative rates additional studies covid<NUMBER> samples highlighted importance successive sampling testing sarscov<NUMBER> rtpcr <NUMBER> yuan et al reported pcr assays returned positive <NUMBER> covid<NUMBER> patients discharge <NUMBER> therefore repeated viral rtpcr testing separated <NUMBER> h essential addition parameters ddimer absolute lymphocyte count etc combined negative rtpcr test additional measures assure recovered patients released isolation protocols several rtpcr assays implemented published online https wwwwhointemergenciesdiseasesnovelcoronavirus<NUMBER> technicalguidancelaboratoryguidance one assays reverse transcripton loopmediated isothermal amplification assays known rtlamp developed park gs et al assays designed detect sarscov<NUMBER> specifically even low copy numbers without detecting human covs furthermore colorimetric detection method developed assay allowing potential use higher throughput <NUMBER> recently chan jf et al developed novel rtpcr assays covid<NUMBER> targeting different sequence rdrp hel helicasehemagglutininesterase <NUMBER> researchers validated assays using vitro system samples patients confirmed diagnosis covid<NUMBER> new rdrphel assay exhibited higher sensitivity specificity without crossreactivity common respiratory viruses authors speculated new rdrphel assay might employed detecting covid<NUMBER> cases low viral loads particularly samples upper respiratory tract saliva plasma used testing moreover proposed using assays serial monitoring viral load plasma covid<NUMBER> patients detect cases sarscov<NUMBER> rnaemia circulating viral rna blood thereby inform prognostic treatment decisions serologic assays urgently needed <NUMBER> infection prevention measures including identifying viral sources <NUMBER> epidemiologic serosurveillance studies infer burden disease taking account rate asymptomatic infection extent disease transmission households <NUMBER> analyzing results vaccine trials therapeutic antibodies however exceptions <NUMBER> validated serologic assays relatively lacking present lateral flow assays sarscov<NUMBER> igm igg antibodies may potentially useful assessing burden covid<NUMBER> infection however important limitations exist including low specificity igm responses delayed seroconversion specific igg responses therefore assays cannot used acute diagnostics may represent indirect indication covid<NUMBER> infection best utilized confirm late covid<NUMBER> cases retrospectively assess immunity healthcare providers pandemic addition useful predict patient would benefit repeat testing selfisolation targeted therapies covid<NUMBER> <NUMBER> <NUMBER> finally noted convalescent plasma immunoglobulincontaining fractions obtained recovered covid<NUMBER> cases successfully used treat patients active covid<NUMBER> disease <NUMBER> <NUMBER> spike nucleocapsid proteins main immunogens sarscov<NUMBER> <NUMBER> okba nma et al established serologic assays detection sarscov<NUMBER> neutralizing spike proteinspecific nucleocapsidspecific n antibodies using serum samples patients pcrconfirmed sarscov<NUMBER> infection <NUMBER> investigators validated various antigens using elisa platforms found patients sarscov<NUMBER> infection seroconverted <NUMBER> weeks beginning illness particularly s<NUMBER> subunit specific s<NUMBER> detecting sarscov<NUMBER>specific antibodies finding could explained higher conservation s<NUMBER> subunit covs relative s<NUMBER> therefore s<NUMBER> identified specific antigen sarscov<NUMBER> serology testing remarkably validation s<NUMBER>specific iga igg elisa assays two different groups revealed igabased elisa sensitive igg elisa showed higher specificity iga elisa furthermore compared iga igg longer lasting patients thus preferred serology studies date studies addressed crossreactivity nonspecific proteins lead falsepositive result studies optimization elisa assays necessary frequency detecting antibodies n protein covid<NUMBER> patients indicates n protein may useful immunodominant antigen early diagnosis covid<NUMBER> disease <NUMBER> <NUMBER> <NUMBER> testing antibodies n protein investigators relied high degree similarity sarscov sarscov<NUMBER> proteins estimated <NUMBER> develop new elisa assay sarscov n protein used antigen using <NUMBER> different validated elisas investigators demonstrated higher antibody levels associated severity infection furthermore showed nspecific igg seroconversion occurs second week beginning symptoms remarkably compared s<NUMBER> elisas n protein elisas showed higher sensitivity detecting antibodies mildly infected patients stronger correlations plaque reduction neutralization test however observation requires confirmation larger cohort patients different levels disease severity precisely monitor timing seroconversion even mildly symptomatic patients antibodies two different antigens tested decrease falsenegative results serial disease monitoring studies <NUMBER> welldefined standard references developed standardize serologic assays developed different laboratories account interassay variability unify data interpretation tools different studies finally research efforts currently focused developing vaccine sarscov<NUMBER> validation standardization serologic testing crucial evaluating vaccine immunogenicity effective induction antibody responses prevention rapid antigen assays emerging new class tests used sarscov<NUMBER> pandemic assays designed detect particles viral proteins nasal swabs quickly using simple qualitative semiquantitative vitro diagnostic procedure performed either lab local point care give results within <NUMBER> h <NUMBER> rapid antigen assays currently validated enhance clinical laboratories capacity match urgent need rapid covid<NUMBER> detecting response pandemic first emergency used authorization issued us food drug administration fda quidel corporation sofia <NUMBER> sars antigen fia may<NUMBER> <NUMBER> <NUMBER> test authorized use clia clinical laboratory improvement amendments certified laboratories rapid tests currently validated fda list important advantage antigen test speed test lower cost high specificity however high falsenegative rate due lower sensitivity therefore negative result rapid antigen test requires confirmation pcr test prior formalizing isolation treatment decisions mentioned previously main culprit uncontrolled excessive immune reaction sarscov<NUMBER> il<NUMBER> found increase particularly symptomatic exacerbation covid<NUMBER> disease common molecular laboratory findings early stage covid<NUMBER> disease include decreased white blood cells lymphocytes platelets well metablic acidosis elevated lactate dehydrogenase ldh elevated liver transaminases muscle enzymes reactive protein c addition laboratory indicators systemic shock ards disseminated intravascular coagulopathy reported severely ill patients notably lymphopenia elevated ldh appear negative prognostic factors procalcitonin value reported normal several covid<NUMBER> cohorts <NUMBER> <NUMBER> descriptive data obtained retrospective analysis covid<NUMBER> patients clinical records current literature lacking pathogenic mechanisms clinical preclinical pathological research elucidate pathophysiology underlying various manifestations disease pathomechanisms pneumonia covid<NUMBER> disease poorly understood data available histopathological slides indicate pulmonary edema primary respiratory origin thick proteinaceous exudates consisting large protein globules associated hyperplasia pneumocytes additionally vascular engorgement interstitial inflammatory process involving fibrinoid material multinucleated tissue macrophages reported <NUMBER> current literature evidence indicates <NUMBER> patients positive chest computed tomographic ct findings consistent covid<NUMBER> infection prior positive rtpcr test results <NUMBER> <NUMBER> pulmonology findings chest ct images prominent approximately <NUMBER> days onset disease including bilateral pneumonia noted <NUMBER> cases lung abnormalities include ground glass opacities lobular wall thickening notably progressive consolidation take place <NUMBER> weeks fibrotic bands recognized upon resolution symptoms addition reactive lymphadenopathy resolved within <NUMBER> month noted cases remarkably radiology findings reported change dynamically short period time light high falsenegative result rate nucleic acid testing nat using rtpcr technology thoracic ct imaging become critical diagnostic tool combination close monitoring clinical features epidemiological data covid<NUMBER> confirmation management recently fang et al reported sensitivity ct <NUMBER> exceeded rtpcr <NUMBER> diagnosing covid<NUMBER> <NUMBER> therefore several reports suggested suspected covid<NUMBER> patient pui prematurely cleared quarantine ppe measures discontinued one negative result rtpcr testing <NUMBER> <NUMBER> rather patients symptoms chest ct images laboratory parameters taken account inform clinical decision regarding management ppe measures evaluating need repeating diagnostic test although several studies described imaging features covid<NUMBER> clinical stratification pulmonology abnormalities correlation disease course need conducted future data may lead identification prognostic matrix disease incredible efforts made contain global crisis aggressively testing healthcare systems worldwide infection prevention control officers tasked maximum capacities flatten curve covid<NUMBER> spread clinicians intensely challenged limited therapeutic options specific targets disease scientists full speed develop diagnostic testing vaccines new therapies laboratory investigations determine structural elements sarscov<NUMBER> underlie pathogenicity needed identify diagnostic therapeutic targets longitudinal clinical preclinical studies tasked explain heterogenous clinical manifestation covid<NUMBER> disease prospective longitudinal studies clinical trials necessary understand disease epidemiology clinical course evaluate potential vaccines prevention efficacy specific therapies must acknowledged overview based initial clinical scientific reports date paucity information regarding impact cardiovascular system congenital heart defects population <NUMBER> current therapeutic approaches deal infection mainly symptomatic basic life support measures prevention aimed reducing humantohuman transmission remains best option sir since december <NUMBER> novel coronavirus sarscov<NUMBER> emerged cause pandemic disease known coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> february <NUMBER> th <NUMBER> outbreak began italy presently worlds worst affected country <NUMBER> diagnosis covid <NUMBER> based molecular test aimed detect virus rna respiratory samples nasopharyngeal swabs ns bronchial aspirate ba <NUMBER> imperfect gold standard give false negatives amount viral genoma insufficient correct timewindow viral replication missed <NUMBER> testing igm igg production response viral infection might simple method enhance detection sensitivity accuracy molecular test <NUMBER> addition may used screening purpose assess antibody profiles large population largescale screening programs using antibody tests currently evaluation different governments recently test rapid detection combined igg igm antibodies sarscov<NUMBER> human blood serumplasma become available <NUMBER> soon kits commercially available assessed reliability usefulness <NUMBER>ncov iggigm antibody rapid <NUMBER> <NUMBER> patients suspected covid <NUMBER> suggestive radiologicalclinical findings negative molecular tests <NUMBER> <NUMBER> asymptomatic controls negative molecular tests patients molecular testing using ns ba arrived emergency room covid <NUMBER> symptoms sarscov<NUMBER> rna samples detected realtime reverse transcriptase quantitative pcr rtpcr assay according guidelines <NUMBER> qualitative assessment igg igm performed using rapid immunochromatographic assay hospital stay confirmed cases upon admission emergency room suspicious cases following manufactures instruction response obtained within <NUMBER> minutes using <NUMBER>µl blood test allowed detection single antibody combinations presence absence antibody expressed respectively group confirmed covid <NUMBER> mean age <NUMBER>±<NUMBER> yrs two patients intubated severe disease <NUMBER> treated non invasive ventilation andor <NUMBER> therapy time symptoms onset antibody testing ranged <NUMBER> <NUMBER> days overall seroconversion rate igm igg <NUMBER> <NUMBER> four confirmed cases negative igm igg igmigg among two patients tested day <NUMBER> <NUMBER> symptoms onset since recent report showed median time igm igg detection symptoms onset <NUMBER> <NUMBER> days respectively <NUMBER> reasoned two likely early tests excluding two remaining patients median time <NUMBER> days symptoms onset conversion rate <NUMBER> group suspected covid <NUMBER> mean age <NUMBER>±<NUMBER> yrs <NUMBER> yrs old man considered highly probable case igm igg <NUMBER> days symptoms onset two negative molecular tests based consistent clinicalradiological antibody test findings admitted properly treated covid <NUMBER> remaining <NUMBER> patients suspected covid <NUMBER> two three negative molecular testis na confirmed negative tests bronchial aspirate consistently igmigg healthy controls igmigg overall including <NUMBER> tests concordance rtpcr antibody test <NUMBER> table <NUMBER> cohens k <NUMBER> substantial agreement considering molecular test gold standard diagnosis sensitivity specificity antibody test <NUMBER> <NUMBER> respectively reason two patients confirmed covid <NUMBER> negative iggigm time seroconversion already expected remains unclear one <NUMBER> yrs old woman immunesenescence explain finding however patient young immunocompetent must consider issue related test performance eg lower limit detection correct timing detect igm igg response infection sarscov<NUMBER> far unclear studies available divergent results <NUMBER> <NUMBER> preliminary data suggest rapid iggigm test reliable evidencing seroconversion long testing performed <NUMBER> days symptoms onset finding confirmed larger sample test could putative mean assessing population immunization group suspected covid <NUMBER> anyway small found mainly consistency negative molecular negative antibody test however antibody test performed earlier compared group confirmed disease median <NUMBER> days vs <NUMBER> days may biased results test patients opinion antibody test quite reliable useful since advantage pointofcare test gives response within minutes patients presenting discrepancy clinicalradiological feature molecular test rapid antibody detection might additional element helping clinician make correct diagnosis true long test performed within first days symptoms onset indeed studies granted investigate diagnostic screening value test coronavirus disease <NUMBER> covid<NUMBER> latest pandemic gaoling humanity high spreading rate approximately <NUMBER> mortality worldwide novel beta coronavirus enveloped nonsegmented positive sense rna virus severe acute respiratory syndrome coronavirus<NUMBER> sarscov<NUMBER> genome structure comprises single stranded rna nucleocapsid protein enclosed membrane proteins envelope proteins spike glycoproteins <NUMBER> fig <NUMBER> coronavirus sarscov<NUMBER> high similarity viruses like sarscov merscov <NUMBER> entry novel coronavirus host interaction densely glycosylated spike proteins receptors host cell membrane spike glycoprotein trimeric class fusion protein consisting s<NUMBER> s<NUMBER> domains <NUMBER> reported <NUMBER> similarity s<NUMBER> domain spike glycoproteins among sarscov<NUMBER> sarscov <NUMBER> similarity case s<NUMBER> domain evident sarscov<NUMBER> infect human respiratory epithelial cells interaction spike protein human ace<NUMBER> receptor <NUMBER> coronaviruses large rna viruses <NUMBER> nm diameter come coronaviridae family nidovirales order normally coronavirus genome contains six open reading frame orfs encodes structural well accessory proteins virus nucleocapsid protein nprotein coronavirus binds rna genome forms capsid around enclosed nucleic acid function nprotein includes interaction membrane protein viral assembly assists rna synthesisfolding affects host cell responses including cell cycle translation structural accessory proteins essential viral replication genome maintenance pathogenesis virus <NUMBER> currently available invitro diagnostic techniques broadly classified <NUMBER> nucleic acid based assays <NUMBER> serological assays described present widely used approved test diagnosis covid<NUMBER> polymerase chain reaction pcr two different strategies use pcr based assays reverse transcriptase pcr rtpcr loop mediated isothermal amplification pcr lamp pcr methods offer high sensitivity <NUMBER> specificity covid<NUMBER> diagnosis methods focusing direct amplification virus genetic material rtpcr quantitative nature whereas lamp pcr qualitative compared rtpcr lamp pcr cost effective less time consuming high throughput screening another nucleic acid detection technology costly high equipment dependency making less widely used even though aforementioned methods offer nearly <NUMBER> accurate result improper sample collection handling transportation may lead false negative results obviously decreasing sensitivity assay rtpcr common effective method used market detect sarscov<NUMBER> rtpcr reverse transcriptase converts virus rna cdna following amplification millions copies dna using set specific primers probes amplification taking place <NUMBER> steps <NUMBER> denaturation <NUMBER> annealing <NUMBER> elongation three steps take place <NUMBER>°c <NUMBER> <NUMBER>°for <NUMBER> <NUMBER>°c <NUMBER> respectively primers target amplify different regions sarscov<NUMBER> nucleocapsid protein n gene envelope protein e gene orf<NUMBER>ab gene regions determined within cycle separately confirmatory testing <NUMBER> turnaround time sample analyses <NUMBER> h onestep rtpcr assay detect e gene rnadependent rna polymerase rdrp gene regions sarscov<NUMBER> developed tibmolbiol <NUMBER> predominantly upper respiratory samples including nasopharyngeal swabs oropharyngeal swabs recommended analysis many breakthrough assays developed various ivd manufacturers including abbott bosch cepheid specific gene sarscov<NUMBER> detected within minutes although rtpcr widely used confirmatory test covid<NUMBER> technique robust performed skilled analysts due various biological safety hazards making sample detection cumbersome many cases <NUMBER> even though rtpcr robust technology many factors contributing falsepositive falsenegative results mutations primers targeting virus genome lead false negative results laboratory practices safety procedures including collection transportation handling also contribute false negative results <NUMBER> sampling timing optimum sample types play significant role obtaining highly sensitive highly specific results <NUMBER> pcr assays two different regions genes targeted hence result interpretation positive negative inconclusive genes amplified result positive one gene positive called inconclusive negative could false negative inconclusive negative persons treated doubtful efforts minimizing length entire pcr process practice isothermal amplification resulted development loopmediated isothermal amplification lamp highly specific isothermal amplification technique analytical limit detection <NUMBER> copies per lamp conversion rna dna followed amplification sample genome using <NUMBER> primers forward inner primer forward outer primer reverse inner primer reverse outer primer targeting different regions dna <NUMBER> lamp several advantages rtpcr considered user friendly easy detection speed less background signal compared rtpcr addition speed lamp shows high level specificity high amplification efficiency rtpcr <NUMBER> recently developed chitra gene lampn sree chitra thirunal medical institute technology collaboration agappe diagnostics ltd detects two different regions n gene turnaround time <NUMBER> min analysis <NUMBER> samples remarkable achievement however stringent evaluations commercial lamp kits needed accuracy check processing large samples impetus covid<NUMBER> testing apart rtpcr lamp united states centers disease control prevention cdc approved onestep real time reverse transcriptase polymerase chain reaction rrtpcr quantitatively detect viral particles <NUMBER> samples within <NUMBER> min <NUMBER> recently specific high sensitivity enzymatic reporter unlocking sherlock allows multiplexed portable ultrasensitive detection rna detection strategy used combat sarscov<NUMBER> cas<NUMBER>a ribonucleases used rna sensing binds amplified rna activated cleaves fluorophorequencher probes emitting fluorescence sherlock previously used detect clinical samples zika virus <NUMBER> nevertheless need optimisation technique larger samples achieve large scale evaluation sarscov<NUMBER> though rrtpcr considered gold standard clinical diagnosis covid<NUMBER> limitations pandemic screening isolation infected patients way reduce spread covid<NUMBER> rtpcr testing directly look presence viral dna serological tests detect presence antibodiesantigens human blood covid<NUMBER> hence rtpcr give positive results <NUMBER> days infection serological test take <NUMBER> days give positive results test cost testing time pcr based assays inevitably demands development rapid serology tests <NUMBER> <NUMBER> <NUMBER> several immunoassays developed various ivd companies detecting covid<NUMBER> infection serum plasma whole blood among strategies lateral flow immunoassays elisa chemiluminescence promising approaches limitation rrtpcr detect covid<NUMBER> past infection progress disease increases importance serological assays serological tests detect active past infections tests performed within correct time frame onset disease case antibody detection assay igg igm antibodies covid<NUMBER> target analytes igm appears blood within week time igg expression take <NUMBER> days apart antibody detection antigen detection spike glycoprotein nucleocapsid protein also development offers early detection covid<NUMBER> infection case rtpcr one important reasons false negative results improper sampling throat swab transport whereas sample choice serological test serumplasmawhole blood easy handle transport serological tests like lfia antigenantibody detection used rapid test point care testing offers quick screening patients limited expertise <NUMBER> detecting antibody titre important convalescent plasma therapy development vaccines covid<NUMBER> apart serological testing would also provide valuable information regarding course degree immune response well durability immunity infected individuals participants vaccine clinical trials <NUMBER> lfia utilized preliminary testing tool covid<NUMBER> case community spread mass population screening present covid<NUMBER> iggigm antibody evaluation kits based lfia widely available market upon covid<NUMBER> infection igm igg antibodies start develop body <NUMBER> days <NUMBER> days respectively though igm detected earlier also decreases disappears earlier igg persist long time infection even though antibody test kits reliable preliminary screening test cannot used confirmatory test nonspecific interaction antibodies proteins blood capture detector molecules membrane may results false positive false negative results <NUMBER> main advantages lfia used rapid poc test detected using fingerpricked blood serumplasma require instruments expertise staff carrying test gives result <NUMBER> min <NUMBER> lfia antibody test covid<NUMBER> also considered prognostic tool provides information immune status patient mostly lfia results qualitative made quantitative use customized color readers currently covid<NUMBER> antigen lfia test development offer sensitive specific result covid<NUMBER> diagnosis detect viral antigen <NUMBER> days infection <NUMBER> enzyme linked immunosorbent assay elisa chemiluminescence immunoassay clia elisa clia platforms widely using serology techniques quantitative detection specific antigen antibody samples zhang et al developed enzyme linked immunosorbent assay detection covid<NUMBER> igm igg antibody serum sample sarscov<NUMBER> rp<NUMBER> nucleocapsid protein adsorbed surface <NUMBER> well plate capture molecule antiigg antibody conjugated horse radish peroxidase used detector molecule <NUMBER> manual elisa kits detecting covid<NUMBER> developed ivd manufactures like ibl international drg diagnostics gmbh epitope diagnostics euroimmun detecting igg igm antibodies developed response covid<NUMBER> infection <NUMBER> elisa clia based covid<NUMBER> antigen detection kits development ivd manufacturers worldwide automated clia method also detect igg igm antibody serum plasma advantages automated clia analyzers compared rapid lfia tests high throughput samples ability detect biomarkers like creactive protein simultaneously <NUMBER> dzlite sarscov<NUMBER> clia developed diazyme usa maglumi clia developed snibe china chemiluminescent analyzers detect igg igm antibodies covid<NUMBER> besides aforementioned specific tests certain routine biochemical haematological tests show abnormal results covid <NUMBER> patients upon covid<NUMBER> infection level prothrombin time lactate dehydrogenase ldh ddimer alanine transaminase alt creactive protein crp erythrocyte sedimentation rate esr creatine kinase elevated <NUMBER> marked lymphopenia depletion cd<NUMBER> cd<NUMBER> lymphocytes early phase disease disease progress patients show higher levels interleukin<NUMBER> il<NUMBER> il<NUMBER> il<NUMBER> granulocyte colonystimulating factorgcsf interferon gammainduced protein monocyte chemotactic protein <NUMBER> mcp<NUMBER> macrophage inflammatory protein alpha tumour necrosis factora tnfa also noted patients intensive care show significant increase amylase ddimer case non survivors marked elevation level ferritin blood urea neutrophil count ddimer creatinine levels procalcitonin pct elevated covid <NUMBER> procalcitonin level used differential diagnosis covid <NUMBER> bacterial pneumonia <NUMBER> <NUMBER> level crp starts rise time mild pneumonia reaches peak severe pneumonia crp also used marker inflammation rise correlates level inflammation regardless factors age sex physical condition reported crp levels positively correlated lung lesions early stage covid <NUMBER> cases used key indicator disease monitoring <NUMBER> <NUMBER> nucleic acid based diagnostics methods serological assays described serving strong diagnostics tools covid<NUMBER> diagnosis assurance quality developed diagnostics kits prime importance scenario even though recently many developments happened field serological diagnosis covid<NUMBER> still many concerns regarding sensitivity specificity assays complexity cost effectiveness limitations nucleic acid based diagnostic tools impetus innovative development well standardized high sensitive specific low cost serological assays covid<NUMBER> diagnosis recently novel coronavirus first reported cause lethal pneumonia humans interperson transmission china <NUMBER> subsequent molecular studies confirmed origin transmissible pneumonia due novel coronavirus named sarscov<NUMBER> causing new corona virus disease covid<NUMBER> <NUMBER> covid<NUMBER> disease rapidly spread asian european countries italian governmenthad take drastic measures contain outbreak actions rolled outhave included establishing strict criteria define patients whomoropharingeal swabsshould collected molecular pcr diagnosis covid<NUMBER> quarantine individualswho may contacted infected people <NUMBER> measures active since <NUMBER> weeks trend new sarscov<NUMBER> infected casesin italy still increasing <NUMBER> new casesdaily <NUMBER> several attempts made interpret epidemiological trend covid<NUMBER> italy experts pinpointed importance limited possibilityof making early diagnosis infection <NUMBER> well impossibility detect asymptomatic subjects carrying virus <NUMBER> rtpcr test identificationof viral nucleic acid current standard diagnostic method diagnosis covid<NUMBER> however assay practical limitations <NUMBER>such annoying method obtain biological material nasopharynx relatively long time generate results need certified laboratories specific expertise limitations make rtpcr unsuitable quick simple patient screening therefore search precise rapid simple test quickly identify sarscov<NUMBER> infected patients large scale screening become urgent prevent virus transmission ensure timely treatment patients saw swee hock school public health national university singapore httpssphnusedusgwpcontentuploads<NUMBER>covid<NUMBER>sciencereportdiagnostics<NUMBER>marpdf recently reviewed diagnostic test covid<NUMBER> infection currently undergoing clinical validation listing dozens assays based rtpcr realtimepcr ngs microfluidics twelve immunoassays based evidence covid<NUMBER> related igg andigmwere also listed latter experimental attempt based previous experiences epidemic viral sars infection argued igm specific sarscov<NUMBER> antibody could detected blood <NUMBER> days iggsome days later <NUMBER> also speculated since sarsall rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint cov<NUMBER> belongs large family viruses caused mers sars epidemics antibody seroconversion similar <NUMBER> previously mentioned report singapore national university immunoassay described available information regarding sensitivity specificity vivadiag tm kit produced jiangsu medomics medical technologies kit httpswwwvivachekcomvivachekenglishprodsprodcovid<NUMBER>html according preliminary data available <NUMBER> may potential candidate reliable rapid <NUMBER> minutes testing test reported based utilization antihuman igg anti igm recombinant antigen representing receptorbinding domain covid<NUMBER> spike protein based assumptions designed study verify clinical information serological vivadiag tm test provide compared standard rt pcr lab test sarscov<NUMBER> andregarding clinical outcome patientsto purpose set upa prospective monoinstitutional ad hoc blind independent study enrolling series <NUMBER> patients march <NUMBER> rd march <NUMBER> th consecutive cohort <NUMBER> patients access emergency room ospedale policlinico consorziale bari covid<NUMBER> disease orientingsymptoms enrolled patients received oropharingeal swap standard sarscov<NUMBER> rtpcr analysis simultaneously venous blood sampling vivadiag tm test performance registries main clinical information comprising timing appearance symptoms collected togheter informed consent oropharingeal swap samples suddenly analyzed sarscov<NUMBER> rtpcr laboratory molecular epidemiology public health hygiene unit policlinico hospital bari italy regional reference laboratory sarscov<NUMBER> identification venous blood sampled analyzed clinical pathology laboratory certified iso<NUMBER>head e savino institutional biobank certified iso<NUMBER>head paradiso istituto tumori g paolo ii irccs bari study approved ethical committee istitutotumori g paolo ii irccs bari protocol number ce <NUMBER> nasopharyngealoropharyngeal swabs weresubjected nucleic acid extraction magna pure roche diagnostics mannheim germany according manufacturers instructions presence e gene rdrp gene n gene sarscov<NUMBER> virus identified commercial realtime pcr assay allplex<NUMBER>ncov assay seegene seoul republic korea samples rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint considered positive molecular screening three genes detected moreover realtime rrtpcr protocol used confirm presence sarscov<NUMBER> httpswwwwhointdocsdefaultsourcecoronaviruseuscdcrtpcrp n e l f r e e c n n r u c n p f f v r n <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> <NUMBER> sarscov<NUMBER> rapid iggigm test sarscov<NUMBER> rapid iggigm vivadiag tm test combined antibody test kit designed manufactured jiangsu medomics medical technologiesthe test based lateral flow qualitative immunoassay rapid determination presence absence antisarscov<NUMBER>igm antisarscov<NUMBER>igg human specimens whole blood serum plasma surface antigen sarscov<NUMBER> specifically bind sarscov<NUMBER> antibodies including igm igg conjugated colloidal gold nanoparticles sprayed conjugation pads sarscov<NUMBER> rapid iggigm combined antibody test strip two mouse antihuman monoclonal antibodies antiigg antiigm stripped two separated test lines testing <NUMBER>ul specimen added sample port followed addition sample dilution buffer specimen flows device antisarscov<NUMBER> igg igm antibodies present specimen bound sarscov<NUMBER> antigen labeled gold colorimetric reagent fixed conjugate pad conjugated sample continues travel strip antisarscov<NUMBER> igm antibodies bound migm line anticovid<NUMBER> igg antibodies bound g igg line specimen contain sarscov<NUMBER> antibodies labeled complexes bind test presence sarscov<NUMBER> igg igm antibodies indicated redpurple line specific region indicated deviceeach test evaluated two operators picture taken case disagreement picture evaluated third party performance thevivadiag tm tests compared rtpcr tests via caret r package computed parameters needed accuracy precision recall kappa univariate multivariate logistic regression performed age dichotomized using median cutoff days onset symptoms also transformed categorical variable <NUMBER> days <NUMBER> days <NUMBER> days <NUMBER> days <NUMBER> days analyses carried outin r v<NUMBER> <NUMBER> results considered significant pvalue <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint <NUMBER> subjects enrolled study sarscov<NUMBER> rtpcr test rapidiggigm test performed cohort median age <NUMBER> years <NUMBER> male presented emergency room different times onset symptoms description symptoms wasavailable <NUMBER> the<NUMBER> patients fourteen subjects <NUMBER> asymptomatic time came emergency room <NUMBER> patients <NUMBER> positive sarscov<NUMBER> rtpcr tests <NUMBER> <NUMBER> positive serum igmiggtests compared rtpcrtest serological test showed accuracy <NUMBER> <NUMBER>ci <NUMBER> sensitivity <NUMBER> specificity <NUMBER> cohens kappa value <NUMBER> whose strength agreement according altman <NUMBER> considered fair notably<NUMBER> patients <NUMBER> positiveserological testsbut negative rtpcrresult distribution percentage positive results detected tests broken days symptom onset shown figure <NUMBER> aclear increase inpositive serological tests observed days elapsed symptom appearance reaching <NUMBER> <NUMBER> days symptom onset conversely highest likelihood positive rtpcr test resultwas seen<NUMBER> days symptom onset decreased point time amongstthe asymptomatic individuals<NUMBER> positive rtpcr test result while<NUMBER> serological test one analysis regardingthe behavior igm iggaccording time symptom onset described figure <NUMBER> minimal differences behavior two immunoglobulins respect tothe time symptom appearance became evident however <NUMBER> patients withvivadiag tm positive test negative rtpcr result <NUMBER> positive igm <NUMBER> subjects resulted positive igg univariate multivariate logistic regressions performedto look independent variables predictive positive vivadiag tm rtpcr test results table <NUMBER> univariate multivariate analysesshowed age<NUMBER>years <NUMBER> days symptom onset significantly associated vivadiag tm positivity <NUMBER> days symptom onset related positive rtpcr test result clinical relevance socalled rapid serological testing still open issue since data currently available still scarce <NUMBER> reason analyzed performance compared standard rtpcr testing respect time onset covid<NUMBER> related symptoms end set monoall rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint institutional consecutive cohort patients tested assays single qualified laboratory design study allowed us specifically analyze two aspects open issue concordance rapid serological test standard molecular testing trend immunoglobulinsiggigmexpression respect onset clinical symptoms regarding degree concordance two tests results reported table <NUMBER> clearly show precision rapidserological test vivadiag tm unsatisfactory notably <NUMBER> patients covid<NUMBER>positive molecular test also positive serological test figure impressively similar performances reported serological tests spain <NUMBER> germany <NUMBER> however first important information study concerns <NUMBER> cases tested negative molecular test positive serological results two tests produce similar results would obvious assays look different aspects covid<NUMBER> fact molecular test demonstrates presence sarscov<NUMBER> virus samples specific anatomical parts respiratory system kinetics immunoglobulinsis devoted describe body reacts viral infection negative serological test results patients positive molecular test could mean latter infected subjects yet reached stage developing immunoglobulin reaction conversely subjects whose serological tests show presence specific igg andor igm antibodies negative molecular tests may considered recovering covid<NUMBER> data shown figure <NUMBER> seem confirm assumptions molecular test yielded positive results early symptomatic phases disease serological test performed better late phases disease ie <NUMBER> days symptom appearance second aspect able analyze study regarded seroconversion kinetics immunoglobulins respect onset covid<NUMBER> related symptoms figure <NUMBER> shows behavior two immunoglobulins respect symptom appearance interestingly igg igm seem behave differently based number days elapsing symptom appearance display clear progressive increase along course disease unexpected finding contrast common thinking concerning kinetics two immunoglobulins supported results reported zhang <NUMBER> lou <NUMBER> reportingthat detectable serology markers igg igm similar seroconversion covid<NUMBER> patients antibody levels increasing rapidly starting <NUMBER> days post exposure trend occurred concomitant decline viral load behavior <NUMBER> day time window rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint symptom appearance accompanied improvement serological test sensitivity compared standard molecular testing study important limitations firstly vivadiag tm test based colorimetric evaluation igg igm bands operator thus implying limitations qualitative interintraoperator evaluation produce terms variability <NUMBER> study aspect partially solved resorting double operator evaluation taking picture test results reanalyzed third party case first level evaluation disagreement however regard next step research overcome issues metwill use quantitative immunoenzymatic methods analyze sarscov<NUMBER> specific immunoglobulins <NUMBER> limitation study regarded fact neutralizing antibodies used vivadiag tm test might crossreact coronavirus antigens like sarscov recombinant antigen utilized vivadiagis receptor binding domain sarscov<NUMBER> spike protein information possible crossreactivity corona flu viruses yet studied <NUMBER> studies urgently needed definitely clarify point study analyzed theclinical performance rapid serological test vivadiag tm confirmedthe tests limited applicability diagnosis sarscov<NUMBER> infection compared standard molecular testing however rapid serological test seems provide important information concerning immunoreaction individuals infection importantly may detect previous exposure virus currently healthy persons trial recently registered clinicaltrialgov nct<NUMBER> specifically addresses issue planning investigate monitoringof seroconversion covid<NUMBER> iggigm healthy subjects may develop covid<NUMBER> related symptoms <NUMBER> <NUMBER> rights reserved reuse allowed without permission authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint authorfunder granted medrxiv license display preprint perpetuity authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed authorfunder granted medrxiv license display preprint perpetuity copyright holder preprint peerreviewed httpsdoiorg<NUMBER> doi medrxiv preprint december <NUMBER> numerous cases pneumonia unknown etiology reported <NUMBER> wuhan china <NUMBER> january novel causative virus named sarscov<NUMBER> identified <NUMBER> spread chinese regions countries causing world pandemic <NUMBER> <NUMBER> <NUMBER> clinical presentation disease named coronavirus disease <NUMBER> covid<NUMBER> <NUMBER> varied asymptomatic mild flulike symptoms severe bilateral pneumonia acute <NUMBER> respiratory distress death rapid replication virus within first <NUMBER> hours <NUMBER> infection relatively high <NUMBER> reproduction number described <NUMBER> <NUMBER> available viral genome sequences allowed soon recognize close relationship recombination thus donating genomic plasticity <NUMBER> furthermore rna <NUMBER> biosynthesis seems use virusspecific template switch results transcription <NUMBER> subgenomic mrnas eventually leading homologous rna recombination <NUMBER> <NUMBER> nevertheless encoding <NUMBER>exoribonuclease within nonstructural protein <NUMBER> nsp<NUMBER> exon required highfidelity replication mutation capacity sarscov<NUMBER> <NUMBER> debated <NUMBER> end somehow plasticity allowed coronaviridae acquire rich <NUMBER> strains biodiversity ability jump species already caused previous zoonotic <NUMBER> outbreaks merscov sarscov <NUMBER> <NUMBER> starting observed similarities short region rdrp gene sarscov<NUMBER> <NUMBER> bat coronavirus batcovratg<NUMBER> sequences identified <NUMBER> identical <NUMBER> wholegenome level corroborating hypothesis animals humans spillover <NUMBER> june <NUMBER> <NUMBER> million cases covid<NUMBER> declared including rna extraction methods generally classified onestep rt step <NUMBER> pcr reaction tube ii twosteps rtpcr initial creation dna copies <NUMBER> rt reaction followed addiction pcr reaction typically onestep pcr table <NUMBER> allow improve sensitivity <NUMBER> tat also sometimes increase costs despite good performance validated naats still risk false negative <NUMBER> results concern preanalytic setting timing specimen <NUMBER> collection early late infection course including limit detection due <NUMBER> late infections atypical manifestations quality sampling insufficient material <NUMBER> type specimens bronchoalveolar lavage bal exhibits highest sensitivity followed <NUMBER> induced sputum nasopharyngeal np swab oropharyngeal op swab feces finally <NUMBER> sample transport inappropriate container exposure extreme temperatures etc <NUMBER> <NUMBER> sensitivity specificity serological assays also affected target antigen <NUMBER> highlighted meyer colleagues protein produced advanced stage <NUMBER> sarscov<NUMBER> infection showed lower levels sensitivity specificity especially <NUMBER> s<NUMBER> subunit compared n protein <NUMBER> noteworthy recently observed coste <NUMBER> et al data shown antibodies directed n protein seems decrease <NUMBER> earlier protein thus sensitivity assays targeting n protein may <NUMBER> impaired according timing infection figure <NUMBER> reason recommend <NUMBER> systematically use two tests one targeting protein one targeting n protein <NUMBER> diagnostic purposes seroepidmiological studies test targeting protein <NUMBER> recommended added value target protein titers likely better reflect <NUMBER> protection reinfection table <NUMBER> summarized interpretation diagnostic assays sensitivity greater <NUMBER> specificity superior equal <NUMBER> <NUMBER> used well naats different platforms considered also serological tests interestingly appearance igm occurs time igg thus main <NUMBER> advantage also test igm assess timing infection table <NUMBER> <NUMBER> serological assays represent useful epidemiological asset naats remains <NUMBER> gold standard diagnosis due high sensitivity even early stages disease samples like blood urines found weaklytonone sensitive virus <NUMBER> also found feces perineal swabs patients gastrointestinal symptoms <NUMBER> <NUMBER> 